data_2kfu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kfu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 92.2 t -102.24 137.38 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.272 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 12.6 t80 174.08 159.77 0.16 Allowed 'General case' 0 C--O 1.213 -0.859 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.505 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.676 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 10.4 tpt85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.444 -0.761 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.4 42.98 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 72' ' ' LEU . 5.1 mp -148.38 139.24 23.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 101' ' ' PHE . 3.6 mp -85.87 135.21 33.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 68' ' ' SER . 3.8 p -125.23 128.57 72.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.158 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 1.5 m -73.11 109.89 5.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HZ1' HG11 ' A' ' 145' ' ' VAL . 2.2 ttmp? -57.76 -60.6 3.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.97 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.56 146.59 8.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.364 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 152.02 130.3 1.59 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -175.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.676 ' CD ' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 1.67 -71.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.876 5.051 . . . . 0.0 118.054 -159.22 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.4 t30 -62.94 -51.67 66.0 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 119.116 0.871 . . . . 0.0 109.123 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 53.5 165.29 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.221 -1.808 . . . . 0.0 114.172 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.08 4.45 90.24 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.841 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.813 ' H ' HG21 ' A' ' 60' ' ' VAL . 19.9 m -106.71 -167.79 1.33 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 118.053 0.926 . . . . 0.0 112.027 -166.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.86 151.74 3.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -168.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.701 ' HE1' HD21 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.69 118.16 33.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 166.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.21 107.13 15.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.615 HD21 HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.04 28.02 4.22 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.469 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.4 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 25.1 t70 -67.83 -28.24 67.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -96.89 164.19 12.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.683 171.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.85 -16.84 62.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -168.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -173.94 126.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.425 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.41 131.98 55.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.899 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 87' ' ' ILE . 70.0 m -71.76 129.53 38.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.358 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 87' ' ' ILE . . . -116.32 121.31 41.6 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 147.0 -127.99 2.85 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.244 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.26 102.93 14.4 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.511 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 79.3 m-70 . . . . . 0 C--N 1.318 -0.768 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.729 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 . . . . . 0 CA--C 1.516 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -90.23 91.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.911 0.862 . . . . 0.0 110.416 178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -104.58 123.89 48.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.353 172.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.937 HD13 HD23 ' A' ' 144' ' ' LEU . 15.4 mt -110.46 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.476 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 37.4 t70 74.09 -26.28 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.471 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.8 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 16.9 t70 63.52 28.15 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 122.658 1.218 . . . . 0.0 110.524 174.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HB ' ' OD2' ' A' ' 90' ' ' ASP . 46.2 t -135.73 -12.75 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.987 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.571 ' HB ' HD22 ' A' ' 117' ' ' ASN . 1.5 p -108.38 -29.85 8.62 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.8 t -103.39 151.65 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.107 -0.371 . . . . 0.0 110.899 -169.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m -74.56 69.3 1.7 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.591 0.356 . . . . 0.0 110.074 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.677 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 56.33 -62.94 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.01 -166.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.609 ' HG2' ' NE ' ' A' ' 96' ' ' ARG . 7.6 ptp180 -133.85 139.38 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 120.849 -1.157 . . . . 0.0 111.047 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.57 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -83.88 -43.79 14.95 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -147.3 163.35 36.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.308 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.651 ' HB2' HD12 ' A' ' 76' ' ' ILE . 7.5 pt-20 -122.47 122.14 38.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 165.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.776 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.3 OUTLIER -79.58 92.03 5.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -173.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HD2' HG21 ' A' ' 111' ' ' VAL . 11.6 ptp180 -92.8 131.85 37.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.713 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 106' ' ' ASN . 6.2 tt -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.455 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 63.02 31.58 15.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.211 0.319 . . . . 0.0 110.456 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.709 ' HA ' HD22 ' A' ' 103' ' ' LEU . 56.3 m-20 68.81 7.46 6.17 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.802 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.35 133.51 55.89 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.004 0.431 . . . . 0.0 110.391 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.661 ' CE2' HD11 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -85.64 140.2 30.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.776 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 33.0 m-80 -144.73 157.15 44.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.386 -173.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -102.13 118.98 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.591 0.71 . . . . 0.0 110.329 177.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 2.1 t -99.81 113.36 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.792 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB2' HG22 ' A' ' 119' ' ' THR . 14.4 t70 -74.67 129.86 38.47 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.929 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.53 HG12 HG12 ' A' ' 111' ' ' VAL . 20.3 m -132.16 19.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 103.99 0.55 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.654 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 31.9 p -104.17 152.83 21.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.55 ' CD1' HG21 ' A' ' 24' ' ' VAL . 3.2 tm? -59.42 -55.84 29.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -170.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.571 HD22 ' HB ' ' A' ' 93' ' ' THR . 31.2 m-80 -67.81 -36.39 80.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.876 0.369 . . . . 0.0 110.611 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.89 150.76 5.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.213 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.546 HG23 ' CE1' ' A' ' 98' ' ' HIS . 19.6 m -109.47 126.6 53.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 111.52 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -139.73 157.15 46.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.109 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.714 HG23 HG21 ' A' ' 137' ' ' VAL . 2.4 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.55 45.28 8.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.069 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? 69.1 9.69 7.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.56 136.74 24.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.355 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.06 138.35 33.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.917 2.411 . . . . 0.0 111.771 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 129' ' ' ALA . 19.7 m -135.47 179.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.674 0.273 . . . . 0.0 111.215 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.8 m-20 -95.84 -53.23 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.1 p -154.0 91.67 1.47 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -89.99 143.78 26.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.15 135.87 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.893 -174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.738 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 2.3 tt -53.08 117.76 3.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.979 168.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -124.7 -175.73 3.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.175 -172.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -103.14 94.55 5.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.45 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.52 -22.89 23.55 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.46 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.85 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 7.1 m-20 -73.0 158.86 34.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.444 0.164 . . . . 0.0 110.652 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 9.2 pt-20 -133.89 150.56 51.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.079 0.942 . . . . 0.0 113.087 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.714 HG21 HG23 ' A' ' 121' ' ' VAL . 46.5 t -115.68 144.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.552 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.565 ' NE2' HH12 ' A' ' 26' ' ' ARG . 6.6 tp-100 -97.17 119.67 36.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 172.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.745 HG12 HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.08 120.6 65.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 63.39 -102.14 0.51 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 118.871 -1.633 . . . . 0.0 110.889 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.583 ' HD2' ' HG2' ' A' ' 64' ' ' PRO . 8.9 pttt -142.14 42.32 1.66 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.259 0.552 . . . . 0.0 111.651 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.732 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -134.97 148.92 50.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -98.71 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.937 HD23 HD13 ' A' ' 89' ' ' LEU . 2.9 mp -116.6 110.65 18.8 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -103.4 140.85 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 120.9 0.381 . . . . 0.0 110.395 -177.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.85 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -107.88 147.22 31.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.215 0.531 . . . . 0.0 112.397 -177.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.412 HD23 ' C ' ' A' ' 146' ' ' PHE . 2.3 mm? . . . . . 0 C--O 1.234 0.278 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 117' ' ' ASN . 9.4 p -131.35 153.92 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.827 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.623 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 36.8 t80 178.98 -163.6 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.238 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 119.008 0.822 . . . . 0.0 111.171 179.46 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.67 168.98 16.8 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.543 HD11 HG23 ' A' ' 59' ' ' VAL . 1.2 pp -152.53 134.06 14.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 3.8 mp -88.08 126.36 35.06 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.679 162.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.543 HG23 HD11 ' A' ' 57' ' ' LEU . 92.6 t -120.83 133.55 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 117.996 0.362 . . . . 0.0 110.616 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.14 119.7 27.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.78 -80.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.625 1.203 . . . . 0.0 111.663 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.64 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 43.3 ttt180 -161.74 81.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.568 -174.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.5 -143.84 9.05 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.681 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 42.5 Cg_exo -58.17 -66.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.21 1.94 . . . . 0.0 113.039 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 61.6 t30 -69.35 -52.8 23.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 62' ' ' ARG . . . 55.09 166.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.227 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.55 3.21 90.11 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.277 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.819 ' H ' HG23 ' A' ' 60' ' ' VAL . 4.2 m -96.39 177.45 5.69 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.598 -167.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.661 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -166.29 153.43 9.62 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -173.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.652 ' HE1' ' CD2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -95.46 122.88 38.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 167.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -83.17 93.84 7.73 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.43 0.633 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.641 HD23 HD11 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -88.46 45.78 1.32 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.916 0.865 . . . . 0.0 109.219 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.95 -13.47 33.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.951 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.48 174.75 5.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.783 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -66.0 -60.89 2.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 100' ' ' GLU . 1.3 tp -125.68 122.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.313 0.578 . . . . 0.0 111.802 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -104.83 171.71 7.17 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.062 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.778 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -117.27 124.09 48.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.495 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.75 121.34 42.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 139.07 -129.95 4.64 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.204 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -84.88 103.27 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.495 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 89.0 m-70 . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.082 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.331 0.586 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -100.64 95.87 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.632 0.73 . . . . 0.0 110.867 -175.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -109.14 128.97 55.46 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.552 177.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.913 HD13 HG12 ' A' ' 60' ' ' VAL . 4.0 mm? -113.28 84.63 2.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.695 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t70 66.18 -1.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.22 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 2.9 p30 41.01 37.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.171 1.388 . . . . 0.0 113.921 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 92' ' ' VAL . 9.9 p -161.11 21.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.625 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.628 HG23 ' HZ ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -123.17 -7.15 8.28 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.495 -0.753 . . . . 0.0 111.675 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.546 HG21 ' HA3' ' A' ' 140' ' ' GLY . 1.9 t -125.47 152.16 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m -73.05 70.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.05 0.452 . . . . 0.0 110.279 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.689 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.56 -67.93 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.936 -168.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.596 ' HG2' ' NH2' ' A' ' 96' ' ' ARG . 7.2 ptp180 -136.31 128.74 30.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.544 -1.347 . . . . 0.0 111.493 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.814 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -65.31 -46.05 81.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 171.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -148.95 179.13 8.1 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.008 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.655 ' HB2' HD13 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.29 123.55 14.71 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.12 93.05 3.28 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.098 0.951 . . . . 0.0 109.82 -168.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HA ' HD12 ' A' ' 76' ' ' ILE . 6.1 tpp180 -81.3 123.6 28.65 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.762 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.04 126.58 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 22.3 tt0 -150.55 126.52 10.46 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 64.82 41.69 4.87 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.651 0.594 . . . . 0.0 109.721 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.873 ' HA ' HD13 ' A' ' 103' ' ' LEU . 3.1 p-10 51.4 22.19 1.39 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.581 1.152 . . . . 0.0 113.313 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 12.5 pt-20 -118.19 134.27 55.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.574 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -87.91 143.25 27.22 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 25.0 m-80 -147.36 156.25 42.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.574 0.625 . . . . 0.0 111.447 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -102.54 116.26 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.116 176.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 76.2 t -101.03 111.52 30.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.345 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.59 126.03 28.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.021 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 99' ' ' ALA . 18.9 m -134.9 14.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.23 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.47 105.08 2.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.791 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.2 t -118.57 128.04 54.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 29.3 tp -55.17 -56.24 22.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.877 -174.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.745 ' HB2' HG21 ' A' ' 24' ' ' VAL . 16.9 t30 -62.85 -38.41 90.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.984 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.87 161.26 8.94 Favored Glycine 0 C--O 1.256 1.483 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.646 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.563 HG22 ' HE1' ' A' ' 98' ' ' HIS . 8.1 m -111.39 134.11 53.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.103 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 123' ' ' ARG . 0.1 OUTLIER -141.48 131.27 24.28 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.707 HG21 HG11 ' A' ' 137' ' ' VAL . 80.8 t -142.01 114.19 3.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.01 43.54 14.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.534 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 79.8 mtp180 66.86 14.13 9.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -142.3 141.59 21.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 121.914 -0.492 . . . . 0.0 110.622 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 122.96 11.09 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.968 1.779 . . . . 0.0 110.748 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.484 HG11 ' HB ' ' A' ' 121' ' ' VAL . 20.4 m -111.61 174.0 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.389 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 6.1 m-20 -98.11 -47.67 5.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.045 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.895 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.4 p -160.67 102.45 1.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.571 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -99.9 142.45 31.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.83 131.06 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 123.421 0.45 . . . . 0.0 110.739 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.615 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 2.1 tt -51.43 115.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . . . -120.05 -175.21 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.51 96.78 6.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.624 0.249 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.14 4.98 29.01 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.144 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.904 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 11.6 m-20 -107.46 160.83 15.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.32 0.56 . . . . 0.0 110.247 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -118.08 155.87 29.61 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -166.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.707 HG11 HG21 ' A' ' 121' ' ' VAL . 59.8 t -133.69 141.82 43.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.765 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.521 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -116.77 124.52 49.82 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.814 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -131.22 132.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.986 175.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 94' ' ' VAL . . . 84.11 -56.44 5.04 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 119.258 -1.448 . . . . 0.0 113.763 166.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.681 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 43.3 pttt 171.17 27.18 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.144 0.578 . . . . 0.0 110.688 168.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.726 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.56 146.8 51.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -92.68 119.21 31.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.237 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -110.08 156.93 19.9 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.12 143.11 28.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 172.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.904 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -102.15 141.64 34.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.935 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.603 HD11 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.218 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 17.2 m . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.668 ' HB ' HD13 ' A' ' 116' ' ' LEU . 4.4 p -134.77 157.57 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.633 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -177.07 -171.78 0.37 Allowed 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.52 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 CA-C-N 118.222 0.465 . . . . 0.0 110.078 171.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -124.45 167.72 14.03 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.74 145.76 12.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 5.2 mp -95.37 115.92 28.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.889 163.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.6 125.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.893 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -70.37 116.49 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -68.72 -82.81 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.744 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.645 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 41.7 mtm180 -144.22 123.38 12.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 111.009 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' H ' ' HB3' ' A' ' 66' ' ' ALA . . . -164.12 -105.37 0.19 Allowed Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.205 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 4.8 Cg_exo -77.76 -88.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.954 2.436 . . . . 0.0 112.333 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.767 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.5 t30 -64.73 -48.29 75.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 62' ' ' ARG . . . 57.34 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.221 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 0.92 89.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.09 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.844 ' H ' HG21 ' A' ' 60' ' ' VAL . 2.7 m -86.29 171.55 11.14 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 117.212 0.506 . . . . 0.0 109.673 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.654 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -167.68 153.62 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.377 0.535 . . . . 0.0 111.581 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.559 ' O ' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.64 126.82 40.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 71' ' ' LEU . 1.1 tm? -84.7 96.08 9.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.33 1.019 . . . . 0.0 108.571 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.839 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -93.38 50.3 1.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.844 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.426 ' H ' HD12 ' A' ' 71' ' ' LEU . 21.3 t70 -104.97 -19.41 13.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.832 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.82 -166.9 1.34 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.426 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.56 -40.63 56.46 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.423 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.32 135.6 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.721 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -116.42 141.75 47.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.084 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.745 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 43.2 m -85.61 124.79 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HB3' HG12 ' A' ' 87' ' ' ILE . . . -121.07 106.34 11.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.886 ' HA2' HD21 ' A' ' 89' ' ' LEU . . . 161.61 -129.47 2.11 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.713 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -68.77 108.34 3.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.72 0.771 . . . . 0.0 110.456 173.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.745 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.511 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 -174.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.416 0.627 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -127.75 110.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.187 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 134.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.2 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HG ' HD13 ' A' ' 139' ' ' ILE . 3.0 mm? -117.39 72.27 0.83 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.551 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.767 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 34.1 t70 62.8 4.21 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.381 0.61 . . . . 0.0 109.853 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.713 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 t70 66.73 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.261 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' SER . 14.2 p -80.57 69.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.42 1.105 . . . . 0.0 112.866 -167.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -162.69 4.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.941 167.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.4 t -140.63 141.82 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -76.14 72.76 2.96 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.665 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 66.1 -48.87 0.42 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.072 -173.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.1 ptp85 -154.46 135.0 13.45 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.592 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.854 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -72.13 -36.84 69.49 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -159.95 176.56 11.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.225 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 102' ' ' ARG . 6.0 pt-20 -134.04 135.19 43.18 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.839 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -61.17 95.89 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -92.49 98.17 11.29 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.678 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -77.98 107.83 10.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.267 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.57 139.85 45.68 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.036 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 58.61 32.52 22.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.914 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.848 ' HA ' HD21 ' A' ' 103' ' ' LEU . 89.0 m-20 67.5 9.11 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.895 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 17.5 mm-40 -105.49 151.67 23.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.398 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.914 ' HB2' HD11 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -99.34 124.32 44.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.517 ' OD1' ' HB ' ' A' ' 130' ' ' VAL . 11.6 m-80 -136.19 157.8 45.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -174.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 128' ' ' SER . 12.3 m -107.94 123.29 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.196 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 78.0 t -100.52 110.47 27.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.732 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -67.35 122.33 17.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.45 -11.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.72 77.39 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.272 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.854 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 28.6 t -86.34 137.23 32.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.668 HD13 ' HB ' ' A' ' 24' ' ' VAL . 1.7 tm? -53.47 -54.01 43.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.042 -174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -35.75 64.9 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.831 0.741 . . . . 0.0 109.936 172.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.12 171.9 12.84 Favored Glycine 0 C--O 1.253 1.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.076 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.4 m -111.37 130.26 55.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.651 -0.775 . . . . 0.0 110.904 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -138.41 104.2 5.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.896 0.379 . . . . 0.0 110.859 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 137' ' ' VAL . 58.1 t -100.73 125.92 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 m120 64.53 22.89 12.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 61.79 38.2 15.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.764 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -142.35 144.63 31.81 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.76 122.54 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.423 2.082 . . . . 0.0 111.197 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' A' ' 121' ' ' VAL . 19.3 m -114.74 171.51 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.6 t70 -111.93 -41.97 3.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.669 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.873 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.7 p -164.86 91.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.7 0.762 . . . . 0.0 110.21 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.95 128.13 53.09 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.307 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.517 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 9.1 p -73.01 154.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.429 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 108' ' ' PHE . 10.4 mp -62.25 165.7 5.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.52 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.408 ' HB1' ' HE1' ' A' ' 146' ' ' PHE . . . -152.0 -176.78 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.3 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.31 90.94 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.825 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.55 4.89 37.09 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 119.922 -1.132 . . . . 0.0 114.538 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.99 166.59 12.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.954 0.877 . . . . 0.0 110.117 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 3.5 pt-20 -127.76 150.27 49.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.773 HG12 HG22 ' A' ' 121' ' ' VAL . 38.5 t -125.97 141.92 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.62 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -99.69 125.58 45.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 169.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.956 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.15 131.53 45.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 169.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.07 -76.33 1.07 Allowed Glycine 0 C--O 1.222 -0.649 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.949 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.76 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 7.4 pttt -171.93 28.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 111.08 171.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.24 143.51 44.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.583 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -90.67 100.81 13.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.872 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.0 mp -93.93 158.47 15.63 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.7 143.14 27.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -107.08 147.16 30.34 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.28 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 146' ' ' PHE . 3.1 mm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.543 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 93' ' ' THR . 74.6 m . . . . . 0 CA--C 1.518 -0.272 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 116' ' ' LEU . 5.5 p -140.81 150.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.924 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' H ' ' HD2' ' A' ' 141' ' ' LYS . 8.5 t80 -176.73 -139.65 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.548 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.761 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 124.001 0.921 . . . . 0.0 110.614 -177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . . . -126.42 172.29 10.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.699 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.2 pt? -161.24 139.44 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 118.296 -1.362 . . . . 0.0 114.454 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 131' ' ' LEU . 2.7 mp -85.86 112.35 21.05 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.991 167.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.46 125.31 55.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.032 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.871 HG23 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -70.46 109.89 3.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.89 -44.36 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.184 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -155.18 143.77 20.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 172.49 -155.45 23.32 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.685 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 24.7 Cg_exo -63.87 -59.96 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.061 1.841 . . . . 0.0 111.958 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.732 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 48.2 t30 -75.67 -49.94 16.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 52.96 164.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.403 -174.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 2.71 90.61 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.723 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.871 ' H ' HG23 ' A' ' 60' ' ' VAL . 6.6 m -101.45 -169.05 1.64 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 117.6 0.7 . . . . 0.0 110.616 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.79 160.08 5.48 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -171.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.462 ' HB2' HD22 ' A' ' 72' ' ' LEU . 1.6 m-30 -96.48 127.88 42.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 167.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 73' ' ' ASP . 1.3 tm? -80.77 97.34 7.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.5 mt -94.13 46.29 1.16 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.553 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.489 ' H ' HD12 ' A' ' 71' ' ' LEU . 13.0 t70 -100.48 -19.15 16.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.756 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.58 -166.66 1.26 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.615 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.1 36.53 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.552 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.742 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -157.79 120.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.034 -175.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 71' ' ' LEU . 8.7 p -113.41 119.86 39.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 87' ' ' ILE . 15.2 m -66.04 128.56 36.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 87' ' ' ILE . . . -125.98 107.56 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -166.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.31 -132.97 2.85 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.854 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.802 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.49 110.56 6.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.828 0.823 . . . . 0.0 108.946 173.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -162.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.443 0.64 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -124.12 117.38 50.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.622 -174.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -115.57 127.48 55.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.036 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 60' ' ' VAL . 11.5 mt -115.91 80.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.1 t70 70.02 -8.49 0.82 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p-10 43.6 32.41 0.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.396 1.479 . . . . 0.0 113.105 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 23' ' ' SER . 26.0 t -138.8 -9.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.428 -176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -110.56 -13.55 14.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.754 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -118.58 146.74 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.679 -171.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.525 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 27.1 m -71.59 75.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.999 0.428 . . . . 0.0 109.924 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.771 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.84 -61.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.319 -172.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.684 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -153.7 139.53 18.08 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.687 0.756 . . . . 0.0 110.967 177.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.653 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -69.51 -40.3 77.04 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.227 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -158.26 179.27 9.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.474 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.625 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.44 131.27 22.86 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -59.64 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.291 -175.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 102' ' ' ARG . 3.0 tpp180 -89.98 100.4 13.23 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.239 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 106' ' ' ASN . 8.6 tt -77.63 110.87 12.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -131.98 138.81 48.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.459 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 59.32 31.35 21.07 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.583 0.552 . . . . 0.0 110.11 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.815 ' HA ' HD22 ' A' ' 103' ' ' LEU . 47.1 m-80 70.19 3.21 4.3 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.877 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.63 149.19 22.06 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.503 ' HD1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -93.8 124.08 37.57 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.435 ' OD1' HG22 ' A' ' 130' ' ' VAL . 12.9 m-80 -133.55 154.6 50.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.412 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 128' ' ' SER . 14.0 m -107.87 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.203 0.525 . . . . 0.0 110.867 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 84.1 t -101.22 111.47 31.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.833 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 119.52 12.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 111' ' ' VAL . 15.7 m -120.48 -11.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.432 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 146.36 71.47 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.354 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 m -84.97 132.13 34.39 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.566 HD22 ' HB ' ' A' ' 24' ' ' VAL . 41.2 tp -60.94 -56.65 18.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.166 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -72.92 -35.78 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.38 0.61 . . . . 0.0 109.745 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.0 169.15 11.98 Favored Glycine 0 C--O 1.256 1.525 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.26 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -113.82 125.85 54.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.382 -0.909 . . . . 0.0 110.969 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -132.75 105.7 7.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.03 0.443 . . . . 0.0 110.906 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.793 HG22 HG11 ' A' ' 137' ' ' VAL . 45.7 t -101.44 110.3 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.738 HD21 HG12 ' A' ' 121' ' ' VAL . 29.2 m-80 56.73 38.38 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.132 0.492 . . . . 0.0 110.484 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 9.6 mmm180 77.43 1.87 3.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.389 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.83 130.89 23.72 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.474 0.654 . . . . 0.0 111.442 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.6 125.85 15.1 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 129' ' ' ALA . 27.8 m -115.54 165.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 111.701 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 m-20 -82.81 -51.83 7.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 171.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.854 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.3 p -160.31 91.03 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.554 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 126' ' ' VAL . . . -86.07 141.86 29.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.301 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 109' ' ' ASN . 39.7 t -78.32 124.17 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.956 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -59.28 156.18 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.342 0.401 . . . . 0.0 111.659 176.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.472 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -157.02 154.71 30.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -69.12 98.82 1.04 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.878 0.37 . . . . 0.0 110.011 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.23 0.84 29.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.06 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 17.2 t70 -69.17 148.87 49.28 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 143' ' ' ARG . 9.0 tt0 -135.9 127.15 28.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.607 0.718 . . . . 0.0 111.824 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.793 HG11 HG22 ' A' ' 121' ' ' VAL . 42.0 t -123.64 133.19 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.568 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -94.27 128.55 40.82 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.66 HG23 HD13 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -134.65 140.87 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 173.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 73.5 -68.12 1.52 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.231 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.698 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 12.7 ptmt -176.2 22.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.416 0.686 . . . . 0.0 109.345 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.732 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -123.15 161.83 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -171.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.408 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 26.9 ttp85 -112.18 119.59 38.91 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.434 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.822 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -109.5 154.11 23.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.411 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -141.26 139.87 32.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.155 171.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 147' ' ' LEU . 47.0 t80 -98.21 138.55 35.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.812 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.318 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' THR . 16.3 m . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 120.874 0.369 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' HB ' HD23 ' A' ' 116' ' ' LEU . 14.7 p -138.7 135.89 43.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.646 -168.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.2 t80 173.34 -170.64 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.352 0.261 . . . . 0.0 110.759 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.574 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.466 0.706 . . . . 0.0 111.284 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -123.77 172.8 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.493 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -155.06 144.27 21.05 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 117.566 -1.654 . . . . 0.0 114.743 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 72' ' ' LEU . 5.2 mp -93.56 112.57 24.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.807 166.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 5.9 p -111.97 131.67 62.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.695 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.989 HG13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -76.51 110.48 11.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -72.33 -58.59 3.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.343 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -145.07 131.8 20.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.717 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.479 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -171.01 -174.34 38.77 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.635 ' CG ' ' HE2' ' A' ' 141' ' ' LYS . 44.7 Cg_exo -56.59 -47.55 23.21 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.964 1.776 . . . . 0.0 113.015 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 64.1 t30 -82.91 -51.76 7.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.815 0.816 . . . . 0.0 108.817 172.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.656 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 54.91 170.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.079 -171.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.79 2.5 90.56 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.778 -0.725 . . . . 0.0 114.057 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.2 m -99.91 179.32 4.55 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 117.901 0.85 . . . . 0.0 110.653 -170.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.672 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.81 154.7 4.41 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.008 0.367 . . . . 0.0 111.821 -175.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.529 ' HB2' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -93.54 116.26 28.78 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 171.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.8 tt -74.27 97.19 2.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 124.403 1.064 . . . . 0.0 108.809 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 58' ' ' LEU . 12.5 mt -91.19 32.27 1.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.786 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -88.69 -15.71 34.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.72 -167.08 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.375 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.68 -30.87 16.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.0 109.802 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -160.98 133.1 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 176.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 23.1 p -121.51 147.89 45.19 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.899 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -93.63 126.54 38.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 87' ' ' ILE . . . -115.83 128.87 56.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -173.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.33 -117.0 1.1 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.109 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.677 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -101.55 101.69 12.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.277 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 10.9 m-20 . . . . . 0 CA--C 1.521 -0.136 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.784 HD13 HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -132.54 97.65 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.078 0.942 . . . . 0.0 110.203 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -110.74 130.26 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.33 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.989 HD11 HG13 ' A' ' 60' ' ' VAL . 4.5 mm? -116.2 76.09 1.0 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.94 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 67.98 -0.64 1.99 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.644 0.735 . . . . 0.0 110.019 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.3 p-10 35.67 44.0 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.306 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' SER . 9.9 p -151.85 2.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.396 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' SER . 18.9 p -111.85 -7.95 14.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.849 -0.532 . . . . 0.0 112.045 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.9 t -126.81 147.3 31.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 O-C-N 122.043 -0.41 . . . . 0.0 110.292 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 m -71.01 73.76 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.4 -61.59 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.292 -165.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 40.9 ttm180 -145.39 132.3 20.19 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.276 -0.89 . . . . 0.0 111.603 -163.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.853 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -87.92 -46.78 9.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.514 170.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.73 158.38 43.86 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.201 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 111' ' ' VAL . 7.8 pt-20 -124.27 130.96 53.42 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 166.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.708 ' CG ' HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -61.07 95.97 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.272 -174.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -92.87 106.48 18.44 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.235 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.812 HD22 ' HA ' ' A' ' 106' ' ' ASN . 9.3 tt -76.24 109.11 9.65 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.23 136.17 50.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.923 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 60.03 31.83 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.812 ' HA ' HD22 ' A' ' 103' ' ' LEU . 67.3 m-20 63.5 15.36 8.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.415 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -114.15 156.36 24.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.855 ' HB2' HD12 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -94.68 133.52 38.27 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.449 ' OD1' HG22 ' A' ' 130' ' ' VAL . 14.5 m-80 -139.91 159.49 42.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -107.79 126.3 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.267 171.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 34.2 m -101.92 123.64 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.684 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.93 126.35 30.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.819 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.77 -3.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 110.619 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 121.45 91.6 1.16 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.402 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.763 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 18.1 t -98.83 134.97 40.95 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD23 ' HB ' ' A' ' 24' ' ' VAL . 20.4 tp -52.47 -58.15 7.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.698 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 11.5 m-80 -70.6 -37.61 73.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.69 8.28 Favored Glycine 0 C--O 1.242 0.646 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.54 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.519 HG21 ' CE1' ' A' ' 98' ' ' HIS . 15.6 m -112.13 132.92 54.58 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.795 0.438 . . . . 0.0 111.148 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -141.29 140.14 33.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.655 0.264 . . . . 0.0 110.557 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.659 HG22 HG11 ' A' ' 137' ' ' VAL . 73.1 t -127.89 107.63 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.414 ' HA ' ' OE2' ' A' ' 136' ' ' GLU . 1.9 m120 64.0 35.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 109.386 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 59.42 30.18 19.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.926 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.8 pt-20 -139.62 128.06 13.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.43 122.66 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.142 1.895 . . . . 0.0 110.955 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.36 162.1 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 14.0 m-20 -72.16 -59.02 2.95 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.741 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 46.7 t -159.64 109.63 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -116.02 141.93 47.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.449 HG22 ' OD1' ' A' ' 109' ' ' ASN . 4.1 t -74.28 142.34 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.596 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 108' ' ' PHE . 11.1 mp -51.0 150.93 2.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 111.489 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.33 -176.47 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.55 98.75 8.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.655 0.264 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.5 4.42 40.29 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.1 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.917 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 19.7 m-20 -101.81 157.84 16.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.134 0.467 . . . . 0.0 110.331 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -105.22 162.04 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 121' ' ' VAL . 47.7 t -136.22 126.57 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.595 172.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 111.35 23.77 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.933 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.853 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -111.95 134.97 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 61.64 -101.4 0.34 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.635 ' HE2' ' CG ' ' A' ' 64' ' ' PRO . 15.2 ptmt -141.64 19.36 2.18 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.76 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.656 ' CD2' HD12 ' A' ' 89' ' ' LEU . 1.5 m-85 -112.3 144.31 41.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.509 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -92.4 87.1 5.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.865 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -83.14 160.82 21.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.026 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.88 139.2 31.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.917 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -97.53 141.87 30.05 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.213 178.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.44 ' CD2' HG23 ' A' ' 145' ' ' VAL . 2.7 mm? . . . . . 0 N--CA 1.447 -0.593 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.422 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.74 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 43.1 m . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.871 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 8.1 t -110.92 131.86 60.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.11 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.611 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 20.6 t80 175.73 -177.38 0.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 173.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.623 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 C-N-CA 124.233 1.013 . . . . 0.0 111.21 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.21 172.78 9.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 1.8 pt? -160.76 142.05 11.96 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.81 -1.556 . . . . 0.0 114.964 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.2 mp -85.69 117.35 24.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.95 167.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.08 129.0 63.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.824 HG23 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -71.5 109.86 4.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.1 -67.37 0.44 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.048 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -145.26 125.23 13.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.726 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -163.27 -140.33 2.85 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.649 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 21.5 Cg_exo -66.87 -69.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.67 2.246 . . . . 0.0 112.446 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.74 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.5 t30 -69.09 -48.22 63.19 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.611 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 56.01 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.671 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.3 2.11 90.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.221 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.824 ' H ' HG23 ' A' ' 60' ' ' VAL . 6.0 m -86.76 -179.86 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.316 0.558 . . . . 0.0 110.287 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.66 150.15 3.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.596 0.635 . . . . 0.0 112.412 -172.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.537 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -94.47 120.39 34.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.604 ' O ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -80.92 91.37 6.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.715 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.8 mt -83.38 52.12 2.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.063 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.491 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 17.7 t70 -96.36 -37.85 10.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.574 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -96.51 -166.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.774 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.22 39.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -154.0 123.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.634 0.73 . . . . 0.0 112.546 -177.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 65.2 p -103.99 138.74 40.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.519 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.718 ' O ' HG23 ' A' ' 87' ' ' ILE . 48.8 m -82.05 124.88 30.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -121.77 114.77 21.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -171.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.733 ' HA2' HD22 ' A' ' 89' ' ' LEU . . . 152.25 -140.31 7.63 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -70.68 104.04 2.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 57.4 m-70 . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.778 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 7.1 m-20 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -126.48 105.33 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.647 0.737 . . . . 0.0 111.124 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -103.89 134.44 47.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.647 177.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.884 ' HG ' HD12 ' A' ' 139' ' ' ILE . 2.8 mm? -118.6 77.14 1.14 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.738 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 67.81 -18.5 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.473 0.654 . . . . 0.0 111.267 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 33.1 t70 67.05 24.13 9.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.429 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.8 p -156.47 53.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 122.296 1.046 . . . . 0.0 110.769 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.479 ' HB ' ' CD ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -152.81 0.06 0.27 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.123 172.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.665 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.8 t -137.23 140.49 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.218 -173.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m -73.68 74.03 1.52 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.238 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 66.96 -66.64 0.18 Allowed 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.248 -173.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -139.57 144.1 37.64 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.702 -0.624 . . . . 0.0 110.523 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.808 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.96 -41.39 12.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.834 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.17 165.54 28.02 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.396 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.618 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.9 pt-20 -132.69 127.04 33.94 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -58.28 100.73 0.07 Allowed 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.692 -174.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -94.62 100.35 12.32 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.735 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -79.48 104.6 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.128 175.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -134.75 140.67 46.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.717 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 62.34 32.13 17.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.397 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.652 ' HA ' HD22 ' A' ' 103' ' ' LEU . 43.2 m-80 64.58 15.01 9.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.882 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -121.86 146.43 47.1 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.873 0.368 . . . . 0.0 110.809 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.568 ' CB ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -85.8 122.14 29.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.534 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.8 OUTLIER -123.87 166.16 16.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.8 m -115.65 128.53 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.245 172.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.834 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.8 t -101.51 111.87 32.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.298 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.77 119.88 21.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.537 HG13 HG11 ' A' ' 111' ' ' VAL . 35.6 m -116.59 -27.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 111.085 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.23 105.97 0.43 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.797 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.9 t -101.48 146.88 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.264 0.226 . . . . 0.0 110.6 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.52 -55.76 29.52 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.628 0.252 . . . . 0.0 110.904 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.871 ' OD1' ' HA ' ' A' ' 24' ' ' VAL . 61.5 m-20 -74.05 -36.42 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.22 160.82 8.6 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.559 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.2 m -112.81 132.5 55.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.616 0.367 . . . . 0.0 111.727 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -141.37 105.38 4.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.995 0.426 . . . . 0.0 110.683 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.935 HG22 HG12 ' A' ' 137' ' ' VAL . 88.0 t -92.04 114.24 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.17 36.98 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 53.85 31.99 14.21 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.974 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.7 pt-20 -141.8 137.86 16.56 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 109.979 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.95 122.93 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.09 1.86 . . . . 0.0 111.8 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.0 m -116.93 176.89 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.561 0.219 . . . . 0.0 110.806 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 27.2 t70 -94.75 -66.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 43.4 t -153.15 92.45 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.82 142.41 29.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.023 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -79.45 129.83 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.09 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 1.0 OUTLIER -59.78 163.75 4.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -167.96 168.99 11.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -61.44 115.52 3.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.849 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.51 5.24 72.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.319 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.5 108.96 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 110.453 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 8.2 tt0 -94.79 131.8 40.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 121' ' ' VAL . 42.0 t -124.14 130.84 73.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -101.24 121.68 42.3 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.904 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.884 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.52 140.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 58.12 -98.87 0.1 OUTLIER Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.3 -0.952 . . . . 0.0 110.869 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.634 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 17.2 ptmt -140.85 18.22 2.32 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.235 0.54 . . . . 0.0 111.096 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.74 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -110.42 150.29 29.04 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -107.37 105.46 15.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.82 ' HG ' HG11 ' A' ' 60' ' ' VAL . 5.3 mp -98.71 157.51 16.22 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.505 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.78 141.32 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.106 169.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.61 ' O ' HD21 ' A' ' 147' ' ' LEU . 37.3 t80 -100.07 137.65 38.23 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.61 HD21 ' O ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.207 170.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.238 0.462 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.62 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 54.4 t -68.47 143.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.822 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 16.7 t80 174.29 -177.9 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.418 0.449 . . . . 0.0 110.794 168.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.77 HH22 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.933 0.893 . . . . 0.0 111.819 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 73' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.88 171.79 10.43 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 57' ' ' LEU . 2.7 pp -155.0 137.91 15.43 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 117.541 -1.664 . . . . 0.0 114.93 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.73 HD11 HD23 ' A' ' 131' ' ' LEU . 1.3 mp -85.29 110.88 19.39 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.457 162.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.483 ' HB ' HD11 ' A' ' 57' ' ' LEU . 5.8 p -105.41 127.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.086 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.809 HG21 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -71.44 108.97 3.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 175.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.94 -57.5 6.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.604 -1.634 . . . . 0.0 109.881 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -150.7 131.06 13.71 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.304 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -169.93 -161.18 19.94 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.634 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 31.2 Cg_exo -60.55 -51.92 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.974 1.782 . . . . 0.0 113.055 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 63.9 t30 -78.2 -49.29 14.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 55.6 158.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.956 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.66 89.82 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.809 ' H ' HG21 ' A' ' 60' ' ' VAL . 12.3 t -98.49 -178.01 3.87 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.343 1.071 . . . . 0.0 110.811 -173.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.24 156.68 5.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.283 0.492 . . . . 0.0 112.112 -173.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -95.77 113.47 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 170.316 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 1.3 pt? -79.65 92.61 5.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.067 1.413 . . . . 0.0 108.609 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.578 HD13 ' CB ' ' A' ' 108' ' ' PHE . 12.1 mt -74.18 46.51 0.25 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.009 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 55' ' ' SER . 35.2 t70 -94.73 -25.49 16.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.743 0.782 . . . . 0.0 109.173 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -84.61 -167.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.745 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.67 -30.08 22.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.721 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.54 137.66 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.478 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 59.7 p -128.51 132.79 48.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.753 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.798 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 35.8 m -82.55 125.53 31.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 110.419 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.667 ' HB2' HG22 ' A' ' 87' ' ' ILE . . . -122.54 117.41 25.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 154.83 -82.72 0.16 Allowed Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.182 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -124.6 103.1 7.95 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.798 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.268 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.471 -171.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.591 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.386 0.612 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.667 HG22 ' HB2' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -118.42 109.83 28.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.667 0.746 . . . . 0.0 110.481 -177.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 135.07 54.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.979 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.913 ' HG ' HD12 ' A' ' 139' ' ' ILE . 2.8 mm? -122.37 74.04 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.652 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.419 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 39.0 t70 75.28 -22.49 0.26 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.488 0.661 . . . . 0.0 111.01 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 30.0 t70 59.68 36.19 22.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.036 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 92' ' ' VAL . 41.6 t -137.87 -10.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.626 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.495 ' HG1' ' HZ ' ' A' ' 142' ' ' PHE . 31.3 p -106.98 -24.48 11.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.59 147.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -169.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -76.12 81.31 2.94 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.053 -0.404 . . . . 0.0 110.228 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' CG ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 67.28 -69.4 0.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.567 -173.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.509 ' HG2' ' CG ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -156.04 142.28 18.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.566 0.698 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.799 ' CD2' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -79.46 -42.26 25.72 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.396 172.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.823 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.62 153.6 44.86 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.067 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 77' ' ' THR . 5.4 pt-20 -115.51 126.92 54.88 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 166.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.84 98.99 0.11 Allowed 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.552 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 100' ' ' GLU . 19.9 tpp85 -90.07 101.13 13.85 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.019 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.834 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -83.2 110.76 18.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -132.21 128.35 37.75 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.115 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 60.64 36.97 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.053 0.454 . . . . 0.0 110.484 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.834 ' HA ' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER 69.3 8.44 6.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.773 178.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 26.0 mm-40 -109.21 140.83 42.32 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.906 -0.496 . . . . 0.0 110.935 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.578 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -90.07 127.8 36.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.808 -177.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.541 HD21 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -127.03 159.99 32.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.34 -178.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -106.27 124.79 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 169.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.3 t -102.75 113.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.889 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 119' ' ' THR . 18.2 t0 -70.93 118.26 13.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.514 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.762 HG12 HG11 ' A' ' 111' ' ' VAL . 11.1 m -122.93 -37.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.77 79.68 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.099 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.636 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 25.7 t -93.34 122.98 36.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -45.45 90.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.592 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.636 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 23.8 m-80 -82.52 -36.72 26.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 110.128 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 146.2 152.2 5.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 112' ' ' ASP . 17.1 m -111.87 128.44 56.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.01 146.58 41.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 173.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.782 HG21 HG12 ' A' ' 137' ' ' VAL . 97.0 t -134.3 106.6 8.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.648 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.5 OUTLIER 64.18 41.0 6.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 63.97 17.23 10.45 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.009 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.5 pt-20 -134.61 126.15 17.93 Favored Pre-proline 0 C--N 1.331 -0.218 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.89 122.34 9.46 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.294 1.996 . . . . 0.0 111.712 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.5 m -111.97 178.74 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 110.707 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.2 p-10 -101.86 -46.77 4.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.724 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 17.4 p -159.17 94.32 1.19 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.019 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.18 144.34 30.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.434 HG23 HD22 ' A' ' 109' ' ' ASN . 26.0 t -76.96 131.29 35.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.127 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.73 HD23 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -61.03 155.18 20.83 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.846 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -156.31 156.81 34.63 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.182 0.515 . . . . 0.0 111.738 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.27 111.02 2.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.702 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.88 1.58 59.85 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.839 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 15.6 t70 -72.29 128.45 35.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.618 0.247 . . . . 0.0 110.761 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -112.81 129.56 56.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.401 0.62 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.782 HG12 HG21 ' A' ' 121' ' ' VAL . 44.7 t -124.83 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.378 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.44 118.53 37.06 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.913 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -117.53 125.4 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 63.88 -103.03 0.63 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.101 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 26' ' ' ARG . 10.1 pttt -143.02 24.75 1.81 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.283 0.563 . . . . 0.0 111.424 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.611 ' HD1' ' O ' ' A' ' 139' ' ' ILE . 0.1 OUTLIER -116.37 136.7 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -175.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.77 ' HB2' HH22 ' A' ' 26' ' ' ARG . 7.2 ttm180 -89.47 109.31 20.25 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.94 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 60' ' ' VAL . 6.7 mp -98.9 159.22 15.11 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.146 0.498 . . . . 0.0 111.825 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -141.76 140.99 30.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.004 166.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.609 ' CD1' ' HG ' ' A' ' 131' ' ' LEU . 47.7 t80 -97.03 132.38 42.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.605 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 169.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HB ' HD11 ' A' ' 116' ' ' LEU . 1.4 p -143.42 157.31 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 O-C-N 121.259 -0.901 . . . . 0.0 112.42 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -172.76 -143.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.524 HH21 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-N 118.365 0.529 . . . . 0.0 109.948 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.571 ' CB ' HD11 ' A' ' 131' ' ' LEU . . . -125.84 169.12 12.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -153.68 129.78 10.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.064 -1.054 . . . . 0.0 113.698 -173.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.685 ' HG ' ' CB ' ' A' ' 146' ' ' PHE . 4.8 mp -86.61 137.74 32.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.904 162.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 4.2 p -131.82 128.96 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.431 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.887 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -72.98 109.78 5.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.022 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -64.27 -70.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 113.079 -1.873 . . . . 0.0 110.413 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 14.0 mtp85 -148.54 138.03 21.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.476 0.655 . . . . 0.0 109.781 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.485 ' H ' ' HB3' ' A' ' 66' ' ' ALA . . . -162.28 -127.02 0.85 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.659 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 3.8 Cg_endo -89.18 -62.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.9 0 C-N-CA 122.163 1.909 . . . . 0.0 111.442 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -69.42 -53.35 19.75 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.751 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.18 174.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.113 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.73 89.52 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.871 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.887 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.5 m -96.87 179.61 4.9 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 117.308 0.554 . . . . 0.0 111.017 -169.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.729 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -168.5 147.2 4.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -169.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.848 ' HD2' ' HB2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -97.26 121.07 38.74 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 71' ' ' LEU . 2.0 tt -83.68 101.38 11.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.662 0.744 . . . . 0.0 110.218 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.648 HD23 ' CD1' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -92.99 41.51 1.08 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.438 0.637 . . . . 0.0 110.254 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -92.0 -26.24 18.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.792 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.03 178.99 4.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.481 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.78 -44.46 81.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -162.56 128.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.933 -174.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 p -113.8 121.6 44.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.133 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 87' ' ' ILE . 65.4 m -64.86 126.14 27.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.964 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' HG23 ' A' ' 87' ' ' ILE . . . -119.59 115.98 25.09 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.669 ' HA2' HD21 ' A' ' 89' ' ' LEU . . . 149.39 -142.96 10.28 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.12 104.38 3.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 109.966 173.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.521 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 69.7 m-70 . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 CA--C 1.515 -0.399 0 CA-C-O 121.41 0.624 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -101.05 94.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.0 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -100.07 134.92 42.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.817 174.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.946 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -117.02 75.21 0.96 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.2 t70 58.92 15.75 4.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.745 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 2.3 p30 46.12 -73.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.285 1.434 . . . . 0.0 113.696 -170.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 92' ' ' VAL . 12.7 p -73.63 64.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -156.08 -1.24 0.13 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.263 164.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.874 HG12 ' HG ' ' A' ' 115' ' ' SER . 9.2 t -131.7 137.83 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.125 -0.36 . . . . 0.0 110.732 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 19.4 m -72.48 71.22 0.93 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.436 ' CD ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 68.55 -59.63 0.45 Allowed 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.822 -174.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.0 ptp85 -149.31 138.67 21.53 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.661 -0.649 . . . . 0.0 110.625 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.682 ' CB ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -70.58 -43.16 69.98 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -159.46 175.12 13.68 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 112.704 -2.043 . . . . 0.0 108.949 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.647 ' HB2' HD12 ' A' ' 76' ' ' ILE . 8.6 pt-20 -128.37 115.05 17.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 1.016 ' HD1' HG11 ' A' ' 110' ' ' VAL . 2.4 t80 -78.07 91.46 4.28 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.877 0.846 . . . . 0.0 108.719 -171.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.605 ' HD2' HG21 ' A' ' 111' ' ' VAL . 12.8 ptp180 -101.54 140.3 36.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.343 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -83.25 112.29 19.74 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.501 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.35 139.75 39.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 36.2 m-80 62.51 32.52 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.699 ' HA ' HD21 ' A' ' 103' ' ' LEU . 6.8 t30 72.03 -0.1 3.35 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.568 0.747 . . . . 0.0 111.517 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 12.9 mm-40 -111.62 142.54 43.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.544 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.726 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.62 128.9 36.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 18.0 m-80 -138.05 161.86 35.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 1.016 HG11 ' HD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -104.54 117.34 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 117.962 0.346 . . . . 0.0 111.019 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.605 HG21 ' HD2' ' A' ' 102' ' ' ARG . 76.5 t -99.03 110.17 25.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -70.27 135.38 48.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.49 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.61 7.62 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.112 0.482 . . . . 0.0 109.78 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 102.96 107.19 3.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.292 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.874 ' HG ' HG12 ' A' ' 94' ' ' VAL . 25.6 t -102.35 157.26 17.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.629 HD11 ' HB ' ' A' ' 24' ' ' VAL . 1.6 tm? -58.13 -53.18 61.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.773 -174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -36.03 73.25 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.725 0.774 . . . . 0.0 109.014 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 132.35 177.55 14.98 Favored Glycine 0 C--O 1.25 1.095 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.214 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.434 HG21 ' CE1' ' A' ' 98' ' ' HIS . 5.6 m -111.57 136.68 50.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.901 0.48 . . . . 0.0 111.474 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -139.57 132.8 29.83 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.84 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.716 HG22 HG11 ' A' ' 137' ' ' VAL . 84.6 t -129.3 121.69 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.75 32.6 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 56.89 26.36 11.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.595 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.0 pt-20 -137.86 143.21 39.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.426 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.99 123.26 10.74 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.847 2.364 . . . . 0.0 112.348 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.43 175.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 p-10 -103.35 -49.94 3.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.12 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.877 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 33.3 t -157.72 91.44 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.41 137.81 36.57 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.025 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.401 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 7.4 p -80.57 143.16 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.784 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.713 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -49.44 133.19 20.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.227 174.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.588 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . . . -128.38 -175.15 3.42 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -107.0 86.03 2.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.32 2.29 38.28 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.445 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.416 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 4.8 t70 -89.98 158.18 17.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.487 0.644 . . . . 0.0 109.744 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.5 pm0 -107.42 143.51 35.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.898 0.856 . . . . 0.0 113.209 -172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.716 HG11 HG22 ' A' ' 121' ' ' VAL . 58.4 t -119.9 141.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.739 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.42 HE22 ' N ' ' A' ' 142' ' ' PHE . 56.1 tp60 -108.05 122.97 47.95 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.082 0.467 . . . . 0.0 110.186 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.946 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.92 139.99 50.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 168.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 63.27 -90.27 0.07 OUTLIER Glycine 0 C--O 1.208 -1.481 0 C-N-CA 119.717 -1.23 . . . . 0.0 112.322 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 24' ' ' VAL . 14.8 ptmt -156.95 31.9 0.3 Allowed 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.519 -0.989 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.659 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -123.87 138.44 54.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.524 ' HB2' HH21 ' A' ' 26' ' ' ARG . 0.7 OUTLIER -89.5 108.84 19.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.788 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.08 161.05 13.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.41 143.45 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.713 ' HB2' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -109.34 144.6 37.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.528 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? . . . . . 0 N--CA 1.453 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 93' ' ' THR . 57.2 m . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.388 0.614 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 117' ' ' ASN . 14.1 p -127.87 141.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.482 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 t80 179.13 -168.1 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 141' ' ' LYS . 7.8 tpt180 . . . . . 0 N--CA 1.475 0.821 0 O-C-N 123.876 0.735 . . . . 0.0 110.542 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -136.19 170.15 16.48 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 57' ' ' LEU . 3.1 pp -161.29 145.2 13.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.561 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.6 mp -87.1 116.5 25.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.759 164.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -113.11 130.02 67.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 118.158 0.435 . . . . 0.0 110.522 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.901 HG13 ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -71.16 109.38 3.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -62.46 -54.46 39.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.216 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 14.6 ttm-85 -165.42 106.94 0.77 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.989 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.68 -133.07 3.69 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.574 ' HG2' ' H ' ' A' ' 65' ' ' ASN . 82.4 Cg_endo -76.0 -64.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.34 2.027 . . . . 0.0 112.191 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.626 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 66.5 t30 -70.13 -47.3 62.29 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 60.31 166.94 0.08 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.847 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.35 4.45 89.95 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.77 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.862 ' H ' HG21 ' A' ' 60' ' ' VAL . 5.6 m -101.92 179.18 4.4 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 117.651 0.726 . . . . 0.0 110.655 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.582 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.49 154.98 3.29 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.802 0.728 . . . . 0.0 112.24 -172.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.539 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.15 127.94 41.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.634 ' O ' HD22 ' A' ' 71' ' ' LEU . 1.5 tt -87.82 91.82 8.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.72 0.771 . . . . 0.0 109.534 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.792 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -85.39 55.78 3.66 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -108.75 -23.94 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -103.77 -166.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.52 -41.17 69.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.3 129.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.463 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.514 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 71.8 p -113.2 126.02 54.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 87' ' ' ILE . 39.1 m -68.29 126.58 30.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.564 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -122.54 108.65 13.38 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 165.45 -139.3 5.72 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.095 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.98 103.88 7.16 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.527 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 11.5 m-70 . . . . . 0 N--CA 1.436 -1.133 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.229 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.514 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 6.3 m-20 . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -115.44 110.95 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.0 0.905 . . . . 0.0 111.672 -171.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.33 114.61 28.43 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.714 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.791 HD12 HG12 ' A' ' 139' ' ' ILE . 4.7 mt -102.4 80.05 1.9 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.942 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 14.6 t70 70.11 -7.48 0.95 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.148 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.773 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.6 p30 39.47 36.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 113.075 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.471 HG11 ' O ' ' A' ' 92' ' ' VAL . 41.1 t -148.42 -2.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' SER . 27.7 p -113.2 -34.92 5.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.526 ' HB ' ' HA2' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -116.72 154.6 18.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 122.116 -0.365 . . . . 0.0 110.602 -171.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.1 m -68.41 72.79 0.21 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.706 0.403 . . . . 0.0 112.049 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.693 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 59.36 -49.31 0.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.054 0.942 . . . . 0.0 112.709 -173.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.777 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 10.3 ptp85 -149.42 141.85 24.28 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.691 -0.631 . . . . 0.0 110.308 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.809 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.85 -41.3 12.55 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.888 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -140.26 170.55 15.61 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.808 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.623 ' HB2' HD13 ' A' ' 76' ' ' ILE . 6.6 pt-20 -137.45 123.27 20.03 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.792 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -55.52 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 124.413 1.071 . . . . 0.0 108.931 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -94.14 98.04 10.7 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.939 -174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -78.95 104.8 9.83 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.817 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.63 134.99 54.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.3 OUTLIER 40.75 47.24 2.43 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.313 1.008 . . . . 0.0 112.092 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 103' ' ' LEU . 3.6 m-20 76.55 2.18 3.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.693 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 50.2 mt-10 -106.28 141.3 37.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.807 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.595 ' CB ' HD23 ' A' ' 72' ' ' LEU . 1.1 m-85 -89.05 126.99 35.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 130' ' ' VAL . 24.4 m-80 -132.12 160.29 36.43 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.718 0.294 . . . . 0.0 110.576 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.865 ' O ' ' HA ' ' A' ' 128' ' ' SER . 5.6 m -111.76 126.96 69.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.016 0.436 . . . . 0.0 110.211 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 3.8 t -101.38 112.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.354 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 13.4 t0 -74.78 128.64 36.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.493 HG13 HG11 ' A' ' 111' ' ' VAL . 36.0 m -128.04 4.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 109.608 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.17 87.63 2.01 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.282 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.721 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.4 t -87.79 141.01 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.15 -57.26 11.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.734 HD22 ' HA2' ' A' ' 140' ' ' GLY . 1.8 p30 -65.91 -37.79 87.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.642 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.11 164.06 9.84 Favored Glycine 0 C--O 1.262 1.847 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.724 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.508 HG21 ' CE1' ' A' ' 98' ' ' HIS . 17.7 m -113.82 129.27 56.61 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.239 -1.481 . . . . 0.0 110.297 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.63 105.22 4.69 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 111.67 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 1.001 HG23 HG23 ' A' ' 137' ' ' VAL . 52.5 t -100.33 127.11 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 0.9 OUTLIER 63.22 25.61 14.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 63.05 13.8 7.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.834 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.85 156.88 58.7 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 120.762 0.315 . . . . 0.0 110.385 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.75 131.85 12.66 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.44 2.093 . . . . 0.0 112.645 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.26 176.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 10.0 m-20 -120.1 -31.34 4.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.56 174.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.865 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.0 p -161.63 91.48 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.509 0.671 . . . . 0.0 109.866 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -100.91 145.58 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.498 HG22 ' OD1' ' A' ' 109' ' ' ASN . 14.5 t -88.18 119.81 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -58.74 162.3 4.11 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -163.52 164.59 24.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.622 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -71.06 114.49 9.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.346 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.39 -7.96 51.77 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.856 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.49 110.64 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.621 0.369 . . . . 0.0 110.142 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -93.83 152.3 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.172 0.51 . . . . 0.0 112.251 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.001 HG23 HG23 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -133.4 141.24 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 1.1 tm0? -109.58 116.68 32.22 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 169.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.809 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -138.4 131.77 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.243 175.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.734 ' HA2' HD22 ' A' ' 117' ' ' ASN . . . 82.9 -56.88 5.07 Favored Glycine 0 C--N 1.317 -0.502 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.25 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.751 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 59.9 pttt 168.03 32.11 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.751 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.5 161.52 17.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.232 -173.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.77 99.62 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.977 ' HB2' HG12 ' A' ' 137' ' ' VAL . 5.8 mp -88.83 163.54 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.365 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -141.53 140.29 31.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 166.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.599 ' O ' HD13 ' A' ' 147' ' ' LEU . 45.9 t80 -100.04 143.08 30.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.402 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.76 170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 93' ' ' THR . 70.4 m . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 12.3 p -127.64 147.18 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.986 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.3 t80 172.8 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.921 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.7 tpt180 . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 122.873 0.469 . . . . 0.0 109.931 172.042 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.87 170.63 14.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.457 HD12 ' HB ' ' A' ' 59' ' ' VAL . 2.5 pp -158.1 142.63 16.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.612 ' HG ' ' CB ' ' A' ' 146' ' ' PHE . 6.0 mp -87.9 110.96 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.999 163.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.457 ' HB ' HD12 ' A' ' 57' ' ' LEU . 4.9 p -107.94 124.81 64.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.351 0.596 . . . . 0.0 111.216 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.957 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -72.74 111.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.073 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.5 -70.12 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.708 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.562 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 8.3 mtm180 -142.99 128.11 18.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.607 0.717 . . . . 0.0 110.736 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -167.13 -153.69 8.07 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.707 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 52.9 Cg_exo -56.07 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 122.598 2.198 . . . . 0.0 113.052 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.612 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 8.1 t30 -70.39 -49.12 52.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 55.61 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.531 -173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.08 0.07 84.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.316 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.843 ' H ' HG23 ' A' ' 60' ' ' VAL . 33.1 t -99.81 -171.59 2.08 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 118.412 1.106 . . . . 0.0 110.383 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.51 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.83 164.18 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -175.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.582 ' HZ ' HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -95.95 129.13 43.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.601 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -85.94 96.54 9.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.761 0.791 . . . . 0.0 109.457 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.819 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -89.43 31.51 0.91 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.336 0.588 . . . . 0.0 109.703 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.0 -28.63 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.697 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.413 ' NE2' HG23 ' A' ' 77' ' ' THR . 13.2 pt20 -95.72 -166.35 1.43 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.747 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.86 -38.05 46.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -162.07 135.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 111.937 -177.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 71' ' ' LEU . 54.1 p -123.77 133.28 53.86 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.58 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.714 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 44.3 m -76.84 126.08 30.38 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -119.45 112.4 19.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -167.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.538 ' HA3' HG12 ' A' ' 94' ' ' VAL . . . 156.56 -88.92 0.12 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.887 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -108.44 104.41 13.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.702 0.763 . . . . 0.0 109.002 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.714 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.289 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.586 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -107.29 109.91 29.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.44 0.638 . . . . 0.0 111.574 -171.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.85 127.22 47.4 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.984 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.957 HD21 HG11 ' A' ' 60' ' ' VAL . 8.1 mt -121.1 82.78 1.97 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.077 170.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.26 -11.16 0.72 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.082 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' LEU . 3.9 p30 40.23 32.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.489 1.515 . . . . 0.0 112.781 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.93 -9.28 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.84 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.693 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.64 -9.94 13.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -172.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.601 HG22 ' CA ' ' A' ' 140' ' ' GLY . 3.4 t -122.41 147.1 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.941 -0.474 . . . . 0.0 110.836 -171.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.9 t -77.39 73.49 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.5 OUTLIER 58.52 -58.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.788 -166.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 10.0 ptp85 -142.58 136.5 29.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.635 0.731 . . . . 0.0 111.35 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.06 -37.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.22 177.75 10.72 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.323 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -133.98 134.46 42.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.819 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -64.18 104.08 0.7 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 102' ' ' ARG . 23.1 ttm180 -105.16 112.34 25.43 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.646 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.786 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.6 tt -84.28 103.77 13.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.577 0.704 . . . . 0.0 110.033 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.08 141.41 51.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 37.3 m-20 62.56 30.98 17.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.786 ' HA ' HD22 ' A' ' 103' ' ' LEU . 16.0 m120 62.15 11.97 4.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.253 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 9.3 pt-20 -117.56 147.11 43.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.632 ' CB ' HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -93.19 119.38 32.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.8 -174.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -123.61 163.02 21.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -107.75 118.49 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.982 170.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 83.5 t -99.41 110.72 27.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.27 136.75 55.41 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.581 0.551 . . . . 0.0 110.047 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.422 HG22 ' CD ' ' A' ' 97' ' ' ARG . 24.2 m -133.69 3.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.093 0.473 . . . . 0.0 110.173 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.33 110.49 2.24 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.307 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.473 ' HB2' HG11 ' A' ' 94' ' ' VAL . 24.3 p -109.61 169.91 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.538 HD23 ' HB ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -64.26 -55.17 23.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.506 -175.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.404 HD22 ' H ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -66.62 -37.45 84.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.97 161.32 10.58 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 121.438 0.465 . . . . 0.0 113.321 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.3 m -112.13 131.21 55.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.954 0.901 . . . . 0.0 111.274 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -141.8 104.95 4.61 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.503 0.192 . . . . 0.0 111.483 175.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.961 HG21 HG12 ' A' ' 137' ' ' VAL . 93.6 t -102.6 119.82 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.964 -0.46 . . . . 0.0 109.97 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.3 37.5 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 64.06 25.11 13.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -176.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.55 133.09 8.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.811 -0.556 . . . . 0.0 110.867 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.78 122.64 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.099 1.866 . . . . 0.0 111.547 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.614 HG13 ' HB ' ' A' ' 121' ' ' VAL . 26.1 m -106.29 179.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 111.309 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 24.2 t70 -108.95 -40.97 4.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.0 t -165.14 91.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.0 124.0 40.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.585 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.6 p -70.69 144.16 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.557 0.694 . . . . 0.0 111.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 1.1 tt -52.05 134.53 32.27 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.592 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -127.59 -176.25 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.66 88.47 2.93 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.015 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.86 -16.82 30.54 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.6 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.885 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 4.2 m-20 -68.85 155.08 40.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.133 0.492 . . . . 0.0 110.786 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -110.1 156.2 20.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 112.566 -170.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.961 HG12 HG21 ' A' ' 121' ' ' VAL . 47.0 t -135.39 132.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.04 118.07 33.8 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.628 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -128.96 131.35 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.368 173.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.601 ' CA ' HG22 ' A' ' 94' ' ' VAL . . . 82.03 -55.76 4.93 Favored Glycine 0 C--N 1.322 -0.231 0 C-N-CA 119.315 -1.421 . . . . 0.0 112.944 167.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.81 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 58.5 pttt 169.21 32.36 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 124.406 1.083 . . . . 0.0 109.082 163.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.81 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.08 150.96 44.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -169.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -93.2 92.15 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.0 mp -88.48 158.34 18.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.204 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.97 143.09 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.885 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -108.49 143.89 36.86 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.742 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? . . . . . 0 C--O 1.234 0.237 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.771 ' O ' ' HA ' ' A' ' 93' ' ' THR . 69.1 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.179 0.514 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HB ' HD21 ' A' ' 116' ' ' LEU . 8.0 p -135.36 147.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.315 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -177.35 -160.06 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.071 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.553 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 O-C-N 124.222 0.951 . . . . 0.0 110.676 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.78 168.7 13.44 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -161.01 146.18 14.13 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.049 -1.06 . . . . 0.0 113.537 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.591 HD21 ' CG1' ' A' ' 110' ' ' VAL . 4.1 mp -87.91 141.16 28.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.634 164.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.602 HG12 HD22 ' A' ' 147' ' ' LEU . 7.3 p -132.74 132.48 59.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.215 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.921 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -74.17 109.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -63.32 -54.74 32.23 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.885 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 71.9 mtt180 -158.38 138.18 12.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.054 174.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -175.65 -155.28 12.55 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 78.2 Cg_exo -55.68 -65.0 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.712 2.274 . . . . 0.0 112.949 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.751 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 52.3 t30 -71.03 -48.38 53.29 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 56.71 153.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.044 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.55 2.22 90.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.811 ' H ' HG21 ' A' ' 60' ' ' VAL . 4.0 m -88.34 176.35 7.25 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.258 0.529 . . . . 0.0 110.26 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.65 HH21 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -170.23 148.27 3.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.812 0.733 . . . . 0.0 112.868 -169.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.49 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -95.89 129.67 43.08 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.65 ' HB2' HH21 ' A' ' 69' ' ' ARG . 1.5 tm? -85.79 101.37 12.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.764 ' HG ' ' CG ' ' A' ' 101' ' ' PHE . 0.7 OUTLIER -95.86 31.58 2.07 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.297 -177.003 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 71' ' ' LEU . 34.7 t70 -89.85 -11.52 41.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.84 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.569 ' O ' ' HE2' ' A' ' 101' ' ' PHE . 1.4 pp0? -121.42 153.84 37.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -42.63 -39.01 2.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.82 123.08 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.255 0.55 . . . . 0.0 112.149 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 1.6 p -113.79 121.84 45.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.802 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.596 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 30.5 m -76.61 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.579 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.675 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -122.21 116.47 24.21 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 170.66 -108.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.671 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -111.79 101.75 10.07 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.596 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.972 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.955 -160.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 87' ' ' ILE . 2.8 m-20 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.437 0.636 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.675 HG22 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -127.75 122.02 57.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.229 -176.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.71 133.16 56.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.238 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.68 HD12 HG12 ' A' ' 139' ' ' ILE . 6.2 mt -108.15 80.33 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 29.7 t70 71.71 -6.84 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.57 0.7 . . . . 0.0 110.134 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.3 p30 40.5 38.77 0.62 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.121 1.368 . . . . 0.0 113.523 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 92' ' ' VAL . 70.8 t -145.67 6.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.737 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 23' ' ' SER . 10.3 p -124.47 -2.2 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -168.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.53 155.55 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.72 -172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.0 m -75.52 79.28 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.032 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 1.021 ' HG2' ' HD2' ' A' ' 97' ' ' ARG . 11.4 ttm180 55.69 -58.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.753 -1.112 . . . . 0.0 112.869 -164.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 1.021 ' HD2' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -157.84 153.87 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.484 -0.76 . . . . 0.0 111.697 -177.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.976 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -95.41 -40.54 9.44 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.304 177.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.86 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -148.61 131.52 16.16 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.667 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -102.98 122.53 44.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.764 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -53.19 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 124.614 1.196 . . . . 0.0 108.406 -176.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.85 107.67 19.95 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 119.359 -0.937 . . . . 0.0 108.742 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.845 HD23 ' HA ' ' A' ' 106' ' ' ASN . 8.8 tt -77.02 107.87 9.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.494 ' C ' HD21 ' A' ' 105' ' ' ASN . 23.6 mt-10 -117.19 134.05 55.25 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.494 HD21 ' C ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER 39.07 43.34 0.8 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.1 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.845 ' HA ' HD23 ' A' ' 103' ' ' LEU . 53.2 m-80 72.08 15.63 5.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.561 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 15.5 pt-20 -122.26 151.68 40.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.939 173.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.947 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -93.42 129.13 39.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.942 -174.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 18.4 m-80 -135.19 161.82 34.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.882 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.4 m -107.03 126.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.37 174.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.86 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 4.0 t -100.3 111.59 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.297 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 11.2 t70 -73.26 115.05 12.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.629 HG13 HG13 ' A' ' 111' ' ' VAL . 16.0 m -115.17 -12.36 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.122 0.487 . . . . 0.0 111.096 -174.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.8 87.57 0.34 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.586 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.976 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 30.7 t -92.32 145.15 24.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.47 HD21 ' HB ' ' A' ' 24' ' ' VAL . 23.9 tp -63.73 -55.41 23.47 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.334 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -67.77 -36.44 80.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.48 169.57 12.42 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.102 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.2 m -112.85 123.53 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.618 -0.791 . . . . 0.0 111.298 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -140.96 103.67 4.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.995 HG11 HG13 ' A' ' 137' ' ' VAL . 1.3 m -99.45 130.27 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.62 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.6 OUTLIER 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.139 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 58.12 32.13 21.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.12 138.79 13.96 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 110.664 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.46 123.26 11.19 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.599 2.199 . . . . 0.0 111.412 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.456 HG22 ' CG2' ' A' ' 121' ' ' VAL . 27.3 m -123.65 169.41 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.41 -61.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.809 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.882 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.5 t -143.84 91.91 2.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.333 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.32 124.89 44.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 8.7 p -67.11 150.81 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.728 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.947 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.0 mp -58.67 145.93 38.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.497 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.443 ' H ' ' HB2' ' A' ' 146' ' ' PHE . . . -151.3 130.79 12.97 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -69.42 121.85 17.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.441 0.639 . . . . 0.0 111.234 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.79 60.98 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.17 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 36.0 m-20 -105.02 147.53 27.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.631 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.58 161.85 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -168.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.995 HG13 HG11 ' A' ' 121' ' ' VAL . 40.6 t -134.51 131.74 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.558 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.414 ' OE1' ' N ' ' A' ' 142' ' ' PHE . 6.6 tp-100 -96.8 120.06 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 169.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.823 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -135.98 129.5 47.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.386 171.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.591 ' N ' HD21 ' A' ' 117' ' ' ASN . . . 76.81 -62.25 3.25 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.597 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.83 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 54.1 pttt 176.41 28.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.122 0.569 . . . . 0.0 111.379 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.83 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -122.82 146.84 47.19 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 109.053 -168.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.631 ' NH1' ' HG2' ' A' ' 136' ' ' GLU . 11.6 ttm-85 -97.1 100.18 11.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.626 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.921 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.4 mp -91.75 166.08 12.95 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.922 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.571 HG23 HD21 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -143.36 144.25 23.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 171.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.507 ' CD2' ' HA ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -84.51 136.87 33.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.953 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 59' ' ' VAL . 2.0 mm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.063 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.875 HG12 ' H ' ' A' ' 25' ' ' PHE . 2.1 t 46.52 -152.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.11 0.564 . . . . 0.0 111.99 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.875 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER 100.1 -165.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.374 1.47 . . . . 0.0 114.376 160.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.524 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 C-N-CA 125.041 1.337 . . . . 0.0 110.578 -172.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.58 36.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' A' ' 72' ' ' LEU . 2.3 pt? -160.71 140.02 10.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.943 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 HD11 ' A' ' 131' ' ' LEU . 5.5 mp -89.67 112.33 23.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.679 168.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.53 125.82 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.916 HG11 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -73.0 113.43 10.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -77.51 -55.94 4.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.014 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -141.53 129.27 21.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.415 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -177.38 178.58 48.31 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.708 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 97.0 Cg_exo -48.46 -48.41 17.31 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.948 2.432 . . . . 0.0 113.465 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 58.0 t30 -83.16 -52.72 6.36 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.97 171.21 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.5 -1.682 . . . . 0.0 112.796 -170.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.6 2.54 89.84 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.917 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.849 ' H ' HG22 ' A' ' 60' ' ' VAL . 3.4 m -98.01 177.76 5.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.626 0.713 . . . . 0.0 110.465 -171.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.19 151.96 3.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.102 0.41 . . . . 0.0 111.636 -176.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HD1' HD12 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -94.95 134.05 38.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.493 ' O ' HD22 ' A' ' 71' ' ' LEU . 6.4 tt -87.05 93.85 9.47 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.727 HD21 ' CD1' ' A' ' 101' ' ' PHE . 4.1 mp -93.39 45.43 1.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -99.0 -28.22 13.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.131 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -92.59 -162.3 0.92 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.006 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.2 -51.5 20.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -158.89 139.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 111.949 -178.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 71' ' ' LEU . 38.3 p -121.16 152.03 39.23 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.343 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 75.8 m -95.57 124.8 39.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.609 ' HB2' HG12 ' A' ' 87' ' ' ILE . . . -126.54 116.23 20.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -166.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 148.99 -85.94 0.16 Allowed Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.176 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.587 ' HG2' ' OD1' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.67 104.03 11.29 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.617 0.722 . . . . 0.0 109.174 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.617 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.096 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.023 -169.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.323 0.583 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.696 HD13 ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -126.85 113.94 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.215 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -116.77 134.32 54.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.132 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.916 HD13 HG11 ' A' ' 60' ' ' VAL . 4.5 mm? -122.22 74.43 1.16 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.934 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.6 t70 72.49 -17.37 0.39 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.454 0.645 . . . . 0.0 110.592 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.587 ' OD1' ' HG2' ' A' ' 81' ' ' ARG . 35.0 t70 61.82 29.52 17.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.386 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -153.75 32.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.952 0.882 . . . . 0.0 109.821 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.621 HG23 ' HZ ' ' A' ' 142' ' ' PHE . 65.3 p -132.81 -9.57 3.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.965 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.0 t -136.38 159.57 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -87.57 77.3 8.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.807 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 58.48 -59.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.929 -165.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.807 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 5.7 ptt85 -143.65 137.63 28.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.621 0.724 . . . . 0.0 111.066 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -75.02 -39.27 61.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 170.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -156.94 149.45 23.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.547 ' CD ' HH21 ' A' ' 102' ' ' ARG . 7.8 pt-20 -108.0 133.1 52.8 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.727 ' CD1' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -56.98 106.12 0.28 Allowed 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.547 HH21 ' CD ' ' A' ' 100' ' ' GLU . 21.1 tpp85 -103.16 104.04 14.15 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.62 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 106' ' ' ASN . 7.3 tt -86.44 110.72 19.92 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.351 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.28 135.36 48.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 57.51 37.74 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.606 0.566 . . . . 0.0 110.329 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.854 ' HA ' HD23 ' A' ' 103' ' ' LEU . 21.1 m120 64.64 12.52 7.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.03 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.1 mt-10 -106.33 144.73 32.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.893 0.377 . . . . 0.0 111.396 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.43 ' HB2' HD22 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -95.9 126.29 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.384 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 11.0 m-80 -135.86 163.36 30.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.894 ' O ' ' HA ' ' A' ' 128' ' ' SER . 7.2 m -111.26 122.59 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.942 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 36.7 t -101.18 110.4 27.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.865 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 18.6 t70 -68.5 128.29 36.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.643 HG22 HH11 ' A' ' 97' ' ' ARG . 18.9 m -126.0 9.51 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.22 0.533 . . . . 0.0 109.734 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.62 71.77 0.59 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.307 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 39.3 t -67.11 134.98 52.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.573 HD12 HG21 ' A' ' 24' ' ' VAL . 1.8 tm? -52.83 -55.82 20.3 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.17 -37.33 58.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 109.825 172.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.73 163.85 9.9 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.15 -173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -111.69 137.41 49.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.394 0.678 . . . . 0.0 111.282 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.11 103.78 4.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.292 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.963 HG22 HG11 ' A' ' 137' ' ' VAL . 61.7 t -112.8 121.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 122.079 -0.388 . . . . 0.0 110.236 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.7 m120 61.29 36.91 17.5 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 63.66 22.11 12.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.477 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.59 148.48 25.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 121.028 0.442 . . . . 0.0 110.949 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.03 123.6 11.5 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.271 1.981 . . . . 0.0 111.78 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.49 155.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.7 0.286 . . . . 0.0 110.281 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.3 m-20 -87.54 -47.08 9.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.641 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.894 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.6 p -154.86 91.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.342 0.592 . . . . 0.0 110.733 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.61 132.85 47.05 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.367 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.1 p -76.06 149.63 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.629 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.801 HD11 HD13 ' A' ' 58' ' ' LEU . 8.7 mp -65.49 133.44 51.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.653 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.08 -176.32 3.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.859 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -93.81 103.78 15.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.36 0.124 . . . . 0.0 111.306 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.09 69.64 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.114 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.59 162.25 23.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.675 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.7 pt-20 -126.89 148.26 50.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -166.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.963 HG11 HG22 ' A' ' 121' ' ' VAL . 61.4 t -123.09 141.44 43.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.024 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.44 ' NE2' ' HA ' ' A' ' 141' ' ' LYS . 20.9 tm0? -106.67 131.12 54.17 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.916 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.48 140.32 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.784 174.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 71.3 -73.73 0.72 Allowed Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.344 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.708 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 52.1 pttt -172.3 29.13 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.078 0.466 . . . . 0.0 110.445 170.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.684 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -127.02 149.32 49.95 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -171.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -98.6 120.26 38.72 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.64 175.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.853 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 4.3 mp -108.16 162.77 13.76 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.575 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.05 137.08 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.687 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.96 154.29 20.29 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.732 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 131' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.06 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.513 ' HB2' HG22 ' A' ' 93' ' ' THR . 41.9 m . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 117' ' ' ASN . 7.1 p -112.46 125.69 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.273 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 176.52 -165.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.822 0.076 . . . . 0.0 110.937 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.514 ' NH1' ' HA2' ' A' ' 63' ' ' GLY . 1.2 tmm_? . . . . . 0 N--CA 1.481 1.096 0 C-N-CA 124.348 1.059 . . . . 0.0 112.484 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' A' ' 131' ' ' LEU . . . -126.86 169.66 13.02 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.5 pt? -153.19 131.92 12.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.742 ' HG ' ' CB ' ' A' ' 146' ' ' PHE . 4.7 mp -87.48 146.64 25.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.6 163.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.8 p -136.1 128.94 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.806 0.336 . . . . 0.0 110.383 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.849 HG21 ' H ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -74.37 115.15 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 18.8 tptp -76.5 -66.35 0.82 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 -172.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -138.92 132.93 31.16 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.978 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.514 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -178.05 -171.37 41.35 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.607 ' CG ' ' HE2' ' A' ' 141' ' ' LYS . 51.0 Cg_exo -53.87 -52.23 8.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.25 1.967 . . . . 0.0 112.893 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.4 t30 -81.36 -54.14 5.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.647 0.737 . . . . 0.0 109.262 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.697 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 53.1 170.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.03 -170.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.35 2.28 90.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.849 ' H ' HG21 ' A' ' 60' ' ' VAL . 5.5 m -97.96 179.55 4.75 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 118.423 1.111 . . . . 0.0 110.966 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -166.25 153.02 9.36 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.3 0.5 . . . . 0.0 111.743 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.636 ' HE1' HD22 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.95 125.35 42.83 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.654 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.12 94.41 9.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.63 0.729 . . . . 0.0 109.481 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.633 ' HG ' ' HD2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -91.37 54.79 2.63 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.776 0.798 . . . . 0.0 109.642 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -98.71 -26.61 14.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.007 171.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.412 ' HG2' HD22 ' A' ' 71' ' ' LEU . 13.2 pt20 -97.31 161.11 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.45 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -16.14 55.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -171.15 133.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 111.761 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 71' ' ' LEU . 35.3 p -120.82 144.34 48.39 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.351 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.732 ' O ' HG22 ' A' ' 87' ' ' ILE . 74.4 m -89.96 124.64 34.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -116.15 123.38 47.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 141.84 -142.07 11.55 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.319 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.861 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.14 104.7 3.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.575 0.702 . . . . 0.0 110.066 174.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.508 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 41.4 m-70 . . . . . 0 N--CA 1.436 -1.136 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.289 -173.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.214 0.531 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -107.33 96.68 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -101.15 130.64 47.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.398 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.679 HD21 HG11 ' A' ' 60' ' ' VAL . 3.8 mm? -115.93 80.64 1.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 37.7 t70 70.46 -10.12 0.72 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.824 0.702 . . . . 0.0 110.481 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.848 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.6 p-10 41.89 33.25 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.581 1.553 . . . . 0.0 113.16 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 t -138.69 -10.7 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.183 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.587 ' HG1' ' HZ ' ' A' ' 142' ' ' PHE . 30.4 p -103.29 -33.64 9.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.79 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.4 t -98.36 149.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 122.238 -0.289 . . . . 0.0 111.358 -170.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.7 t -74.44 77.02 1.92 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.861 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER 59.17 -75.68 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.149 -168.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.669 ' HD2' ' CD ' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -136.45 134.87 38.14 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -174.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.541 ' HE1' HG21 ' A' ' 119' ' ' THR . 0.0 OUTLIER -71.26 -45.7 62.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.69 -179.5 7.92 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.402 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -137.84 124.74 21.27 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.836 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -81.12 90.67 6.05 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.064 0.935 . . . . 0.0 108.82 -177.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.49 ' HD2' HG23 ' A' ' 111' ' ' VAL . 10.6 ptp180 -94.17 151.97 19.07 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.762 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.823 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.0 tt -89.1 105.95 18.12 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -115.52 133.96 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 1.5 p30 48.74 33.44 4.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.692 0.797 . . . . 0.0 111.477 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.823 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.9 m-20 75.92 21.99 1.52 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.663 175.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.81 142.32 40.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.619 ' C ' HD21 ' A' ' 109' ' ' ASN . 7.0 m-85 -84.58 137.64 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -175.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -141.38 160.56 39.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -171.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -103.7 116.71 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.724 177.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 45.3 t -99.21 111.38 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.36 127.36 30.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.338 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 99' ' ' ALA . 10.4 m -127.36 -37.28 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.46 76.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.959 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 48.3 t -88.28 122.22 31.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.9 -55.58 19.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -170.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.502 ' HB2' HG22 ' A' ' 24' ' ' VAL . 7.4 t30 -74.86 -34.91 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.0 110.454 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.49 160.67 9.32 Favored Glycine 0 C--O 1.247 0.95 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.001 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.541 HG21 ' HE1' ' A' ' 98' ' ' HIS . 17.7 m -112.47 122.34 47.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.282 0.633 . . . . 0.0 111.073 171.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 126.13 28.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 137' ' ' VAL . 75.5 t -124.91 119.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 61.31 37.17 17.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.7 19.27 10.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.104 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -143.26 145.08 30.9 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.736 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.8 122.87 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.358 2.039 . . . . 0.0 111.113 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.17 176.73 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 13.6 t70 -109.66 -41.94 4.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.525 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.885 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 10.1 p -165.16 91.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.886 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -92.17 145.3 24.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.001 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.59 135.64 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.668 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -46.51 129.09 10.76 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.022 174.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -135.45 -174.75 3.72 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -106.56 113.15 26.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.356 0.598 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.63 -5.62 84.69 Favored Glycine 0 C--N 1.32 -0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.908 170.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.429 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -88.02 154.66 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER -112.15 149.0 32.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 121' ' ' VAL . 60.7 t -124.9 141.4 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.721 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -109.18 130.8 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.328 0.585 . . . . 0.0 110.42 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.535 ' O ' ' HD1' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -125.09 130.55 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.18 -91.23 0.19 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.023 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.607 ' HE2' ' CG ' ' A' ' 64' ' ' PRO . 19.6 ptmt -147.23 14.19 1.12 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.8 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.611 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -111.03 157.81 19.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -105.48 112.96 26.26 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -107.78 156.69 18.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.542 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.23 143.56 29.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.742 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.37 150.04 27.17 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.685 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.6 mm? . . . . . 0 C--O 1.235 0.338 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.177 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.637 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 27.8 m . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HB ' HD21 ' A' ' 116' ' ' LEU . 10.0 p -130.2 149.42 33.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.077 -171.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.7 t80 177.34 -146.36 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.017 -173.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.3 tpt180 . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 123.406 0.683 . . . . 0.0 110.972 171.84 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.81 167.32 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 57' ' ' LEU . 3.3 pp -161.09 142.52 11.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 mp -86.51 114.02 22.91 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.092 166.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 68' ' ' SER . 4.2 p -109.62 128.39 65.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.621 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.822 HG12 ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -71.56 109.89 4.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.025 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -65.53 -60.68 2.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.914 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -150.95 109.56 3.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.132 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.36 -147.55 5.62 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 72.8 Cg_endo -75.44 -48.99 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.232 1.955 . . . . 0.0 111.911 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.631 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 50.8 t30 -74.36 -49.69 21.74 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 59.31 154.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.56 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.62 1.38 90.14 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.7 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.808 ' H ' HG23 ' A' ' 60' ' ' VAL . 15.6 t -88.36 -178.3 5.85 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.863 0.832 . . . . 0.0 109.896 -174.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.62 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -173.26 150.32 1.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.441 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -95.16 127.19 41.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 172.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.28 91.5 7.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.966 0.791 . . . . 0.0 109.249 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 mp -86.12 53.93 2.96 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.0 109.688 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 55' ' ' SER . 22.9 t70 -113.47 -25.72 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.046 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.401 ' HB2' HE21 ' A' ' 74' ' ' GLN . 22.3 mt-30 -86.44 -167.54 1.91 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.328 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.07 35.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.11 134.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.608 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.448 ' HG1' ' HD2' ' A' ' 101' ' ' PHE . 7.6 p -119.68 128.33 53.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.669 ' O ' HG22 ' A' ' 87' ' ' ILE . 69.9 m -74.93 125.26 28.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 87' ' ' ILE . . . -120.57 108.22 13.79 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -170.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.842 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.08 -146.96 12.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.335 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -69.24 107.63 3.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.604 0.716 . . . . 0.0 109.56 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 61.5 m-70 . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.968 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.513 0.673 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -120.68 113.01 38.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.167 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.45 ' HD2' ' O ' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -104.05 127.2 51.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.247 -174.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.664 ' CD2' HD13 ' A' ' 139' ' ' ILE . 3.2 mm? -114.77 76.22 0.98 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 9.5 t70 66.53 -0.77 1.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.543 0.687 . . . . 0.0 109.641 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.9 p-10 40.62 30.03 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.749 1.62 . . . . 0.0 113.389 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.1 p -166.19 59.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 110.973 172.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 23' ' ' SER . 3.0 p -143.93 -13.99 0.63 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.149 0.5 . . . . 0.0 110.803 170.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -140.84 141.83 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -64.78 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.118 0.567 . . . . 0.0 112.104 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.489 ' CD ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 68.53 -63.08 0.36 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 -177.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.842 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -154.83 132.99 11.71 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.656 -0.653 . . . . 0.0 111.839 175.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.803 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -63.24 -43.56 97.71 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.757 176.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -155.82 174.56 15.14 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.921 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.619 ' HB2' HD13 ' A' ' 76' ' ' ILE . 4.8 pt-20 -135.74 128.9 31.75 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.776 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -54.66 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 124.477 1.11 . . . . 0.0 108.117 -178.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HE ' ' HB2' ' A' ' 102' ' ' ARG . 14.0 ttm180 -98.97 105.84 18.03 Favored 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.454 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.746 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.5 tt -80.24 105.11 11.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.604 0.716 . . . . 0.0 109.575 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.25 135.66 49.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.637 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 62.1 33.47 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.122 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.746 ' HA ' HD22 ' A' ' 103' ' ' LEU . 73.7 m-20 70.94 4.14 4.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.825 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.0 mm-40 -103.47 144.82 30.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.55 ' CB ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -91.24 125.65 36.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 21.1 m-80 -131.18 163.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.619 0.247 . . . . 0.0 111.183 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -105.27 124.44 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 68.3 t -108.9 110.41 31.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.806 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.0 125.62 26.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.559 0.537 . . . . 0.0 109.722 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.53 -27.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.39 83.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.576 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.866 ' HA ' HG22 ' A' ' 94' ' ' VAL . 37.2 t -108.6 120.46 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.526 HD21 ' HB ' ' A' ' 24' ' ' VAL . 58.4 tp -53.16 -56.27 17.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.639 ' ND2' HE22 ' A' ' 138' ' ' GLN . 0.4 OUTLIER -63.44 -34.76 78.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.49 0.662 . . . . 0.0 109.641 177.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.75 169.49 12.37 Favored Glycine 0 C--O 1.253 1.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.145 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 m -112.02 117.33 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.761 0.424 . . . . 0.0 110.917 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -127.72 106.82 9.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.894 HG22 HG21 ' A' ' 137' ' ' VAL . 21.2 t -101.88 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.64 ' ND2' HG13 ' A' ' 121' ' ' VAL . 25.4 m-80 65.06 44.23 3.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 109.319 -174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 63.44 13.25 6.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.004 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.89 131.4 20.98 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-O 121.344 0.592 . . . . 0.0 110.804 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 123.21 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.783 2.322 . . . . 0.0 112.257 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.669 HG21 ' HB3' ' A' ' 129' ' ' ALA . 14.2 m -121.76 165.1 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 2.8 m-20 -108.38 -24.81 11.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.758 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.823 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 21.5 p -164.52 91.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.441 0.639 . . . . 0.0 109.59 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.669 ' HB3' HG21 ' A' ' 126' ' ' VAL . . . -110.22 148.41 31.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.355 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.62 127.63 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.086 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.57 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -63.32 162.9 11.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -166.33 160.83 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.297 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.14 100.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.132 0.492 . . . . 0.0 111.369 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.72 4.38 36.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.727 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.52 119.74 20.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 5.0 tt0 -106.73 134.25 50.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.666 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.964 HG11 ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -117.68 142.22 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.639 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -111.72 115.59 29.34 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.664 HD13 ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -123.83 129.47 74.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.507 175.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.422 ' CA ' HD21 ' A' ' 117' ' ' ASN . . . 74.32 -68.21 1.78 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.066 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.727 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 17.7 ptmt -173.7 31.36 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 116.953 0.377 . . . . 0.0 110.712 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.727 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.71 149.95 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -172.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -103.12 100.87 10.82 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.964 ' HB2' HG11 ' A' ' 137' ' ' VAL . 4.7 mp -96.12 157.85 15.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.75 141.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.292 169.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.57 ' CD1' ' HG ' ' A' ' 131' ' ' LEU . 43.7 t80 -97.81 136.85 37.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.248 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.524 0.678 . . . . 0.0 110.958 170.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 48.6 m . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 6.8 t -101.91 146.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.656 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.8 t80 172.13 -159.11 0.01 OUTLIER 'General case' 0 C--N 1.35 0.592 0 O-C-N 123.603 0.564 . . . . 0.0 110.751 171.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 124.512 1.125 . . . . 0.0 112.691 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.64 168.34 16.6 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.19 147.77 12.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.631 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.907 ' HB2' ' HD1' ' A' ' 70' ' ' PHE . 2.5 mp -86.42 144.32 27.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -123.19 133.02 70.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.012 0.434 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 68' ' ' SER . 79.1 t -65.57 105.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HD2' HG11 ' A' ' 145' ' ' VAL . 59.0 tttm -70.4 -47.49 60.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.762 1.289 . . . . 0.0 110.151 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.419 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 17.9 ttm180 -165.78 144.55 6.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.576 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' CD ' ' A' ' 26' ' ' ARG . . . -173.67 -157.83 16.33 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.716 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 13.9 Cg_exo -67.22 -48.81 1.55 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 119.481 1.64 . . . . 0.0 111.723 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -77.63 -53.51 7.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.009 173.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 62' ' ' ARG . . . 57.14 160.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.109 -172.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.4 2.02 90.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.564 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.722 ' HB2' HG23 ' A' ' 60' ' ' VAL . 6.7 m -88.69 -172.42 3.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.226 0.513 . . . . 0.0 111.362 -173.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.05 152.51 2.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.962 0.346 . . . . 0.0 111.787 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.907 ' HD1' ' HB2' ' A' ' 58' ' ' LEU . 1.5 m-85 -98.2 116.95 31.5 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.536 ' O ' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -78.04 90.13 4.2 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.705 0.764 . . . . 0.0 109.453 -174.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.621 HD11 HD13 ' A' ' 58' ' ' LEU . 15.4 mt -82.75 59.46 4.78 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.573 0.701 . . . . 0.0 109.955 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.01 -26.87 6.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.645 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -98.67 177.64 5.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.84 97.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -157.56 135.8 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -109.91 140.37 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.665 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 87' ' ' ILE . 37.0 m -88.31 124.23 33.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.719 ' HB2' HG22 ' A' ' 87' ' ' ILE . . . -123.21 119.9 31.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 89' ' ' LEU . . . 150.2 -138.29 6.64 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.757 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.9 tmm_? -71.5 104.37 3.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 109.85 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.539 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 55.3 m-70 . . . . . 0 N--CA 1.438 -1.045 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.027 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 N--CA 1.467 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.731 HG21 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -130.36 91.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 122.087 0.946 . . . . 0.0 110.987 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.4 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -95.41 134.19 38.51 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.269 174.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.923 ' HG ' HD13 ' A' ' 139' ' ' ILE . 2.5 mm? -122.03 77.54 1.39 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.768 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.62 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 24.6 t0 66.01 -3.76 0.73 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.757 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.6 p30 43.69 25.65 0.1 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.372 1.469 . . . . 0.0 113.817 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 23' ' ' SER . 10.8 p -147.43 45.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.32 1.057 . . . . 0.0 110.222 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.2 OUTLIER -151.97 -0.6 0.31 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.045 172.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.66 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -135.64 143.15 37.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.9 t -78.29 73.0 4.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER 67.24 -58.47 0.41 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.672 0.749 . . . . 0.0 110.114 -171.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.591 ' HD2' HG13 ' A' ' 113' ' ' VAL . 22.5 ttm180 -146.18 125.28 12.88 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.879 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.767 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -67.18 -46.07 75.07 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -169.98 160.09 8.09 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.869 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.573 ' HB2' HD13 ' A' ' 76' ' ' ILE . 7.3 pt-20 -112.66 117.97 33.75 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.84 ' CZ ' ' HB ' ' A' ' 110' ' ' VAL . 4.4 m-85 -76.37 95.33 3.78 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.124 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -103.05 148.62 25.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.408 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 106' ' ' ASN . 7.2 tt -91.73 117.54 29.85 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -142.88 135.68 27.9 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 48.8 m-80 62.45 32.35 16.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.683 0.615 . . . . 0.0 110.094 -172.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 103' ' ' LEU . 5.1 t30 74.84 -1.29 3.12 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.085 0.865 . . . . 0.0 112.341 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 1.5 mm-40 -109.13 147.19 32.85 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.086 -0.383 . . . . 0.0 109.977 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' CE1' HD11 ' A' ' 103' ' ' LEU . 12.9 m-85 -88.89 130.96 35.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' A' ' 130' ' ' VAL . 13.1 m-80 -140.34 162.63 34.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.0 OUTLIER -107.09 122.02 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.37 172.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 t -101.93 110.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.999 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 99' ' ' ALA . 24.9 t0 -59.28 144.03 47.52 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.867 0.729 . . . . 0.0 109.713 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.591 HG13 ' HD2' ' A' ' 97' ' ' ARG . 1.2 t -142.44 -32.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.824 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.93 103.35 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.723 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 44.2 t -110.23 145.7 36.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.902 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.476 ' CD2' HG21 ' A' ' 24' ' ' VAL . 18.1 tp -58.81 -55.77 30.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.544 0.611 . . . . 0.0 111.675 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 59.2 m-80 -61.37 -38.06 85.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.238 0.542 . . . . 0.0 110.327 177.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.18 167.43 11.52 Favored Glycine 0 C--O 1.246 0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.97 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.495 HG22 ' HE1' ' A' ' 98' ' ' HIS . 16.0 m -111.66 133.63 53.78 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.004 0.522 . . . . 0.0 111.225 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -140.73 131.19 25.31 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.848 173.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.797 HG22 HG13 ' A' ' 137' ' ' VAL . 77.4 t -127.91 113.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.0 42.01 16.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.813 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.64 -2.03 2.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.902 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 141.98 41.64 Favored Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 121.747 -0.596 . . . . 0.0 111.204 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.83 121.99 8.41 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.11 1.874 . . . . 0.0 111.689 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.84 178.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.58 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 21.9 t70 -93.41 -64.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 5.8 p -146.77 92.9 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.231 0.538 . . . . 0.0 109.91 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.99 143.55 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.631 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.512 HG21 ' OD1' ' A' ' 109' ' ' ASN . 3.3 t -84.26 135.85 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.187 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.898 HD13 HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -62.18 161.5 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -158.56 154.67 27.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.25 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.96 97.72 0.69 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.78 4.81 29.74 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.84 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.87 150.96 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.1 tt0 -141.32 133.39 27.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.467 0.651 . . . . 0.0 111.421 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 121' ' ' VAL . 48.0 t -129.13 141.64 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.373 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.84 121.02 44.27 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 173.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.923 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.38 140.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 57.95 -109.79 2.05 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.04 -1.552 . . . . 0.0 109.274 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 64' ' ' PRO . 1.8 pttm -136.3 34.03 2.79 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.907 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -114.96 150.81 35.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 143' ' ' ARG . 14.1 ttm180 -102.19 106.45 17.29 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.662 ' HG ' HG21 ' A' ' 60' ' ' VAL . 2.0 mp -110.29 150.86 28.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.715 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.35 144.2 28.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.851 ' HB2' ' HG ' ' A' ' 58' ' ' LEU . 84.5 t80 -94.22 125.79 39.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.985 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.651 HD21 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? . . . . . 0 N--CA 1.444 -0.733 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.223 169.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.679 ' O ' ' HA ' ' A' ' 93' ' ' THR . 17.9 m . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.02 134.33 41.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.388 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 t80 176.51 176.08 0.31 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.051 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 7.5 tpt180 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 159.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.07 170.03 11.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.539 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.1 pt? -155.5 133.03 11.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.734 HD12 ' CZ ' ' A' ' 101' ' ' PHE . 3.3 mp -85.49 128.43 34.73 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.631 163.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -110.88 125.6 68.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.231 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.886 HG21 ' HG ' ' A' ' 144' ' ' LEU . 67.9 t -65.57 104.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 52.1 tttp -73.45 -57.25 4.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 124.23 0.956 . . . . 0.0 109.873 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -153.34 131.19 11.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.971 0.891 . . . . 0.0 110.944 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.78 -162.35 20.75 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.691 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_exo -59.37 -56.33 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 119.401 1.601 . . . . 0.0 112.669 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 59.8 t30 -70.01 -52.57 23.06 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.05 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.252 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.72 1.04 90.04 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.979 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.711 ' HB2' HG23 ' A' ' 60' ' ' VAL . 18.7 m -85.38 -167.93 2.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.584 0.692 . . . . 0.0 111.542 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.727 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -170.23 154.74 5.02 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -175.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.592 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -95.39 125.1 39.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.683 ' O ' HG23 ' A' ' 77' ' ' THR . 1.1 tm? -84.48 98.27 10.01 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.673 HD21 HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.12 51.61 1.03 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.454 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.439 ' H ' HD13 ' A' ' 71' ' ' LEU . 11.3 t70 -95.68 -19.38 19.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.149 169.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.16 166.58 13.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.85 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.31 63.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.183 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 100' ' ' GLU . 3.2 tp -168.99 130.03 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.76 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 71' ' ' LEU . 22.9 p -123.68 146.91 47.89 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.081 -176.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 87' ' ' ILE . 23.4 m -82.13 125.2 30.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.533 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 97' ' ' ARG . . . -119.04 128.39 54.31 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.18 -132.1 6.1 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.525 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.928 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -80.31 103.93 10.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.666 0.746 . . . . 0.0 109.905 174.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 67.1 m-70 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.971 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.443 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 28.3 m-20 . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -109.06 98.96 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 0.0 111.354 -171.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.65 128.13 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.29 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.77 HD11 ' CD2' ' A' ' 142' ' ' PHE . 3.3 mm? -120.03 86.91 2.65 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.208 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 17.1 t70 69.5 -7.74 0.82 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 0.0 109.611 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 p-10 37.9 34.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.034 1.734 . . . . 0.0 113.749 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.99 0.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.433 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 23' ' ' SER . 1.6 p -104.58 -25.53 12.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.823 -0.548 . . . . 0.0 111.658 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.611 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.9 t -105.12 150.18 8.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -172.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 6.3 t -75.49 72.67 2.5 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.928 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 7.8 ttt180 56.53 -62.37 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.328 -165.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -141.25 127.6 19.86 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.802 -1.186 . . . . 0.0 112.178 -171.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.832 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.13 -45.04 24.35 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -144.23 174.52 10.82 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.104 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.643 ' HB2' HD13 ' A' ' 76' ' ' ILE . 3.7 pt-20 -138.09 120.13 15.54 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.078 -1.874 . . . . 0.0 106.072 166.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.741 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.4 93.16 5.93 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.654 0.74 . . . . 0.0 109.55 -171.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CB ' HD12 ' A' ' 76' ' ' ILE . 9.3 ptp180 -92.61 134.51 34.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.525 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 108' ' ' PHE . 6.3 tt -85.23 114.08 22.06 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -124.5 139.86 53.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.83 39.7 1.81 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.902 0.751 . . . . 0.0 112.229 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.685 ' HA ' HD22 ' A' ' 103' ' ' LEU . 8.0 t30 75.23 13.9 3.1 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 112.429 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 2.3 mp0 -120.87 140.87 51.19 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.922 -0.486 . . . . 0.0 110.413 172.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 103' ' ' LEU . 2.1 m-85 -89.25 139.92 30.0 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.741 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 32.8 m-80 -143.49 155.98 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.963 -170.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -103.49 120.74 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.634 0.731 . . . . 0.0 110.839 179.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.725 HG11 HG12 ' A' ' 113' ' ' VAL . 2.3 t -99.8 118.05 45.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.957 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.14 119.07 19.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.725 HG12 HG11 ' A' ' 111' ' ' VAL . 5.8 m -121.54 -53.03 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -171.19 79.02 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.118 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 32.4 t -91.75 122.64 34.48 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.0 tp -61.78 -54.13 46.51 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.961 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 24.2 m-80 -65.92 -38.77 89.56 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 141.37 157.36 7.14 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.43 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.452 HG23 ' CE1' ' A' ' 98' ' ' HIS . 16.6 m -111.6 125.63 54.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.602 0.361 . . . . 0.0 110.851 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -139.74 105.53 5.16 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.88 174.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.907 HG21 HG11 ' A' ' 137' ' ' VAL . 83.4 t -101.77 122.75 54.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 172.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 63.71 33.34 13.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 52.28 37.78 23.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.803 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.94 139.44 13.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.116 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 122.7 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.014 1.81 . . . . 0.0 111.278 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -114.49 178.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.914 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 18.5 t70 -96.71 -58.88 1.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.115 0.483 . . . . 0.0 109.844 174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 41.8 t -155.81 91.21 1.27 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.051 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.36 149.71 21.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.699 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.73 136.88 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.681 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 146' ' ' PHE . 2.6 tt -56.11 106.67 0.29 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.953 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.29 124.37 24.33 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.823 0.344 . . . . 0.0 111.358 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . 0.461 ' HA ' HD11 ' A' ' 147' ' ' LEU . 3.4 m-20 -54.23 123.93 14.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.84 24.88 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.619 168.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.465 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 1.7 t70 -97.26 165.89 11.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.619 0.71 . . . . 0.0 110.555 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.4 pp20? -116.12 156.99 25.46 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.813 0.816 . . . . 0.0 113.023 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.907 HG11 HG21 ' A' ' 121' ' ' VAL . 68.5 t -131.8 130.08 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.253 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 113.76 25.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.072 0.463 . . . . 0.0 110.249 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.832 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -113.19 124.58 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.223 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 64.8 -108.13 2.18 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.476 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.591 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 7.8 pttt -134.93 21.08 3.5 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.597 0.713 . . . . 0.0 111.354 -174.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.77 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -113.04 143.99 43.37 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -95.65 102.87 14.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.886 ' HG ' HG21 ' A' ' 60' ' ' VAL . 5.1 mp -95.78 161.42 14.02 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.535 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.23 139.46 36.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 172.03 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.7 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.45 130.67 49.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.466 ' CD2' HG21 ' A' ' 145' ' ' VAL . 2.6 mm? . . . . . 0 C--O 1.232 0.177 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.76 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 18.8 m . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.589 ' HB ' HD21 ' A' ' 116' ' ' LEU . 9.5 p -129.73 154.91 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.876 -0.515 . . . . 0.0 112.189 -173.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.6 t80 179.68 -156.51 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.183 0.593 . . . . 0.0 110.274 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -129.14 172.67 11.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.805 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.9 pp -161.07 140.08 10.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.7 mp -85.66 111.28 19.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.4 125.56 59.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.979 HG11 HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -71.04 110.63 4.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HB2' HG12 ' A' ' 145' ' ' VAL . 2.9 tpmt? -64.28 -65.58 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.063 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 36.4 mtt-85 -146.54 134.75 21.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.831 0.824 . . . . 0.0 110.451 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.11 -159.7 17.83 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.732 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 37.4 Cg_exo -62.97 -57.94 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.96 1.773 . . . . 0.0 112.595 178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.622 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 53.9 t30 -73.04 -53.0 12.26 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.643 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 55.18 165.28 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.317 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.33 3.17 90.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.061 170.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -100.73 -170.32 1.84 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 117.729 0.765 . . . . 0.0 111.033 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.747 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -171.7 154.46 3.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.19 0.45 . . . . 0.0 112.042 -170.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' HB2' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -95.79 121.6 37.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 165.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.632 HD21 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -79.89 92.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.681 0.753 . . . . 0.0 109.469 -176.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.805 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 5.6 mt -85.23 51.4 2.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.367 0.603 . . . . 0.0 109.507 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -104.03 -22.18 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.487 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -104.29 -165.54 1.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.018 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.42 -39.85 45.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.793 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.684 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.64 133.1 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 111.534 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 70.7 p -111.29 143.94 41.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.762 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.725 ' O ' HG22 ' A' ' 87' ' ' ILE . 44.6 m -80.57 123.46 28.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 171.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -122.83 113.37 19.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 149.89 -136.96 5.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.731 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.4 104.64 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 75.1 m-70 . . . . . 0 N--CA 1.439 -0.99 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.807 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 8.7 m-20 . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.64 105.59 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.24 178.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -108.16 116.66 32.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.293 176.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.979 HD22 HG11 ' A' ' 60' ' ' VAL . 12.5 mt -102.67 87.57 3.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.635 177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 25.7 t70 66.88 -2.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.344 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.673 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p30 40.65 36.44 0.39 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.189 1.396 . . . . 0.0 113.418 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 23' ' ' SER . 11.9 p -168.64 44.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.421 173.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.507 HG23 ' CZ ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -138.11 -5.16 1.67 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.13 -0.981 . . . . 0.0 111.987 176.148 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -143.16 146.53 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.364 -173.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 12.2 m -66.5 77.35 0.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.811 0.445 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.09 -70.02 0.08 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 123.425 0.69 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 ptp180 -140.41 130.68 25.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.801 -0.562 . . . . 0.0 110.737 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 1.093 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.83 -41.01 45.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.58 164.23 30.78 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.928 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' HD13 ' A' ' 76' ' ' ILE . 8.7 pt-20 -129.54 125.7 36.89 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.688 ' CG ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -61.42 99.23 0.1 Allowed 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -90.45 96.65 10.76 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.975 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.762 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -83.78 104.71 14.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.51 138.24 46.01 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 62.3 31.89 17.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 -173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.762 ' HA ' HD22 ' A' ' 103' ' ' LEU . 7.4 t30 72.58 0.67 3.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.487 0.715 . . . . 0.0 111.831 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 28.2 mm-40 -104.69 139.67 39.18 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.934 -0.479 . . . . 0.0 111.021 -174.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.506 ' CB ' HD12 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.29 125.35 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -126.04 162.04 26.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.336 -178.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.4 m -106.71 124.82 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 9.2 t -101.77 112.52 35.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.32 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 14.1 t70 -74.31 116.4 14.92 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.57 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.785 HG11 HG13 ' A' ' 111' ' ' VAL . 27.0 m -124.67 -20.7 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.409 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 156.21 94.31 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.667 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 1.093 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.3 t -108.64 128.85 55.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.589 HD21 ' HB ' ' A' ' 24' ' ' VAL . 44.3 tp -54.55 -54.37 42.19 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.408 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -65.67 -35.97 82.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.492 0.663 . . . . 0.0 109.3 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.29 170.19 12.59 Favored Glycine 0 C--O 1.257 1.537 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.52 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 m -112.59 122.48 47.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.485 -0.857 . . . . 0.0 110.967 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.59 103.05 5.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.698 HG21 HG22 ' A' ' 137' ' ' VAL . 2.6 p -102.95 110.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.566 HD21 HG23 ' A' ' 121' ' ' VAL . 30.6 m-80 68.7 37.64 2.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.499 -171.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 60.84 26.91 16.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.4 140.92 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.566 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.86 123.42 5.21 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.223 2.616 . . . . 0.0 111.306 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 129' ' ' ALA . 34.3 m -118.6 -179.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 111.49 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 28.3 t70 -100.76 -50.33 3.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.77 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.82 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 42.1 t -158.03 91.55 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.233 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.517 ' HB3' HG22 ' A' ' 126' ' ' VAL . . . -94.15 138.97 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.22 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 109' ' ' ASN . 21.3 t -79.71 129.56 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.823 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -62.57 161.42 12.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.294 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.495 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -160.2 156.11 26.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.81 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -65.77 104.0 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.3 5.75 48.86 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.482 ' HB2' ' HB1' ' A' ' 132' ' ' ALA . 16.3 t70 -83.82 118.12 23.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.958 0.103 . . . . 0.0 110.795 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 53.7 mp0 -94.57 139.6 30.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.266 0.555 . . . . 0.0 112.343 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.698 HG22 HG21 ' A' ' 121' ' ' VAL . 16.4 t -127.72 132.22 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.736 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -95.04 123.44 38.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.99 0.424 . . . . 0.0 110.353 174.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.757 HG12 HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.76 140.16 49.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.37 -72.62 0.45 Allowed Glycine 0 C--O 1.216 -0.987 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.865 167.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.732 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 15.9 ptmt -170.49 16.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.278 0.539 . . . . 0.0 110.276 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.622 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -118.82 147.18 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.182 -169.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -96.02 105.92 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.5 mp -98.42 153.7 18.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.978 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 1.9 m -141.42 145.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.642 ' HE1' HD11 ' A' ' 72' ' ' LEU . 63.4 t80 -97.24 134.52 40.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 146' ' ' PHE . 1.5 mm? . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.741 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 93' ' ' THR . 8.4 m . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HB ' HD21 ' A' ' 116' ' ' LEU . 5.3 p -136.64 155.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -177.92 -147.61 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.186 0.594 . . . . 0.0 109.926 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.95 172.69 9.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.629 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 3.3 pp -160.31 140.55 11.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.4 mp -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.152 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 68' ' ' SER . 3.3 p -103.13 125.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.212 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.862 HG21 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.07 114.69 9.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -68.87 -69.72 0.31 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.331 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -147.54 131.07 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.406 0.622 . . . . 0.0 110.268 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -176.13 -150.16 7.95 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.672 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 37.5 Cg_exo -62.07 -64.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.284 1.989 . . . . 0.0 112.867 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 54.9 t30 -76.31 -52.51 9.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 52.9 169.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.5 -172.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.24 90.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.011 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.862 ' H ' HG21 ' A' ' 60' ' ' VAL . 10.3 m -94.66 -178.03 4.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.34 0.57 . . . . 0.0 110.838 -170.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -169.14 149.25 4.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.259 0.481 . . . . 0.0 111.726 -173.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -94.35 121.9 36.36 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.547 ' O ' HG21 ' A' ' 77' ' ' THR . 0.8 OUTLIER -79.86 94.58 5.86 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -175.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.693 HD23 ' CG ' ' A' ' 101' ' ' PHE . 6.0 mt -90.04 46.59 1.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.867 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.34 -24.12 14.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.277 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -102.33 -166.65 1.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.531 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.24 -37.63 60.95 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.419 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -159.99 131.47 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.547 HG21 ' O ' ' A' ' 71' ' ' LEU . 11.3 p -119.12 127.21 53.14 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.375 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.648 ' O ' HG22 ' A' ' 87' ' ' ILE . 66.5 m -76.45 132.7 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 87' ' ' ILE . . . -126.27 120.98 31.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.11 -127.89 2.61 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.1 tmm_? -73.82 105.77 5.25 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.903 0.859 . . . . 0.0 109.612 175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.159 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.465 -169.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.413 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.378 0.609 . . . . 0.0 111.653 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.758 HD11 HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.46 110.11 20.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.89 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -110.63 132.27 54.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.341 -178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.947 ' HG ' HD13 ' A' ' 139' ' ' ILE . 4.4 mm? -119.85 78.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.614 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 36.0 t0 68.75 -6.34 0.87 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.508 0.67 . . . . 0.0 109.93 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.788 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.4 p-10 41.89 32.86 0.3 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.422 1.489 . . . . 0.0 113.258 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.91 8.06 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.089 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -124.19 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.391 -177.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.3 t -109.16 152.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -173.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.3 m -77.2 66.25 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 0.0 110.454 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.453 ' HE ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 67.43 -56.51 0.45 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.976 -173.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.533 ' HG2' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -146.54 147.04 30.74 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.78 0.8 . . . . 0.0 110.64 175.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.687 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -90.53 -40.75 11.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.912 170.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.835 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -151.15 142.62 23.48 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.58 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.636 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.5 pt-20 -109.72 120.83 43.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.693 ' CG ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.92 104.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.537 -174.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -96.01 107.12 19.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.662 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.852 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.7 tt -89.27 107.28 18.97 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.796 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -128.53 137.76 51.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.074 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 57.19 34.11 24.32 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.49 . . . . 0.0 110.314 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.852 ' HA ' HD22 ' A' ' 103' ' ' LEU . 19.5 t-20 61.29 33.37 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.159 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.6 mt-10 -125.28 135.07 52.13 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.745 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.511 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -86.75 120.19 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.9 OUTLIER -122.64 159.77 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.0 m -107.77 127.86 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.581 173.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.1 t -100.37 111.09 28.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.342 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 12.4 t70 -76.65 114.06 14.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 97' ' ' ARG . 24.1 m -105.24 -20.21 6.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.34 0.59 . . . . 0.0 110.331 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.32 91.93 0.88 Allowed Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.442 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' HB2' ' A' ' 98' ' ' HIS . 0.7 OUTLIER -80.4 162.16 24.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.581 HD21 ' HB ' ' A' ' 24' ' ' VAL . 50.3 tp -61.68 -55.47 30.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.564 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -69.02 -37.6 78.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.246 0.546 . . . . 0.0 110.301 177.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 127.24 169.98 12.79 Favored Glycine 0 C--O 1.254 1.374 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.845 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.2 m -112.1 136.58 51.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.632 0.773 . . . . 0.0 111.118 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -138.05 104.68 5.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.756 HG21 HG11 ' A' ' 137' ' ' VAL . 47.2 t -94.52 105.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.615 HD21 HG12 ' A' ' 121' ' ' VAL . 20.4 m-80 56.61 43.03 26.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER 76.82 -6.9 1.94 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.969 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -119.2 123.92 28.52 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.339 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.62 123.15 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.645 2.23 . . . . 0.0 111.695 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.68 175.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.802 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 31.5 t70 -96.1 -45.81 6.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.873 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.1 t -162.77 105.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.82 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.56 136.33 50.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.332 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.57 129.39 33.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.372 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.573 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -63.9 159.89 18.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.043 177.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -161.44 152.61 18.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.26 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -64.45 105.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.169 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.33 4.32 35.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.604 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.81 136.17 34.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.7 tt0 -122.52 134.01 54.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 111.432 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 121' ' ' VAL . 24.8 t -129.61 141.28 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.159 -174.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -99.4 128.19 45.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.391 172.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.947 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -135.0 138.38 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.088 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 94' ' ' VAL . . . 73.72 -69.08 1.52 Allowed Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.468 165.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.672 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 17.9 ptmt -176.38 16.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.654 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -117.4 149.95 39.68 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.817 -171.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -92.99 129.2 38.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.786 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.2 mp -124.04 152.57 42.49 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.804 0.335 . . . . 0.0 111.743 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.73 143.58 26.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.99 170.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.665 ' O ' HD11 ' A' ' 147' ' ' LEU . 45.8 t80 -100.87 136.58 40.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.892 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.665 HD11 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.58 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 93' ' ' THR . 15.2 m . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.7 p -144.28 168.68 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.047 -169.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 9.3 t80 171.91 -147.0 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 O-C-N 123.922 0.764 . . . . 0.0 110.554 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 131' ' ' LEU . . . -124.59 170.64 10.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.614 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -159.87 137.1 9.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.75 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 72' ' ' LEU . 6.0 mp -87.08 111.41 20.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.275 161.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 p -108.73 128.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.444 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.866 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -72.19 109.01 4.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 35.0 ttpt -61.96 -60.55 3.46 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.511 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -149.93 115.47 5.53 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.506 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.9 -166.15 11.49 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.639 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 23.0 Cg_exo -64.3 -46.6 7.41 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.698 1.599 . . . . 0.0 111.572 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.799 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 41.7 t30 -74.69 -50.43 17.63 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 56.05 155.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.633 -1.622 . . . . 0.0 113.359 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.09 2.42 90.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.11 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.861 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -88.22 -179.83 6.23 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 117.397 0.598 . . . . 0.0 109.996 -171.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.86 151.78 3.48 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.861 0.755 . . . . 0.0 112.107 -173.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.726 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -93.94 125.49 38.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 77' ' ' THR . 1.1 tm? -80.9 94.89 6.58 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.807 HD21 ' CG ' ' A' ' 101' ' ' PHE . 5.2 mt -91.52 50.75 1.77 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.711 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' H ' HD13 ' A' ' 71' ' ' LEU . 23.7 t70 -104.79 -21.88 13.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.923 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -103.29 -167.78 1.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.0 59.48 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.747 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.78 130.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.507 HG23 ' OD2' ' A' ' 86' ' ' ASP . 22.3 p -118.99 132.03 56.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.361 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.6 m -73.99 126.33 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.66 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -118.5 116.34 26.46 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.654 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 157.94 -139.58 6.45 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.21 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.51 104.1 8.89 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.575 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 68.1 m-70 . . . . . 0 C--N 1.315 -0.933 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.291 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.507 ' OD2' HG23 ' A' ' 77' ' ' THR . 16.8 m-20 . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.726 ' HB ' ' HA ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -114.2 100.0 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.808 0.814 . . . . 0.0 111.755 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.93 134.41 50.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.366 173.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.913 ' HG ' HD12 ' A' ' 139' ' ' ILE . 2.9 mm? -115.21 73.15 0.82 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.5 t70 68.23 -5.01 0.95 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.544 0.688 . . . . 0.0 110.175 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.8 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.0 p-10 38.06 42.42 0.46 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.647 1.579 . . . . 0.0 113.133 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.449 ' CG1' ' HB2' ' A' ' 23' ' ' SER . 18.5 t -142.81 -11.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -113.09 -12.16 13.22 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -170.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 115' ' ' SER . 0.9 OUTLIER -135.64 150.88 29.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.872 -0.518 . . . . 0.0 110.986 -170.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -69.15 71.97 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.231 0.613 . . . . 0.0 112.63 -171.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.671 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.34 -54.69 0.15 Allowed 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.426 0.69 . . . . 0.0 111.493 -174.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.664 ' N ' ' HE ' ' A' ' 96' ' ' ARG . 3.5 ttm180 -155.63 124.67 6.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.687 -0.633 . . . . 0.0 110.84 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.62 -40.56 48.96 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.014 176.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -150.39 149.32 29.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.168 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 111' ' ' VAL . 5.3 pt-20 -113.11 130.58 56.13 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.807 ' CG ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -63.42 101.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.501 ' NH2' HG23 ' A' ' 111' ' ' VAL . 19.6 ttm180 -100.55 114.12 27.5 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.571 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 108' ' ' PHE . 14.7 tp -75.64 109.06 8.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.472 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -112.37 123.98 51.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.473 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 42.47 44.26 3.44 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.049 0.843 . . . . 0.0 111.806 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t30 75.7 0.18 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.149 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.6 mm-40 -104.5 133.13 49.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -85.79 131.92 34.22 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -172.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 14.2 m-80 -134.1 171.21 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.822 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.3 m -110.1 156.58 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 168.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.771 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 27.0 m -126.28 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 170.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.77 116.77 14.76 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.42 -22.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.764 0.316 . . . . 0.0 111.366 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.82 102.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.991 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.9 t -115.81 133.53 55.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.599 HD12 ' HB ' ' A' ' 24' ' ' VAL . 2.7 tm? -56.44 -55.46 33.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -36.02 78.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.06 170.64 12.08 Favored Glycine 0 C--O 1.251 1.205 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.866 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -112.04 133.22 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.036 0.535 . . . . 0.0 110.753 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -138.19 103.35 4.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 120.938 0.399 . . . . 0.0 111.043 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.732 HG23 HG13 ' A' ' 137' ' ' VAL . 55.2 t -98.61 123.11 50.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 64.1 33.33 12.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 61.32 28.01 17.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.953 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.7 pt-20 -146.47 150.9 42.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 121.65 -0.656 . . . . 0.0 111.025 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 125.7 11.1 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.572 2.181 . . . . 0.0 111.88 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.24 179.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.741 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -106.55 -47.35 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.3 0.572 . . . . 0.0 109.808 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.8 t -158.16 91.75 1.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.946 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.56 136.65 38.36 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.616 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.94 150.51 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.919 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.695 HD11 HD13 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -63.72 119.41 9.87 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.307 175.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.61 121.89 25.11 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.2 118.88 7.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.743 0.782 . . . . 0.0 111.939 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.31 -13.1 33.6 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.254 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.405 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 2.3 t0 -96.63 173.01 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 5.2 pt-20 -139.74 151.87 46.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.572 -168.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 121' ' ' VAL . 39.8 t -127.56 141.57 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -98.28 129.64 44.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.944 0.402 . . . . 0.0 110.517 169.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ILE . . . . . 0.913 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -134.55 133.51 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 166.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 71.03 -77.14 0.56 Allowed Glycine 0 C--O 1.215 -1.04 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.956 172.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.639 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 12.9 ptmt -168.03 25.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.516 0.658 . . . . 0.0 110.755 173.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.799 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -115.81 141.43 48.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -173.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 143' ' ' ARG . 5.5 ttp85 -94.9 106.32 18.3 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.312 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.4 159.51 14.96 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.803 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.9 142.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.738 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -110.49 138.4 46.92 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.283 0.563 . . . . 0.0 112.326 -178.06 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 131' ' ' LEU . 2.8 mm? . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.156 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.235 0.308 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 m 63.23 48.74 3.54 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.888 0.851 . . . . 0.0 109.274 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.44 -153.41 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.136 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.8 mtt 65.65 50.19 1.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 42.7 t30 70.45 96.91 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.588 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 24.1 Cg_endo -62.48 -3.68 4.57 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.247 2.631 . . . . 0.0 113.147 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -66.97 -27.69 67.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mt -78.05 74.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.624 0.726 . . . . 0.0 109.233 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -81.75 52.12 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.983 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -135.93 137.22 41.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.058 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -124.26 -176.48 3.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.29 -65.26 0.73 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 m -161.0 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.597 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 24.0 p -167.06 -164.61 0.63 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.896 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.7 m-20 75.15 169.06 0.28 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.926 0.766 . . . . 0.0 112.834 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -145.52 -47.07 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.467 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.5 m -73.01 132.65 33.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.561 0.696 . . . . 0.0 111.295 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -141.44 -49.15 0.4 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.08 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.53 75.5 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.32 0.581 . . . . 0.0 110.249 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -90.41 -38.16 13.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 22' ' ' TPO . 94.4 m -103.24 142.05 34.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.41 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.702 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -66.61 134.5 52.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -162.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.58 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 92.2 t -102.24 137.38 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.272 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 12.6 t80 174.08 159.77 0.16 Allowed 'General case' 0 C--O 1.213 -0.859 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.505 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.676 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 10.4 tpt85 64.31 -23.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 163.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . . . -45.63 164.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -167.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.741 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 8.2 t70 -63.15 68.19 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.001 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CE2' ' HE2' ' A' ' 120' ' ' TYR . 51.3 m-85 -145.95 -48.81 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.943 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.587 HD21 ' H ' ' A' ' 30' ' ' LEU . 2.7 pt? -117.28 -40.15 3.12 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.598 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 55.0 m -132.39 178.09 7.09 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.683 -0.636 . . . . 0.0 112.601 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 6.9 tp10 75.7 -57.18 0.58 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.509 1.124 . . . . 0.0 111.005 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.5 -76.44 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.207 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 68.74 -60.85 0.43 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.364 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.64 154.7 78.35 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.66 57.59 3.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 112.355 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.77 103.46 16.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.109 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -96.52 122.28 39.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.21 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.08 102.91 15.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.74 77.95 2.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.687 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -133.06 146.37 51.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.97 0.414 . . . . 0.0 110.675 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.27 170.48 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.958 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 m -84.47 65.45 8.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.93 -84.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.566 0.746 . . . . 0.0 112.42 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -93.25 -7.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.936 0.398 . . . . 0.0 110.877 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.564 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 66.7 m 67.84 169.41 0.27 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.609 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.32 -1.56 28.08 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.13 21.26 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.258 1.027 . . . . 0.0 110.297 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.564 ' OE2' ' HA ' ' A' ' 46' ' ' SER . 0.0 OUTLIER -128.47 -42.34 1.48 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.306 171.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -96.44 60.04 1.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.593 ' O ' ' HG ' ' A' ' 51' ' ' LEU . 1.1 pt? -103.13 109.58 61.88 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -108.11 28.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.412 0 C-N-CA 123.098 2.532 . . . . 0.0 115.795 170.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.38 39.7 0.84 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 CA-C-N 121.646 1.624 . . . . 0.0 112.726 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 15.62 76.95 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -144.15 147.89 34.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.202 -0.499 . . . . 0.0 109.773 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.4 42.98 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 72' ' ' LEU . 5.1 mp -148.38 139.24 23.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.669 HD21 ' CE1' ' A' ' 101' ' ' PHE . 3.6 mp -85.87 135.21 33.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 68' ' ' SER . 3.8 p -125.23 128.57 72.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.158 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.86 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 1.5 m -73.11 109.89 5.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HZ1' HG11 ' A' ' 145' ' ' VAL . 2.2 ttmp? -57.76 -60.6 3.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.97 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.56 146.59 8.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.364 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 152.02 130.3 1.59 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -175.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.676 ' CD ' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 1.67 -71.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.876 5.051 . . . . 0.0 118.054 -159.22 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.4 t30 -62.94 -51.67 66.0 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 119.116 0.871 . . . . 0.0 109.123 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.623 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 53.5 165.29 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.221 -1.808 . . . . 0.0 114.172 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.08 4.45 90.24 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.841 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.813 ' H ' HG21 ' A' ' 60' ' ' VAL . 19.9 m -106.71 -167.79 1.33 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 118.053 0.926 . . . . 0.0 112.027 -166.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.466 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.86 151.74 3.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -168.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.701 ' HE1' HD21 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.69 118.16 33.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 166.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.608 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.21 107.13 15.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.615 HD21 HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.04 28.02 4.22 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.469 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.4 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 25.1 t70 -67.83 -28.24 67.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -96.89 164.19 12.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.683 171.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.85 -16.84 62.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -168.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -173.94 126.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.425 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.41 131.98 55.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.899 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 87' ' ' ILE . 70.0 m -71.76 129.53 38.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.358 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.624 ' HB3' HG23 ' A' ' 87' ' ' ILE . . . -116.32 121.31 41.6 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.519 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 147.0 -127.99 2.85 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.244 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.26 102.93 14.4 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.511 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 79.3 m-70 -137.73 123.77 13.0 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.729 -171.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.56 -40.13 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.671 2.248 . . . . 0.0 111.001 166.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -146.44 104.52 3.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.154 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 42.9 m -160.76 -88.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -173.99 -59.91 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -90.23 91.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.911 0.862 . . . . 0.0 110.416 178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.519 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -104.58 123.89 48.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.353 172.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.937 HD13 HD23 ' A' ' 144' ' ' LEU . 15.4 mt -110.46 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.476 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 37.4 t70 74.09 -26.28 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.471 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.8 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 16.9 t70 63.52 28.15 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 122.658 1.218 . . . . 0.0 110.524 174.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 22' ' ' TPO . 46.2 t -135.73 -12.75 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.987 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.571 ' HB ' HD22 ' A' ' 117' ' ' ASN . 1.5 p -108.38 -29.85 8.62 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.477 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.8 t -103.39 151.65 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.107 -0.371 . . . . 0.0 110.899 -169.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.702 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 15.9 m -74.56 69.3 1.7 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.591 0.356 . . . . 0.0 110.074 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.677 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 56.33 -62.94 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.01 -166.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.609 ' HG2' ' NE ' ' A' ' 96' ' ' ARG . 7.6 ptp180 -133.85 139.38 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 120.849 -1.157 . . . . 0.0 111.047 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.57 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -83.88 -43.79 14.95 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.727 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -147.3 163.35 36.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.308 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.651 ' HB2' HD12 ' A' ' 76' ' ' ILE . 7.5 pt-20 -122.47 122.14 38.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 165.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.776 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.3 OUTLIER -79.58 92.03 5.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -173.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.429 ' HD2' HG21 ' A' ' 111' ' ' VAL . 11.6 ptp180 -92.8 131.85 37.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.713 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.709 HD22 ' HA ' ' A' ' 106' ' ' ASN . 6.2 tt -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.455 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 63.02 31.58 15.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.211 0.319 . . . . 0.0 110.456 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.709 ' HA ' HD22 ' A' ' 103' ' ' LEU . 56.3 m-20 68.81 7.46 6.17 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.802 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -117.35 133.51 55.89 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.004 0.431 . . . . 0.0 110.391 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.661 ' CE2' HD11 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -85.64 140.2 30.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.776 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 33.0 m-80 -144.73 157.15 44.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.386 -173.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -102.13 118.98 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.591 0.71 . . . . 0.0 110.329 177.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 2.1 t -99.81 113.36 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.792 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.445 ' HB2' HG22 ' A' ' 119' ' ' THR . 14.4 t70 -74.67 129.86 38.47 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.929 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.53 HG12 HG12 ' A' ' 111' ' ' VAL . 20.3 m -132.16 19.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 103.99 0.55 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.654 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 98' ' ' HIS . 31.9 p -104.17 152.83 21.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.598 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 3.2 tm? -59.42 -55.84 29.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -170.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.571 HD22 ' HB ' ' A' ' 93' ' ' THR . 31.2 m-80 -67.81 -36.39 80.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.876 0.369 . . . . 0.0 110.611 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.89 150.76 5.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.213 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.546 HG23 ' CE1' ' A' ' 98' ' ' HIS . 19.6 m -109.47 126.6 53.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 111.52 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.455 ' HE2' ' CE2' ' A' ' 29' ' ' PHE . 38.1 m-85 -139.73 157.15 46.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.109 171.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.714 HG23 HG21 ' A' ' 137' ' ' VAL . 2.4 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.55 45.28 8.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.069 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? 69.1 9.69 7.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 176.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.56 136.74 24.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.355 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.06 138.35 33.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.917 2.411 . . . . 0.0 111.771 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.623 HG23 ' HB2' ' A' ' 129' ' ' ALA . 19.7 m -135.47 179.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.674 0.273 . . . . 0.0 111.215 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.8 m-20 -95.84 -53.23 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.1 p -154.0 91.67 1.47 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.623 ' HB2' HG23 ' A' ' 126' ' ' VAL . . . -89.99 143.78 26.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.15 135.87 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.893 -174.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.738 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 2.3 tt -53.08 117.76 3.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.979 168.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.418 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -124.7 -175.73 3.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.175 -172.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -103.14 94.55 5.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.45 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.52 -22.89 23.55 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.46 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.85 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 7.1 m-20 -73.0 158.86 34.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.444 0.164 . . . . 0.0 110.652 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.663 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 9.2 pt-20 -133.89 150.56 51.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.079 0.942 . . . . 0.0 113.087 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.714 HG21 HG23 ' A' ' 121' ' ' VAL . 46.5 t -115.68 144.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.552 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.741 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.6 tp-100 -97.17 119.67 36.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 172.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.745 HG12 HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.08 120.6 65.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.537 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 63.39 -102.14 0.51 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 118.871 -1.633 . . . . 0.0 110.889 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.583 ' HD2' ' HG2' ' A' ' 64' ' ' PRO . 8.9 pttt -142.14 42.32 1.66 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.259 0.552 . . . . 0.0 111.651 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.732 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -134.97 148.92 50.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 33' ' ' LEU . 4.7 ttm180 -98.71 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.937 HD23 HD13 ' A' ' 89' ' ' LEU . 2.9 mp -116.6 110.65 18.8 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.663 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -103.4 140.85 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 120.9 0.381 . . . . 0.0 110.395 -177.033 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.85 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -107.88 147.22 31.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.215 0.531 . . . . 0.0 112.397 -177.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.552 ' HG ' ' HB2' ' A' ' 49' ' ' GLU . 2.3 mm? -137.91 161.93 35.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.529 ' OG1' ' HD2' ' A' ' 150' ' ' PRO . 15.3 t -172.83 161.3 4.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.002 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.431 ' O ' ' HG2' ' A' ' 151' ' ' LYS . . . -60.47 -56.88 21.95 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.254 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.529 ' HD2' ' OG1' ' A' ' 148' ' ' THR . 82.6 Cg_exo -47.1 134.92 18.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.97 2.447 . . . . 0.0 112.367 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 149' ' ' GLY . 19.6 pttm -165.69 -63.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.042 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -137.12 19.0 2.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.14 157.45 33.38 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -124.27 106.42 10.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.3 -21.43 36.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.22 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.87 140.3 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.036 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -165.4 117.14 0.73 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.205 -0.997 . . . . 0.0 113.074 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.0 m -108.14 -12.19 15.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.025 0.44 . . . . 0.0 109.888 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 31.7 m -88.38 107.61 18.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -162.13 48.7 0.34 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.76 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -110.55 103.91 1.71 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.021 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 C--O 1.247 0.945 0 C-N-CA 123.219 2.613 . . . . 0.0 112.056 178.961 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 121.813 0.816 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.7 m -98.48 132.78 43.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.044 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t70 71.27 136.09 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.08 0.863 . . . . 0.0 111.043 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 38.5 tpp -95.11 15.32 19.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.409 HD21 HD12 ' A' ' 8' ' ' ILE . 18.9 m120 -126.49 67.4 65.62 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.75 96.47 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.869 2.379 . . . . 0.0 112.136 -176.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 59.03 59.51 2.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.683 177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.409 HD12 HD21 ' A' ' 5' ' ' ASN . 66.5 mt -102.02 125.88 56.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.81 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 58.28 53.78 6.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.465 0.65 . . . . 0.0 110.677 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -88.93 21.63 3.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.49 139.32 58.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.113 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 6.5 tp60 -123.54 140.84 52.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 m 70.1 83.38 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.709 0.631 . . . . 0.0 110.901 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.3 m 72.66 160.4 0.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.05 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.825 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 19.4 m-20 -118.03 171.67 7.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.852 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -67.48 -65.06 0.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 t -120.15 79.2 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.825 ' HB ' ' HB2' ' A' ' 15' ' ' ASP . 11.6 t -80.84 -9.41 59.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.404 -173.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.08 126.9 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -63.37 100.7 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.616 HG21 HD23 ' A' ' 116' ' ' LEU . 12.3 m -97.51 138.01 35.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.431 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.644 ' HB ' HD21 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -15.92 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.96 1.704 . . . . 0.0 114.961 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.745 HG21 ' HB2' ' A' ' 117' ' ' ASN . 9.4 p -131.35 153.92 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.827 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.623 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 36.8 t80 178.98 -163.6 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.238 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' A' ' 27' ' ' ALA . 7.5 tpt180 50.5 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.008 0.822 . . . . 0.0 111.171 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.55 ' H ' ' HB2' ' A' ' 141' ' ' LYS . . . 60.41 149.31 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 122.203 1.001 . . . . 0.0 112.392 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -104.92 67.36 0.79 Allowed 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.954 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' O ' HD13 ' A' ' 33' ' ' LEU . 71.4 m-85 -121.71 -52.97 2.0 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 173.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.51 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 15.4 tp -141.37 43.84 1.76 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.96 0.886 . . . . 0.0 110.508 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -138.84 -73.39 0.39 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.265 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -74.66 -26.91 60.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.074 0.464 . . . . 0.0 109.927 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -86.33 -77.8 0.3 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.62 -84.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.665 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.68 160.37 29.35 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.74 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 113.052 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.47 50.95 15.0 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.457 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.524 ' HA ' ' OE1' ' A' ' 38' ' ' GLN . 5.4 tp60 57.52 43.24 23.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.943 0.877 . . . . 0.0 110.476 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.35 162.7 39.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.486 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.92 151.51 18.68 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.681 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 m -64.55 108.6 1.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 66.13 101.22 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 O-C-N 123.878 0.736 . . . . 0.0 110.748 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.4 m -61.31 -33.92 74.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.348 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.7 -89.65 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.15 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.6 172.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 p -139.59 31.79 2.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.12 -73.36 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.782 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.8 m 36.23 55.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.979 0.912 . . . . 0.0 112.392 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -80.11 -29.31 38.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.566 -175.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 60.04 53.54 44.9 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.835 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.657 HD12 ' HG ' ' A' ' 57' ' ' LEU . 1.1 pt? -106.01 112.22 64.28 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -174.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 53.4 Cg_endo -112.93 32.11 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.403 2.735 . . . . 0.0 114.379 161.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 5.1 Cg_exo -77.91 57.05 5.93 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 121.826 1.684 . . . . 0.0 112.522 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.06 13.55 72.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.914 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -164.81 150.09 9.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.081 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.67 168.98 16.8 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.657 ' HG ' HD12 ' A' ' 51' ' ' LEU . 1.2 pp -152.53 134.06 14.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 101' ' ' PHE . 3.8 mp -88.08 126.36 35.06 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.679 162.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.543 HG23 HD11 ' A' ' 57' ' ' LEU . 92.6 t -120.83 133.55 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 117.996 0.362 . . . . 0.0 110.616 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.14 119.7 27.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -53.78 -80.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.625 1.203 . . . . 0.0 111.663 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.64 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 43.3 ttt180 -161.74 81.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.568 -174.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -112.5 -143.84 9.05 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 174.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.681 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 42.5 Cg_exo -58.17 -66.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.21 1.94 . . . . 0.0 113.039 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 61.6 t30 -69.35 -52.8 23.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 62' ' ' ARG . . . 55.09 166.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.227 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.55 3.21 90.11 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.277 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.819 ' H ' HG23 ' A' ' 60' ' ' VAL . 4.2 m -96.39 177.45 5.69 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.598 -167.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.661 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -166.29 153.43 9.62 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -173.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.652 ' HE1' ' CD2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -95.46 122.88 38.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 167.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.66 HD21 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -83.17 93.84 7.73 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.43 0.633 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.641 HD23 HD11 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -88.46 45.78 1.32 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.916 0.865 . . . . 0.0 109.219 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -90.95 -13.47 33.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.951 172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.48 174.75 5.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.783 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -66.0 -60.89 2.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.655 HD13 ' HB2' ' A' ' 100' ' ' GLU . 1.3 tp -125.68 122.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.313 0.578 . . . . 0.0 111.802 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -104.83 171.71 7.17 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.062 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.778 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -117.27 124.09 48.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.495 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.75 121.34 42.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 139.07 -129.95 4.64 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.204 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -84.88 103.27 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.495 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 89.0 m-70 -137.94 132.52 17.19 Favored Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.082 -173.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -64.78 -65.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.943 2.429 . . . . 0.0 112.839 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -126.28 29.78 5.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 82' ' ' HIS . 10.0 m -93.4 -170.88 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.841 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -66.69 0.78 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.331 0.586 . . . . 0.0 111.085 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.778 HG23 ' O ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -100.64 95.87 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.632 0.73 . . . . 0.0 110.867 -175.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -109.14 128.97 55.46 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.552 177.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.913 HD13 HG12 ' A' ' 60' ' ' VAL . 4.0 mm? -113.28 84.63 2.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.695 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.4 t70 66.18 -1.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.22 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 2.9 p30 41.01 37.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.171 1.388 . . . . 0.0 113.921 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.427 ' O ' HG21 ' A' ' 92' ' ' VAL . 9.9 p -161.11 21.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.625 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.628 HG23 ' HZ ' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -123.17 -7.15 8.28 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.495 -0.753 . . . . 0.0 111.675 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.546 HG21 ' HA3' ' A' ' 140' ' ' GLY . 1.9 t -125.47 152.16 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -173.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.622 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 15.8 m -73.05 70.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.05 0.452 . . . . 0.0 110.279 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.689 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.56 -67.93 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.936 -168.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.596 ' HG2' ' NH2' ' A' ' 96' ' ' ARG . 7.2 ptp180 -136.31 128.74 30.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.544 -1.347 . . . . 0.0 111.493 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.814 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -65.31 -46.05 81.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 171.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.497 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -148.95 179.13 8.1 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.008 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.655 ' HB2' HD13 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.29 123.55 14.71 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.774 ' CZ ' HD13 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.12 93.05 3.28 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.098 0.951 . . . . 0.0 109.82 -168.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.5 ' HA ' HD12 ' A' ' 76' ' ' ILE . 6.1 tpp180 -81.3 123.6 28.65 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.762 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.873 HD13 ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.04 126.58 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 22.3 tt0 -150.55 126.52 10.46 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 64.82 41.69 4.87 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.651 0.594 . . . . 0.0 109.721 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.873 ' HA ' HD13 ' A' ' 103' ' ' LEU . 3.1 p-10 51.4 22.19 1.39 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.581 1.152 . . . . 0.0 113.313 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 12.5 pt-20 -118.19 134.27 55.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.574 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -87.91 143.25 27.22 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.629 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 25.0 m-80 -147.36 156.25 42.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.574 0.625 . . . . 0.0 111.447 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -102.54 116.26 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.116 176.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 76.2 t -101.03 111.52 30.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.345 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.59 126.03 28.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.021 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 99' ' ' ALA . 18.9 m -134.9 14.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.23 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.47 105.08 2.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.791 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.708 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.2 t -118.57 128.04 54.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.644 HD21 ' HB ' ' A' ' 22' ' ' TPO . 29.3 tp -55.17 -56.24 22.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.877 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.745 ' HB2' HG21 ' A' ' 24' ' ' VAL . 16.9 t30 -62.85 -38.41 90.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.984 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.87 161.26 8.94 Favored Glycine 0 C--O 1.256 1.483 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.646 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.563 HG22 ' HE1' ' A' ' 98' ' ' HIS . 8.1 m -111.39 134.11 53.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.103 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.534 ' CE2' ' HA ' ' A' ' 123' ' ' ARG . 0.1 OUTLIER -141.48 131.27 24.28 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.707 HG21 HG11 ' A' ' 137' ' ' VAL . 80.8 t -142.01 114.19 3.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.01 43.54 14.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.534 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 79.8 mtp180 66.86 14.13 9.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -142.3 141.59 21.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 121.914 -0.492 . . . . 0.0 110.622 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 122.96 11.09 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.968 1.779 . . . . 0.0 110.748 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.484 HG11 ' HB ' ' A' ' 121' ' ' VAL . 20.4 m -111.61 174.0 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.389 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.589 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 6.1 m-20 -98.11 -47.67 5.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.045 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.895 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.4 p -160.67 102.45 1.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.571 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -99.9 142.45 31.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.83 131.06 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 123.421 0.45 . . . . 0.0 110.739 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.627 HD23 ' HB ' ' A' ' 148' ' ' THR . 2.1 tt -51.43 115.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.424 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . . . -120.05 -175.21 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -174.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.51 96.78 6.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.624 0.249 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.14 4.98 29.01 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.144 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.904 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 11.6 m-20 -107.46 160.83 15.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.32 0.56 . . . . 0.0 110.247 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -118.08 155.87 29.61 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -166.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.707 HG11 HG21 ' A' ' 121' ' ' VAL . 59.8 t -133.69 141.82 43.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.765 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.521 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -116.77 124.52 49.82 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.814 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -131.22 132.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.986 175.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 94' ' ' VAL . . . 84.11 -56.44 5.04 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 119.258 -1.448 . . . . 0.0 113.763 166.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.681 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 43.3 pttt 171.17 27.18 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.144 0.578 . . . . 0.0 110.688 168.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.726 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.56 146.8 51.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.405 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . 10.0 ttm180 -92.68 119.21 31.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.237 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -110.08 156.93 19.9 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.12 143.11 28.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 172.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.904 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -102.15 141.64 34.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.935 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.603 HD11 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -129.48 142.78 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.218 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.627 ' HB ' HD23 ' A' ' 131' ' ' LEU . 14.5 t -159.15 155.48 27.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.959 0.409 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -98.99 110.24 3.96 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.609 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.46 -45.06 32.65 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.522 2.148 . . . . 0.0 112.045 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.41 ' HB2' ' HE2' ' A' ' 151' ' ' LYS . 23.0 ttmm -154.25 0.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 63.52 6.13 2.42 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.486 -173.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.495 ' C ' ' H ' ' A' ' 155' ' ' ASP . . . -66.53 148.39 50.62 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.088 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.33 29.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.19 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 153' ' ' GLY . 19.4 t70 -74.69 101.65 4.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.803 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.25 -52.89 6.18 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 124.73 137.52 4.84 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.823 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.9 t -112.69 84.48 1.99 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.46 -18.75 29.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.965 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 135.76 -64.53 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.24 -67.08 1.66 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 N--CA 1.447 -1.226 0 C-N-CA 122.788 2.325 . . . . 0.0 110.629 169.041 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 121.439 0.637 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -113.79 -16.76 12.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.174 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -143.6 34.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.4 mtt -136.61 -76.65 0.42 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.541 -172.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.78 159.91 27.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.76 111.61 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.423 2.749 . . . . 0.0 113.261 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.22 12.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.431 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 tt -90.05 -7.75 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 110.944 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -85.38 107.85 17.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.334 -0.394 . . . . 0.0 109.957 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 51.1 mttp 72.76 1.77 4.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.383 0.673 . . . . 0.0 112.572 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.33 159.08 44.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 52.18 43.71 30.34 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.686 0.755 . . . . 0.0 110.266 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -94.0 -54.43 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.886 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -131.87 41.17 3.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -133.49 57.59 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.495 0.664 . . . . 0.0 110.697 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.76 116.96 12.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.2 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.81 -51.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.453 0.644 . . . . 0.0 109.462 174.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 t -148.34 125.89 11.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.48 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.89 107.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 51.56 55.56 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.073 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.7 m -108.93 133.06 53.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.369 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.791 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 17.2 m 9.84 115.08 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.509 1.924 . . . . 0.0 115.666 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.668 ' HB ' HD13 ' A' ' 116' ' ' LEU . 4.4 p -134.77 157.57 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.633 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -177.07 -171.78 0.37 Allowed 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.52 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 51.66 -111.46 0.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.222 0.465 . . . . 0.0 110.078 171.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . . . 64.11 169.24 0.17 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 167.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.579 ' HA ' HD21 ' A' ' 33' ' ' LEU . 12.4 t70 -84.19 77.85 9.89 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.739 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -143.22 -51.12 0.35 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.36 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.7 tp -93.59 -68.64 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.775 -176.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.8 p -169.73 -158.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.721 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 63.22 25.64 14.87 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.831 0.824 . . . . 0.0 110.497 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.579 HD21 ' HA ' ' A' ' 28' ' ' ASP . 1.9 pp -165.04 -34.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.151 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.518 ' N ' HD11 ' A' ' 33' ' ' LEU . 38.7 t70 -80.08 59.04 3.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.21 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -168.13 67.78 0.78 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.5 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.0 67.54 8.04 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.153 2.568 . . . . 0.0 111.758 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.93 81.19 1.38 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -142.97 111.38 6.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.647 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.22 120.98 24.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.17 -79.93 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.788 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.7 m -139.58 58.05 1.62 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.464 0.649 . . . . 0.0 110.295 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 42' ' ' GLU . 1.5 pm0 -83.97 78.99 9.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.497 0.665 . . . . 0.0 110.643 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -125.67 145.48 50.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.39 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.54 92.15 2.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.981 0.419 . . . . 0.0 111.45 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.7 m -111.12 144.74 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.743 175.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.5 m -142.94 114.71 8.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.815 0.341 . . . . 0.0 110.535 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.08 -42.96 0.31 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.541 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.91 26.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.228 0.514 . . . . 0.0 112.097 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -85.38 -59.96 2.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.653 ' CA ' ' HA ' ' A' ' 148' ' ' THR . . . 173.46 20.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.212 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.604 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -44.21 134.95 4.23 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 122.073 0.939 . . . . 0.0 112.875 174.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.526 ' HA ' ' HZ ' ' A' ' 108' ' ' PHE . 72.8 Cg_exo -50.25 -34.71 41.0 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.128 3.219 . . . . 0.0 115.11 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.604 ' HD2' ' HB2' ' A' ' 51' ' ' LEU . 6.3 Cg_exo -80.63 36.34 0.62 Allowed 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.99 1.793 . . . . 0.0 112.191 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.85 -90.77 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.476 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 1.6 m -156.34 153.68 29.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -124.45 167.72 14.03 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.424 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.74 145.76 12.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 5.2 mp -95.37 115.92 28.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.889 163.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.6 125.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.893 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.872 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -70.37 116.49 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -68.72 -82.81 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.744 -171.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.645 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 41.7 mtm180 -144.22 123.38 12.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 111.009 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' H ' ' HB3' ' A' ' 66' ' ' ALA . . . -164.12 -105.37 0.19 Allowed Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.205 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.458 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 4.8 Cg_exo -77.76 -88.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.954 2.436 . . . . 0.0 112.333 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.767 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.5 t30 -64.73 -48.29 75.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 62' ' ' ARG . . . 57.34 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.221 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 0.92 89.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.09 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.844 ' H ' HG21 ' A' ' 60' ' ' VAL . 2.7 m -86.29 171.55 11.14 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 117.212 0.506 . . . . 0.0 109.673 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.654 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -167.68 153.62 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.377 0.535 . . . . 0.0 111.581 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.559 ' O ' HD11 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.64 126.82 40.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 71' ' ' LEU . 1.1 tm? -84.7 96.08 9.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.33 1.019 . . . . 0.0 108.571 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.839 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -93.38 50.3 1.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.844 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.426 ' H ' HD12 ' A' ' 71' ' ' LEU . 21.3 t70 -104.97 -19.41 13.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.832 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.82 -166.9 1.34 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.426 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.56 -40.63 56.46 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.423 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.599 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.32 135.6 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.721 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.3 p -116.42 141.75 47.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.084 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.745 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 43.2 m -85.61 124.79 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HB3' HG12 ' A' ' 87' ' ' ILE . . . -121.07 106.34 11.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.886 ' HA2' HD21 ' A' ' 89' ' ' LEU . . . 161.61 -129.47 2.11 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.713 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -68.77 108.34 3.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.72 0.771 . . . . 0.0 110.456 173.343 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.745 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -138.91 129.89 15.07 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -68.97 -62.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.871 2.381 . . . . 0.0 112.358 173.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.49 101.62 1.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.112 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 82' ' ' HIS . 3.1 p -164.59 -85.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.188 171.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.08 -75.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.416 0.627 . . . . 0.0 111.115 -172.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.654 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -127.75 110.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.187 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.27 134.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.2 177.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HG ' HD13 ' A' ' 139' ' ' ILE . 3.0 mm? -117.39 72.27 0.83 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.551 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.767 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 34.1 t70 62.8 4.21 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.381 0.61 . . . . 0.0 109.853 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.713 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 t70 66.73 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.261 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' SER . 14.2 p -80.57 69.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.42 1.105 . . . . 0.0 112.866 -167.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.454 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.5 OUTLIER -162.69 4.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.941 167.412 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.4 t -140.63 141.82 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.611 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 10.9 t -76.14 72.76 2.96 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.665 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 66.1 -48.87 0.42 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.072 -173.218 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.565 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.1 ptp85 -154.46 135.0 13.45 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.592 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.854 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -72.13 -36.84 69.49 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -159.95 176.56 11.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.225 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 102' ' ' ARG . 6.0 pt-20 -134.04 135.19 43.18 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.839 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -61.17 95.89 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.451 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -92.49 98.17 11.29 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.678 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -77.98 107.83 10.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.267 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.57 139.85 45.68 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.036 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 58.61 32.52 22.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.914 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.848 ' HA ' HD21 ' A' ' 103' ' ' LEU . 89.0 m-20 67.5 9.11 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.895 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 17.5 mm-40 -105.49 151.67 23.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.398 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.914 ' HB2' HD11 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -99.34 124.32 44.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.517 ' OD1' ' HB ' ' A' ' 130' ' ' VAL . 11.6 m-80 -136.19 157.8 45.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -174.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 128' ' ' SER . 12.3 m -107.94 123.29 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.196 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.586 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 78.0 t -100.52 110.47 27.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.732 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -67.35 122.33 17.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.45 -11.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 141.72 77.39 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.272 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.854 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 28.6 t -86.34 137.23 32.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.791 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.7 tm? -53.47 -54.01 43.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.042 -174.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -73.81 -35.75 64.9 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.831 0.741 . . . . 0.0 109.936 172.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.12 171.9 12.84 Favored Glycine 0 C--O 1.253 1.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.076 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.4 m -111.37 130.26 55.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.651 -0.775 . . . . 0.0 110.904 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -138.41 104.2 5.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.896 0.379 . . . . 0.0 110.859 173.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.773 HG22 HG12 ' A' ' 137' ' ' VAL . 58.1 t -100.73 125.92 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 m120 64.53 22.89 12.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 61.79 38.2 15.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.764 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -142.35 144.63 31.81 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.76 122.54 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.423 2.082 . . . . 0.0 111.197 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' A' ' 121' ' ' VAL . 19.3 m -114.74 171.51 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.6 t70 -111.93 -41.97 3.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.669 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.873 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.7 p -164.86 91.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.7 0.762 . . . . 0.0 110.21 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.95 128.13 53.09 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.307 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.517 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 9.1 p -73.01 154.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.429 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 108' ' ' PHE . 10.4 mp -62.25 165.7 5.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.52 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.408 ' HB1' ' HE1' ' A' ' 146' ' ' PHE . . . -152.0 -176.78 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.3 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.31 90.94 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.825 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.55 4.89 37.09 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 119.922 -1.132 . . . . 0.0 114.538 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.99 166.59 12.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.954 0.877 . . . . 0.0 110.117 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.557 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 3.5 pt-20 -127.76 150.27 49.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.773 HG12 HG22 ' A' ' 121' ' ' VAL . 38.5 t -125.97 141.92 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.62 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.405 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 6.6 tp-100 -99.69 125.58 45.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.956 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.15 131.53 45.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 169.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 74.07 -76.33 1.07 Allowed Glycine 0 C--O 1.222 -0.649 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.949 177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.76 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 7.4 pttt -171.93 28.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 111.08 171.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.24 143.51 44.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.583 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 ttm180 -90.67 100.81 13.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.872 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.0 mp -93.93 158.47 15.63 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.7 143.14 27.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -107.08 147.16 30.34 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.28 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.402 HD22 ' C ' ' A' ' 146' ' ' PHE . 3.1 mm? -131.25 150.4 52.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.543 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.653 ' HA ' ' CA ' ' A' ' 50' ' ' GLY . 12.2 t -145.05 175.06 10.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -64.34 123.41 27.51 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.851 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -62.02 112.57 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.807 2.338 . . . . 0.0 111.906 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -84.63 50.29 1.87 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.426 0.631 . . . . 0.0 110.487 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -150.25 128.92 12.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.149 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.1 2.58 61.55 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.013 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 155.74 46.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -135.35 130.29 34.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.427 0.632 . . . . 0.0 111.063 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -122.68 -2.69 8.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.444 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.34 8.96 78.7 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.764 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 p -79.67 62.29 3.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.54 0.686 . . . . 0.0 110.761 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.5 m -89.69 123.39 33.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.468 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.93 113.83 4.74 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.388 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -75.42 128.44 9.79 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.49 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.211 2.607 . . . . 0.0 111.732 176.752 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.7 m -80.14 -15.99 55.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.5 166.55 10.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.985 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -130.6 152.73 49.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.848 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -91.69 132.62 32.72 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 -177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -73.69 101.6 1.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.377 2.718 . . . . 0.0 112.672 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -86.21 88.05 7.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.1 162.79 38.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.198 -167.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -110.52 115.94 30.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -169.24 38.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.2 100.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.883 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 53.46 29.69 9.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.966 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m -96.41 52.16 1.23 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.462 0.648 . . . . 0.0 110.014 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -105.94 -76.61 0.6 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.208 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -128.4 -55.01 1.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.386 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -115.84 137.65 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.811 0.339 . . . . 0.0 110.661 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 t -106.91 78.98 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.363 0.601 . . . . 0.0 109.403 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -88.87 63.85 6.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.786 0.803 . . . . 0.0 110.819 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -82.7 57.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.695 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 55.28 67.87 0.95 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.635 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -147.92 143.05 27.09 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.696 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.742 ' O ' ' HA ' ' A' ' 93' ' ' THR . 74.6 m -61.24 122.78 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -168.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 116' ' ' LEU . 5.5 p -140.81 150.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.924 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' H ' ' HD2' ' A' ' 141' ' ' LYS . 8.5 t80 -176.73 -139.65 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.548 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.761 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER 36.53 -100.19 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.001 0.921 . . . . 0.0 110.614 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.85 120.25 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 122.587 1.184 . . . . 0.0 112.723 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.569 ' HA ' HH21 ' A' ' 26' ' ' ARG . 0.9 OUTLIER -88.76 84.77 6.69 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.453 -167.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.436 ' HE1' ' CD1' ' A' ' 120' ' ' TYR . 25.2 m-85 -116.3 -59.23 2.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.607 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 30' ' ' LEU . 2.6 pt? -120.63 17.32 12.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.762 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 p -148.72 164.82 33.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 21.7 tp10 67.52 -69.23 0.14 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.241 0.963 . . . . 0.0 110.756 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 34' ' ' ASP . 0.4 OUTLIER -65.46 -33.2 75.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 171.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.429 ' N ' HD12 ' A' ' 33' ' ' LEU . 38.7 t70 42.12 75.07 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.273 0.983 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.89 117.83 35.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.994 -175.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.6 21.98 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.263 2.642 . . . . 0.0 111.896 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.68 157.8 30.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.106 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -110.32 128.62 55.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.12 72.55 9.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.612 -174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.67 79.45 1.11 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.694 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -147.28 101.68 3.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.782 0.325 . . . . 0.0 110.477 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -85.01 -78.94 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.767 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t 50.39 43.8 26.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.614 0.721 . . . . 0.0 109.295 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.94 107.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.872 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -95.59 115.78 35.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.183 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 m -102.39 120.41 40.46 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.266 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.8 36.04 0.33 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.121 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 49.6 t 66.78 95.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.203 0.601 . . . . 0.0 111.382 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.68 -71.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.37 5.37 0.37 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.336 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 148' ' ' THR . 4.0 mp -74.57 117.8 65.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -109.02 31.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 123.108 2.538 . . . . 0.0 115.13 170.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -92.75 153.64 2.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 121.516 1.477 . . . . 0.0 113.26 -176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.41 -19.32 52.88 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.58 129.13 20.23 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.516 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . . . -126.42 172.29 10.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.699 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.2 pt? -161.24 139.44 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 118.296 -1.362 . . . . 0.0 114.454 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.684 HD11 HD22 ' A' ' 131' ' ' LEU . 2.7 mp -85.86 112.35 21.05 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.991 167.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -101.46 125.31 55.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.032 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.871 HG23 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -70.46 109.89 3.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.396 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.89 -44.36 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.184 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -155.18 143.77 20.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 172.49 -155.45 23.32 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.685 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 24.7 Cg_exo -63.87 -59.96 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.061 1.841 . . . . 0.0 111.958 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.732 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 48.2 t30 -75.67 -49.94 16.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.685 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 52.96 164.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.403 -174.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 2.71 90.61 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.723 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.871 ' H ' HG23 ' A' ' 60' ' ' VAL . 6.6 m -101.45 -169.05 1.64 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 117.6 0.7 . . . . 0.0 110.616 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.79 160.08 5.48 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -171.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.462 ' HB2' HD22 ' A' ' 72' ' ' LEU . 1.6 m-30 -96.48 127.88 42.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 167.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.489 HD12 ' H ' ' A' ' 73' ' ' ASP . 1.3 tm? -80.77 97.34 7.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.699 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.5 mt -94.13 46.29 1.16 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.553 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.489 ' H ' HD12 ' A' ' 71' ' ' LEU . 13.0 t70 -100.48 -19.15 16.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.756 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.58 -166.66 1.26 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.615 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.1 36.53 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.552 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.742 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -157.79 120.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.034 -175.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.414 HG21 ' O ' ' A' ' 71' ' ' LEU . 8.7 p -113.41 119.86 39.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.577 ' O ' HG21 ' A' ' 87' ' ' ILE . 15.2 m -66.04 128.56 36.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' HA ' HG21 ' A' ' 87' ' ' ILE . . . -125.98 107.56 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -166.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.684 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.31 -132.97 2.85 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.854 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.802 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.49 110.56 6.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.828 0.823 . . . . 0.0 108.946 173.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER -137.97 136.39 19.68 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -162.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.06 179.95 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.376 2.05 . . . . 0.0 108.872 155.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.6 73.89 3.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 111.738 -173.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -117.34 -69.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -125.94 -80.04 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.443 0.64 . . . . 0.0 111.169 -174.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.577 HG21 ' O ' ' A' ' 78' ' ' SER . 0.2 OUTLIER -124.12 117.38 50.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.622 -174.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.471 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -115.57 127.48 55.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.036 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.854 HD21 HG12 ' A' ' 60' ' ' VAL . 11.5 mt -115.91 80.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.1 t70 70.02 -8.49 0.82 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.802 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p-10 43.6 32.41 0.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.396 1.479 . . . . 0.0 113.105 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 23' ' ' SER . 26.0 t -138.8 -9.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.428 -176.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.742 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -110.56 -13.55 14.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.754 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -118.58 146.74 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.679 -171.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.696 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 27.1 m -71.59 75.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.999 0.428 . . . . 0.0 109.924 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.771 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.84 -61.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.319 -172.024 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.684 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -153.7 139.53 18.08 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.687 0.756 . . . . 0.0 110.967 177.008 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.653 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -69.51 -40.3 77.04 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.227 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -158.26 179.27 9.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.474 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.625 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.44 131.27 22.86 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.742 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -59.64 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.291 -175.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 102' ' ' ARG . 3.0 tpp180 -89.98 100.4 13.23 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.239 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 106' ' ' ASN . 8.6 tt -77.63 110.87 12.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -131.98 138.81 48.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.459 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 59.32 31.35 21.07 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.583 0.552 . . . . 0.0 110.11 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.815 ' HA ' HD22 ' A' ' 103' ' ' LEU . 47.1 m-80 70.19 3.21 4.3 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.877 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.63 149.19 22.06 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.503 ' HD1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -93.8 124.08 37.57 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.435 ' OD1' HG22 ' A' ' 130' ' ' VAL . 12.9 m-80 -133.55 154.6 50.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.412 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 128' ' ' SER . 14.0 m -107.87 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.203 0.525 . . . . 0.0 110.867 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 84.1 t -101.22 111.47 31.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.833 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 119.52 12.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 111' ' ' VAL . 15.7 m -120.48 -11.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.432 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 146.36 71.47 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.354 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 m -84.97 132.13 34.39 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 22' ' ' TPO . 41.2 tp -60.94 -56.65 18.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.166 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -72.92 -35.78 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.38 0.61 . . . . 0.0 109.745 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.0 169.15 11.98 Favored Glycine 0 C--O 1.256 1.525 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.26 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -113.82 125.85 54.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.382 -0.909 . . . . 0.0 110.969 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' CD1' ' HE1' ' A' ' 29' ' ' PHE . 10.1 m-85 -132.75 105.7 7.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.03 0.443 . . . . 0.0 110.906 173.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.793 HG22 HG11 ' A' ' 137' ' ' VAL . 45.7 t -101.44 110.3 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.738 HD21 HG12 ' A' ' 121' ' ' VAL . 29.2 m-80 56.73 38.38 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.132 0.492 . . . . 0.0 110.484 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 9.6 mmm180 77.43 1.87 3.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.389 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.83 130.89 23.72 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.474 0.654 . . . . 0.0 111.442 174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.6 125.85 15.1 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.479 HG23 ' HB3' ' A' ' 129' ' ' ALA . 27.8 m -115.54 165.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 111.701 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 m-20 -82.81 -51.83 7.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 171.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.854 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.3 p -160.31 91.03 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.554 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' A' ' 126' ' ' VAL . . . -86.07 141.86 29.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.301 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 109' ' ' ASN . 39.7 t -78.32 124.17 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.956 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.684 HD22 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -59.28 156.18 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.342 0.401 . . . . 0.0 111.659 176.242 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.472 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -157.02 154.71 30.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -69.12 98.82 1.04 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.878 0.37 . . . . 0.0 110.011 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.23 0.84 29.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.06 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 17.2 t70 -69.17 148.87 49.28 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.408 ' OE1' ' HD2' ' A' ' 143' ' ' ARG . 9.0 tt0 -135.9 127.15 28.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.607 0.718 . . . . 0.0 111.824 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.793 HG11 HG22 ' A' ' 121' ' ' VAL . 42.0 t -123.64 133.19 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.568 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.513 ' CG ' ' HB2' ' A' ' 28' ' ' ASP . 20.1 tm0? -94.27 128.55 40.82 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.66 HG23 HD13 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -134.65 140.87 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 173.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 73.5 -68.12 1.52 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.231 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.698 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 12.7 ptmt -176.2 22.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.416 0.686 . . . . 0.0 109.345 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.732 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -123.15 161.83 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -171.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.457 ' HB2' ' CG ' ' A' ' 28' ' ' ASP . 26.9 ttp85 -112.18 119.59 38.91 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.434 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.822 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -109.5 154.11 23.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.411 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -141.26 139.87 32.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.155 171.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.65 ' O ' HD12 ' A' ' 147' ' ' LEU . 47.0 t80 -98.21 138.55 35.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.812 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.65 HD12 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? -130.43 155.46 46.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.318 172.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.555 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 14.1 t -155.79 -175.39 5.41 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -124.48 79.66 0.36 Allowed Glycine 0 C--O 1.226 -0.344 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.95 -59.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.111 2.541 . . . . 0.0 113.317 -173.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -80.5 79.2 7.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.147 0.499 . . . . 0.0 111.198 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -92.94 98.47 11.39 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -69.2 118.85 8.98 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.732 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -73.09 128.51 35.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.12 0.486 . . . . 0.0 110.213 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -68.79 -24.5 64.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.06 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.1 107.16 18.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.973 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.24 4.26 2.6 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.136 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.8 m -95.43 68.17 2.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.872 0.368 . . . . 0.0 110.617 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -93.83 119.77 33.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.282 0.563 . . . . 0.0 110.587 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.37 -33.87 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.246 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.45 160.98 32.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.003 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 123.208 2.605 . . . . 0.0 112.123 179.116 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -165.85 154.58 11.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.625 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -102.7 133.8 47.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.354 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -78.58 72.78 5.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.13 0.49 . . . . 0.0 111.069 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.771 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 38.7 m-80 -106.68 -45.69 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.807 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.771 ' HD2' ' H ' ' A' ' 5' ' ' ASN . 15.1 Cg_endo -57.78 167.43 4.12 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.095 1.863 . . . . 0.0 112.684 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 13.8 m-20 74.2 -62.28 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.144 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.71 -55.54 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.45 107.85 18.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.247 0.546 . . . . 0.0 109.815 -178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -94.9 72.35 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.685 -174.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 47.7 66.88 0.92 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.591 0.71 . . . . 0.0 110.866 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -100.98 82.31 2.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.279 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -66.0 102.01 0.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 m -86.62 43.29 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.002 0.429 . . . . 0.0 111.569 -173.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.94 25.2 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 57.34 42.99 24.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.742 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.481 ' HB ' ' CB ' ' A' ' 20' ' ' GLU . 16.9 m -92.1 47.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 p -67.98 -26.07 65.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.328 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.86 15.34 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 110.483 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' CB ' ' HB ' ' A' ' 17' ' ' VAL . 19.0 tp10 -81.88 -43.32 18.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.586 HG21 ' O ' ' A' ' 22' ' ' TPO . 94.2 m -152.86 133.01 13.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.441 174.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.636 ' HB ' HD21 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.608 ' O ' ' HA ' ' A' ' 93' ' ' THR . 16.3 m -54.68 125.65 20.73 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.874 0.369 . . . . 0.0 111.613 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' HB ' HD23 ' A' ' 116' ' ' LEU . 14.7 p -138.7 135.89 43.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.646 -168.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 2.2 t80 173.34 -170.64 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.352 0.261 . . . . 0.0 110.759 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.574 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.9 OUTLIER 54.75 -153.03 0.32 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.466 0.706 . . . . 0.0 111.284 172.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.937 ' HB1' ' HA ' ' A' ' 141' ' ' LYS . . . 67.32 -177.91 0.21 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 171.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.551 ' HA ' HD11 ' A' ' 33' ' ' LEU . 29.7 t70 -72.84 51.34 0.28 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.459 1.123 . . . . 0.0 110.964 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 14.1 m-85 -142.04 -36.66 0.41 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.8 tp -100.96 -68.82 0.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.958 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m 176.29 -171.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.095 0.558 . . . . 0.0 110.779 -170.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 78.33 43.72 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 166.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.765 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -153.05 -99.05 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.737 172.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.07 42.21 31.69 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.989 0.806 . . . . 0.0 111.566 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 70.48 133.22 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 123.918 0.761 . . . . 0.0 111.23 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.5 -25.34 9.69 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.476 2.117 . . . . 0.0 112.001 -177.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.17 161.37 16.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -91.3 94.91 9.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.69 -79.16 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 O-C-N 123.877 0.736 . . . . 0.0 111.318 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.97 108.89 0.21 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.31 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -99.1 -25.26 14.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -152.96 93.75 1.78 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.172 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.8 m -138.72 34.31 2.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.21 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.87 -47.09 12.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.669 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -63.65 -29.33 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.05 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.738 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 4.7 p -93.97 -12.57 28.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.102 0.477 . . . . 0.0 110.841 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.22 -32.91 12.7 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.21 10.48 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.519 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -97.97 -29.36 13.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.298 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 147' ' ' LEU . . . -100.23 -68.05 0.85 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.062 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.691 HD22 ' HA3' ' A' ' 149' ' ' GLY . 11.5 mt 44.42 -175.46 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -171.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.616 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 14.1 Cg_endo -94.73 14.83 1.24 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.243 1.962 . . . . 0.0 116.865 174.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD2' ' C ' ' A' ' 51' ' ' LEU . 18.5 Cg_endo -61.38 -158.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 121.998 1.798 . . . . 0.0 113.462 167.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -54.59 -28.24 44.79 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 137.41 26.71 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -123.77 172.8 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.493 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -155.06 144.27 21.05 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 117.566 -1.654 . . . . 0.0 114.743 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 72' ' ' LEU . 5.2 mp -93.56 112.57 24.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.807 166.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 5.9 p -111.97 131.67 62.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.695 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.989 HG13 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -76.51 110.48 11.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -72.33 -58.59 3.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.343 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -145.07 131.8 20.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.717 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.479 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -171.01 -174.34 38.77 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.635 ' CG ' ' HE2' ' A' ' 141' ' ' LYS . 44.7 Cg_exo -56.59 -47.55 23.21 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.964 1.776 . . . . 0.0 113.015 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 64.1 t30 -82.91 -51.76 7.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.815 0.816 . . . . 0.0 108.817 172.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.656 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 54.91 170.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.079 -171.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.79 2.5 90.56 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.778 -0.725 . . . . 0.0 114.057 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.2 m -99.91 179.32 4.55 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 117.901 0.85 . . . . 0.0 110.653 -170.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.672 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.81 154.7 4.41 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.008 0.367 . . . . 0.0 111.821 -175.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.529 ' HB2' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -93.54 116.26 28.78 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 171.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.584 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.8 tt -74.27 97.19 2.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 124.403 1.064 . . . . 0.0 108.809 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 58' ' ' LEU . 12.5 mt -91.19 32.27 1.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.786 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -88.69 -15.71 34.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.72 -167.08 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.375 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.68 -30.87 16.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.0 109.802 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -160.98 133.1 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 176.48 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.457 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 23.1 p -121.51 147.89 45.19 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.899 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -93.63 126.54 38.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.569 ' HB2' HG12 ' A' ' 87' ' ' ILE . . . -115.83 128.87 56.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -173.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.33 -117.0 1.1 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.109 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.677 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -101.55 101.69 12.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.65 122.1 10.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -80.51 -13.84 11.91 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 123.683 2.922 . . . . 0.0 112.332 168.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -124.11 -34.89 2.89 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.579 ' CB ' ' HB2' ' A' ' 78' ' ' SER . 1.4 m -78.52 -173.56 3.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -164.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 10.9 m-20 -91.26 -16.91 26.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.791 -171.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.784 HD13 HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -132.54 97.65 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.078 0.942 . . . . 0.0 110.203 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' C ' HD23 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -110.74 130.26 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.33 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.989 HD11 HG13 ' A' ' 60' ' ' VAL . 4.5 mm? -116.2 76.09 1.0 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.94 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 67.98 -0.64 1.99 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.644 0.735 . . . . 0.0 110.019 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.3 p-10 35.67 44.0 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.306 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' SER . 9.9 p -151.85 2.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.396 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.608 ' HA ' ' O ' ' A' ' 23' ' ' SER . 18.9 p -111.85 -7.95 14.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.849 -0.532 . . . . 0.0 112.045 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' O ' ' O1P' ' A' ' 22' ' ' TPO . 2.9 t -126.81 147.3 31.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 O-C-N 122.043 -0.41 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.592 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 4.2 m -71.01 73.76 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.4 -61.59 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.292 -165.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 40.9 ttm180 -145.39 132.3 20.19 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.276 -0.89 . . . . 0.0 111.603 -163.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.853 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -87.92 -46.78 9.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.514 170.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.731 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.73 158.38 43.86 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.201 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 111' ' ' VAL . 7.8 pt-20 -124.27 130.96 53.42 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 166.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.708 ' CG ' HD21 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -61.07 95.97 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.272 -174.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -92.87 106.48 18.44 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.235 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.812 HD22 ' HA ' ' A' ' 106' ' ' ASN . 9.3 tt -76.24 109.11 9.65 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.23 136.17 50.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.923 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 60.03 31.83 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.812 ' HA ' HD22 ' A' ' 103' ' ' LEU . 67.3 m-20 63.5 15.36 8.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.415 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -114.15 156.36 24.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.855 ' HB2' HD12 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -94.68 133.52 38.27 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.483 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.449 ' OD1' HG22 ' A' ' 130' ' ' VAL . 14.5 m-80 -139.91 159.49 42.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -107.79 126.3 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.267 171.061 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.731 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 34.2 m -101.92 123.64 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.684 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.93 126.35 30.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.819 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.77 -3.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 110.619 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 121.45 91.6 1.16 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.402 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.763 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 18.1 t -98.83 134.97 40.95 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.636 HD21 ' HB ' ' A' ' 22' ' ' TPO . 20.4 tp -52.47 -58.15 7.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.698 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 11.5 m-80 -70.6 -37.61 73.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.69 8.28 Favored Glycine 0 C--O 1.242 0.646 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.54 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.519 HG21 ' CE1' ' A' ' 98' ' ' HIS . 15.6 m -112.13 132.92 54.58 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.795 0.438 . . . . 0.0 111.148 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -141.29 140.14 33.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.655 0.264 . . . . 0.0 110.557 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.659 HG22 HG11 ' A' ' 137' ' ' VAL . 73.1 t -127.89 107.63 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.414 ' HA ' ' OE2' ' A' ' 136' ' ' GLU . 1.9 m120 64.0 35.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 109.386 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 59.42 30.18 19.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.926 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.8 pt-20 -139.62 128.06 13.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.43 122.66 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.142 1.895 . . . . 0.0 110.955 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.36 162.1 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 14.0 m-20 -72.16 -59.02 2.95 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.741 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 46.7 t -159.64 109.63 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -116.02 141.93 47.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.449 HG22 ' OD1' ' A' ' 109' ' ' ASN . 4.1 t -74.28 142.34 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.596 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.855 HD12 ' HB2' ' A' ' 108' ' ' PHE . 11.1 mp -51.0 150.93 2.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 111.489 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -134.33 -176.47 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.55 98.75 8.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.655 0.264 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.5 4.42 40.29 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.1 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.917 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 19.7 m-20 -101.81 157.84 16.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.134 0.467 . . . . 0.0 110.331 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -105.22 162.04 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.659 HG11 HG22 ' A' ' 121' ' ' VAL . 47.7 t -136.22 126.57 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.595 172.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.533 ' OE1' ' HB3' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.87 111.35 23.77 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.933 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.853 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -111.95 134.97 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 61.64 -101.4 0.34 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.937 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 15.2 ptmt -141.64 19.36 2.18 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.76 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.656 ' CD2' HD12 ' A' ' 89' ' ' LEU . 1.5 m-85 -112.3 144.31 41.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.509 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.765 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 10.1 ttm180 -92.4 87.1 5.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.865 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -83.14 160.82 21.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.026 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.88 139.2 31.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.917 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -97.53 141.87 30.05 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.213 178.438 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.738 ' HG ' ' HB2' ' A' ' 46' ' ' SER . 2.7 mm? -126.6 114.9 18.69 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.422 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 t -126.23 -167.57 1.73 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.691 ' HA3' HD22 ' A' ' 51' ' ' LEU . . . -135.65 108.38 0.68 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.478 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -66.63 103.23 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.925 2.417 . . . . 0.0 110.097 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 1.016 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -92.55 -14.64 28.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -168.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 152' ' ' GLN . 1.8 mp0 -89.61 -37.91 14.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 146.24 -46.27 0.76 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 55.76 33.1 20.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.566 0.698 . . . . 0.0 110.997 174.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.63 -6.64 54.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.863 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.18 103.02 3.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.413 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.33 137.56 2.23 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.5 t -162.07 145.14 11.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 m 57.46 58.84 3.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.72 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -123.61 140.54 12.96 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.742 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.6 -70.33 0.4 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.883 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.95 2.433 . . . . 0.0 111.887 178.143 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 121.963 0.887 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.9 m 66.91 79.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.287 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.54 111.68 19.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.185 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -141.75 14.1 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.599 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -120.21 108.58 38.01 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.668 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.97 -27.16 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.36 2.04 . . . . 0.0 110.964 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.97 162.86 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.883 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -111.58 16.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 110.564 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.122 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -82.83 7.61 14.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.845 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -69.04 -43.74 74.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 109.885 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.52 133.83 52.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 p -112.18 -11.58 13.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.5 t 57.56 78.24 0.24 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.431 0.634 . . . . 0.0 109.881 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.3 -34.98 11.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -77.73 -10.04 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.55 -30.04 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.042 0.448 . . . . 0.0 111.198 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.2 p -98.26 87.12 3.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.99 0.424 . . . . 0.0 111.522 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG21 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -96.2 -106.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.798 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.478 ' H ' HG21 ' A' ' 19' ' ' VAL . 47.8 mt-10 -87.4 80.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 110.307 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 m -155.89 133.59 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.754 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.74 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 43.1 m 33.34 124.96 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.871 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 8.1 t -110.92 131.86 60.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.11 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.611 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 20.6 t80 175.73 -177.38 0.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 173.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.905 ' HD2' ' H ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 54.86 -158.41 0.2 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.233 1.013 . . . . 0.0 111.21 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.905 ' H ' ' HD2' ' A' ' 26' ' ' ARG . . . 62.17 -174.87 0.14 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 170.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.685 ' HA ' HD11 ' A' ' 33' ' ' LEU . 25.6 t70 -72.71 57.45 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.18 0.991 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.509 ' HD1' ' HB2' ' A' ' 27' ' ' ALA . 20.6 m-85 -145.21 -45.27 0.22 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.4 tp -90.01 -16.32 30.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.337 168.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 p 77.91 30.35 0.46 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.75 1.22 . . . . 0.0 111.717 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -79.18 66.73 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.804 0.812 . . . . 0.0 110.26 176.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -143.56 -50.21 0.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.473 -1.239 . . . . 0.0 107.821 -176.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 52.21 83.96 0.05 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.869 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 48.17 65.86 6.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.553 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.413 ' HB2' ' OE2' ' A' ' 136' ' ' GLU . 86.1 Cg_endo -86.98 178.45 3.61 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.764 2.309 . . . . 0.0 112.534 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.389 0.614 . . . . 0.0 110.445 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.4 -15.9 59.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.71 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.48 16.71 8.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.406 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.61 93.54 1.48 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.931 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -122.84 141.24 52.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.653 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -79.2 70.83 5.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.967 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -137.11 133.64 35.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.34 91.29 8.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.517 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -104.53 121.01 55.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.164 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -76.0 77.61 2.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.39 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.56 64.91 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.728 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.92 -114.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -100.78 -25.57 14.08 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.588 0.709 . . . . 0.0 110.187 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 76.06 45.07 16.77 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.395 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 148' ' ' THR . 70.6 mt -116.26 76.64 6.92 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -104.59 39.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.677 2.251 . . . . 0.0 115.271 170.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -92.51 -151.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.832 1.688 . . . . 0.0 111.181 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 7.72 50.65 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.691 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 p -146.1 141.18 27.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.21 172.78 9.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.715 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 1.8 pt? -160.76 142.05 11.96 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.81 -1.556 . . . . 0.0 114.964 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.2 mp -85.69 117.35 24.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.95 167.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.08 129.0 63.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.824 HG23 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -71.5 109.86 4.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.1 -67.37 0.44 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.048 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -145.26 125.23 13.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.726 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.409 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -163.27 -140.33 2.85 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.649 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 21.5 Cg_exo -66.87 -69.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.67 2.246 . . . . 0.0 112.446 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.74 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.5 t30 -69.09 -48.22 63.19 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.611 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 56.01 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.671 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.3 2.11 90.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.221 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.824 ' H ' HG23 ' A' ' 60' ' ' VAL . 6.0 m -86.76 -179.86 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.316 0.558 . . . . 0.0 110.287 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.66 150.15 3.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.596 0.635 . . . . 0.0 112.412 -172.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.537 ' HB2' HD12 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -94.47 120.39 34.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.122 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.604 ' O ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -80.92 91.37 6.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.715 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.8 mt -83.38 52.12 2.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.063 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.491 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 17.7 t70 -96.36 -37.85 10.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.574 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -96.51 -166.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.774 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.22 39.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.705 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -154.0 123.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.634 0.73 . . . . 0.0 112.546 -177.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 65.2 p -103.99 138.74 40.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.519 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.718 ' O ' HG23 ' A' ' 87' ' ' ILE . 48.8 m -82.05 124.88 30.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -121.77 114.77 21.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -171.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.733 ' HA2' HD22 ' A' ' 89' ' ' LEU . . . 152.25 -140.31 7.63 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.686 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -70.68 104.04 2.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 57.4 m-70 -139.63 115.09 8.11 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -68.47 -50.92 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.694 2.262 . . . . 0.0 111.389 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.21 77.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 8.2 m -146.74 -161.2 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.448 177.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.778 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 7.1 m-20 -91.63 -42.57 10.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.718 HG23 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -126.48 105.33 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.647 0.737 . . . . 0.0 111.124 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -103.89 134.44 47.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.647 177.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.884 ' HG ' HD12 ' A' ' 139' ' ' ILE . 2.8 mm? -118.6 77.14 1.14 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.738 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.6 t70 67.81 -18.5 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.473 0.654 . . . . 0.0 111.267 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 33.1 t70 67.05 24.13 9.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.429 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.8 p -156.47 53.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 122.296 1.046 . . . . 0.0 110.769 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.479 ' HB ' ' CD ' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -152.81 0.06 0.27 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.123 172.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.665 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.8 t -137.23 140.49 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.218 -173.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.45 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 15.9 m -73.68 74.03 1.52 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.238 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 66.96 -66.64 0.18 Allowed 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.248 -173.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.405 ' HG2' HG22 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -139.57 144.1 37.64 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.702 -0.624 . . . . 0.0 110.523 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.808 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.96 -41.39 12.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.834 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.17 165.54 28.02 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.396 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.618 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.9 pt-20 -132.69 127.04 33.94 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -58.28 100.73 0.07 Allowed 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.692 -174.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -94.62 100.35 12.32 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.735 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -79.48 104.6 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.128 175.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -134.75 140.67 46.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.717 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 62.34 32.13 17.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.397 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.652 ' HA ' HD22 ' A' ' 103' ' ' LEU . 43.2 m-80 64.58 15.01 9.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.882 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -121.86 146.43 47.1 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.873 0.368 . . . . 0.0 110.809 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.568 ' CB ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -85.8 122.14 29.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.534 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.475 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.8 OUTLIER -123.87 166.16 16.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.704 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.8 m -115.65 128.53 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.245 172.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.834 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.8 t -101.51 111.87 32.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.298 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.77 119.88 21.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.537 HG13 HG11 ' A' ' 111' ' ' VAL . 35.6 m -116.59 -27.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 111.085 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.23 105.97 0.43 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.797 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.679 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.9 t -101.48 146.88 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.264 0.226 . . . . 0.0 110.6 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.754 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 3.2 tm? -60.52 -55.76 29.52 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.628 0.252 . . . . 0.0 110.904 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.871 ' OD1' ' HA ' ' A' ' 24' ' ' VAL . 61.5 m-20 -74.05 -36.42 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.402 ' HA3' ' CZ ' ' A' ' 29' ' ' PHE . . . 138.22 160.82 8.6 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.559 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.2 m -112.81 132.5 55.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.616 0.367 . . . . 0.0 111.727 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -141.37 105.38 4.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.995 0.426 . . . . 0.0 110.683 171.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.935 HG22 HG12 ' A' ' 137' ' ' VAL . 88.0 t -92.04 114.24 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.17 36.98 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 53.85 31.99 14.21 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.974 -172.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.7 pt-20 -141.8 137.86 16.56 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 109.979 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.95 122.93 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.09 1.86 . . . . 0.0 111.8 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.0 m -116.93 176.89 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.561 0.219 . . . . 0.0 110.806 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 27.2 t70 -94.75 -66.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 43.4 t -153.15 92.45 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.82 142.41 29.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.023 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -79.45 129.83 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.09 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 1.0 OUTLIER -59.78 163.75 4.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.42 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -167.96 168.99 11.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -61.44 115.52 3.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.849 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.51 5.24 72.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.319 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.5 108.96 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 110.453 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.413 ' OE2' ' HB2' ' A' ' 36' ' ' PRO . 8.2 tt0 -94.79 131.8 40.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG12 HG22 ' A' ' 121' ' ' VAL . 42.0 t -124.14 130.84 73.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -101.24 121.68 42.3 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.904 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.884 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.52 140.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.219 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 58.12 -98.87 0.1 OUTLIER Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.3 -0.952 . . . . 0.0 110.869 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.813 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 17.2 ptmt -140.85 18.22 2.32 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.235 0.54 . . . . 0.0 111.096 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.74 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -110.42 150.29 29.04 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -107.37 105.46 15.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.82 ' HG ' HG11 ' A' ' 60' ' ' VAL . 5.3 mp -98.71 157.51 16.22 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.505 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.78 141.32 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.106 169.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.61 ' O ' HD21 ' A' ' 147' ' ' LEU . 37.3 t80 -100.07 137.65 38.23 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.61 HD21 ' O ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -135.74 169.93 16.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.207 170.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.675 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 13.9 t -175.54 168.62 3.19 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -173.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -110.06 138.59 14.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.561 171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.71 113.63 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.852 2.368 . . . . 0.0 112.225 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -102.38 2.89 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.468 0.651 . . . . 0.0 110.015 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.87 53.41 1.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.675 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.36 -116.96 0.46 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.127 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -165.82 -71.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.47 45.72 26.45 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.85 171.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.99 140.92 31.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.65 45.23 0.56 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.4 m -87.97 135.57 33.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.704 0.288 . . . . 0.0 111.169 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.2 t -172.0 74.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.007 0.908 . . . . 0.0 109.788 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -73.12 -15.66 78.62 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.675 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 149.02 156.76 7.3 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.791 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.832 2.355 . . . . 0.0 111.687 179.173 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 t -58.57 105.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.739 0.78 . . . . 0.0 111.844 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.59 87.75 2.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.3 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.7 ptm -75.46 173.56 10.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.934 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -59.1 120.36 46.54 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.608 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.09 53.79 2.08 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.296 2.664 . . . . 0.0 112.998 -177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.2 138.22 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.794 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -82.01 89.86 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.564 0.697 . . . . 0.0 112.1 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -81.78 58.18 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.33 98.17 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.3 -176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -127.6 146.8 50.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -141.67 25.06 2.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -144.3 -27.17 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.961 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -121.35 59.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.688 0.756 . . . . 0.0 109.079 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -89.92 -155.87 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.801 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.36 33.43 16.4 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 121.311 0.576 . . . . 0.0 110.147 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 HG22 HG23 ' A' ' 19' ' ' VAL . 5.1 p -73.51 100.75 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.863 0.84 . . . . 0.0 110.061 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 55.97 3.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.216 1.007 . . . . 0.0 111.59 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.457 HG23 HG22 ' A' ' 17' ' ' VAL . 15.5 m -92.64 57.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.116 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.24 61.12 3.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.469 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 HD21 ' A' ' 116' ' ' LEU . 95.8 m -103.47 132.14 49.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.647 HG21 ' O ' ' A' ' 94' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -74.17 112.23 10.12 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.62 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 54.4 t -68.47 143.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.822 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 16.7 t80 174.29 -177.9 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.418 0.449 . . . . 0.0 110.794 168.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.77 HH22 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER 42.88 -110.1 0.14 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.933 0.893 . . . . 0.0 111.819 174.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . . . 65.38 158.49 0.1 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.619 ' HA ' HD22 ' A' ' 33' ' ' LEU . 9.7 t70 -82.09 69.54 8.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.589 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE2' ' HE1' ' A' ' 120' ' ' TYR . 85.7 m-85 -139.22 -72.15 0.39 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.657 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 16.2 tp -141.4 45.36 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.703 0.763 . . . . 0.0 111.48 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.9 p -128.19 -146.42 0.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.233 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.664 ' HB2' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 -71.75 67.7 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.964 0.506 . . . . 0.0 111.886 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 28' ' ' ASP . 1.6 pp -174.12 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.363 0.601 . . . . 0.0 110.351 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.22 98.09 11.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.117 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -148.32 134.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.348 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -75.12 65.47 6.17 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.401 2.734 . . . . 0.0 112.486 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.73 88.65 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 56.87 71.94 0.54 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.597 0.713 . . . . 0.0 110.566 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 34.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.396 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.08 83.43 1.63 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -85.69 74.41 10.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.468 0.651 . . . . 0.0 110.326 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -114.93 90.11 3.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 m -83.93 153.77 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.56 73.2 10.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.326 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.501 ' HA ' ' CB ' ' A' ' 132' ' ' ALA . 5.8 p -59.84 -47.89 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.129 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -95.33 44.75 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 109.873 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.24 27.31 4.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.716 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.597 HG23 ' HA ' ' A' ' 132' ' ' ALA . 3.1 t -111.94 -109.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' H ' ' HB ' ' A' ' 48' ' ' VAL . 25.9 mt-10 52.15 91.45 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.383 175.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.74 31.83 0.58 Allowed Glycine 0 C--N 1.317 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.619 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.23 126.85 78.27 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 110.551 175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.412 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 40.0 Cg_endo -68.73 -29.03 29.91 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.335 2.69 . . . . 0.0 116.557 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 72.6 Cg_endo -91.94 158.62 3.34 Favored 'Trans proline' 0 C--N 1.36 1.178 0 CA-C-N 121.645 1.623 . . . . 0.0 112.825 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.0 -19.32 57.84 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -107.51 125.18 50.95 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.069 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.42 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.88 171.79 10.43 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 57' ' ' LEU . 2.7 pp -155.0 137.91 15.43 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 117.541 -1.664 . . . . 0.0 114.93 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.73 HD11 HD23 ' A' ' 131' ' ' LEU . 1.3 mp -85.29 110.88 19.39 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.457 162.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.483 ' HB ' HD11 ' A' ' 57' ' ' LEU . 5.8 p -105.41 127.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.086 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.809 HG21 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -71.44 108.97 3.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 175.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.94 -57.5 6.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.604 -1.634 . . . . 0.0 109.881 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -150.7 131.06 13.71 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.304 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -169.93 -161.18 19.94 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.634 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 31.2 Cg_exo -60.55 -51.92 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.974 1.782 . . . . 0.0 113.055 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.492 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 63.9 t30 -78.2 -49.29 14.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 55.6 158.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.956 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.66 89.82 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.809 ' H ' HG21 ' A' ' 60' ' ' VAL . 12.3 t -98.49 -178.01 3.87 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.343 1.071 . . . . 0.0 110.811 -173.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.562 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.24 156.68 5.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.283 0.492 . . . . 0.0 112.112 -173.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.0 OUTLIER -95.77 113.47 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 170.316 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 1.3 pt? -79.65 92.61 5.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.067 1.413 . . . . 0.0 108.609 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.578 HD13 ' CB ' ' A' ' 108' ' ' PHE . 12.1 mt -74.18 46.51 0.25 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.009 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.447 ' HB2' ' CB ' ' A' ' 55' ' ' SER . 35.2 t70 -94.73 -25.49 16.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.743 0.782 . . . . 0.0 109.173 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -84.61 -167.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.745 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.67 -30.08 22.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.721 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.54 137.66 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.478 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 59.7 p -128.51 132.79 48.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.753 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.798 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 35.8 m -82.55 125.53 31.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 110.419 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.667 ' HB2' HG22 ' A' ' 87' ' ' ILE . . . -122.54 117.41 25.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 154.83 -82.72 0.16 Allowed Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.182 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.542 ' HG2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -124.6 103.1 7.95 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.798 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -138.75 126.52 13.52 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.471 -171.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.58 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.365 2.043 . . . . 0.0 112.228 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -162.74 92.17 0.77 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.596 0.236 . . . . 0.0 111.051 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -82.0 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.524 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.591 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -128.55 -74.6 0.57 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.386 0.612 . . . . 0.0 111.096 -172.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.667 HG22 ' HB2' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -118.42 109.83 28.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.667 0.746 . . . . 0.0 110.481 -177.489 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.17 135.07 54.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.979 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.913 ' HG ' HD12 ' A' ' 139' ' ' ILE . 2.8 mm? -122.37 74.04 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.652 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.419 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 39.0 t70 75.28 -22.49 0.26 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.488 0.661 . . . . 0.0 111.01 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 30.0 t70 59.68 36.19 22.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.036 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 22' ' ' TPO . 41.6 t -137.87 -10.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.626 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.495 ' HG1' ' HZ ' ' A' ' 142' ' ' PHE . 31.3 p -106.98 -24.48 11.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.647 ' O ' HG21 ' A' ' 22' ' ' TPO . 2.7 t -118.59 147.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -169.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 20.3 m -76.12 81.31 2.94 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.053 -0.404 . . . . 0.0 110.228 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' CG ' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 67.28 -69.4 0.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.567 -173.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.509 ' HG2' ' CG ' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -156.04 142.28 18.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.566 0.698 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.799 ' CD2' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -79.46 -42.26 25.72 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.396 172.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.823 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.62 153.6 44.86 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.067 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.609 ' HA ' ' O ' ' A' ' 77' ' ' THR . 5.4 pt-20 -115.51 126.92 54.88 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 166.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.721 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.84 98.99 0.11 Allowed 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.552 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.469 HH21 ' CD ' ' A' ' 100' ' ' GLU . 19.9 tpp85 -90.07 101.13 13.85 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.019 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.834 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -83.2 110.76 18.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -132.21 128.35 37.75 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.115 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 60.64 36.97 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.053 0.454 . . . . 0.0 110.484 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.834 ' HA ' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER 69.3 8.44 6.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.773 178.083 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 26.0 mm-40 -109.21 140.83 42.32 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.906 -0.496 . . . . 0.0 110.935 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.578 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -90.07 127.8 36.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.808 -177.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.541 HD21 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -127.03 159.99 32.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.34 -178.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.724 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -106.27 124.79 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 169.226 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.3 t -102.75 113.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.889 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.492 ' HB2' HG22 ' A' ' 119' ' ' THR . 18.2 t0 -70.93 118.26 13.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.514 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.762 HG12 HG11 ' A' ' 111' ' ' VAL . 11.1 m -122.93 -37.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.77 79.68 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.099 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.636 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 25.7 t -93.34 122.98 36.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.539 HD21 HG21 ' A' ' 21' ' ' THR . 3.0 tm? -63.41 -45.45 90.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.592 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.636 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 23.8 m-80 -82.52 -36.72 26.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 110.128 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 146.2 152.2 5.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 112' ' ' ASP . 17.1 m -111.87 128.44 56.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.439 ' HE1' ' CE2' ' A' ' 29' ' ' PHE . 23.3 m-85 -139.01 146.58 41.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 173.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.782 HG21 HG12 ' A' ' 137' ' ' VAL . 97.0 t -134.3 106.6 8.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.648 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.5 OUTLIER 64.18 41.0 6.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 63.97 17.23 10.45 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.009 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.5 pt-20 -134.61 126.15 17.93 Favored Pre-proline 0 C--N 1.331 -0.218 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.89 122.34 9.46 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.294 1.996 . . . . 0.0 111.712 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.5 m -111.97 178.74 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 110.707 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.2 p-10 -101.86 -46.77 4.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.724 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 17.4 p -159.17 94.32 1.19 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.019 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.18 144.34 30.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.434 HG23 HD22 ' A' ' 109' ' ' ASN . 26.0 t -76.96 131.29 35.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.127 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.73 HD23 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -61.03 155.18 20.83 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.846 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.597 ' HA ' HG23 ' A' ' 48' ' ' VAL . . . -156.31 156.81 34.63 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.182 0.515 . . . . 0.0 111.738 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.27 111.02 2.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.702 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.88 1.58 59.85 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.839 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 15.6 t70 -72.29 128.45 35.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.618 0.247 . . . . 0.0 110.761 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -112.81 129.56 56.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.401 0.62 . . . . 0.0 111.197 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.782 HG12 HG21 ' A' ' 121' ' ' VAL . 44.7 t -124.83 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.378 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -102.44 118.53 37.06 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.913 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -117.53 125.4 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.636 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 63.88 -103.03 0.63 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.101 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.709 ' HB2' ' CB ' ' A' ' 26' ' ' ARG . 10.1 pttt -143.02 24.75 1.81 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.283 0.563 . . . . 0.0 111.424 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.611 ' HD1' ' O ' ' A' ' 139' ' ' ILE . 0.1 OUTLIER -116.37 136.7 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -175.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.77 ' HB2' HH22 ' A' ' 26' ' ' ARG . 7.2 ttm180 -89.47 109.31 20.25 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.94 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.767 ' HG ' HG13 ' A' ' 60' ' ' VAL . 6.7 mp -98.9 159.22 15.11 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.146 0.498 . . . . 0.0 111.825 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -141.76 140.99 30.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.004 166.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.609 ' CD1' ' HG ' ' A' ' 131' ' ' LEU . 47.7 t80 -97.03 132.38 42.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.605 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.8 OUTLIER -135.62 171.58 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 169.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.4 t -165.83 166.06 17.92 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.111 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.66 88.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.422 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.47 154.78 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.629 2.219 . . . . 0.0 111.898 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -75.16 102.36 4.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.923 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.1 140.71 54.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -132.32 90.42 0.27 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -62.38 -34.25 76.34 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -75.5 103.43 5.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.762 0.792 . . . . 0.0 110.297 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.72 -13.05 27.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.111 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.37 124.11 7.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.767 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.1 m -88.28 105.73 17.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.8 m -76.47 75.78 3.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.597 0.713 . . . . 0.0 110.701 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.2 121.48 1.11 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -98.57 109.63 3.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.806 -175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.246 0.924 0 C-N-CA 122.855 2.37 . . . . 0.0 111.754 177.443 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.708 0.766 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 t -130.27 -1.35 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.533 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -82.55 147.83 28.41 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt -116.56 117.13 29.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -117.95 78.15 12.64 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.69 49.26 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.926 2.418 . . . . 0.0 112.772 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD2' ' HG2' ' A' ' 9' ' ' GLU . 30.9 t70 -129.95 126.65 38.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.944 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.78 75.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' HG2' ' OD2' ' A' ' 7' ' ' ASP . 25.4 mt-10 -63.33 -45.32 91.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.586 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 56.51 59.91 3.37 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -170.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.55 -41.25 80.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.47 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -120.84 136.82 54.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 16' ' ' GLU . 32.7 p -77.77 91.03 4.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.457 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -59.54 -33.3 71.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -132.92 118.23 18.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.594 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 13' ' ' THR . 10.1 pt-20 -71.86 149.5 45.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.392 0.615 . . . . 0.0 111.809 -172.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -101.67 96.92 5.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.311 -172.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -90.94 126.51 36.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.29 74.59 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 110.848 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 177.06 -45.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.53 ' CG2' HD13 ' A' ' 116' ' ' LEU . 25.3 m -104.62 133.6 49.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.916 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.772 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m -2.65 105.85 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.363 1.865 . . . . 0.0 115.139 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.629 ' HB ' HD11 ' A' ' 116' ' ' LEU . 1.4 p -143.42 157.31 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 O-C-N 121.259 -0.901 . . . . 0.0 112.42 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -172.76 -143.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.953 HH22 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 45.19 -116.38 0.55 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.365 0.529 . . . . 0.0 109.948 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.689 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 65.56 165.79 0.18 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 163.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.943 ' HA ' HD22 ' A' ' 33' ' ' LEU . 23.8 t70 -79.74 74.69 6.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.917 -172.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -149.6 -46.83 0.14 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.709 0.766 . . . . 0.0 109.52 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.83 -70.33 0.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.196 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.1 p -171.61 -152.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.242 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 26' ' ' ARG . 3.9 mm-40 62.89 27.79 16.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.675 0.79 . . . . 0.0 110.912 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.953 HD21 HH22 ' A' ' 26' ' ' ARG . 1.2 pp -158.06 -33.92 0.07 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.798 0.809 . . . . 0.0 109.138 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.486 ' N ' HD13 ' A' ' 33' ' ' LEU . 20.9 p-10 -67.0 -48.48 68.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.994 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -96.76 123.13 54.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.464 176.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.79 113.54 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.101 2.534 . . . . 0.0 111.951 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.1 -51.01 68.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.347 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.52 149.82 34.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.206 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.97 64.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.162 0.506 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.26 -76.75 1.77 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.933 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m 62.76 25.41 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.986 0.898 . . . . 0.0 110.302 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.5 145.66 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.262 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m 62.55 30.12 17.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.441 0.638 . . . . 0.0 110.084 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.64 176.11 7.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.386 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t 65.27 -77.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -167.47 79.84 0.19 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.631 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.04 -7.89 73.14 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.406 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.8 t 57.58 49.1 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-O 122.206 1.003 . . . . 0.0 109.189 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.57 -28.45 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.57 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -129.22 94.81 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.772 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 50.1 mt -149.54 134.88 9.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 123.267 0.627 . . . . 0.0 109.734 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -55.68 -36.96 95.83 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.022 2.482 . . . . 0.0 114.829 173.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.456 ' HD2' ' CB ' ' A' ' 51' ' ' LEU . 92.2 Cg_endo -93.51 45.03 0.29 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 121.731 1.621 . . . . 0.0 113.304 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.63 -80.05 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.869 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.94 139.01 24.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.76 ' HA ' ' HA2' ' A' ' 50' ' ' GLY . . . -125.84 169.12 12.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -153.68 129.78 10.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.064 -1.054 . . . . 0.0 113.698 -173.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.685 ' HG ' ' CB ' ' A' ' 146' ' ' PHE . 4.8 mp -86.61 137.74 32.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.904 162.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 4.2 p -131.82 128.96 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.431 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.887 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -72.98 109.78 5.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.022 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -64.27 -70.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 113.079 -1.873 . . . . 0.0 110.413 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 14.0 mtp85 -148.54 138.03 21.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.476 0.655 . . . . 0.0 109.781 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.485 ' H ' ' HB3' ' A' ' 66' ' ' ALA . . . -162.28 -127.02 0.85 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.659 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 3.8 Cg_endo -89.18 -62.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.9 0 C-N-CA 122.163 1.909 . . . . 0.0 111.442 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -69.42 -53.35 19.75 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.751 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.18 174.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.113 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.73 89.52 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.871 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.887 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.5 m -96.87 179.61 4.9 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 117.308 0.554 . . . . 0.0 111.017 -169.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.729 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -168.5 147.2 4.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -169.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.848 ' HD2' ' HB2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -97.26 121.07 38.74 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.583 HD21 ' O ' ' A' ' 71' ' ' LEU . 2.0 tt -83.68 101.38 11.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.662 0.744 . . . . 0.0 110.218 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.648 HD23 ' CD1' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -92.99 41.51 1.08 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.438 0.637 . . . . 0.0 110.254 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -92.0 -26.24 18.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.792 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.03 178.99 4.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.481 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.78 -44.46 81.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -162.56 128.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.933 -174.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 p -113.8 121.6 44.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.133 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.686 ' O ' HG22 ' A' ' 87' ' ' ILE . 65.4 m -64.86 126.14 27.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.964 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.546 ' HB3' HG23 ' A' ' 87' ' ' ILE . . . -119.59 115.98 25.09 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.669 ' HA2' HD21 ' A' ' 89' ' ' LEU . . . 149.39 -142.96 10.28 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.12 104.38 3.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 109.966 173.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.521 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 69.7 m-70 -137.09 118.43 11.02 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 -173.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.02 -44.66 12.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.186 1.924 . . . . 0.0 110.848 166.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -147.33 110.59 4.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.641 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.501 ' CB ' ' HB2' ' A' ' 78' ' ' SER . 33.7 m -158.3 -86.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.954 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -171.71 -58.16 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.375 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.729 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -101.05 94.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.0 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -100.07 134.92 42.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.817 174.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.946 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -117.02 75.21 0.96 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.2 t70 58.92 15.75 4.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.745 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 2.3 p30 46.12 -73.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.285 1.434 . . . . 0.0 113.696 -170.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 92' ' ' VAL . 12.7 p -73.63 64.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -156.08 -1.24 0.13 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.263 164.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.874 HG12 ' HG ' ' A' ' 115' ' ' SER . 9.2 t -131.7 137.83 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.125 -0.36 . . . . 0.0 110.732 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.479 ' HA ' ' O3P' ' A' ' 22' ' ' TPO . 19.4 m -72.48 71.22 0.93 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.436 ' CD ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 68.55 -59.63 0.45 Allowed 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.822 -174.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.0 ptp85 -149.31 138.67 21.53 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.661 -0.649 . . . . 0.0 110.625 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.682 ' CB ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -70.58 -43.16 69.98 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.556 ' HB2' HG13 ' A' ' 110' ' ' VAL . . . -159.46 175.12 13.68 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 112.704 -2.043 . . . . 0.0 108.949 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.647 ' HB2' HD12 ' A' ' 76' ' ' ILE . 8.6 pt-20 -128.37 115.05 17.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 1.016 ' HD1' HG11 ' A' ' 110' ' ' VAL . 2.4 t80 -78.07 91.46 4.28 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.877 0.846 . . . . 0.0 108.719 -171.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.605 ' HD2' HG21 ' A' ' 111' ' ' VAL . 12.8 ptp180 -101.54 140.3 36.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.343 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -83.25 112.29 19.74 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.501 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.35 139.75 39.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 36.2 m-80 62.51 32.52 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.699 ' HA ' HD21 ' A' ' 103' ' ' LEU . 6.8 t30 72.03 -0.1 3.35 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.568 0.747 . . . . 0.0 111.517 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.538 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 12.9 mm-40 -111.62 142.54 43.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.544 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.726 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.62 128.9 36.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.024 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.626 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 18.0 m-80 -138.05 161.86 35.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 1.016 HG11 ' HD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -104.54 117.34 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 117.962 0.346 . . . . 0.0 111.019 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.605 HG21 ' HD2' ' A' ' 102' ' ' ARG . 76.5 t -99.03 110.17 25.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -70.27 135.38 48.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.49 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 27.2 m -135.61 7.62 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.112 0.482 . . . . 0.0 109.78 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 102.96 107.19 3.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.292 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.874 ' HG ' HG12 ' A' ' 94' ' ' VAL . 25.6 t -102.35 157.26 17.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.772 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.6 tm? -58.13 -53.18 61.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.773 -174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -36.03 73.25 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.725 0.774 . . . . 0.0 109.014 172.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 132.35 177.55 14.98 Favored Glycine 0 C--O 1.25 1.095 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.214 -173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.434 HG21 ' CE1' ' A' ' 98' ' ' HIS . 5.6 m -111.57 136.68 50.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.901 0.48 . . . . 0.0 111.474 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -139.57 132.8 29.83 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.84 170.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.716 HG22 HG11 ' A' ' 137' ' ' VAL . 84.6 t -129.3 121.69 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.75 32.6 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 56.89 26.36 11.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.595 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.0 pt-20 -137.86 143.21 39.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.426 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -66.99 123.26 10.74 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.847 2.364 . . . . 0.0 112.348 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.43 175.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 p-10 -103.35 -49.94 3.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.12 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.877 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 33.3 t -157.72 91.44 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.41 137.81 36.57 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.025 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.401 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 7.4 p -80.57 143.16 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.784 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.713 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -49.44 133.19 20.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.227 174.197 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.588 ' HB2' ' CE1' ' A' ' 146' ' ' PHE . . . -128.38 -175.15 3.42 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -107.0 86.03 2.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.32 2.29 38.28 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.445 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.416 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 4.8 t70 -89.98 158.18 17.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.487 0.644 . . . . 0.0 109.744 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.5 pm0 -107.42 143.51 35.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.898 0.856 . . . . 0.0 113.209 -172.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.716 HG11 HG22 ' A' ' 121' ' ' VAL . 58.4 t -119.9 141.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.739 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.689 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 56.1 tp60 -108.05 122.97 47.95 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.082 0.467 . . . . 0.0 110.186 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.946 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.92 139.99 50.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 168.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 63.27 -90.27 0.07 OUTLIER Glycine 0 C--O 1.208 -1.481 0 C-N-CA 119.717 -1.23 . . . . 0.0 112.322 173.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 24' ' ' VAL . 14.8 ptmt -156.95 31.9 0.3 Allowed 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.519 -0.989 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.659 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -123.87 138.44 54.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.659 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -89.5 108.84 19.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.788 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.08 161.05 13.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.41 143.45 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.713 ' HB2' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -109.34 144.6 37.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.528 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? -127.66 128.11 44.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.615 ' HB ' ' HB1' ' A' ' 56' ' ' ALA . 14.2 t -160.93 137.61 8.69 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 167.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -132.27 124.62 3.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.603 -175.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.85 1.04 9.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.898 2.399 . . . . 0.0 112.148 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 57.48 45.9 18.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.931 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -76.28 109.64 10.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.61 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 178.26 113.64 0.37 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -65.05 -35.11 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 111.024 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -157.48 -58.0 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -80.16 150.19 30.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -106.38 160.4 14.56 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.171 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.2 m -80.32 94.06 6.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.083 0.468 . . . . 0.0 110.33 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.3 m -86.55 137.15 32.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.365 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.45 -32.43 30.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.131 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 152.49 -71.6 0.28 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.06 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 176.154 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -103.16 1.52 33.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.031 0.919 . . . . 0.0 108.629 170.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.85 53.27 2.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.536 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.5 ptp -67.62 148.52 51.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.408 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -124.87 67.9 53.33 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.25 -68.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.415 2.077 . . . . 0.0 111.421 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -149.07 76.69 1.34 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.698 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.8 10.75 7.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.967 0.889 . . . . 0.0 109.168 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.17 156.07 19.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.115 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -129.59 53.93 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.518 0.675 . . . . 0.0 109.449 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -90.09 -7.74 53.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.014 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.48 -41.47 93.25 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 86.22 3.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.358 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.1 m -153.84 -38.31 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.324 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 41.8 -97.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 124.538 1.149 . . . . 0.0 113.468 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.57 73.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.879 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 t 59.1 38.68 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.992 0.901 . . . . 0.0 109.683 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.8 m -100.03 89.14 3.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.932 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.28 17.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.749 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.19 99.27 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.731 HG23 ' O ' ' A' ' 22' ' ' TPO . 54.1 m -78.65 137.09 37.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.731 ' O ' HG23 ' A' ' 21' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.646 ' O ' ' HA ' ' A' ' 93' ' ' THR . 57.2 m -80.08 140.42 36.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 120.801 -1.187 . . . . 0.0 112.547 -173.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG21 ' CB ' ' A' ' 117' ' ' ASN . 14.1 p -127.87 141.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.482 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 t80 179.13 -168.1 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.563 ' HD2' ' HB2' ' A' ' 31' ' ' SER . 7.8 tpt180 46.33 -123.29 1.26 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.876 0.735 . . . . 0.0 110.542 170.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 141' ' ' LYS . . . 60.07 179.62 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.655 ' HA ' HD12 ' A' ' 33' ' ' LEU . 7.3 t70 -78.08 56.81 1.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.989 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 13.4 m-85 -147.4 -52.56 0.2 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.724 -178.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.22 -44.42 4.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.63 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.563 ' HB2' ' HD2' ' A' ' 26' ' ' ARG . 19.4 m -141.64 169.83 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.816 -167.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.648 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 2.1 mm-40 67.67 -150.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.839 0.712 . . . . 0.0 111.604 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.655 HD12 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 49.99 -101.19 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.227 1.011 . . . . 0.0 112.014 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p30 -178.37 -169.64 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.078 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.783 ' H ' ' HD2' ' A' ' 36' ' ' PRO . . . -122.6 -47.62 0.04 OUTLIER Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.913 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.783 ' HD2' ' H ' ' A' ' 35' ' ' ALA . 63.0 Cg_endo -72.08 -146.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.372 2.048 . . . . 0.0 111.817 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' H ' ' HB2' ' A' ' 36' ' ' PRO . . . -156.94 101.67 1.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 110.595 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -140.69 129.44 23.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.184 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.05 144.05 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.39 86.17 0.28 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.266 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -119.02 147.42 44.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 0.0 110.977 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -113.01 104.59 12.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -76.94 74.36 3.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.238 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.74 154.73 18.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.173 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 1.045 ' HA ' ' HA2' ' A' ' 50' ' ' GLY . 12.7 m -124.22 120.91 60.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 0.0 111.662 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.1 p -81.96 -70.06 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.571 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.57 -94.15 2.29 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.74 13.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.297 0.57 . . . . 0.0 110.742 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -111.98 -16.96 12.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 1.045 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 82.32 -54.13 4.85 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD13 ' CE2' ' A' ' 108' ' ' PHE . 16.9 mt -56.36 119.94 31.83 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 123.752 0.821 . . . . 0.0 110.902 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.435 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 95.4 Cg_endo -98.18 11.59 0.89 Allowed 'Trans proline' 0 CA--C 1.557 1.642 0 C-N-CA 122.341 2.027 . . . . 0.0 117.022 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 39.1 Cg_endo -103.95 161.83 0.22 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 122.401 1.893 . . . . 0.0 113.581 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.43 -20.75 36.95 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.56 132.65 31.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -136.19 170.15 16.48 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 57' ' ' LEU . 3.1 pp -161.29 145.2 13.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.561 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.6 mp -87.1 116.5 25.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.759 164.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -113.11 130.02 67.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 118.158 0.435 . . . . 0.0 110.522 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.901 HG13 ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -71.16 109.38 3.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -62.46 -54.46 39.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.216 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 14.6 ttm-85 -165.42 106.94 0.77 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.989 173.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.68 -133.07 3.69 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 176.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.574 ' HG2' ' H ' ' A' ' 65' ' ' ASN . 82.4 Cg_endo -76.0 -64.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.34 2.027 . . . . 0.0 112.191 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.626 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 66.5 t30 -70.13 -47.3 62.29 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 60.31 166.94 0.08 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.847 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.35 4.45 89.95 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.77 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.862 ' H ' HG21 ' A' ' 60' ' ' VAL . 5.6 m -101.92 179.18 4.4 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 117.651 0.726 . . . . 0.0 110.655 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.582 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.49 154.98 3.29 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.802 0.728 . . . . 0.0 112.24 -172.623 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.539 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.15 127.94 41.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.634 ' O ' HD22 ' A' ' 71' ' ' LEU . 1.5 tt -87.82 91.82 8.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.72 0.771 . . . . 0.0 109.534 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.792 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -85.39 55.78 3.66 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -108.75 -23.94 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.869 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -103.77 -166.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.52 -41.17 69.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.696 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.3 129.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.463 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.514 ' HB ' ' CB ' ' A' ' 86' ' ' ASP . 71.8 p -113.2 126.02 54.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.676 ' O ' HG22 ' A' ' 87' ' ' ILE . 39.1 m -68.29 126.58 30.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.564 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -122.54 108.65 13.38 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.777 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 165.45 -139.3 5.72 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.095 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.773 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.98 103.88 7.16 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.527 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 11.5 m-70 -129.75 120.73 19.69 Favored Pre-proline 0 N--CA 1.436 -1.133 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.229 -172.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.72 -16.23 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.292 1.994 . . . . 0.0 109.559 164.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -160.42 125.12 3.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.014 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.1 p 120.82 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 125.562 1.789 . . . . 0.0 113.362 164.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.514 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 6.3 m-20 56.91 -80.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 161.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.676 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -115.44 110.95 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.0 0.905 . . . . 0.0 111.672 -171.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.33 114.61 28.43 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.714 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.791 HD12 HG12 ' A' ' 139' ' ' ILE . 4.7 mt -102.4 80.05 1.9 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.942 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 14.6 t70 70.11 -7.48 0.95 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.148 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.773 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.6 p30 39.47 36.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 113.075 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.603 ' O ' HG23 ' A' ' 22' ' ' TPO . 41.1 t -148.42 -2.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 23' ' ' SER . 27.7 p -113.2 -34.92 5.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.526 ' HB ' ' HA2' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -116.72 154.6 18.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 122.116 -0.365 . . . . 0.0 110.602 -171.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.677 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 7.1 m -68.41 72.79 0.21 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.706 0.403 . . . . 0.0 112.049 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.693 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 59.36 -49.31 0.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.054 0.942 . . . . 0.0 112.709 -173.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.777 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 10.3 ptp85 -149.42 141.85 24.28 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.691 -0.631 . . . . 0.0 110.308 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.809 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.85 -41.3 12.55 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.888 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -140.26 170.55 15.61 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.808 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.623 ' HB2' HD13 ' A' ' 76' ' ' ILE . 6.6 pt-20 -137.45 123.27 20.03 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.792 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -55.52 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 124.413 1.071 . . . . 0.0 108.931 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.452 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -94.14 98.04 10.7 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.939 -174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -78.95 104.8 9.83 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.817 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.63 134.99 54.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.3 OUTLIER 40.75 47.24 2.43 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.313 1.008 . . . . 0.0 112.092 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 103' ' ' LEU . 3.6 m-20 76.55 2.18 3.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.693 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 50.2 mt-10 -106.28 141.3 37.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.807 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.595 ' CB ' HD23 ' A' ' 72' ' ' LEU . 1.1 m-85 -89.05 126.99 35.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.498 ' OD1' HG22 ' A' ' 130' ' ' VAL . 24.4 m-80 -132.12 160.29 36.43 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.718 0.294 . . . . 0.0 110.576 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.865 ' O ' ' HA ' ' A' ' 128' ' ' SER . 5.6 m -111.76 126.96 69.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.016 0.436 . . . . 0.0 110.211 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 3.8 t -101.38 112.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.354 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 13.4 t0 -74.78 128.64 36.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.493 HG13 HG11 ' A' ' 111' ' ' VAL . 36.0 m -128.04 4.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 109.608 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.17 87.63 2.01 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.282 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.721 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.4 t -87.79 141.01 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.567 ' HB2' ' O3P' ' A' ' 22' ' ' TPO . 13.0 tp -53.15 -57.26 11.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.734 HD22 ' HA2' ' A' ' 140' ' ' GLY . 1.8 p30 -65.91 -37.79 87.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.642 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.11 164.06 9.84 Favored Glycine 0 C--O 1.262 1.847 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.724 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.508 HG21 ' CE1' ' A' ' 98' ' ' HIS . 17.7 m -113.82 129.27 56.61 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.239 -1.481 . . . . 0.0 110.297 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -141.63 105.22 4.69 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 111.67 173.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 1.001 HG23 HG23 ' A' ' 137' ' ' VAL . 52.5 t -100.33 127.11 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 0.9 OUTLIER 63.22 25.61 14.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 63.05 13.8 7.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.834 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.85 156.88 58.7 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 120.762 0.315 . . . . 0.0 110.385 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.75 131.85 12.66 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.44 2.093 . . . . 0.0 112.645 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.26 176.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 10.0 m-20 -120.1 -31.34 4.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.56 174.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.865 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.0 p -161.63 91.48 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.509 0.671 . . . . 0.0 109.866 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -100.91 145.58 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.498 HG22 ' OD1' ' A' ' 109' ' ' ASN . 14.5 t -88.18 119.81 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.578 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -58.74 162.3 4.11 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.433 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -163.52 164.59 24.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.622 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -71.06 114.49 9.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.346 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.39 -7.96 51.77 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.856 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.49 110.64 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.621 0.369 . . . . 0.0 110.142 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -93.83 152.3 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.172 0.51 . . . . 0.0 112.251 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.001 HG23 HG23 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -133.4 141.24 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 142' ' ' PHE . 1.1 tm0? -109.58 116.68 32.22 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 169.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.809 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -138.4 131.77 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.243 175.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.734 ' HA2' HD22 ' A' ' 117' ' ' ASN . . . 82.9 -56.88 5.07 Favored Glycine 0 C--N 1.317 -0.502 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.25 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.751 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 59.9 pttt 168.03 32.11 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.751 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.5 161.52 17.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.232 -173.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.77 99.62 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.977 ' HB2' HG12 ' A' ' 137' ' ' VAL . 5.8 mp -88.83 163.54 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.365 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -141.53 140.29 31.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 166.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.599 ' O ' HD13 ' A' ' 147' ' ' LEU . 45.9 t80 -100.04 143.08 30.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.402 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.599 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -130.34 134.6 47.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.76 170.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.589 ' HB ' ' CE2' ' A' ' 146' ' ' PHE . 2.5 t -116.02 149.67 38.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 63.14 91.08 0.03 OUTLIER Glycine 0 CA--C 1.52 0.36 0 O-C-N 123.584 0.553 . . . . 0.0 112.318 -172.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.0 57.12 2.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.026 2.484 . . . . 0.0 112.058 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -66.43 -32.29 73.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.41 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -105.9 -3.68 21.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 -177.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.82 -96.02 0.5 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.417 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 67.97 -69.22 0.15 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.553 0.741 . . . . 0.0 111.759 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -104.33 -67.72 0.89 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.53 137.82 33.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.3 18.95 54.45 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.283 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.496 ' C ' ' HG1' ' A' ' 159' ' ' THR . 18.8 t -82.31 -9.0 59.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 110.345 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.496 ' HG1' ' C ' ' A' ' 158' ' ' SER . 25.1 p 54.29 -94.16 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 112.356 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.39 -43.3 2.01 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.05 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.16 -159.03 24.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.171 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--O 1.246 0.908 0 C-N-CA 123.27 2.647 . . . . 0.0 111.705 179.137 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.4 p -109.32 153.43 23.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.24 116.02 27.9 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -135.47 149.19 49.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.951 0.405 . . . . 0.0 110.535 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -132.6 126.26 19.95 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.639 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.85 106.89 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.583 2.188 . . . . 0.0 112.194 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.71 -7.5 58.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.603 0.716 . . . . 0.0 109.424 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -92.93 143.22 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.591 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -76.95 134.39 38.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -81.62 73.29 8.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.52 -43.24 71.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.164 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -77.16 119.24 20.57 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -33.04 -56.45 0.39 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.481 1.113 . . . . 0.0 113.619 -169.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -131.21 -9.54 3.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.162 0.506 . . . . 0.0 110.127 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t70 65.4 40.62 4.64 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.792 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.93 117.81 15.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.022 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.75 -16.78 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.589 0.709 . . . . 0.0 109.326 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -86.45 78.16 9.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.632 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.1 129.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.782 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.39 70.56 7.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.645 0.736 . . . . 0.0 111.142 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 73.1 m -155.77 132.84 10.7 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.456 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.772 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 93' ' ' THR . 70.4 m -34.55 146.84 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -162.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 12.3 p -127.64 147.18 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.986 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.3 t80 172.8 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.921 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.624 ' CG ' ' H ' ' A' ' 27' ' ' ALA . 8.7 tpt180 47.64 -130.47 1.56 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.873 0.469 . . . . 0.0 109.931 172.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.792 ' HB1' ' HA ' ' A' ' 141' ' ' LYS . . . 64.83 173.36 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.592 ' HA ' HD23 ' A' ' 33' ' ' LEU . 8.5 t70 -76.18 55.24 0.93 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.68 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.457 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 22.4 m-85 -147.46 -42.08 0.17 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.966 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 tp -97.58 -67.87 0.83 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.982 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.6 m -158.18 179.13 9.45 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.46 57.47 1.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.913 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.592 HD23 ' HA ' ' A' ' 28' ' ' ASP . 1.2 mt -141.36 -60.62 0.48 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.475 1.131 . . . . 0.0 108.892 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -54.58 139.11 39.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.38 -2.191 . . . . 0.0 112.06 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 69.25 98.24 0.04 OUTLIER Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.158 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.68 76.06 3.37 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.929 2.419 . . . . 0.0 111.961 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.93 -44.84 87.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.552 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -85.7 67.97 10.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.37 118.58 19.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.72 109.81 1.22 Allowed Glycine 0 C--N 1.33 0.196 0 O-C-N 123.594 0.559 . . . . 0.0 113.179 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -82.62 -29.27 30.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.89 0.376 . . . . 0.0 111.246 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -90.15 6.0 44.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 t -88.75 55.45 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.91 52.8 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 110.636 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 17.9 m -102.43 131.3 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.567 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 152' ' ' GLN . 24.1 m -145.69 124.39 12.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.262 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.19 -56.3 0.29 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.735 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 62.49 81.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -167.24 98.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.756 -172.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.56 85.81 0.01 OUTLIER Glycine 0 C--N 1.327 0.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.714 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' O ' HD11 ' A' ' 51' ' ' LEU . 3.0 pp -48.96 121.73 10.68 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.65 0.738 . . . . 0.0 111.709 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.46 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 32.0 Cg_exo -61.17 -39.48 58.45 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.894 3.063 . . . . 0.0 115.999 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.24 128.02 4.75 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.9 1.733 . . . . 0.0 112.689 -170.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.0 -31.48 61.84 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.22 123.73 41.09 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.87 170.63 14.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.457 HD12 ' HB ' ' A' ' 59' ' ' VAL . 2.5 pp -158.1 142.63 16.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.612 ' HG ' ' CB ' ' A' ' 146' ' ' PHE . 6.0 mp -87.9 110.96 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.999 163.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.457 ' HB ' HD12 ' A' ' 57' ' ' LEU . 4.9 p -107.94 124.81 64.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.351 0.596 . . . . 0.0 111.216 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.957 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -72.74 111.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.073 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.5 -70.12 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.708 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.562 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 8.3 mtm180 -142.99 128.11 18.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.607 0.717 . . . . 0.0 110.736 176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -167.13 -153.69 8.07 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.707 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 52.9 Cg_exo -56.07 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 122.598 2.198 . . . . 0.0 113.052 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.612 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 8.1 t30 -70.39 -49.12 52.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 55.61 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.531 -173.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.08 0.07 84.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.316 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.843 ' H ' HG23 ' A' ' 60' ' ' VAL . 33.1 t -99.81 -171.59 2.08 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 118.412 1.106 . . . . 0.0 110.383 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.51 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.83 164.18 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -175.301 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.582 ' HZ ' HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -95.95 129.13 43.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.601 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -85.94 96.54 9.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.761 0.791 . . . . 0.0 109.457 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.819 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -89.43 31.51 0.91 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.336 0.588 . . . . 0.0 109.703 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.0 -28.63 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.697 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.413 ' NE2' HG23 ' A' ' 77' ' ' THR . 13.2 pt20 -95.72 -166.35 1.43 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.747 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.86 -38.05 46.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.692 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -162.07 135.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 111.937 -177.089 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.433 HG21 ' O ' ' A' ' 71' ' ' LEU . 54.1 p -123.77 133.28 53.86 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.58 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.714 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 44.3 m -76.84 126.08 30.38 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -119.45 112.4 19.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -167.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.538 ' HA3' HG12 ' A' ' 94' ' ' VAL . . . 156.56 -88.92 0.12 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.887 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -108.44 104.41 13.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.702 0.763 . . . . 0.0 109.002 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.714 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -130.73 103.77 15.9 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.289 -174.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -64.41 -37.17 40.6 Favored 'Trans proline' 0 C--N 1.328 -0.505 0 C-N-CA 122.677 2.251 . . . . 0.0 113.602 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -147.0 30.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.4 p -151.2 -164.78 2.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -32.44 -89.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.793 1.637 . . . . 0.0 115.273 -167.412 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.586 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -107.29 109.91 29.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.44 0.638 . . . . 0.0 111.574 -171.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.85 127.22 47.4 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.984 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.957 HD21 HG11 ' A' ' 60' ' ' VAL . 8.1 mt -121.1 82.78 1.97 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.077 170.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.26 -11.16 0.72 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.082 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' A' ' 89' ' ' LEU . 3.9 p30 40.23 32.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.489 1.515 . . . . 0.0 112.781 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.93 -9.28 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.84 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.693 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -112.64 -9.94 13.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -172.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.601 HG22 ' CA ' ' A' ' 140' ' ' GLY . 3.4 t -122.41 147.1 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.941 -0.474 . . . . 0.0 110.836 -171.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.772 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 3.9 t -77.39 73.49 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.5 OUTLIER 58.52 -58.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.788 -166.267 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.591 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 10.0 ptp85 -142.58 136.5 29.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.635 0.731 . . . . 0.0 111.35 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.06 -37.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.22 177.75 10.72 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.323 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -133.98 134.46 42.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.819 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -64.18 104.08 0.7 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.41 ' HE ' ' HB2' ' A' ' 102' ' ' ARG . 23.1 ttm180 -105.16 112.34 25.43 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.646 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.786 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.6 tt -84.28 103.77 13.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.577 0.704 . . . . 0.0 110.033 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.08 141.41 51.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.462 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 37.3 m-20 62.56 30.98 17.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.786 ' HA ' HD22 ' A' ' 103' ' ' LEU . 16.0 m120 62.15 11.97 4.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.253 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 9.3 pt-20 -117.56 147.11 43.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.632 ' CB ' HD21 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -93.19 119.38 32.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.8 -174.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -123.61 163.02 21.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.452 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.806 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -107.75 118.49 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.982 170.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 83.5 t -99.41 110.72 27.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.27 136.75 55.41 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.581 0.551 . . . . 0.0 110.047 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.422 HG22 ' CD ' ' A' ' 97' ' ' ARG . 24.2 m -133.69 3.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.093 0.473 . . . . 0.0 110.173 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.33 110.49 2.24 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.307 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.473 ' HB2' HG11 ' A' ' 94' ' ' VAL . 24.3 p -109.61 169.91 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 22' ' ' TPO . 0.7 OUTLIER -64.26 -55.17 23.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.506 -175.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.404 HD22 ' H ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -66.62 -37.45 84.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.97 161.32 10.58 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 121.438 0.465 . . . . 0.0 113.321 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.3 m -112.13 131.21 55.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.954 0.901 . . . . 0.0 111.274 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.469 ' HD2' ' HA ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -141.8 104.95 4.61 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.503 0.192 . . . . 0.0 111.483 175.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.961 HG21 HG12 ' A' ' 137' ' ' VAL . 93.6 t -102.6 119.82 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.964 -0.46 . . . . 0.0 109.97 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.3 37.5 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 64.06 25.11 13.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -176.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.55 133.09 8.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.811 -0.556 . . . . 0.0 110.867 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.78 122.64 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.099 1.866 . . . . 0.0 111.547 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.614 HG13 ' HB ' ' A' ' 121' ' ' VAL . 26.1 m -106.29 179.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 111.309 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 24.2 t70 -108.95 -40.97 4.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.806 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.0 t -165.14 91.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.0 124.0 40.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.585 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.6 p -70.69 144.16 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.557 0.694 . . . . 0.0 111.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 1.1 tt -52.05 134.53 32.27 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.592 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.425 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -127.59 -176.25 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.66 88.47 2.93 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.015 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.86 -16.82 30.54 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.6 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.885 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 4.2 m-20 -68.85 155.08 40.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.133 0.492 . . . . 0.0 110.786 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -110.1 156.2 20.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 112.566 -170.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.961 HG12 HG21 ' A' ' 121' ' ' VAL . 47.0 t -135.39 132.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.04 118.07 33.8 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.628 ' CG1' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -128.96 131.35 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.368 173.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.601 ' CA ' HG22 ' A' ' 94' ' ' VAL . . . 82.03 -55.76 4.93 Favored Glycine 0 C--N 1.322 -0.231 0 C-N-CA 119.315 -1.421 . . . . 0.0 112.944 167.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.81 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 58.5 pttt 169.21 32.36 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 124.406 1.083 . . . . 0.0 109.082 163.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.81 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.08 150.96 44.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -169.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -93.2 92.15 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.0 mp -88.48 158.34 18.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.204 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.97 143.09 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.225 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.885 ' HE1' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -108.49 143.89 36.86 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.742 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? -132.85 167.41 20.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -174.85 -150.4 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.389 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.46 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . -64.69 167.59 29.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.417 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.28 85.14 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.012 2.475 . . . . 0.0 113.751 -175.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -101.23 46.06 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 46' ' ' SER . 36.3 tt0 -145.51 151.11 37.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.742 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.97 -165.92 16.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -78.0 63.55 3.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.595 0.698 . . . . 0.0 110.639 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -97.62 92.76 6.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.4 t70 78.37 139.18 0.07 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 124.447 1.092 . . . . 0.0 110.002 -169.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.0 68.8 1.94 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.047 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -87.35 68.45 9.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.845 0.355 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.3 m -75.83 -32.65 59.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.443 . . . . 0.0 110.38 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.13 -128.44 9.55 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.788 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -101.22 -67.65 0.82 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.966 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 122.951 2.434 . . . . 0.0 112.609 -177.927 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.48 0.657 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 p -133.0 -60.85 0.85 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.67 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 t70 69.94 120.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.861 0.726 . . . . 0.0 111.851 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ptp -140.31 8.08 2.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.471 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -92.59 112.09 53.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.879 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.81 114.41 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.782 2.321 . . . . 0.0 113.669 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 63.79 73.45 0.44 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.95 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 pt -88.75 22.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.8 -0.97 36.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -90.68 4.03 52.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 65.24 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.354 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -84.79 106.74 16.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -118.74 142.16 47.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.453 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.1 m -148.04 -71.41 0.21 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.511 ' O ' HG11 ' A' ' 19' ' ' VAL . 16.9 m-20 -123.71 -15.8 6.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.94 0.4 . . . . 0.0 111.196 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.51 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -75.1 46.57 0.32 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 111.613 -177.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.9 -60.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.044 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.7 p -97.01 -40.76 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 HG11 ' O ' ' A' ' 15' ' ' ASP . 6.9 p -86.23 6.48 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.335 0.588 . . . . 0.0 110.834 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.15 69.11 8.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.37 0.605 . . . . 0.0 109.733 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.724 HG21 ' O ' ' A' ' 22' ' ' TPO . 87.7 m -154.28 137.86 16.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.553 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.791 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.771 ' O ' ' HA ' ' A' ' 93' ' ' THR . 69.1 m -72.56 140.54 48.16 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.515 -0.741 . . . . 0.0 111.741 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' HB ' HD21 ' A' ' 116' ' ' LEU . 8.0 p -135.36 147.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.315 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -177.35 -160.06 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.071 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.553 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 42.52 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.222 0.951 . . . . 0.0 110.676 176.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . . . 66.08 172.12 0.23 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 165.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.826 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 7.4 t70 -89.7 53.87 2.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.744 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -148.09 -49.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.818 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.6 tp -74.64 -67.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.675 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.7 t -162.9 -178.85 6.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.191 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.455 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.9 OUTLIER 68.69 36.18 2.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.944 0.898 . . . . 0.0 110.943 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.846 HD21 HH21 ' A' ' 143' ' ' ARG . 1.4 mt -133.71 -75.94 0.48 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 52.12 -89.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.212 172.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -164.87 -50.48 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.207 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.54 118.15 5.51 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.301 2.001 . . . . 0.0 113.091 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.84 75.18 7.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.21 117.2 6.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.84 75.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.235 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.43 60.48 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.779 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m 60.07 85.53 0.11 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.121 0.486 . . . . 0.0 111.731 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.17 -71.73 0.57 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 m -115.2 -49.98 2.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.05 48.51 22.95 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.515 0.509 . . . . 0.0 111.376 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.84 116.35 31.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 m 70.43 -55.57 0.62 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.382 0.673 . . . . 0.0 111.449 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -53.43 0.49 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 12.0 t 50.97 59.02 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.301 0.572 . . . . 0.0 109.817 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -150.67 -65.0 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.75 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.58 ' HA2' ' HA2' ' A' ' 149' ' ' GLY . . . -77.74 75.5 1.84 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.894 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 18.0 mt -108.95 89.89 7.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -111.93 33.4 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 123.343 2.696 . . . . 0.0 114.756 168.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.606 ' HD2' ' O ' ' A' ' 55' ' ' SER . 88.0 Cg_endo -88.27 39.78 0.53 Allowed 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.726 1.617 . . . . 0.0 112.419 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.7 -12.17 70.45 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.606 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.783 -0.708 . . . . 0.0 109.738 -178.485 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.618 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.78 168.7 13.44 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 pp -161.01 146.18 14.13 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.049 -1.06 . . . . 0.0 113.537 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.591 HD21 ' CG1' ' A' ' 110' ' ' VAL . 4.1 mp -87.91 141.16 28.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.634 164.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.602 HG12 HD22 ' A' ' 147' ' ' LEU . 7.3 p -132.74 132.48 59.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.215 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.921 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 0.8 OUTLIER -74.17 109.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -63.32 -54.74 32.23 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.885 -173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 71.9 mtt180 -158.38 138.18 12.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.054 174.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -175.65 -155.28 12.55 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 78.2 Cg_exo -55.68 -65.0 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.712 2.274 . . . . 0.0 112.949 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.751 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 52.3 t30 -71.03 -48.38 53.29 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.563 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 56.71 153.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.044 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.55 2.22 90.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.811 ' H ' HG21 ' A' ' 60' ' ' VAL . 4.0 m -88.34 176.35 7.25 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.258 0.529 . . . . 0.0 110.26 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.65 HH21 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -170.23 148.27 3.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.812 0.733 . . . . 0.0 112.868 -169.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.49 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -95.89 129.67 43.08 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.023 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.65 ' HB2' HH21 ' A' ' 69' ' ' ARG . 1.5 tm? -85.79 101.37 12.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.764 ' HG ' ' CG ' ' A' ' 101' ' ' PHE . 0.7 OUTLIER -95.86 31.58 2.07 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.297 -177.003 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.454 ' H ' HD13 ' A' ' 71' ' ' LEU . 34.7 t70 -89.85 -11.52 41.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.84 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.569 ' O ' ' HE2' ' A' ' 101' ' ' PHE . 1.4 pp0? -121.42 153.84 37.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -42.63 -39.01 2.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.647 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.82 123.08 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.255 0.55 . . . . 0.0 112.149 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 1.6 p -113.79 121.84 45.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.802 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.596 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 30.5 m -76.61 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.579 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.675 ' HB3' HG22 ' A' ' 87' ' ' ILE . . . -122.21 116.47 24.21 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.862 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 170.66 -108.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.671 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.715 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -111.79 101.75 10.07 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.696 ' CD2' ' HB2' ' A' ' 85' ' ' SER . 0.2 OUTLIER -139.37 146.86 50.36 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.955 -160.5 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.91 -157.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.412 2.074 . . . . 0.0 110.039 165.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -78.25 52.42 1.12 Allowed 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.204 -0.31 . . . . 0.0 111.138 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.696 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . 5.7 m -91.02 -70.4 0.68 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 110.663 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB2' ' H ' ' A' ' 87' ' ' ILE . 2.8 m-20 -143.14 -77.18 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.437 0.636 . . . . 0.0 110.818 -171.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.675 HG22 ' HB3' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -127.75 122.02 57.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.229 -176.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.71 133.16 56.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.238 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.68 HD12 HG12 ' A' ' 139' ' ' ILE . 6.2 mt -108.15 80.33 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.432 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 29.7 t70 71.71 -6.84 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.57 0.7 . . . . 0.0 110.134 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.715 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.3 p30 40.5 38.77 0.62 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.121 1.368 . . . . 0.0 113.523 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.511 ' O ' HG13 ' A' ' 92' ' ' VAL . 70.8 t -145.67 6.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.737 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.771 ' HA ' ' O ' ' A' ' 23' ' ' SER . 10.3 p -124.47 -2.2 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -168.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.53 155.55 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.72 -172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.791 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 51.0 m -75.52 79.28 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.032 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 1.021 ' HG2' ' HD2' ' A' ' 97' ' ' ARG . 11.4 ttm180 55.69 -58.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.753 -1.112 . . . . 0.0 112.869 -164.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 1.021 ' HD2' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -157.84 153.87 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.484 -0.76 . . . . 0.0 111.697 -177.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.976 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -95.41 -40.54 9.44 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.304 177.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.86 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -148.61 131.52 16.16 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.667 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' HB2' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -102.98 122.53 44.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.764 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -53.19 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 124.614 1.196 . . . . 0.0 108.406 -176.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.85 107.67 19.95 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 119.359 -0.937 . . . . 0.0 108.742 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.845 HD23 ' HA ' ' A' ' 106' ' ' ASN . 8.8 tt -77.02 107.87 9.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.494 ' C ' HD21 ' A' ' 105' ' ' ASN . 23.6 mt-10 -117.19 134.05 55.25 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.494 HD21 ' C ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER 39.07 43.34 0.8 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.1 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.845 ' HA ' HD23 ' A' ' 103' ' ' LEU . 53.2 m-80 72.08 15.63 5.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.561 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 15.5 pt-20 -122.26 151.68 40.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.939 173.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.947 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -93.42 129.13 39.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.942 -174.166 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 18.4 m-80 -135.19 161.82 34.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.882 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.4 m -107.03 126.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.37 174.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.86 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 4.0 t -100.3 111.59 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.297 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 11.2 t70 -73.26 115.05 12.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.629 HG13 HG13 ' A' ' 111' ' ' VAL . 16.0 m -115.17 -12.36 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.122 0.487 . . . . 0.0 111.096 -174.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.8 87.57 0.34 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.586 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.976 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 30.7 t -92.32 145.15 24.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.47 HD21 ' HB ' ' A' ' 24' ' ' VAL . 23.9 tp -63.73 -55.41 23.47 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.334 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.591 HD21 ' N ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -67.77 -36.44 80.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.48 169.57 12.42 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.102 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.2 m -112.85 123.53 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.618 -0.791 . . . . 0.0 111.298 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -140.96 103.67 4.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.995 HG11 HG13 ' A' ' 137' ' ' VAL . 1.3 m -99.45 130.27 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.62 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.6 OUTLIER 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.139 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 58.12 32.13 21.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -146.12 138.79 13.96 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 110.664 173.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -65.46 123.26 11.19 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.599 2.199 . . . . 0.0 111.412 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.456 HG22 ' CG2' ' A' ' 121' ' ' VAL . 27.3 m -123.65 169.41 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.41 -61.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.809 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.882 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.5 t -143.84 91.91 2.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.333 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.32 124.89 44.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 8.7 p -67.11 150.81 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.728 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.947 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.0 mp -58.67 145.93 38.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.497 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.443 ' H ' ' HB2' ' A' ' 146' ' ' PHE . . . -151.3 130.79 12.97 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -69.42 121.85 17.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.441 0.639 . . . . 0.0 111.234 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.79 60.98 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.17 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 36.0 m-20 -105.02 147.53 27.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.631 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.58 161.85 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -168.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.995 HG13 HG11 ' A' ' 121' ' ' VAL . 40.6 t -134.51 131.74 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.558 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.826 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.6 tp-100 -96.8 120.06 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 169.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.823 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -135.98 129.5 47.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.386 171.105 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.591 ' N ' HD21 ' A' ' 117' ' ' ASN . . . 76.81 -62.25 3.25 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.597 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.83 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 54.1 pttt 176.41 28.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.122 0.569 . . . . 0.0 111.379 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.83 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -122.82 146.84 47.19 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 109.053 -168.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.846 HH21 HD21 ' A' ' 33' ' ' LEU . 11.6 ttm-85 -97.1 100.18 11.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.626 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.921 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.4 mp -91.75 166.08 12.95 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.922 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.571 HG23 HD21 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -143.36 144.25 23.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 171.13 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.507 ' CD2' ' HA ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -84.51 136.87 33.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.953 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD22 HG12 ' A' ' 59' ' ' VAL . 2.0 mm? -129.06 131.73 47.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.063 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.6 t -166.98 145.47 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.02 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.58 ' HA2' ' HA2' ' A' ' 50' ' ' GLY . . . -63.55 116.98 9.95 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.841 -176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.49 130.06 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.353 2.702 . . . . 0.0 110.835 173.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -59.03 116.15 3.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 111.334 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -87.47 63.41 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.72 3.44 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.892 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -127.01 121.95 33.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.335 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -93.93 -152.02 0.33 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 157' ' ' GLY . 19.0 t70 73.2 -166.79 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.519 ' H ' ' CG ' ' A' ' 156' ' ' ASP . . . 90.16 -59.77 3.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.4 m -99.88 76.75 1.98 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.404 HG21 ' HD2' ' A' ' 162' ' ' PRO . 8.9 m -73.37 76.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.331 0.586 . . . . 0.0 111.298 -173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -84.51 69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.889 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -155.93 -91.25 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.821 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 159' ' ' THR . 18.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 123.031 2.487 . . . . 0.0 112.046 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.3 m 69.95 97.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.501 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -92.41 -12.12 33.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.4 mtp 69.32 -75.53 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.862 0.726 . . . . 0.0 111.342 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.65 159.4 31.91 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.51 -77.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.077 1.851 . . . . 0.0 111.724 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -133.39 -56.7 0.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.803 0.335 . . . . 0.0 110.645 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.29 -54.12 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.476 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -179.58 -72.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.352 0.596 . . . . 0.0 110.645 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.44 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 3.0 ttmp? -104.39 49.09 0.82 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.659 -173.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.53 108.01 6.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.871 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.54 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 10.7 mm-40 -85.41 72.82 10.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.28 0.562 . . . . 0.0 112.125 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -122.35 32.02 5.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.811 0.815 . . . . 0.0 108.913 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -87.96 -32.87 18.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.464 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.596 ' HB2' HG11 ' A' ' 17' ' ' VAL . 3.8 p30 -69.61 -46.23 66.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.069 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 54.71 47.57 22.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.596 HG11 ' HB2' ' A' ' 15' ' ' ASP . 36.0 m -87.44 26.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.936 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -67.41 125.96 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.882 0.372 . . . . 0.0 110.128 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -56.88 137.71 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.696 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.96 96.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.058 -171.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.2 m -157.23 155.37 30.72 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.782 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -70.94 5.14 2.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -159.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.875 HG12 ' H ' ' A' ' 25' ' ' PHE . 2.1 t 46.52 -152.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.11 0.564 . . . . 0.0 111.99 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.875 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER 100.1 -165.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.374 1.47 . . . . 0.0 114.376 160.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.752 ' HD2' ' N ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 32.64 -95.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.041 1.337 . . . . 0.0 110.578 -172.177 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.785 ' H ' ' HB2' ' A' ' 141' ' ' LYS . . . 66.01 121.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 113.087 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.635 ' HB2' ' CG ' ' A' ' 138' ' ' GLN . 2.2 m-20 -87.83 59.95 5.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.59 -173.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.641 ' HE1' HD22 ' A' ' 117' ' ' ASN . 30.5 m-85 -116.6 -42.27 3.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.771 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.0 tp -98.81 -27.49 13.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.292 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 33' ' ' LEU . 49.3 m -160.9 -173.72 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -169.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 72.03 -13.47 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.904 0.752 . . . . 0.0 111.298 177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.614 ' HA ' ' NH2' ' A' ' 143' ' ' ARG . 2.9 mt -82.78 -44.31 15.7 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 64.23 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.44 -2.164 . . . . 0.0 112.541 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.33 141.18 14.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 110.933 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -87.91 -1.29 7.22 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.981 2.454 . . . . 0.0 112.604 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.51 53.77 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.321 0.582 . . . . 0.0 111.036 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -120.79 -38.77 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.437 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.77 133.7 36.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.561 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.89 78.72 0.41 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.801 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 m -73.04 81.22 1.23 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.087 0.47 . . . . 0.0 110.556 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.48 -62.08 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.931 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -145.38 -138.3 0.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.55 68.03 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.328 0.585 . . . . 0.0 110.919 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.66 132.06 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.185 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.0 p 57.07 170.25 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.164 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.33 -65.01 0.48 Allowed Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 m -86.08 26.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.1 -8.95 3.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.92 -45.91 7.41 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.412 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 148' ' ' THR . 5.2 mp -62.1 130.16 92.6 Favored Pre-proline 0 CA--C 1.516 -0.359 0 CA-C-O 120.527 0.203 . . . . 0.0 111.006 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -106.39 63.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.798 2.998 . . . . 0.0 112.203 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.517 ' HA ' ' O ' ' A' ' 149' ' ' GLY . 14.8 Cg_exo -29.13 109.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 124.277 3.318 . . . . 0.0 114.421 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.84 -48.11 0.76 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 p -143.11 147.33 34.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.58 36.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' A' ' 72' ' ' LEU . 2.3 pt? -160.71 140.02 10.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.943 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.801 HD13 HD11 ' A' ' 131' ' ' LEU . 5.5 mp -89.67 112.33 23.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.679 168.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.53 125.82 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.916 HG11 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -73.0 113.43 10.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -77.51 -55.94 4.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.014 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -141.53 129.27 21.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.415 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -177.38 178.58 48.31 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.708 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 97.0 Cg_exo -48.46 -48.41 17.31 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.948 2.432 . . . . 0.0 113.465 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 58.0 t30 -83.16 -52.72 6.36 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.696 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.97 171.21 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.5 -1.682 . . . . 0.0 112.796 -170.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.6 2.54 89.84 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.917 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.849 ' H ' HG22 ' A' ' 60' ' ' VAL . 3.4 m -98.01 177.76 5.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.626 0.713 . . . . 0.0 110.465 -171.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.19 151.96 3.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.102 0.41 . . . . 0.0 111.636 -176.356 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HD1' HD12 ' A' ' 87' ' ' ILE . 0.1 OUTLIER -94.95 134.05 38.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.493 ' O ' HD22 ' A' ' 71' ' ' LEU . 6.4 tt -87.05 93.85 9.47 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.727 HD21 ' CD1' ' A' ' 101' ' ' PHE . 4.1 mp -93.39 45.43 1.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -99.0 -28.22 13.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.131 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -92.59 -162.3 0.92 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.006 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.2 -51.5 20.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -158.89 139.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 111.949 -178.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 71' ' ' LEU . 38.3 p -121.16 152.03 39.23 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.343 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 75.8 m -95.57 124.8 39.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.609 ' HB2' HG12 ' A' ' 87' ' ' ILE . . . -126.54 116.23 20.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -166.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 148.99 -85.94 0.16 Allowed Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.176 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.587 ' HG2' ' OD1' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.67 104.03 11.29 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.617 0.722 . . . . 0.0 109.174 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.617 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER -139.47 126.61 12.8 Favored Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.023 -169.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.05 -50.18 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.654 2.236 . . . . 0.0 112.291 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -172.37 93.4 0.13 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.515 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 2.1 m -151.14 -62.42 0.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.155 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -140.14 -72.74 0.37 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.323 0.583 . . . . 0.0 111.285 -170.525 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.696 HD13 ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -126.85 113.94 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.215 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -116.77 134.32 54.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.132 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.916 HD13 HG11 ' A' ' 60' ' ' VAL . 4.5 mm? -122.22 74.43 1.16 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.934 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.6 t70 72.49 -17.37 0.39 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.454 0.645 . . . . 0.0 110.592 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.587 ' OD1' ' HG2' ' A' ' 81' ' ' ARG . 35.0 t70 61.82 29.52 17.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.386 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' C ' HG22 ' A' ' 22' ' ' TPO . 9.1 p -153.75 32.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.952 0.882 . . . . 0.0 109.821 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.621 HG23 ' HZ ' ' A' ' 142' ' ' PHE . 65.3 p -132.81 -9.57 3.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.965 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.505 ' N ' HG21 ' A' ' 22' ' ' TPO . 2.0 t -136.38 159.57 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -173.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.717 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 11.4 t -87.57 77.3 8.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.807 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 58.48 -59.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.929 -165.33 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.807 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 5.7 ptt85 -143.65 137.63 28.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.621 0.724 . . . . 0.0 111.066 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.696 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -75.02 -39.27 61.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 170.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -156.94 149.45 23.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.547 ' CD ' HH21 ' A' ' 102' ' ' ARG . 7.8 pt-20 -108.0 133.1 52.8 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.727 ' CD1' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -56.98 106.12 0.28 Allowed 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.198 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.547 HH21 ' CD ' ' A' ' 100' ' ' GLU . 21.1 tpp85 -103.16 104.04 14.15 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.62 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.854 HD23 ' HA ' ' A' ' 106' ' ' ASN . 7.3 tt -86.44 110.72 19.92 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.351 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.28 135.36 48.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 57.51 37.74 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.606 0.566 . . . . 0.0 110.329 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.854 ' HA ' HD23 ' A' ' 103' ' ' LEU . 21.1 m120 64.64 12.52 7.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.03 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.1 mt-10 -106.33 144.73 32.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.893 0.377 . . . . 0.0 111.396 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.43 ' HB2' HD22 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -95.9 126.29 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.384 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 11.0 m-80 -135.86 163.36 30.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.894 ' O ' ' HA ' ' A' ' 128' ' ' SER . 7.2 m -111.26 122.59 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.942 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 36.7 t -101.18 110.4 27.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.865 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 18.6 t70 -68.5 128.29 36.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.643 HG22 HH11 ' A' ' 97' ' ' ARG . 18.9 m -126.0 9.51 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.22 0.533 . . . . 0.0 109.734 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.62 71.77 0.59 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.307 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 39.3 t -67.11 134.98 52.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.782 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.8 tm? -52.83 -55.82 20.3 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.641 HD22 ' HE1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -76.17 -37.33 58.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 109.825 172.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.73 163.85 9.9 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.15 -173.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -111.69 137.41 49.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.394 0.678 . . . . 0.0 111.282 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.11 103.78 4.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.292 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.963 HG22 HG11 ' A' ' 137' ' ' VAL . 61.7 t -112.8 121.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 122.079 -0.388 . . . . 0.0 110.236 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.7 m120 61.29 36.91 17.5 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 63.66 22.11 12.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.477 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.59 148.48 25.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 121.028 0.442 . . . . 0.0 110.949 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.03 123.6 11.5 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.271 1.981 . . . . 0.0 111.78 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.49 155.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.7 0.286 . . . . 0.0 110.281 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.3 m-20 -87.54 -47.08 9.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.641 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.894 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.6 p -154.86 91.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.342 0.592 . . . . 0.0 110.733 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.61 132.85 47.05 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.367 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.1 p -76.06 149.63 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.629 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.801 HD11 HD13 ' A' ' 58' ' ' LEU . 8.7 mp -65.49 133.44 51.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.653 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.08 -176.32 3.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.859 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -93.81 103.78 15.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.36 0.124 . . . . 0.0 111.306 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.09 69.64 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.114 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -81.59 162.25 23.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.675 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.7 pt-20 -126.89 148.26 50.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -166.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.963 HG11 HG22 ' A' ' 121' ' ' VAL . 61.4 t -123.09 141.44 43.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.024 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.635 ' CG ' ' HB2' ' A' ' 28' ' ' ASP . 20.9 tm0? -106.67 131.12 54.17 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.916 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.48 140.32 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.784 174.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 71.3 -73.73 0.72 Allowed Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.344 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.785 ' HB2' ' H ' ' A' ' 27' ' ' ALA . 52.1 pttt -172.3 29.13 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.078 0.466 . . . . 0.0 110.445 170.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.684 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -127.02 149.32 49.95 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -171.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.614 ' NH2' ' HA ' ' A' ' 33' ' ' LEU . 3.8 ttm180 -98.6 120.26 38.72 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.64 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.853 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 4.3 mp -108.16 162.77 13.76 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.575 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.05 137.08 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.687 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.96 154.29 20.29 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.732 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.414 ' O ' HD23 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -127.75 171.63 11.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.06 171.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 9.5 t -138.11 159.79 41.11 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.428 -174.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . -160.64 70.89 0.23 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.44 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -63.18 137.34 60.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.612 2.208 . . . . 0.0 111.215 175.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.15 51.23 2.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.327 . . . . 0.0 111.495 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.56 89.72 4.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.253 0.549 . . . . 0.0 109.659 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.8 150.47 50.57 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.683 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.31 41.23 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.03 69.28 6.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -151.79 80.07 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.962 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.68 106.85 0.39 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.171 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.9 t -110.49 -18.52 13.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.0 m -125.8 115.63 20.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 172.39 -20.04 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.811 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.99 149.5 20.39 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.164 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.606 2.204 . . . . 0.0 111.854 177.938 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 121.455 0.645 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.9 t -107.97 13.34 26.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -108.18 111.19 23.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.699 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.8 mmm -109.75 113.57 26.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.34 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -68.17 -51.8 24.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -95.5 62.49 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.621 2.214 . . . . 0.0 111.12 169.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.32 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.178 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.6 -9.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.003 0.906 . . . . 0.0 108.678 172.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -166.36 160.19 15.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -141.31 101.76 4.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.0 110.709 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.6 125.54 28.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.395 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -169.8 -51.73 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.092 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -135.52 161.23 36.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.903 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 t -144.06 142.52 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -71.88 145.77 48.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.893 177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 17' ' ' VAL . 44.0 tt0 75.36 127.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.041 0.838 . . . . 0.0 109.944 -175.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 16' ' ' GLU . 12.5 t 66.15 28.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 122.364 1.078 . . . . 0.0 109.099 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -85.03 83.87 7.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.627 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.69 170.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.5 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 66.58 169.16 0.23 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.975 0.797 . . . . 0.0 111.145 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 m 68.35 159.42 0.16 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -171.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.716 ' HB ' HD21 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.513 ' HB2' HG22 ' A' ' 93' ' ' THR . 41.9 m -60.21 108.55 0.81 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 HG22 ' HB2' ' A' ' 117' ' ' ASN . 7.1 p -112.46 125.69 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.273 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.5 t80 176.52 -165.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.822 0.076 . . . . 0.0 110.937 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.514 ' NH1' ' HA2' ' A' ' 63' ' ' GLY . 1.2 tmm_? 43.48 -123.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.348 1.059 . . . . 0.0 112.484 171.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.852 ' HB1' ' HA ' ' A' ' 141' ' ' LYS . . . 65.05 174.74 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.681 ' HA ' HD21 ' A' ' 33' ' ' LEU . 13.5 t70 -76.87 56.61 1.21 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.488 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 56.3 m-85 -146.95 -48.97 0.19 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.645 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.29 -69.1 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.252 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 m -170.17 -167.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 70.31 35.55 2.02 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.686 0.616 . . . . 0.0 110.622 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -176.36 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.378 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.32 54.28 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.243 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.25 77.08 5.57 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.751 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.65 101.19 0.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.915 2.41 . . . . 0.0 111.864 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.07 -29.28 63.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.173 0.511 . . . . 0.0 110.175 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 74.4 mt-30 62.58 20.6 12.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.189 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.82 -33.67 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.922 0.392 . . . . 0.0 110.692 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.29 24.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.112 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.0 m -150.39 -65.38 0.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 56.41 53.14 9.03 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.261 0.553 . . . . 0.0 110.68 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -75.79 76.82 2.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.226 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.72 98.52 9.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.898 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -95.1 -29.79 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.664 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.9 t -169.07 141.88 2.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.67 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.466 ' CA ' ' HD2' ' A' ' 150' ' ' PRO . . . -114.93 -33.33 1.7 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.4 43.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -168.37 -46.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.358 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.18 -23.49 76.21 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 114.202 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' CB ' ' HD2' ' A' ' 53' ' ' PRO . 96.1 mt -53.73 150.76 12.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.861 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.666 ' HA ' ' HE2' ' A' ' 108' ' ' PHE . 86.3 Cg_exo -47.92 -36.77 27.89 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.083 3.189 . . . . 0.0 115.188 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 51' ' ' LEU . 57.5 Cg_endo -72.09 55.13 2.32 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 121.518 1.479 . . . . 0.0 112.434 175.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 171.59 -79.99 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -164.7 132.81 3.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' A' ' 131' ' ' LEU . . . -126.86 169.66 13.02 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.536 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.5 pt? -153.19 131.92 12.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.742 ' HG ' ' CB ' ' A' ' 146' ' ' PHE . 4.7 mp -87.48 146.64 25.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.6 163.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.8 p -136.1 128.94 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.806 0.336 . . . . 0.0 110.383 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.849 HG21 ' H ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -74.37 115.15 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 18.8 tptp -76.5 -66.35 0.82 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 -172.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -138.92 132.93 31.16 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.978 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.514 ' HA2' ' NH1' ' A' ' 26' ' ' ARG . . . -178.05 -171.37 41.35 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.607 ' CG ' ' HE2' ' A' ' 141' ' ' LYS . 51.0 Cg_exo -53.87 -52.23 8.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.25 1.967 . . . . 0.0 112.893 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.4 t30 -81.36 -54.14 5.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.647 0.737 . . . . 0.0 109.262 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.697 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 53.1 170.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.03 -170.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.35 2.28 90.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.849 ' H ' HG21 ' A' ' 60' ' ' VAL . 5.5 m -97.96 179.55 4.75 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 118.423 1.111 . . . . 0.0 110.966 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -166.25 153.02 9.36 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.3 0.5 . . . . 0.0 111.743 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.636 ' HE1' HD22 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.95 125.35 42.83 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.654 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.12 94.41 9.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.63 0.729 . . . . 0.0 109.481 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.633 ' HG ' ' HD2' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -91.37 54.79 2.63 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.776 0.798 . . . . 0.0 109.642 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -98.71 -26.61 14.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.007 171.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.412 ' HG2' HD22 ' A' ' 71' ' ' LEU . 13.2 pt20 -97.31 161.11 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.45 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -16.14 55.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -171.15 133.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 111.761 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.401 HG23 ' O ' ' A' ' 71' ' ' LEU . 35.3 p -120.82 144.34 48.39 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.351 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.732 ' O ' HG22 ' A' ' 87' ' ' ILE . 74.4 m -89.96 124.64 34.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.484 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -116.15 123.38 47.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 141.84 -142.07 11.55 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.319 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.861 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.14 104.7 3.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.575 0.702 . . . . 0.0 110.066 174.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.508 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 41.4 m-70 -136.86 111.4 9.49 Favored Pre-proline 0 N--CA 1.436 -1.136 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.289 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -83.36 -10.22 10.03 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.603 2.202 . . . . 0.0 111.428 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -164.82 69.72 0.16 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.097 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.427 ' HB2' ' CB ' ' A' ' 82' ' ' HIS . 34.6 m -147.95 -153.48 0.49 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.839 0.352 . . . . 0.0 110.72 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.48 -61.92 1.42 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 0.0 110.582 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.732 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -107.33 96.68 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -101.15 130.64 47.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.398 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.679 HD21 HG11 ' A' ' 60' ' ' VAL . 3.8 mm? -115.93 80.64 1.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 37.7 t70 70.46 -10.12 0.72 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.824 0.702 . . . . 0.0 110.481 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.848 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.6 p-10 41.89 33.25 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.581 1.553 . . . . 0.0 113.16 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 t -138.69 -10.7 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.183 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.587 ' HG1' ' HZ ' ' A' ' 142' ' ' PHE . 30.4 p -103.29 -33.64 9.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.79 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.4 t -98.36 149.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 122.238 -0.289 . . . . 0.0 111.358 -170.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.696 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 6.7 t -74.44 77.02 1.92 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.861 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER 59.17 -75.68 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.149 -168.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.669 ' HD2' ' CD ' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -136.45 134.87 38.14 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -174.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.541 ' HE1' HG21 ' A' ' 119' ' ' THR . 0.0 OUTLIER -71.26 -45.7 62.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.454 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.69 -179.5 7.92 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.402 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -137.84 124.74 21.27 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.836 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -81.12 90.67 6.05 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.064 0.935 . . . . 0.0 108.82 -177.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.49 ' HD2' HG23 ' A' ' 111' ' ' VAL . 10.6 ptp180 -94.17 151.97 19.07 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.762 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.823 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.0 tt -89.1 105.95 18.12 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -115.52 133.96 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 1.5 p30 48.74 33.44 4.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.692 0.797 . . . . 0.0 111.477 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.823 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.9 m-20 75.92 21.99 1.52 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.663 175.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.81 142.32 40.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.666 ' HE2' ' HA ' ' A' ' 52' ' ' PRO . 7.0 m-85 -84.58 137.64 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -175.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -141.38 160.56 39.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -171.199 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.885 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -103.7 116.71 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.724 177.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 45.3 t -99.21 111.38 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.36 127.36 30.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.338 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.451 HG21 ' HA ' ' A' ' 99' ' ' ALA . 10.4 m -127.36 -37.28 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 167.46 76.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.959 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 48.3 t -88.28 122.22 31.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.716 HD21 ' HB ' ' A' ' 22' ' ' TPO . 41.7 tp -51.9 -55.58 19.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -170.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.502 ' HB2' HG22 ' A' ' 24' ' ' VAL . 7.4 t30 -74.86 -34.91 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.0 110.454 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.49 160.67 9.32 Favored Glycine 0 C--O 1.247 0.95 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.001 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.541 HG21 ' HE1' ' A' ' 98' ' ' HIS . 17.7 m -112.47 122.34 47.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.282 0.633 . . . . 0.0 111.073 171.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 126.13 28.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 1.023 HG22 HG12 ' A' ' 137' ' ' VAL . 75.5 t -124.91 119.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 61.31 37.17 17.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.7 19.27 10.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.104 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -143.26 145.08 30.9 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.736 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.8 122.87 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.358 2.039 . . . . 0.0 111.113 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.7 m -115.17 176.73 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 -177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 13.6 t70 -109.66 -41.94 4.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.525 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.885 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 10.1 p -165.16 91.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.886 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -92.17 145.3 24.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.001 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.59 135.64 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.668 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -46.51 129.09 10.76 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.022 174.784 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.459 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -135.45 -174.75 3.72 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -106.56 113.15 26.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.356 0.598 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.63 -5.62 84.69 Favored Glycine 0 C--N 1.32 -0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.908 170.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.429 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -88.02 154.66 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER -112.15 149.0 32.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 1.023 HG12 HG22 ' A' ' 121' ' ' VAL . 60.7 t -124.9 141.4 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.721 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 28' ' ' ASP . 12.0 tm0? -109.18 130.8 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.328 0.585 . . . . 0.0 110.42 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.535 ' O ' ' HD1' ' A' ' 142' ' ' PHE . 0.5 OUTLIER -125.09 130.55 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.29 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 67.18 -91.23 0.19 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.023 174.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.852 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 19.6 ptmt -147.23 14.19 1.12 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.8 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.611 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -111.03 157.81 19.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -105.48 112.96 26.26 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -107.78 156.69 18.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.542 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.23 143.56 29.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.786 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.742 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.37 150.04 27.17 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.685 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.445 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.6 mm? -136.09 146.42 47.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.177 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.1 t -134.12 -164.51 1.51 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -69.04 133.62 26.72 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.261 176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.466 ' HD2' ' CA ' ' A' ' 47' ' ' GLY . 17.0 Cg_exo -69.04 50.1 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.394 2.729 . . . . 0.0 112.674 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.436 ' HB2' HD23 ' A' ' 51' ' ' LEU . 35.0 mmtp -130.74 -75.35 0.53 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.142 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.464 ' H ' HD23 ' A' ' 51' ' ' LEU . 38.1 tp60 46.54 68.86 0.55 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.14 0.9 . . . . 0.0 110.908 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 130.48 56.17 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -140.02 -67.35 0.43 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 49.09 55.65 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.847 0.717 . . . . 0.0 111.295 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.33 91.19 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.939 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -146.64 -161.16 9.15 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.715 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -83.34 116.01 22.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.775 0.322 . . . . 0.0 110.417 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 19.0 m -117.64 92.62 3.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.842 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.17 -153.97 12.22 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.518 -176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.68 89.46 0.5 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.45 -1.065 0 C-N-CA 123.279 2.653 . . . . 0.0 111.6 177.14 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.209 0.528 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -103.31 62.53 0.79 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.715 0.769 . . . . 0.0 110.837 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.22 145.03 56.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.501 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.5 mtt -133.92 132.16 39.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.397 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.428 ' O ' HG22 ' A' ' 8' ' ' ILE . 26.9 p-10 -104.85 108.05 60.09 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.45 -10.13 28.0 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.086 2.524 . . . . 0.0 112.463 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.58 -28.95 69.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.427 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 5' ' ' ASN . 10.4 tp -69.54 -20.23 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -115.2 37.29 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.075 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.37 -39.31 65.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.047 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.6 ' CG ' ' H ' ' A' ' 12' ' ' GLN . 8.4 p-10 -137.69 -86.02 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.978 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.6 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 76.0 mt-30 -148.83 155.36 40.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.405 ' HG1' ' C ' ' A' ' 12' ' ' GLN . 16.5 m -151.82 56.44 0.85 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.637 0.732 . . . . 0.0 109.906 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.5 m -83.3 42.86 0.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.424 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.59 67.42 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.454 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 48.43 36.0 6.62 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.349 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.12 -24.85 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 110.58 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -96.03 1.19 52.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.87 86.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.429 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 60.37 -152.2 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.225 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -135.1 133.46 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 173.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.688 ' HB ' HD23 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.637 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 27.8 m -67.39 99.9 0.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.949 0.5 . . . . 0.0 112.173 -172.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' HB ' HD21 ' A' ' 116' ' ' LEU . 10.0 p -130.2 149.42 33.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.077 -171.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.7 t80 177.34 -146.36 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.017 -173.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' CG ' ' H ' ' A' ' 27' ' ' ALA . 7.3 tpt180 46.28 -107.84 0.16 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.406 0.683 . . . . 0.0 110.972 171.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 26' ' ' ARG . . . 60.36 176.42 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.901 ' HA ' HD22 ' A' ' 33' ' ' LEU . 24.6 t70 -80.92 48.5 1.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.407 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.456 ' HE2' ' OD1' ' A' ' 117' ' ' ASN . 21.5 m-85 -145.38 -44.84 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.484 -172.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.7 tp -106.42 -50.1 3.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -174.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 m -132.2 147.95 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 66.91 42.08 2.59 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 166.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.901 HD22 ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -168.53 -28.56 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 171.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -86.26 53.51 2.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.142 0.496 . . . . 0.0 110.984 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -114.13 129.53 24.73 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.242 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -61.89 151.67 79.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.806 2.338 . . . . 0.0 111.994 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 59.19 59.6 2.67 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.605 0.566 . . . . 0.0 110.361 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -57.77 108.92 0.63 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.175 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.11 154.43 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.62 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -96.47 0.11 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.547 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -123.81 -35.14 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.608 0.242 . . . . 0.0 111.4 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 56.12 -99.72 0.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.571 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m 48.99 44.29 22.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.666 ' HB1' ' HB2' ' A' ' 133' ' ' ASN . . . -79.88 70.72 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.362 0.601 . . . . 0.0 109.821 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.75 87.5 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.031 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.454 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 16.9 m -80.69 49.66 1.22 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.433 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.67 61.79 0.38 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.589 HG12 ' HD2' ' A' ' 151' ' ' LYS . 22.1 t 63.82 77.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.938 0.495 . . . . 0.0 111.685 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 35.4 tt0 171.71 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.948 175.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.3 -54.43 19.9 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.658 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.581 ' O ' HD11 ' A' ' 51' ' ' LEU . 4.3 pp -92.9 120.14 67.33 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-O 121.676 0.751 . . . . 0.0 110.623 169.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.35 -41.93 4.31 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.374 2.716 . . . . 0.0 114.737 170.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -104.53 -154.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 123.514 2.809 . . . . 0.0 112.431 -168.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.45 39.99 2.75 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -152.37 170.65 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.912 -0.644 . . . . 0.0 109.317 -169.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.631 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.81 167.32 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 57' ' ' LEU . 3.3 pp -161.09 142.52 11.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 mp -86.51 114.02 22.91 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.092 166.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 68' ' ' SER . 4.2 p -109.62 128.39 65.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.621 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.822 HG12 ' HG ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -71.56 109.89 4.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.025 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -65.53 -60.68 2.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.914 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.5 mtm-85 -150.95 109.56 3.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.132 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -134.36 -147.55 5.62 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.566 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 72.8 Cg_endo -75.44 -48.99 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.232 1.955 . . . . 0.0 111.911 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.631 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 50.8 t30 -74.36 -49.69 21.74 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' A' ' 60' ' ' VAL . . . 59.31 154.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.56 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.62 1.38 90.14 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.7 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.808 ' H ' HG23 ' A' ' 60' ' ' VAL . 15.6 t -88.36 -178.3 5.85 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.863 0.832 . . . . 0.0 109.896 -174.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.62 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -173.26 150.32 1.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.389 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.441 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -95.16 127.19 41.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 172.694 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.28 91.5 7.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.966 0.791 . . . . 0.0 109.249 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.776 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 mp -86.12 53.93 2.96 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.0 109.688 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 55' ' ' SER . 22.9 t70 -113.47 -25.72 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.046 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.401 ' HB2' HE21 ' A' ' 74' ' ' GLN . 22.3 mt-30 -86.44 -167.54 1.91 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.328 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.07 35.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.765 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.11 134.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.608 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.448 ' HG1' ' HD2' ' A' ' 101' ' ' PHE . 7.6 p -119.68 128.33 53.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.669 ' O ' HG22 ' A' ' 87' ' ' ILE . 69.9 m -74.93 125.26 28.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 87' ' ' ILE . . . -120.57 108.22 13.79 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -170.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.842 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.08 -146.96 12.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.335 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -69.24 107.63 3.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.604 0.716 . . . . 0.0 109.56 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.57 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 61.5 m-70 -135.33 116.62 12.1 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.968 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -42.96 8.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.523 2.149 . . . . 0.0 110.734 170.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -155.27 96.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.338 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -146.32 -96.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.01 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -145.35 -59.45 0.34 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.513 0.673 . . . . 0.0 110.43 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.669 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -120.68 113.01 38.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.167 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.45 ' HD2' ' O ' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -104.05 127.2 51.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.247 -174.513 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.664 ' CD2' HD13 ' A' ' 139' ' ' ILE . 3.2 mm? -114.77 76.22 0.98 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.445 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 9.5 t70 66.53 -0.77 1.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.543 0.687 . . . . 0.0 109.641 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.9 p-10 40.62 30.03 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.749 1.62 . . . . 0.0 113.389 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.1 p -166.19 59.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 110.973 172.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 23' ' ' SER . 3.0 p -143.93 -13.99 0.63 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.149 0.5 . . . . 0.0 110.803 170.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.866 HG22 ' HA ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -140.84 141.83 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.451 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 4.9 m -64.78 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.118 0.567 . . . . 0.0 112.104 -173.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.489 ' CD ' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 68.53 -63.08 0.36 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 -177.516 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.842 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -154.83 132.99 11.71 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.656 -0.653 . . . . 0.0 111.839 175.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.803 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -63.24 -43.56 97.71 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.757 176.824 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -155.82 174.56 15.14 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.921 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.619 ' HB2' HD13 ' A' ' 76' ' ' ILE . 4.8 pt-20 -135.74 128.9 31.75 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.776 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -54.66 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 124.477 1.11 . . . . 0.0 108.117 -178.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.442 ' HE ' ' HB2' ' A' ' 102' ' ' ARG . 14.0 ttm180 -98.97 105.84 18.03 Favored 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.454 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.746 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.5 tt -80.24 105.11 11.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.604 0.716 . . . . 0.0 109.575 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -129.25 135.66 49.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.637 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.9 m-80 62.1 33.47 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.122 -175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.746 ' HA ' HD22 ' A' ' 103' ' ' LEU . 73.7 m-20 70.94 4.14 4.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.825 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.0 mm-40 -103.47 144.82 30.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.55 ' CB ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -91.24 125.65 36.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 21.1 m-80 -131.18 163.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.619 0.247 . . . . 0.0 111.183 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.823 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -105.27 124.44 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.159 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 68.3 t -108.9 110.41 31.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.806 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.0 125.62 26.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.559 0.537 . . . . 0.0 109.722 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.53 -27.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.39 83.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.576 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.866 ' HA ' HG22 ' A' ' 94' ' ' VAL . 37.2 t -108.6 120.46 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.688 HD23 ' HB ' ' A' ' 22' ' ' TPO . 58.4 tp -53.16 -56.27 17.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.639 ' ND2' HE22 ' A' ' 138' ' ' GLN . 0.4 OUTLIER -63.44 -34.76 78.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.49 0.662 . . . . 0.0 109.641 177.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.75 169.49 12.37 Favored Glycine 0 C--O 1.253 1.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.145 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 m -112.02 117.33 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.761 0.424 . . . . 0.0 110.917 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -127.72 106.82 9.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.894 HG22 HG21 ' A' ' 137' ' ' VAL . 21.2 t -101.88 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.64 ' ND2' HG13 ' A' ' 121' ' ' VAL . 25.4 m-80 65.06 44.23 3.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 109.319 -174.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 63.44 13.25 6.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.004 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -133.89 131.4 20.98 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-O 121.344 0.592 . . . . 0.0 110.804 174.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.81 123.21 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.783 2.322 . . . . 0.0 112.257 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.669 HG21 ' HB3' ' A' ' 129' ' ' ALA . 14.2 m -121.76 165.1 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 2.8 m-20 -108.38 -24.81 11.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.758 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.823 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 21.5 p -164.52 91.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.441 0.639 . . . . 0.0 109.59 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.669 ' HB3' HG21 ' A' ' 126' ' ' VAL . . . -110.22 148.41 31.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.355 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.62 127.63 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.086 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.57 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -63.32 162.9 11.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -166.33 160.83 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.297 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.666 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 1.7 p-10 -60.14 100.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.132 0.492 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.72 4.38 36.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.727 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.52 119.74 20.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 5.0 tt0 -106.73 134.25 50.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.666 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.964 HG11 ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -117.68 142.22 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.639 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -111.72 115.59 29.34 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.664 HD13 ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -123.83 129.47 74.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.507 175.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.422 ' CA ' HD21 ' A' ' 117' ' ' ASN . . . 74.32 -68.21 1.78 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.066 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.727 ' H ' ' HD1' ' A' ' 142' ' ' PHE . 17.7 ptmt -173.7 31.36 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 116.953 0.377 . . . . 0.0 110.712 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.727 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.71 149.95 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -172.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -103.12 100.87 10.82 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.964 ' HB2' HG11 ' A' ' 137' ' ' VAL . 4.7 mp -96.12 157.85 15.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.75 141.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.292 169.264 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.57 ' CD1' ' HG ' ' A' ' 131' ' ' LEU . 43.7 t80 -97.81 136.85 37.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.248 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -128.55 152.19 48.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.524 0.678 . . . . 0.0 110.958 170.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 14.8 t -156.98 141.98 17.08 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.014 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.468 ' N ' ' H ' ' A' ' 51' ' ' LEU . . . -135.7 85.51 0.25 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.558 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD2' ' HA2' ' A' ' 149' ' ' GLY . 2.8 Cg_endo -39.49 114.6 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.321 3.347 . . . . 0.0 113.474 -175.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.589 ' HD2' HG12 ' A' ' 48' ' ' VAL . 64.1 tttp -126.75 103.75 7.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.651 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 62.63 76.99 0.35 Allowed 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.944 0.777 . . . . 0.0 110.048 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.41 -165.43 17.24 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.073 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.14 39.7 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -140.42 101.33 4.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.44 -60.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.094 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.77 -96.74 0.31 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.2 p -136.99 16.62 3.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.637 0.256 . . . . 0.0 111.344 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.2 m 65.17 96.47 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.023 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.34 107.81 2.22 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.643 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -94.92 -114.7 2.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.973 -175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--O 1.246 0.921 0 C-N-CA 122.838 2.359 . . . . 0.0 112.414 -177.674 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.613 0.72 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -111.41 -61.88 1.63 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.287 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -111.05 110.83 21.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.191 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.7 ttt -140.2 -48.93 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.21 115.86 59.16 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.035 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.93 97.75 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.718 2.279 . . . . 0.0 110.406 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -56.74 104.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.638 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.9 mm -82.56 -35.01 12.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.537 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.17 3.38 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.637 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 65.65 -148.98 0.23 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.253 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.8 t70 73.84 -80.44 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.528 0.731 . . . . 0.0 110.61 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 42.78 46.73 4.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.092 0.949 . . . . 0.0 111.24 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -115.61 54.26 0.82 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.852 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.7 t -107.73 104.31 13.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.055 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 t70 58.09 78.58 0.24 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.48 101.21 13.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.23 111.88 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.139 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.5 m -78.97 113.21 16.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 12.5 p -68.06 -23.42 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.608 0.242 . . . . 0.0 110.668 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 5.2 mm-40 75.52 166.78 0.28 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.778 0.799 . . . . 0.0 112.274 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m -131.4 137.79 48.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.68 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.607 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 48.6 m 18.36 120.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 6.8 t -101.91 146.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.656 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.8 t80 172.13 -159.11 0.01 OUTLIER 'General case' 0 C--N 1.35 0.592 0 O-C-N 123.603 0.564 . . . . 0.0 110.751 171.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 35.64 -119.03 0.12 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.512 1.125 . . . . 0.0 112.691 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 61.82 -175.59 0.13 Allowed 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.45 ' HA ' HD11 ' A' ' 33' ' ' LEU . 1.4 t70 -80.93 40.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.148 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' HE1' ' CE2' ' A' ' 120' ' ' TYR . 2.1 m-30 -120.73 -55.22 2.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.8 tp -63.38 -17.61 62.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.52 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m 73.65 25.99 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.485 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -79.43 56.46 2.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.71 0.767 . . . . 0.0 109.919 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.45 HD11 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -143.63 -73.48 0.27 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -177.08 122.99 0.13 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.397 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.9 -51.41 6.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.547 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.21 117.05 4.22 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.99 1.794 . . . . 0.0 111.865 177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.22 171.7 7.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.003 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 156.73 37.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.39 39.12 3.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.127 0.489 . . . . 0.0 111.413 -173.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.6 49.95 0.72 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.331 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -69.49 137.29 52.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 110.637 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.83 74.35 3.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.175 0.512 . . . . 0.0 110.241 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t -138.78 45.11 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.677 0.751 . . . . 0.0 109.576 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.37 53.96 2.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.471 0.653 . . . . 0.0 109.461 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 130' ' ' VAL . 59.7 t -110.7 133.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -156.44 76.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.284 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 15.95 6.1 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.798 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -157.92 65.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.123 0.569 . . . . 0.0 109.559 -177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.787 ' HG2' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.11 -40.56 64.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.324 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.55 -1.43 77.33 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.815 HD23 HG22 ' A' ' 148' ' ' THR . 40.5 mt -67.41 121.13 77.48 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 123.621 0.768 . . . . 0.0 111.226 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.85 -35.95 75.66 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.147 2.565 . . . . 0.0 115.105 175.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -98.09 177.8 0.42 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 121.968 1.779 . . . . 0.0 112.941 -172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.78 -34.42 13.43 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -116.78 134.46 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.64 168.34 16.6 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.19 147.77 12.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.631 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.907 ' HB2' ' HD1' ' A' ' 70' ' ' PHE . 2.5 mp -86.42 144.32 27.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -123.19 133.02 70.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.012 0.434 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 68' ' ' SER . 79.1 t -65.57 105.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HD2' HG11 ' A' ' 145' ' ' VAL . 59.0 tttm -70.4 -47.49 60.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.762 1.289 . . . . 0.0 110.151 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.419 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 17.9 ttm180 -165.78 144.55 6.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.576 173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' HA2' ' CD ' ' A' ' 26' ' ' ARG . . . -173.67 -157.83 16.33 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.716 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 13.9 Cg_exo -67.22 -48.81 1.55 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 119.481 1.64 . . . . 0.0 111.723 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -77.63 -53.51 7.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.009 173.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB1' ' HA ' ' A' ' 62' ' ' ARG . . . 57.14 160.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.109 -172.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.4 2.02 90.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.564 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.722 ' HB2' HG23 ' A' ' 60' ' ' VAL . 6.7 m -88.69 -172.42 3.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.226 0.513 . . . . 0.0 111.362 -173.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.495 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.05 152.51 2.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.962 0.346 . . . . 0.0 111.787 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.907 ' HD1' ' HB2' ' A' ' 58' ' ' LEU . 1.5 m-85 -98.2 116.95 31.5 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.536 ' O ' HD11 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -78.04 90.13 4.2 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.705 0.764 . . . . 0.0 109.453 -174.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.621 HD11 HD13 ' A' ' 58' ' ' LEU . 15.4 mt -82.75 59.46 4.78 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.573 0.701 . . . . 0.0 109.955 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -117.01 -26.87 6.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.645 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -98.67 177.64 5.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.84 97.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.573 HD13 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -157.56 135.8 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -109.91 140.37 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.665 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.731 ' O ' HG21 ' A' ' 87' ' ' ILE . 37.0 m -88.31 124.23 33.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.719 ' HB2' HG22 ' A' ' 87' ' ' ILE . . . -123.21 119.9 31.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 89' ' ' LEU . . . 150.2 -138.29 6.64 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.757 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.9 tmm_? -71.5 104.37 3.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 109.85 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.539 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 55.3 m-70 -137.36 119.12 11.01 Favored Pre-proline 0 N--CA 1.438 -1.045 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.027 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.16 -48.37 8.3 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 167.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.48 95.14 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.827 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 5.3 p -169.51 -165.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.607 168.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -61.74 -51.89 66.51 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -167.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.731 HG21 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -130.36 91.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 122.087 0.946 . . . . 0.0 110.987 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.4 ' O ' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -95.41 134.19 38.51 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.269 174.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.923 ' HG ' HD13 ' A' ' 139' ' ' ILE . 2.5 mm? -122.03 77.54 1.39 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.768 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.62 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 24.6 t0 66.01 -3.76 0.73 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.757 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.6 p30 43.69 25.65 0.1 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.372 1.469 . . . . 0.0 113.817 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.607 ' O ' ' HB2' ' A' ' 23' ' ' SER . 10.8 p -147.43 45.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.32 1.057 . . . . 0.0 110.222 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 22' ' ' TPO . 0.2 OUTLIER -151.97 -0.6 0.31 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.045 172.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.66 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -135.64 143.15 37.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.68 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 11.9 t -78.29 73.0 4.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.45 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER 67.24 -58.47 0.41 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.672 0.749 . . . . 0.0 110.114 -171.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.591 ' HD2' HG13 ' A' ' 113' ' ' VAL . 22.5 ttm180 -146.18 125.28 12.88 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.879 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.767 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -67.18 -46.07 75.07 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -169.98 160.09 8.09 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.869 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.573 ' HB2' HD13 ' A' ' 76' ' ' ILE . 7.3 pt-20 -112.66 117.97 33.75 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.84 ' CZ ' ' HB ' ' A' ' 110' ' ' VAL . 4.4 m-85 -76.37 95.33 3.78 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.124 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -103.05 148.62 25.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.408 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.692 HD23 ' HA ' ' A' ' 106' ' ' ASN . 7.2 tt -91.73 117.54 29.85 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -142.88 135.68 27.9 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.426 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 48.8 m-80 62.45 32.35 16.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.683 0.615 . . . . 0.0 110.094 -172.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.692 ' HA ' HD23 ' A' ' 103' ' ' LEU . 5.1 t30 74.84 -1.29 3.12 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.085 0.865 . . . . 0.0 112.341 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 1.5 mm-40 -109.13 147.19 32.85 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.086 -0.383 . . . . 0.0 109.977 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' CE1' HD11 ' A' ' 103' ' ' LEU . 12.9 m-85 -88.89 130.96 35.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.512 ' OD1' HG21 ' A' ' 130' ' ' VAL . 13.1 m-80 -140.34 162.63 34.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.0 OUTLIER -107.09 122.02 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.37 172.412 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 26.8 t -101.93 110.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.999 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 99' ' ' ALA . 24.9 t0 -59.28 144.03 47.52 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.867 0.729 . . . . 0.0 109.713 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.591 HG13 ' HD2' ' A' ' 97' ' ' ARG . 1.2 t -142.44 -32.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.824 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.93 103.35 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.723 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.615 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 44.2 t -110.23 145.7 36.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.902 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.476 ' CD2' HG21 ' A' ' 24' ' ' VAL . 18.1 tp -58.81 -55.77 30.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.544 0.611 . . . . 0.0 111.675 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 59.2 m-80 -61.37 -38.06 85.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.238 0.542 . . . . 0.0 110.327 177.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.18 167.43 11.52 Favored Glycine 0 C--O 1.246 0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.97 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.495 HG22 ' HE1' ' A' ' 98' ' ' HIS . 16.0 m -111.66 133.63 53.78 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.004 0.522 . . . . 0.0 111.225 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' CE2' ' HE1' ' A' ' 29' ' ' PHE . 23.2 m-85 -140.73 131.19 25.31 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.848 173.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.797 HG22 HG13 ' A' ' 137' ' ' VAL . 77.4 t -127.91 113.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.0 42.01 16.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.813 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.64 -2.03 2.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.902 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -134.03 141.98 41.64 Favored Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 121.747 -0.596 . . . . 0.0 111.204 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -70.83 121.99 8.41 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.11 1.874 . . . . 0.0 111.689 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.84 178.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.58 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 21.9 t70 -93.41 -64.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 5.8 p -146.77 92.9 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.231 0.538 . . . . 0.0 109.91 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.99 143.55 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.631 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.512 HG21 ' OD1' ' A' ' 109' ' ' ASN . 3.3 t -84.26 135.85 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.187 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.898 HD13 HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -62.18 161.5 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.417 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -158.56 154.67 27.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.25 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.96 97.72 0.69 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.78 4.81 29.74 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.84 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.87 150.96 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.1 tt0 -141.32 133.39 27.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.467 0.651 . . . . 0.0 111.421 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.797 HG13 HG22 ' A' ' 121' ' ' VAL . 48.0 t -129.13 141.64 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.373 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -109.84 121.02 44.27 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 173.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.923 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.38 140.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 57.95 -109.79 2.05 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.04 -1.552 . . . . 0.0 109.274 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.481 ' HE2' ' CG ' ' A' ' 64' ' ' PRO . 1.8 pttm -136.3 34.03 2.79 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.907 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.716 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -114.96 150.81 35.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 143' ' ' ARG . 14.1 ttm180 -102.19 106.45 17.29 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.662 ' HG ' HG21 ' A' ' 60' ' ' VAL . 2.0 mp -110.29 150.86 28.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.715 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.35 144.2 28.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.851 ' HB2' ' HG ' ' A' ' 58' ' ' LEU . 84.5 t80 -94.22 125.79 39.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.985 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.651 HD21 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? -128.14 169.32 14.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.223 169.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.815 HG22 HD23 ' A' ' 51' ' ' LEU . 8.7 t -155.12 -172.19 4.09 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.924 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -59.74 166.19 10.09 Favored Glycine 0 C--O 1.236 0.241 0 O-C-N 123.632 0.582 . . . . 0.0 114.466 -170.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . 0.579 ' HB2' ' O ' ' A' ' 153' ' ' GLY . 73.0 Cg_endo -76.29 118.3 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.19 2.593 . . . . 0.0 112.98 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -83.16 -3.86 57.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.255 -177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -112.63 14.59 20.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 150' ' ' PRO . . . 74.02 -168.22 54.29 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -169.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -78.05 69.45 4.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.795 0.798 . . . . 0.0 109.997 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 70.35 101.95 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.648 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t70 72.45 116.72 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.085 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -138.55 -114.82 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.077 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.1 t -128.27 -166.32 1.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 64.53 75.22 0.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.532 0.682 . . . . 0.0 110.383 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -175.23 -47.27 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.69 64.42 0.37 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.025 2.483 . . . . 0.0 112.007 -175.748 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.977 0.417 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 p -83.03 118.2 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 111.561 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -142.13 170.57 15.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.057 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.0 ttm -145.24 74.19 1.39 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.578 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 3.7 t-20 -99.21 -51.58 0.2 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.727 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.578 ' HD2' ' H ' ' A' ' 5' ' ' ASN . 19.4 Cg_endo -60.78 116.58 3.44 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -79.67 106.84 11.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.627 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tp -96.08 -17.99 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.13 104.04 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.451 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 66.56 117.48 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.954 0.783 . . . . 0.0 112.015 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -82.28 99.33 9.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.048 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -88.11 6.44 36.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 0.0 110.316 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 m -67.1 -32.68 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.013 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -69.49 -13.69 62.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.89 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.01 106.99 19.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.936 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.39 120.56 42.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.45 109.02 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -92.26 139.48 30.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.15 -3.6 10.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -140.86 130.88 24.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.587 HG21 ' O ' ' A' ' 22' ' ' TPO . 50.6 m -101.08 135.52 42.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 170.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.661 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.679 ' O ' ' HA ' ' A' ' 93' ' ' THR . 17.9 m -59.96 130.52 47.16 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.96 -0.463 . . . . 0.0 112.037 -173.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.02 134.33 41.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.388 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.7 t80 176.51 176.08 0.31 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.051 -169.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.499 ' HA ' HD23 ' A' ' 30' ' ' LEU . 7.5 tpt180 72.54 -42.41 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 159.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.716 ' HB1' ' HA ' ' A' ' 141' ' ' LYS . . . -60.11 -169.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -169.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.559 ' HA ' HD13 ' A' ' 33' ' ' LEU . 25.1 t0 -61.04 58.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.424 1.107 . . . . 0.0 112.386 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' CE2' ' HB2' ' A' ' 27' ' ' ALA . 11.6 m-85 -154.4 -34.69 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.499 HD23 ' HA ' ' A' ' 26' ' ' ARG . 38.3 tp -98.88 -67.96 0.82 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.292 -1.776 . . . . 0.0 111.848 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.2 p 177.05 -177.44 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 60.5 59.88 2.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.629 -1.168 . . . . 0.0 113.839 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.559 HD13 ' HA ' ' A' ' 28' ' ' ASP . 1.2 pp 178.46 -24.62 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.694 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -53.15 147.41 9.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.822 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.95 84.9 62.24 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.93 -43.48 30.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.593 2.195 . . . . 0.0 111.111 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.8 69.11 3.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -79.28 52.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.1 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.75 2.63 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 121.01 11.08 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.233 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.4 m -128.52 71.9 1.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.603 0.716 . . . . 0.0 109.149 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.38 26.96 6.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.034 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -79.42 49.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.69 49.73 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.532 0.682 . . . . 0.0 109.615 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.84 144.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.619 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.419 ' HA ' ' CB ' ' A' ' 49' ' ' GLU . 14.8 m 66.88 31.7 7.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.266 0.555 . . . . 0.0 110.883 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.66 -39.58 1.87 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 11.93 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.469 1.128 . . . . 0.0 109.067 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' CB ' ' HA ' ' A' ' 46' ' ' SER . 15.1 tp10 -87.1 -58.82 2.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -121.56 53.68 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.687 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' O ' HD11 ' A' ' 51' ' ' LEU . 3.5 pp -60.87 128.15 88.53 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.002 0.43 . . . . 0.0 111.118 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.503 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 72.1 Cg_endo -91.06 0.82 4.84 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.902 2.402 . . . . 0.0 117.989 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 52' ' ' PRO . 44.4 Cg_endo -95.63 161.31 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 CA-C-N 122.801 2.036 . . . . 0.0 112.787 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.92 -9.11 57.58 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.24 136.7 38.34 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.07 170.03 11.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.539 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.1 pt? -155.5 133.03 11.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.734 HD12 ' CZ ' ' A' ' 101' ' ' PHE . 3.3 mp -85.49 128.43 34.73 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.631 163.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -110.88 125.6 68.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.231 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.886 HG21 ' HG ' ' A' ' 144' ' ' LEU . 67.9 t -65.57 104.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 52.1 tttp -73.45 -57.25 4.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 124.23 0.956 . . . . 0.0 109.873 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -153.34 131.19 11.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.971 0.891 . . . . 0.0 110.944 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.78 -162.35 20.75 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 177.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.691 ' HD2' ' CD2' ' A' ' 142' ' ' PHE . 40.5 Cg_exo -59.37 -56.33 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 119.401 1.601 . . . . 0.0 112.669 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 59.8 t30 -70.01 -52.57 23.06 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 57.05 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.252 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.72 1.04 90.04 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.979 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.711 ' HB2' HG23 ' A' ' 60' ' ' VAL . 18.7 m -85.38 -167.93 2.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.584 0.692 . . . . 0.0 111.542 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.727 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -170.23 154.74 5.02 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -175.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.592 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -95.39 125.1 39.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.683 ' O ' HG23 ' A' ' 77' ' ' THR . 1.1 tm? -84.48 98.27 10.01 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.673 HD21 HD13 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -98.12 51.61 1.03 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.454 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.439 ' H ' HD13 ' A' ' 71' ' ' LEU . 11.3 t70 -95.68 -19.38 19.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.149 169.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.16 166.58 13.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.85 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.31 63.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.183 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 100' ' ' GLU . 3.2 tp -168.99 130.03 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.76 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.683 HG23 ' O ' ' A' ' 71' ' ' LEU . 22.9 p -123.68 146.91 47.89 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.081 -176.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.789 ' O ' HG22 ' A' ' 87' ' ' ILE . 23.4 m -82.13 125.2 30.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.533 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.528 ' O ' ' HA ' ' A' ' 97' ' ' ARG . . . -119.04 128.39 54.31 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.18 -132.1 6.1 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.525 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.928 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -80.31 103.93 10.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.666 0.746 . . . . 0.0 109.905 174.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 67.1 m-70 -138.02 128.84 15.66 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.971 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.26 -63.97 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.267 1.978 . . . . 0.0 111.813 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -145.19 47.19 1.31 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.3 p -128.53 97.37 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 112.125 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.443 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 28.3 m-20 57.44 -91.2 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.659 1.184 . . . . 0.0 113.575 171.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -109.06 98.96 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 0.0 111.354 -171.224 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -103.65 128.13 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.29 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.77 HD11 ' CD2' ' A' ' 142' ' ' PHE . 3.3 mm? -120.03 86.91 2.65 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.208 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.518 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 17.1 t70 69.5 -7.74 0.82 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 0.0 109.611 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 p-10 37.9 34.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.034 1.734 . . . . 0.0 113.749 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.99 0.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.433 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 23' ' ' SER . 1.6 p -104.58 -25.53 12.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.823 -0.548 . . . . 0.0 111.658 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.611 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.9 t -105.12 150.18 8.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -172.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.661 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 6.3 t -75.49 72.67 2.5 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.928 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 7.8 ttt180 56.53 -62.37 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.328 -165.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.528 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -141.25 127.6 19.86 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.802 -1.186 . . . . 0.0 112.178 -171.161 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.832 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.13 -45.04 24.35 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.718 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -144.23 174.52 10.82 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.104 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.643 ' HB2' HD13 ' A' ' 76' ' ' ILE . 3.7 pt-20 -138.09 120.13 15.54 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.078 -1.874 . . . . 0.0 106.072 166.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.741 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.4 93.16 5.93 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.654 0.74 . . . . 0.0 109.55 -171.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.54 ' CB ' HD12 ' A' ' 76' ' ' ILE . 9.3 ptp180 -92.61 134.51 34.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.525 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 108' ' ' PHE . 6.3 tt -85.23 114.08 22.06 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -124.5 139.86 53.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.83 39.7 1.81 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.902 0.751 . . . . 0.0 112.229 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.685 ' HA ' HD22 ' A' ' 103' ' ' LEU . 8.0 t30 75.23 13.9 3.1 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 112.429 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 2.3 mp0 -120.87 140.87 51.19 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.922 -0.486 . . . . 0.0 110.413 172.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 103' ' ' LEU . 2.1 m-85 -89.25 139.92 30.0 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.741 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 32.8 m-80 -143.49 155.98 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.963 -170.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -103.49 120.74 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.634 0.731 . . . . 0.0 110.839 179.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.725 HG11 HG12 ' A' ' 113' ' ' VAL . 2.3 t -99.8 118.05 45.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.957 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.14 119.07 19.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.725 HG12 HG11 ' A' ' 111' ' ' VAL . 5.8 m -121.54 -53.03 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -171.19 79.02 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.118 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.629 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 32.4 t -91.75 122.64 34.48 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.659 HD23 ' HB ' ' A' ' 22' ' ' TPO . 16.0 tp -61.78 -54.13 46.51 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.961 -175.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 24.2 m-80 -65.92 -38.77 89.56 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 141.37 157.36 7.14 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.43 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.452 HG23 ' CE1' ' A' ' 98' ' ' HIS . 16.6 m -111.6 125.63 54.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.602 0.361 . . . . 0.0 110.851 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HE2' ' CZ ' ' A' ' 29' ' ' PHE . 65.8 m-85 -139.74 105.53 5.16 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.88 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.907 HG21 HG11 ' A' ' 137' ' ' VAL . 83.4 t -101.77 122.75 54.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 172.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 63.71 33.34 13.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 14.8 mtp-105 52.28 37.78 23.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.803 -171.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.94 139.44 13.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.116 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 122.7 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.014 1.81 . . . . 0.0 111.278 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -114.49 178.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.914 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 18.5 t70 -96.71 -58.88 1.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.115 0.483 . . . . 0.0 109.844 174.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 41.8 t -155.81 91.21 1.27 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.051 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.36 149.71 21.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.699 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.73 136.88 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.681 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 146' ' ' PHE . 2.6 tt -56.11 106.67 0.29 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.953 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.29 124.37 24.33 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.823 0.344 . . . . 0.0 111.358 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.556 ' OD1' HG23 ' A' ' 148' ' ' THR . 3.4 m-20 -54.23 123.93 14.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.84 24.88 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.619 168.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.465 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 1.7 t70 -97.26 165.89 11.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.619 0.71 . . . . 0.0 110.555 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.4 pp20? -116.12 156.99 25.46 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.813 0.816 . . . . 0.0 113.023 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.907 HG11 HG21 ' A' ' 121' ' ' VAL . 68.5 t -131.8 130.08 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.253 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 113.76 25.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.072 0.463 . . . . 0.0 110.249 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.832 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -113.19 124.58 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.223 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 64.8 -108.13 2.18 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.476 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.716 ' HA ' ' HB1' ' A' ' 27' ' ' ALA . 7.8 pttt -134.93 21.08 3.5 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.597 0.713 . . . . 0.0 111.354 -174.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.77 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -113.04 143.99 43.37 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.968 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 5.7 ttm180 -95.65 102.87 14.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.886 ' HG ' HG21 ' A' ' 60' ' ' VAL . 5.1 mp -95.78 161.42 14.02 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.535 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.23 139.46 36.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 172.03 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.7 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.45 130.67 49.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.466 ' CD2' HG21 ' A' ' 145' ' ' VAL . 2.6 mm? -129.82 125.38 35.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.76 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.556 HG23 ' OD1' ' A' ' 133' ' ' ASN . 15.2 t -94.77 -158.31 0.63 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.503 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . -54.04 121.77 20.46 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.542 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.69 163.49 38.76 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.914 2.409 . . . . 0.0 111.667 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -76.95 51.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.986 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -89.05 81.17 6.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.4 -32.12 79.85 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.654 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -92.61 62.99 3.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.437 0.636 . . . . 0.0 111.085 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -113.18 132.34 55.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.551 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -119.63 21.47 12.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.024 0.916 . . . . 0.0 108.594 174.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.47 -3.04 67.23 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.3 t -52.81 -36.2 58.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 109.751 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 m -131.06 50.0 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 171.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.6 96.19 0.35 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.474 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.95 -148.21 7.54 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 123.109 2.539 . . . . 0.0 112.034 177.409 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.235 0.302 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 m -79.51 69.11 5.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.27 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.006 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.1 ttt -124.54 135.85 53.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.512 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -106.8 96.46 14.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.888 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.2 -48.6 2.47 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.309 2.673 . . . . 0.0 113.254 -174.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -109.05 155.28 21.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 110.51 -177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 tt -168.11 124.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.083 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 73.92 147.48 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.738 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? 58.02 59.27 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.074 -172.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.19 121.56 15.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.081 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 64.64 -84.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.227 0.955 . . . . 0.0 112.307 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 p -127.35 108.24 10.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.982 0.42 . . . . 0.0 112.047 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 t -151.47 134.31 15.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.18 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 t0 68.84 -83.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.912 0.758 . . . . 0.0 111.883 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -82.75 67.64 8.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.224 0.535 . . . . 0.0 111.288 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -87.12 -70.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 m 67.79 -70.75 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.867 0.73 . . . . 0.0 112.576 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -91.52 133.06 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.28 0.562 . . . . 0.0 110.865 -175.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.402 ' O ' ' HB ' ' A' ' 21' ' ' THR . 45.0 tt0 -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.445 ' CG2' HD22 ' A' ' 116' ' ' LEU . 33.4 m 76.37 130.2 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.544 0.528 . . . . 0.0 111.16 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.558 ' O1P' HG21 ' A' ' 22' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 18.8 m -0.95 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.118 1.767 . . . . 0.0 115.049 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.589 ' HB ' HD21 ' A' ' 116' ' ' LEU . 9.5 p -129.73 154.91 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.876 -0.515 . . . . 0.0 112.189 -173.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.6 t80 179.68 -156.51 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 49.65 -105.02 0.16 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.183 0.593 . . . . 0.0 110.274 175.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.687 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 61.0 -174.32 0.13 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 166.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.79 ' HA ' HD21 ' A' ' 33' ' ' LEU . 13.6 t70 -77.9 41.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.796 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -136.18 -43.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.804 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.09 -10.2 38.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.998 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t 78.5 8.72 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.163 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -77.99 60.56 2.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 110.275 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.79 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -137.88 -54.45 0.66 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -178.5 145.11 0.31 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.354 -2.203 . . . . 0.0 108.264 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.21 117.24 41.2 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -45.32 89.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.121 3.214 . . . . 0.0 113.702 -174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 173.62 -115.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.575 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.852 ' HG2' ' H ' ' A' ' 39' ' ' ALA . 3.0 tt0 63.55 -177.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.413 0.625 . . . . 0.0 111.136 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.852 ' H ' ' HG2' ' A' ' 38' ' ' GLN . . . -155.18 -37.74 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.098 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -174.57 29.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.559 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -94.89 -2.55 50.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.375 0.607 . . . . 0.0 109.643 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 70.38 103.2 0.06 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.028 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -83.59 73.85 10.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.403 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.42 67.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.308 177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.79 124.3 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 155.75 17.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.088 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.97 59.75 0.5 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.04 69.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 122.078 0.942 . . . . 0.0 110.622 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.441 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 35.3 tt0 -117.97 -89.3 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.685 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' C ' ' HD2' ' A' ' 53' ' ' PRO . . . -97.31 26.08 24.4 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.633 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.531 ' HB2' ' CD ' ' A' ' 52' ' ' PRO . 1.1 mm? -89.17 -54.0 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.531 ' CD ' ' HB2' ' A' ' 51' ' ' LEU . 77.7 Cg_exo -51.08 -34.9 49.22 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.155 1.903 . . . . 0.0 114.001 172.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.608 ' HD2' ' C ' ' A' ' 50' ' ' GLY . 11.9 Cg_exo -72.55 69.61 3.46 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.123 1.882 . . . . 0.0 112.582 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.87 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -151.39 138.61 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -129.14 172.67 11.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.805 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.9 pp -161.07 140.08 10.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.7 mp -85.66 111.28 19.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.4 125.56 59.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.979 HG11 HD22 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -71.04 110.63 4.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HB2' HG12 ' A' ' 145' ' ' VAL . 2.9 tpmt? -64.28 -65.58 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.063 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 36.4 mtt-85 -146.54 134.75 21.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.831 0.824 . . . . 0.0 110.451 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.11 -159.7 17.83 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.732 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 37.4 Cg_exo -62.97 -57.94 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.96 1.773 . . . . 0.0 112.595 178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.622 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 53.9 t30 -73.04 -53.0 12.26 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.643 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 55.18 165.28 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.317 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.33 3.17 90.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.061 170.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.844 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -100.73 -170.32 1.84 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 117.729 0.765 . . . . 0.0 111.033 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.747 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -171.7 154.46 3.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.19 0.45 . . . . 0.0 112.042 -170.653 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' HB2' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -95.79 121.6 37.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 165.628 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.632 HD21 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -79.89 92.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.681 0.753 . . . . 0.0 109.469 -176.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.805 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 5.6 mt -85.23 51.4 2.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.367 0.603 . . . . 0.0 109.507 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -104.03 -22.18 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.487 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -104.29 -165.54 1.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.018 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.42 -39.85 45.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.793 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.684 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.64 133.1 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 111.534 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.661 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 70.7 p -111.29 143.94 41.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.762 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.725 ' O ' HG22 ' A' ' 87' ' ' ILE . 44.6 m -80.57 123.46 28.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 171.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.601 ' HA ' HG22 ' A' ' 87' ' ' ILE . . . -122.83 113.37 19.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 149.89 -136.96 5.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.731 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.673 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.4 104.64 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 75.1 m-70 -138.11 119.35 10.43 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.807 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.45 -42.7 38.85 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.457 2.104 . . . . 0.0 111.339 171.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -161.95 95.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.366 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.488 ' CB ' ' HB2' ' A' ' 78' ' ' SER . 5.9 m -137.76 -100.33 0.19 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.661 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 8.7 m-20 -138.39 -48.15 0.53 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.747 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.64 105.59 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.24 178.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -108.16 116.66 32.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.293 176.349 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.979 HD22 HG11 ' A' ' 60' ' ' VAL . 12.5 mt -102.67 87.57 3.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.635 177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.449 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 25.7 t70 66.88 -2.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.344 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.673 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p30 40.65 36.44 0.39 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.189 1.396 . . . . 0.0 113.418 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 23' ' ' SER . 11.9 p -168.64 44.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.421 173.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.507 HG23 ' CZ ' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -138.11 -5.16 1.67 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.13 -0.981 . . . . 0.0 111.987 176.148 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.679 HG21 ' HA ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -143.16 146.53 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.364 -173.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.55 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 12.2 m -66.5 77.35 0.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.811 0.445 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.09 -70.02 0.08 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 123.425 0.69 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 ptp180 -140.41 130.68 25.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.801 -0.562 . . . . 0.0 110.737 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 1.093 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.83 -41.01 45.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.858 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.58 164.23 30.78 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.928 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' HD13 ' A' ' 76' ' ' ILE . 8.7 pt-20 -129.54 125.7 36.89 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.688 ' CG ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -61.42 99.23 0.1 Allowed 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.562 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 15.9 tpp85 -90.45 96.65 10.76 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.975 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.762 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -83.78 104.71 14.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.51 138.24 46.01 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 62.3 31.89 17.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 -173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.762 ' HA ' HD22 ' A' ' 103' ' ' LEU . 7.4 t30 72.58 0.67 3.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.487 0.715 . . . . 0.0 111.831 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 28.2 mm-40 -104.69 139.67 39.18 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.934 -0.479 . . . . 0.0 111.021 -174.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.506 ' CB ' HD12 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.29 125.35 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -126.04 162.04 26.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.336 -178.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.82 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.4 m -106.71 124.82 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 9.2 t -101.77 112.52 35.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.32 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 14.1 t70 -74.31 116.4 14.92 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.57 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.785 HG11 HG13 ' A' ' 111' ' ' VAL . 27.0 m -124.67 -20.7 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.409 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 156.21 94.31 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.667 178.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 1.093 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.3 t -108.64 128.85 55.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.589 HD21 ' HB ' ' A' ' 24' ' ' VAL . 44.3 tp -54.55 -54.37 42.19 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.408 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.488 ' OD1' ' HB1' ' A' ' 27' ' ' ALA . 0.2 OUTLIER -65.67 -35.97 82.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.492 0.663 . . . . 0.0 109.3 175.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.29 170.19 12.59 Favored Glycine 0 C--O 1.257 1.537 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.52 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.7 m -112.59 122.48 47.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.485 -0.857 . . . . 0.0 110.967 174.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -136.59 103.05 5.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.698 HG21 HG22 ' A' ' 137' ' ' VAL . 2.6 p -102.95 110.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.566 HD21 HG23 ' A' ' 121' ' ' VAL . 30.6 m-80 68.7 37.64 2.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.499 -171.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 60.84 26.91 16.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.4 140.92 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.566 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.86 123.42 5.21 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.223 2.616 . . . . 0.0 111.306 174.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' A' ' 129' ' ' ALA . 34.3 m -118.6 -179.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 111.49 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 28.3 t70 -100.76 -50.33 3.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.77 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.82 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 42.1 t -158.03 91.55 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.233 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.517 ' HB3' HG22 ' A' ' 126' ' ' VAL . . . -94.15 138.97 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.22 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 109' ' ' ASN . 21.3 t -79.71 129.56 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.823 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.629 HD21 HD13 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -62.57 161.42 12.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.294 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.495 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -160.2 156.11 26.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.81 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -65.77 104.0 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.3 5.75 48.86 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.482 ' HB2' ' HB1' ' A' ' 132' ' ' ALA . 16.3 t70 -83.82 118.12 23.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.958 0.103 . . . . 0.0 110.795 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 53.7 mp0 -94.57 139.6 30.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.266 0.555 . . . . 0.0 112.343 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.698 HG22 HG21 ' A' ' 121' ' ' VAL . 16.4 t -127.72 132.22 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.736 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.771 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 54.8 tp60 -95.04 123.44 38.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.99 0.424 . . . . 0.0 110.353 174.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.757 HG12 HD11 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.76 140.16 49.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.37 -72.62 0.45 Allowed Glycine 0 C--O 1.216 -0.987 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.865 167.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.732 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 15.9 ptmt -170.49 16.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.278 0.539 . . . . 0.0 110.276 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.622 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.3 OUTLIER -118.82 147.18 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.182 -169.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -96.02 105.92 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.897 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.5 mp -98.42 153.7 18.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.978 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 1.9 m -141.42 145.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.665 ' CZ ' ' HB ' ' A' ' 148' ' ' THR . 63.4 t80 -97.24 134.52 40.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 146' ' ' PHE . 1.5 mm? -135.4 141.05 45.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.741 166.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.665 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -106.56 -108.01 0.31 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.887 -177.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.405 ' N ' ' HG1' ' A' ' 148' ' ' THR . . . -69.8 135.53 26.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.829 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -73.33 67.25 4.38 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.312 2.674 . . . . 0.0 112.48 -177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -67.42 117.15 9.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.929 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -95.14 109.56 21.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.39 90.4 1.03 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.46 -177.87 4.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.879 0.371 . . . . 0.0 111.082 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.56 85.62 6.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -93.01 143.07 26.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.897 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -134.98 81.12 0.3 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.614 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.4 m -72.46 110.34 6.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.819 0.342 . . . . 0.0 110.116 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.2 t -103.04 91.21 4.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.586 0.708 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -170.18 52.07 0.2 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.067 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.88 -86.23 0.52 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.267 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.101 2.534 . . . . 0.0 111.086 175.08 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.595 0.712 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.5 p -84.28 30.16 0.55 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.34 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 59.03 28.84 18.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.459 0.647 . . . . 0.0 110.454 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.2 mmt -113.8 127.51 56.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.438 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -87.12 123.35 70.25 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.67 114.17 1.83 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.353 2.702 . . . . 0.0 113.097 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -84.27 85.94 7.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.769 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tt -115.13 119.18 61.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.25 0.548 . . . . 0.0 111.306 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.57 153.23 17.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 170.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 10' ' ' LYS . 22.5 tptp -79.17 110.1 14.12 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.501 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.442 ' CG ' ' H ' ' A' ' 12' ' ' GLN . 5.1 t70 67.51 -169.75 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.76 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.442 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 25.4 tt0 -161.29 102.11 1.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 124.01 20.41 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.214 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -46.22 -64.27 0.79 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.843 0.715 . . . . 0.0 112.566 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.38 149.42 13.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -135.46 116.43 14.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.5 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.97 140.35 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.296 0.569 . . . . 0.0 111.618 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 m -92.12 -17.66 24.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.767 0.794 . . . . 0.0 109.05 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 20' ' ' GLU . 8.2 p -83.36 -179.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.514 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.723 ' H ' HG22 ' A' ' 19' ' ' VAL . 34.0 mm-40 67.18 25.29 9.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.515 0.674 . . . . 0.0 110.55 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.0 m -82.73 137.27 34.46 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.044 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.662 ' HB ' HD23 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 93' ' ' THR . 8.4 m -79.44 106.95 11.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 122.533 0.333 . . . . 0.0 111.729 -172.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.581 ' HB ' HD21 ' A' ' 116' ' ' LEU . 5.3 p -136.64 155.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -177.92 -147.61 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER 46.33 -113.69 0.45 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.186 0.594 . . . . 0.0 109.926 177.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.739 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 63.62 173.27 0.17 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 167.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.94 ' HA ' HD23 ' A' ' 33' ' ' LEU . 8.5 t70 -76.72 60.38 1.69 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.424 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 45.7 m-85 -150.46 -44.03 0.12 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.207 -178.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.2 tp -73.94 -66.77 0.67 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.765 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -167.21 -72.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.431 -0.508 . . . . 0.0 112.035 -168.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 26' ' ' ARG . 8.8 mm-40 -78.79 108.83 12.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.779 0.323 . . . . 0.0 111.221 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.94 HD23 ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -166.27 -40.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.748 -174.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.02 122.92 45.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.316 0.579 . . . . 0.0 111.463 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.486 ' HB1' HH11 ' A' ' 143' ' ' ARG . . . -106.28 -55.3 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.329 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -69.95 109.05 2.25 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.06 1.84 . . . . 0.0 112.587 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 133.5 48.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 64.41 87.56 0.11 Allowed 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.639 0.587 . . . . 0.0 109.881 -172.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.86 117.7 5.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.34 65.87 1.75 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -79.25 -9.73 59.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 110.666 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.15 161.73 40.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.951 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.8 m -69.51 84.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.34 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.75 57.27 3.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.487 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.33 12.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.766 -178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 m -143.13 100.7 3.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.485 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.79 -35.13 0.57 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.12 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.597 HG21 HD11 ' A' ' 51' ' ' LEU . 6.8 p -119.6 67.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.545 1.164 . . . . 0.0 109.956 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.68 -63.82 0.42 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.937 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.79 48.39 4.04 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.127 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.629 HD23 HG23 ' A' ' 148' ' ' THR . 4.1 mt -86.14 115.91 63.75 Favored Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 122.265 0.226 . . . . 0.0 111.12 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.603 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 18.7 Cg_endo -63.45 -32.94 70.66 Favored 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 122.3 2.0 . . . . 0.0 114.93 169.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -98.59 170.52 0.59 Allowed 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.3 2.0 . . . . 0.0 112.769 -175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.6 14.16 59.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.625 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -149.85 144.56 26.04 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.95 172.69 9.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.629 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 3.3 pp -160.31 140.55 11.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.691 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.4 mp -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.152 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 68' ' ' SER . 3.3 p -103.13 125.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.212 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.862 HG21 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.07 114.69 9.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.151 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -68.87 -69.72 0.31 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.331 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -147.54 131.07 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.406 0.622 . . . . 0.0 110.268 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -176.13 -150.16 7.95 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.672 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 37.5 Cg_exo -62.07 -64.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.284 1.989 . . . . 0.0 112.867 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 54.9 t30 -76.31 -52.51 9.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HA ' HG22 ' A' ' 60' ' ' VAL . . . 52.9 169.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.5 -172.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.24 90.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.011 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.862 ' H ' HG21 ' A' ' 60' ' ' VAL . 10.3 m -94.66 -178.03 4.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.34 0.57 . . . . 0.0 110.838 -170.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -169.14 149.25 4.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.259 0.481 . . . . 0.0 111.726 -173.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -94.35 121.9 36.36 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.547 ' O ' HG21 ' A' ' 77' ' ' THR . 0.8 OUTLIER -79.86 94.58 5.86 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -175.382 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.693 HD23 ' CG ' ' A' ' 101' ' ' PHE . 6.0 mt -90.04 46.59 1.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.867 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -99.34 -24.12 14.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.277 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -102.33 -166.65 1.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.531 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.24 -37.63 60.95 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.419 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -159.99 131.47 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.547 HG21 ' O ' ' A' ' 71' ' ' LEU . 11.3 p -119.12 127.21 53.14 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.375 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.648 ' O ' HG22 ' A' ' 87' ' ' ILE . 66.5 m -76.45 132.7 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB2' HG12 ' A' ' 87' ' ' ILE . . . -126.27 120.98 31.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.11 -127.89 2.61 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.788 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.1 tmm_? -73.82 105.77 5.25 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.903 0.859 . . . . 0.0 109.612 175.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -137.01 134.72 19.16 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.465 -169.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -65.59 -67.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.581 2.187 . . . . 0.0 113.132 173.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -156.01 9.35 0.25 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -174.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -77.53 -88.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.413 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -105.33 -76.73 0.6 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.378 0.609 . . . . 0.0 111.653 -170.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.758 HD11 HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.46 110.11 20.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.89 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -110.63 132.27 54.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.341 -178.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.947 ' HG ' HD13 ' A' ' 139' ' ' ILE . 4.4 mm? -119.85 78.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.614 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 36.0 t0 68.75 -6.34 0.87 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.508 0.67 . . . . 0.0 109.93 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.788 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.4 p-10 41.89 32.86 0.3 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.422 1.489 . . . . 0.0 113.258 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 22' ' ' TPO . 5.7 p -144.91 8.06 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.089 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -124.19 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.391 -177.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.617 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.3 t -109.16 152.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -173.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.442 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 49.3 m -77.2 66.25 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 0.0 110.454 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.453 ' HE ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 67.43 -56.51 0.45 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.976 -173.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.533 ' HG2' HG22 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -146.54 147.04 30.74 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.78 0.8 . . . . 0.0 110.64 175.427 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.687 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -90.53 -40.75 11.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.912 170.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.835 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -151.15 142.62 23.48 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.58 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.636 ' HB2' HD12 ' A' ' 76' ' ' ILE . 3.5 pt-20 -109.72 120.83 43.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.693 ' CG ' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.92 104.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.537 -174.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 10.4 tpp180 -96.01 107.12 19.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.662 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.852 HD22 ' HA ' ' A' ' 106' ' ' ASN . 7.7 tt -89.27 107.28 18.97 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.796 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -128.53 137.76 51.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.074 176.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 57.19 34.11 24.32 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.49 . . . . 0.0 110.314 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.852 ' HA ' HD22 ' A' ' 103' ' ' LEU . 19.5 t-20 61.29 33.37 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.159 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.593 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.6 mt-10 -125.28 135.07 52.13 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.745 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.511 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -86.75 120.19 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 109' ' ' ASN . 0.9 OUTLIER -122.64 159.77 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.0 m -107.77 127.86 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.581 173.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.835 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.1 t -100.37 111.09 28.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.342 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 12.4 t70 -76.65 114.06 14.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 97' ' ' ARG . 24.1 m -105.24 -20.21 6.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.34 0.59 . . . . 0.0 110.331 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.32 91.93 0.88 Allowed Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.442 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.675 ' OG ' ' HB2' ' A' ' 98' ' ' HIS . 0.7 OUTLIER -80.4 162.16 24.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 22' ' ' TPO . 50.3 tp -61.68 -55.47 30.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.564 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.692 HD21 ' HB3' ' A' ' 27' ' ' ALA . 18.6 p-10 -69.02 -37.6 78.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.246 0.546 . . . . 0.0 110.301 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 127.24 169.98 12.79 Favored Glycine 0 C--O 1.254 1.374 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.845 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.2 m -112.1 136.58 51.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.632 0.773 . . . . 0.0 111.118 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -138.05 104.68 5.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 172.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.756 HG21 HG11 ' A' ' 137' ' ' VAL . 47.2 t -94.52 105.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.615 HD21 HG12 ' A' ' 121' ' ' VAL . 20.4 m-80 56.61 43.03 26.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER 76.82 -6.9 1.94 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.969 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -119.2 123.92 28.52 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.339 179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.62 123.15 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.645 2.23 . . . . 0.0 111.695 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.68 175.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.802 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 31.5 t70 -96.1 -45.81 6.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.873 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.1 t -162.77 105.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.82 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.56 136.33 50.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.332 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.57 129.39 33.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.372 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.573 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -63.9 159.89 18.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.043 177.364 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -161.44 152.61 18.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.26 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -64.45 105.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.169 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.33 4.32 35.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.604 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.81 136.17 34.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.7 tt0 -122.52 134.01 54.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 111.432 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.756 HG11 HG21 ' A' ' 121' ' ' VAL . 24.8 t -129.61 141.28 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.159 -174.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.739 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 53.3 tp60 -99.4 128.19 45.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.391 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.947 HD13 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -135.0 138.38 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.088 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.546 ' HA3' HG21 ' A' ' 94' ' ' VAL . . . 73.72 -69.08 1.52 Allowed Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.468 165.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.672 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 17.9 ptmt -176.38 16.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.654 ' CD2' HD11 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -117.4 149.95 39.68 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.817 -171.577 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.486 HH11 ' HB1' ' A' ' 35' ' ' ALA . 7.8 ttm180 -92.99 129.2 38.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.786 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.2 mp -124.04 152.57 42.49 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.804 0.335 . . . . 0.0 111.743 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.73 143.58 26.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.99 170.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.679 ' CZ ' ' HB ' ' A' ' 148' ' ' THR . 45.8 t80 -100.87 136.58 40.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.892 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.665 HD11 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -130.68 149.04 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.58 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.679 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 13.8 t -143.49 143.86 31.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.603 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . 55.99 56.02 26.19 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.915 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.05 98.47 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.035 2.49 . . . . 0.0 112.479 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.27 127.46 35.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 110.295 174.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -117.35 57.04 0.81 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 146.87 32.11 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.752 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.09 106.86 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.3 0.572 . . . . 0.0 109.628 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.49 73.0 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.551 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 t70 50.4 77.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.503 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.12 134.26 3.35 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.131 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.0 t -134.67 18.95 3.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.3 t -86.45 68.34 10.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.308 1.051 . . . . 0.0 110.645 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.73 51.42 0.7 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.669 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.82 134.27 3.63 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.088 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.147 2.565 . . . . 0.0 111.619 178.269 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 p -87.11 49.63 1.86 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.65 133.12 55.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.241 0.543 . . . . 0.0 111.398 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.6 mtt -90.88 64.76 5.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.349 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -121.02 91.86 48.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.74 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.08 89.14 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.01 2.473 . . . . 0.0 112.633 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -88.81 -17.38 29.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.577 HD11 ' HA ' ' A' ' 15' ' ' ASP . 5.7 tp -82.39 82.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 122.021 0.915 . . . . 0.0 110.411 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -90.37 -45.95 8.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.159 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -82.72 93.62 7.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.354 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -106.86 75.6 1.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.562 0.696 . . . . 0.0 110.774 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 6.7 tp60 -139.03 -46.03 0.47 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -88.55 141.86 28.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.482 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.5 p -56.93 98.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.776 -175.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HA ' HD11 ' A' ' 8' ' ' ILE . 2.2 m-20 58.76 22.4 10.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.485 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 50.87 42.55 28.07 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.166 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -80.63 73.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.825 0.821 . . . . 0.0 110.059 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -110.09 93.94 4.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.266 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -41.97 -71.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 124.128 0.892 . . . . 0.0 112.162 -170.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -146.76 -100.06 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -163.37 128.98 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TPO . . . . . 0.689 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.704 ' O ' ' HA ' ' A' ' 93' ' ' THR . 15.2 m -54.35 120.12 6.13 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.599 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.7 p -144.28 168.68 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.047 -169.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 9.3 t80 171.91 -147.0 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.567 ' HD2' ' N ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 43.26 -107.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.922 0.764 . . . . 0.0 110.554 174.581 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.567 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 63.5 176.59 0.16 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.939 ' HA ' HD23 ' A' ' 33' ' ' LEU . 9.9 t70 -94.82 79.46 3.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.517 -170.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -137.58 -90.46 0.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.434 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.428 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.2 pt? -126.75 -0.24 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -62.98 -86.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.186 -171.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -121.85 50.72 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.933 0.873 . . . . 0.0 110.546 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.939 HD23 ' HA ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -161.91 -143.86 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.79 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 t70 62.13 86.03 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.355 0.598 . . . . 0.0 109.649 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.13 147.34 55.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.6 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -59.63 103.65 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.85 2.366 . . . . 0.0 111.653 176.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 112.0 4.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -85.91 -60.3 2.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.25 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . . . 56.35 77.64 0.24 Allowed 'General case' 0 C--O 1.232 0.152 0 O-C-N 123.632 0.582 . . . . 0.0 110.526 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.06 -125.24 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 m -87.6 40.68 0.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.905 0.86 . . . . 0.0 110.156 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' A' ' 39' ' ' ALA . 35.5 mt-10 -82.3 57.26 3.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.179 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 m -93.84 100.51 12.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.915 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 131.96 43.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.35 -15.13 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.98 0.419 . . . . 0.0 111.016 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -154.67 112.74 3.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.87 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.636 ' HA2' ' ND2' ' A' ' 133' ' ' ASN . . . -95.81 -57.81 1.15 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 m -137.58 51.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.244 172.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -120.02 -86.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.427 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.63 51.86 4.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.778 HD23 HG23 ' A' ' 148' ' ' THR . 34.6 mt -64.65 121.02 70.78 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 122.678 0.391 . . . . 0.0 111.375 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.626 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 71.3 Cg_endo -109.78 46.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.633 2.889 . . . . 0.0 114.527 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.07 145.07 1.13 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.855 1.703 . . . . 0.0 113.284 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.32 -28.75 24.13 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 170.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -146.53 152.28 38.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.43 ' HB3' ' CD1' ' A' ' 131' ' ' LEU . . . -124.59 170.64 10.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.614 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -159.87 137.1 9.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.75 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.75 HD11 HD12 ' A' ' 72' ' ' LEU . 6.0 mp -87.08 111.41 20.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.275 161.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 p -108.73 128.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.444 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.866 ' HA ' ' HA ' ' A' ' 144' ' ' LEU . 0.6 OUTLIER -72.19 109.01 4.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 35.0 ttpt -61.96 -60.55 3.46 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.511 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -149.93 115.47 5.53 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.506 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.9 -166.15 11.49 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.639 ' HG2' ' CG ' ' A' ' 141' ' ' LYS . 23.0 Cg_exo -64.3 -46.6 7.41 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.698 1.599 . . . . 0.0 111.572 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.799 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 41.7 t30 -74.69 -50.43 17.63 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.595 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 56.05 155.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.633 -1.622 . . . . 0.0 113.359 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.09 2.42 90.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.11 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.861 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -88.22 -179.83 6.23 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 117.397 0.598 . . . . 0.0 109.996 -171.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.86 151.78 3.48 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.861 0.755 . . . . 0.0 112.107 -173.199 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.726 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -93.94 125.49 38.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 77' ' ' THR . 1.1 tm? -80.9 94.89 6.58 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.807 HD21 ' CG ' ' A' ' 101' ' ' PHE . 5.2 mt -91.52 50.75 1.77 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.711 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' H ' HD13 ' A' ' 71' ' ' LEU . 23.7 t70 -104.79 -21.88 13.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.923 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -103.29 -167.78 1.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.0 59.48 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.747 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.716 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.78 130.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.618 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.507 HG23 ' OD2' ' A' ' 86' ' ' ASP . 22.3 p -118.99 132.03 56.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.361 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.6 m -73.99 126.33 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.66 ' HB1' HG21 ' A' ' 87' ' ' ILE . . . -118.5 116.34 26.46 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.654 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 157.94 -139.58 6.45 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.21 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.51 104.1 8.89 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.575 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 68.1 m-70 -136.85 118.08 11.13 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.291 -171.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.04 -42.77 10.33 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.12 1.88 . . . . 0.0 110.618 162.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -129.9 118.49 21.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.347 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 78' ' ' SER . 4.2 m 174.4 -175.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.8 1.24 . . . . 0.0 108.092 174.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.507 ' OD2' HG23 ' A' ' 77' ' ' THR . 16.8 m-20 -89.89 -36.93 14.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.029 0.442 . . . . 0.0 111.446 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.726 ' HB ' ' HA ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -114.2 100.0 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.808 0.814 . . . . 0.0 111.755 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.93 134.41 50.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.366 173.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.913 ' HG ' HD12 ' A' ' 139' ' ' ILE . 2.9 mm? -115.21 73.15 0.82 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.5 t70 68.23 -5.01 0.95 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.544 0.688 . . . . 0.0 110.175 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.8 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.0 p-10 38.06 42.42 0.46 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.647 1.579 . . . . 0.0 113.133 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.672 ' O ' HG22 ' A' ' 22' ' ' TPO . 18.5 t -142.81 -11.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.704 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -113.09 -12.16 13.22 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -170.072 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 115' ' ' SER . 0.9 OUTLIER -135.64 150.88 29.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.872 -0.518 . . . . 0.0 110.986 -170.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.638 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 2.5 m -69.15 71.97 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.231 0.613 . . . . 0.0 112.63 -171.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.671 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.34 -54.69 0.15 Allowed 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.426 0.69 . . . . 0.0 111.493 -174.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.664 ' N ' ' HE ' ' A' ' 96' ' ' ARG . 3.5 ttm180 -155.63 124.67 6.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.687 -0.633 . . . . 0.0 110.84 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.991 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.62 -40.56 48.96 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.014 176.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.771 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -150.39 149.32 29.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.168 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' O ' HG21 ' A' ' 111' ' ' VAL . 5.3 pt-20 -113.11 130.58 56.13 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.807 ' CG ' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -63.42 101.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.501 ' NH2' HG23 ' A' ' 111' ' ' VAL . 19.6 ttm180 -100.55 114.12 27.5 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.571 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.59 HD13 ' CD1' ' A' ' 108' ' ' PHE . 14.7 tp -75.64 109.06 8.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.472 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -112.37 123.98 51.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.473 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.5 p30 42.47 44.26 3.44 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.049 0.843 . . . . 0.0 111.806 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.0 t30 75.7 0.18 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.149 173.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.6 mm-40 -104.5 133.13 49.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.59 ' CD1' HD13 ' A' ' 103' ' ' LEU . 0.9 OUTLIER -85.79 131.92 34.22 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -172.593 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 14.2 m-80 -134.1 171.21 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.822 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.3 m -110.1 156.58 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 168.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.771 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 27.0 m -126.28 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 170.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.77 116.77 14.76 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.5 m -123.42 -22.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.764 0.316 . . . . 0.0 111.366 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.82 102.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.991 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.9 t -115.81 133.53 55.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.689 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 2.7 tm? -56.44 -55.46 33.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.63 -36.02 78.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.06 170.64 12.08 Favored Glycine 0 C--O 1.251 1.205 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.866 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -112.04 133.22 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.036 0.535 . . . . 0.0 110.753 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -138.19 103.35 4.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 120.938 0.399 . . . . 0.0 111.043 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.732 HG23 HG13 ' A' ' 137' ' ' VAL . 55.2 t -98.61 123.11 50.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 64.1 33.33 12.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 61.32 28.01 17.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.953 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.7 pt-20 -146.47 150.9 42.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 121.65 -0.656 . . . . 0.0 111.025 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 125.7 11.1 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.572 2.181 . . . . 0.0 111.88 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.24 179.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.741 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -106.55 -47.35 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.3 0.572 . . . . 0.0 109.808 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.822 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.8 t -158.16 91.75 1.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.946 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.56 136.65 38.36 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.616 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.94 150.51 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.919 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.695 HD11 HD13 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -63.72 119.41 9.87 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.307 175.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.61 121.89 25.11 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.636 ' ND2' ' HA2' ' A' ' 47' ' ' GLY . 9.4 p30 -61.2 118.88 7.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.743 0.782 . . . . 0.0 111.939 -171.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.31 -13.1 33.6 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.254 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.405 ' CB ' ' HE1' ' A' ' 146' ' ' PHE . 2.3 t0 -96.63 173.01 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 5.2 pt-20 -139.74 151.87 46.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.572 -168.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 121' ' ' VAL . 39.8 t -127.56 141.57 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.766 ' HB2' ' HB2' ' A' ' 28' ' ' ASP . 6.3 tp-100 -98.28 129.64 44.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.944 0.402 . . . . 0.0 110.517 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . 0.913 HD12 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -134.55 133.51 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 166.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 71.03 -77.14 0.56 Allowed Glycine 0 C--O 1.215 -1.04 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.956 172.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.639 ' CG ' ' HG2' ' A' ' 64' ' ' PRO . 12.9 ptmt -168.03 25.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.516 0.658 . . . . 0.0 110.755 173.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.799 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -115.81 141.43 48.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -173.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 143' ' ' ARG . 5.5 ttp85 -94.9 106.32 18.3 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.312 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.4 159.51 14.96 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.803 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.625 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.9 142.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.299 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.738 ' CB ' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -110.49 138.4 46.92 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.283 0.563 . . . . 0.0 112.326 -178.06 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.407 ' N ' HD21 ' A' ' 131' ' ' LEU . 2.8 mm? -127.96 145.53 50.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.156 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.778 HG23 HD23 ' A' ' 51' ' ' LEU . 10.9 t -135.46 151.06 50.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.626 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . 60.65 61.94 6.5 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.409 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.67 118.62 5.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.519 2.146 . . . . 0.0 111.737 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.65 60.68 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.646 0.736 . . . . 0.0 110.974 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -148.53 177.59 9.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.737 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -150.6 81.8 0.18 Allowed Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.93 111.42 23.67 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -136.59 160.89 37.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -110.23 6.03 22.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.823 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -138.8 -71.07 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.953 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.5 m 56.37 46.96 19.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.597 . . . . 0.0 109.829 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 p -80.83 102.3 9.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.198 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -106.99 -88.35 2.02 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.12 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 146.36 -160.12 28.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.116 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.02 2.48 . . . . 0.0 111.672 178.586 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.594 HG22 ' CD1' ' A' ' 116' ' ' LEU . 92.2 t -102.24 137.38 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.272 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' H ' HD21 ' A' ' 117' ' ' ASN . 12.6 t80 174.08 159.77 0.16 Allowed 'General case' 0 C--O 1.213 -0.859 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.505 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.676 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 10.4 tpt85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.444 -0.761 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.4 42.98 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 5.1 mp -148.38 139.24 23.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.06 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.6 mp -85.87 135.21 33.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 68' ' ' SER . 3.8 p -125.23 128.57 72.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.158 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.876 HG22 ' H ' ' A' ' 68' ' ' SER . 1.5 m -73.11 109.89 5.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HD2' ' HD2' ' A' ' 143' ' ' ARG . 2.2 ttmp? -57.76 -60.6 3.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.97 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.56 146.59 8.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.364 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 152.02 130.3 1.59 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -175.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.676 ' CD ' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 1.67 -71.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.876 5.051 . . . . 0.0 118.054 -159.22 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.573 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.4 t30 -62.94 -51.67 66.0 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 119.116 0.871 . . . . 0.0 109.123 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.66 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 53.5 165.29 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.221 -1.808 . . . . 0.0 114.172 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.08 4.45 90.24 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.841 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.876 ' H ' HG22 ' A' ' 60' ' ' VAL . 19.9 m -106.71 -167.79 1.33 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 118.053 0.926 . . . . 0.0 112.027 -166.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -170.86 151.74 3.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -168.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.699 ' HE1' ' CD2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.69 118.16 33.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 166.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.586 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.21 107.13 15.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.04 28.02 4.22 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.469 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.482 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 25.1 t70 -67.83 -28.24 67.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -96.89 164.19 12.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.683 171.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.85 -16.84 62.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -168.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -173.94 126.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.425 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.41 131.98 55.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.899 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 87' ' ' ILE . 70.0 m -71.76 129.53 38.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.358 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.32 121.31 41.6 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 147.0 -127.99 2.85 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.244 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.26 102.93 14.4 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 96' ' ' ARG . 33.8 m80 . . . . . 0 C--N 1.318 -0.768 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.729 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' HB3' ' A' ' 71' ' ' LEU . 16.1 t70 . . . . . 0 CA--C 1.516 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -90.23 91.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.911 0.862 . . . . 0.0 110.416 178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -104.58 123.89 48.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.353 172.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.982 HD11 HD21 ' A' ' 144' ' ' LEU . 15.4 mt -110.46 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 37.4 t70 74.09 -26.28 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.471 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 16.9 t70 63.52 28.15 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 122.658 1.218 . . . . 0.0 110.524 174.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' OD2' ' A' ' 90' ' ' ASP . 46.2 t -135.73 -12.75 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.987 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.619 HG21 ' HE3' ' A' ' 141' ' ' LYS . 1.5 p -108.38 -29.85 8.62 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.536 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.8 t -103.39 151.65 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.107 -0.371 . . . . 0.0 110.899 -169.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m -74.56 69.3 1.7 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.591 0.356 . . . . 0.0 110.074 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.678 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 56.33 -62.94 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.01 -166.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.639 ' HG3' HG21 ' A' ' 113' ' ' VAL . 7.6 ptp180 -133.85 139.38 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 120.849 -1.157 . . . . 0.0 111.047 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.815 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -83.88 -43.79 14.95 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.733 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -147.3 163.35 36.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.308 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.5 pt-20 -122.47 122.14 38.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 165.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.793 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.3 OUTLIER -79.58 92.03 5.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -173.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 111' ' ' VAL . 11.6 ptp180 -92.8 131.85 37.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.713 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.706 HD21 ' HA ' ' A' ' 106' ' ' ASN . 6.2 tt -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.455 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 62.6 mm-40 -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 63.02 31.58 15.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.211 0.319 . . . . 0.0 110.456 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.706 ' HA ' HD21 ' A' ' 103' ' ' LEU . 56.3 m-20 68.81 7.46 6.17 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.802 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.666 ' HG3' HD21 ' A' ' 109' ' ' ASN . 11.2 pt-20 -117.35 133.51 55.89 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.004 0.431 . . . . 0.0 110.391 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -85.64 140.2 30.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 33.0 m-80 -144.73 157.15 44.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.386 -173.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -102.13 118.98 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.591 0.71 . . . . 0.0 110.329 177.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 2.1 t -99.81 113.36 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.792 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 119' ' ' THR . 14.4 t70 -74.67 129.86 38.47 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.929 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.639 HG21 ' HG3' ' A' ' 97' ' ' ARG . 20.3 m -132.16 19.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 103.99 0.55 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.654 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.815 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.9 p -104.17 152.83 21.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 93' ' ' THR . 3.2 tm? -59.42 -55.84 29.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -170.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.602 HD21 ' H ' ' A' ' 25' ' ' PHE . 19.0 m120 -67.81 -36.39 80.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.876 0.369 . . . . 0.0 110.611 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.89 150.76 5.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.213 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 98' ' ' HIS . 19.6 m -109.47 126.6 53.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 111.52 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 38.1 m-85 -139.73 157.15 46.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.109 171.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 137' ' ' VAL . 2.4 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.448 HD22 HG22 ' A' ' 121' ' ' VAL . 57.1 m-80 61.55 45.28 8.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.069 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 3.0 mmp_? 69.1 9.69 7.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.56 136.74 24.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.355 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.06 138.35 33.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.917 2.411 . . . . 0.0 111.771 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 129' ' ' ALA . 19.7 m -135.47 179.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.674 0.273 . . . . 0.0 111.215 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.8 m-20 -95.84 -53.23 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.1 p -154.0 91.67 1.47 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -89.99 143.78 26.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.15 135.87 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.893 -174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.736 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 2.3 tt -53.08 117.76 3.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.979 168.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -124.7 -175.73 3.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.175 -172.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -103.14 94.55 5.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.45 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.52 -22.89 23.55 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.46 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.855 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 7.1 m-20 -73.0 158.86 34.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.444 0.164 . . . . 0.0 110.652 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 145' ' ' VAL . 9.2 pt-20 -133.89 150.56 51.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.079 0.942 . . . . 0.0 113.087 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 121' ' ' VAL . 46.5 t -115.68 144.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.552 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.583 ' NE2' HH12 ' A' ' 26' ' ' ARG . 6.6 tp-100 -97.17 119.67 36.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 172.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -116.08 120.6 65.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 63.39 -102.14 0.51 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 118.871 -1.633 . . . . 0.0 110.889 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.619 ' HE3' HG21 ' A' ' 93' ' ' THR . 8.9 pttt -142.14 42.32 1.66 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.259 0.552 . . . . 0.0 111.651 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.758 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -134.97 148.92 50.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.463 ' HD3' ' CD ' ' A' ' 136' ' ' GLU . 4.7 ttm180 -98.71 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 89' ' ' LEU . 2.9 mp -116.6 110.65 18.8 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -103.4 140.85 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 120.9 0.381 . . . . 0.0 110.395 -177.033 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.06 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.88 147.22 31.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.215 0.531 . . . . 0.0 112.397 -177.491 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 146' ' ' PHE . 2.3 mm? . . . . . 0 C--O 1.234 0.278 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 117' ' ' ASN . 9.4 p -131.35 153.92 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.827 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 36.8 t80 178.98 -163.6 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.238 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HG2' ' HD3' ' A' ' 64' ' ' PRO . 7.5 tpt180 . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 119.008 0.822 . . . . 0.0 111.171 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.67 168.98 16.8 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 1.2 pp -152.53 134.06 14.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.03 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 mp -88.08 126.36 35.06 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.679 162.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 69' ' ' ARG . 92.6 t -120.83 133.55 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 117.996 0.362 . . . . 0.0 110.616 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.14 119.7 27.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' CG1' ' A' ' 145' ' ' VAL . 26.0 mtpp -53.78 -80.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.625 1.203 . . . . 0.0 111.663 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 43.3 ttt180 -161.74 81.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.568 -174.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 66' ' ' ALA . . . -112.5 -143.84 9.05 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.058 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 42.5 Cg_exo -58.17 -66.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.21 1.94 . . . . 0.0 113.039 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 2.2 t-20 -69.35 -52.8 23.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 55.09 166.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.227 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.55 3.21 90.11 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.277 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.902 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -96.39 177.45 5.69 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.598 -167.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -166.29 153.43 9.62 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -173.387 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.46 122.88 38.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 167.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.1 tt -83.17 93.84 7.73 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.43 0.633 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.8 OUTLIER -88.46 45.78 1.32 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.916 0.865 . . . . 0.0 109.219 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.449 ' HB3' HD21 ' A' ' 71' ' ' LEU . 13.5 t70 -90.95 -13.47 33.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.951 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.48 174.75 5.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.783 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -66.0 -60.89 2.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 100' ' ' GLU . 1.3 tp -125.68 122.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.313 0.578 . . . . 0.0 111.802 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -104.83 171.71 7.17 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.062 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -117.27 124.09 48.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.737 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.75 121.34 42.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 139.07 -129.95 4.64 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.204 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -84.88 103.27 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 97' ' ' ARG . 38.8 m80 . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.082 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.331 0.586 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.737 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -100.64 95.87 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.632 0.73 . . . . 0.0 110.867 -175.194 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -109.14 128.97 55.46 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.552 177.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 HG11 ' A' ' 60' ' ' VAL . 4.0 mm? -113.28 84.63 2.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.695 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 6.4 t70 66.18 -1.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.22 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.789 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 2.9 p30 41.01 37.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.171 1.388 . . . . 0.0 113.921 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 92' ' ' VAL . 9.9 p -161.11 21.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.625 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -123.17 -7.15 8.28 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.495 -0.753 . . . . 0.0 111.675 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 140' ' ' GLY . 1.9 t -125.47 152.16 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m -73.05 70.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.05 0.452 . . . . 0.0 110.279 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.7 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.56 -67.93 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.936 -168.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.713 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 7.2 ptp180 -136.31 128.74 30.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.544 -1.347 . . . . 0.0 111.493 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.825 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -65.31 -46.05 81.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 171.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -148.95 179.13 8.1 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.008 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.29 123.55 14.71 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.12 93.05 3.28 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.098 0.951 . . . . 0.0 109.82 -168.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.1 tpp180 -81.3 123.6 28.65 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.762 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.904 HD11 ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.04 126.58 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 22.3 tt0 -150.55 126.52 10.46 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 64.82 41.69 4.87 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.651 0.594 . . . . 0.0 109.721 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.904 ' HA ' HD11 ' A' ' 103' ' ' LEU . 3.1 p-10 51.4 22.19 1.39 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.581 1.152 . . . . 0.0 113.313 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.793 ' HG3' HD21 ' A' ' 109' ' ' ASN . 12.5 pt-20 -118.19 134.27 55.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -87.91 143.25 27.22 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.793 HD21 ' HG3' ' A' ' 107' ' ' GLU . 25.0 m-80 -147.36 156.25 42.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.574 0.625 . . . . 0.0 111.447 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -102.54 116.26 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.116 176.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 76.2 t -101.03 111.52 30.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.345 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.59 126.03 28.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.021 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 18.9 m -134.9 14.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.23 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.47 105.08 2.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.791 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.2 t -118.57 128.04 54.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 24' ' ' VAL . 29.3 tp -55.17 -56.24 22.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.877 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 24' ' ' VAL . 2.6 t-20 -62.85 -38.41 90.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.984 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.87 161.26 8.94 Favored Glycine 0 C--O 1.256 1.483 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.646 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.599 HG23 ' HE1' ' A' ' 98' ' ' HIS . 8.1 m -111.39 134.11 53.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.103 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 123' ' ' ARG . 0.1 OUTLIER -141.48 131.27 24.28 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.751 HG22 HG13 ' A' ' 137' ' ' VAL . 80.8 t -142.01 114.19 3.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.01 43.54 14.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 79.8 mtp180 66.86 14.13 9.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -142.3 141.59 21.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 121.914 -0.492 . . . . 0.0 110.622 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 122.96 11.09 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.968 1.779 . . . . 0.0 110.748 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.543 HG13 ' HB ' ' A' ' 121' ' ' VAL . 20.4 m -111.61 174.0 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.389 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 6.1 m-20 -98.11 -47.67 5.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.045 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.891 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.4 p -160.67 102.45 1.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.571 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -99.9 142.45 31.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.83 131.06 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 123.421 0.45 . . . . 0.0 110.739 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.627 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 2.1 tt -51.43 115.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -120.05 -175.21 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.51 96.78 6.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.624 0.249 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.14 4.98 29.01 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.144 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.915 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 11.6 m-20 -107.46 160.83 15.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.32 0.56 . . . . 0.0 110.247 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -118.08 155.87 29.61 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -166.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.751 HG13 HG22 ' A' ' 121' ' ' VAL . 59.8 t -133.69 141.82 43.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.765 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 142' ' ' PHE . 0.3 OUTLIER -116.77 124.52 49.82 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.825 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -131.22 132.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.986 175.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 84.11 -56.44 5.04 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 119.258 -1.448 . . . . 0.0 113.763 166.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.058 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 43.3 pttt 171.17 27.18 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.144 0.578 . . . . 0.0 110.688 168.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.737 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.56 146.8 51.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -92.68 119.21 31.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.237 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.907 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -110.08 156.93 19.9 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.12 143.11 28.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 172.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.03 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.15 141.64 34.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.935 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.218 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 17.2 m . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 116' ' ' LEU . 4.4 p -134.77 157.57 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.633 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -177.07 -171.78 0.37 Allowed 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.912 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 CA-C-N 118.222 0.465 . . . . 0.0 110.078 171.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -124.45 167.72 14.03 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.74 145.76 12.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.971 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -95.37 115.92 28.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.889 163.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.6 125.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.893 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -70.37 116.49 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 45.1 tptt -68.72 -82.81 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.744 -171.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -144.22 123.38 12.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 111.009 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.722 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -164.12 -105.37 0.19 Allowed Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.205 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.659 ' CG ' ' HG3' ' A' ' 141' ' ' LYS . 4.8 Cg_exo -77.76 -88.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.954 2.436 . . . . 0.0 112.333 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.796 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.5 t30 -64.73 -48.29 75.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.722 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.34 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.221 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 0.92 89.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.09 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.911 ' H ' HG22 ' A' ' 60' ' ' VAL . 2.7 m -86.29 171.55 11.14 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 117.212 0.506 . . . . 0.0 109.673 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.669 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -167.68 153.62 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.377 0.535 . . . . 0.0 111.581 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.64 126.82 40.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.1 tm? -84.7 96.08 9.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.33 1.019 . . . . 0.0 108.571 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.864 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -93.38 50.3 1.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.844 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB3' HD11 ' A' ' 71' ' ' LEU . 21.3 t70 -104.97 -19.41 13.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.832 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.82 -166.9 1.34 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.426 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.56 -40.63 56.46 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.423 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.32 135.6 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.721 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 22.3 p -116.42 141.75 47.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.084 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 43.2 m -85.61 124.79 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.07 106.34 11.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 161.61 -129.47 2.11 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -68.77 108.34 3.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.72 0.771 . . . . 0.0 110.456 173.343 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.762 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.511 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 -174.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.416 0.627 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -127.75 110.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.187 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -109.27 134.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.2 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.045 ' HG ' HD11 ' A' ' 139' ' ' ILE . 3.0 mm? -117.39 72.27 0.83 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.551 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 34.1 t70 62.8 4.21 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.381 0.61 . . . . 0.0 109.853 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 t70 66.73 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.261 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' SER . 14.2 p -80.57 69.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.42 1.105 . . . . 0.0 112.866 -167.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -162.69 4.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.941 167.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.4 t -140.63 141.82 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 10.9 t -76.14 72.76 2.96 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 66.1 -48.87 0.42 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.072 -173.218 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.572 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 8.1 ptp85 -154.46 135.0 13.45 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.592 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -72.13 -36.84 69.49 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -159.95 176.56 11.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.225 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 102' ' ' ARG . 6.0 pt-20 -134.04 135.19 43.18 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.864 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -61.17 95.89 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -92.49 98.17 11.29 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.678 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -77.98 107.83 10.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.267 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.57 139.85 45.68 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.036 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 58.61 32.52 22.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.914 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.871 ' HA ' HD21 ' A' ' 103' ' ' LEU . 89.0 m-20 67.5 9.11 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.895 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 17.5 mm-40 -105.49 151.67 23.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.398 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -99.34 124.32 44.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.531 ' OD1' ' HB ' ' A' ' 130' ' ' VAL . 11.6 m-80 -136.19 157.8 45.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -174.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 12.3 m -107.94 123.29 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.196 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' A' ' 128' ' ' SER . 78.0 t -100.52 110.47 27.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.732 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -67.35 122.33 17.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 97' ' ' ARG . 17.1 m -127.45 -11.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 141.72 77.39 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.272 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 28.6 t -86.34 137.23 32.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.698 HD12 ' HB ' ' A' ' 24' ' ' VAL . 1.7 tm? -53.47 -54.01 43.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.042 -174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.662 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -73.81 -35.75 64.9 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.831 0.741 . . . . 0.0 109.936 172.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.12 171.9 12.84 Favored Glycine 0 C--O 1.253 1.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.076 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.4 m -111.37 130.26 55.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.651 -0.775 . . . . 0.0 110.904 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 68.0 m-85 -138.41 104.2 5.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.896 0.379 . . . . 0.0 110.859 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 137' ' ' VAL . 58.1 t -100.73 125.92 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 m120 64.53 22.89 12.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 61.79 38.2 15.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.764 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -142.35 144.63 31.81 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.76 122.54 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.423 2.082 . . . . 0.0 111.197 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 121' ' ' VAL . 19.3 m -114.74 171.51 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.6 t70 -111.93 -41.97 3.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.669 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.7 p -164.86 91.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.7 0.762 . . . . 0.0 110.21 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.95 128.13 53.09 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.307 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 9.1 p -73.01 154.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.429 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 108' ' ' PHE . 10.4 mp -62.25 165.7 5.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.52 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . . . -152.0 -176.78 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.3 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.31 90.94 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.825 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.55 4.89 37.09 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 119.922 -1.132 . . . . 0.0 114.538 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.645 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 2.4 t70 -93.99 166.59 12.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.954 0.877 . . . . 0.0 110.117 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 3.5 pt-20 -127.76 150.27 49.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.768 HG13 HG22 ' A' ' 121' ' ' VAL . 38.5 t -125.97 141.92 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.62 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -99.69 125.58 45.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.045 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.15 131.53 45.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 169.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.07 -76.33 1.07 Allowed Glycine 0 C--O 1.222 -0.649 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.949 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.912 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 7.4 pttt -171.93 28.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 111.08 171.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.811 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.24 143.51 44.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.583 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.427 ' HD3' ' OE1' ' A' ' 136' ' ' GLU . 7.0 ttm180 -90.67 100.81 13.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.0 mp -93.93 158.47 15.63 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.7 143.14 27.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.971 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -107.08 147.16 30.34 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.28 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 146' ' ' PHE . 3.1 mm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.543 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 93' ' ' THR . 74.6 m . . . . . 0 CA--C 1.518 -0.272 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.5 p -140.81 150.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.924 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' H ' ' HD2' ' A' ' 141' ' ' LYS . 8.5 t80 -176.73 -139.65 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.548 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.773 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 124.001 0.921 . . . . 0.0 110.614 -177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.577 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -126.42 172.29 10.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.708 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.2 pt? -161.24 139.44 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 118.296 -1.362 . . . . 0.0 114.454 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 72' ' ' LEU . 2.7 mp -85.86 112.35 21.05 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.991 167.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 69' ' ' ARG . 62.1 t -101.46 125.31 55.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.032 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -70.46 109.89 3.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.396 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.89 -44.36 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.184 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -155.18 143.77 20.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 172.49 -155.45 23.32 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.081 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 24.7 Cg_exo -63.87 -59.96 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.061 1.841 . . . . 0.0 111.958 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.742 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 48.2 t30 -75.67 -49.94 16.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.655 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.96 164.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.403 -174.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 2.71 90.61 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.723 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.939 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.6 m -101.45 -169.05 1.64 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 117.6 0.7 . . . . 0.0 110.616 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.79 160.08 5.48 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -171.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.6 m-30 -96.48 127.88 42.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 167.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.3 tm? -80.77 97.34 7.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.708 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.5 mt -94.13 46.29 1.16 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.553 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 13.0 t70 -100.48 -19.15 16.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.756 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.58 -166.66 1.26 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.615 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.1 36.53 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.552 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -157.79 120.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.034 -175.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 8.7 p -113.41 119.86 39.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 87' ' ' ILE . 15.2 m -66.04 128.56 36.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -125.98 107.56 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -166.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.31 -132.97 2.85 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.854 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.855 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.49 110.56 6.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.828 0.823 . . . . 0.0 108.946 173.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -162.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.443 0.64 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -124.12 117.38 50.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.622 -174.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -115.57 127.48 55.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.036 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.854 HD21 HG11 ' A' ' 60' ' ' VAL . 11.5 mt -115.91 80.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.1 t70 70.02 -8.49 0.82 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p-10 43.6 32.41 0.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.396 1.479 . . . . 0.0 113.105 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 23' ' ' SER . 26.0 t -138.8 -9.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.428 -176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -110.56 -13.55 14.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.465 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.819 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -118.58 146.74 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.679 -171.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 27.1 m -71.59 75.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.999 0.428 . . . . 0.0 109.924 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.84 -61.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.319 -172.024 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -153.7 139.53 18.08 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.687 0.756 . . . . 0.0 110.967 177.008 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.663 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -69.51 -40.3 77.04 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.227 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -158.26 179.27 9.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.474 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.44 131.27 22.86 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -59.64 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.291 -175.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG3' ' HG2' ' A' ' 104' ' ' GLU . 3.0 tpp180 -89.98 100.4 13.23 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.239 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.825 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.6 tt -77.63 110.87 12.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 77.5 mm-40 -131.98 138.81 48.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.459 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 59.32 31.35 21.07 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.583 0.552 . . . . 0.0 110.11 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HD21 ' A' ' 103' ' ' LEU . 47.1 m-80 70.19 3.21 4.3 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.877 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.63 149.19 22.06 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.501 ' HD1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -93.8 124.08 37.57 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' HG22 ' A' ' 130' ' ' VAL . 12.9 m-80 -133.55 154.6 50.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.412 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 128' ' ' SER . 14.0 m -107.87 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.203 0.525 . . . . 0.0 110.867 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 128' ' ' SER . 84.1 t -101.22 111.47 31.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.833 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 119.52 12.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 111' ' ' VAL . 15.7 m -120.48 -11.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.432 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 146.36 71.47 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.354 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 98' ' ' HIS . 4.5 m -84.97 132.13 34.39 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 24' ' ' VAL . 41.2 tp -60.94 -56.65 18.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.166 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -72.92 -35.78 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.38 0.61 . . . . 0.0 109.745 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.0 169.15 11.98 Favored Glycine 0 C--O 1.256 1.525 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.26 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -113.82 125.85 54.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.382 -0.909 . . . . 0.0 110.969 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -132.75 105.7 7.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.03 0.443 . . . . 0.0 110.906 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 137' ' ' VAL . 45.7 t -101.44 110.3 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 15.2 m120 56.73 38.38 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.132 0.492 . . . . 0.0 110.484 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 9.6 mmm180 77.43 1.87 3.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.389 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.7 pt-20 -126.83 130.89 23.72 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.474 0.654 . . . . 0.0 111.442 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 23.2 Cg_exo -65.6 125.85 15.1 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 129' ' ' ALA . 27.8 m -115.54 165.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 111.701 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 m-20 -82.81 -51.83 7.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 171.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.3 p -160.31 91.03 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.554 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 126' ' ' VAL . . . -86.07 141.86 29.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.301 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 109' ' ' ASN . 39.7 t -78.32 124.17 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.956 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -59.28 156.18 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.342 0.401 . . . . 0.0 111.659 176.242 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.472 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -157.02 154.71 30.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -69.12 98.82 1.04 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.878 0.37 . . . . 0.0 110.011 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.23 0.84 29.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.06 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 17.2 t70 -69.17 148.87 49.28 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 9.0 tt0 -135.9 127.15 28.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.607 0.718 . . . . 0.0 111.824 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -123.64 133.19 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.568 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -94.27 128.55 40.82 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.716 HG23 HD13 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -134.65 140.87 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 173.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 73.5 -68.12 1.52 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.231 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.081 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.7 ptmt -176.2 22.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.416 0.686 . . . . 0.0 109.345 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.742 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -123.15 161.83 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -171.124 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.41 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 26.9 ttp85 -112.18 119.59 38.91 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.434 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.828 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -109.5 154.11 23.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.411 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -141.26 139.87 32.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.155 171.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.654 ' O ' HD13 ' A' ' 147' ' ' LEU . 47.0 t80 -98.21 138.55 35.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.812 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.318 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 93' ' ' THR . 16.3 m . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 120.874 0.369 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HB ' HD21 ' A' ' 116' ' ' LEU . 14.7 p -138.7 135.89 43.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.646 -168.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 2.2 t80 173.34 -170.64 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.352 0.261 . . . . 0.0 110.759 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.466 0.706 . . . . 0.0 111.284 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -123.77 172.8 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -155.06 144.27 21.05 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 117.566 -1.654 . . . . 0.0 114.743 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -93.56 112.57 24.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.807 166.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 5.9 p -111.97 131.67 62.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.695 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -76.51 110.48 11.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -72.33 -58.59 3.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.343 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -145.07 131.8 20.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.717 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.01 -174.34 38.77 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.921 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 44.7 Cg_exo -56.59 -47.55 23.21 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.964 1.776 . . . . 0.0 113.015 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 2.9 t-20 -82.91 -51.76 7.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.815 0.816 . . . . 0.0 108.817 172.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.636 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 54.91 170.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.079 -171.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.79 2.5 90.56 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.778 -0.725 . . . . 0.0 114.057 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.976 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.2 m -99.91 179.32 4.55 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 117.901 0.85 . . . . 0.0 110.653 -170.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.689 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.81 154.7 4.41 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.008 0.367 . . . . 0.0 111.821 -175.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -93.54 116.26 28.78 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 171.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.8 tt -74.27 97.19 2.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 124.403 1.064 . . . . 0.0 108.809 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 58' ' ' LEU . 12.5 mt -91.19 32.27 1.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.786 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -88.69 -15.71 34.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -87.72 -167.08 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.375 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.68 -30.87 16.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.0 109.802 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -160.98 133.1 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 176.48 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 23.1 p -121.51 147.89 45.19 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.899 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.632 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -93.63 126.54 38.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.83 128.87 56.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -173.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.33 -117.0 1.1 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.109 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -101.55 101.69 12.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 32.9 m80 . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 10.9 m-20 . . . . . 0 CA--C 1.521 -0.136 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -132.54 97.65 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.078 0.942 . . . . 0.0 110.203 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.441 ' C ' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -110.74 130.26 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.33 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 60' ' ' VAL . 4.5 mm? -116.2 76.09 1.0 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.94 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 67.98 -0.64 1.99 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.644 0.735 . . . . 0.0 110.019 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.3 p-10 35.67 44.0 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.306 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . 9.9 p -151.85 2.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.396 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 23' ' ' SER . 18.9 p -111.85 -7.95 14.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.849 -0.532 . . . . 0.0 112.045 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.9 t -126.81 147.3 31.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 O-C-N 122.043 -0.41 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 m -71.01 73.76 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.4 -61.59 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.292 -165.494 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 40.9 ttm180 -145.39 132.3 20.19 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.276 -0.89 . . . . 0.0 111.603 -163.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.867 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -87.92 -46.78 9.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.514 170.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.73 158.38 43.86 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.201 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 97' ' ' ARG . 7.8 pt-20 -124.27 130.96 53.42 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 166.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.07 95.97 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.272 -174.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -92.87 106.48 18.44 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.235 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 106' ' ' ASN . 9.3 tt -76.24 109.11 9.65 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.23 136.17 50.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.923 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 60.03 31.83 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.888 ' HA ' HD21 ' A' ' 103' ' ' LEU . 67.3 m-20 63.5 15.36 8.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.415 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -114.15 156.36 24.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.882 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -94.68 133.52 38.27 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.447 ' OD1' HG22 ' A' ' 130' ' ' VAL . 14.5 m-80 -139.91 159.49 42.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -107.79 126.3 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.267 171.061 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 34.2 m -101.92 123.64 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.684 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.93 126.35 30.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.819 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.77 -3.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 110.619 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 121.45 91.6 1.16 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.402 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 18.1 t -98.83 134.97 40.95 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' A' ' 24' ' ' VAL . 20.4 tp -52.47 -58.15 7.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 11.5 m-80 -70.6 -37.61 73.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.69 8.28 Favored Glycine 0 C--O 1.242 0.646 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.54 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.519 HG23 ' CE1' ' A' ' 98' ' ' HIS . 15.6 m -112.13 132.92 54.58 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.795 0.438 . . . . 0.0 111.148 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -141.29 140.14 33.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.655 0.264 . . . . 0.0 110.557 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 137' ' ' VAL . 73.1 t -127.89 107.63 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.425 ' HA ' ' OE2' ' A' ' 136' ' ' GLU . 5.0 m-20 64.0 35.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 109.386 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 59.42 30.18 19.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.926 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.8 pt-20 -139.62 128.06 13.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.43 122.66 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.142 1.895 . . . . 0.0 110.955 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.36 162.1 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 14.0 m-20 -72.16 -59.02 2.95 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 46.7 t -159.64 109.63 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.02 141.93 47.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 ' OD1' ' A' ' 109' ' ' ASN . 4.1 t -74.28 142.34 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.596 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.1 mp -51.0 150.93 2.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 111.489 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -134.33 -176.47 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.55 98.75 8.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.655 0.264 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.5 4.42 40.29 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.1 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.934 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 19.7 m-20 -101.81 157.84 16.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.134 0.467 . . . . 0.0 110.331 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -105.22 162.04 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 121' ' ' VAL . 47.7 t -136.22 126.57 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.595 172.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 111.35 23.77 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.933 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.867 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -111.95 134.97 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 61.64 -101.4 0.34 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.921 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 15.2 ptmt -141.64 19.36 2.18 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.76 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.678 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 m-85 -112.3 144.31 41.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.509 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -92.4 87.1 5.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -83.14 160.82 21.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.026 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.88 139.2 31.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.004 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -97.53 141.87 30.05 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.213 178.438 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.48 ' CD2' HG22 ' A' ' 145' ' ' VAL . 2.7 mm? . . . . . 0 N--CA 1.447 -0.593 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.422 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.758 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 43.1 m . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.02 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . 8.1 t -110.92 131.86 60.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.11 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 20.6 t80 175.73 -177.38 0.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 173.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.633 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 C-N-CA 124.233 1.013 . . . . 0.0 111.21 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.21 172.78 9.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.732 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 1.8 pt? -160.76 142.05 11.96 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.81 -1.556 . . . . 0.0 114.964 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.2 mp -85.69 117.35 24.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.95 167.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.08 129.0 63.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.934 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -71.5 109.86 4.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.1 -67.37 0.44 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.048 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -145.26 125.23 13.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.726 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.758 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -163.27 -140.33 2.85 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.995 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 21.5 Cg_exo -66.87 -69.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.67 2.246 . . . . 0.0 112.446 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.752 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.5 t30 -69.09 -48.22 63.19 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.01 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.671 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.3 2.11 90.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.221 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.0 m -86.76 -179.86 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.316 0.558 . . . . 0.0 110.287 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.66 150.15 3.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.596 0.635 . . . . 0.0 112.412 -172.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -94.47 120.39 34.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.625 ' O ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -80.92 91.37 6.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.145 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.732 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.8 mt -83.38 52.12 2.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.063 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.614 ' HB2' HD21 ' A' ' 71' ' ' LEU . 17.7 t70 -96.36 -37.85 10.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.574 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -96.51 -166.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.774 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.22 39.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -154.0 123.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.634 0.73 . . . . 0.0 112.546 -177.165 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 65.2 p -103.99 138.74 40.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.519 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 48.8 m -82.05 124.88 30.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.688 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.77 114.77 21.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -171.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.716 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 152.25 -140.31 7.63 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -70.68 104.04 2.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 26.3 m170 . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.821 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 7.1 m-20 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.688 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -126.48 105.33 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.647 0.737 . . . . 0.0 111.124 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -103.89 134.44 47.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.647 177.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.049 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -118.6 77.14 1.14 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.738 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.6 t70 67.81 -18.5 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.473 0.654 . . . . 0.0 111.267 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 33.1 t70 67.05 24.13 9.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.429 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.758 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.8 p -156.47 53.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 122.296 1.046 . . . . 0.0 110.769 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -152.81 0.06 0.27 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.123 172.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.714 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.8 t -137.23 140.49 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.218 -173.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m -73.68 74.03 1.52 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.238 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HD3' ' HD2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER 66.96 -66.64 0.18 Allowed 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.248 -173.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.423 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -139.57 144.1 37.64 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.702 -0.624 . . . . 0.0 110.523 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.96 -41.39 12.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.854 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.17 165.54 28.02 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.396 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.9 pt-20 -132.69 127.04 33.94 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.715 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -58.28 100.73 0.07 Allowed 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.692 -174.318 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -94.62 100.35 12.32 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.735 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -79.48 104.6 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.128 175.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -134.75 140.67 46.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.717 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 62.34 32.13 17.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.397 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.657 ' HA ' HD21 ' A' ' 103' ' ' LEU . 43.2 m-80 64.58 15.01 9.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.882 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -121.86 146.43 47.1 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.873 0.368 . . . . 0.0 110.809 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -85.8 122.14 29.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.534 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 2.3 m120 -123.87 166.16 16.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.8 m -115.65 128.53 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.245 172.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.8 t -101.51 111.87 32.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.298 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.77 119.88 21.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.564 HG13 HG12 ' A' ' 111' ' ' VAL . 35.6 m -116.59 -27.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 111.085 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.23 105.97 0.43 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.797 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.9 t -101.48 146.88 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.264 0.226 . . . . 0.0 110.6 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.52 -55.76 29.52 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.628 0.252 . . . . 0.0 110.904 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 1.02 ' ND2' ' HA ' ' A' ' 24' ' ' VAL . 10.9 m120 -74.05 -36.42 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.22 160.82 8.6 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.559 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.2 m -112.81 132.5 55.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.616 0.367 . . . . 0.0 111.727 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.823 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 57.0 m-85 -141.37 105.38 4.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.995 0.426 . . . . 0.0 110.683 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 137' ' ' VAL . 88.0 t -92.04 114.24 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.17 36.98 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.823 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 35.0 mtp-105 53.85 31.99 14.21 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.974 -172.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.7 pt-20 -141.8 137.86 16.56 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 109.979 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.95 122.93 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.09 1.86 . . . . 0.0 111.8 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.0 m -116.93 176.89 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.561 0.219 . . . . 0.0 110.806 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 27.2 t70 -94.75 -66.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 43.4 t -153.15 92.45 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.82 142.41 29.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.023 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -79.45 129.83 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.09 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.725 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 1.0 OUTLIER -59.78 163.75 4.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -167.96 168.99 11.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -61.44 115.52 3.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.849 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.51 5.24 72.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.319 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.5 108.96 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 110.453 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 8.2 tt0 -94.79 131.8 40.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -124.14 130.84 73.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -101.24 121.68 42.3 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.904 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.049 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.52 140.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.219 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 58.12 -98.87 0.1 OUTLIER Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.3 -0.952 . . . . 0.0 110.869 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.995 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.2 ptmt -140.85 18.22 2.32 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.235 0.54 . . . . 0.0 111.096 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.752 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -110.42 150.29 29.04 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -107.37 105.46 15.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' A' ' 60' ' ' VAL . 5.3 mp -98.71 157.51 16.22 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.505 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.78 141.32 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.106 169.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.725 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 37.3 t80 -100.07 137.65 38.23 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.207 170.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.238 0.462 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 54.4 t -68.47 143.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.822 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 16.7 t80 174.29 -177.9 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.418 0.449 . . . . 0.0 110.794 168.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.792 HH22 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.933 0.893 . . . . 0.0 111.819 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.88 171.79 10.43 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.7 pp -155.0 137.91 15.43 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 117.541 -1.664 . . . . 0.0 114.93 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 131' ' ' LEU . 1.3 mp -85.29 110.88 19.39 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.457 162.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 57' ' ' LEU . 5.8 p -105.41 127.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.086 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.924 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -71.44 108.97 3.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 175.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.94 -57.5 6.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.604 -1.634 . . . . 0.0 109.881 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -150.7 131.06 13.71 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.304 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -169.93 -161.18 19.94 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.103 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 31.2 Cg_exo -60.55 -51.92 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.974 1.782 . . . . 0.0 113.055 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 63.9 t30 -78.2 -49.29 14.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.6 158.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.956 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.66 89.82 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.924 ' H ' HG22 ' A' ' 60' ' ' VAL . 12.3 t -98.49 -178.01 3.87 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.343 1.071 . . . . 0.0 110.811 -173.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.24 156.68 5.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.283 0.492 . . . . 0.0 112.112 -173.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.77 113.47 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 170.316 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 1.3 pt? -79.65 92.61 5.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.067 1.413 . . . . 0.0 108.609 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.592 HD13 ' CB ' ' A' ' 108' ' ' PHE . 12.1 mt -74.18 46.51 0.25 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.009 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 35.2 t70 -94.73 -25.49 16.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.743 0.782 . . . . 0.0 109.173 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -84.61 -167.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.745 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.67 -30.08 22.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.54 137.66 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.478 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 59.7 p -128.51 132.79 48.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.753 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.817 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 35.8 m -82.55 125.53 31.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 110.419 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' A' ' 87' ' ' ILE . . . -122.54 117.41 25.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.523 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 154.83 -82.72 0.16 Allowed Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.182 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -124.6 103.1 7.95 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.817 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.268 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.471 -171.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.386 0.612 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.42 109.83 28.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.667 0.746 . . . . 0.0 110.481 -177.489 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -116.17 135.07 54.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.979 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -122.37 74.04 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.652 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 39.0 t70 75.28 -22.49 0.26 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.488 0.661 . . . . 0.0 111.01 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 30.0 t70 59.68 36.19 22.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.036 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HB ' ' OD2' ' A' ' 90' ' ' ASP . 41.6 t -137.87 -10.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.626 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.433 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 31.3 p -106.98 -24.48 11.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.7 t -118.59 147.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -169.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -76.12 81.31 2.94 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.053 -0.404 . . . . 0.0 110.228 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HG3' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 67.28 -69.4 0.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.567 -173.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -156.04 142.28 18.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.566 0.698 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.806 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -79.46 -42.26 25.72 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.396 172.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.829 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.62 153.6 44.86 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.067 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' A' ' 76' ' ' ILE . 5.4 pt-20 -115.51 126.92 54.88 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 166.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.84 98.99 0.11 Allowed 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.552 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.477 HH21 ' CD ' ' A' ' 100' ' ' GLU . 19.9 tpp85 -90.07 101.13 13.85 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.019 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -83.2 110.76 18.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -132.21 128.35 37.75 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.115 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 60.64 36.97 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.053 0.454 . . . . 0.0 110.484 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.842 ' HA ' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER 69.3 8.44 6.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.773 178.083 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 26.0 mm-40 -109.21 140.83 42.32 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.906 -0.496 . . . . 0.0 110.935 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.592 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -90.07 127.8 36.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.808 -177.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -127.03 159.99 32.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.34 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -106.27 124.79 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 169.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.3 t -102.75 113.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.889 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' THR . 18.2 t0 -70.93 118.26 13.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.514 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.815 HG13 HG12 ' A' ' 111' ' ' VAL . 11.1 m -122.93 -37.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.77 79.68 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.099 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 25.7 t -93.34 122.98 36.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -45.45 90.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.592 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 23.8 m-80 -82.52 -36.72 26.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 110.128 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 146.2 152.2 5.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 112' ' ' ASP . 17.1 m -111.87 128.44 56.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 23.3 m-85 -139.01 146.58 41.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 173.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 137' ' ' VAL . 97.0 t -134.3 106.6 8.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 64.18 41.0 6.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -174.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 63.97 17.23 10.45 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.009 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.5 pt-20 -134.61 126.15 17.93 Favored Pre-proline 0 C--N 1.331 -0.218 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.89 122.34 9.46 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.294 1.996 . . . . 0.0 111.712 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.5 m -111.97 178.74 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 110.707 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.2 p-10 -101.86 -46.77 4.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.729 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 17.4 p -159.17 94.32 1.19 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.019 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.18 144.34 30.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.96 131.29 35.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.127 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -61.03 155.18 20.83 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.846 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -156.31 156.81 34.63 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.182 0.515 . . . . 0.0 111.738 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.27 111.02 2.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.702 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.88 1.58 59.85 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.839 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 15.6 t70 -72.29 128.45 35.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.618 0.247 . . . . 0.0 110.761 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.461 ' OE1' ' HD3' ' A' ' 143' ' ' ARG . 7.1 tt0 -112.81 129.56 56.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.401 0.62 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 121' ' ' VAL . 44.7 t -124.83 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.378 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -102.44 118.53 37.06 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.956 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -117.53 125.4 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 63.88 -103.03 0.63 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.101 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.103 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 10.1 pttt -143.02 24.75 1.81 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.283 0.563 . . . . 0.0 111.424 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.37 136.7 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -175.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.792 ' HB2' HH22 ' A' ' 26' ' ' ARG . 7.2 ttm180 -89.47 109.31 20.25 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.94 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 60' ' ' VAL . 6.7 mp -98.9 159.22 15.11 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.146 0.498 . . . . 0.0 111.825 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -141.76 140.99 30.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.004 166.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.622 ' O ' HD22 ' A' ' 147' ' ' LEU . 47.7 t80 -97.03 132.38 42.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 169.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 116' ' ' LEU . 1.4 p -143.42 157.31 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 O-C-N 121.259 -0.901 . . . . 0.0 112.42 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -172.76 -143.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.548 HH21 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-N 118.365 0.529 . . . . 0.0 109.948 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.603 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -125.84 169.12 12.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.462 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -153.68 129.78 10.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.064 -1.054 . . . . 0.0 113.698 -173.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.028 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.8 mp -86.61 137.74 32.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.904 162.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 4.2 p -131.82 128.96 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.431 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -72.98 109.78 5.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.022 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -64.27 -70.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 113.079 -1.873 . . . . 0.0 110.413 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 62' ' ' ARG . 14.0 mtp85 -148.54 138.03 21.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.476 0.655 . . . . 0.0 109.781 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -162.28 -127.02 0.85 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.824 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 3.8 Cg_endo -89.18 -62.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.9 0 C-N-CA 122.163 1.909 . . . . 0.0 111.442 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.682 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -69.42 -53.35 19.75 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.18 174.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.113 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.73 89.52 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.871 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.5 m -96.87 179.61 4.9 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 117.308 0.554 . . . . 0.0 111.017 -169.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.75 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -168.5 147.2 4.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -169.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.845 ' HD2' ' HB2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -97.26 121.07 38.74 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.0 tt -83.68 101.38 11.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.662 0.744 . . . . 0.0 110.218 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -92.99 41.51 1.08 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.438 0.637 . . . . 0.0 110.254 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' A' ' 71' ' ' LEU . 25.2 t70 -92.0 -26.24 18.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.792 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.03 178.99 4.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.481 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.78 -44.46 81.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -162.56 128.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.933 -174.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 p -113.8 121.6 44.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.133 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 65.4 m -64.86 126.14 27.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.964 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.59 115.98 25.09 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.663 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 149.39 -142.96 10.28 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.12 104.38 3.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 109.966 173.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.564 ' NE2' ' HD3' ' A' ' 96' ' ' ARG . 34.6 m80 . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 CA--C 1.515 -0.399 0 CA-C-O 121.41 0.624 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -101.05 94.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.0 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -100.07 134.92 42.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.817 174.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.024 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -117.02 75.21 0.96 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.2 t70 58.92 15.75 4.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.74 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 2.3 p30 46.12 -73.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.285 1.434 . . . . 0.0 113.696 -170.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 92' ' ' VAL . 12.7 p -73.63 64.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -156.08 -1.24 0.13 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.263 164.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.581 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 9.2 t -131.7 137.83 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.125 -0.36 . . . . 0.0 110.732 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 19.4 m -72.48 71.22 0.93 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.564 ' HD3' ' NE2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 68.55 -59.63 0.45 Allowed 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.822 -174.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.518 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.0 ptp85 -149.31 138.67 21.53 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.661 -0.649 . . . . 0.0 110.625 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.705 ' CB ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -70.58 -43.16 69.98 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.46 175.12 13.68 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 112.704 -2.043 . . . . 0.0 108.949 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.691 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -128.37 115.05 17.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 1.041 ' HD1' HG13 ' A' ' 110' ' ' VAL . 2.4 t80 -78.07 91.46 4.28 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.877 0.846 . . . . 0.0 108.719 -171.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.69 ' HB3' HG13 ' A' ' 76' ' ' ILE . 12.8 ptp180 -101.54 140.3 36.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.343 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -83.25 112.29 19.74 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.501 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.35 139.75 39.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 36.2 m-80 62.51 32.52 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.704 ' HA ' HD21 ' A' ' 103' ' ' LEU . 6.8 t30 72.03 -0.1 3.35 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.568 0.747 . . . . 0.0 111.517 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 12.9 mm-40 -111.62 142.54 43.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.544 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.62 128.9 36.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.024 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 18.0 m-80 -138.05 161.86 35.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 1.041 HG13 ' HD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -104.54 117.34 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 117.962 0.346 . . . . 0.0 111.019 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.588 HG21 ' HD2' ' A' ' 102' ' ' ARG . 76.5 t -99.03 110.17 25.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -70.27 135.38 48.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.49 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 27.2 m -135.61 7.62 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.112 0.482 . . . . 0.0 109.78 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 102.96 107.19 3.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.292 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 25.6 t -102.35 157.26 17.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.661 HD12 ' HB ' ' A' ' 24' ' ' VAL . 1.6 tm? -58.13 -53.18 61.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.773 -174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.617 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -70.62 -36.03 73.25 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.725 0.774 . . . . 0.0 109.014 172.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 115' ' ' SER . . . 132.35 177.55 14.98 Favored Glycine 0 C--O 1.25 1.095 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.214 -173.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 98' ' ' HIS . 5.6 m -111.57 136.68 50.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.901 0.48 . . . . 0.0 111.474 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.9 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 22.8 m-85 -139.57 132.8 29.83 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.84 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 137' ' ' VAL . 84.6 t -129.3 121.69 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.75 32.6 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 56.89 26.36 11.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.595 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.0 pt-20 -137.86 143.21 39.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.426 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 20.2 Cg_exo -66.99 123.26 10.74 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.847 2.364 . . . . 0.0 112.348 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.43 175.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 p-10 -103.35 -49.94 3.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.12 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.87 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 33.3 t -157.72 91.44 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.41 137.81 36.57 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.025 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.411 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 7.4 p -80.57 143.16 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.784 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -49.44 133.19 20.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.227 174.197 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -128.38 -175.15 3.42 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -107.0 86.03 2.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.32 2.29 38.28 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.445 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.713 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 4.8 t70 -89.98 158.18 17.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.487 0.644 . . . . 0.0 109.744 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.5 pm0 -107.42 143.51 35.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.898 0.856 . . . . 0.0 113.209 -172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 121' ' ' VAL . 58.4 t -119.9 141.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.739 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.9 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 7.1 tp-100 -108.05 122.97 47.95 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.082 0.467 . . . . 0.0 110.186 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.024 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.92 139.99 50.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 168.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 63.27 -90.27 0.07 OUTLIER Glycine 0 C--O 1.208 -1.481 0 C-N-CA 119.717 -1.23 . . . . 0.0 112.322 173.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.824 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 14.8 ptmt -156.95 31.9 0.3 Allowed 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.519 -0.989 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -123.87 138.44 54.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.548 ' HB2' HH21 ' A' ' 26' ' ' ARG . 0.7 OUTLIER -89.5 108.84 19.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.08 161.05 13.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.41 143.45 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.028 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -109.34 144.6 37.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.528 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? . . . . . 0 N--CA 1.453 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' THR . 57.2 m . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.388 0.614 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 117' ' ' ASN . 14.1 p -127.87 141.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.482 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 t80 179.13 -168.1 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.903 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.8 tpt180 . . . . . 0 N--CA 1.475 0.821 0 O-C-N 123.876 0.735 . . . . 0.0 110.542 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -136.19 170.15 16.48 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -161.29 145.2 13.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.6 mp -87.1 116.5 25.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.759 164.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -113.11 130.02 67.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 118.158 0.435 . . . . 0.0 110.522 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.001 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.16 109.38 3.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -62.46 -54.46 39.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.216 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -165.42 106.94 0.77 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.989 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -127.68 -133.07 3.69 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.076 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 82.4 Cg_endo -76.0 -64.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.34 2.027 . . . . 0.0 112.191 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.916 ' HB3' ' HE2' ' A' ' 142' ' ' PHE . 66.5 t30 -70.13 -47.3 62.29 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 60.31 166.94 0.08 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.847 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.35 4.45 89.95 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.77 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.001 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -101.92 179.18 4.4 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 117.651 0.726 . . . . 0.0 110.655 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.49 154.98 3.29 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.802 0.728 . . . . 0.0 112.24 -172.623 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.15 127.94 41.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.5 tt -87.82 91.82 8.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.72 0.771 . . . . 0.0 109.534 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.812 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -85.39 55.78 3.66 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.512 ' HB3' HD21 ' A' ' 71' ' ' LEU . 16.7 t70 -108.75 -23.94 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.869 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -103.77 -166.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.52 -41.17 69.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.3 129.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.463 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 71.8 p -113.2 126.02 54.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 87' ' ' ILE . 39.1 m -68.29 126.58 30.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.54 108.65 13.38 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 165.45 -139.3 5.72 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.095 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.98 103.88 7.16 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 11.5 m-70 . . . . . 0 N--CA 1.436 -1.133 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.229 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 6.3 m-20 . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -115.44 110.95 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.0 0.905 . . . . 0.0 111.672 -171.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.33 114.61 28.43 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.714 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.778 HD12 HG12 ' A' ' 139' ' ' ILE . 4.7 mt -102.4 80.05 1.9 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.942 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 14.6 t70 70.11 -7.48 0.95 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.148 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.6 p30 39.47 36.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 113.075 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 23' ' ' SER . 41.1 t -148.42 -2.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 23' ' ' SER . 27.7 p -113.2 -34.92 5.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -116.72 154.6 18.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 122.116 -0.365 . . . . 0.0 110.602 -171.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.1 m -68.41 72.79 0.21 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.706 0.403 . . . . 0.0 112.049 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 59.36 -49.31 0.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.054 0.942 . . . . 0.0 112.709 -173.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.767 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 10.3 ptp85 -149.42 141.85 24.28 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.691 -0.631 . . . . 0.0 110.308 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.85 -41.3 12.55 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.911 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -140.26 170.55 15.61 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.808 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.6 pt-20 -137.45 123.27 20.03 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.812 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -55.52 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 124.413 1.071 . . . . 0.0 108.931 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.465 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -94.14 98.04 10.7 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.939 -174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -78.95 104.8 9.83 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.817 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.63 134.99 54.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.3 OUTLIER 40.75 47.24 2.43 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.313 1.008 . . . . 0.0 112.092 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.737 ' HA ' HD21 ' A' ' 103' ' ' LEU . 3.6 m-20 76.55 2.18 3.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.693 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 50.2 mt-10 -106.28 141.3 37.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.807 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.627 ' CB ' HD23 ' A' ' 72' ' ' LEU . 1.1 m-85 -89.05 126.99 35.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' ' 130' ' ' VAL . 24.4 m-80 -132.12 160.29 36.43 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.718 0.294 . . . . 0.0 110.576 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 128' ' ' SER . 5.6 m -111.76 126.96 69.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.016 0.436 . . . . 0.0 110.211 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.911 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 3.8 t -101.38 112.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.354 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 13.4 t0 -74.78 128.64 36.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.515 HG21 ' HG3' ' A' ' 97' ' ' ARG . 36.0 m -128.04 4.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 109.608 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.17 87.63 2.01 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.282 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.745 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.4 t -87.79 141.01 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.15 -57.26 11.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.711 HD21 ' HA2' ' A' ' 140' ' ' GLY . 1.8 p30 -65.91 -37.79 87.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.642 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.11 164.06 9.84 Favored Glycine 0 C--O 1.262 1.847 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.724 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.533 HG23 ' CE1' ' A' ' 98' ' ' HIS . 17.7 m -113.82 129.27 56.61 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.239 -1.481 . . . . 0.0 110.297 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 14.0 m-85 -141.63 105.22 4.69 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 111.67 173.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 1.088 HG22 HG23 ' A' ' 137' ' ' VAL . 52.5 t -100.33 127.11 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 4.4 m-20 63.22 25.61 14.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 63.05 13.8 7.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.834 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.85 156.88 58.7 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 120.762 0.315 . . . . 0.0 110.385 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.75 131.85 12.66 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.44 2.093 . . . . 0.0 112.645 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.26 176.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 10.0 m-20 -120.1 -31.34 4.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.56 174.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.858 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.0 p -161.63 91.48 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.509 0.671 . . . . 0.0 109.866 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -100.91 145.58 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.489 HG22 ' OD1' ' A' ' 109' ' ' ASN . 14.5 t -88.18 119.81 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.764 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -58.74 162.3 4.11 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -163.52 164.59 24.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.622 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -71.06 114.49 9.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.346 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.39 -7.96 51.77 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.856 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.49 110.64 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.621 0.369 . . . . 0.0 110.142 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -93.83 152.3 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.172 0.51 . . . . 0.0 112.251 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -133.4 141.24 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.653 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.1 tm0? -109.58 116.68 32.22 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 169.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.823 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -138.4 131.77 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.243 175.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.711 ' HA2' HD21 ' A' ' 117' ' ' ASN . . . 82.9 -56.88 5.07 Favored Glycine 0 C--N 1.317 -0.502 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.25 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.076 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 59.9 pttt 168.03 32.11 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.916 ' HE2' ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -114.5 161.52 17.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.232 -173.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.77 99.62 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 1.0 ' HB2' HG12 ' A' ' 137' ' ' VAL . 5.8 mp -88.83 163.54 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.365 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -141.53 140.29 31.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 166.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.764 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 45.9 t80 -100.04 143.08 30.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.402 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.76 170.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 93' ' ' THR . 70.4 m . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 12.3 p -127.64 147.18 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.986 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.3 t80 172.8 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.921 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 8.7 tpt180 . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 122.873 0.469 . . . . 0.0 109.931 172.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.87 170.63 14.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.5 pp -158.1 142.63 16.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.9 110.96 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.999 163.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 57' ' ' LEU . 4.9 p -107.94 124.81 64.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.351 0.596 . . . . 0.0 111.216 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.023 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -72.74 111.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.073 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.5 -70.12 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.708 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -142.99 128.11 18.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.607 0.717 . . . . 0.0 110.736 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -167.13 -153.69 8.07 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.01 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 52.9 Cg_exo -56.07 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 122.598 2.198 . . . . 0.0 113.052 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 8.1 t30 -70.39 -49.12 52.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.61 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.531 -173.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.08 0.07 84.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.316 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.897 ' H ' HG22 ' A' ' 60' ' ' VAL . 33.1 t -99.81 -171.59 2.08 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 118.412 1.106 . . . . 0.0 110.383 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.83 164.18 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -175.301 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HZ ' HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -95.95 129.13 43.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.596 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -85.94 96.54 9.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.761 0.791 . . . . 0.0 109.457 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.838 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -89.43 31.51 0.91 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.336 0.588 . . . . 0.0 109.703 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.0 -28.63 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.697 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' NE2' HG22 ' A' ' 77' ' ' THR . 13.2 pt20 -95.72 -166.35 1.43 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.747 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.86 -38.05 46.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -162.07 135.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 111.937 -177.089 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 54.1 p -123.77 133.28 53.86 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.58 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.735 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 44.3 m -76.84 126.08 30.38 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.45 112.4 19.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -167.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.624 ' HA3' HG11 ' A' ' 94' ' ' VAL . . . 156.56 -88.92 0.12 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.887 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -108.44 104.41 13.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.702 0.763 . . . . 0.0 109.002 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.735 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.289 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.29 109.91 29.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.44 0.638 . . . . 0.0 111.574 -171.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.85 127.22 47.4 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.984 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.023 HD21 HG11 ' A' ' 60' ' ' VAL . 8.1 mt -121.1 82.78 1.97 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.077 170.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.26 -11.16 0.72 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.082 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.9 p30 40.23 32.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.489 1.515 . . . . 0.0 112.781 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.93 -9.28 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.84 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.675 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -112.64 -9.94 13.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -172.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.624 HG11 ' HA3' ' A' ' 80' ' ' GLY . 3.4 t -122.41 147.1 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.941 -0.474 . . . . 0.0 110.836 -171.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.9 t -77.39 73.49 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.5 OUTLIER 58.52 -58.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.788 -166.267 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 10.0 ptp85 -142.58 136.5 29.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.635 0.731 . . . . 0.0 111.35 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -78.06 -37.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.22 177.75 10.72 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.323 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 77' ' ' THR . 5.1 pt-20 -133.98 134.46 42.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.838 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -64.18 104.08 0.7 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.61 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 23.1 ttm180 -105.16 112.34 25.43 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.646 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.6 tt -84.28 103.77 13.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.577 0.704 . . . . 0.0 110.033 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.61 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 43.2 mt-10 -128.08 141.41 51.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 37.3 m-20 62.56 30.98 17.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.802 ' HA ' HD21 ' A' ' 103' ' ' LEU . 16.0 m120 62.15 11.97 4.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.253 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 9.3 pt-20 -117.56 147.11 43.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.645 ' CB ' HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -93.19 119.38 32.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.8 -174.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 2.4 m120 -123.61 163.02 21.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -107.75 118.49 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.982 170.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 83.5 t -99.41 110.72 27.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.27 136.75 55.41 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.581 0.551 . . . . 0.0 110.047 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 97' ' ' ARG . 24.2 m -133.69 3.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.093 0.473 . . . . 0.0 110.173 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.33 110.49 2.24 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.307 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.59 ' HB3' ' HA ' ' A' ' 98' ' ' HIS . 24.3 p -109.61 169.91 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD23 ' HB ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -64.26 -55.17 23.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.506 -175.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.53 HD21 ' H ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -66.62 -37.45 84.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.97 161.32 10.58 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 121.438 0.465 . . . . 0.0 113.321 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.3 m -112.13 131.21 55.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.954 0.901 . . . . 0.0 111.274 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -141.8 104.95 4.61 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.503 0.192 . . . . 0.0 111.483 175.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 137' ' ' VAL . 93.6 t -102.6 119.82 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.964 -0.46 . . . . 0.0 109.97 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 59.3 37.5 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.481 ' HA ' ' HD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 64.06 25.11 13.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -176.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.55 133.09 8.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.811 -0.556 . . . . 0.0 110.867 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.78 122.64 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.099 1.866 . . . . 0.0 111.547 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.605 HG13 ' HB ' ' A' ' 121' ' ' VAL . 26.1 m -106.29 179.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 111.309 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 24.2 t70 -108.95 -40.97 4.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.0 t -165.14 91.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.0 124.0 40.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.585 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.6 p -70.69 144.16 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.557 0.694 . . . . 0.0 111.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 1.1 tt -52.05 134.53 32.27 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.592 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -127.59 -176.25 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.66 88.47 2.93 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.015 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.86 -16.82 30.54 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.6 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.902 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 4.2 m-20 -68.85 155.08 40.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.133 0.492 . . . . 0.0 110.786 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -110.1 156.2 20.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 112.566 -170.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.98 HG13 HG22 ' A' ' 121' ' ' VAL . 47.0 t -135.39 132.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.04 118.07 33.8 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.641 ' CG1' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -128.96 131.35 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.368 173.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.62 ' CA ' HG22 ' A' ' 94' ' ' VAL . . . 82.03 -55.76 4.93 Favored Glycine 0 C--N 1.322 -0.231 0 C-N-CA 119.315 -1.421 . . . . 0.0 112.944 167.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.01 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 58.5 pttt 169.21 32.36 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 124.406 1.083 . . . . 0.0 109.082 163.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.808 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.08 150.96 44.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -169.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -93.2 92.15 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.0 mp -88.48 158.34 18.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.204 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.654 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.97 143.09 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.225 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.958 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -108.49 143.89 36.86 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.742 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? . . . . . 0 C--O 1.234 0.237 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 93' ' ' THR . 69.1 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.179 0.514 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 116' ' ' LEU . 8.0 p -135.36 147.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.315 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -177.35 -160.06 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.071 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.844 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 O-C-N 124.222 0.951 . . . . 0.0 110.676 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.78 168.7 13.44 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -161.01 146.18 14.13 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.049 -1.06 . . . . 0.0 113.537 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.572 HD21 ' CG1' ' A' ' 110' ' ' VAL . 4.1 mp -87.91 141.16 28.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.634 164.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 147' ' ' LEU . 7.3 p -132.74 132.48 59.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.215 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.935 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -74.17 109.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 25.2 tptp -63.32 -54.74 32.23 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.885 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 71.9 mtt180 -158.38 138.18 12.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.054 174.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.727 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -175.65 -155.28 12.55 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 78.2 Cg_exo -55.68 -65.0 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.712 2.274 . . . . 0.0 112.949 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.775 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 52.3 t30 -71.03 -48.38 53.29 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.71 153.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.044 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.55 2.22 90.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.935 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.0 m -88.34 176.35 7.25 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.258 0.529 . . . . 0.0 110.26 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.665 HH21 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -170.23 148.27 3.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.812 0.733 . . . . 0.0 112.868 -169.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.89 129.67 43.08 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.023 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HH21 ' A' ' 69' ' ' ARG . 1.5 tm? -85.79 101.37 12.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.8 ' HG ' ' CG ' ' A' ' 101' ' ' PHE . 0.7 OUTLIER -95.86 31.58 2.07 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.297 -177.003 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 34.7 t70 -89.85 -11.52 41.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.84 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.568 ' O ' ' HE2' ' A' ' 101' ' ' PHE . 1.4 pp0? -121.42 153.84 37.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -42.63 -39.01 2.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.82 123.08 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.255 0.55 . . . . 0.0 112.149 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.63 ' CG2' ' HB3' ' A' ' 86' ' ' ASP . 1.6 p -113.79 121.84 45.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.802 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.615 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 30.5 m -76.61 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.579 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.611 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -122.21 116.47 24.21 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.871 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 170.66 -108.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.671 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -111.79 101.75 10.07 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.972 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.955 -160.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.63 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 2.8 m-20 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.437 0.636 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.611 HG12 ' HB1' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -127.75 122.02 57.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.229 -176.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.71 133.16 56.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.238 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 139' ' ' ILE . 6.2 mt -108.15 80.33 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 29.7 t70 71.71 -6.84 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.57 0.7 . . . . 0.0 110.134 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.794 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.3 p30 40.5 38.77 0.62 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.121 1.368 . . . . 0.0 113.523 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 92' ' ' VAL . 70.8 t -145.67 6.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.737 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 23' ' ' SER . 10.3 p -124.47 -2.2 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -168.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.8 t -136.53 155.55 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.72 -172.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.0 m -75.52 79.28 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.032 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 1.054 ' HG2' ' HD2' ' A' ' 97' ' ' ARG . 11.4 ttm180 55.69 -58.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.753 -1.112 . . . . 0.0 112.869 -164.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 1.054 ' HD2' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -157.84 153.87 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.484 -0.76 . . . . 0.0 111.697 -177.132 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 1.01 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -95.41 -40.54 9.44 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.304 177.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.884 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -148.61 131.52 16.16 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.667 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -102.98 122.53 44.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -53.19 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 124.614 1.196 . . . . 0.0 108.406 -176.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.85 107.67 19.95 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 119.359 -0.937 . . . . 0.0 108.742 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.8 tt -77.02 107.87 9.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 23.6 mt-10 -117.19 134.05 55.25 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 39.07 43.34 0.8 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.1 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.892 ' HA ' HD21 ' A' ' 103' ' ' LEU . 53.2 m-80 72.08 15.63 5.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.561 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 15.5 pt-20 -122.26 151.68 40.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.939 173.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.95 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -93.42 129.13 39.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.942 -174.166 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 13.4 m120 -135.19 161.82 34.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.4 m -107.03 126.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.37 174.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 4.0 t -100.3 111.59 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.297 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 11.2 t70 -73.26 115.05 12.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 111' ' ' VAL . 16.0 m -115.17 -12.36 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.122 0.487 . . . . 0.0 111.096 -174.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.8 87.57 0.34 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.586 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' SER . . . . . 1.01 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 30.7 t -92.32 145.15 24.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' CD2' ' HB ' ' A' ' 24' ' ' VAL . 23.9 tp -63.73 -55.41 23.47 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.334 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.78 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -67.77 -36.44 80.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.48 169.57 12.42 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.102 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.2 m -112.85 123.53 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.618 -0.791 . . . . 0.0 111.298 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 52.2 m-85 -140.96 103.67 4.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 172.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 1.007 HG12 HG13 ' A' ' 137' ' ' VAL . 1.3 m -99.45 130.27 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.581 ' HA ' ' OE2' ' A' ' 136' ' ' GLU . 1.8 m-20 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 58.12 32.13 21.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 13.5 pt-20 -146.12 138.79 13.96 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 110.664 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 19.9 Cg_exo -65.46 123.26 11.19 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.599 2.199 . . . . 0.0 111.412 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 121' ' ' VAL . 27.3 m -123.65 169.41 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.41 -61.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.809 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.888 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.5 t -143.84 91.91 2.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.333 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.32 124.89 44.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 8.7 p -67.11 150.81 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.728 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.95 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.0 mp -58.67 145.93 38.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.497 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 146' ' ' PHE . . . -151.3 130.79 12.97 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -69.42 121.85 17.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.441 0.639 . . . . 0.0 111.234 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.79 60.98 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.17 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 36.0 m-20 -105.02 147.53 27.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.58 161.85 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -168.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.007 HG13 HG12 ' A' ' 121' ' ' VAL . 40.6 t -134.51 131.74 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.558 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.414 ' OE1' ' N ' ' A' ' 142' ' ' PHE . 6.6 tp-100 -96.8 120.06 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 169.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.842 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -135.98 129.5 47.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.386 171.105 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.78 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 76.81 -62.25 3.25 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.597 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.006 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 54.1 pttt 176.41 28.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.122 0.569 . . . . 0.0 111.379 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.847 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -122.82 146.84 47.19 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 109.053 -168.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.622 ' NH1' ' HG2' ' A' ' 136' ' ' GLU . 11.6 ttm-85 -97.1 100.18 11.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.626 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.926 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.4 mp -91.75 166.08 12.95 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.922 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -143.36 144.25 23.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 171.13 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.818 ' HB3' ' HG ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -84.51 136.87 33.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.953 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 59' ' ' VAL . 2.0 mm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.063 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.905 HG12 ' H ' ' A' ' 25' ' ' PHE . 2.1 t 46.52 -152.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.11 0.564 . . . . 0.0 111.99 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.905 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER 100.1 -165.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.374 1.47 . . . . 0.0 114.376 160.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.967 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 C-N-CA 125.041 1.337 . . . . 0.0 110.578 -172.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.58 36.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.693 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 pt? -160.71 140.02 10.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.943 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.053 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.5 mp -89.67 112.33 23.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.679 168.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.53 125.82 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.993 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -73.0 113.43 10.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -77.51 -55.94 4.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.014 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -141.53 129.27 21.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -177.38 178.58 48.31 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 97.0 Cg_exo -48.46 -48.41 17.31 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.948 2.432 . . . . 0.0 113.465 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.531 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 58.0 t30 -83.16 -52.72 6.36 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.97 171.21 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.5 -1.682 . . . . 0.0 112.796 -170.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.6 2.54 89.84 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.917 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.993 ' H ' HG22 ' A' ' 60' ' ' VAL . 3.4 m -98.01 177.76 5.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.626 0.713 . . . . 0.0 110.465 -171.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.19 151.96 3.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.102 0.41 . . . . 0.0 111.636 -176.356 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.692 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -94.95 134.05 38.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.622 ' O ' HD23 ' A' ' 71' ' ' LEU . 6.4 tt -87.05 93.85 9.47 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.734 HD23 ' CD1' ' A' ' 101' ' ' PHE . 4.1 mp -93.39 45.43 1.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -99.0 -28.22 13.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.131 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.59 -162.3 0.92 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.006 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.2 -51.5 20.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -158.89 139.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 111.949 -178.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 38.3 p -121.16 152.03 39.23 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.343 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.636 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 75.8 m -95.57 124.8 39.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -126.54 116.23 20.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -166.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 148.99 -85.94 0.16 Allowed Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.176 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HG2' ' OD1' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.67 104.03 11.29 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.617 0.722 . . . . 0.0 109.174 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.636 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.096 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.023 -169.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 87' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.323 0.583 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.85 113.94 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.215 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HD1' ' O ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -116.77 134.32 54.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.132 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.5 mm? -122.22 74.43 1.16 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.934 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.6 t70 72.49 -17.37 0.39 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.454 0.645 . . . . 0.0 110.592 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.595 ' OD1' ' HG2' ' A' ' 81' ' ' ARG . 35.0 t70 61.82 29.52 17.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.386 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -153.75 32.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.952 0.882 . . . . 0.0 109.821 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.552 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 65.3 p -132.81 -9.57 3.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.965 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG21 ' CA ' ' A' ' 80' ' ' GLY . 2.0 t -136.38 159.57 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -87.57 77.3 8.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 58.48 -59.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.929 -165.33 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 5.7 ptt85 -143.65 137.63 28.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.621 0.724 . . . . 0.0 111.066 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -75.02 -39.27 61.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 170.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -156.94 149.45 23.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' CD ' HH21 ' A' ' 102' ' ' ARG . 7.8 pt-20 -108.0 133.1 52.8 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.734 ' CD1' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -56.98 106.12 0.28 Allowed 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.559 HH21 ' CD ' ' A' ' 100' ' ' GLU . 21.1 tpp85 -103.16 104.04 14.15 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.62 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.3 tt -86.44 110.72 19.92 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.351 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.28 135.36 48.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 57.51 37.74 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.606 0.566 . . . . 0.0 110.329 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.872 ' HA ' HD21 ' A' ' 103' ' ' LEU . 21.1 m120 64.64 12.52 7.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.03 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.1 mt-10 -106.33 144.73 32.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.893 0.377 . . . . 0.0 111.396 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.441 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -95.9 126.29 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.384 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 11.0 m-80 -135.86 163.36 30.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 128' ' ' SER . 7.2 m -111.26 122.59 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.942 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 36.7 t -101.18 110.4 27.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.865 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 18.6 t70 -68.5 128.29 36.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.689 HG21 HH11 ' A' ' 97' ' ' ARG . 18.9 m -126.0 9.51 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.22 0.533 . . . . 0.0 109.734 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.62 71.77 0.59 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.307 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 39.3 t -67.11 134.98 52.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.688 HD11 HG22 ' A' ' 24' ' ' VAL . 1.8 tm? -52.83 -55.82 20.3 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.682 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -76.17 -37.33 58.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 109.825 172.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.73 163.85 9.9 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.15 -173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -111.69 137.41 49.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.394 0.678 . . . . 0.0 111.282 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.11 103.78 4.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.292 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.977 HG22 HG13 ' A' ' 137' ' ' VAL . 61.7 t -112.8 121.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 122.079 -0.388 . . . . 0.0 110.236 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 61.29 36.91 17.5 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 63.66 22.11 12.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.477 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.59 148.48 25.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 121.028 0.442 . . . . 0.0 110.949 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.03 123.6 11.5 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.271 1.981 . . . . 0.0 111.78 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.49 155.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.7 0.286 . . . . 0.0 110.281 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.3 m-20 -87.54 -47.08 9.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.641 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.895 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.6 p -154.86 91.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.342 0.592 . . . . 0.0 110.733 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.61 132.85 47.05 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.367 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.1 p -76.06 149.63 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.629 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.837 HD11 HD11 ' A' ' 58' ' ' LEU . 8.7 mp -65.49 133.44 51.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.653 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.08 -176.32 3.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.859 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -93.81 103.78 15.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.36 0.124 . . . . 0.0 111.306 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.09 69.64 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.114 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.718 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 3.8 t0 -81.59 162.25 23.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.7 pt-20 -126.89 148.26 50.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -166.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.977 HG13 HG22 ' A' ' 121' ' ' VAL . 61.4 t -123.09 141.44 43.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.024 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -106.67 131.12 54.17 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.971 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.48 140.32 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.784 174.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.3 -73.73 0.72 Allowed Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.344 170.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.063 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 52.1 pttt -172.3 29.13 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.078 0.466 . . . . 0.0 110.445 170.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -127.02 149.32 49.95 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -171.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.569 ' HD3' ' OE1' ' A' ' 136' ' ' GLU . 3.8 ttm180 -98.6 120.26 38.72 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.64 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 4.3 mp -108.16 162.77 13.76 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.575 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.05 137.08 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.053 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.96 154.29 20.29 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.732 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 131' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.06 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.597 ' HB2' HG22 ' A' ' 93' ' ' THR . 41.9 m . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 117' ' ' ASN . 7.1 p -112.46 125.69 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.273 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' HB3' ' HE3' ' A' ' 141' ' ' LYS . 2.5 t80 176.52 -165.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.822 0.076 . . . . 0.0 110.937 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.591 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 1.2 tmm_? . . . . . 0 N--CA 1.481 1.096 0 C-N-CA 124.348 1.059 . . . . 0.0 112.484 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -126.86 169.66 13.02 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.568 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.5 pt? -153.19 131.92 12.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.015 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.7 mp -87.48 146.64 25.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.6 163.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.8 p -136.1 128.94 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.806 0.336 . . . . 0.0 110.383 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -74.37 115.15 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 18.8 tptp -76.5 -66.35 0.82 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 -172.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -138.92 132.93 31.16 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.978 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -178.05 -171.37 41.35 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 51.0 Cg_exo -53.87 -52.23 8.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.25 1.967 . . . . 0.0 112.893 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 2.5 t-20 -81.36 -54.14 5.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.647 0.737 . . . . 0.0 109.262 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.674 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.1 170.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.03 -170.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.35 2.28 90.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.994 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.5 m -97.96 179.55 4.75 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 118.423 1.111 . . . . 0.0 110.966 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.621 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -166.25 153.02 9.36 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.3 0.5 . . . . 0.0 111.743 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.674 ' HE1' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.95 125.35 42.83 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.657 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.12 94.41 9.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.63 0.729 . . . . 0.0 109.481 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -91.37 54.79 2.63 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.776 0.798 . . . . 0.0 109.642 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -98.71 -26.61 14.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.007 171.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.466 ' HG2' HD23 ' A' ' 71' ' ' LEU . 13.2 pt20 -97.31 161.11 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.45 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -16.14 55.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -171.15 133.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 111.761 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 35.3 p -120.82 144.34 48.39 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.351 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 87' ' ' ILE . 74.4 m -89.96 124.64 34.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.15 123.38 47.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 141.84 -142.07 11.55 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.319 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.898 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.14 104.7 3.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.575 0.702 . . . . 0.0 110.066 174.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 29.5 m170 . . . . . 0 N--CA 1.436 -1.136 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.289 -173.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.214 0.531 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.33 96.68 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -101.15 130.64 47.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.398 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 60' ' ' VAL . 3.8 mm? -115.93 80.64 1.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 37.7 t70 70.46 -10.12 0.72 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.824 0.702 . . . . 0.0 110.481 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.6 p-10 41.89 33.25 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.581 1.553 . . . . 0.0 113.16 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 t -138.69 -10.7 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.183 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.597 HG22 ' HB2' ' A' ' 23' ' ' SER . 30.4 p -103.29 -33.64 9.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.85 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.4 t -98.36 149.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 122.238 -0.289 . . . . 0.0 111.358 -170.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 6.7 t -74.44 77.02 1.92 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER 59.17 -75.68 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.149 -168.258 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.755 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -136.45 134.87 38.14 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -174.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -71.26 -45.7 62.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.69 -179.5 7.92 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.402 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.9 pt-20 -137.84 124.74 21.27 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.833 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -81.12 90.67 6.05 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.064 0.935 . . . . 0.0 108.82 -177.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' HG21 ' A' ' 111' ' ' VAL . 10.6 ptp180 -94.17 151.97 19.07 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.762 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.0 tt -89.1 105.95 18.12 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 54.3 mm-40 -115.52 133.96 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.6 OUTLIER 48.74 33.44 4.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.692 0.797 . . . . 0.0 111.477 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.861 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.9 m-20 75.92 21.99 1.52 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.663 175.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.81 142.32 40.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.51 ' CE1' HD12 ' A' ' 103' ' ' LEU . 7.0 m-85 -84.58 137.64 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -175.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.833 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 4.3 m-20 -141.38 160.56 39.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -171.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -103.7 116.71 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.724 177.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 45.3 t -99.21 111.38 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.36 127.36 30.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.338 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 97' ' ' ARG . 10.4 m -127.36 -37.28 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 167.46 76.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.959 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 48.3 t -88.28 122.22 31.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.9 -55.58 19.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -170.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.643 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 7.4 t30 -74.86 -34.91 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.0 110.454 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.49 160.67 9.32 Favored Glycine 0 C--O 1.247 0.95 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.001 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' HE1' ' A' ' 98' ' ' HIS . 17.7 m -112.47 122.34 47.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.282 0.633 . . . . 0.0 111.073 171.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 126.13 28.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 1.013 HG22 HG13 ' A' ' 137' ' ' VAL . 75.5 t -124.91 119.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 61.31 37.17 17.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.7 19.27 10.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.104 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -143.26 145.08 30.9 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.736 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.8 122.87 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.358 2.039 . . . . 0.0 111.113 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 17.7 m -115.17 176.73 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 13.6 t70 -109.66 -41.94 4.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.525 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.877 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 10.1 p -165.16 91.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.886 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -92.17 145.3 24.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.001 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.535 HG22 HD22 ' A' ' 109' ' ' ASN . 8.2 t -88.59 135.64 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -174.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -46.51 129.09 10.76 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.022 174.784 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -135.45 -174.75 3.72 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -106.56 113.15 26.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.356 0.598 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.63 -5.62 84.69 Favored Glycine 0 C--N 1.32 -0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.908 170.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -88.02 154.66 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER -112.15 149.0 32.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 121' ' ' VAL . 60.7 t -124.9 141.4 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.721 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -109.18 130.8 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.328 0.585 . . . . 0.0 110.42 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -125.09 130.55 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.29 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 67.18 -91.23 0.19 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.023 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.977 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 19.6 ptmt -147.23 14.19 1.12 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.8 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -111.03 157.81 19.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -105.48 112.96 26.26 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.871 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -107.78 156.69 18.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.542 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.23 143.56 29.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.015 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.37 150.04 27.17 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.685 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.6 mm? . . . . . 0 C--O 1.235 0.338 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.177 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 27.8 m . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.703 ' HB ' HD23 ' A' ' 116' ' ' LEU . 10.0 p -130.2 149.42 33.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.077 -171.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.7 t80 177.34 -146.36 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.017 -173.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.782 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.3 tpt180 . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 123.406 0.683 . . . . 0.0 110.972 171.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.81 167.32 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.09 142.52 11.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 mp -86.51 114.02 22.91 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.092 166.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 68' ' ' SER . 4.2 p -109.62 128.39 65.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.621 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.56 109.89 4.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.025 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -65.53 -60.68 2.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.914 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 62' ' ' ARG . 27.5 mtm-85 -150.95 109.56 3.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.132 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -134.36 -147.55 5.62 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.033 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 72.8 Cg_endo -75.44 -48.99 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.232 1.955 . . . . 0.0 111.911 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.633 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 50.8 t30 -74.36 -49.69 21.74 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 59.31 154.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.56 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.62 1.38 90.14 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.7 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.903 ' H ' HG22 ' A' ' 60' ' ' VAL . 15.6 t -88.36 -178.3 5.85 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.863 0.832 . . . . 0.0 109.896 -174.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.648 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -173.26 150.32 1.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.389 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.44 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -95.16 127.19 41.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 172.694 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -83.28 91.5 7.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.966 0.791 . . . . 0.0 109.249 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.802 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 mp -86.12 53.93 2.96 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.0 109.688 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 22.9 t70 -113.47 -25.72 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.046 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -86.44 -167.54 1.91 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.328 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.07 35.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.781 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.11 134.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.608 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 7.6 p -119.68 128.33 53.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.9 m -74.93 125.26 28.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -120.57 108.22 13.79 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -170.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.844 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.08 -146.96 12.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.335 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -69.24 107.63 3.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.604 0.716 . . . . 0.0 109.56 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 97' ' ' ARG . 29.7 m80 . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.968 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.513 0.673 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -120.68 113.01 38.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.167 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' HD2' ' O ' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -104.05 127.2 51.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.247 -174.513 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 3.2 mm? -114.77 76.22 0.98 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 9.5 t70 66.53 -0.77 1.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.543 0.687 . . . . 0.0 109.641 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.9 p-10 40.62 30.03 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.749 1.62 . . . . 0.0 113.389 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.1 p -166.19 59.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 110.973 172.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.67 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 3.0 p -143.93 -13.99 0.63 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.149 0.5 . . . . 0.0 110.803 170.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -140.84 141.83 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -64.78 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.118 0.567 . . . . 0.0 112.104 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.795 ' HD3' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 68.53 -63.08 0.36 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 -177.516 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.844 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -154.83 132.99 11.71 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.656 -0.653 . . . . 0.0 111.839 175.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -63.24 -43.56 97.71 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.757 176.824 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -155.82 174.56 15.14 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.921 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.8 pt-20 -135.74 128.9 31.75 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.802 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -54.66 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 124.477 1.11 . . . . 0.0 108.117 -178.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 14.0 ttm180 -98.97 105.84 18.03 Favored 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.454 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.5 tt -80.24 105.11 11.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.604 0.716 . . . . 0.0 109.575 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 37.3 mt-10 -129.25 135.66 49.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.637 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 52.9 m-80 62.1 33.47 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.122 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.763 ' HA ' HD21 ' A' ' 103' ' ' LEU . 73.7 m-20 70.94 4.14 4.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.825 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.0 mm-40 -103.47 144.82 30.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -91.24 125.65 36.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 21.1 m-80 -131.18 163.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.619 0.247 . . . . 0.0 111.183 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -105.27 124.44 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.159 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 68.3 t -108.9 110.41 31.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.806 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.0 125.62 26.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.559 0.537 . . . . 0.0 109.722 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.53 -27.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.39 83.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.576 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.911 ' HA ' HG23 ' A' ' 94' ' ' VAL . 37.2 t -108.6 120.46 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' HB ' ' A' ' 24' ' ' VAL . 58.4 tp -53.16 -56.27 17.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -63.44 -34.76 78.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.49 0.662 . . . . 0.0 109.641 177.349 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.75 169.49 12.37 Favored Glycine 0 C--O 1.253 1.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.145 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 m -112.02 117.33 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.761 0.424 . . . . 0.0 110.917 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -127.72 106.82 9.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.864 HG22 HG23 ' A' ' 137' ' ' VAL . 21.2 t -101.88 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.664 ' ND2' HG12 ' A' ' 121' ' ' VAL . 25.4 m-80 65.06 44.23 3.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 109.319 -174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 63.44 13.25 6.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.004 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 9.9 pt-20 -133.89 131.4 20.98 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-O 121.344 0.592 . . . . 0.0 110.804 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 16.4 Cg_exo -67.81 123.21 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.783 2.322 . . . . 0.0 112.257 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 129' ' ' ALA . 14.2 m -121.76 165.1 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 2.8 m-20 -108.38 -24.81 11.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.758 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 21.5 p -164.52 91.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.441 0.639 . . . . 0.0 109.59 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -110.22 148.41 31.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.355 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.62 127.63 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.086 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -63.32 162.9 11.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -166.33 160.83 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.297 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.14 100.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.132 0.492 . . . . 0.0 111.369 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.72 4.38 36.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.727 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.52 119.74 20.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 5.0 tt0 -106.73 134.25 50.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.666 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.962 HG12 ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -117.68 142.22 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.483 HE22 ' CG ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -111.72 115.59 29.34 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.67 ' HB ' ' CB ' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -123.83 129.47 74.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.507 175.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.32 -68.21 1.78 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.066 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.033 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 17.7 ptmt -173.7 31.36 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 116.953 0.377 . . . . 0.0 110.712 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.71 149.95 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -172.085 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -103.12 100.87 10.82 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.7 mp -96.12 157.85 15.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.75 141.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.292 169.264 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 43.7 t80 -97.81 136.85 37.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.248 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.524 0.678 . . . . 0.0 110.958 170.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.616 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 48.6 m . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 6.8 t -101.91 146.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.656 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.8 t80 172.13 -159.11 0.01 OUTLIER 'General case' 0 C--N 1.35 0.592 0 O-C-N 123.603 0.564 . . . . 0.0 110.751 171.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 124.512 1.125 . . . . 0.0 112.691 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 m . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.64 168.34 16.6 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.19 147.77 12.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.631 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 131' ' ' LEU . 2.5 mp -86.42 144.32 27.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -123.19 133.02 70.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.012 0.434 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.695 ' HB ' ' H ' ' A' ' 68' ' ' SER . 79.1 t -65.57 105.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 145' ' ' VAL . 59.0 tttm -70.4 -47.49 60.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.762 1.289 . . . . 0.0 110.151 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -165.78 144.55 6.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.576 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -173.67 -157.83 16.33 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 13.9 Cg_exo -67.22 -48.81 1.55 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 119.481 1.64 . . . . 0.0 111.723 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -77.63 -53.51 7.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.009 173.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.614 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.14 160.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.109 -172.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.4 2.02 90.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.564 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.695 ' H ' ' HB ' ' A' ' 60' ' ' VAL . 6.7 m -88.69 -172.42 3.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.226 0.513 . . . . 0.0 111.362 -173.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.05 152.51 2.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.962 0.346 . . . . 0.0 111.787 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.913 ' HD1' ' HB2' ' A' ' 58' ' ' LEU . 1.5 m-85 -98.2 116.95 31.5 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -78.04 90.13 4.2 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.705 0.764 . . . . 0.0 109.453 -174.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 58' ' ' LEU . 15.4 mt -82.75 59.46 4.78 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.573 0.701 . . . . 0.0 109.955 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -117.01 -26.87 6.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.645 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -98.67 177.64 5.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.84 97.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -157.56 135.8 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 43.2 p -109.91 140.37 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.665 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 37.0 m -88.31 124.23 33.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -123.21 119.9 31.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.515 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 150.2 -138.29 6.64 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.9 tmm_? -71.5 104.37 3.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 109.85 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.502 ' HE1' ' N ' ' A' ' 79' ' ' ALA . 31.2 m170 . . . . . 0 N--CA 1.438 -1.045 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.027 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 87' ' ' ILE . 3.2 m-20 . . . . . 0 N--CA 1.467 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -130.36 91.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 122.087 0.946 . . . . 0.0 110.987 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -95.41 134.19 38.51 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.269 174.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.019 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.5 mm? -122.03 77.54 1.39 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.768 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 24.6 t0 66.01 -3.76 0.73 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.6 p30 43.69 25.65 0.1 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.372 1.469 . . . . 0.0 113.817 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 23' ' ' SER . 10.8 p -147.43 45.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.32 1.057 . . . . 0.0 110.222 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.673 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.97 -0.6 0.31 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.045 172.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.667 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -135.64 143.15 37.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.9 t -78.29 73.0 4.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER 67.24 -58.47 0.41 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.672 0.749 . . . . 0.0 110.114 -171.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' HD2' HG11 ' A' ' 113' ' ' VAL . 22.5 ttm180 -146.18 125.28 12.88 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.879 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.776 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -67.18 -46.07 75.07 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -169.98 160.09 8.09 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.869 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.3 pt-20 -112.66 117.97 33.75 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.862 ' CZ ' ' HB ' ' A' ' 110' ' ' VAL . 4.4 m-85 -76.37 95.33 3.78 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.124 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -103.05 148.62 25.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.408 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.2 tt -91.73 117.54 29.85 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -142.88 135.68 27.9 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 48.8 m-80 62.45 32.35 16.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.683 0.615 . . . . 0.0 110.094 -172.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.71 ' HA ' HD21 ' A' ' 103' ' ' LEU . 5.1 t30 74.84 -1.29 3.12 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.085 0.865 . . . . 0.0 112.341 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 1.5 mm-40 -109.13 147.19 32.85 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.086 -0.383 . . . . 0.0 109.977 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 103' ' ' LEU . 12.9 m-85 -88.89 130.96 35.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 130' ' ' VAL . 13.1 m-80 -140.34 162.63 34.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.0 OUTLIER -107.09 122.02 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.37 172.412 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 128' ' ' SER . 26.8 t -101.93 110.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.999 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 24.9 t0 -59.28 144.03 47.52 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.867 0.729 . . . . 0.0 109.713 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.61 HG11 ' HD2' ' A' ' 97' ' ' ARG . 1.2 t -142.44 -32.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.824 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.93 103.35 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.723 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 44.2 t -110.23 145.7 36.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.902 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 24' ' ' VAL . 18.1 tp -58.81 -55.77 30.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.544 0.611 . . . . 0.0 111.675 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 59.2 m-80 -61.37 -38.06 85.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.238 0.542 . . . . 0.0 110.327 177.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.18 167.43 11.52 Favored Glycine 0 C--O 1.246 0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.97 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 ' HE1' ' A' ' 98' ' ' HIS . 16.0 m -111.66 133.63 53.78 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.004 0.522 . . . . 0.0 111.225 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 23.2 m-85 -140.73 131.19 25.31 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.848 173.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.853 HG22 HG13 ' A' ' 137' ' ' VAL . 77.4 t -127.91 113.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.0 42.01 16.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.813 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.64 -2.03 2.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.902 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.4 pt-20 -134.03 141.98 41.64 Favored Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 121.747 -0.596 . . . . 0.0 111.204 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 9.7 Cg_exo -70.83 121.99 8.41 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.11 1.874 . . . . 0.0 111.689 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.84 178.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.58 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 21.9 t70 -93.41 -64.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.864 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 5.8 p -146.77 92.9 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.231 0.538 . . . . 0.0 109.91 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.99 143.55 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.631 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.521 HG22 ' OD1' ' A' ' 109' ' ' ASN . 3.3 t -84.26 135.85 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.187 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -62.18 161.5 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -158.56 154.67 27.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.25 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.96 97.72 0.69 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.78 4.81 29.74 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.84 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 19.4 t70 -72.87 150.96 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.1 tt0 -141.32 133.39 27.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.467 0.651 . . . . 0.0 111.421 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG13 HG22 ' A' ' 121' ' ' VAL . 48.0 t -129.13 141.64 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.373 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -109.84 121.02 44.27 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.019 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.38 140.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 57.95 -109.79 2.05 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.04 -1.552 . . . . 0.0 109.274 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.812 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 1.8 pttm -136.3 34.03 2.79 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.907 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.732 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -114.96 150.81 35.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 143' ' ' ARG . 14.1 ttm180 -102.19 106.45 17.29 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 60' ' ' VAL . 2.0 mp -110.29 150.86 28.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.715 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.35 144.2 28.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.823 ' HB2' ' HG ' ' A' ' 58' ' ' LEU . 84.5 t80 -94.22 125.79 39.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.985 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? . . . . . 0 N--CA 1.444 -0.733 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.223 169.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 93' ' ' THR . 17.9 m . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.02 134.33 41.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.388 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 42.7 t80 176.51 176.08 0.31 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.051 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.5 tpt180 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 159.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.07 170.03 11.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 72' ' ' LEU . 2.1 pt? -155.5 133.03 11.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.066 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.3 mp -85.49 128.43 34.73 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.631 163.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -110.88 125.6 68.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.231 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.865 HG22 ' HG ' ' A' ' 144' ' ' LEU . 67.9 t -65.57 104.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 52.1 tttp -73.45 -57.25 4.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 124.23 0.956 . . . . 0.0 109.873 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -153.34 131.19 11.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.971 0.891 . . . . 0.0 110.944 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -168.78 -162.35 20.75 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.09 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 40.5 Cg_exo -59.37 -56.33 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 119.401 1.601 . . . . 0.0 112.669 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 1.8 t-20 -70.01 -52.57 23.06 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.645 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.05 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.252 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.72 1.04 90.04 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.979 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.748 ' HB2' HG21 ' A' ' 60' ' ' VAL . 18.7 m -85.38 -167.93 2.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.584 0.692 . . . . 0.0 111.542 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.73 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -170.23 154.74 5.02 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -175.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -95.39 125.1 39.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.668 ' O ' HG21 ' A' ' 77' ' ' THR . 1.1 tm? -84.48 98.27 10.01 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HG ' ' HD2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.12 51.61 1.03 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.454 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 11.3 t70 -95.68 -19.38 19.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.149 169.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -89.16 166.58 13.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.85 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.31 63.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.183 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 102' ' ' ARG . 3.2 tp -168.99 130.03 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.76 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.668 HG21 ' O ' ' A' ' 71' ' ' LEU . 22.9 p -123.68 146.91 47.89 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.081 -176.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 87' ' ' ILE . 23.4 m -82.13 125.2 30.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.533 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.04 128.39 54.31 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.18 -132.1 6.1 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.525 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.982 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -80.31 103.93 10.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.666 0.746 . . . . 0.0 109.905 174.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 36.5 m80 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.971 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 28.3 m-20 . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.713 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -109.06 98.96 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 0.0 111.354 -171.224 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -103.65 128.13 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.29 178.714 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.781 HD12 ' CD2' ' A' ' 142' ' ' PHE . 3.3 mm? -120.03 86.91 2.65 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.208 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 17.1 t70 69.5 -7.74 0.82 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 0.0 109.611 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.762 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 p-10 37.9 34.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.034 1.734 . . . . 0.0 113.749 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.99 0.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.433 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' SER . 1.6 p -104.58 -25.53 12.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.823 -0.548 . . . . 0.0 111.658 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.9 t -105.12 150.18 8.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -172.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 6.3 t -75.49 72.67 2.5 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.982 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 7.8 ttt180 56.53 -62.37 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.328 -165.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -141.25 127.6 19.86 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.802 -1.186 . . . . 0.0 112.178 -171.161 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.858 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.13 -45.04 24.35 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.415 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -144.23 174.52 10.82 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.104 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.716 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.7 pt-20 -138.09 120.13 15.54 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.078 -1.874 . . . . 0.0 106.072 166.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.751 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.4 93.16 5.93 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.654 0.74 . . . . 0.0 109.55 -171.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.759 ' HB3' HD13 ' A' ' 76' ' ' ILE . 9.3 ptp180 -92.61 134.51 34.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.525 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.707 HD12 ' CE2' ' A' ' 108' ' ' PHE . 6.3 tt -85.23 114.08 22.06 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -124.5 139.86 53.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.83 39.7 1.81 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.902 0.751 . . . . 0.0 112.229 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HA ' HD21 ' A' ' 103' ' ' LEU . 8.0 t30 75.23 13.9 3.1 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 112.429 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 2.3 mp0 -120.87 140.87 51.19 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.922 -0.486 . . . . 0.0 110.413 172.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.707 ' CE2' HD12 ' A' ' 103' ' ' LEU . 2.1 m-85 -89.25 139.92 30.0 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 32.8 m-80 -143.49 155.98 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.963 -170.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -103.49 120.74 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.634 0.731 . . . . 0.0 110.839 179.481 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 113' ' ' VAL . 2.3 t -99.8 118.05 45.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.957 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.14 119.07 19.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.764 HG13 HG12 ' A' ' 111' ' ' VAL . 5.8 m -121.54 -53.03 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . -171.19 79.02 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.118 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 32.4 t -91.75 122.64 34.48 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.0 tp -61.78 -54.13 46.51 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.961 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 24.2 m-80 -65.92 -38.77 89.56 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 141.37 157.36 7.14 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.43 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.454 HG23 ' CE1' ' A' ' 98' ' ' HIS . 16.6 m -111.6 125.63 54.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.602 0.361 . . . . 0.0 110.851 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 65.8 m-85 -139.74 105.53 5.16 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.88 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 137' ' ' VAL . 83.4 t -101.77 122.75 54.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 172.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 63.71 33.34 13.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 14.8 mtp-105 52.28 37.78 23.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.803 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.94 139.44 13.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.116 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 122.7 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.014 1.81 . . . . 0.0 111.278 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -114.49 178.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.914 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 18.5 t70 -96.71 -58.88 1.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.115 0.483 . . . . 0.0 109.844 174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.857 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 41.8 t -155.81 91.21 1.27 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.051 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.36 149.71 21.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.699 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.73 136.88 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.681 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 146' ' ' PHE . 2.6 tt -56.11 106.67 0.29 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.953 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.29 124.37 24.33 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.823 0.344 . . . . 0.0 111.358 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . 0.451 ' HA ' HD13 ' A' ' 147' ' ' LEU . 3.4 m-20 -54.23 123.93 14.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.84 24.88 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.619 168.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.8 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 1.7 t70 -97.26 165.89 11.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.619 0.71 . . . . 0.0 110.555 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.4 pp20? -116.12 156.99 25.46 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.813 0.816 . . . . 0.0 113.023 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 121' ' ' VAL . 68.5 t -131.8 130.08 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.253 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 113.76 25.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.072 0.463 . . . . 0.0 110.249 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.858 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -113.19 124.58 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.223 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 64.8 -108.13 2.18 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.476 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.09 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 7.8 pttt -134.93 21.08 3.5 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.597 0.713 . . . . 0.0 111.354 -174.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.781 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -113.04 143.99 43.37 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.968 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -95.65 102.87 14.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.865 ' HG ' HG22 ' A' ' 60' ' ' VAL . 5.1 mp -95.78 161.42 14.02 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.535 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.5 HG22 ' CD2' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -140.23 139.46 36.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 172.03 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.066 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.45 130.67 49.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD2' HG22 ' A' ' 145' ' ' VAL . 2.6 mm? . . . . . 0 C--O 1.232 0.177 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.76 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 18.8 m . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 116' ' ' LEU . 9.5 p -129.73 154.91 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.876 -0.515 . . . . 0.0 112.189 -173.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.6 t80 179.68 -156.51 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.183 0.593 . . . . 0.0 110.274 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -129.14 172.67 11.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.814 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.9 pp -161.07 140.08 10.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.7 mp -85.66 111.28 19.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.4 125.56 59.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.018 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -71.04 110.63 4.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' HG13 ' A' ' 145' ' ' VAL . 2.9 tpmt? -64.28 -65.58 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.063 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 62' ' ' ARG . 36.4 mtt-85 -146.54 134.75 21.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.831 0.824 . . . . 0.0 110.451 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.11 -159.7 17.83 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.126 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.4 Cg_exo -62.97 -57.94 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.96 1.773 . . . . 0.0 112.595 178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.634 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 53.9 t30 -73.04 -53.0 12.26 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.762 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.18 165.28 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.317 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.33 3.17 90.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.061 170.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -100.73 -170.32 1.84 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 117.729 0.765 . . . . 0.0 111.033 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -171.7 154.46 3.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.19 0.45 . . . . 0.0 112.042 -170.653 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -95.79 121.6 37.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 165.628 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.1 tt -79.89 92.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.681 0.753 . . . . 0.0 109.469 -176.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.814 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 5.6 mt -85.23 51.4 2.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.367 0.603 . . . . 0.0 109.507 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.523 ' HB3' HD21 ' A' ' 71' ' ' LEU . 22.6 t70 -104.03 -22.18 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.487 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -104.29 -165.54 1.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.018 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.42 -39.85 45.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.793 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.64 133.1 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 111.534 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 70.7 p -111.29 143.94 41.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.762 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 87' ' ' ILE . 44.6 m -80.57 123.46 28.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 171.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.728 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.83 113.37 19.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 139' ' ' ILE . . . 149.89 -136.96 5.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.731 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.4 104.64 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 35.0 m80 . . . . . 0 N--CA 1.439 -0.99 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.807 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 8.7 m-20 . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.64 105.59 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.24 178.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -108.16 116.66 32.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.293 176.349 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.018 HD21 HG11 ' A' ' 60' ' ' VAL . 12.5 mt -102.67 87.57 3.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.635 177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 25.7 t70 66.88 -2.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.344 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.71 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p30 40.65 36.44 0.39 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.189 1.396 . . . . 0.0 113.418 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' SER . 11.9 p -168.64 44.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.421 173.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.703 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -138.11 -5.16 1.67 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.13 -0.981 . . . . 0.0 111.987 176.148 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -143.16 146.53 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.364 -173.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 m -66.5 77.35 0.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.811 0.445 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.09 -70.02 0.08 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 123.425 0.69 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 ptp180 -140.41 130.68 25.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.801 -0.562 . . . . 0.0 110.737 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 1.092 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.83 -41.01 45.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.873 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.58 164.23 30.78 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.928 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.7 pt-20 -129.54 125.7 36.89 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.42 99.23 0.1 Allowed 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 100' ' ' GLU . 15.9 tpp85 -90.45 96.65 10.76 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.975 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -83.78 104.71 14.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.51 138.24 46.01 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 37.5 m-80 62.3 31.89 17.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 -173.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' HD21 ' A' ' 103' ' ' LEU . 7.4 t30 72.58 0.67 3.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.487 0.715 . . . . 0.0 111.831 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 28.2 mm-40 -104.69 139.67 39.18 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.934 -0.479 . . . . 0.0 111.021 -174.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.568 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.29 125.35 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -126.04 162.04 26.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.336 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.4 m -106.71 124.82 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 9.2 t -101.77 112.52 35.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.32 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 14.1 t70 -74.31 116.4 14.92 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.57 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.812 HG13 HG12 ' A' ' 111' ' ' VAL . 27.0 m -124.67 -20.7 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.409 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.21 94.31 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.667 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' SER . . . . . 1.092 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.3 t -108.64 128.85 55.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 24' ' ' VAL . 44.3 tp -54.55 -54.37 42.19 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.408 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -65.67 -35.97 82.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.492 0.663 . . . . 0.0 109.3 175.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.29 170.19 12.59 Favored Glycine 0 C--O 1.257 1.537 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.52 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 98' ' ' HIS . 34.7 m -112.59 122.48 47.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.485 -0.857 . . . . 0.0 110.967 174.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 62.5 m-85 -136.59 103.05 5.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 173.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.736 ' HB ' HG13 ' A' ' 137' ' ' VAL . 2.6 p -102.95 110.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 14.9 m120 68.7 37.64 2.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.499 -171.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 60.84 26.91 16.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.8 pt-20 -139.4 140.92 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.566 173.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 5.6 Cg_exo -79.86 123.42 5.21 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.223 2.616 . . . . 0.0 111.306 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 129' ' ' ALA . 34.3 m -118.6 -179.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 111.49 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 28.3 t70 -100.76 -50.33 3.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.77 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 42.1 t -158.03 91.55 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.233 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -94.15 138.97 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.22 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.71 129.56 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.823 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.618 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -62.57 161.42 12.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.294 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 135' ' ' ASP . . . -160.2 156.11 26.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.81 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -65.77 104.0 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.3 5.75 48.86 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 16.3 t70 -83.82 118.12 23.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.958 0.103 . . . . 0.0 110.795 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 53.7 mp0 -94.57 139.6 30.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.266 0.555 . . . . 0.0 112.343 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 121' ' ' VAL . 16.4 t -127.72 132.22 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.736 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.9 tp-100 -95.04 123.44 38.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.99 0.424 . . . . 0.0 110.353 174.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.742 HG12 HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.76 140.16 49.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 69.37 -72.62 0.45 Allowed Glycine 0 C--O 1.216 -0.987 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.865 167.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.126 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 15.9 ptmt -170.49 16.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.278 0.539 . . . . 0.0 110.276 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.703 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -118.82 147.18 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.182 -169.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -96.02 105.92 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.9 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.5 mp -98.42 153.7 18.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.978 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 1.9 m -141.42 145.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.661 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 63.4 t80 -97.24 134.52 40.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 146' ' ' PHE . 1.5 mm? . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.741 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 93' ' ' THR . 8.4 m . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.765 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.3 p -136.64 155.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -177.92 -147.61 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.186 0.594 . . . . 0.0 109.926 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -125.95 172.69 9.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 3.3 pp -160.31 140.55 11.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.4 mp -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.152 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 68' ' ' SER . 3.3 p -103.13 125.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.212 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.967 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.07 114.69 9.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.151 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -68.87 -69.72 0.31 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.331 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -147.54 131.07 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.406 0.622 . . . . 0.0 110.268 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.707 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -176.13 -150.16 7.95 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.028 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.5 Cg_exo -62.07 -64.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.284 1.989 . . . . 0.0 112.867 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 54.9 t30 -76.31 -52.51 9.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 52.9 169.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.5 -172.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.24 90.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.011 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.967 ' H ' HG22 ' A' ' 60' ' ' VAL . 10.3 m -94.66 -178.03 4.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.34 0.57 . . . . 0.0 110.838 -170.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -169.14 149.25 4.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.259 0.481 . . . . 0.0 111.726 -173.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.497 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -94.35 121.9 36.36 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -79.86 94.58 5.86 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -175.382 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 101' ' ' PHE . 6.0 mt -90.04 46.59 1.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.867 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.466 ' HB3' HD11 ' A' ' 71' ' ' LEU . 7.8 t70 -99.34 -24.12 14.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.277 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -102.33 -166.65 1.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.531 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.24 -37.63 60.95 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.419 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -159.99 131.47 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 11.3 p -119.12 127.21 53.14 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.375 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 87' ' ' ILE . 66.5 m -76.45 132.7 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -126.27 120.98 31.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.11 -127.89 2.61 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.1 tmm_? -73.82 105.77 5.25 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.903 0.859 . . . . 0.0 109.612 175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.159 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.465 -169.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.378 0.609 . . . . 0.0 111.653 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.707 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.46 110.11 20.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.89 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -110.63 132.27 54.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.341 -178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.943 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.4 mm? -119.85 78.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.614 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 36.0 t0 68.75 -6.34 0.87 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.508 0.67 . . . . 0.0 109.93 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.4 p-10 41.89 32.86 0.3 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.422 1.489 . . . . 0.0 113.258 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.91 8.06 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.089 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.511 HG21 ' HD3' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -124.19 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.391 -177.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.653 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.3 t -109.16 152.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -173.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.3 m -77.2 66.25 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 0.0 110.454 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HE ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 67.43 -56.51 0.45 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.976 -173.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.567 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -146.54 147.04 30.74 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.78 0.8 . . . . 0.0 110.64 175.427 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB2' ' OG ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -90.53 -40.75 11.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.912 170.644 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.855 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -151.15 142.62 23.48 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.58 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.5 pt-20 -109.72 120.83 43.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.705 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.92 104.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.537 -174.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 10.4 tpp180 -96.01 107.12 19.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.662 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.85 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.7 tt -89.27 107.28 18.97 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.796 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 102' ' ' ARG . 34.8 mt-10 -128.53 137.76 51.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.074 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 57.19 34.11 24.32 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.49 . . . . 0.0 110.314 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.85 ' HA ' HD21 ' A' ' 103' ' ' LEU . 19.5 t-20 61.29 33.37 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.159 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.6 mt-10 -125.28 135.07 52.13 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.745 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -86.75 120.19 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 2.6 m120 -122.64 159.77 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.0 m -107.77 127.86 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.581 173.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.855 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.1 t -100.37 111.09 28.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.342 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 12.4 t70 -76.65 114.06 14.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.567 HG21 ' HG2' ' A' ' 97' ' ' ARG . 24.1 m -105.24 -20.21 6.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.34 0.59 . . . . 0.0 110.331 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.32 91.93 0.88 Allowed Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.442 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.684 ' OG ' ' HB2' ' A' ' 98' ' ' HIS . 0.7 OUTLIER -80.4 162.16 24.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.765 HD23 ' HB ' ' A' ' 24' ' ' VAL . 50.3 tp -61.68 -55.47 30.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.564 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.445 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 18.6 p-10 -69.02 -37.6 78.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.246 0.546 . . . . 0.0 110.301 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 127.24 169.98 12.79 Favored Glycine 0 C--O 1.254 1.374 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.845 -172.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.2 m -112.1 136.58 51.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.632 0.773 . . . . 0.0 111.118 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.4 m-85 -138.05 104.68 5.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 137' ' ' VAL . 47.2 t -94.52 105.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 11.8 m120 56.61 43.03 26.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER 76.82 -6.9 1.94 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.969 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.6 pt-20 -119.2 123.92 28.52 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.339 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 17.1 Cg_exo -67.62 123.15 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.645 2.23 . . . . 0.0 111.695 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.68 175.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.802 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 31.5 t70 -96.1 -45.81 6.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.879 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.1 t -162.77 105.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.82 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.56 136.33 50.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.332 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.57 129.39 33.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.372 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.648 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -63.9 159.89 18.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.043 177.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -161.44 152.61 18.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.26 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -64.45 105.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.169 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.33 4.32 35.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.604 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.81 136.17 34.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.7 tt0 -122.52 134.01 54.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 111.432 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 121' ' ' VAL . 24.8 t -129.61 141.28 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.159 -174.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.7 tp-100 -99.4 128.19 45.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.391 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 0.943 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -135.0 138.38 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.088 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.606 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 73.72 -69.08 1.52 Allowed Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.468 165.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.028 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.9 ptmt -176.38 16.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -117.4 149.95 39.68 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.817 -171.577 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -92.99 129.2 38.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.2 mp -124.04 152.57 42.49 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.804 0.335 . . . . 0.0 111.743 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.73 143.58 26.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.99 170.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.673 ' O ' HD13 ' A' ' 147' ' ' LEU . 45.8 t80 -100.87 136.58 40.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.892 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.58 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 93' ' ' THR . 15.2 m . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.686 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.7 p -144.28 168.68 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.047 -169.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 9.3 t80 171.91 -147.0 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 O-C-N 123.922 0.764 . . . . 0.0 110.554 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.4 m . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 131' ' ' LEU . . . -124.59 170.64 10.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -159.87 137.1 9.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.75 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.078 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.08 111.41 20.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.275 161.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 p -108.73 128.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.444 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -72.19 109.01 4.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 35.0 ttpt -61.96 -60.55 3.46 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.511 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -149.93 115.47 5.53 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.506 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -144.9 -166.15 11.49 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 23.0 Cg_exo -64.3 -46.6 7.41 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.698 1.599 . . . . 0.0 111.572 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.819 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 41.7 t30 -74.69 -50.43 17.63 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.598 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 56.05 155.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.633 -1.622 . . . . 0.0 113.359 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.09 2.42 90.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.11 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -88.22 -179.83 6.23 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 117.397 0.598 . . . . 0.0 109.996 -171.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.86 151.78 3.48 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.861 0.755 . . . . 0.0 112.107 -173.199 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.759 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -93.94 125.49 38.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.1 tm? -80.9 94.89 6.58 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.805 HD22 ' CG ' ' A' ' 101' ' ' PHE . 5.2 mt -91.52 50.75 1.77 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.711 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' HD11 ' A' ' 71' ' ' LEU . 23.7 t70 -104.79 -21.88 13.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.923 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.434 HE21 HG22 ' A' ' 77' ' ' THR . 9.9 pt20 -103.29 -167.78 1.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.0 59.48 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.747 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.72 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.78 130.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.618 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.496 HG22 ' OD2' ' A' ' 86' ' ' ASP . 22.3 p -118.99 132.03 56.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.361 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.6 m -73.99 126.33 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -118.5 116.34 26.46 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 157.94 -139.58 6.45 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.21 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.51 104.1 8.89 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.676 ' CE1' ' HB2' ' A' ' 97' ' ' ARG . 29.1 m80 . . . . . 0 C--N 1.315 -0.933 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.291 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 16.8 m-20 . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -114.2 100.0 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.808 0.814 . . . . 0.0 111.755 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.93 134.41 50.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.366 173.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.015 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.9 mm? -115.21 73.15 0.82 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.5 t70 68.23 -5.01 0.95 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.544 0.688 . . . . 0.0 110.175 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.0 p-10 38.06 42.42 0.46 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.647 1.579 . . . . 0.0 113.133 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 23' ' ' SER . 18.5 t -142.81 -11.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -113.09 -12.16 13.22 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -170.072 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.9 OUTLIER -135.64 150.88 29.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.872 -0.518 . . . . 0.0 110.986 -170.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -69.15 71.97 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.231 0.613 . . . . 0.0 112.63 -171.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.74 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 62.34 -54.69 0.15 Allowed 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.426 0.69 . . . . 0.0 111.493 -174.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.74 ' HB3' ' NE ' ' A' ' 96' ' ' ARG . 3.5 ttm180 -155.63 124.67 6.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.687 -0.633 . . . . 0.0 110.84 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.978 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.62 -40.56 48.96 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.014 176.913 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.79 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -150.39 149.32 29.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.168 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 111' ' ' VAL . 5.3 pt-20 -113.11 130.58 56.13 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.805 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -63.42 101.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 111' ' ' VAL . 19.6 ttm180 -100.55 114.12 27.5 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.571 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 108' ' ' PHE . 14.7 tp -75.64 109.06 8.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.472 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -112.37 123.98 51.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.473 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 7.5 p30 42.47 44.26 3.44 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.049 0.843 . . . . 0.0 111.806 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 105' ' ' ASN . 8.0 t30 75.7 0.18 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.149 173.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.6 mm-40 -104.5 133.13 49.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.646 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -85.79 131.92 34.22 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -172.593 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 14.2 m-80 -134.1 171.21 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.3 m -110.1 156.58 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 168.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 27.0 m -126.28 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 170.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.77 116.77 14.76 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG21 ' HD2' ' A' ' 97' ' ' ARG . 31.5 m -123.42 -22.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.764 0.316 . . . . 0.0 111.366 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.82 102.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.9 t -115.81 133.53 55.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 24' ' ' VAL . 2.7 tm? -56.44 -55.46 33.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.626 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -68.63 -36.02 78.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.06 170.64 12.08 Favored Glycine 0 C--O 1.251 1.205 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.866 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -112.04 133.22 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.036 0.535 . . . . 0.0 110.753 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.647 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.1 m-85 -138.19 103.35 4.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 120.938 0.399 . . . . 0.0 111.043 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.794 HG22 HG13 ' A' ' 137' ' ' VAL . 55.2 t -98.61 123.11 50.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 64.1 33.33 12.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 61.32 28.01 17.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.953 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.7 pt-20 -146.47 150.9 42.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 121.65 -0.656 . . . . 0.0 111.025 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 125.7 11.1 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.572 2.181 . . . . 0.0 111.88 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.24 179.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.741 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -106.55 -47.35 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.3 0.572 . . . . 0.0 109.808 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.8 t -158.16 91.75 1.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.946 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.56 136.65 38.36 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.616 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.94 150.51 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.919 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -63.72 119.41 9.87 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.307 175.314 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.61 121.89 25.11 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.2 118.88 7.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.743 0.782 . . . . 0.0 111.939 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.31 -13.1 33.6 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.254 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.798 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 2.3 t0 -96.63 173.01 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 5.2 pt-20 -139.74 151.87 46.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.572 -168.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.794 HG13 HG22 ' A' ' 121' ' ' VAL . 39.8 t -127.56 141.57 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.3 tp-100 -98.28 129.64 44.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.944 0.402 . . . . 0.0 110.517 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ILE . . . . . 1.015 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -134.55 133.51 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 166.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.03 -77.14 0.56 Allowed Glycine 0 C--O 1.215 -1.04 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.956 172.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 1.031 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.9 ptmt -168.03 25.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.516 0.658 . . . . 0.0 110.755 173.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.819 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -115.81 141.43 48.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -173.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 143' ' ' ARG . 5.5 ttp85 -94.9 106.32 18.3 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.312 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.4 159.51 14.96 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.803 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.9 142.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.299 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 1.078 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -110.49 138.4 46.92 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.283 0.563 . . . . 0.0 112.326 -178.06 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 131' ' ' LEU . 2.8 mm? . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.156 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.235 0.308 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 m 63.23 48.74 3.54 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.888 0.851 . . . . 0.0 109.274 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.44 -153.41 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.136 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.8 mtt 65.65 50.19 1.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 42.7 t30 70.45 96.91 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.588 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 24.1 Cg_endo -62.48 -3.68 4.57 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.247 2.631 . . . . 0.0 113.147 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.402 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 19.5 t70 -66.97 -27.69 67.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mt -78.05 74.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.624 0.726 . . . . 0.0 109.233 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -81.75 52.12 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.983 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -135.93 137.22 41.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.058 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -124.26 -176.48 3.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.29 -65.26 0.73 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 m -161.0 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.597 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 24.0 p -167.06 -164.61 0.63 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.896 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.7 m-20 75.15 169.06 0.28 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.926 0.766 . . . . 0.0 112.834 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -145.52 -47.07 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.467 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.5 m -73.01 132.65 33.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.561 0.696 . . . . 0.0 111.295 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -141.44 -49.15 0.4 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.08 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.53 75.5 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.32 0.581 . . . . 0.0 110.249 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -90.41 -38.16 13.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 22' ' ' TPO . 94.4 m -103.24 142.05 34.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.41 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.704 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -66.61 134.5 52.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -162.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.594 HG22 ' CD1' ' A' ' 116' ' ' LEU . 92.2 t -102.24 137.38 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.272 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' H ' HD21 ' A' ' 117' ' ' ASN . 12.6 t80 174.08 159.77 0.16 Allowed 'General case' 0 C--O 1.213 -0.859 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.505 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.676 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 10.4 tpt85 64.31 -23.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 163.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.819 ' HB2' ' HB3' ' A' ' 117' ' ' ASN . . . -45.63 164.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -167.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.755 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 8.2 t70 -63.15 68.19 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.001 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.456 ' CE2' ' HE2' ' A' ' 120' ' ' TYR . 51.3 m-85 -145.95 -48.81 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.943 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.7 pt? -117.28 -40.15 3.12 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 55.0 m -132.39 178.09 7.09 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.683 -0.636 . . . . 0.0 112.601 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 6.9 tp10 75.7 -57.18 0.58 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.509 1.124 . . . . 0.0 111.005 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.5 -76.44 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.207 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 68.74 -60.85 0.43 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.364 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -135.64 154.7 78.35 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 8.3 Cg_exo -72.66 57.59 3.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 112.355 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.77 103.46 16.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.109 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -96.52 122.28 39.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.21 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.08 102.91 15.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.74 77.95 2.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.687 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -133.06 146.37 51.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.97 0.414 . . . . 0.0 110.675 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -101.27 170.48 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.958 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 m -84.47 65.45 8.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.93 -84.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.566 0.746 . . . . 0.0 112.42 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -93.25 -7.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.936 0.398 . . . . 0.0 110.877 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.574 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 66.7 m 67.84 169.41 0.27 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.609 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.32 -1.56 28.08 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.13 21.26 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.258 1.027 . . . . 0.0 110.297 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -128.47 -42.34 1.48 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.306 171.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -96.44 60.04 1.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 pt? -103.13 109.58 61.88 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 48.5 Cg_endo -108.11 28.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.412 0 C-N-CA 123.098 2.532 . . . . 0.0 115.795 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.38 39.7 0.84 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 CA-C-N 121.646 1.624 . . . . 0.0 112.726 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 15.62 76.95 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -144.15 147.89 34.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.202 -0.499 . . . . 0.0 109.773 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.4 42.98 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 5.1 mp -148.38 139.24 23.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.06 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.6 mp -85.87 135.21 33.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 68' ' ' SER . 3.8 p -125.23 128.57 72.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.158 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.876 HG22 ' H ' ' A' ' 68' ' ' SER . 1.5 m -73.11 109.89 5.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HD2' ' HD2' ' A' ' 143' ' ' ARG . 2.2 ttmp? -57.76 -60.6 3.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.97 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.56 146.59 8.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.364 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 152.02 130.3 1.59 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -175.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.676 ' CD ' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 1.67 -71.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.876 5.051 . . . . 0.0 118.054 -159.22 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.573 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.4 t30 -62.94 -51.67 66.0 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 119.116 0.871 . . . . 0.0 109.123 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.66 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 53.5 165.29 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.221 -1.808 . . . . 0.0 114.172 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.08 4.45 90.24 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.841 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.876 ' H ' HG22 ' A' ' 60' ' ' VAL . 19.9 m -106.71 -167.79 1.33 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 118.053 0.926 . . . . 0.0 112.027 -166.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -170.86 151.74 3.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -168.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.699 ' HE1' ' CD2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.69 118.16 33.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 166.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.586 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.21 107.13 15.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.04 28.02 4.22 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.469 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 25.1 t70 -67.83 -28.24 67.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -96.89 164.19 12.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.683 171.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.85 -16.84 62.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -168.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -173.94 126.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.425 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.41 131.98 55.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.899 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 87' ' ' ILE . 70.0 m -71.76 129.53 38.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.358 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.32 121.31 41.6 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 147.0 -127.99 2.85 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.244 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.26 102.93 14.4 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 96' ' ' ARG . 33.8 m80 -137.73 123.77 13.0 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.729 -171.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 17.2 Cg_exo -71.56 -40.13 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.671 2.248 . . . . 0.0 111.001 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -146.44 104.52 3.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.154 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 42.9 m -160.76 -88.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' HB3' ' A' ' 71' ' ' LEU . 16.1 t70 -173.99 -59.91 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 174.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -90.23 91.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.911 0.862 . . . . 0.0 110.416 178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -104.58 123.89 48.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.353 172.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.982 HD11 HD21 ' A' ' 144' ' ' LEU . 15.4 mt -110.46 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 37.4 t70 74.09 -26.28 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.471 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 16.9 t70 63.52 28.15 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 122.658 1.218 . . . . 0.0 110.524 174.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 22' ' ' TPO . 46.2 t -135.73 -12.75 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.987 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.619 HG21 ' HE3' ' A' ' 141' ' ' LYS . 1.5 p -108.38 -29.85 8.62 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.536 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.8 t -103.39 151.65 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.107 -0.371 . . . . 0.0 110.899 -169.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.704 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 15.9 m -74.56 69.3 1.7 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.591 0.356 . . . . 0.0 110.074 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.678 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 56.33 -62.94 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.01 -166.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.639 ' HG3' HG21 ' A' ' 113' ' ' VAL . 7.6 ptp180 -133.85 139.38 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 120.849 -1.157 . . . . 0.0 111.047 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.815 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -83.88 -43.79 14.95 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.733 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -147.3 163.35 36.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.308 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.5 pt-20 -122.47 122.14 38.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 165.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.793 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.3 OUTLIER -79.58 92.03 5.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -173.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 111' ' ' VAL . 11.6 ptp180 -92.8 131.85 37.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.713 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.706 HD21 ' HA ' ' A' ' 106' ' ' ASN . 6.2 tt -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.455 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 62.6 mm-40 -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 63.02 31.58 15.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.211 0.319 . . . . 0.0 110.456 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.706 ' HA ' HD21 ' A' ' 103' ' ' LEU . 56.3 m-20 68.81 7.46 6.17 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.802 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.666 ' HG3' HD21 ' A' ' 109' ' ' ASN . 11.2 pt-20 -117.35 133.51 55.89 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.004 0.431 . . . . 0.0 110.391 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -85.64 140.2 30.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 33.0 m-80 -144.73 157.15 44.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.386 -173.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -102.13 118.98 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.591 0.71 . . . . 0.0 110.329 177.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 2.1 t -99.81 113.36 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.792 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 119' ' ' THR . 14.4 t70 -74.67 129.86 38.47 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.929 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.639 HG21 ' HG3' ' A' ' 97' ' ' ARG . 20.3 m -132.16 19.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 103.99 0.55 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.654 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.815 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.9 p -104.17 152.83 21.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 3.2 tm? -59.42 -55.84 29.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -170.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.819 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 19.0 m120 -67.81 -36.39 80.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.876 0.369 . . . . 0.0 110.611 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.89 150.76 5.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.213 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 98' ' ' HIS . 19.6 m -109.47 126.6 53.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 111.52 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 38.1 m-85 -139.73 157.15 46.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.109 171.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 137' ' ' VAL . 2.4 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.448 HD22 HG22 ' A' ' 121' ' ' VAL . 57.1 m-80 61.55 45.28 8.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.069 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 3.0 mmp_? 69.1 9.69 7.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.56 136.74 24.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.355 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.06 138.35 33.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.917 2.411 . . . . 0.0 111.771 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 129' ' ' ALA . 19.7 m -135.47 179.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.674 0.273 . . . . 0.0 111.215 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.8 m-20 -95.84 -53.23 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.1 p -154.0 91.67 1.47 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -89.99 143.78 26.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.15 135.87 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.893 -174.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.736 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 2.3 tt -53.08 117.76 3.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.979 168.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -124.7 -175.73 3.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.175 -172.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -103.14 94.55 5.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.45 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.52 -22.89 23.55 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.46 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.855 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 7.1 m-20 -73.0 158.86 34.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.444 0.164 . . . . 0.0 110.652 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 145' ' ' VAL . 9.2 pt-20 -133.89 150.56 51.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.079 0.942 . . . . 0.0 113.087 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 121' ' ' VAL . 46.5 t -115.68 144.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.552 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.755 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.6 tp-100 -97.17 119.67 36.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 172.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -116.08 120.6 65.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 63.39 -102.14 0.51 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 118.871 -1.633 . . . . 0.0 110.889 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.619 ' HE3' HG21 ' A' ' 93' ' ' THR . 8.9 pttt -142.14 42.32 1.66 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.259 0.552 . . . . 0.0 111.651 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.758 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -134.97 148.92 50.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.463 ' HD3' ' CD ' ' A' ' 136' ' ' GLU . 4.7 ttm180 -98.71 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 89' ' ' LEU . 2.9 mp -116.6 110.65 18.8 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -103.4 140.85 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 120.9 0.381 . . . . 0.0 110.395 -177.033 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.06 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.88 147.22 31.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.215 0.531 . . . . 0.0 112.397 -177.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.625 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 2.3 mm? -137.91 161.93 35.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.534 ' OG1' ' HD2' ' A' ' 150' ' ' PRO . 15.3 t -172.83 161.3 4.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.002 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 151' ' ' LYS . . . -60.47 -56.88 21.95 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.254 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.534 ' HD2' ' OG1' ' A' ' 148' ' ' THR . 82.6 Cg_exo -47.1 134.92 18.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.97 2.447 . . . . 0.0 112.367 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.641 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 19.6 pttm -165.69 -63.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.042 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.641 ' H ' ' HG3' ' A' ' 151' ' ' LYS . 31.8 mt-30 -137.12 19.0 2.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.14 157.45 33.38 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -124.27 106.42 10.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.3 -21.43 36.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.22 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.87 140.3 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.036 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -165.4 117.14 0.73 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.205 -0.997 . . . . 0.0 113.074 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.0 m -108.14 -12.19 15.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.025 0.44 . . . . 0.0 109.888 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 31.7 m -88.38 107.61 18.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -162.13 48.7 0.34 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.76 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -110.55 103.91 1.71 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.021 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 C--O 1.247 0.945 0 C-N-CA 123.219 2.613 . . . . 0.0 112.056 178.961 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 121.813 0.816 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 1.7 m -98.48 132.78 43.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.044 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 2' ' ' THR . 32.6 t70 71.27 136.09 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.08 0.863 . . . . 0.0 111.043 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.434 ' C ' ' HD3' ' A' ' 6' ' ' PRO . 38.5 tpp -95.11 15.32 19.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -126.49 67.4 65.62 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -83.75 96.47 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.869 2.379 . . . . 0.0 112.136 -176.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 5.9 m-20 59.03 59.51 2.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.683 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.5 mt -102.02 125.88 56.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.81 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 58.28 53.78 6.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.465 0.65 . . . . 0.0 110.677 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.618 ' HD3' ' HB3' ' A' ' 7' ' ' ASP . 20.3 pttp -88.93 21.63 3.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.49 139.32 58.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.113 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 6.5 tp60 -123.54 140.84 52.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 m 70.1 83.38 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.709 0.631 . . . . 0.0 110.901 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.3 m 72.66 160.4 0.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.05 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.831 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 19.4 m-20 -118.03 171.67 7.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.852 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -67.48 -65.06 0.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 t -120.15 79.2 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.831 ' HB ' ' HB2' ' A' ' 15' ' ' ASP . 11.6 t -80.84 -9.41 59.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.404 -173.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.08 126.9 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -63.37 100.7 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.654 HG22 HD21 ' A' ' 116' ' ' LEU . 12.3 m -97.51 138.01 35.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.431 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.714 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -15.92 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.96 1.704 . . . . 0.0 114.961 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 117' ' ' ASN . 9.4 p -131.35 153.92 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.827 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 36.8 t80 178.98 -163.6 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.238 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.732 ' HG3' ' N ' ' A' ' 27' ' ' ALA . 7.5 tpt180 50.5 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.008 0.822 . . . . 0.0 111.171 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' N ' ' HG3' ' A' ' 26' ' ' ARG . . . 60.41 149.31 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 122.203 1.001 . . . . 0.0 112.392 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.594 ' HB2' ' HG3' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -104.92 67.36 0.79 Allowed 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.954 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' O ' HD12 ' A' ' 33' ' ' LEU . 71.4 m-85 -121.71 -52.97 2.0 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 173.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 15.4 tp -141.37 43.84 1.76 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.96 0.886 . . . . 0.0 110.508 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -138.84 -73.39 0.39 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.265 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HG3' HH21 ' A' ' 143' ' ' ARG . 15.8 tp10 -74.66 -26.91 60.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.074 0.464 . . . . 0.0 109.927 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -86.33 -77.8 0.3 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.62 -84.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.665 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.68 160.37 29.35 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.74 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 113.052 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.47 50.95 15.0 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.457 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.554 ' OE1' ' HA ' ' A' ' 38' ' ' GLN . 5.4 tp60 57.52 43.24 23.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.943 0.877 . . . . 0.0 110.476 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.35 162.7 39.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.486 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.92 151.51 18.68 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.681 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 m -64.55 108.6 1.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 66.13 101.22 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 O-C-N 123.878 0.736 . . . . 0.0 110.748 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.4 m -61.31 -33.92 74.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.348 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.7 -89.65 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.15 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.6 172.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 p -139.59 31.79 2.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.12 -73.36 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.782 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.8 m 36.23 55.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.979 0.912 . . . . 0.0 112.392 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB3' HD22 ' A' ' 51' ' ' LEU . 6.4 tp10 -80.11 -29.31 38.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.566 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 60.04 53.54 44.9 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.835 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD11 ' HG ' ' A' ' 57' ' ' LEU . 1.1 pt? -106.01 112.22 64.28 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -174.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.683 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 53.4 Cg_endo -112.93 32.11 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.403 2.735 . . . . 0.0 114.379 161.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 52' ' ' PRO . 5.1 Cg_exo -77.91 57.05 5.93 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 121.826 1.684 . . . . 0.0 112.522 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.06 13.55 72.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.914 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -164.81 150.09 9.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.081 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.67 168.98 16.8 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.677 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.2 pp -152.53 134.06 14.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.03 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 mp -88.08 126.36 35.06 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.679 162.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 69' ' ' ARG . 92.6 t -120.83 133.55 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 117.996 0.362 . . . . 0.0 110.616 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.14 119.7 27.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' CG1' ' A' ' 145' ' ' VAL . 26.0 mtpp -53.78 -80.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.625 1.203 . . . . 0.0 111.663 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 43.3 ttt180 -161.74 81.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.568 -174.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 66' ' ' ALA . . . -112.5 -143.84 9.05 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.058 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 42.5 Cg_exo -58.17 -66.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.21 1.94 . . . . 0.0 113.039 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 2.2 t-20 -69.35 -52.8 23.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 55.09 166.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.227 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.55 3.21 90.11 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.277 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.902 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -96.39 177.45 5.69 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.598 -167.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -166.29 153.43 9.62 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -173.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.46 122.88 38.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 167.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.1 tt -83.17 93.84 7.73 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.43 0.633 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.8 OUTLIER -88.46 45.78 1.32 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.916 0.865 . . . . 0.0 109.219 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.449 ' HB3' HD21 ' A' ' 71' ' ' LEU . 13.5 t70 -90.95 -13.47 33.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.951 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.48 174.75 5.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.783 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -66.0 -60.89 2.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 100' ' ' GLU . 1.3 tp -125.68 122.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.313 0.578 . . . . 0.0 111.802 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -104.83 171.71 7.17 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.062 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -117.27 124.09 48.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.737 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.75 121.34 42.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 139.07 -129.95 4.64 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.204 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -84.88 103.27 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.521 ' CE1' ' HB3' ' A' ' 97' ' ' ARG . 38.8 m80 -137.94 132.52 17.19 Favored Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.082 -173.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 37.9 Cg_exo -64.78 -65.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.943 2.429 . . . . 0.0 112.839 173.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -126.28 29.78 5.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 10.0 m -93.4 -170.88 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.841 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -66.69 0.78 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.331 0.586 . . . . 0.0 111.085 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.737 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -100.64 95.87 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.632 0.73 . . . . 0.0 110.867 -175.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -109.14 128.97 55.46 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.552 177.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 HG11 ' A' ' 60' ' ' VAL . 4.0 mm? -113.28 84.63 2.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.695 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 6.4 t70 66.18 -1.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.22 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.789 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 2.9 p30 41.01 37.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.171 1.388 . . . . 0.0 113.921 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 92' ' ' VAL . 9.9 p -161.11 21.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.625 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -123.17 -7.15 8.28 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.495 -0.753 . . . . 0.0 111.675 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 140' ' ' GLY . 1.9 t -125.47 152.16 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -173.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.626 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 15.8 m -73.05 70.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.05 0.452 . . . . 0.0 110.279 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.7 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.56 -67.93 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.936 -168.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.713 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 7.2 ptp180 -136.31 128.74 30.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.544 -1.347 . . . . 0.0 111.493 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.825 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -65.31 -46.05 81.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 171.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -148.95 179.13 8.1 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.008 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.29 123.55 14.71 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.12 93.05 3.28 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.098 0.951 . . . . 0.0 109.82 -168.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.1 tpp180 -81.3 123.6 28.65 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.762 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.904 HD11 ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.04 126.58 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 22.3 tt0 -150.55 126.52 10.46 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 64.82 41.69 4.87 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.651 0.594 . . . . 0.0 109.721 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.904 ' HA ' HD11 ' A' ' 103' ' ' LEU . 3.1 p-10 51.4 22.19 1.39 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.581 1.152 . . . . 0.0 113.313 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.793 ' HG3' HD21 ' A' ' 109' ' ' ASN . 12.5 pt-20 -118.19 134.27 55.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -87.91 143.25 27.22 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.793 HD21 ' HG3' ' A' ' 107' ' ' GLU . 25.0 m-80 -147.36 156.25 42.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.574 0.625 . . . . 0.0 111.447 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -102.54 116.26 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.116 176.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 76.2 t -101.03 111.52 30.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.345 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.59 126.03 28.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.021 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 18.9 m -134.9 14.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.23 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.47 105.08 2.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.791 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.2 t -118.57 128.04 54.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 22' ' ' TPO . 29.3 tp -55.17 -56.24 22.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.877 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 24' ' ' VAL . 2.6 t-20 -62.85 -38.41 90.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.984 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.87 161.26 8.94 Favored Glycine 0 C--O 1.256 1.483 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.646 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.599 HG23 ' HE1' ' A' ' 98' ' ' HIS . 8.1 m -111.39 134.11 53.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.103 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 123' ' ' ARG . 0.1 OUTLIER -141.48 131.27 24.28 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.751 HG22 HG13 ' A' ' 137' ' ' VAL . 80.8 t -142.01 114.19 3.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.01 43.54 14.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 79.8 mtp180 66.86 14.13 9.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -142.3 141.59 21.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 121.914 -0.492 . . . . 0.0 110.622 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 122.96 11.09 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.968 1.779 . . . . 0.0 110.748 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.543 HG13 ' HB ' ' A' ' 121' ' ' VAL . 20.4 m -111.61 174.0 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.389 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 6.1 m-20 -98.11 -47.67 5.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.045 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.891 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.4 p -160.67 102.45 1.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.571 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -99.9 142.45 31.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.83 131.06 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 123.421 0.45 . . . . 0.0 110.739 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD22 ' HB ' ' A' ' 148' ' ' THR . 2.1 tt -51.43 115.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -120.05 -175.21 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -174.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.51 96.78 6.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.624 0.249 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.14 4.98 29.01 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.144 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.915 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 11.6 m-20 -107.46 160.83 15.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.32 0.56 . . . . 0.0 110.247 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -118.08 155.87 29.61 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -166.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.751 HG13 HG22 ' A' ' 121' ' ' VAL . 59.8 t -133.69 141.82 43.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.765 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.594 ' HG3' ' HB2' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -116.77 124.52 49.82 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.825 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -131.22 132.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.986 175.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 84.11 -56.44 5.04 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 119.258 -1.448 . . . . 0.0 113.763 166.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.058 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 43.3 pttt 171.17 27.18 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.144 0.578 . . . . 0.0 110.688 168.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.737 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.56 146.8 51.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.581 HH21 ' HG3' ' A' ' 32' ' ' GLU . 10.0 ttm180 -92.68 119.21 31.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.237 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.907 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -110.08 156.93 19.9 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.12 143.11 28.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 172.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.03 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.15 141.64 34.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.935 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -129.48 142.78 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.218 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.637 ' HB ' HD22 ' A' ' 131' ' ' LEU . 14.5 t -159.15 155.48 27.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.959 0.409 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -98.99 110.24 3.96 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.609 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.46 -45.06 32.65 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.522 2.148 . . . . 0.0 112.045 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 151' ' ' LYS . 23.0 ttmm -154.25 0.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.561 ' HG3' ' CG ' ' A' ' 52' ' ' PRO . 73.6 mt-30 63.52 6.13 2.42 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.486 -173.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 155' ' ' ASP . . . -66.53 148.39 50.62 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.088 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.33 29.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.19 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 153' ' ' GLY . 19.4 t70 -74.69 101.65 4.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.803 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.25 -52.89 6.18 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 124.73 137.52 4.84 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.823 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.9 t -112.69 84.48 1.99 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.46 -18.75 29.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.965 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 135.76 -64.53 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.24 -67.08 1.66 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 N--CA 1.447 -1.226 0 C-N-CA 122.788 2.325 . . . . 0.0 110.629 169.041 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 4' ' ' MET . 13.7 m . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 121.439 0.637 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -113.79 -16.76 12.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.174 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -143.6 34.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.403 ' HB2' HG12 ' A' ' 1' ' ' VAL . 62.4 mtt -136.61 -76.65 0.42 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.541 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.78 159.91 27.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.76 111.61 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.423 2.749 . . . . 0.0 113.261 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.22 12.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.431 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 tt -90.05 -7.75 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 110.944 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -85.38 107.85 17.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.334 -0.394 . . . . 0.0 109.957 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 51.1 mttp 72.76 1.77 4.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.383 0.673 . . . . 0.0 112.572 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.33 159.08 44.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 52.18 43.71 30.34 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.686 0.755 . . . . 0.0 110.266 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -94.0 -54.43 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.886 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -131.87 41.17 3.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -133.49 57.59 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.495 0.664 . . . . 0.0 110.697 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.76 116.96 12.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.2 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.81 -51.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.453 0.644 . . . . 0.0 109.462 174.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 t -148.34 125.89 11.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.48 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.89 107.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 51.56 55.56 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.073 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.7 m -108.93 133.06 53.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.369 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.79 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 17.2 m 9.84 115.08 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.509 1.924 . . . . 0.0 115.666 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 116' ' ' LEU . 4.4 p -134.77 157.57 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.633 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -177.07 -171.78 0.37 Allowed 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.912 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 51.66 -111.46 0.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.222 0.465 . . . . 0.0 110.078 171.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.465 ' HB1' ' ND2' ' A' ' 117' ' ' ASN . . . 64.11 169.24 0.17 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 167.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.577 ' HA ' HD21 ' A' ' 33' ' ' LEU . 12.4 t70 -84.19 77.85 9.89 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.739 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -143.22 -51.12 0.35 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.36 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.7 tp -93.59 -68.64 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.775 -176.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.8 p -169.73 -158.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.721 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 63.22 25.64 14.87 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.831 0.824 . . . . 0.0 110.497 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 28' ' ' ASP . 1.9 pp -165.04 -34.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.151 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 33' ' ' LEU . 38.7 t70 -80.08 59.04 3.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.21 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -168.13 67.78 0.78 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.5 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.0 67.54 8.04 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.153 2.568 . . . . 0.0 111.758 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.93 81.19 1.38 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 60.5 tp60 -142.97 111.38 6.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.647 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.22 120.98 24.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.17 -79.93 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.788 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.7 m -139.58 58.05 1.62 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.464 0.649 . . . . 0.0 110.295 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.5 pm0 -83.97 78.99 9.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.497 0.665 . . . . 0.0 110.643 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -125.67 145.48 50.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.39 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.54 92.15 2.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.981 0.419 . . . . 0.0 111.45 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 150' ' ' PRO . 26.7 m -111.12 144.74 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.743 175.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.5 m -142.94 114.71 8.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.815 0.341 . . . . 0.0 110.535 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.08 -42.96 0.31 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.541 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.91 26.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.228 0.514 . . . . 0.0 112.097 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -85.38 -59.96 2.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.644 ' CA ' ' HA ' ' A' ' 148' ' ' THR . . . 173.46 20.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.212 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -44.21 134.95 4.23 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 122.073 0.939 . . . . 0.0 112.875 174.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HA ' ' HZ ' ' A' ' 108' ' ' PHE . 72.8 Cg_exo -50.25 -34.71 41.0 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.128 3.219 . . . . 0.0 115.11 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 51' ' ' LEU . 6.3 Cg_exo -80.63 36.34 0.62 Allowed 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.99 1.793 . . . . 0.0 112.191 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.85 -90.77 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.474 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 1.6 m -156.34 153.68 29.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -124.45 167.72 14.03 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.74 145.76 12.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.971 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -95.37 115.92 28.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.889 163.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.6 125.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.893 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -70.37 116.49 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 45.1 tptt -68.72 -82.81 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.744 -171.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -144.22 123.38 12.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 111.009 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.722 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -164.12 -105.37 0.19 Allowed Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.205 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.659 ' CG ' ' HG3' ' A' ' 141' ' ' LYS . 4.8 Cg_exo -77.76 -88.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.954 2.436 . . . . 0.0 112.333 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.796 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.5 t30 -64.73 -48.29 75.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.722 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.34 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.221 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 0.92 89.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.09 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.911 ' H ' HG22 ' A' ' 60' ' ' VAL . 2.7 m -86.29 171.55 11.14 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 117.212 0.506 . . . . 0.0 109.673 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.669 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -167.68 153.62 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.377 0.535 . . . . 0.0 111.581 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.64 126.82 40.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.1 tm? -84.7 96.08 9.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.33 1.019 . . . . 0.0 108.571 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.864 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -93.38 50.3 1.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.844 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB3' HD11 ' A' ' 71' ' ' LEU . 21.3 t70 -104.97 -19.41 13.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.832 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.82 -166.9 1.34 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.426 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.56 -40.63 56.46 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.423 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.32 135.6 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.721 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 22.3 p -116.42 141.75 47.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.084 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 43.2 m -85.61 124.79 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.07 106.34 11.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 161.61 -129.47 2.11 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -68.77 108.34 3.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.72 0.771 . . . . 0.0 110.456 173.343 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.762 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -138.91 129.89 15.07 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 19.2 Cg_exo -68.97 -62.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.871 2.381 . . . . 0.0 112.358 173.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.49 101.62 1.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.112 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 82' ' ' HIS . 3.1 p -164.59 -85.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.188 171.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.08 -75.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.416 0.627 . . . . 0.0 111.115 -172.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -127.75 110.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.187 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -109.27 134.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.2 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.045 ' HG ' HD11 ' A' ' 139' ' ' ILE . 3.0 mm? -117.39 72.27 0.83 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.551 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 34.1 t70 62.8 4.21 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.381 0.61 . . . . 0.0 109.853 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 t70 66.73 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.261 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' SER . 14.2 p -80.57 69.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.42 1.105 . . . . 0.0 112.866 -167.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -162.69 4.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.941 167.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.4 t -140.63 141.82 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.621 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 10.9 t -76.14 72.76 2.96 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 66.1 -48.87 0.42 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.072 -173.218 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.572 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 8.1 ptp85 -154.46 135.0 13.45 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.592 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -72.13 -36.84 69.49 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -159.95 176.56 11.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.225 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 102' ' ' ARG . 6.0 pt-20 -134.04 135.19 43.18 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.864 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -61.17 95.89 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -92.49 98.17 11.29 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.678 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -77.98 107.83 10.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.267 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.57 139.85 45.68 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.036 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 58.61 32.52 22.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.914 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.871 ' HA ' HD21 ' A' ' 103' ' ' LEU . 89.0 m-20 67.5 9.11 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.895 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 17.5 mm-40 -105.49 151.67 23.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.398 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -99.34 124.32 44.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.531 ' OD1' ' HB ' ' A' ' 130' ' ' VAL . 11.6 m-80 -136.19 157.8 45.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -174.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 12.3 m -107.94 123.29 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.196 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' A' ' 128' ' ' SER . 78.0 t -100.52 110.47 27.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.732 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -67.35 122.33 17.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 97' ' ' ARG . 17.1 m -127.45 -11.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 141.72 77.39 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.272 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 28.6 t -86.34 137.23 32.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.79 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.7 tm? -53.47 -54.01 43.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.042 -174.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.662 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -73.81 -35.75 64.9 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.831 0.741 . . . . 0.0 109.936 172.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.12 171.9 12.84 Favored Glycine 0 C--O 1.253 1.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.076 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.4 m -111.37 130.26 55.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.651 -0.775 . . . . 0.0 110.904 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 68.0 m-85 -138.41 104.2 5.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.896 0.379 . . . . 0.0 110.859 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 137' ' ' VAL . 58.1 t -100.73 125.92 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 m120 64.53 22.89 12.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 61.79 38.2 15.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.764 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -142.35 144.63 31.81 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.76 122.54 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.423 2.082 . . . . 0.0 111.197 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 121' ' ' VAL . 19.3 m -114.74 171.51 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.6 t70 -111.93 -41.97 3.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.669 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.7 p -164.86 91.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.7 0.762 . . . . 0.0 110.21 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.95 128.13 53.09 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.307 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 9.1 p -73.01 154.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.429 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 108' ' ' PHE . 10.4 mp -62.25 165.7 5.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.52 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . . . -152.0 -176.78 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.3 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.31 90.94 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.825 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.55 4.89 37.09 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 119.922 -1.132 . . . . 0.0 114.538 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.645 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 2.4 t70 -93.99 166.59 12.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.954 0.877 . . . . 0.0 110.117 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 3.5 pt-20 -127.76 150.27 49.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.768 HG13 HG22 ' A' ' 121' ' ' VAL . 38.5 t -125.97 141.92 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.62 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -99.69 125.58 45.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.045 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.15 131.53 45.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 169.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.07 -76.33 1.07 Allowed Glycine 0 C--O 1.222 -0.649 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.949 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.912 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 7.4 pttt -171.93 28.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 111.08 171.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.811 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.24 143.51 44.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.583 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 ttm180 -90.67 100.81 13.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.0 mp -93.93 158.47 15.63 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.7 143.14 27.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.971 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -107.08 147.16 30.34 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.28 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 146' ' ' PHE . 3.1 mm? -131.25 150.4 52.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.543 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.644 ' HA ' ' CA ' ' A' ' 50' ' ' GLY . 12.2 t -145.05 175.06 10.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 51' ' ' LEU . . . -64.34 123.41 27.51 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.851 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 149' ' ' GLY . 29.1 Cg_exo -62.02 112.57 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.807 2.338 . . . . 0.0 111.906 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -84.63 50.29 1.87 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.426 0.631 . . . . 0.0 110.487 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -150.25 128.92 12.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.149 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.1 2.58 61.55 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.013 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 155.74 46.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -135.35 130.29 34.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.427 0.632 . . . . 0.0 111.063 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -122.68 -2.69 8.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.444 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.34 8.96 78.7 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.764 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 p -79.67 62.29 3.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.54 0.686 . . . . 0.0 110.761 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.5 m -89.69 123.39 33.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.468 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.93 113.83 4.74 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.388 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -75.42 128.44 9.79 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.49 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.211 2.607 . . . . 0.0 111.732 176.752 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.7 m -80.14 -15.99 55.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.5 166.55 10.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.985 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -130.6 152.73 49.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.848 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 5.5 m-20 -91.69 132.62 32.72 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 7.6 Cg_exo -73.69 101.6 1.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.377 2.718 . . . . 0.0 112.672 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -86.21 88.05 7.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.1 162.79 38.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.198 -167.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -110.52 115.94 30.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -169.24 38.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.2 100.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.883 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 53.46 29.69 9.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.966 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m -96.41 52.16 1.23 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.462 0.648 . . . . 0.0 110.014 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -105.94 -76.61 0.6 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.208 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -128.4 -55.01 1.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.386 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -115.84 137.65 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.811 0.339 . . . . 0.0 110.661 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 t -106.91 78.98 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.363 0.601 . . . . 0.0 109.403 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -88.87 63.85 6.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.786 0.803 . . . . 0.0 110.819 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -82.7 57.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.695 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 55.28 67.87 0.95 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.635 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -147.92 143.05 27.09 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.693 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 93' ' ' THR . 74.6 m -61.24 122.78 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -168.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.5 p -140.81 150.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.924 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' H ' ' HD2' ' A' ' 141' ' ' LYS . 8.5 t80 -176.73 -139.65 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.548 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.773 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER 36.53 -100.19 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.001 0.921 . . . . 0.0 110.614 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' H ' ' HB3' ' A' ' 26' ' ' ARG . . . 63.85 120.25 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 122.587 1.184 . . . . 0.0 112.723 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.724 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -88.76 84.77 6.69 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.453 -167.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.444 ' HZ ' ' ND2' ' A' ' 117' ' ' ASN . 25.2 m-85 -116.3 -59.23 2.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.607 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.6 pt? -120.63 17.32 12.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.762 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 p -148.72 164.82 33.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.712 ' HG3' ' HE ' ' A' ' 143' ' ' ARG . 21.7 tp10 67.52 -69.23 0.14 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.241 0.963 . . . . 0.0 110.756 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.724 ' CD2' ' HB3' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -65.46 -33.2 75.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 171.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' HD12 ' A' ' 33' ' ' LEU . 38.7 t70 42.12 75.07 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.273 0.983 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -117.89 117.83 35.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.994 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 1.6 Cg_endo -83.6 21.98 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.263 2.642 . . . . 0.0 111.896 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.68 157.8 30.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.106 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -110.32 128.62 55.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.12 72.55 9.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.612 -174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.67 79.45 1.11 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.694 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -147.28 101.68 3.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.782 0.325 . . . . 0.0 110.477 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -85.01 -78.94 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.767 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t 50.39 43.8 26.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.614 0.721 . . . . 0.0 109.295 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.94 107.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.872 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -95.59 115.78 35.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.183 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 m -102.39 120.41 40.46 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.266 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.8 36.04 0.33 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.121 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HA ' ' OE2' ' A' ' 107' ' ' GLU . 49.6 t 66.78 95.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.203 0.601 . . . . 0.0 111.382 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.68 -71.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.37 5.37 0.37 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.336 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.0 mp -74.57 117.8 65.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 43.1 Cg_endo -109.02 31.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 123.108 2.538 . . . . 0.0 115.13 170.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' PRO . 43.8 Cg_endo -92.75 153.64 2.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 121.516 1.477 . . . . 0.0 113.26 -176.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.41 -19.32 52.88 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -142.58 129.13 20.23 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.577 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -126.42 172.29 10.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.708 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.2 pt? -161.24 139.44 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 118.296 -1.362 . . . . 0.0 114.454 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 72' ' ' LEU . 2.7 mp -85.86 112.35 21.05 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.991 167.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 69' ' ' ARG . 62.1 t -101.46 125.31 55.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.032 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -70.46 109.89 3.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.396 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.89 -44.36 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.184 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -155.18 143.77 20.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 172.49 -155.45 23.32 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.081 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 24.7 Cg_exo -63.87 -59.96 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.061 1.841 . . . . 0.0 111.958 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.742 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 48.2 t30 -75.67 -49.94 16.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.655 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.96 164.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.403 -174.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 2.71 90.61 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.723 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.939 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.6 m -101.45 -169.05 1.64 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 117.6 0.7 . . . . 0.0 110.616 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.79 160.08 5.48 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -171.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.6 m-30 -96.48 127.88 42.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 167.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.3 tm? -80.77 97.34 7.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.708 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.5 mt -94.13 46.29 1.16 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.553 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 13.0 t70 -100.48 -19.15 16.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.756 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.58 -166.66 1.26 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.615 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.1 36.53 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.552 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -157.79 120.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.034 -175.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 8.7 p -113.41 119.86 39.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 87' ' ' ILE . 15.2 m -66.04 128.56 36.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -125.98 107.56 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -166.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.31 -132.97 2.85 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.854 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.855 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.49 110.56 6.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.828 0.823 . . . . 0.0 108.946 173.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER -137.97 136.39 19.68 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -162.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.06 179.95 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.376 2.05 . . . . 0.0 108.872 155.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.6 73.89 3.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 111.738 -173.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -117.34 -69.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.1 OUTLIER -125.94 -80.04 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.443 0.64 . . . . 0.0 111.169 -174.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -124.12 117.38 50.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.622 -174.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -115.57 127.48 55.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.036 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.854 HD21 HG11 ' A' ' 60' ' ' VAL . 11.5 mt -115.91 80.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.1 t70 70.02 -8.49 0.82 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p-10 43.6 32.41 0.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.396 1.479 . . . . 0.0 113.105 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 23' ' ' SER . 26.0 t -138.8 -9.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.428 -176.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -110.56 -13.55 14.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.465 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.819 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -118.58 146.74 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.679 -171.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.693 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 27.1 m -71.59 75.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.999 0.428 . . . . 0.0 109.924 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.84 -61.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.319 -172.024 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -153.7 139.53 18.08 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.687 0.756 . . . . 0.0 110.967 177.008 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.663 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -69.51 -40.3 77.04 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.227 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -158.26 179.27 9.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.474 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.44 131.27 22.86 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -59.64 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.291 -175.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG3' ' HG2' ' A' ' 104' ' ' GLU . 3.0 tpp180 -89.98 100.4 13.23 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.239 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.825 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.6 tt -77.63 110.87 12.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 77.5 mm-40 -131.98 138.81 48.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.459 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 59.32 31.35 21.07 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.583 0.552 . . . . 0.0 110.11 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HD21 ' A' ' 103' ' ' LEU . 47.1 m-80 70.19 3.21 4.3 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.877 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.63 149.19 22.06 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.501 ' HD1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -93.8 124.08 37.57 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' HG22 ' A' ' 130' ' ' VAL . 12.9 m-80 -133.55 154.6 50.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.412 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 128' ' ' SER . 14.0 m -107.87 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.203 0.525 . . . . 0.0 110.867 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 128' ' ' SER . 84.1 t -101.22 111.47 31.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.833 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 119.52 12.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 111' ' ' VAL . 15.7 m -120.48 -11.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.432 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 146.36 71.47 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.354 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 98' ' ' HIS . 4.5 m -84.97 132.13 34.39 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.675 HD22 ' HB ' ' A' ' 22' ' ' TPO . 41.2 tp -60.94 -56.65 18.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.166 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -72.92 -35.78 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.38 0.61 . . . . 0.0 109.745 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.0 169.15 11.98 Favored Glycine 0 C--O 1.256 1.525 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.26 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -113.82 125.85 54.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.382 -0.909 . . . . 0.0 110.969 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' CD1' ' HE1' ' A' ' 29' ' ' PHE . 10.1 m-85 -132.75 105.7 7.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.03 0.443 . . . . 0.0 110.906 173.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 137' ' ' VAL . 45.7 t -101.44 110.3 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 15.2 m120 56.73 38.38 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.132 0.492 . . . . 0.0 110.484 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 9.6 mmm180 77.43 1.87 3.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.389 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.7 pt-20 -126.83 130.89 23.72 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.474 0.654 . . . . 0.0 111.442 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 23.2 Cg_exo -65.6 125.85 15.1 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 129' ' ' ALA . 27.8 m -115.54 165.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 111.701 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 m-20 -82.81 -51.83 7.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 171.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.3 p -160.31 91.03 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.554 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 126' ' ' VAL . . . -86.07 141.86 29.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.301 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 109' ' ' ASN . 39.7 t -78.32 124.17 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.956 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -59.28 156.18 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.342 0.401 . . . . 0.0 111.659 176.242 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.472 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -157.02 154.71 30.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -69.12 98.82 1.04 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.878 0.37 . . . . 0.0 110.011 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.23 0.84 29.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.06 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 17.2 t70 -69.17 148.87 49.28 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 9.0 tt0 -135.9 127.15 28.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.607 0.718 . . . . 0.0 111.824 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -123.64 133.19 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.568 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.528 ' CG ' ' HB2' ' A' ' 28' ' ' ASP . 20.1 tm0? -94.27 128.55 40.82 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.716 HG23 HD13 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -134.65 140.87 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 173.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 73.5 -68.12 1.52 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.231 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.081 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.7 ptmt -176.2 22.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.416 0.686 . . . . 0.0 109.345 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.742 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -123.15 161.83 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -171.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.712 ' HE ' ' HG3' ' A' ' 32' ' ' GLU . 26.9 ttp85 -112.18 119.59 38.91 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.434 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.828 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -109.5 154.11 23.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.411 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -141.26 139.87 32.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.155 171.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.654 ' O ' HD13 ' A' ' 147' ' ' LEU . 47.0 t80 -98.21 138.55 35.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.812 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? -130.43 155.46 46.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.318 172.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.558 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 14.1 t -155.79 -175.39 5.41 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -124.48 79.66 0.36 Allowed Glycine 0 C--O 1.226 -0.344 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.95 -59.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.111 2.541 . . . . 0.0 113.317 -173.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -80.5 79.2 7.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.147 0.499 . . . . 0.0 111.198 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -92.94 98.47 11.39 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -69.2 118.85 8.98 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.732 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -73.09 128.51 35.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.12 0.486 . . . . 0.0 110.213 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -68.79 -24.5 64.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.06 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.1 107.16 18.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.973 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.24 4.26 2.6 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.136 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.8 m -95.43 68.17 2.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.872 0.368 . . . . 0.0 110.617 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -93.83 119.77 33.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.282 0.563 . . . . 0.0 110.587 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.37 -33.87 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.246 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.45 160.98 32.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.003 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 123.208 2.605 . . . . 0.0 112.123 179.116 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -165.85 154.58 11.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.625 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -102.7 133.8 47.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.354 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -78.58 72.78 5.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.13 0.49 . . . . 0.0 111.069 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.849 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 38.7 m-80 -106.68 -45.69 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.807 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.849 ' HD2' ' H ' ' A' ' 5' ' ' ASN . 15.1 Cg_endo -57.78 167.43 4.12 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.095 1.863 . . . . 0.0 112.684 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 13.8 m-20 74.2 -62.28 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.144 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.71 -55.54 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.45 107.85 18.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.247 0.546 . . . . 0.0 109.815 -178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -94.9 72.35 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.685 -174.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 47.7 66.88 0.92 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.591 0.71 . . . . 0.0 110.866 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -100.98 82.31 2.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.279 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -66.0 102.01 0.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 m -86.62 43.29 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.002 0.429 . . . . 0.0 111.569 -173.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.94 25.2 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 57.34 42.99 24.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.742 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 20' ' ' GLU . 16.9 m -92.1 47.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 p -67.98 -26.07 65.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.328 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.86 15.34 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 110.483 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 19.0 tp10 -81.88 -43.32 18.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 22' ' ' TPO . 94.2 m -152.86 133.01 13.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.441 174.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.708 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 93' ' ' THR . 16.3 m -54.68 125.65 20.73 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.874 0.369 . . . . 0.0 111.613 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HB ' HD21 ' A' ' 116' ' ' LEU . 14.7 p -138.7 135.89 43.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.646 -168.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 2.2 t80 173.34 -170.64 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.352 0.261 . . . . 0.0 110.759 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.9 OUTLIER 54.75 -153.03 0.32 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.466 0.706 . . . . 0.0 111.284 172.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 67.32 -177.91 0.21 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 171.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 33' ' ' LEU . 29.7 t70 -72.84 51.34 0.28 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.459 1.123 . . . . 0.0 110.964 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 14.1 m-85 -142.04 -36.66 0.41 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.8 tp -100.96 -68.82 0.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.958 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m 176.29 -171.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.095 0.558 . . . . 0.0 110.779 -170.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 78.33 43.72 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 166.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.775 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -153.05 -99.05 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.737 172.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.07 42.21 31.69 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.989 0.806 . . . . 0.0 111.566 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HA ' ' HG3' ' A' ' 136' ' ' GLU . . . 70.48 133.22 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 123.918 0.761 . . . . 0.0 111.23 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.696 ' HD3' ' HG3' ' A' ' 136' ' ' GLU . 70.3 Cg_endo -76.5 -25.34 9.69 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.476 2.117 . . . . 0.0 112.001 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.17 161.37 16.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -91.3 94.91 9.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.69 -79.16 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 O-C-N 123.877 0.736 . . . . 0.0 111.318 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.97 108.89 0.21 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.31 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -99.1 -25.26 14.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -152.96 93.75 1.78 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.172 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.8 m -138.72 34.31 2.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.21 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.87 -47.09 12.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.669 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -63.65 -29.33 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.05 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.745 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 4.7 p -93.97 -12.57 28.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.102 0.477 . . . . 0.0 110.841 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.22 -32.91 12.7 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.21 10.48 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.519 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -97.97 -29.36 13.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.298 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 147' ' ' LEU . . . -100.23 -68.05 0.85 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.062 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.687 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 11.5 mt 44.42 -175.46 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -171.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 14.1 Cg_endo -94.73 14.83 1.24 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.243 1.962 . . . . 0.0 116.865 174.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.687 ' HD2' ' C ' ' A' ' 51' ' ' LEU . 18.5 Cg_endo -61.38 -158.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 121.998 1.798 . . . . 0.0 113.462 167.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -54.59 -28.24 44.79 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 137.41 26.71 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -123.77 172.8 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -155.06 144.27 21.05 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 117.566 -1.654 . . . . 0.0 114.743 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -93.56 112.57 24.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.807 166.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 5.9 p -111.97 131.67 62.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.695 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -76.51 110.48 11.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -72.33 -58.59 3.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.343 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -145.07 131.8 20.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.717 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.01 -174.34 38.77 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.921 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 44.7 Cg_exo -56.59 -47.55 23.21 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.964 1.776 . . . . 0.0 113.015 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 2.9 t-20 -82.91 -51.76 7.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.815 0.816 . . . . 0.0 108.817 172.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.636 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 54.91 170.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.079 -171.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.79 2.5 90.56 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.778 -0.725 . . . . 0.0 114.057 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.976 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.2 m -99.91 179.32 4.55 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 117.901 0.85 . . . . 0.0 110.653 -170.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.689 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.81 154.7 4.41 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.008 0.367 . . . . 0.0 111.821 -175.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -93.54 116.26 28.78 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 171.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.8 tt -74.27 97.19 2.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 124.403 1.064 . . . . 0.0 108.809 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 58' ' ' LEU . 12.5 mt -91.19 32.27 1.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.786 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -88.69 -15.71 34.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -87.72 -167.08 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.375 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.68 -30.87 16.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.0 109.802 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -160.98 133.1 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 176.48 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 23.1 p -121.51 147.89 45.19 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.899 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.643 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 59.8 m -93.63 126.54 38.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.83 128.87 56.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -173.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.33 -117.0 1.1 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.109 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -101.55 101.69 12.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.55 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 32.9 m80 -139.65 122.1 10.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 8.3 Cg_exo -80.51 -13.84 11.91 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 123.683 2.922 . . . . 0.0 112.332 168.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -124.11 -34.89 2.89 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 1.4 m -78.52 -173.56 3.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -164.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 10.9 m-20 -91.26 -16.91 26.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.791 -171.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -132.54 97.65 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.078 0.942 . . . . 0.0 110.203 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.441 ' C ' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -110.74 130.26 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.33 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 60' ' ' VAL . 4.5 mm? -116.2 76.09 1.0 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.94 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 67.98 -0.64 1.99 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.644 0.735 . . . . 0.0 110.019 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.3 p-10 35.67 44.0 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.306 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . 9.9 p -151.85 2.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.396 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 23' ' ' SER . 18.9 p -111.85 -7.95 14.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.849 -0.532 . . . . 0.0 112.045 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.9 t -126.81 147.3 31.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 O-C-N 122.043 -0.41 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.594 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 4.2 m -71.01 73.76 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.4 -61.59 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.292 -165.494 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 40.9 ttm180 -145.39 132.3 20.19 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.276 -0.89 . . . . 0.0 111.603 -163.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.867 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -87.92 -46.78 9.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.514 170.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.73 158.38 43.86 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.201 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 97' ' ' ARG . 7.8 pt-20 -124.27 130.96 53.42 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 166.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.07 95.97 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.272 -174.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -92.87 106.48 18.44 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.235 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 106' ' ' ASN . 9.3 tt -76.24 109.11 9.65 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.23 136.17 50.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.923 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 60.03 31.83 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.888 ' HA ' HD21 ' A' ' 103' ' ' LEU . 67.3 m-20 63.5 15.36 8.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.415 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -114.15 156.36 24.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.882 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -94.68 133.52 38.27 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.447 ' OD1' HG22 ' A' ' 130' ' ' VAL . 14.5 m-80 -139.91 159.49 42.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -107.79 126.3 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.267 171.061 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 34.2 m -101.92 123.64 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.684 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.93 126.35 30.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.819 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.77 -3.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 110.619 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 121.45 91.6 1.16 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.402 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 18.1 t -98.83 134.97 40.95 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.708 HD22 ' HB ' ' A' ' 22' ' ' TPO . 20.4 tp -52.47 -58.15 7.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 11.5 m-80 -70.6 -37.61 73.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.69 8.28 Favored Glycine 0 C--O 1.242 0.646 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.54 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.519 HG23 ' CE1' ' A' ' 98' ' ' HIS . 15.6 m -112.13 132.92 54.58 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.795 0.438 . . . . 0.0 111.148 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -141.29 140.14 33.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.655 0.264 . . . . 0.0 110.557 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 137' ' ' VAL . 73.1 t -127.89 107.63 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.425 ' HA ' ' OE2' ' A' ' 136' ' ' GLU . 5.0 m-20 64.0 35.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 109.386 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 59.42 30.18 19.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.926 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.8 pt-20 -139.62 128.06 13.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.43 122.66 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.142 1.895 . . . . 0.0 110.955 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.36 162.1 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 14.0 m-20 -72.16 -59.02 2.95 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 46.7 t -159.64 109.63 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.02 141.93 47.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 ' OD1' ' A' ' 109' ' ' ASN . 4.1 t -74.28 142.34 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.596 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.1 mp -51.0 150.93 2.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 111.489 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -134.33 -176.47 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.55 98.75 8.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.655 0.264 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.5 4.42 40.29 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.1 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.934 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 19.7 m-20 -101.81 157.84 16.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.134 0.467 . . . . 0.0 110.331 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HG3' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -105.22 162.04 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 121' ' ' VAL . 47.7 t -136.22 126.57 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.595 172.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.531 ' OE1' ' HB1' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.87 111.35 23.77 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.933 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.867 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -111.95 134.97 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 61.64 -101.4 0.34 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.99 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 15.2 ptmt -141.64 19.36 2.18 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.76 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.678 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 m-85 -112.3 144.31 41.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.509 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.775 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 10.1 ttm180 -92.4 87.1 5.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -83.14 160.82 21.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.026 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.88 139.2 31.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.004 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -97.53 141.87 30.05 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.213 178.438 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.745 ' HG ' ' HB2' ' A' ' 46' ' ' SER . 2.7 mm? -126.6 114.9 18.69 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.422 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 t -126.23 -167.57 1.73 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.661 ' HA3' HD23 ' A' ' 51' ' ' LEU . . . -135.65 108.38 0.68 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.478 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 21.7 Cg_exo -66.63 103.23 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.925 2.417 . . . . 0.0 110.097 171.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 1.021 ' HE2' ' HA ' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -92.55 -14.64 28.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -168.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 27.0 mp0 -89.61 -37.91 14.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 146.24 -46.27 0.76 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 2.2 mp0 55.76 33.1 20.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.566 0.698 . . . . 0.0 110.997 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.63 -6.64 54.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.863 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.18 103.02 3.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.413 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.33 137.56 2.23 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.5 t -162.07 145.14 11.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 m 57.46 58.84 3.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.72 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -123.61 140.54 12.96 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.742 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.6 -70.33 0.4 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.883 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.95 2.433 . . . . 0.0 111.887 178.143 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 121.963 0.887 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.9 m 66.91 79.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.287 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.54 111.68 19.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.185 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -141.75 14.1 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.599 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -120.21 108.58 38.01 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.668 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.97 -27.16 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.36 2.04 . . . . 0.0 110.964 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.97 162.86 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.883 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -111.58 16.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 110.564 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.122 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -82.83 7.61 14.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.845 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -69.04 -43.74 74.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 109.885 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.52 133.83 52.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 p -112.18 -11.58 13.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.5 t 57.56 78.24 0.24 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.431 0.634 . . . . 0.0 109.881 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.3 -34.98 11.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -77.73 -10.04 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.55 -30.04 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.042 0.448 . . . . 0.0 111.198 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.2 p -98.26 87.12 3.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.99 0.424 . . . . 0.0 111.522 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -96.2 -106.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.798 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' H ' HG23 ' A' ' 19' ' ' VAL . 47.8 mt-10 -87.4 80.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 110.307 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 m -155.89 133.59 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.762 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.758 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 43.1 m 33.34 124.96 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.02 ' HA ' ' ND2' ' A' ' 117' ' ' ASN . 8.1 t -110.92 131.86 60.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.11 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 20.6 t80 175.73 -177.38 0.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 173.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.957 ' HD2' ' H ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 54.86 -158.41 0.2 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.233 1.013 . . . . 0.0 111.21 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.957 ' H ' ' HD2' ' A' ' 26' ' ' ARG . . . 62.17 -174.87 0.14 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 170.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.725 ' HA ' HD11 ' A' ' 33' ' ' LEU . 25.6 t70 -72.71 57.45 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.18 0.991 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HD1' ' HB3' ' A' ' 27' ' ' ALA . 20.6 m-85 -145.21 -45.27 0.22 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.4 tp -90.01 -16.32 30.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.337 168.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 p 77.91 30.35 0.46 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.75 1.22 . . . . 0.0 111.717 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.708 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 46.0 mt-10 -79.18 66.73 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.804 0.812 . . . . 0.0 110.26 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -143.56 -50.21 0.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.473 -1.239 . . . . 0.0 107.821 -176.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 52.21 83.96 0.05 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.869 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 48.17 65.86 6.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.553 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 86.1 Cg_endo -86.98 178.45 3.61 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.764 2.309 . . . . 0.0 112.534 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.389 0.614 . . . . 0.0 110.445 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.4 -15.9 59.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.71 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.48 16.71 8.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.406 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.61 93.54 1.48 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.931 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -122.84 141.24 52.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.653 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -79.2 70.83 5.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.967 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -137.11 133.64 35.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.34 91.29 8.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.517 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -104.53 121.01 55.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.164 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -76.0 77.61 2.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.39 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.56 64.91 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.728 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.92 -114.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -100.78 -25.57 14.08 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.588 0.709 . . . . 0.0 110.187 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' C ' ' HD3' ' A' ' 52' ' ' PRO . . . 76.06 45.07 16.77 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.395 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 148' ' ' THR . 70.6 mt -116.26 76.64 6.92 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 89.3 Cg_endo -104.59 39.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.677 2.251 . . . . 0.0 115.271 170.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 51' ' ' LEU . 53.1 Cg_endo -92.51 -151.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.832 1.688 . . . . 0.0 111.181 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 7.72 50.65 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.691 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 p -146.1 141.18 27.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.21 172.78 9.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.732 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 1.8 pt? -160.76 142.05 11.96 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.81 -1.556 . . . . 0.0 114.964 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.2 mp -85.69 117.35 24.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.95 167.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.08 129.0 63.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.934 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -71.5 109.86 4.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.1 -67.37 0.44 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.048 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -145.26 125.23 13.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.726 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.758 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -163.27 -140.33 2.85 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.995 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 21.5 Cg_exo -66.87 -69.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.67 2.246 . . . . 0.0 112.446 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.752 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.5 t30 -69.09 -48.22 63.19 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.01 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.671 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.3 2.11 90.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.221 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.0 m -86.76 -179.86 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.316 0.558 . . . . 0.0 110.287 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.66 150.15 3.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.596 0.635 . . . . 0.0 112.412 -172.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -94.47 120.39 34.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.625 ' O ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -80.92 91.37 6.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.732 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.8 mt -83.38 52.12 2.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.063 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.614 ' HB2' HD21 ' A' ' 71' ' ' LEU . 17.7 t70 -96.36 -37.85 10.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.574 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -96.51 -166.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.774 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.22 39.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -154.0 123.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.634 0.73 . . . . 0.0 112.546 -177.165 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 65.2 p -103.99 138.74 40.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.519 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.799 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 48.8 m -82.05 124.88 30.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.688 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.77 114.77 21.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -171.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.716 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 152.25 -140.31 7.63 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -70.68 104.04 2.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.415 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 26.3 m170 -139.63 115.09 8.11 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -68.47 -50.92 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.694 2.262 . . . . 0.0 111.389 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.21 77.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.799 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 8.2 m -146.74 -161.2 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.448 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.821 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 7.1 m-20 -91.63 -42.57 10.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.688 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -126.48 105.33 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.647 0.737 . . . . 0.0 111.124 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -103.89 134.44 47.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.647 177.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.049 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -118.6 77.14 1.14 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.738 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.6 t70 67.81 -18.5 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.473 0.654 . . . . 0.0 111.267 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 33.1 t70 67.05 24.13 9.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.429 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.758 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.8 p -156.47 53.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 122.296 1.046 . . . . 0.0 110.769 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -152.81 0.06 0.27 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.123 172.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.714 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.8 t -137.23 140.49 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.218 -173.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.455 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 15.9 m -73.68 74.03 1.52 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.238 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HD3' ' HD2' ' A' ' 97' ' ' ARG . 0.2 OUTLIER 66.96 -66.64 0.18 Allowed 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.248 -173.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.423 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -139.57 144.1 37.64 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.702 -0.624 . . . . 0.0 110.523 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.96 -41.39 12.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.854 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.17 165.54 28.02 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.396 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.9 pt-20 -132.69 127.04 33.94 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.715 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -58.28 100.73 0.07 Allowed 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.692 -174.318 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -94.62 100.35 12.32 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.735 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -79.48 104.6 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.128 175.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -134.75 140.67 46.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.717 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 62.34 32.13 17.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.397 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.657 ' HA ' HD21 ' A' ' 103' ' ' LEU . 43.2 m-80 64.58 15.01 9.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.882 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -121.86 146.43 47.1 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.873 0.368 . . . . 0.0 110.809 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -85.8 122.14 29.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.534 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 2.3 m120 -123.87 166.16 16.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.8 m -115.65 128.53 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.245 172.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.8 t -101.51 111.87 32.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.298 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.77 119.88 21.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.564 HG13 HG12 ' A' ' 111' ' ' VAL . 35.6 m -116.59 -27.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 111.085 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.23 105.97 0.43 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.797 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.9 t -101.48 146.88 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.264 0.226 . . . . 0.0 110.6 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 3.2 tm? -60.52 -55.76 29.52 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.628 0.252 . . . . 0.0 110.904 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 1.02 ' ND2' ' HA ' ' A' ' 24' ' ' VAL . 10.9 m120 -74.05 -36.42 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.22 160.82 8.6 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.559 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.2 m -112.81 132.5 55.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.616 0.367 . . . . 0.0 111.727 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.823 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 57.0 m-85 -141.37 105.38 4.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.995 0.426 . . . . 0.0 110.683 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 137' ' ' VAL . 88.0 t -92.04 114.24 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.17 36.98 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.823 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 35.0 mtp-105 53.85 31.99 14.21 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.974 -172.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.7 pt-20 -141.8 137.86 16.56 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 109.979 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.95 122.93 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.09 1.86 . . . . 0.0 111.8 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.0 m -116.93 176.89 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.561 0.219 . . . . 0.0 110.806 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 27.2 t70 -94.75 -66.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 43.4 t -153.15 92.45 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.82 142.41 29.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.023 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -79.45 129.83 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.09 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.725 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 1.0 OUTLIER -59.78 163.75 4.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -167.96 168.99 11.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -61.44 115.52 3.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.849 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.51 5.24 72.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.319 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.5 108.96 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 110.453 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' OE2' ' HB2' ' A' ' 36' ' ' PRO . 8.2 tt0 -94.79 131.8 40.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -124.14 130.84 73.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -101.24 121.68 42.3 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.904 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.049 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.52 140.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.219 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 58.12 -98.87 0.1 OUTLIER Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.3 -0.952 . . . . 0.0 110.869 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.995 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.2 ptmt -140.85 18.22 2.32 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.235 0.54 . . . . 0.0 111.096 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.752 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -110.42 150.29 29.04 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -107.37 105.46 15.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' A' ' 60' ' ' VAL . 5.3 mp -98.71 157.51 16.22 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.505 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.78 141.32 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.106 169.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.725 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 37.3 t80 -100.07 137.65 38.23 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -135.74 169.93 16.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.207 170.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.696 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 13.9 t -175.54 168.62 3.19 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -173.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' N ' ' H ' ' A' ' 51' ' ' LEU . . . -110.06 138.59 14.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.561 171.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.71 113.63 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.852 2.368 . . . . 0.0 112.225 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -102.38 2.89 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.468 0.651 . . . . 0.0 110.015 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.87 53.41 1.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.675 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.36 -116.96 0.46 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.127 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -165.82 -71.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.47 45.72 26.45 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.85 171.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.99 140.92 31.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.65 45.23 0.56 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.4 m -87.97 135.57 33.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.704 0.288 . . . . 0.0 111.169 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.2 t -172.0 74.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.007 0.908 . . . . 0.0 109.788 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -73.12 -15.66 78.62 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.675 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 149.02 156.76 7.3 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.791 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.832 2.355 . . . . 0.0 111.687 179.173 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 t -58.57 105.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.739 0.78 . . . . 0.0 111.844 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.59 87.75 2.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.3 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.7 ptm -75.46 173.56 10.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.934 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 48.9 t30 -59.1 120.36 46.54 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.608 175.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 11.3 Cg_exo -72.09 53.79 2.08 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.296 2.664 . . . . 0.0 112.998 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.2 138.22 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.847 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -82.01 89.86 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.564 0.697 . . . . 0.0 112.1 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -81.78 58.18 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 1.2 tmmt? -156.33 98.17 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.3 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -127.6 146.8 50.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -141.67 25.06 2.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -144.3 -27.17 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.961 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -121.35 59.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.688 0.756 . . . . 0.0 109.079 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -89.92 -155.87 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.801 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.36 33.43 16.4 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 121.311 0.576 . . . . 0.0 110.147 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 19' ' ' VAL . 5.1 p -73.51 100.75 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.863 0.84 . . . . 0.0 110.061 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 55.97 3.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.216 1.007 . . . . 0.0 111.59 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 17' ' ' VAL . 15.5 m -92.64 57.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.116 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.24 61.12 3.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.469 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 HD21 ' A' ' 116' ' ' LEU . 95.8 m -103.47 132.14 49.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.67 HG21 ' O ' ' A' ' 94' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -74.17 112.23 10.12 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 54.4 t -68.47 143.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.822 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 16.7 t80 174.29 -177.9 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.418 0.449 . . . . 0.0 110.794 168.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.792 HH22 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER 42.88 -110.1 0.14 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.933 0.893 . . . . 0.0 111.819 174.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . . . 65.38 158.49 0.1 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 33' ' ' LEU . 9.7 t70 -82.09 69.54 8.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.589 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE2' ' HE1' ' A' ' 120' ' ' TYR . 85.7 m-85 -139.22 -72.15 0.39 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.657 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 16.2 tp -141.4 45.36 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.703 0.763 . . . . 0.0 111.48 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.9 p -128.19 -146.42 0.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.233 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.677 ' HB2' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 -71.75 67.7 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.964 0.506 . . . . 0.0 111.886 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.631 ' HA ' ' NH2' ' A' ' 143' ' ' ARG . 1.6 pp -174.12 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.363 0.601 . . . . 0.0 110.351 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.22 98.09 11.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.117 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -148.32 134.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.348 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 5.1 Cg_exo -75.12 65.47 6.17 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.401 2.734 . . . . 0.0 112.486 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.73 88.65 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 56.87 71.94 0.54 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.597 0.713 . . . . 0.0 110.566 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 34.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.396 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.08 83.43 1.63 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -85.69 74.41 10.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.468 0.651 . . . . 0.0 110.326 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -114.93 90.11 3.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 m -83.93 153.77 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.56 73.2 10.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.326 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' HA ' ' CB ' ' A' ' 132' ' ' ALA . 5.8 p -59.84 -47.89 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.129 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -95.33 44.75 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 109.873 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.24 27.31 4.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.716 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 132' ' ' ALA . 3.1 t -111.94 -109.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.15 91.45 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.383 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.74 31.83 0.58 Allowed Glycine 0 C--N 1.317 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.619 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD21 ' HE2' ' A' ' 108' ' ' PHE . 3.1 pp -80.23 126.85 78.27 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 110.551 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' CD ' ' HD3' ' A' ' 53' ' ' PRO . 40.0 Cg_endo -68.73 -29.03 29.91 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.335 2.69 . . . . 0.0 116.557 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.802 ' HG3' ' HD3' ' A' ' 150' ' ' PRO . 72.6 Cg_endo -91.94 158.62 3.34 Favored 'Trans proline' 0 C--N 1.36 1.178 0 CA-C-N 121.645 1.623 . . . . 0.0 112.825 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.0 -19.32 57.84 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -107.51 125.18 50.95 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.069 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.88 171.79 10.43 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.7 pp -155.0 137.91 15.43 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 117.541 -1.664 . . . . 0.0 114.93 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 131' ' ' LEU . 1.3 mp -85.29 110.88 19.39 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.457 162.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 57' ' ' LEU . 5.8 p -105.41 127.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.086 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.924 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -71.44 108.97 3.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 175.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.94 -57.5 6.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.604 -1.634 . . . . 0.0 109.881 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -150.7 131.06 13.71 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.304 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -169.93 -161.18 19.94 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.103 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 31.2 Cg_exo -60.55 -51.92 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.974 1.782 . . . . 0.0 113.055 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 63.9 t30 -78.2 -49.29 14.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.6 158.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.956 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.66 89.82 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.924 ' H ' HG22 ' A' ' 60' ' ' VAL . 12.3 t -98.49 -178.01 3.87 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.343 1.071 . . . . 0.0 110.811 -173.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.24 156.68 5.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.283 0.492 . . . . 0.0 112.112 -173.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.77 113.47 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 170.316 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 1.3 pt? -79.65 92.61 5.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.067 1.413 . . . . 0.0 108.609 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.592 HD13 ' CB ' ' A' ' 108' ' ' PHE . 12.1 mt -74.18 46.51 0.25 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.009 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 35.2 t70 -94.73 -25.49 16.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.743 0.782 . . . . 0.0 109.173 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -84.61 -167.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.745 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.67 -30.08 22.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.54 137.66 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.478 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 59.7 p -128.51 132.79 48.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.753 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.817 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 35.8 m -82.55 125.53 31.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 110.419 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' A' ' 87' ' ' ILE . . . -122.54 117.41 25.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.523 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 154.83 -82.72 0.16 Allowed Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.182 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -124.6 103.1 7.95 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.817 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -138.75 126.52 13.52 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.471 -171.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.58 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.365 2.043 . . . . 0.0 112.228 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -162.74 92.17 0.77 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.596 0.236 . . . . 0.0 111.051 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -82.0 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.524 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -128.55 -74.6 0.57 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.386 0.612 . . . . 0.0 111.096 -172.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.42 109.83 28.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.667 0.746 . . . . 0.0 110.481 -177.489 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -116.17 135.07 54.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.979 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -122.37 74.04 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.652 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 39.0 t70 75.28 -22.49 0.26 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.488 0.661 . . . . 0.0 111.01 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 30.0 t70 59.68 36.19 22.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.036 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 22' ' ' TPO . 41.6 t -137.87 -10.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.626 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.433 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 31.3 p -106.98 -24.48 11.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.67 ' O ' HG21 ' A' ' 22' ' ' TPO . 2.7 t -118.59 147.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -169.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 20.3 m -76.12 81.31 2.94 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.053 -0.404 . . . . 0.0 110.228 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HG3' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 67.28 -69.4 0.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.567 -173.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -156.04 142.28 18.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.566 0.698 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.806 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -79.46 -42.26 25.72 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.396 172.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.829 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.62 153.6 44.86 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.067 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' A' ' 76' ' ' ILE . 5.4 pt-20 -115.51 126.92 54.88 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 166.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.84 98.99 0.11 Allowed 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.552 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.477 HH21 ' CD ' ' A' ' 100' ' ' GLU . 19.9 tpp85 -90.07 101.13 13.85 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.019 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -83.2 110.76 18.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -132.21 128.35 37.75 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.115 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.7 m120 60.64 36.97 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.053 0.454 . . . . 0.0 110.484 -174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.842 ' HA ' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER 69.3 8.44 6.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.773 178.083 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 26.0 mm-40 -109.21 140.83 42.32 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.906 -0.496 . . . . 0.0 110.935 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.592 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -90.07 127.8 36.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.808 -177.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -127.03 159.99 32.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.34 -178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -106.27 124.79 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 169.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.3 t -102.75 113.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.889 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' THR . 18.2 t0 -70.93 118.26 13.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.514 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.815 HG13 HG12 ' A' ' 111' ' ' VAL . 11.1 m -122.93 -37.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.77 79.68 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.099 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 25.7 t -93.34 122.98 36.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.617 HD21 HG23 ' A' ' 21' ' ' THR . 3.0 tm? -63.41 -45.45 90.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.592 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 23.8 m-80 -82.52 -36.72 26.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 110.128 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 146.2 152.2 5.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 112' ' ' ASP . 17.1 m -111.87 128.44 56.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 23.3 m-85 -139.01 146.58 41.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 173.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 137' ' ' VAL . 97.0 t -134.3 106.6 8.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.5 OUTLIER 64.18 41.0 6.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 63.97 17.23 10.45 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.009 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.5 pt-20 -134.61 126.15 17.93 Favored Pre-proline 0 C--N 1.331 -0.218 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.89 122.34 9.46 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.294 1.996 . . . . 0.0 111.712 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.5 m -111.97 178.74 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 110.707 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.2 p-10 -101.86 -46.77 4.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.729 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 17.4 p -159.17 94.32 1.19 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.019 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.18 144.34 30.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -76.96 131.29 35.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.127 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -61.03 155.18 20.83 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.846 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 48' ' ' VAL . . . -156.31 156.81 34.63 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.182 0.515 . . . . 0.0 111.738 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.27 111.02 2.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.702 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.88 1.58 59.85 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.839 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 15.6 t70 -72.29 128.45 35.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.618 0.247 . . . . 0.0 110.761 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.461 ' OE1' ' HD3' ' A' ' 143' ' ' ARG . 7.1 tt0 -112.81 129.56 56.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.401 0.62 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 121' ' ' VAL . 44.7 t -124.83 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.378 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -102.44 118.53 37.06 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.956 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -117.53 125.4 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 63.88 -103.03 0.63 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.101 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.103 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 10.1 pttt -143.02 24.75 1.81 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.283 0.563 . . . . 0.0 111.424 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.37 136.7 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -175.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.792 ' HB2' HH22 ' A' ' 26' ' ' ARG . 7.2 ttm180 -89.47 109.31 20.25 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.94 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 60' ' ' VAL . 6.7 mp -98.9 159.22 15.11 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.146 0.498 . . . . 0.0 111.825 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -141.76 140.99 30.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.004 166.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.622 ' O ' HD22 ' A' ' 147' ' ' LEU . 47.7 t80 -97.03 132.38 42.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.8 OUTLIER -135.62 171.58 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 169.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.4 t -165.83 166.06 17.92 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.111 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.66 88.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.422 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.802 ' HD3' ' HG3' ' A' ' 53' ' ' PRO . 87.5 Cg_endo -83.47 154.78 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.629 2.219 . . . . 0.0 111.898 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -75.16 102.36 4.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.923 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.1 140.71 54.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -132.32 90.42 0.27 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -62.38 -34.25 76.34 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -75.5 103.43 5.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.762 0.792 . . . . 0.0 110.297 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.72 -13.05 27.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.111 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.37 124.11 7.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.767 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.1 m -88.28 105.73 17.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.8 m -76.47 75.78 3.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.597 0.713 . . . . 0.0 110.701 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.2 121.48 1.11 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -98.57 109.63 3.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.806 -175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.246 0.924 0 C-N-CA 122.855 2.37 . . . . 0.0 111.754 177.443 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.708 0.766 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 t -130.27 -1.35 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.533 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -82.55 147.83 28.41 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt -116.56 117.13 29.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -117.95 78.15 12.64 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.69 49.26 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.926 2.418 . . . . 0.0 112.772 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD2' ' HG2' ' A' ' 9' ' ' GLU . 30.9 t70 -129.95 126.65 38.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.944 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.78 75.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG2' ' OD2' ' A' ' 7' ' ' ASP . 25.4 mt-10 -63.33 -45.32 91.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.586 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 56.51 59.91 3.37 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -170.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.55 -41.25 80.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.47 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -120.84 136.82 54.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 16' ' ' GLU . 32.7 p -77.77 91.03 4.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.457 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -59.54 -33.3 71.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -132.92 118.23 18.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.594 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 13' ' ' THR . 10.1 pt-20 -71.86 149.5 45.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.392 0.615 . . . . 0.0 111.809 -172.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -101.67 96.92 5.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.311 -172.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -90.94 126.51 36.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.29 74.59 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 110.848 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 177.06 -45.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.543 ' CG2' HD11 ' A' ' 116' ' ' LEU . 25.3 m -104.62 133.6 49.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.916 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.771 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m -2.65 105.85 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.363 1.865 . . . . 0.0 115.139 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 116' ' ' LEU . 1.4 p -143.42 157.31 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 O-C-N 121.259 -0.901 . . . . 0.0 112.42 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -172.76 -143.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.993 HH22 HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 45.19 -116.38 0.55 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.365 0.529 . . . . 0.0 109.948 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.52 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . . . 65.56 165.79 0.18 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 163.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.962 ' HA ' HD21 ' A' ' 33' ' ' LEU . 23.8 t70 -79.74 74.69 6.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.917 -172.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.583 ' HE2' HD21 ' A' ' 117' ' ' ASN . 47.8 m-85 -149.6 -46.83 0.14 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.709 0.766 . . . . 0.0 109.52 176.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.83 -70.33 0.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.196 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.1 p -171.61 -152.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.242 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 26' ' ' ARG . 3.9 mm-40 62.89 27.79 16.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.675 0.79 . . . . 0.0 110.912 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.993 HD23 HH22 ' A' ' 26' ' ' ARG . 1.2 pp -158.06 -33.92 0.07 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.798 0.809 . . . . 0.0 109.138 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.493 ' N ' HD12 ' A' ' 33' ' ' LEU . 20.9 p-10 -67.0 -48.48 68.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.994 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -96.76 123.13 54.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.464 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 2.8 Cg_exo -77.79 113.54 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.101 2.534 . . . . 0.0 111.951 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.1 -51.01 68.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.347 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.52 149.82 34.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.206 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.97 64.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.162 0.506 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.26 -76.75 1.77 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.933 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m 62.76 25.41 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.986 0.898 . . . . 0.0 110.302 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.5 145.66 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.262 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m 62.55 30.12 17.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.441 0.638 . . . . 0.0 110.084 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.64 176.11 7.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.386 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t 65.27 -77.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -167.47 79.84 0.19 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.631 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.04 -7.89 73.14 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.406 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.8 t 57.58 49.1 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-O 122.206 1.003 . . . . 0.0 109.189 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.57 -28.45 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.57 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -129.22 94.81 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.772 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.793 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 50.1 mt -149.54 134.88 9.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 123.267 0.627 . . . . 0.0 109.734 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.561 ' HG2' ' HD3' ' A' ' 53' ' ' PRO . 10.5 Cg_endo -55.68 -36.96 95.83 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.022 2.482 . . . . 0.0 114.829 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.793 ' HD2' ' HB3' ' A' ' 51' ' ' LEU . 92.2 Cg_endo -93.51 45.03 0.29 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 121.731 1.621 . . . . 0.0 113.304 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.63 -80.05 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.869 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.94 139.01 24.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.78 ' HA ' ' HA2' ' A' ' 50' ' ' GLY . . . -125.84 169.12 12.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.462 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -153.68 129.78 10.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.064 -1.054 . . . . 0.0 113.698 -173.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.028 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.8 mp -86.61 137.74 32.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.904 162.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 4.2 p -131.82 128.96 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.431 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -72.98 109.78 5.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.022 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -64.27 -70.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 113.079 -1.873 . . . . 0.0 110.413 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 62' ' ' ARG . 14.0 mtp85 -148.54 138.03 21.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.476 0.655 . . . . 0.0 109.781 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -162.28 -127.02 0.85 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.824 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 3.8 Cg_endo -89.18 -62.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.9 0 C-N-CA 122.163 1.909 . . . . 0.0 111.442 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.682 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -69.42 -53.35 19.75 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.18 174.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.113 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.73 89.52 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.871 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.5 m -96.87 179.61 4.9 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 117.308 0.554 . . . . 0.0 111.017 -169.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.75 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -168.5 147.2 4.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -169.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.845 ' HD2' ' HB2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -97.26 121.07 38.74 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' O ' HD23 ' A' ' 71' ' ' LEU . 2.0 tt -83.68 101.38 11.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.662 0.744 . . . . 0.0 110.218 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -92.99 41.51 1.08 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.438 0.637 . . . . 0.0 110.254 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' A' ' 71' ' ' LEU . 25.2 t70 -92.0 -26.24 18.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.792 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.03 178.99 4.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.481 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.78 -44.46 81.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -162.56 128.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.933 -174.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 p -113.8 121.6 44.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.133 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 65.4 m -64.86 126.14 27.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.964 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.59 115.98 25.09 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.663 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 149.39 -142.96 10.28 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.12 104.38 3.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 109.966 173.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.564 ' NE2' ' HD3' ' A' ' 96' ' ' ARG . 34.6 m80 -137.09 118.43 11.02 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 -173.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.02 -44.66 12.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.186 1.924 . . . . 0.0 110.848 166.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -147.33 110.59 4.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.641 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.672 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 33.7 m -158.3 -86.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.954 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -171.71 -58.16 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.375 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -101.05 94.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.0 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -100.07 134.92 42.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.817 174.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.024 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -117.02 75.21 0.96 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.2 t70 58.92 15.75 4.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.74 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 2.3 p30 46.12 -73.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.285 1.434 . . . . 0.0 113.696 -170.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 92' ' ' VAL . 12.7 p -73.63 64.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -156.08 -1.24 0.13 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.263 164.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.581 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 9.2 t -131.7 137.83 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.125 -0.36 . . . . 0.0 110.732 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.477 ' HA ' ' O3P' ' A' ' 22' ' ' TPO . 19.4 m -72.48 71.22 0.93 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.564 ' HD3' ' NE2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 68.55 -59.63 0.45 Allowed 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.822 -174.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.518 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.0 ptp85 -149.31 138.67 21.53 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.661 -0.649 . . . . 0.0 110.625 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.705 ' CB ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -70.58 -43.16 69.98 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.46 175.12 13.68 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 112.704 -2.043 . . . . 0.0 108.949 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.691 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -128.37 115.05 17.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 1.041 ' HD1' HG13 ' A' ' 110' ' ' VAL . 2.4 t80 -78.07 91.46 4.28 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.877 0.846 . . . . 0.0 108.719 -171.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.69 ' HB3' HG13 ' A' ' 76' ' ' ILE . 12.8 ptp180 -101.54 140.3 36.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.343 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -83.25 112.29 19.74 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.501 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.35 139.75 39.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 36.2 m-80 62.51 32.52 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.704 ' HA ' HD21 ' A' ' 103' ' ' LEU . 6.8 t30 72.03 -0.1 3.35 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.568 0.747 . . . . 0.0 111.517 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 12.9 mm-40 -111.62 142.54 43.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.544 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.62 128.9 36.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.024 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 18.0 m-80 -138.05 161.86 35.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 1.041 HG13 ' HD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -104.54 117.34 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 117.962 0.346 . . . . 0.0 111.019 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.588 HG21 ' HD2' ' A' ' 102' ' ' ARG . 76.5 t -99.03 110.17 25.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -70.27 135.38 48.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.49 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 27.2 m -135.61 7.62 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.112 0.482 . . . . 0.0 109.78 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 102.96 107.19 3.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.292 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 25.6 t -102.35 157.26 17.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.771 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.6 tm? -58.13 -53.18 61.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.773 -174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.617 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -70.62 -36.03 73.25 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.725 0.774 . . . . 0.0 109.014 172.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 115' ' ' SER . . . 132.35 177.55 14.98 Favored Glycine 0 C--O 1.25 1.095 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.214 -173.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 98' ' ' HIS . 5.6 m -111.57 136.68 50.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.901 0.48 . . . . 0.0 111.474 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.9 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 22.8 m-85 -139.57 132.8 29.83 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.84 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 137' ' ' VAL . 84.6 t -129.3 121.69 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.75 32.6 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 56.89 26.36 11.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.595 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.0 pt-20 -137.86 143.21 39.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.426 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 20.2 Cg_exo -66.99 123.26 10.74 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.847 2.364 . . . . 0.0 112.348 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.43 175.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 p-10 -103.35 -49.94 3.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.12 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.87 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 33.3 t -157.72 91.44 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.41 137.81 36.57 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.025 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.411 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 7.4 p -80.57 143.16 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.784 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -49.44 133.19 20.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.227 174.197 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -128.38 -175.15 3.42 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -107.0 86.03 2.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.32 2.29 38.28 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.445 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.713 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 4.8 t70 -89.98 158.18 17.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.487 0.644 . . . . 0.0 109.744 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.5 pm0 -107.42 143.51 35.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.898 0.856 . . . . 0.0 113.209 -172.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 121' ' ' VAL . 58.4 t -119.9 141.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.739 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.9 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 7.1 tp-100 -108.05 122.97 47.95 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.082 0.467 . . . . 0.0 110.186 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.024 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.92 139.99 50.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 168.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 63.27 -90.27 0.07 OUTLIER Glycine 0 C--O 1.208 -1.481 0 C-N-CA 119.717 -1.23 . . . . 0.0 112.322 173.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.824 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 14.8 ptmt -156.95 31.9 0.3 Allowed 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.519 -0.989 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -123.87 138.44 54.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.665 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -89.5 108.84 19.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.08 161.05 13.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.41 143.45 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.028 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -109.34 144.6 37.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.528 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? -127.66 128.11 44.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.629 ' HB ' ' HB1' ' A' ' 56' ' ' ALA . 14.2 t -160.93 137.61 8.69 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 167.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 150' ' ' PRO . . . -132.27 124.62 3.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.603 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HD3' ' HA2' ' A' ' 149' ' ' GLY . 6.0 Cg_exo -78.85 1.04 9.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.898 2.399 . . . . 0.0 112.148 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 57.48 45.9 18.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.931 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -76.28 109.64 10.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.61 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 178.26 113.64 0.37 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -65.05 -35.11 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 111.024 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -157.48 -58.0 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -80.16 150.19 30.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -106.38 160.4 14.56 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.171 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.2 m -80.32 94.06 6.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.083 0.468 . . . . 0.0 110.33 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.3 m -86.55 137.15 32.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.365 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.45 -32.43 30.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.131 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 152.49 -71.6 0.28 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.06 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 176.154 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -103.16 1.52 33.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.031 0.919 . . . . 0.0 108.629 170.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.85 53.27 2.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.536 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.439 ' C ' ' HD3' ' A' ' 6' ' ' PRO . 22.5 ptp -67.62 148.52 51.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.408 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -124.87 67.9 53.33 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 4' ' ' MET . 7.0 Cg_exo -73.25 -68.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.415 2.077 . . . . 0.0 111.421 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -149.07 76.69 1.34 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.698 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.8 10.75 7.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.967 0.889 . . . . 0.0 109.168 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.17 156.07 19.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.115 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -129.59 53.93 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.518 0.675 . . . . 0.0 109.449 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -90.09 -7.74 53.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.014 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.48 -41.47 93.25 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 86.22 3.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.358 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.1 m -153.84 -38.31 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.324 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 41.8 -97.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 124.538 1.149 . . . . 0.0 113.468 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.57 73.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.879 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 t 59.1 38.68 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.992 0.901 . . . . 0.0 109.683 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.8 m -100.03 89.14 3.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.932 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.28 17.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.749 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.19 99.27 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 22' ' ' TPO . 54.1 m -78.65 137.09 37.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.734 ' O ' HG22 ' A' ' 21' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' THR . 57.2 m -80.08 140.42 36.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 120.801 -1.187 . . . . 0.0 112.547 -173.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 117' ' ' ASN . 14.1 p -127.87 141.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.482 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 t80 179.13 -168.1 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.903 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.8 tpt180 46.33 -123.29 1.26 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.876 0.735 . . . . 0.0 110.542 170.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' H ' ' HG3' ' A' ' 26' ' ' ARG . . . 60.07 179.62 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.653 ' HA ' HD11 ' A' ' 33' ' ' LEU . 7.3 t70 -78.08 56.81 1.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.989 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.4 -52.56 0.2 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.724 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.22 -44.42 4.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.63 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.596 ' HB2' ' HD2' ' A' ' 26' ' ' ARG . 19.4 m -141.64 169.83 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.816 -167.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.65 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 2.1 mm-40 67.67 -150.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.839 0.712 . . . . 0.0 111.604 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 49.99 -101.19 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.227 1.011 . . . . 0.0 112.014 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p30 -178.37 -169.64 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.078 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.863 ' H ' ' HD2' ' A' ' 36' ' ' PRO . . . -122.6 -47.62 0.04 OUTLIER Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.913 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.863 ' HD2' ' H ' ' A' ' 35' ' ' ALA . 63.0 Cg_endo -72.08 -146.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.372 2.048 . . . . 0.0 111.817 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.94 101.67 1.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 110.595 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -140.69 129.44 23.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.184 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.05 144.05 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.39 86.17 0.28 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.266 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -119.02 147.42 44.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 0.0 110.977 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -113.01 104.59 12.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -76.94 74.36 3.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.238 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.74 154.73 18.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.173 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 1.069 ' HA ' ' HA2' ' A' ' 50' ' ' GLY . 12.7 m -124.22 120.91 60.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 0.0 111.662 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 20.1 p -81.96 -70.06 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.571 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.57 -94.15 2.29 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.74 13.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.297 0.57 . . . . 0.0 110.742 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -111.98 -16.96 12.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 1.069 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 82.32 -54.13 4.85 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD13 ' CE2' ' A' ' 108' ' ' PHE . 16.9 mt -56.36 119.94 31.83 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 123.752 0.821 . . . . 0.0 110.902 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.612 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 95.4 Cg_endo -98.18 11.59 0.89 Allowed 'Trans proline' 0 CA--C 1.557 1.642 0 C-N-CA 122.341 2.027 . . . . 0.0 117.022 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.735 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 39.1 Cg_endo -103.95 161.83 0.22 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 122.401 1.893 . . . . 0.0 113.581 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.43 -20.75 36.95 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.56 132.65 31.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -136.19 170.15 16.48 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -161.29 145.2 13.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.6 mp -87.1 116.5 25.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.759 164.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -113.11 130.02 67.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 118.158 0.435 . . . . 0.0 110.522 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.001 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.16 109.38 3.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -62.46 -54.46 39.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.216 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -165.42 106.94 0.77 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.989 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -127.68 -133.07 3.69 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.076 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 82.4 Cg_endo -76.0 -64.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.34 2.027 . . . . 0.0 112.191 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.916 ' HB3' ' HE2' ' A' ' 142' ' ' PHE . 66.5 t30 -70.13 -47.3 62.29 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 60.31 166.94 0.08 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.847 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.35 4.45 89.95 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.77 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.001 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -101.92 179.18 4.4 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 117.651 0.726 . . . . 0.0 110.655 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.49 154.98 3.29 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.802 0.728 . . . . 0.0 112.24 -172.623 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.15 127.94 41.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.623 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.5 tt -87.82 91.82 8.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.72 0.771 . . . . 0.0 109.534 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.812 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -85.39 55.78 3.66 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.512 ' HB3' HD21 ' A' ' 71' ' ' LEU . 16.7 t70 -108.75 -23.94 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.869 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -103.77 -166.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.52 -41.17 69.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.3 129.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.463 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 71.8 p -113.2 126.02 54.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 87' ' ' ILE . 39.1 m -68.29 126.58 30.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.54 108.65 13.38 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 165.45 -139.3 5.72 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.095 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.98 103.88 7.16 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 11.5 m-70 -129.75 120.73 19.69 Favored Pre-proline 0 N--CA 1.436 -1.133 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.229 -172.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.72 -16.23 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.292 1.994 . . . . 0.0 109.559 164.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -160.42 125.12 3.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.014 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.1 p 120.82 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 125.562 1.789 . . . . 0.0 113.362 164.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 6.3 m-20 56.91 -80.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 161.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -115.44 110.95 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.0 0.905 . . . . 0.0 111.672 -171.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.33 114.61 28.43 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.714 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.778 HD12 HG12 ' A' ' 139' ' ' ILE . 4.7 mt -102.4 80.05 1.9 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.942 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 14.6 t70 70.11 -7.48 0.95 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.148 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.6 p30 39.47 36.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 113.075 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 22' ' ' TPO . 41.1 t -148.42 -2.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 23' ' ' SER . 27.7 p -113.2 -34.92 5.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -116.72 154.6 18.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 122.116 -0.365 . . . . 0.0 110.602 -171.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.695 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 7.1 m -68.41 72.79 0.21 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.706 0.403 . . . . 0.0 112.049 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 59.36 -49.31 0.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.054 0.942 . . . . 0.0 112.709 -173.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.767 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 10.3 ptp85 -149.42 141.85 24.28 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.691 -0.631 . . . . 0.0 110.308 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.85 -41.3 12.55 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.911 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -140.26 170.55 15.61 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.808 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.6 pt-20 -137.45 123.27 20.03 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.812 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -55.52 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 124.413 1.071 . . . . 0.0 108.931 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.465 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -94.14 98.04 10.7 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.939 -174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -78.95 104.8 9.83 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.817 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.63 134.99 54.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.3 OUTLIER 40.75 47.24 2.43 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.313 1.008 . . . . 0.0 112.092 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.737 ' HA ' HD21 ' A' ' 103' ' ' LEU . 3.6 m-20 76.55 2.18 3.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.693 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 50.2 mt-10 -106.28 141.3 37.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.807 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.627 ' CB ' HD23 ' A' ' 72' ' ' LEU . 1.1 m-85 -89.05 126.99 35.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' ' 130' ' ' VAL . 24.4 m-80 -132.12 160.29 36.43 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.718 0.294 . . . . 0.0 110.576 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 128' ' ' SER . 5.6 m -111.76 126.96 69.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.016 0.436 . . . . 0.0 110.211 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.911 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 3.8 t -101.38 112.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.354 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 13.4 t0 -74.78 128.64 36.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.515 HG21 ' HG3' ' A' ' 97' ' ' ARG . 36.0 m -128.04 4.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 109.608 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.17 87.63 2.01 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.282 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.745 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.4 t -87.79 141.01 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.586 HD22 ' HB ' ' A' ' 22' ' ' TPO . 13.0 tp -53.15 -57.26 11.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.711 HD21 ' HA2' ' A' ' 140' ' ' GLY . 1.8 p30 -65.91 -37.79 87.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.642 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.11 164.06 9.84 Favored Glycine 0 C--O 1.262 1.847 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.724 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.533 HG23 ' CE1' ' A' ' 98' ' ' HIS . 17.7 m -113.82 129.27 56.61 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.239 -1.481 . . . . 0.0 110.297 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 14.0 m-85 -141.63 105.22 4.69 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 111.67 173.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.088 HG22 HG23 ' A' ' 137' ' ' VAL . 52.5 t -100.33 127.11 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 4.4 m-20 63.22 25.61 14.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 63.05 13.8 7.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.834 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.85 156.88 58.7 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 120.762 0.315 . . . . 0.0 110.385 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.75 131.85 12.66 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.44 2.093 . . . . 0.0 112.645 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.26 176.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 10.0 m-20 -120.1 -31.34 4.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.56 174.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.858 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.0 p -161.63 91.48 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.509 0.671 . . . . 0.0 109.866 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -100.91 145.58 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.489 HG22 ' OD1' ' A' ' 109' ' ' ASN . 14.5 t -88.18 119.81 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.764 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -58.74 162.3 4.11 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -163.52 164.59 24.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.622 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -71.06 114.49 9.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.346 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.39 -7.96 51.77 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.856 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.49 110.64 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.621 0.369 . . . . 0.0 110.142 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -93.83 152.3 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.172 0.51 . . . . 0.0 112.251 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -133.4 141.24 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.653 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.1 tm0? -109.58 116.68 32.22 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 169.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.823 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -138.4 131.77 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.243 175.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.711 ' HA2' HD21 ' A' ' 117' ' ' ASN . . . 82.9 -56.88 5.07 Favored Glycine 0 C--N 1.317 -0.502 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.25 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.076 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 59.9 pttt 168.03 32.11 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.916 ' HE2' ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -114.5 161.52 17.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.232 -173.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.488 ' HG3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.77 99.62 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 1.0 ' HB2' HG12 ' A' ' 137' ' ' VAL . 5.8 mp -88.83 163.54 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.365 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -141.53 140.29 31.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 166.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.764 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 45.9 t80 -100.04 143.08 30.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.402 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -130.34 134.6 47.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.76 170.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.607 ' HB ' ' CE2' ' A' ' 146' ' ' PHE . 2.5 t -116.02 149.67 38.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.644 ' H ' ' HG3' ' A' ' 53' ' ' PRO . . . 63.14 91.08 0.03 OUTLIER Glycine 0 CA--C 1.52 0.36 0 O-C-N 123.584 0.553 . . . . 0.0 112.318 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 9.7 Cg_exo -72.0 57.12 2.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.026 2.484 . . . . 0.0 112.058 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.743 ' HG3' ' HG3' ' A' ' 152' ' ' GLN . 59.2 pttt -66.43 -32.29 73.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.41 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.743 ' HG3' ' HG3' ' A' ' 151' ' ' LYS . 49.7 mt-30 -105.9 -3.68 21.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.82 -96.02 0.5 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.417 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 67.97 -69.22 0.15 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.553 0.741 . . . . 0.0 111.759 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -104.33 -67.72 0.89 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.53 137.82 33.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.3 18.95 54.45 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.283 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.8 t -82.31 -9.0 59.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 110.345 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.1 p 54.29 -94.16 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 112.356 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.39 -43.3 2.01 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.05 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.16 -159.03 24.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.171 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--O 1.246 0.908 0 C-N-CA 123.27 2.647 . . . . 0.0 111.705 179.137 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.4 p -109.32 153.43 23.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.24 116.02 27.9 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -135.47 149.19 49.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.951 0.405 . . . . 0.0 110.535 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -132.6 126.26 19.95 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.639 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.85 106.89 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.583 2.188 . . . . 0.0 112.194 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.71 -7.5 58.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.603 0.716 . . . . 0.0 109.424 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -92.93 143.22 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.591 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -76.95 134.39 38.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 12' ' ' GLN . 3.6 tppp? -81.62 73.29 8.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.52 -43.24 71.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.164 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 19.3 mp0 -77.16 119.24 20.57 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -33.04 -56.45 0.39 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.481 1.113 . . . . 0.0 113.619 -169.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -131.21 -9.54 3.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.162 0.506 . . . . 0.0 110.127 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t70 65.4 40.62 4.64 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.792 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.93 117.81 15.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.022 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.75 -16.78 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.589 0.709 . . . . 0.0 109.326 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -86.45 78.16 9.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.632 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.1 129.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.782 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.39 70.56 7.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.645 0.736 . . . . 0.0 111.142 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 73.1 m -155.77 132.84 10.7 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.456 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.797 ' O ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 93' ' ' THR . 70.4 m -34.55 146.84 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -162.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 12.3 p -127.64 147.18 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.986 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.3 t80 172.8 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.921 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.943 ' HG3' ' H ' ' A' ' 27' ' ' ALA . 8.7 tpt180 47.64 -130.47 1.56 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.873 0.469 . . . . 0.0 109.931 172.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.943 ' H ' ' HG3' ' A' ' 26' ' ' ARG . . . 64.83 173.36 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.788 ' H ' ' HG3' ' A' ' 138' ' ' GLN . 8.5 t70 -76.18 55.24 0.93 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.68 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.462 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 22.4 m-85 -147.46 -42.08 0.17 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.966 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 tp -97.58 -67.87 0.83 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.982 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.6 m -158.18 179.13 9.45 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.46 57.47 1.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.913 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 28' ' ' ASP . 1.2 mt -141.36 -60.62 0.48 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.475 1.131 . . . . 0.0 108.892 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -54.58 139.11 39.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.38 -2.191 . . . . 0.0 112.06 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 69.25 98.24 0.04 OUTLIER Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.158 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.68 76.06 3.37 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.929 2.419 . . . . 0.0 111.961 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.93 -44.84 87.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.552 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -85.7 67.97 10.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.37 118.58 19.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.72 109.81 1.22 Allowed Glycine 0 C--N 1.33 0.196 0 O-C-N 123.594 0.559 . . . . 0.0 113.179 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -82.62 -29.27 30.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.89 0.376 . . . . 0.0 111.246 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.3 pm0 -90.15 6.0 44.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 t -88.75 55.45 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.91 52.8 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 110.636 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 150' ' ' PRO . 17.9 m -102.43 131.3 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.567 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 152' ' ' GLN . 24.1 m -145.69 124.39 12.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.262 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.19 -56.3 0.29 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.735 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 62.49 81.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -167.24 98.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.756 -172.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.56 85.81 0.01 OUTLIER Glycine 0 C--N 1.327 0.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.714 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 3.0 pp -48.96 121.73 10.68 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.65 0.738 . . . . 0.0 111.709 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 32.0 Cg_exo -61.17 -39.48 58.45 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.894 3.063 . . . . 0.0 115.999 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 Cg_endo -83.24 128.02 4.75 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.9 1.733 . . . . 0.0 112.689 -170.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.0 -31.48 61.84 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.22 123.73 41.09 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.87 170.63 14.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.5 pp -158.1 142.63 16.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.9 110.96 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.999 163.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 57' ' ' LEU . 4.9 p -107.94 124.81 64.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.351 0.596 . . . . 0.0 111.216 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.023 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -72.74 111.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.073 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.5 -70.12 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.708 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -142.99 128.11 18.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.607 0.717 . . . . 0.0 110.736 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -167.13 -153.69 8.07 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.01 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 52.9 Cg_exo -56.07 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 122.598 2.198 . . . . 0.0 113.052 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 8.1 t30 -70.39 -49.12 52.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.61 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.531 -173.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.08 0.07 84.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.316 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.897 ' H ' HG22 ' A' ' 60' ' ' VAL . 33.1 t -99.81 -171.59 2.08 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 118.412 1.106 . . . . 0.0 110.383 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.83 164.18 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -175.301 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HZ ' HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -95.95 129.13 43.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.596 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -85.94 96.54 9.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.761 0.791 . . . . 0.0 109.457 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.838 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -89.43 31.51 0.91 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.336 0.588 . . . . 0.0 109.703 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.0 -28.63 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.697 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' NE2' HG22 ' A' ' 77' ' ' THR . 13.2 pt20 -95.72 -166.35 1.43 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.747 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.86 -38.05 46.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -162.07 135.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 111.937 -177.089 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 54.1 p -123.77 133.28 53.86 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.58 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.735 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 44.3 m -76.84 126.08 30.38 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.45 112.4 19.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -167.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.624 ' HA3' HG11 ' A' ' 94' ' ' VAL . . . 156.56 -88.92 0.12 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.887 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -108.44 104.41 13.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.702 0.763 . . . . 0.0 109.002 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.735 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -130.73 103.77 15.9 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.289 -174.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -64.41 -37.17 40.6 Favored 'Trans proline' 0 C--N 1.328 -0.505 0 C-N-CA 122.677 2.251 . . . . 0.0 113.602 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -147.0 30.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 2.4 p -151.2 -164.78 2.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' H ' ' HB2' ' A' ' 85' ' ' SER . 0.1 OUTLIER -32.44 -89.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.793 1.637 . . . . 0.0 115.273 -167.412 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.29 109.91 29.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.44 0.638 . . . . 0.0 111.574 -171.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.85 127.22 47.4 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.984 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.023 HD21 HG11 ' A' ' 60' ' ' VAL . 8.1 mt -121.1 82.78 1.97 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.077 170.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.26 -11.16 0.72 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.082 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.9 p30 40.23 32.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.489 1.515 . . . . 0.0 112.781 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.93 -9.28 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.84 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.675 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -112.64 -9.94 13.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -172.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.624 HG11 ' HA3' ' A' ' 80' ' ' GLY . 3.4 t -122.41 147.1 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.941 -0.474 . . . . 0.0 110.836 -171.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.763 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 3.9 t -77.39 73.49 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.5 OUTLIER 58.52 -58.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.788 -166.267 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 10.0 ptp85 -142.58 136.5 29.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.635 0.731 . . . . 0.0 111.35 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -78.06 -37.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.22 177.75 10.72 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.323 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 77' ' ' THR . 5.1 pt-20 -133.98 134.46 42.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.838 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -64.18 104.08 0.7 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.61 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 23.1 ttm180 -105.16 112.34 25.43 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.646 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.6 tt -84.28 103.77 13.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.577 0.704 . . . . 0.0 110.033 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.61 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 43.2 mt-10 -128.08 141.41 51.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 37.3 m-20 62.56 30.98 17.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.802 ' HA ' HD21 ' A' ' 103' ' ' LEU . 16.0 m120 62.15 11.97 4.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.253 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 9.3 pt-20 -117.56 147.11 43.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.645 ' CB ' HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -93.19 119.38 32.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.8 -174.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 2.4 m120 -123.61 163.02 21.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -107.75 118.49 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.982 170.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 83.5 t -99.41 110.72 27.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.27 136.75 55.41 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.581 0.551 . . . . 0.0 110.047 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 97' ' ' ARG . 24.2 m -133.69 3.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.093 0.473 . . . . 0.0 110.173 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.33 110.49 2.24 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.307 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.59 ' HB3' ' HA ' ' A' ' 98' ' ' HIS . 24.3 p -109.61 169.91 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.797 HD22 ' O ' ' A' ' 22' ' ' TPO . 0.7 OUTLIER -64.26 -55.17 23.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.506 -175.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.53 HD21 ' H ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -66.62 -37.45 84.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.97 161.32 10.58 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 121.438 0.465 . . . . 0.0 113.321 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.3 m -112.13 131.21 55.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.954 0.901 . . . . 0.0 111.274 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -141.8 104.95 4.61 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.503 0.192 . . . . 0.0 111.483 175.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 137' ' ' VAL . 93.6 t -102.6 119.82 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.964 -0.46 . . . . 0.0 109.97 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 59.3 37.5 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.481 ' HA ' ' HD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 64.06 25.11 13.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -176.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.55 133.09 8.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.811 -0.556 . . . . 0.0 110.867 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.78 122.64 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.099 1.866 . . . . 0.0 111.547 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.605 HG13 ' HB ' ' A' ' 121' ' ' VAL . 26.1 m -106.29 179.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 111.309 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 24.2 t70 -108.95 -40.97 4.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.0 t -165.14 91.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.0 124.0 40.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.585 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.6 p -70.69 144.16 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.557 0.694 . . . . 0.0 111.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 1.1 tt -52.05 134.53 32.27 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.592 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . . . -127.59 -176.25 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.66 88.47 2.93 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.015 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.86 -16.82 30.54 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.6 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.902 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 4.2 m-20 -68.85 155.08 40.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.133 0.492 . . . . 0.0 110.786 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -110.1 156.2 20.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 112.566 -170.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.98 HG13 HG22 ' A' ' 121' ' ' VAL . 47.0 t -135.39 132.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.788 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -98.04 118.07 33.8 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 172.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.641 ' CG1' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -128.96 131.35 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.368 173.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.62 ' CA ' HG22 ' A' ' 94' ' ' VAL . . . 82.03 -55.76 4.93 Favored Glycine 0 C--N 1.322 -0.231 0 C-N-CA 119.315 -1.421 . . . . 0.0 112.944 167.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.01 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 58.5 pttt 169.21 32.36 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 124.406 1.083 . . . . 0.0 109.082 163.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.808 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.08 150.96 44.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -169.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -93.2 92.15 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.0 mp -88.48 158.34 18.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.204 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.654 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.97 143.09 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.225 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.958 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -108.49 143.89 36.86 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.742 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? -132.85 167.41 20.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -174.85 -150.4 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.389 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.509 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . -64.69 167.59 29.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.417 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.691 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 31.8 Cg_exo -59.28 85.14 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.012 2.475 . . . . 0.0 113.751 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 132' ' ' ALA . 86.3 tttt -101.23 46.06 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' SER . 36.3 tt0 -145.51 151.11 37.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.742 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.97 -165.92 16.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -78.0 63.55 3.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.595 0.698 . . . . 0.0 110.639 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 156' ' ' ASP . 23.8 t70 -97.62 92.76 6.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 155' ' ' ASP . 21.4 t70 78.37 139.18 0.07 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 124.447 1.092 . . . . 0.0 110.002 -169.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.0 68.8 1.94 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.047 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -87.35 68.45 9.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.845 0.355 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.3 m -75.83 -32.65 59.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.443 . . . . 0.0 110.38 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.13 -128.44 9.55 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.788 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -101.22 -67.65 0.82 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.966 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 122.951 2.434 . . . . 0.0 112.609 -177.927 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.48 0.657 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 p -133.0 -60.85 0.85 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.67 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 t70 69.94 120.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.861 0.726 . . . . 0.0 111.851 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ptp -140.31 8.08 2.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.471 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -92.59 112.09 53.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.879 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.81 114.41 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.782 2.321 . . . . 0.0 113.669 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 63.79 73.45 0.44 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.95 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 pt -88.75 22.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.8 -0.97 36.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -90.68 4.03 52.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 65.24 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.354 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -84.79 106.74 16.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -118.74 142.16 47.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.453 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.1 m -148.04 -71.41 0.21 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 19' ' ' VAL . 16.9 m-20 -123.71 -15.8 6.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.94 0.4 . . . . 0.0 111.196 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -75.1 46.57 0.32 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 111.613 -177.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.9 -60.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.044 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.7 p -97.01 -40.76 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 15' ' ' ASP . 6.9 p -86.23 6.48 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.335 0.588 . . . . 0.0 110.834 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.15 69.11 8.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.37 0.605 . . . . 0.0 109.733 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 22' ' ' TPO . 87.7 m -154.28 137.86 16.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.553 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.786 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 93' ' ' THR . 69.1 m -72.56 140.54 48.16 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.515 -0.741 . . . . 0.0 111.741 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 116' ' ' LEU . 8.0 p -135.36 147.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.315 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -177.35 -160.06 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.071 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.844 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 42.52 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.222 0.951 . . . . 0.0 110.676 176.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.587 ' HB1' HD21 ' A' ' 117' ' ' ASN . . . 66.08 172.12 0.23 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 165.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 7.4 t70 -89.7 53.87 2.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.744 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.57 ' HE2' HD21 ' A' ' 117' ' ' ASN . 60.3 m-85 -148.09 -49.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.818 -177.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.6 tp -74.64 -67.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.675 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.7 t -162.9 -178.85 6.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.191 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.9 OUTLIER 68.69 36.18 2.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.944 0.898 . . . . 0.0 110.943 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.827 HD22 HH21 ' A' ' 143' ' ' ARG . 1.4 mt -133.71 -75.94 0.48 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 6.7 m-20 52.12 -89.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.212 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -164.87 -50.48 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.207 -177.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 11.0 Cg_exo -71.54 118.15 5.51 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.301 2.001 . . . . 0.0 113.091 -177.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.84 75.18 7.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.21 117.2 6.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.84 75.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.235 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.43 60.48 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.779 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m 60.07 85.53 0.11 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.121 0.486 . . . . 0.0 111.731 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.17 -71.73 0.57 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 m -115.2 -49.98 2.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.05 48.51 22.95 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.515 0.509 . . . . 0.0 111.376 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.84 116.35 31.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 m 70.43 -55.57 0.62 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.382 0.673 . . . . 0.0 111.449 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -53.43 0.49 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 12.0 t 50.97 59.02 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.301 0.572 . . . . 0.0 109.817 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.705 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 10.7 pt-20 -150.67 -65.0 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.75 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.705 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -77.74 75.5 1.84 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.894 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 18.0 mt -108.95 89.89 7.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 50' ' ' GLY . 90.4 Cg_endo -111.93 33.4 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 123.343 2.696 . . . . 0.0 114.756 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 55' ' ' SER . 88.0 Cg_endo -88.27 39.78 0.53 Allowed 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.726 1.617 . . . . 0.0 112.419 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.7 -12.17 70.45 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.619 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.783 -0.708 . . . . 0.0 109.738 -178.485 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.78 168.7 13.44 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -161.01 146.18 14.13 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.049 -1.06 . . . . 0.0 113.537 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.572 HD21 ' CG1' ' A' ' 110' ' ' VAL . 4.1 mp -87.91 141.16 28.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.634 164.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 147' ' ' LEU . 7.3 p -132.74 132.48 59.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.215 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.935 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -74.17 109.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 25.2 tptp -63.32 -54.74 32.23 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.885 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 71.9 mtt180 -158.38 138.18 12.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.054 174.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.727 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -175.65 -155.28 12.55 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 78.2 Cg_exo -55.68 -65.0 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.712 2.274 . . . . 0.0 112.949 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.775 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 52.3 t30 -71.03 -48.38 53.29 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.71 153.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.044 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.55 2.22 90.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.935 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.0 m -88.34 176.35 7.25 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.258 0.529 . . . . 0.0 110.26 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.665 HH21 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -170.23 148.27 3.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.812 0.733 . . . . 0.0 112.868 -169.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.89 129.67 43.08 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.023 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HH21 ' A' ' 69' ' ' ARG . 1.5 tm? -85.79 101.37 12.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.8 ' HG ' ' CG ' ' A' ' 101' ' ' PHE . 0.7 OUTLIER -95.86 31.58 2.07 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.297 -177.003 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 34.7 t70 -89.85 -11.52 41.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.84 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.568 ' O ' ' HE2' ' A' ' 101' ' ' PHE . 1.4 pp0? -121.42 153.84 37.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -42.63 -39.01 2.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.82 123.08 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.255 0.55 . . . . 0.0 112.149 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.63 ' CG2' ' HB3' ' A' ' 86' ' ' ASP . 1.6 p -113.79 121.84 45.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.802 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.615 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 30.5 m -76.61 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.579 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.611 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -122.21 116.47 24.21 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.871 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 170.66 -108.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.671 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -111.79 101.75 10.07 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.7 ' CD2' ' HB2' ' A' ' 85' ' ' SER . 0.2 OUTLIER -139.37 146.86 50.36 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.955 -160.5 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.91 -157.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.412 2.074 . . . . 0.0 110.039 165.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -78.25 52.42 1.12 Allowed 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.204 -0.31 . . . . 0.0 111.138 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.7 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . 5.7 m -91.02 -70.4 0.68 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 110.663 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.63 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 2.8 m-20 -143.14 -77.18 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.437 0.636 . . . . 0.0 110.818 -171.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.611 HG12 ' HB1' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -127.75 122.02 57.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.229 -176.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.71 133.16 56.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.238 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 139' ' ' ILE . 6.2 mt -108.15 80.33 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 29.7 t70 71.71 -6.84 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.57 0.7 . . . . 0.0 110.134 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.794 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.3 p30 40.5 38.77 0.62 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.121 1.368 . . . . 0.0 113.523 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 92' ' ' VAL . 70.8 t -145.67 6.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.737 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 23' ' ' SER . 10.3 p -124.47 -2.2 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -168.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.8 t -136.53 155.55 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.72 -172.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.786 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 51.0 m -75.52 79.28 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.032 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 1.054 ' HG2' ' HD2' ' A' ' 97' ' ' ARG . 11.4 ttm180 55.69 -58.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.753 -1.112 . . . . 0.0 112.869 -164.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 1.054 ' HD2' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -157.84 153.87 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.484 -0.76 . . . . 0.0 111.697 -177.132 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 1.01 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -95.41 -40.54 9.44 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.304 177.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.884 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -148.61 131.52 16.16 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.667 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -102.98 122.53 44.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -53.19 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 124.614 1.196 . . . . 0.0 108.406 -176.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.85 107.67 19.95 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 119.359 -0.937 . . . . 0.0 108.742 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.8 tt -77.02 107.87 9.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 23.6 mt-10 -117.19 134.05 55.25 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 39.07 43.34 0.8 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.1 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.892 ' HA ' HD21 ' A' ' 103' ' ' LEU . 53.2 m-80 72.08 15.63 5.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.561 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 15.5 pt-20 -122.26 151.68 40.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.939 173.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.95 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -93.42 129.13 39.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.942 -174.166 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 13.4 m120 -135.19 161.82 34.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.4 m -107.03 126.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.37 174.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 4.0 t -100.3 111.59 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.297 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 11.2 t70 -73.26 115.05 12.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 111' ' ' VAL . 16.0 m -115.17 -12.36 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.122 0.487 . . . . 0.0 111.096 -174.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.8 87.57 0.34 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.586 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . 1.01 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 30.7 t -92.32 145.15 24.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' CD2' ' HB ' ' A' ' 24' ' ' VAL . 23.9 tp -63.73 -55.41 23.47 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.334 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.78 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -67.77 -36.44 80.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.48 169.57 12.42 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.102 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.2 m -112.85 123.53 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.618 -0.791 . . . . 0.0 111.298 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 52.2 m-85 -140.96 103.67 4.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 172.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.007 HG12 HG13 ' A' ' 137' ' ' VAL . 1.3 m -99.45 130.27 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.581 ' HA ' ' OE2' ' A' ' 136' ' ' GLU . 1.8 m-20 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.139 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 58.12 32.13 21.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 13.5 pt-20 -146.12 138.79 13.96 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 110.664 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 19.9 Cg_exo -65.46 123.26 11.19 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.599 2.199 . . . . 0.0 111.412 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 121' ' ' VAL . 27.3 m -123.65 169.41 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.41 -61.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.809 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.888 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.5 t -143.84 91.91 2.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.333 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.32 124.89 44.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 8.7 p -67.11 150.81 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.728 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.95 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.0 mp -58.67 145.93 38.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.497 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 146' ' ' PHE . . . -151.3 130.79 12.97 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -69.42 121.85 17.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.441 0.639 . . . . 0.0 111.234 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.79 60.98 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.17 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 36.0 m-20 -105.02 147.53 27.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.58 161.85 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -168.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.007 HG13 HG12 ' A' ' 121' ' ' VAL . 40.6 t -134.51 131.74 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.558 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.859 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.6 tp-100 -96.8 120.06 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 169.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.842 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -135.98 129.5 47.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.386 171.105 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.78 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 76.81 -62.25 3.25 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.597 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.006 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 54.1 pttt 176.41 28.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.122 0.569 . . . . 0.0 111.379 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.847 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -122.82 146.84 47.19 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 109.053 -168.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.827 HH21 HD22 ' A' ' 33' ' ' LEU . 11.6 ttm-85 -97.1 100.18 11.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.626 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.926 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.4 mp -91.75 166.08 12.95 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.922 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -143.36 144.25 23.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 171.13 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.818 ' HB3' ' HG ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -84.51 136.87 33.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.953 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 59' ' ' VAL . 2.0 mm? -129.06 131.73 47.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.063 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.6 t -166.98 145.47 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.02 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.603 ' HA2' ' HA2' ' A' ' 50' ' ' GLY . . . -63.55 116.98 9.95 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.841 -176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.49 130.06 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.353 2.702 . . . . 0.0 110.835 173.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -59.03 116.15 3.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 111.334 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -87.47 63.41 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.72 3.44 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.892 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -127.01 121.95 33.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.335 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -93.93 -152.02 0.33 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 157' ' ' GLY . 19.0 t70 73.2 -166.79 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.48 ' H ' ' CG ' ' A' ' 156' ' ' ASP . . . 90.16 -59.77 3.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.4 m -99.88 76.75 1.98 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 162' ' ' PRO . 8.9 m -73.37 76.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.331 0.586 . . . . 0.0 111.298 -173.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -84.51 69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.889 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -155.93 -91.25 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.821 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 159' ' ' THR . 18.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 123.031 2.487 . . . . 0.0 112.046 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.3 m 69.95 97.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.501 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -92.41 -12.12 33.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.4 mtp 69.32 -75.53 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.862 0.726 . . . . 0.0 111.342 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.65 159.4 31.91 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.51 -77.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.077 1.851 . . . . 0.0 111.724 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -133.39 -56.7 0.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.803 0.335 . . . . 0.0 110.645 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.29 -54.12 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.476 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -179.58 -72.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.352 0.596 . . . . 0.0 110.645 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 3.0 ttmp? -104.39 49.09 0.82 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.659 -173.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.53 108.01 6.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.871 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 10.7 mm-40 -85.41 72.82 10.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.28 0.562 . . . . 0.0 112.125 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -122.35 32.02 5.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.811 0.815 . . . . 0.0 108.913 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -87.96 -32.87 18.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.464 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.611 ' HB2' HG13 ' A' ' 17' ' ' VAL . 3.8 p30 -69.61 -46.23 66.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.069 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 54.71 47.57 22.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 15' ' ' ASP . 36.0 m -87.44 26.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.936 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -67.41 125.96 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.882 0.372 . . . . 0.0 110.128 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -56.88 137.71 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.696 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.96 96.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.058 -171.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.2 m -157.23 155.37 30.72 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.764 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -70.94 5.14 2.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -159.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.905 HG12 ' H ' ' A' ' 25' ' ' PHE . 2.1 t 46.52 -152.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.11 0.564 . . . . 0.0 111.99 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.905 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER 100.1 -165.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.374 1.47 . . . . 0.0 114.376 160.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.967 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 32.64 -95.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.041 1.337 . . . . 0.0 110.578 -172.177 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' H ' ' HB2' ' A' ' 141' ' ' LYS . . . 66.01 121.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 113.087 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.932 ' HB3' HD21 ' A' ' 33' ' ' LEU . 2.2 m-20 -87.83 59.95 5.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.59 -173.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.438 ' CD1' ' HB1' ' A' ' 27' ' ' ALA . 30.5 m-85 -116.6 -42.27 3.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.771 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.0 tp -98.81 -27.49 13.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.292 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 33' ' ' LEU . 49.3 m -160.9 -173.72 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -169.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.671 ' HG3' ' HD3' ' A' ' 26' ' ' ARG . 12.4 mm-40 72.03 -13.47 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.904 0.752 . . . . 0.0 111.298 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.932 HD21 ' HB3' ' A' ' 28' ' ' ASP . 2.9 mt -82.78 -44.31 15.7 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 64.23 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.44 -2.164 . . . . 0.0 112.541 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.33 141.18 14.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 110.933 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -87.91 -1.29 7.22 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.981 2.454 . . . . 0.0 112.604 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.51 53.77 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.321 0.582 . . . . 0.0 111.036 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -120.79 -38.77 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.437 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.77 133.7 36.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.561 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.89 78.72 0.41 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.801 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 m -73.04 81.22 1.23 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.087 0.47 . . . . 0.0 110.556 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.48 -62.08 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.931 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -145.38 -138.3 0.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.55 68.03 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.328 0.585 . . . . 0.0 110.919 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.66 132.06 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.185 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.0 p 57.07 170.25 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.164 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.33 -65.01 0.48 Allowed Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 m -86.08 26.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.1 -8.95 3.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.92 -45.91 7.41 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.412 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.644 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 5.2 mp -62.1 130.16 92.6 Favored Pre-proline 0 CA--C 1.516 -0.359 0 CA-C-O 120.527 0.203 . . . . 0.0 111.006 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -106.39 63.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.798 2.998 . . . . 0.0 112.203 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -29.13 109.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 124.277 3.318 . . . . 0.0 114.421 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.84 -48.11 0.76 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 p -143.11 147.33 34.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.58 36.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.693 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 pt? -160.71 140.02 10.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.943 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.053 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.5 mp -89.67 112.33 23.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.679 168.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.53 125.82 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.993 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -73.0 113.43 10.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -77.51 -55.94 4.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.014 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -141.53 129.27 21.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -177.38 178.58 48.31 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 97.0 Cg_exo -48.46 -48.41 17.31 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.948 2.432 . . . . 0.0 113.465 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.531 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 58.0 t30 -83.16 -52.72 6.36 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.97 171.21 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.5 -1.682 . . . . 0.0 112.796 -170.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.6 2.54 89.84 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.917 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.993 ' H ' HG22 ' A' ' 60' ' ' VAL . 3.4 m -98.01 177.76 5.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.626 0.713 . . . . 0.0 110.465 -171.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.19 151.96 3.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.102 0.41 . . . . 0.0 111.636 -176.356 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.692 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -94.95 134.05 38.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.622 ' O ' HD23 ' A' ' 71' ' ' LEU . 6.4 tt -87.05 93.85 9.47 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.734 HD23 ' CD1' ' A' ' 101' ' ' PHE . 4.1 mp -93.39 45.43 1.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -99.0 -28.22 13.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.131 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.59 -162.3 0.92 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.006 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.2 -51.5 20.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -158.89 139.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 111.949 -178.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 38.3 p -121.16 152.03 39.23 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.343 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.636 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 75.8 m -95.57 124.8 39.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -126.54 116.23 20.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -166.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 148.99 -85.94 0.16 Allowed Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.176 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HG2' ' OD1' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.67 104.03 11.29 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.617 0.722 . . . . 0.0 109.174 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.636 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER -139.47 126.61 12.8 Favored Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.023 -169.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 16.7 Cg_exo -69.05 -50.18 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.654 2.236 . . . . 0.0 112.291 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -172.37 93.4 0.13 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 2.1 m -151.14 -62.42 0.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.155 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -140.14 -72.74 0.37 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.323 0.583 . . . . 0.0 111.285 -170.525 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.85 113.94 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.215 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' HD1' ' O ' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -116.77 134.32 54.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.132 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.5 mm? -122.22 74.43 1.16 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.934 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.6 t70 72.49 -17.37 0.39 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.454 0.645 . . . . 0.0 110.592 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.595 ' OD1' ' HG2' ' A' ' 81' ' ' ARG . 35.0 t70 61.82 29.52 17.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.386 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.511 ' C ' HG22 ' A' ' 22' ' ' TPO . 9.1 p -153.75 32.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.952 0.882 . . . . 0.0 109.821 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.552 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 65.3 p -132.81 -9.57 3.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.965 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.51 ' N ' HG21 ' A' ' 22' ' ' TPO . 2.0 t -136.38 159.57 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -173.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.724 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 11.4 t -87.57 77.3 8.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 58.48 -59.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.929 -165.33 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 5.7 ptt85 -143.65 137.63 28.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.621 0.724 . . . . 0.0 111.066 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -75.02 -39.27 61.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 170.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -156.94 149.45 23.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' CD ' HH21 ' A' ' 102' ' ' ARG . 7.8 pt-20 -108.0 133.1 52.8 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.734 ' CD1' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -56.98 106.12 0.28 Allowed 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.559 HH21 ' CD ' ' A' ' 100' ' ' GLU . 21.1 tpp85 -103.16 104.04 14.15 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.62 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.3 tt -86.44 110.72 19.92 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.351 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.28 135.36 48.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 57.51 37.74 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.606 0.566 . . . . 0.0 110.329 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.872 ' HA ' HD21 ' A' ' 103' ' ' LEU . 21.1 m120 64.64 12.52 7.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.03 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.1 mt-10 -106.33 144.73 32.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.893 0.377 . . . . 0.0 111.396 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.441 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -95.9 126.29 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.384 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 11.0 m-80 -135.86 163.36 30.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 128' ' ' SER . 7.2 m -111.26 122.59 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.942 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 36.7 t -101.18 110.4 27.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.865 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 18.6 t70 -68.5 128.29 36.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.689 HG21 HH11 ' A' ' 97' ' ' ARG . 18.9 m -126.0 9.51 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.22 0.533 . . . . 0.0 109.734 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.62 71.77 0.59 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.307 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 39.3 t -67.11 134.98 52.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.764 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.8 tm? -52.83 -55.82 20.3 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.682 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -76.17 -37.33 58.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 109.825 172.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.73 163.85 9.9 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.15 -173.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -111.69 137.41 49.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.394 0.678 . . . . 0.0 111.282 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.11 103.78 4.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.292 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.977 HG22 HG13 ' A' ' 137' ' ' VAL . 61.7 t -112.8 121.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 122.079 -0.388 . . . . 0.0 110.236 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 61.29 36.91 17.5 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 63.66 22.11 12.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.477 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.59 148.48 25.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 121.028 0.442 . . . . 0.0 110.949 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.03 123.6 11.5 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.271 1.981 . . . . 0.0 111.78 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.49 155.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.7 0.286 . . . . 0.0 110.281 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.3 m-20 -87.54 -47.08 9.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.641 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.895 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.6 p -154.86 91.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.342 0.592 . . . . 0.0 110.733 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.61 132.85 47.05 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.367 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.1 p -76.06 149.63 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.629 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.837 HD11 HD11 ' A' ' 58' ' ' LEU . 8.7 mp -65.49 133.44 51.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.653 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.08 -176.32 3.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.859 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -93.81 103.78 15.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.36 0.124 . . . . 0.0 111.306 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.09 69.64 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.114 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.718 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 3.8 t0 -81.59 162.25 23.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.7 pt-20 -126.89 148.26 50.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -166.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.977 HG13 HG22 ' A' ' 121' ' ' VAL . 61.4 t -123.09 141.44 43.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.024 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.888 ' HG3' ' HB2' ' A' ' 28' ' ' ASP . 0.8 OUTLIER -106.67 131.12 54.17 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.971 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.48 140.32 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.784 174.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.3 -73.73 0.72 Allowed Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.344 170.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.063 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 52.1 pttt -172.3 29.13 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.078 0.466 . . . . 0.0 110.445 170.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -127.02 149.32 49.95 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -171.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.616 ' NH2' ' HA ' ' A' ' 33' ' ' LEU . 3.8 ttm180 -98.6 120.26 38.72 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.64 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 4.3 mp -108.16 162.77 13.76 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.575 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.05 137.08 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.053 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.96 154.29 20.29 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.732 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -127.75 171.63 11.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.06 171.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 9.5 t -138.11 159.79 41.11 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.428 -174.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . -160.64 70.89 0.23 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.44 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HD2' HD23 ' A' ' 51' ' ' LEU . 32.0 Cg_exo -63.18 137.34 60.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.612 2.208 . . . . 0.0 111.215 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.15 51.23 2.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.327 . . . . 0.0 111.495 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -78.56 89.72 4.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.253 0.549 . . . . 0.0 109.659 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.8 150.47 50.57 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.683 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.31 41.23 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.03 69.28 6.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -151.79 80.07 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.962 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.68 106.85 0.39 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.171 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.9 t -110.49 -18.52 13.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.0 m -125.8 115.63 20.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 172.39 -20.04 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.811 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.99 149.5 20.39 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.164 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.606 2.204 . . . . 0.0 111.854 177.938 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 121.455 0.645 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.9 t -107.97 13.34 26.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -108.18 111.19 23.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.699 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.8 mmm -109.75 113.57 26.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.34 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.751 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 10.4 t30 -68.17 -51.8 24.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.751 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 44.3 Cg_endo -95.5 62.49 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.621 2.214 . . . . 0.0 111.12 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.32 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.178 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.6 -9.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.003 0.906 . . . . 0.0 108.678 172.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -166.36 160.19 15.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -141.31 101.76 4.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.0 110.709 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.6 125.54 28.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.395 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -169.8 -51.73 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.092 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -135.52 161.23 36.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.903 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 t -144.06 142.52 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' GLU . 23.7 t70 -71.88 145.77 48.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.893 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HG2' HG23 ' A' ' 17' ' ' VAL . 44.0 tt0 75.36 127.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.041 0.838 . . . . 0.0 109.944 -175.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG23 ' HG2' ' A' ' 16' ' ' GLU . 12.5 t 66.15 28.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 122.364 1.078 . . . . 0.0 109.099 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -85.03 83.87 7.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.627 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.69 170.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.5 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 66.58 169.16 0.23 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.975 0.797 . . . . 0.0 111.145 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 m 68.35 159.42 0.16 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -171.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.818 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.597 ' HB2' HG22 ' A' ' 93' ' ' THR . 41.9 m -60.21 108.55 0.81 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 117' ' ' ASN . 7.1 p -112.46 125.69 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.273 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' HB3' ' HE3' ' A' ' 141' ' ' LYS . 2.5 t80 176.52 -165.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.822 0.076 . . . . 0.0 110.937 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.591 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 1.2 tmm_? 43.48 -123.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.348 1.059 . . . . 0.0 112.484 171.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.883 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 65.05 174.74 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.907 ' H ' ' HG3' ' A' ' 138' ' ' GLN . 13.5 t70 -76.87 56.61 1.21 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.488 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.95 -48.97 0.19 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.645 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.29 -69.1 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.252 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 m -170.17 -167.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 70.31 35.55 2.02 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.686 0.616 . . . . 0.0 110.622 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -176.36 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.378 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.32 54.28 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.243 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.25 77.08 5.57 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.751 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -67.65 101.19 0.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.915 2.41 . . . . 0.0 111.864 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.07 -29.28 63.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.173 0.511 . . . . 0.0 110.175 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 62.58 20.6 12.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.189 172.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.82 -33.67 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.922 0.392 . . . . 0.0 110.692 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.29 24.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.112 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.0 m -150.39 -65.38 0.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 56.41 53.14 9.03 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.261 0.553 . . . . 0.0 110.68 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -75.79 76.82 2.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.226 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.72 98.52 9.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.898 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -95.1 -29.79 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.664 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.9 t -169.07 141.88 2.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.67 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.497 ' CA ' ' HD2' ' A' ' 150' ' ' PRO . . . -114.93 -33.33 1.7 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.4 43.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -168.37 -46.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.358 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.18 -23.49 76.21 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 114.202 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.665 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 96.1 mt -53.73 150.76 12.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.861 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.684 ' HA ' ' HE2' ' A' ' 108' ' ' PHE . 86.3 Cg_exo -47.92 -36.77 27.89 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.083 3.189 . . . . 0.0 115.188 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 51' ' ' LEU . 57.5 Cg_endo -72.09 55.13 2.32 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 121.518 1.479 . . . . 0.0 112.434 175.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 171.59 -79.99 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -164.7 132.81 3.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -126.86 169.66 13.02 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.568 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.5 pt? -153.19 131.92 12.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.015 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.7 mp -87.48 146.64 25.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.6 163.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.8 p -136.1 128.94 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.806 0.336 . . . . 0.0 110.383 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -74.37 115.15 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 18.8 tptp -76.5 -66.35 0.82 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 -172.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -138.92 132.93 31.16 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.978 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -178.05 -171.37 41.35 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 51.0 Cg_exo -53.87 -52.23 8.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.25 1.967 . . . . 0.0 112.893 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 2.5 t-20 -81.36 -54.14 5.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.647 0.737 . . . . 0.0 109.262 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.674 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.1 170.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.03 -170.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.35 2.28 90.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.994 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.5 m -97.96 179.55 4.75 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 118.423 1.111 . . . . 0.0 110.966 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.621 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -166.25 153.02 9.36 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.3 0.5 . . . . 0.0 111.743 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.674 ' HE1' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.95 125.35 42.83 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.657 ' O ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.12 94.41 9.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.63 0.729 . . . . 0.0 109.481 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -91.37 54.79 2.63 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.776 0.798 . . . . 0.0 109.642 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -98.71 -26.61 14.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.007 171.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.466 ' HG2' HD23 ' A' ' 71' ' ' LEU . 13.2 pt20 -97.31 161.11 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.45 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -16.14 55.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -171.15 133.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 111.761 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 35.3 p -120.82 144.34 48.39 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.351 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 87' ' ' ILE . 74.4 m -89.96 124.64 34.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.15 123.38 47.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 141.84 -142.07 11.55 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.319 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.898 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.14 104.7 3.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.575 0.702 . . . . 0.0 110.066 174.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 29.5 m170 -136.86 111.4 9.49 Favored Pre-proline 0 N--CA 1.436 -1.136 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.289 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -83.36 -10.22 10.03 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.603 2.202 . . . . 0.0 111.428 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -164.82 69.72 0.16 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.097 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 34.6 m -147.95 -153.48 0.49 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.839 0.352 . . . . 0.0 110.72 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.48 -61.92 1.42 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 0.0 110.582 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.33 96.68 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -101.15 130.64 47.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.398 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 60' ' ' VAL . 3.8 mm? -115.93 80.64 1.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 37.7 t70 70.46 -10.12 0.72 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.824 0.702 . . . . 0.0 110.481 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.6 p-10 41.89 33.25 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.581 1.553 . . . . 0.0 113.16 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 t -138.69 -10.7 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.183 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.597 HG22 ' HB2' ' A' ' 23' ' ' SER . 30.4 p -103.29 -33.64 9.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.85 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.4 t -98.36 149.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 122.238 -0.289 . . . . 0.0 111.358 -170.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.686 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 6.7 t -74.44 77.02 1.92 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER 59.17 -75.68 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.149 -168.258 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.755 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -136.45 134.87 38.14 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -174.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -71.26 -45.7 62.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.69 -179.5 7.92 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.402 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.9 pt-20 -137.84 124.74 21.27 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.833 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -81.12 90.67 6.05 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.064 0.935 . . . . 0.0 108.82 -177.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' HG21 ' A' ' 111' ' ' VAL . 10.6 ptp180 -94.17 151.97 19.07 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.762 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.0 tt -89.1 105.95 18.12 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 54.3 mm-40 -115.52 133.96 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.6 OUTLIER 48.74 33.44 4.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.692 0.797 . . . . 0.0 111.477 -178.08 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.861 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.9 m-20 75.92 21.99 1.52 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.663 175.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.81 142.32 40.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.684 ' HE2' ' HA ' ' A' ' 52' ' ' PRO . 7.0 m-85 -84.58 137.64 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -175.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.833 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 4.3 m-20 -141.38 160.56 39.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -171.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -103.7 116.71 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.724 177.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 45.3 t -99.21 111.38 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.36 127.36 30.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.338 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 97' ' ' ARG . 10.4 m -127.36 -37.28 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 167.46 76.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.959 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 48.3 t -88.28 122.22 31.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.818 HD22 ' HB ' ' A' ' 22' ' ' TPO . 41.7 tp -51.9 -55.58 19.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -170.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.643 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 7.4 t30 -74.86 -34.91 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.0 110.454 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.49 160.67 9.32 Favored Glycine 0 C--O 1.247 0.95 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.001 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' HE1' ' A' ' 98' ' ' HIS . 17.7 m -112.47 122.34 47.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.282 0.633 . . . . 0.0 111.073 171.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 126.13 28.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 1.013 HG22 HG13 ' A' ' 137' ' ' VAL . 75.5 t -124.91 119.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 61.31 37.17 17.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.7 19.27 10.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.104 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -143.26 145.08 30.9 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.736 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.8 122.87 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.358 2.039 . . . . 0.0 111.113 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 17.7 m -115.17 176.73 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 13.6 t70 -109.66 -41.94 4.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.525 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.877 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 10.1 p -165.16 91.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.886 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -92.17 145.3 24.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.001 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.535 HG22 HD22 ' A' ' 109' ' ' ASN . 8.2 t -88.59 135.64 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -174.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -46.51 129.09 10.76 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.022 174.784 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -135.45 -174.75 3.72 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -106.56 113.15 26.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.356 0.598 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.63 -5.62 84.69 Favored Glycine 0 C--N 1.32 -0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.908 170.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -88.02 154.66 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER -112.15 149.0 32.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 121' ' ' VAL . 60.7 t -124.9 141.4 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.721 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.907 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 12.0 tm0? -109.18 130.8 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.328 0.585 . . . . 0.0 110.42 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -125.09 130.55 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.29 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 67.18 -91.23 0.19 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.023 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.977 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 19.6 ptmt -147.23 14.19 1.12 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.8 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -111.03 157.81 19.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -105.48 112.96 26.26 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.871 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -107.78 156.69 18.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.542 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.23 143.56 29.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.015 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.37 150.04 27.17 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.685 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.6 mm? -136.09 146.42 47.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.177 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.1 t -134.12 -164.51 1.51 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 150' ' ' PRO . . . -69.04 133.62 26.72 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.261 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.497 ' HD2' ' CA ' ' A' ' 47' ' ' GLY . 17.0 Cg_exo -69.04 50.1 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.394 2.729 . . . . 0.0 112.674 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' HB2' HD21 ' A' ' 51' ' ' LEU . 35.0 mmtp -130.74 -75.35 0.53 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.142 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.469 ' H ' HD21 ' A' ' 51' ' ' LEU . 38.1 tp60 46.54 68.86 0.55 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.14 0.9 . . . . 0.0 110.908 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 130.48 56.17 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -140.02 -67.35 0.43 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 49.09 55.65 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.847 0.717 . . . . 0.0 111.295 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.33 91.19 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.939 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -146.64 -161.16 9.15 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.715 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -83.34 116.01 22.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.775 0.322 . . . . 0.0 110.417 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 19.0 m -117.64 92.62 3.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.842 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 162' ' ' PRO . . . -112.17 -153.97 12.22 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.518 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.68 89.46 0.5 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 160' ' ' GLY . 9.5 Cg_endo . . . . . 0 N--CA 1.45 -1.065 0 C-N-CA 123.279 2.653 . . . . 0.0 111.6 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.209 0.528 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -103.31 62.53 0.79 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.715 0.769 . . . . 0.0 110.837 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.22 145.03 56.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.501 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.5 mtt -133.92 132.16 39.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.397 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' O ' HG22 ' A' ' 8' ' ' ILE . 26.9 p-10 -104.85 108.05 60.09 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.45 -10.13 28.0 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.086 2.524 . . . . 0.0 112.463 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.58 -28.95 69.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.427 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.617 HG23 ' HG3' ' A' ' 9' ' ' GLU . 10.4 tp -69.54 -20.23 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 8' ' ' ILE . 41.9 mt-10 -115.2 37.29 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.075 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.37 -39.31 65.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.047 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 12' ' ' GLN . 8.4 p-10 -137.69 -86.02 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.978 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 76.0 mt-30 -148.83 155.36 40.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 m -151.82 56.44 0.85 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.637 0.732 . . . . 0.0 109.906 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.5 m -83.3 42.86 0.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.424 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.59 67.42 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.454 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 48.43 36.0 6.62 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.349 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.12 -24.85 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 110.58 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -96.03 1.19 52.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.87 86.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.429 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 60.37 -152.2 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.225 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -135.1 133.46 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 173.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.852 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 27.8 m -67.39 99.9 0.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.949 0.5 . . . . 0.0 112.173 -172.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.703 ' HB ' HD23 ' A' ' 116' ' ' LEU . 10.0 p -130.2 149.42 33.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.077 -171.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.7 t80 177.34 -146.36 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.017 -173.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.782 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.3 tpt180 46.28 -107.84 0.16 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.406 0.683 . . . . 0.0 110.972 171.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.576 ' H ' ' HG3' ' A' ' 26' ' ' ARG . . . 60.36 176.42 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.919 ' HA ' HD21 ' A' ' 33' ' ' LEU . 24.6 t70 -80.92 48.5 1.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.407 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' HE2' ' ND2' ' A' ' 117' ' ' ASN . 21.5 m-85 -145.38 -44.84 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.484 -172.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.7 tp -106.42 -50.1 3.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -174.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 m -132.2 147.95 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 66.91 42.08 2.59 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 166.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -168.53 -28.56 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 171.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -86.26 53.51 2.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.142 0.496 . . . . 0.0 110.984 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -114.13 129.53 24.73 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.242 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 29.1 Cg_exo -61.89 151.67 79.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.806 2.338 . . . . 0.0 111.994 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 59.19 59.6 2.67 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.605 0.566 . . . . 0.0 110.361 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -57.77 108.92 0.63 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.175 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.11 154.43 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.62 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -96.47 0.11 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.547 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -123.81 -35.14 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.608 0.242 . . . . 0.0 111.4 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 56.12 -99.72 0.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.571 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m 48.99 44.29 22.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 133' ' ' ASN . . . -79.88 70.72 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.362 0.601 . . . . 0.0 109.821 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.75 87.5 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.031 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.484 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 16.9 m -80.69 49.66 1.22 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.433 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.67 61.79 0.38 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.603 HG13 ' HD2' ' A' ' 151' ' ' LYS . 22.1 t 63.82 77.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.938 0.495 . . . . 0.0 111.685 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 35.4 tt0 171.71 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.948 175.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.3 -54.43 19.9 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.658 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 51' ' ' LEU . 4.3 pp -92.9 120.14 67.33 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-O 121.676 0.751 . . . . 0.0 110.623 169.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.852 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 22.0 Cg_exo -69.35 -41.93 4.31 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.374 2.716 . . . . 0.0 114.737 170.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.852 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 58.8 Cg_endo -104.53 -154.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 123.514 2.809 . . . . 0.0 112.431 -168.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.45 39.99 2.75 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -152.37 170.65 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.912 -0.644 . . . . 0.0 109.317 -169.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.81 167.32 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.09 142.52 11.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 mp -86.51 114.02 22.91 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.092 166.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 68' ' ' SER . 4.2 p -109.62 128.39 65.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.621 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.56 109.89 4.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.025 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -65.53 -60.68 2.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.914 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 62' ' ' ARG . 27.5 mtm-85 -150.95 109.56 3.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.132 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -134.36 -147.55 5.62 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.033 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 72.8 Cg_endo -75.44 -48.99 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.232 1.955 . . . . 0.0 111.911 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.633 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 50.8 t30 -74.36 -49.69 21.74 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 59.31 154.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.56 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.62 1.38 90.14 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.7 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.903 ' H ' HG22 ' A' ' 60' ' ' VAL . 15.6 t -88.36 -178.3 5.85 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.863 0.832 . . . . 0.0 109.896 -174.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.648 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -173.26 150.32 1.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.389 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.44 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -95.16 127.19 41.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 172.694 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -83.28 91.5 7.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.966 0.791 . . . . 0.0 109.249 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.802 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 mp -86.12 53.93 2.96 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.0 109.688 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 22.9 t70 -113.47 -25.72 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.046 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -86.44 -167.54 1.91 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.328 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.07 35.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.781 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.11 134.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.608 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 7.6 p -119.68 128.33 53.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.9 m -74.93 125.26 28.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -120.57 108.22 13.79 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -170.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.844 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.08 -146.96 12.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.335 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -69.24 107.63 3.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.604 0.716 . . . . 0.0 109.56 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 97' ' ' ARG . 29.7 m80 -135.33 116.62 12.1 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.968 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -42.96 8.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.523 2.149 . . . . 0.0 110.734 170.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -155.27 96.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.338 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -146.32 -96.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.01 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -145.35 -59.45 0.34 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.513 0.673 . . . . 0.0 110.43 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -120.68 113.01 38.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.167 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' HD2' ' O ' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -104.05 127.2 51.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.247 -174.513 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 3.2 mm? -114.77 76.22 0.98 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 9.5 t70 66.53 -0.77 1.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.543 0.687 . . . . 0.0 109.641 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.9 p-10 40.62 30.03 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.749 1.62 . . . . 0.0 113.389 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.1 p -166.19 59.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 110.973 172.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.67 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 3.0 p -143.93 -13.99 0.63 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.149 0.5 . . . . 0.0 110.803 170.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -140.84 141.83 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.446 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 4.9 m -64.78 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.118 0.567 . . . . 0.0 112.104 -173.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.795 ' HD3' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 68.53 -63.08 0.36 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 -177.516 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.844 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -154.83 132.99 11.71 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.656 -0.653 . . . . 0.0 111.839 175.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -63.24 -43.56 97.71 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.757 176.824 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -155.82 174.56 15.14 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.921 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.8 pt-20 -135.74 128.9 31.75 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.802 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -54.66 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 124.477 1.11 . . . . 0.0 108.117 -178.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 14.0 ttm180 -98.97 105.84 18.03 Favored 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.454 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.5 tt -80.24 105.11 11.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.604 0.716 . . . . 0.0 109.575 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 37.3 mt-10 -129.25 135.66 49.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.637 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 52.9 m-80 62.1 33.47 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.122 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.763 ' HA ' HD21 ' A' ' 103' ' ' LEU . 73.7 m-20 70.94 4.14 4.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.825 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.0 mm-40 -103.47 144.82 30.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -91.24 125.65 36.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 21.1 m-80 -131.18 163.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.619 0.247 . . . . 0.0 111.183 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -105.27 124.44 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.159 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 68.3 t -108.9 110.41 31.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.806 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.0 125.62 26.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.559 0.537 . . . . 0.0 109.722 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.53 -27.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.39 83.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.576 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.911 ' HA ' HG23 ' A' ' 94' ' ' VAL . 37.2 t -108.6 120.46 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.852 HD22 ' HB ' ' A' ' 22' ' ' TPO . 58.4 tp -53.16 -56.27 17.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.61 ' ND2' ' HE2' ' A' ' 29' ' ' PHE . 0.1 OUTLIER -63.44 -34.76 78.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.49 0.662 . . . . 0.0 109.641 177.349 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.75 169.49 12.37 Favored Glycine 0 C--O 1.253 1.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.145 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 m -112.02 117.33 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.761 0.424 . . . . 0.0 110.917 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -127.72 106.82 9.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.864 HG22 HG23 ' A' ' 137' ' ' VAL . 21.2 t -101.88 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.664 ' ND2' HG12 ' A' ' 121' ' ' VAL . 25.4 m-80 65.06 44.23 3.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 109.319 -174.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 63.44 13.25 6.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.004 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 9.9 pt-20 -133.89 131.4 20.98 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-O 121.344 0.592 . . . . 0.0 110.804 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 16.4 Cg_exo -67.81 123.21 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.783 2.322 . . . . 0.0 112.257 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 129' ' ' ALA . 14.2 m -121.76 165.1 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 2.8 m-20 -108.38 -24.81 11.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.758 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 21.5 p -164.52 91.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.441 0.639 . . . . 0.0 109.59 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -110.22 148.41 31.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.355 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.62 127.63 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.086 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -63.32 162.9 11.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -166.33 160.83 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.297 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.665 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 1.7 p-10 -60.14 100.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.132 0.492 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.72 4.38 36.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.727 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.52 119.74 20.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 5.0 tt0 -106.73 134.25 50.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.666 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.962 HG12 ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -117.68 142.22 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.483 HE22 ' CG ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -111.72 115.59 29.34 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.67 ' HB ' ' CB ' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -123.83 129.47 74.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.507 175.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.32 -68.21 1.78 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.066 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.033 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 17.7 ptmt -173.7 31.36 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 116.953 0.377 . . . . 0.0 110.712 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.71 149.95 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -172.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 33' ' ' LEU . 40.0 ttp85 -103.12 100.87 10.82 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.7 mp -96.12 157.85 15.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.75 141.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.292 169.264 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 43.7 t80 -97.81 136.85 37.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.248 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -128.55 152.19 48.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.524 0.678 . . . . 0.0 110.958 170.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.502 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 14.8 t -156.98 141.98 17.08 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.014 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 46' ' ' SER . . . -135.7 85.51 0.25 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.558 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HD2' ' HA2' ' A' ' 149' ' ' GLY . 2.8 Cg_endo -39.49 114.6 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.321 3.347 . . . . 0.0 113.474 -175.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.603 ' HD2' HG13 ' A' ' 48' ' ' VAL . 64.1 tttp -126.75 103.75 7.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.651 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 62.63 76.99 0.35 Allowed 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.944 0.777 . . . . 0.0 110.048 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.41 -165.43 17.24 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.073 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.14 39.7 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -140.42 101.33 4.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.44 -60.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.094 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.77 -96.74 0.31 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.2 p -136.99 16.62 3.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.637 0.256 . . . . 0.0 111.344 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.2 m 65.17 96.47 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.023 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.34 107.81 2.22 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.643 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -94.92 -114.7 2.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.973 -175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--O 1.246 0.921 0 C-N-CA 122.838 2.359 . . . . 0.0 112.414 -177.674 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.613 0.72 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -111.41 -61.88 1.63 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.287 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -111.05 110.83 21.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.191 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.7 ttt -140.2 -48.93 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.21 115.86 59.16 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.035 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.93 97.75 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.718 2.279 . . . . 0.0 110.406 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -56.74 104.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.638 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.9 mm -82.56 -35.01 12.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.537 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.17 3.38 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.637 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 65.65 -148.98 0.23 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.253 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.8 t70 73.84 -80.44 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.528 0.731 . . . . 0.0 110.61 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 42.78 46.73 4.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.092 0.949 . . . . 0.0 111.24 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -115.61 54.26 0.82 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.852 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.7 t -107.73 104.31 13.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.055 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 t70 58.09 78.58 0.24 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.48 101.21 13.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.23 111.88 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.139 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.5 m -78.97 113.21 16.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 12.5 p -68.06 -23.42 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.608 0.242 . . . . 0.0 110.668 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 5.2 mm-40 75.52 166.78 0.28 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.778 0.799 . . . . 0.0 112.274 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m -131.4 137.79 48.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.675 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.616 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 48.6 m 18.36 120.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 6.8 t -101.91 146.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.656 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.8 t80 172.13 -159.11 0.01 OUTLIER 'General case' 0 C--N 1.35 0.592 0 O-C-N 123.603 0.564 . . . . 0.0 110.751 171.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 35.64 -119.03 0.12 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.512 1.125 . . . . 0.0 112.691 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 61.82 -175.59 0.13 Allowed 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HA ' HD11 ' A' ' 33' ' ' LEU . 1.4 t70 -80.93 40.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.148 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' HE1' ' CE2' ' A' ' 120' ' ' TYR . 2.1 m-30 -120.73 -55.22 2.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.8 tp -63.38 -17.61 62.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.52 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m 73.65 25.99 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.485 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -79.43 56.46 2.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.71 0.767 . . . . 0.0 109.919 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD23 ' HG3' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -143.63 -73.48 0.27 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -177.08 122.99 0.13 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.397 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -72.9 -51.41 6.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.547 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 24.1 Cg_exo -65.21 117.05 4.22 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.99 1.794 . . . . 0.0 111.865 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.22 171.7 7.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.003 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 156.73 37.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.39 39.12 3.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.127 0.489 . . . . 0.0 111.413 -173.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.6 49.95 0.72 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.331 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -69.49 137.29 52.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 110.637 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.83 74.35 3.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.175 0.512 . . . . 0.0 110.241 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t -138.78 45.11 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.677 0.751 . . . . 0.0 109.576 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.37 53.96 2.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.471 0.653 . . . . 0.0 109.461 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 130' ' ' VAL . 59.7 t -110.7 133.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -156.44 76.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.284 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 15.95 6.1 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.798 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -157.92 65.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.123 0.569 . . . . 0.0 109.559 -177.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.874 ' HG2' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.11 -40.56 64.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.324 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.55 -1.43 77.33 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.874 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 40.5 mt -67.41 121.13 77.48 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 123.621 0.768 . . . . 0.0 111.226 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 37.1 Cg_exo -61.85 -35.95 75.66 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.147 2.565 . . . . 0.0 115.105 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.615 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 74.4 Cg_endo -98.09 177.8 0.42 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 121.968 1.779 . . . . 0.0 112.941 -172.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.78 -34.42 13.43 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 m -116.78 134.46 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.64 168.34 16.6 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.19 147.77 12.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.631 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 131' ' ' LEU . 2.5 mp -86.42 144.32 27.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -123.19 133.02 70.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.012 0.434 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.695 ' HB ' ' H ' ' A' ' 68' ' ' SER . 79.1 t -65.57 105.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 145' ' ' VAL . 59.0 tttm -70.4 -47.49 60.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.762 1.289 . . . . 0.0 110.151 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -165.78 144.55 6.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.576 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -173.67 -157.83 16.33 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 13.9 Cg_exo -67.22 -48.81 1.55 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 119.481 1.64 . . . . 0.0 111.723 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -77.63 -53.51 7.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.009 173.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.614 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.14 160.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.109 -172.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.4 2.02 90.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.564 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.695 ' H ' ' HB ' ' A' ' 60' ' ' VAL . 6.7 m -88.69 -172.42 3.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.226 0.513 . . . . 0.0 111.362 -173.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.05 152.51 2.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.962 0.346 . . . . 0.0 111.787 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.913 ' HD1' ' HB2' ' A' ' 58' ' ' LEU . 1.5 m-85 -98.2 116.95 31.5 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -78.04 90.13 4.2 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.705 0.764 . . . . 0.0 109.453 -174.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 58' ' ' LEU . 15.4 mt -82.75 59.46 4.78 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.573 0.701 . . . . 0.0 109.955 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -117.01 -26.87 6.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.645 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -98.67 177.64 5.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.84 97.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -157.56 135.8 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 43.2 p -109.91 140.37 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.665 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 37.0 m -88.31 124.23 33.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -123.21 119.9 31.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.515 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 150.2 -138.29 6.64 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.9 tmm_? -71.5 104.37 3.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 109.85 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.502 ' HE1' ' N ' ' A' ' 79' ' ' ALA . 31.2 m170 -137.36 119.12 11.01 Favored Pre-proline 0 N--CA 1.438 -1.045 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.027 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.16 -48.37 8.3 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 167.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.48 95.14 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.827 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 5.3 p -169.51 -165.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.607 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 85' ' ' SER . 3.2 m-20 -61.74 -51.89 66.51 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -167.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -130.36 91.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 122.087 0.946 . . . . 0.0 110.987 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -95.41 134.19 38.51 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.269 174.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.019 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.5 mm? -122.03 77.54 1.39 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.768 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 24.6 t0 66.01 -3.76 0.73 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.6 p30 43.69 25.65 0.1 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.372 1.469 . . . . 0.0 113.817 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 23' ' ' SER . 10.8 p -147.43 45.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.32 1.057 . . . . 0.0 110.222 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.673 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.97 -0.6 0.31 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.045 172.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.667 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -135.64 143.15 37.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.675 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 11.9 t -78.29 73.0 4.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER 67.24 -58.47 0.41 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.672 0.749 . . . . 0.0 110.114 -171.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' HD2' HG11 ' A' ' 113' ' ' VAL . 22.5 ttm180 -146.18 125.28 12.88 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.879 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.776 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -67.18 -46.07 75.07 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -169.98 160.09 8.09 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.869 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.3 pt-20 -112.66 117.97 33.75 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.862 ' CZ ' ' HB ' ' A' ' 110' ' ' VAL . 4.4 m-85 -76.37 95.33 3.78 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.124 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -103.05 148.62 25.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.408 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.2 tt -91.73 117.54 29.85 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -142.88 135.68 27.9 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 48.8 m-80 62.45 32.35 16.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.683 0.615 . . . . 0.0 110.094 -172.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.71 ' HA ' HD21 ' A' ' 103' ' ' LEU . 5.1 t30 74.84 -1.29 3.12 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.085 0.865 . . . . 0.0 112.341 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 1.5 mm-40 -109.13 147.19 32.85 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.086 -0.383 . . . . 0.0 109.977 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 103' ' ' LEU . 12.9 m-85 -88.89 130.96 35.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 130' ' ' VAL . 13.1 m-80 -140.34 162.63 34.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.0 OUTLIER -107.09 122.02 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.37 172.412 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 128' ' ' SER . 26.8 t -101.93 110.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.999 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 24.9 t0 -59.28 144.03 47.52 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.867 0.729 . . . . 0.0 109.713 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.61 HG11 ' HD2' ' A' ' 97' ' ' ARG . 1.2 t -142.44 -32.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.824 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.93 103.35 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.723 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 44.2 t -110.23 145.7 36.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.902 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 24' ' ' VAL . 18.1 tp -58.81 -55.77 30.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.544 0.611 . . . . 0.0 111.675 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 59.2 m-80 -61.37 -38.06 85.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.238 0.542 . . . . 0.0 110.327 177.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.18 167.43 11.52 Favored Glycine 0 C--O 1.246 0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.97 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 ' HE1' ' A' ' 98' ' ' HIS . 16.0 m -111.66 133.63 53.78 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.004 0.522 . . . . 0.0 111.225 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' CE2' ' HE1' ' A' ' 29' ' ' PHE . 23.2 m-85 -140.73 131.19 25.31 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.848 173.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.853 HG22 HG13 ' A' ' 137' ' ' VAL . 77.4 t -127.91 113.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.0 42.01 16.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.813 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.64 -2.03 2.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.902 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.4 pt-20 -134.03 141.98 41.64 Favored Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 121.747 -0.596 . . . . 0.0 111.204 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 9.7 Cg_exo -70.83 121.99 8.41 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.11 1.874 . . . . 0.0 111.689 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.84 178.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.58 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 21.9 t70 -93.41 -64.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.864 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 5.8 p -146.77 92.9 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.231 0.538 . . . . 0.0 109.91 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.99 143.55 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.631 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.521 HG22 ' OD1' ' A' ' 109' ' ' ASN . 3.3 t -84.26 135.85 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.187 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -62.18 161.5 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -158.56 154.67 27.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.25 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.96 97.72 0.69 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.78 4.81 29.74 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.84 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 19.4 t70 -72.87 150.96 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.1 tt0 -141.32 133.39 27.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.467 0.651 . . . . 0.0 111.421 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG13 HG22 ' A' ' 121' ' ' VAL . 48.0 t -129.13 141.64 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.373 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -109.84 121.02 44.27 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.019 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.38 140.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 57.95 -109.79 2.05 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.04 -1.552 . . . . 0.0 109.274 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.812 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 1.8 pttm -136.3 34.03 2.79 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.907 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.732 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -114.96 150.81 35.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.624 ' HG3' HD23 ' A' ' 33' ' ' LEU . 14.1 ttm180 -102.19 106.45 17.29 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 60' ' ' VAL . 2.0 mp -110.29 150.86 28.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.715 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.35 144.2 28.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.823 ' HB2' ' HG ' ' A' ' 58' ' ' LEU . 84.5 t80 -94.22 125.79 39.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.985 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? -128.14 169.32 14.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.223 169.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.789 HG21 HD22 ' A' ' 51' ' ' LEU . 8.7 t -155.12 -172.19 4.09 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.924 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . -59.74 166.19 10.09 Favored Glycine 0 C--O 1.236 0.241 0 O-C-N 123.632 0.582 . . . . 0.0 114.466 -170.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' A' ' 153' ' ' GLY . 73.0 Cg_endo -76.29 118.3 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.19 2.593 . . . . 0.0 112.98 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 151' ' ' LYS . 31.2 ttmt -83.16 -3.86 57.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.255 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -112.63 14.59 20.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 150' ' ' PRO . . . 74.02 -168.22 54.29 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -169.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -78.05 69.45 4.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.795 0.798 . . . . 0.0 109.997 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 70.35 101.95 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.648 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t70 72.45 116.72 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.085 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -138.55 -114.82 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.077 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.1 t -128.27 -166.32 1.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 64.53 75.22 0.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.532 0.682 . . . . 0.0 110.383 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -175.23 -47.27 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.69 64.42 0.37 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.025 2.483 . . . . 0.0 112.007 -175.748 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.977 0.417 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 p -83.03 118.2 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 111.561 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -142.13 170.57 15.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.057 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.0 ttm -145.24 74.19 1.39 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.659 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 56.5 t30 -99.21 -51.58 0.2 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.727 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' H ' ' A' ' 5' ' ' ASN . 19.4 Cg_endo -60.78 116.58 3.44 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -79.67 106.84 11.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.627 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tp -96.08 -17.99 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.13 104.04 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.451 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 66.56 117.48 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.954 0.783 . . . . 0.0 112.015 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -82.28 99.33 9.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.048 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -88.11 6.44 36.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 0.0 110.316 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 m -67.1 -32.68 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.013 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -69.49 -13.69 62.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.89 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.01 106.99 19.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.936 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.39 120.56 42.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.45 109.02 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -92.26 139.48 30.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.15 -3.6 10.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -140.86 130.88 24.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 22' ' ' TPO . 50.6 m -101.08 135.52 42.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 170.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.753 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 93' ' ' THR . 17.9 m -59.96 130.52 47.16 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.96 -0.463 . . . . 0.0 112.037 -173.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.02 134.33 41.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.388 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 42.7 t80 176.51 176.08 0.31 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.051 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.5 tpt180 72.54 -42.41 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 159.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.752 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . -60.11 -169.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -169.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' HA ' HD11 ' A' ' 33' ' ' LEU . 25.1 t0 -61.04 58.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.424 1.107 . . . . 0.0 112.386 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 11.6 m-85 -154.4 -34.69 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 26' ' ' ARG . 38.3 tp -98.88 -67.96 0.82 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.292 -1.776 . . . . 0.0 111.848 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.2 p 177.05 -177.44 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 60.5 59.88 2.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.629 -1.168 . . . . 0.0 113.839 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 28' ' ' ASP . 1.2 pp 178.46 -24.62 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.694 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -53.15 147.41 9.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.822 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.95 84.9 62.24 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.93 -43.48 30.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.593 2.195 . . . . 0.0 111.111 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.8 69.11 3.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -79.28 52.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.1 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.75 2.63 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 121.01 11.08 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.233 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.4 m -128.52 71.9 1.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.603 0.716 . . . . 0.0 109.149 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -101.38 26.96 6.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.034 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -79.42 49.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.69 49.73 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.532 0.682 . . . . 0.0 109.615 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.84 144.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.619 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' A' ' 49' ' ' GLU . 14.8 m 66.88 31.7 7.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.266 0.555 . . . . 0.0 110.883 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.66 -39.58 1.87 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 11.93 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.469 1.128 . . . . 0.0 109.067 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 46' ' ' SER . 15.1 tp10 -87.1 -58.82 2.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -121.56 53.68 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.687 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 51' ' ' LEU . 3.5 pp -60.87 128.15 88.53 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.002 0.43 . . . . 0.0 111.118 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 72.1 Cg_endo -91.06 0.82 4.84 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.902 2.402 . . . . 0.0 117.989 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.617 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 44.4 Cg_endo -95.63 161.31 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 CA-C-N 122.801 2.036 . . . . 0.0 112.787 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.92 -9.11 57.58 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -137.24 136.7 38.34 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.07 170.03 11.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 72' ' ' LEU . 2.1 pt? -155.5 133.03 11.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.066 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.3 mp -85.49 128.43 34.73 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.631 163.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -110.88 125.6 68.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.231 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.865 HG22 ' HG ' ' A' ' 144' ' ' LEU . 67.9 t -65.57 104.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 52.1 tttp -73.45 -57.25 4.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 124.23 0.956 . . . . 0.0 109.873 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -153.34 131.19 11.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.971 0.891 . . . . 0.0 110.944 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -168.78 -162.35 20.75 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.09 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 40.5 Cg_exo -59.37 -56.33 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 119.401 1.601 . . . . 0.0 112.669 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 1.8 t-20 -70.01 -52.57 23.06 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.645 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.05 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.252 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.72 1.04 90.04 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.979 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.748 ' HB2' HG21 ' A' ' 60' ' ' VAL . 18.7 m -85.38 -167.93 2.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.584 0.692 . . . . 0.0 111.542 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.73 ' O ' ' HD2' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -170.23 154.74 5.02 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -175.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -95.39 125.1 39.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.668 ' O ' HG21 ' A' ' 77' ' ' THR . 1.1 tm? -84.48 98.27 10.01 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HG ' ' HD2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.12 51.61 1.03 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.454 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 11.3 t70 -95.68 -19.38 19.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.149 169.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -89.16 166.58 13.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.85 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.31 63.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.183 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 102' ' ' ARG . 3.2 tp -168.99 130.03 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.76 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.668 HG21 ' O ' ' A' ' 71' ' ' LEU . 22.9 p -123.68 146.91 47.89 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.081 -176.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 87' ' ' ILE . 23.4 m -82.13 125.2 30.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.533 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.04 128.39 54.31 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.18 -132.1 6.1 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.525 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.982 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -80.31 103.93 10.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.666 0.746 . . . . 0.0 109.905 174.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.559 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 36.5 m80 -138.02 128.84 15.66 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.971 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.26 -63.97 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.267 1.978 . . . . 0.0 111.813 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -145.19 47.19 1.31 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 82' ' ' HIS . 2.3 p -128.53 97.37 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 112.125 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 28.3 m-20 57.44 -91.2 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.659 1.184 . . . . 0.0 113.575 171.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.713 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -109.06 98.96 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 0.0 111.354 -171.224 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -103.65 128.13 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.29 178.714 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.781 HD12 ' CD2' ' A' ' 142' ' ' PHE . 3.3 mm? -120.03 86.91 2.65 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.208 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 17.1 t70 69.5 -7.74 0.82 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 0.0 109.611 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.762 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 p-10 37.9 34.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.034 1.734 . . . . 0.0 113.749 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.99 0.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.433 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' SER . 1.6 p -104.58 -25.53 12.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.823 -0.548 . . . . 0.0 111.658 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.9 t -105.12 150.18 8.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -172.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.645 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 6.3 t -75.49 72.67 2.5 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.982 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 7.8 ttt180 56.53 -62.37 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.328 -165.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -141.25 127.6 19.86 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.802 -1.186 . . . . 0.0 112.178 -171.161 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.858 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.13 -45.04 24.35 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.415 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -144.23 174.52 10.82 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.104 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.716 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.7 pt-20 -138.09 120.13 15.54 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.078 -1.874 . . . . 0.0 106.072 166.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.751 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.4 93.16 5.93 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.654 0.74 . . . . 0.0 109.55 -171.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.759 ' HB3' HD13 ' A' ' 76' ' ' ILE . 9.3 ptp180 -92.61 134.51 34.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.525 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.707 HD12 ' CE2' ' A' ' 108' ' ' PHE . 6.3 tt -85.23 114.08 22.06 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -124.5 139.86 53.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.83 39.7 1.81 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.902 0.751 . . . . 0.0 112.229 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HA ' HD21 ' A' ' 103' ' ' LEU . 8.0 t30 75.23 13.9 3.1 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 112.429 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 2.3 mp0 -120.87 140.87 51.19 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.922 -0.486 . . . . 0.0 110.413 172.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.707 ' CE2' HD12 ' A' ' 103' ' ' LEU . 2.1 m-85 -89.25 139.92 30.0 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 32.8 m-80 -143.49 155.98 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.963 -170.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -103.49 120.74 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.634 0.731 . . . . 0.0 110.839 179.481 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 113' ' ' VAL . 2.3 t -99.8 118.05 45.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.957 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.14 119.07 19.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.764 HG13 HG12 ' A' ' 111' ' ' VAL . 5.8 m -121.54 -53.03 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . -171.19 79.02 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.118 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 32.4 t -91.75 122.64 34.48 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.753 HD22 ' HB ' ' A' ' 22' ' ' TPO . 16.0 tp -61.78 -54.13 46.51 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.961 -175.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 24.2 m-80 -65.92 -38.77 89.56 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 141.37 157.36 7.14 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.43 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.454 HG23 ' CE1' ' A' ' 98' ' ' HIS . 16.6 m -111.6 125.63 54.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.602 0.361 . . . . 0.0 110.851 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 65.8 m-85 -139.74 105.53 5.16 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.88 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 137' ' ' VAL . 83.4 t -101.77 122.75 54.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 172.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 63.71 33.34 13.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 14.8 mtp-105 52.28 37.78 23.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.803 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.94 139.44 13.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.116 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 122.7 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.014 1.81 . . . . 0.0 111.278 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -114.49 178.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.914 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 18.5 t70 -96.71 -58.88 1.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.115 0.483 . . . . 0.0 109.844 174.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.857 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 41.8 t -155.81 91.21 1.27 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.051 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.36 149.71 21.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.699 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.73 136.88 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.681 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 146' ' ' PHE . 2.6 tt -56.11 106.67 0.29 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.953 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.29 124.37 24.33 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.823 0.344 . . . . 0.0 111.358 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.562 ' OD1' HG22 ' A' ' 148' ' ' THR . 3.4 m-20 -54.23 123.93 14.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.84 24.88 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.619 168.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.8 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 1.7 t70 -97.26 165.89 11.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.619 0.71 . . . . 0.0 110.555 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.4 pp20? -116.12 156.99 25.46 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.813 0.816 . . . . 0.0 113.023 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 121' ' ' VAL . 68.5 t -131.8 130.08 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.253 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 113.76 25.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.072 0.463 . . . . 0.0 110.249 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.858 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -113.19 124.58 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.223 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 64.8 -108.13 2.18 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.476 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.09 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 7.8 pttt -134.93 21.08 3.5 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.597 0.713 . . . . 0.0 111.354 -174.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.781 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -113.04 143.99 43.37 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.968 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 5.7 ttm180 -95.65 102.87 14.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.865 ' HG ' HG22 ' A' ' 60' ' ' VAL . 5.1 mp -95.78 161.42 14.02 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.535 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.5 HG22 ' CD2' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -140.23 139.46 36.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 172.03 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.066 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.45 130.67 49.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD2' HG22 ' A' ' 145' ' ' VAL . 2.6 mm? -129.82 125.38 35.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.76 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.562 HG22 ' OD1' ' A' ' 133' ' ' ASN . 15.2 t -94.77 -158.31 0.63 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.498 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . -54.04 121.77 20.46 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.542 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.69 163.49 38.76 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.914 2.409 . . . . 0.0 111.667 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -76.95 51.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.986 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -89.05 81.17 6.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.4 -32.12 79.85 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.654 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -92.61 62.99 3.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.437 0.636 . . . . 0.0 111.085 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -113.18 132.34 55.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.551 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -119.63 21.47 12.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.024 0.916 . . . . 0.0 108.594 174.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.47 -3.04 67.23 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.3 t -52.81 -36.2 58.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 109.751 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 m -131.06 50.0 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 171.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.6 96.19 0.35 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.474 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.95 -148.21 7.54 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 123.109 2.539 . . . . 0.0 112.034 177.409 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.235 0.302 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 m -79.51 69.11 5.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.27 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.006 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.418 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 25.1 ttt -124.54 135.85 53.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.512 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -106.8 96.46 14.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.888 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 4' ' ' MET . 21.3 Cg_exo -66.2 -48.6 2.47 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.309 2.673 . . . . 0.0 113.254 -174.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -109.05 155.28 21.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 110.51 -177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 tt -168.11 124.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.083 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.88 ' HG3' ' HD3' ' A' ' 10' ' ' LYS . 8.3 tp10 73.92 147.48 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.738 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.88 ' HD3' ' HG3' ' A' ' 9' ' ' GLU . 4.1 mppt? 58.02 59.27 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.074 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.19 121.56 15.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.081 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 64.64 -84.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.227 0.955 . . . . 0.0 112.307 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 p -127.35 108.24 10.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.982 0.42 . . . . 0.0 112.047 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 t -151.47 134.31 15.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.18 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 t0 68.84 -83.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.912 0.758 . . . . 0.0 111.883 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -82.75 67.64 8.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.224 0.535 . . . . 0.0 111.288 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -87.12 -70.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 172.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 m 67.79 -70.75 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.867 0.73 . . . . 0.0 112.576 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 21' ' ' THR . 7.1 p -91.52 133.06 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.28 0.562 . . . . 0.0 110.865 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' A' ' 21' ' ' THR . 45.0 tt0 -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.48 ' CG2' HD21 ' A' ' 116' ' ' LEU . 33.4 m 76.37 130.2 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.544 0.528 . . . . 0.0 111.16 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.609 ' O1P' HG21 ' A' ' 22' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 18.8 m -0.95 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.118 1.767 . . . . 0.0 115.049 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 116' ' ' LEU . 9.5 p -129.73 154.91 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.876 -0.515 . . . . 0.0 112.189 -173.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.6 t80 179.68 -156.51 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.55 ' HB3' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 49.65 -105.02 0.16 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.183 0.593 . . . . 0.0 110.274 175.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB1' ' ND2' ' A' ' 117' ' ' ASN . . . 61.0 -174.32 0.13 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 166.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 13.6 t70 -77.9 41.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.796 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -136.18 -43.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.804 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.09 -10.2 38.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.998 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t 78.5 8.72 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.163 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -77.99 60.56 2.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 110.275 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -137.88 -54.45 0.66 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -178.5 145.11 0.31 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.354 -2.203 . . . . 0.0 108.264 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.21 117.24 41.2 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -45.32 89.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.121 3.214 . . . . 0.0 113.702 -174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 173.62 -115.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.575 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.826 ' HG2' ' H ' ' A' ' 39' ' ' ALA . 3.0 tt0 63.55 -177.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.413 0.625 . . . . 0.0 111.136 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.826 ' H ' ' HG2' ' A' ' 38' ' ' GLN . . . -155.18 -37.74 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.098 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -174.57 29.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.559 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -94.89 -2.55 50.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.375 0.607 . . . . 0.0 109.643 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 70.38 103.2 0.06 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.028 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -83.59 73.85 10.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.403 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.42 67.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.308 177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.79 124.3 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 155.75 17.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.088 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.97 59.75 0.5 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.04 69.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 122.078 0.942 . . . . 0.0 110.622 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 35.3 tt0 -117.97 -89.3 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.685 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' C ' ' HD2' ' A' ' 53' ' ' PRO . . . -97.31 26.08 24.4 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.633 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.792 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 1.1 mm? -89.17 -54.0 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 51' ' ' LEU . 77.7 Cg_exo -51.08 -34.9 49.22 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.155 1.903 . . . . 0.0 114.001 172.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' C ' ' A' ' 50' ' ' GLY . 11.9 Cg_exo -72.55 69.61 3.46 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.123 1.882 . . . . 0.0 112.582 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.87 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -151.39 138.61 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -129.14 172.67 11.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.814 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.9 pp -161.07 140.08 10.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.7 mp -85.66 111.28 19.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.4 125.56 59.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.018 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -71.04 110.63 4.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' HG13 ' A' ' 145' ' ' VAL . 2.9 tpmt? -64.28 -65.58 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.063 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 62' ' ' ARG . 36.4 mtt-85 -146.54 134.75 21.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.831 0.824 . . . . 0.0 110.451 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.11 -159.7 17.83 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.126 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.4 Cg_exo -62.97 -57.94 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.96 1.773 . . . . 0.0 112.595 178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.634 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 53.9 t30 -73.04 -53.0 12.26 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.762 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.18 165.28 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.317 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.33 3.17 90.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.061 170.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -100.73 -170.32 1.84 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 117.729 0.765 . . . . 0.0 111.033 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -171.7 154.46 3.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.19 0.45 . . . . 0.0 112.042 -170.653 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -95.79 121.6 37.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 165.628 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' O ' HD23 ' A' ' 71' ' ' LEU . 1.1 tt -79.89 92.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.681 0.753 . . . . 0.0 109.469 -176.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.814 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 5.6 mt -85.23 51.4 2.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.367 0.603 . . . . 0.0 109.507 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.523 ' HB3' HD21 ' A' ' 71' ' ' LEU . 22.6 t70 -104.03 -22.18 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.487 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -104.29 -165.54 1.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.018 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.42 -39.85 45.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.793 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.64 133.1 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 111.534 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 70.7 p -111.29 143.94 41.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.762 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 87' ' ' ILE . 44.6 m -80.57 123.46 28.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 171.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.728 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.83 113.37 19.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 139' ' ' ILE . . . 149.89 -136.96 5.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.731 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.4 104.64 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.431 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 35.0 m80 -138.11 119.35 10.43 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.807 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.45 -42.7 38.85 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.457 2.104 . . . . 0.0 111.339 171.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -161.95 95.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.366 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 5.9 m -137.76 -100.33 0.19 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 8.7 m-20 -138.39 -48.15 0.53 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.64 105.59 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.24 178.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -108.16 116.66 32.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.293 176.349 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.018 HD21 HG11 ' A' ' 60' ' ' VAL . 12.5 mt -102.67 87.57 3.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.635 177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 25.7 t70 66.88 -2.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.344 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.71 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p30 40.65 36.44 0.39 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.189 1.396 . . . . 0.0 113.418 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' SER . 11.9 p -168.64 44.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.421 173.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.703 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -138.11 -5.16 1.67 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.13 -0.981 . . . . 0.0 111.987 176.148 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -143.16 146.53 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.364 -173.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.56 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 12.2 m -66.5 77.35 0.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.811 0.445 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 64.09 -70.02 0.08 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 123.425 0.69 . . . . 0.0 110.79 -174.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 ptp180 -140.41 130.68 25.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.801 -0.562 . . . . 0.0 110.737 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 1.092 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.83 -41.01 45.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.873 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.58 164.23 30.78 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.928 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.7 pt-20 -129.54 125.7 36.89 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.42 99.23 0.1 Allowed 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 100' ' ' GLU . 15.9 tpp85 -90.45 96.65 10.76 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.975 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -83.78 104.71 14.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.51 138.24 46.01 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 37.5 m-80 62.3 31.89 17.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 -173.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' HD21 ' A' ' 103' ' ' LEU . 7.4 t30 72.58 0.67 3.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.487 0.715 . . . . 0.0 111.831 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 28.2 mm-40 -104.69 139.67 39.18 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.934 -0.479 . . . . 0.0 111.021 -174.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.568 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.29 125.35 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -126.04 162.04 26.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.336 -178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.4 m -106.71 124.82 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 9.2 t -101.77 112.52 35.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.32 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 14.1 t70 -74.31 116.4 14.92 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.57 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.812 HG13 HG12 ' A' ' 111' ' ' VAL . 27.0 m -124.67 -20.7 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.409 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.21 94.31 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.667 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 1.092 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.3 t -108.64 128.85 55.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 24' ' ' VAL . 44.3 tp -54.55 -54.37 42.19 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.408 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -65.67 -35.97 82.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.492 0.663 . . . . 0.0 109.3 175.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.29 170.19 12.59 Favored Glycine 0 C--O 1.257 1.537 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.52 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 98' ' ' HIS . 34.7 m -112.59 122.48 47.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.485 -0.857 . . . . 0.0 110.967 174.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 62.5 m-85 -136.59 103.05 5.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 173.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.736 ' HB ' HG13 ' A' ' 137' ' ' VAL . 2.6 p -102.95 110.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 14.9 m120 68.7 37.64 2.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.499 -171.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 60.84 26.91 16.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.8 pt-20 -139.4 140.92 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.566 173.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 5.6 Cg_exo -79.86 123.42 5.21 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.223 2.616 . . . . 0.0 111.306 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 129' ' ' ALA . 34.3 m -118.6 -179.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 111.49 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 28.3 t70 -100.76 -50.33 3.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.77 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 42.1 t -158.03 91.55 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.233 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -94.15 138.97 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.22 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.71 129.56 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.823 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.618 ' HG ' ' CD1' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -62.57 161.42 12.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.294 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 135' ' ' ASP . . . -160.2 156.11 26.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.81 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -65.77 104.0 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.3 5.75 48.86 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 16.3 t70 -83.82 118.12 23.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.958 0.103 . . . . 0.0 110.795 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 53.7 mp0 -94.57 139.6 30.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.266 0.555 . . . . 0.0 112.343 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 121' ' ' VAL . 16.4 t -127.72 132.22 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.736 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.804 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.9 tp-100 -95.04 123.44 38.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.99 0.424 . . . . 0.0 110.353 174.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.742 HG12 HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.76 140.16 49.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 69.37 -72.62 0.45 Allowed Glycine 0 C--O 1.216 -0.987 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.865 167.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.126 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 15.9 ptmt -170.49 16.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.278 0.539 . . . . 0.0 110.276 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.703 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -118.82 147.18 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.182 -169.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -96.02 105.92 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.9 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.5 mp -98.42 153.7 18.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.978 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 1.9 m -141.42 145.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 148' ' ' THR . 63.4 t80 -97.24 134.52 40.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 146' ' ' PHE . 1.5 mm? -135.4 141.05 45.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.741 166.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.673 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -106.56 -108.01 0.31 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.887 -177.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . -69.8 135.53 26.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.829 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 149' ' ' GLY . 7.2 Cg_exo -73.33 67.25 4.38 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.312 2.674 . . . . 0.0 112.48 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -67.42 117.15 9.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.929 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -95.14 109.56 21.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.39 90.4 1.03 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.46 -177.87 4.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.879 0.371 . . . . 0.0 111.082 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.56 85.62 6.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -93.01 143.07 26.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.897 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -134.98 81.12 0.3 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.614 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.4 m -72.46 110.34 6.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.819 0.342 . . . . 0.0 110.116 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.2 t -103.04 91.21 4.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.586 0.708 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -170.18 52.07 0.2 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.067 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 162' ' ' PRO . . . -78.88 -86.23 0.52 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.267 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 161' ' ' GLY . 2.7 Cg_exo . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.101 2.534 . . . . 0.0 111.086 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.595 0.712 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.5 p -84.28 30.16 0.55 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.34 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 59.03 28.84 18.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.459 0.647 . . . . 0.0 110.454 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.2 mmt -113.8 127.51 56.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.438 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -87.12 123.35 70.25 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.67 114.17 1.83 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.353 2.702 . . . . 0.0 113.097 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -84.27 85.94 7.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.769 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tt -115.13 119.18 61.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.25 0.548 . . . . 0.0 111.306 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.57 153.23 17.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 170.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HD2' ' HA ' ' A' ' 10' ' ' LYS . 22.5 tptp -79.17 110.1 14.12 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.501 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 12' ' ' GLN . 5.1 t70 67.51 -169.75 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.76 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 25.4 tt0 -161.29 102.11 1.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 124.01 20.41 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.214 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -46.22 -64.27 0.79 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.843 0.715 . . . . 0.0 112.566 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.38 149.42 13.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -135.46 116.43 14.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.5 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.97 140.35 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.296 0.569 . . . . 0.0 111.618 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 m -92.12 -17.66 24.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.767 0.794 . . . . 0.0 109.05 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.724 HG22 ' H ' ' A' ' 20' ' ' GLU . 8.2 p -83.36 -179.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.514 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.724 ' H ' HG22 ' A' ' 19' ' ' VAL . 34.0 mm-40 67.18 25.29 9.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.515 0.674 . . . . 0.0 110.55 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.0 m -82.73 137.27 34.46 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.044 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.849 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 93' ' ' THR . 8.4 m -79.44 106.95 11.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 122.533 0.333 . . . . 0.0 111.729 -172.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.765 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.3 p -136.64 155.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -177.92 -147.61 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 46.33 -113.69 0.45 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.186 0.594 . . . . 0.0 109.926 177.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.684 ' HB1' HD22 ' A' ' 117' ' ' ASN . . . 63.62 173.27 0.17 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 167.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.958 ' HA ' HD22 ' A' ' 33' ' ' LEU . 8.5 t70 -76.72 60.38 1.69 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.424 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -150.46 -44.03 0.12 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.207 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.2 tp -73.94 -66.77 0.67 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.765 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -167.21 -72.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.431 -0.508 . . . . 0.0 112.035 -168.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 26' ' ' ARG . 8.8 mm-40 -78.79 108.83 12.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.779 0.323 . . . . 0.0 111.221 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.958 HD22 ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -166.27 -40.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.748 -174.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.02 122.92 45.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.316 0.579 . . . . 0.0 111.463 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -106.28 -55.3 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.329 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 12.8 Cg_exo -69.95 109.05 2.25 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.06 1.84 . . . . 0.0 112.587 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 133.5 48.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 64.41 87.56 0.11 Allowed 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.639 0.587 . . . . 0.0 109.881 -172.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.86 117.7 5.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.34 65.87 1.75 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -79.25 -9.73 59.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 110.666 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.15 161.73 40.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.951 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.8 m -69.51 84.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.34 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.75 57.27 3.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.487 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.33 12.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.766 -178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 m -143.13 100.7 3.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.485 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.79 -35.13 0.57 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.12 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.618 HG23 HD11 ' A' ' 51' ' ' LEU . 6.8 p -119.6 67.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.545 1.164 . . . . 0.0 109.956 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.68 -63.82 0.42 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.937 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.79 48.39 4.04 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.127 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.618 HD11 HG23 ' A' ' 48' ' ' VAL . 4.1 mt -86.14 115.91 63.75 Favored Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 122.265 0.226 . . . . 0.0 111.12 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 18.7 Cg_endo -63.45 -32.94 70.66 Favored 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 122.3 2.0 . . . . 0.0 114.93 169.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' CD ' ' A' ' 52' ' ' PRO . 31.4 Cg_endo -98.59 170.52 0.59 Allowed 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.3 2.0 . . . . 0.0 112.769 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.6 14.16 59.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.625 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 4.0 p -149.85 144.56 26.04 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -125.95 172.69 9.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 3.3 pp -160.31 140.55 11.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.4 mp -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.152 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 68' ' ' SER . 3.3 p -103.13 125.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.212 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.967 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.07 114.69 9.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.151 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -68.87 -69.72 0.31 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.331 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -147.54 131.07 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.406 0.622 . . . . 0.0 110.268 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.707 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -176.13 -150.16 7.95 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.028 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.5 Cg_exo -62.07 -64.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.284 1.989 . . . . 0.0 112.867 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 54.9 t30 -76.31 -52.51 9.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 52.9 169.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.5 -172.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.24 90.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.011 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.967 ' H ' HG22 ' A' ' 60' ' ' VAL . 10.3 m -94.66 -178.03 4.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.34 0.57 . . . . 0.0 110.838 -170.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -169.14 149.25 4.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.259 0.481 . . . . 0.0 111.726 -173.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.497 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -94.35 121.9 36.36 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -79.86 94.58 5.86 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -175.382 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 101' ' ' PHE . 6.0 mt -90.04 46.59 1.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.867 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.466 ' HB3' HD11 ' A' ' 71' ' ' LEU . 7.8 t70 -99.34 -24.12 14.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.277 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -102.33 -166.65 1.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.531 178.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.24 -37.63 60.95 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.419 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -159.99 131.47 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 11.3 p -119.12 127.21 53.14 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.375 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 87' ' ' ILE . 66.5 m -76.45 132.7 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -126.27 120.98 31.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.11 -127.89 2.61 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.1 tmm_? -73.82 105.77 5.25 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.903 0.859 . . . . 0.0 109.612 175.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -137.01 134.72 19.16 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.465 -169.586 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 30.3 Cg_exo -65.59 -67.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.581 2.187 . . . . 0.0 113.132 173.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -156.01 9.35 0.25 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -174.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -77.53 -88.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.2 OUTLIER -105.33 -76.73 0.6 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.378 0.609 . . . . 0.0 111.653 -170.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.707 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.46 110.11 20.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.89 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -110.63 132.27 54.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.341 -178.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.943 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.4 mm? -119.85 78.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.614 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 36.0 t0 68.75 -6.34 0.87 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.508 0.67 . . . . 0.0 109.93 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.4 p-10 41.89 32.86 0.3 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.422 1.489 . . . . 0.0 113.258 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' TPO . 5.7 p -144.91 8.06 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.089 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.511 HG21 ' HD3' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -124.19 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.391 -177.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.653 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.3 t -109.16 152.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -173.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.446 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 49.3 m -77.2 66.25 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 0.0 110.454 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HE ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 67.43 -56.51 0.45 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.976 -173.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.567 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -146.54 147.04 30.74 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.78 0.8 . . . . 0.0 110.64 175.427 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB2' ' OG ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -90.53 -40.75 11.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.912 170.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.855 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -151.15 142.62 23.48 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.58 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.5 pt-20 -109.72 120.83 43.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.705 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.92 104.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.537 -174.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 10.4 tpp180 -96.01 107.12 19.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.662 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.85 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.7 tt -89.27 107.28 18.97 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.796 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 102' ' ' ARG . 34.8 mt-10 -128.53 137.76 51.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.074 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 57.19 34.11 24.32 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.49 . . . . 0.0 110.314 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.85 ' HA ' HD21 ' A' ' 103' ' ' LEU . 19.5 t-20 61.29 33.37 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.159 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.6 mt-10 -125.28 135.07 52.13 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.745 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -86.75 120.19 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 2.6 m120 -122.64 159.77 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.0 m -107.77 127.86 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.581 173.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.855 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.1 t -100.37 111.09 28.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.342 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 12.4 t70 -76.65 114.06 14.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.567 HG21 ' HG2' ' A' ' 97' ' ' ARG . 24.1 m -105.24 -20.21 6.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.34 0.59 . . . . 0.0 110.331 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.32 91.93 0.88 Allowed Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.442 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.684 ' OG ' ' HB2' ' A' ' 98' ' ' HIS . 0.7 OUTLIER -80.4 162.16 24.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 22' ' ' TPO . 50.3 tp -61.68 -55.47 30.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.564 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.684 HD22 ' HB1' ' A' ' 27' ' ' ALA . 18.6 p-10 -69.02 -37.6 78.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.246 0.546 . . . . 0.0 110.301 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 127.24 169.98 12.79 Favored Glycine 0 C--O 1.254 1.374 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.845 -172.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.2 m -112.1 136.58 51.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.632 0.773 . . . . 0.0 111.118 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.4 m-85 -138.05 104.68 5.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 137' ' ' VAL . 47.2 t -94.52 105.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 11.8 m120 56.61 43.03 26.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER 76.82 -6.9 1.94 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.969 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.6 pt-20 -119.2 123.92 28.52 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.339 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 17.1 Cg_exo -67.62 123.15 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.645 2.23 . . . . 0.0 111.695 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.68 175.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.802 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 31.5 t70 -96.1 -45.81 6.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.879 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.1 t -162.77 105.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.82 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.56 136.33 50.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.332 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.57 129.39 33.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.372 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.648 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -63.9 159.89 18.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.043 177.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -161.44 152.61 18.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.26 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -64.45 105.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.169 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.33 4.32 35.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.604 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.81 136.17 34.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.7 tt0 -122.52 134.01 54.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 111.432 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 121' ' ' VAL . 24.8 t -129.61 141.28 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.159 -174.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.675 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.7 tp-100 -99.4 128.19 45.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.391 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.943 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -135.0 138.38 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.088 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.606 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 73.72 -69.08 1.52 Allowed Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.468 165.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.028 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.9 ptmt -176.38 16.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -117.4 149.95 39.68 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.817 -171.577 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.479 HH11 ' HB2' ' A' ' 35' ' ' ALA . 7.8 ttm180 -92.99 129.2 38.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.2 mp -124.04 152.57 42.49 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.804 0.335 . . . . 0.0 111.743 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.73 143.58 26.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.99 170.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.689 ' CZ ' ' HB ' ' A' ' 148' ' ' THR . 45.8 t80 -100.87 136.58 40.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.892 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -130.68 149.04 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.58 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.689 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 13.8 t -143.49 143.86 31.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.627 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . 55.99 56.02 26.19 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.915 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 149' ' ' GLY . 9.5 Cg_endo -89.05 98.47 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.035 2.49 . . . . 0.0 112.479 -174.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -132.27 127.46 35.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 110.295 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -117.35 57.04 0.81 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 146.87 32.11 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.752 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.09 106.86 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.3 0.572 . . . . 0.0 109.628 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.49 73.0 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.551 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 t70 50.4 77.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.503 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.12 134.26 3.35 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.131 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.0 t -134.67 18.95 3.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.3 t -86.45 68.34 10.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.308 1.051 . . . . 0.0 110.645 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.73 51.42 0.7 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.669 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.82 134.27 3.63 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.088 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.147 2.565 . . . . 0.0 111.619 178.269 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 p -87.11 49.63 1.86 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.65 133.12 55.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.241 0.543 . . . . 0.0 111.398 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.6 mtt -90.88 64.76 5.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.349 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -121.02 91.86 48.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.74 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.08 89.14 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.01 2.473 . . . . 0.0 112.633 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -88.81 -17.38 29.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 15' ' ' ASP . 5.7 tp -82.39 82.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 122.021 0.915 . . . . 0.0 110.411 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -90.37 -45.95 8.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.159 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -82.72 93.62 7.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.354 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -106.86 75.6 1.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.562 0.696 . . . . 0.0 110.774 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 6.7 tp60 -139.03 -46.03 0.47 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -88.55 141.86 28.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.482 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.5 p -56.93 98.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.776 -175.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.59 ' HA ' HD13 ' A' ' 8' ' ' ILE . 2.2 m-20 58.76 22.4 10.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.485 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 50.87 42.55 28.07 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.166 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -80.63 73.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.825 0.821 . . . . 0.0 110.059 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -110.09 93.94 4.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.266 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -41.97 -71.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 124.128 0.892 . . . . 0.0 112.162 -170.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -146.76 -100.06 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -163.37 128.98 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TPO . . . . . 0.692 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 93' ' ' THR . 15.2 m -54.35 120.12 6.13 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.686 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.7 p -144.28 168.68 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.047 -169.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 9.3 t80 171.91 -147.0 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 43.26 -107.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.922 0.764 . . . . 0.0 110.554 174.581 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 63.5 176.59 0.16 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.906 ' HA ' HD21 ' A' ' 33' ' ' LEU . 9.9 t70 -94.82 79.46 3.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.517 -170.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -137.58 -90.46 0.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.434 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.2 pt? -126.75 -0.24 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -62.98 -86.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.186 -171.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -121.85 50.72 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.933 0.873 . . . . 0.0 110.546 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -161.91 -143.86 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.79 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 t70 62.13 86.03 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.355 0.598 . . . . 0.0 109.649 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -138.13 147.34 55.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.6 -174.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 32.6 Cg_exo -59.63 103.65 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.85 2.366 . . . . 0.0 111.653 176.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 112.0 4.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -85.91 -60.3 2.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.25 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . . . 56.35 77.64 0.24 Allowed 'General case' 0 C--O 1.232 0.152 0 O-C-N 123.632 0.582 . . . . 0.0 110.526 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.06 -125.24 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 m -87.6 40.68 0.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.905 0.86 . . . . 0.0 110.156 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 39' ' ' ALA . 35.5 mt-10 -82.3 57.26 3.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.179 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 m -93.84 100.51 12.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.915 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 131.96 43.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.35 -15.13 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.98 0.419 . . . . 0.0 111.016 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -154.67 112.74 3.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.87 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' HA2' ' OD1' ' A' ' 133' ' ' ASN . . . -95.81 -57.81 1.15 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.424 ' HA ' HD21 ' A' ' 51' ' ' LEU . 2.3 m -137.58 51.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.244 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -120.02 -86.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.427 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.63 51.86 4.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.781 HD22 HG23 ' A' ' 148' ' ' THR . 34.6 mt -64.65 121.02 70.78 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 122.678 0.391 . . . . 0.0 111.375 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.67 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 71.3 Cg_endo -109.78 46.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.633 2.889 . . . . 0.0 114.527 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HB3' ' H ' ' A' ' 149' ' ' GLY . 66.0 Cg_endo -96.07 145.07 1.13 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.855 1.703 . . . . 0.0 113.284 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.32 -28.75 24.13 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 170.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.4 m -146.53 152.28 38.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 131' ' ' LEU . . . -124.59 170.64 10.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -159.87 137.1 9.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.75 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.078 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.08 111.41 20.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.275 161.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 p -108.73 128.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.444 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -72.19 109.01 4.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 35.0 ttpt -61.96 -60.55 3.46 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.511 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -149.93 115.47 5.53 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.506 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -144.9 -166.15 11.49 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 23.0 Cg_exo -64.3 -46.6 7.41 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.698 1.599 . . . . 0.0 111.572 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.819 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 41.7 t30 -74.69 -50.43 17.63 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.598 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 56.05 155.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.633 -1.622 . . . . 0.0 113.359 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.09 2.42 90.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.11 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -88.22 -179.83 6.23 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 117.397 0.598 . . . . 0.0 109.996 -171.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.86 151.78 3.48 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.861 0.755 . . . . 0.0 112.107 -173.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.759 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -93.94 125.49 38.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 ' O ' ' A' ' 71' ' ' LEU . 1.1 tm? -80.9 94.89 6.58 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.805 HD22 ' CG ' ' A' ' 101' ' ' PHE . 5.2 mt -91.52 50.75 1.77 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.711 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' HD11 ' A' ' 71' ' ' LEU . 23.7 t70 -104.79 -21.88 13.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.923 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.434 HE21 HG22 ' A' ' 77' ' ' THR . 9.9 pt20 -103.29 -167.78 1.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.0 59.48 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.747 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.72 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.78 130.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.618 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.496 HG22 ' OD2' ' A' ' 86' ' ' ASP . 22.3 p -118.99 132.03 56.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.361 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.6 m -73.99 126.33 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -118.5 116.34 26.46 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 157.94 -139.58 6.45 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.21 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.51 104.1 8.89 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.676 ' CE1' ' HB2' ' A' ' 97' ' ' ARG . 29.1 m80 -136.85 118.08 11.13 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.291 -171.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.04 -42.77 10.33 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.12 1.88 . . . . 0.0 110.618 162.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -129.9 118.49 21.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.347 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 78' ' ' SER . 4.2 m 174.4 -175.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.8 1.24 . . . . 0.0 108.092 174.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 16.8 m-20 -89.89 -36.93 14.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.029 0.442 . . . . 0.0 111.446 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -114.2 100.0 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.808 0.814 . . . . 0.0 111.755 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.93 134.41 50.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.366 173.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.015 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.9 mm? -115.21 73.15 0.82 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.5 t70 68.23 -5.01 0.95 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.544 0.688 . . . . 0.0 110.175 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.0 p-10 38.06 42.42 0.46 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.647 1.579 . . . . 0.0 113.133 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 22' ' ' TPO . 18.5 t -142.81 -11.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -113.09 -12.16 13.22 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -170.072 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.9 OUTLIER -135.64 150.88 29.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.872 -0.518 . . . . 0.0 110.986 -170.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.637 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 2.5 m -69.15 71.97 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.231 0.613 . . . . 0.0 112.63 -171.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.74 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 62.34 -54.69 0.15 Allowed 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.426 0.69 . . . . 0.0 111.493 -174.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.74 ' HB3' ' NE ' ' A' ' 96' ' ' ARG . 3.5 ttm180 -155.63 124.67 6.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.687 -0.633 . . . . 0.0 110.84 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.978 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.62 -40.56 48.96 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.014 176.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.79 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -150.39 149.32 29.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.168 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 111' ' ' VAL . 5.3 pt-20 -113.11 130.58 56.13 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.805 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -63.42 101.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 111' ' ' VAL . 19.6 ttm180 -100.55 114.12 27.5 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.571 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 108' ' ' PHE . 14.7 tp -75.64 109.06 8.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.472 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -112.37 123.98 51.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.473 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 7.5 p30 42.47 44.26 3.44 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.049 0.843 . . . . 0.0 111.806 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 105' ' ' ASN . 8.0 t30 75.7 0.18 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.149 173.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.6 mm-40 -104.5 133.13 49.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.646 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -85.79 131.92 34.22 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -172.593 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 14.2 m-80 -134.1 171.21 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.3 m -110.1 156.58 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 168.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 27.0 m -126.28 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 170.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.77 116.77 14.76 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG21 ' HD2' ' A' ' 97' ' ' ARG . 31.5 m -123.42 -22.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.764 0.316 . . . . 0.0 111.366 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.82 102.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.9 t -115.81 133.53 55.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.692 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 2.7 tm? -56.44 -55.46 33.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.626 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -68.63 -36.02 78.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.06 170.64 12.08 Favored Glycine 0 C--O 1.251 1.205 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.866 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -112.04 133.22 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.036 0.535 . . . . 0.0 110.753 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.647 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.1 m-85 -138.19 103.35 4.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 120.938 0.399 . . . . 0.0 111.043 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.794 HG22 HG13 ' A' ' 137' ' ' VAL . 55.2 t -98.61 123.11 50.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 64.1 33.33 12.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 61.32 28.01 17.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.953 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.7 pt-20 -146.47 150.9 42.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 121.65 -0.656 . . . . 0.0 111.025 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 125.7 11.1 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.572 2.181 . . . . 0.0 111.88 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.24 179.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.741 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -106.55 -47.35 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.3 0.572 . . . . 0.0 109.808 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.8 t -158.16 91.75 1.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.946 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.56 136.65 38.36 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.616 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.94 150.51 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.919 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -63.72 119.41 9.87 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.307 175.314 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.61 121.89 25.11 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 2.1 p-10 -61.2 118.88 7.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.743 0.782 . . . . 0.0 111.939 -171.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.31 -13.1 33.6 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.254 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.798 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 2.3 t0 -96.63 173.01 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 5.2 pt-20 -139.74 151.87 46.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.572 -168.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.794 HG13 HG22 ' A' ' 121' ' ' VAL . 39.8 t -127.56 141.57 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.783 ' HB2' ' HB2' ' A' ' 28' ' ' ASP . 6.3 tp-100 -98.28 129.64 44.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.944 0.402 . . . . 0.0 110.517 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 1.015 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -134.55 133.51 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 166.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.03 -77.14 0.56 Allowed Glycine 0 C--O 1.215 -1.04 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.956 172.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 1.031 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.9 ptmt -168.03 25.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.516 0.658 . . . . 0.0 110.755 173.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.819 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -115.81 141.43 48.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -173.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . 0.451 ' HD3' HD22 ' A' ' 33' ' ' LEU . 5.5 ttp85 -94.9 106.32 18.3 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.312 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.4 159.51 14.96 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.803 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.9 142.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 1.078 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -110.49 138.4 46.92 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.283 0.563 . . . . 0.0 112.326 -178.06 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 131' ' ' LEU . 2.8 mm? -127.96 145.53 50.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.156 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.781 HG23 HD22 ' A' ' 51' ' ' LEU . 10.9 t -135.46 151.06 50.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.67 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . 60.65 61.94 6.5 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.409 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.67 118.62 5.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.519 2.146 . . . . 0.0 111.737 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.65 60.68 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.646 0.736 . . . . 0.0 110.974 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -148.53 177.59 9.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.737 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -150.6 81.8 0.18 Allowed Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.93 111.42 23.67 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -136.59 160.89 37.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -110.23 6.03 22.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.823 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -138.8 -71.07 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.953 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.5 m 56.37 46.96 19.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.597 . . . . 0.0 109.829 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 p -80.83 102.3 9.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.198 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -106.99 -88.35 2.02 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.12 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 146.36 -160.12 28.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.116 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.02 2.48 . . . . 0.0 111.672 178.586 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.594 HG22 ' CD1' ' A' ' 116' ' ' LEU . 92.2 t -102.24 137.38 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.272 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 12.6 t80 174.08 159.77 0.16 Allowed 'General case' 0 C--O 1.213 -0.859 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.505 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.676 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 10.4 tpt85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 163.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.444 -0.761 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.4 42.98 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 5.1 mp -148.38 139.24 23.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.06 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.6 mp -85.87 135.21 33.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 68' ' ' SER . 3.8 p -125.23 128.57 72.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.158 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.876 HG22 ' H ' ' A' ' 68' ' ' SER . 1.5 m -73.11 109.89 5.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HD2' ' HD2' ' A' ' 143' ' ' ARG . 2.2 ttmp? -57.76 -60.6 3.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.97 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.56 146.59 8.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.364 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 152.02 130.3 1.59 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -175.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.676 ' CD ' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 1.67 -71.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.876 5.051 . . . . 0.0 118.054 -159.22 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.573 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.4 t30 -62.94 -51.67 66.0 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 119.116 0.871 . . . . 0.0 109.123 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.66 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 53.5 165.29 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.221 -1.808 . . . . 0.0 114.172 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.08 4.45 90.24 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.841 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.876 ' H ' HG22 ' A' ' 60' ' ' VAL . 19.9 m -106.71 -167.79 1.33 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 118.053 0.926 . . . . 0.0 112.027 -166.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.555 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -170.86 151.74 3.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -168.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.699 ' HE1' ' CD2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.69 118.16 33.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 166.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.21 107.13 15.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.04 28.02 4.22 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.469 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.482 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 25.1 t70 -67.83 -28.24 67.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -96.89 164.19 12.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.683 171.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.85 -16.84 62.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -168.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -173.94 126.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.425 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.41 131.98 55.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.899 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 82' ' ' HIS . 70.0 m -71.76 129.53 38.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.358 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.32 121.31 41.6 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 147.0 -127.99 2.85 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.244 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.26 102.93 14.4 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 79.3 m-70 . . . . . 0 C--N 1.318 -0.768 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.729 -171.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' HB3' ' A' ' 71' ' ' LEU . 16.1 t70 . . . . . 0 CA--C 1.516 -0.331 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -90.23 91.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.911 0.862 . . . . 0.0 110.416 178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -104.58 123.89 48.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.353 172.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.982 HD11 HD21 ' A' ' 144' ' ' LEU . 15.4 mt -110.46 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 37.4 t70 74.09 -26.28 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.471 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 16.9 t70 63.52 28.15 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 122.658 1.218 . . . . 0.0 110.524 174.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' OD2' ' A' ' 90' ' ' ASP . 46.2 t -135.73 -12.75 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.987 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.619 HG21 ' HE3' ' A' ' 141' ' ' LYS . 1.5 p -108.38 -29.85 8.62 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.536 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.8 t -103.39 151.65 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.107 -0.371 . . . . 0.0 110.899 -169.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m -74.56 69.3 1.7 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.591 0.356 . . . . 0.0 110.074 177.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.678 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 56.33 -62.94 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.01 -166.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.639 ' HG3' HG21 ' A' ' 113' ' ' VAL . 7.6 ptp180 -133.85 139.38 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 120.849 -1.157 . . . . 0.0 111.047 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.815 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -83.88 -43.79 14.95 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.733 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -147.3 163.35 36.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.308 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.5 pt-20 -122.47 122.14 38.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 165.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.793 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.3 OUTLIER -79.58 92.03 5.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -173.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 111' ' ' VAL . 11.6 ptp180 -92.8 131.85 37.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.713 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.706 HD21 ' HA ' ' A' ' 106' ' ' ASN . 6.2 tt -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.455 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 62.6 mm-40 -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 63.02 31.58 15.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.211 0.319 . . . . 0.0 110.456 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.706 ' HA ' HD21 ' A' ' 103' ' ' LEU . 56.3 m-20 68.81 7.46 6.17 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.802 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.666 ' HG3' HD21 ' A' ' 109' ' ' ASN . 11.2 pt-20 -117.35 133.51 55.89 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.004 0.431 . . . . 0.0 110.391 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -85.64 140.2 30.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 33.0 m-80 -144.73 157.15 44.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.386 -173.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -102.13 118.98 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.591 0.71 . . . . 0.0 110.329 177.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 2.1 t -99.81 113.36 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.792 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 119' ' ' THR . 14.4 t70 -74.67 129.86 38.47 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.929 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.639 HG21 ' HG3' ' A' ' 97' ' ' ARG . 20.3 m -132.16 19.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 103.99 0.55 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.654 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.815 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.9 p -104.17 152.83 21.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.604 ' HB3' ' O ' ' A' ' 93' ' ' THR . 3.2 tm? -59.42 -55.84 29.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -170.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.614 HD21 ' HB ' ' A' ' 93' ' ' THR . 31.2 m-80 -67.81 -36.39 80.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.876 0.369 . . . . 0.0 110.611 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.89 150.76 5.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.213 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 98' ' ' HIS . 19.6 m -109.47 126.6 53.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 111.52 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 38.1 m-85 -139.73 157.15 46.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.109 171.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 137' ' ' VAL . 2.4 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.448 HD22 HG22 ' A' ' 121' ' ' VAL . 57.1 m-80 61.55 45.28 8.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.069 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 3.0 mmp_? 69.1 9.69 7.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.56 136.74 24.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.355 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.06 138.35 33.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.917 2.411 . . . . 0.0 111.771 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 129' ' ' ALA . 19.7 m -135.47 179.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.674 0.273 . . . . 0.0 111.215 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.8 m-20 -95.84 -53.23 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.1 p -154.0 91.67 1.47 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -89.99 143.78 26.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.15 135.87 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.893 -174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.736 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 2.3 tt -53.08 117.76 3.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.979 168.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -124.7 -175.73 3.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.175 -172.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -103.14 94.55 5.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.45 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.52 -22.89 23.55 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.46 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.855 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 7.1 m-20 -73.0 158.86 34.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.444 0.164 . . . . 0.0 110.652 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 145' ' ' VAL . 9.2 pt-20 -133.89 150.56 51.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.079 0.942 . . . . 0.0 113.087 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 121' ' ' VAL . 46.5 t -115.68 144.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.552 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.583 ' NE2' HH12 ' A' ' 26' ' ' ARG . 6.6 tp-100 -97.17 119.67 36.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 172.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -116.08 120.6 65.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 63.39 -102.14 0.51 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 118.871 -1.633 . . . . 0.0 110.889 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.619 ' HE3' HG21 ' A' ' 93' ' ' THR . 8.9 pttt -142.14 42.32 1.66 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.259 0.552 . . . . 0.0 111.651 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.758 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -134.97 148.92 50.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.463 ' HD3' ' CD ' ' A' ' 136' ' ' GLU . 4.7 ttm180 -98.71 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 89' ' ' LEU . 2.9 mp -116.6 110.65 18.8 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -103.4 140.85 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 120.9 0.381 . . . . 0.0 110.395 -177.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.06 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.88 147.22 31.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.215 0.531 . . . . 0.0 112.397 -177.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.414 HD22 ' C ' ' A' ' 146' ' ' PHE . 2.3 mm? . . . . . 0 C--O 1.234 0.278 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 177.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 117' ' ' ASN . 9.4 p -131.35 153.92 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.827 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 36.8 t80 178.98 -163.6 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.238 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.548 ' HG2' ' HD3' ' A' ' 64' ' ' PRO . 7.5 tpt180 . . . . . 0 N--CA 1.487 1.38 0 CA-C-N 119.008 0.822 . . . . 0.0 111.171 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.67 168.98 16.8 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.549 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 1.2 pp -152.53 134.06 14.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.03 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 mp -88.08 126.36 35.06 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.679 162.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 69' ' ' ARG . 92.6 t -120.83 133.55 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 117.996 0.362 . . . . 0.0 110.616 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.14 119.7 27.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' CG1' ' A' ' 145' ' ' VAL . 26.0 mtpp -53.78 -80.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.625 1.203 . . . . 0.0 111.663 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 43.3 ttt180 -161.74 81.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.568 -174.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 66' ' ' ALA . . . -112.5 -143.84 9.05 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.058 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 42.5 Cg_exo -58.17 -66.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.21 1.94 . . . . 0.0 113.039 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 61.6 t30 -69.35 -52.8 23.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 55.09 166.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.227 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.55 3.21 90.11 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.277 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.902 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -96.39 177.45 5.69 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.598 -167.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -166.29 153.43 9.62 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -173.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.46 122.88 38.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 167.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -83.17 93.84 7.73 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.43 0.633 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.8 OUTLIER -88.46 45.78 1.32 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.916 0.865 . . . . 0.0 109.219 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.449 ' HB3' HD21 ' A' ' 71' ' ' LEU . 13.5 t70 -90.95 -13.47 33.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.951 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.48 174.75 5.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.783 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -66.0 -60.89 2.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 100' ' ' GLU . 1.3 tp -125.68 122.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.313 0.578 . . . . 0.0 111.802 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -104.83 171.71 7.17 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.062 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -117.27 124.09 48.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.737 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.75 121.34 42.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 139.07 -129.95 4.64 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.204 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -84.88 103.27 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 97' ' ' ARG . 89.0 m-70 . . . . . 0 C--N 1.315 -0.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.082 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.331 0.586 . . . . 0.0 111.085 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.737 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -100.64 95.87 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.632 0.73 . . . . 0.0 110.867 -175.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -109.14 128.97 55.46 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.552 177.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 HG11 ' A' ' 60' ' ' VAL . 4.0 mm? -113.28 84.63 2.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.695 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 6.4 t70 66.18 -1.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.22 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.789 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 2.9 p30 41.01 37.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.171 1.388 . . . . 0.0 113.921 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 92' ' ' VAL . 9.9 p -161.11 21.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.625 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -123.17 -7.15 8.28 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.495 -0.753 . . . . 0.0 111.675 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 140' ' ' GLY . 1.9 t -125.47 152.16 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m -73.05 70.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.05 0.452 . . . . 0.0 110.279 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.7 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.56 -67.93 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.936 -168.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.713 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 7.2 ptp180 -136.31 128.74 30.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.544 -1.347 . . . . 0.0 111.493 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.825 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -65.31 -46.05 81.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 171.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -148.95 179.13 8.1 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.008 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.29 123.55 14.71 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.12 93.05 3.28 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.098 0.951 . . . . 0.0 109.82 -168.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.1 tpp180 -81.3 123.6 28.65 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.762 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.904 HD11 ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.04 126.58 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 22.3 tt0 -150.55 126.52 10.46 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 64.82 41.69 4.87 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.651 0.594 . . . . 0.0 109.721 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.904 ' HA ' HD11 ' A' ' 103' ' ' LEU . 3.1 p-10 51.4 22.19 1.39 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.581 1.152 . . . . 0.0 113.313 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.793 ' HG3' HD21 ' A' ' 109' ' ' ASN . 12.5 pt-20 -118.19 134.27 55.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -87.91 143.25 27.22 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.793 HD21 ' HG3' ' A' ' 107' ' ' GLU . 25.0 m-80 -147.36 156.25 42.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.574 0.625 . . . . 0.0 111.447 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -102.54 116.26 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.116 176.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 76.2 t -101.03 111.52 30.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.345 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.59 126.03 28.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.021 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 18.9 m -134.9 14.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.23 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.47 105.08 2.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.791 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.2 t -118.57 128.04 54.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 ' HB ' ' A' ' 24' ' ' VAL . 29.3 tp -55.17 -56.24 22.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.877 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 24' ' ' VAL . 16.9 t30 -62.85 -38.41 90.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.984 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.87 161.26 8.94 Favored Glycine 0 C--O 1.256 1.483 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.646 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.599 HG23 ' HE1' ' A' ' 98' ' ' HIS . 8.1 m -111.39 134.11 53.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.103 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 123' ' ' ARG . 0.1 OUTLIER -141.48 131.27 24.28 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.751 HG22 HG13 ' A' ' 137' ' ' VAL . 80.8 t -142.01 114.19 3.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.01 43.54 14.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 79.8 mtp180 66.86 14.13 9.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -142.3 141.59 21.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 121.914 -0.492 . . . . 0.0 110.622 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 122.96 11.09 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.968 1.779 . . . . 0.0 110.748 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.543 HG13 ' HB ' ' A' ' 121' ' ' VAL . 20.4 m -111.61 174.0 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.389 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 6.1 m-20 -98.11 -47.67 5.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.045 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.891 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.4 p -160.67 102.45 1.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.571 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -99.9 142.45 31.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.83 131.06 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 123.421 0.45 . . . . 0.0 110.739 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.627 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 2.1 tt -51.43 115.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -120.05 -175.21 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.51 96.78 6.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.624 0.249 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.14 4.98 29.01 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.144 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.915 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 11.6 m-20 -107.46 160.83 15.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.32 0.56 . . . . 0.0 110.247 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -118.08 155.87 29.61 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -166.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.751 HG13 HG22 ' A' ' 121' ' ' VAL . 59.8 t -133.69 141.82 43.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.765 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.569 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -116.77 124.52 49.82 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.825 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -131.22 132.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.986 175.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 84.11 -56.44 5.04 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 119.258 -1.448 . . . . 0.0 113.763 166.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.058 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 43.3 pttt 171.17 27.18 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.144 0.578 . . . . 0.0 110.688 168.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.737 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.56 146.8 51.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -92.68 119.21 31.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.237 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.907 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -110.08 156.93 19.9 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.12 143.11 28.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 172.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.03 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.15 141.64 34.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.935 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.218 177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 17.2 m . . . . . 0 N--CA 1.487 1.41 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 116' ' ' LEU . 4.4 p -134.77 157.57 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.633 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -177.07 -171.78 0.37 Allowed 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.912 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 CA-C-N 118.222 0.465 . . . . 0.0 110.078 171.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -124.45 167.72 14.03 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.74 145.76 12.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.971 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -95.37 115.92 28.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.889 163.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.6 125.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.893 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -70.37 116.49 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 45.1 tptt -68.72 -82.81 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.744 -171.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -144.22 123.38 12.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 111.009 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.722 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -164.12 -105.37 0.19 Allowed Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.205 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.659 ' CG ' ' HG3' ' A' ' 141' ' ' LYS . 4.8 Cg_exo -77.76 -88.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.954 2.436 . . . . 0.0 112.333 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.796 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.5 t30 -64.73 -48.29 75.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.722 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.34 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.221 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 0.92 89.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.09 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.911 ' H ' HG22 ' A' ' 60' ' ' VAL . 2.7 m -86.29 171.55 11.14 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 117.212 0.506 . . . . 0.0 109.673 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.669 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -167.68 153.62 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.377 0.535 . . . . 0.0 111.581 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.64 126.82 40.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.1 tm? -84.7 96.08 9.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.33 1.019 . . . . 0.0 108.571 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.864 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -93.38 50.3 1.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.844 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB3' HD11 ' A' ' 71' ' ' LEU . 21.3 t70 -104.97 -19.41 13.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.832 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.82 -166.9 1.34 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.426 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.56 -40.63 56.46 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.423 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.32 135.6 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.721 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 22.3 p -116.42 141.75 47.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.084 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 43.2 m -85.61 124.79 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.07 106.34 11.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 161.61 -129.47 2.11 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -68.77 108.34 3.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.72 0.771 . . . . 0.0 110.456 173.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.762 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.429 -1.511 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 -174.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.416 0.627 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -127.75 110.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.187 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -109.27 134.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.2 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.045 ' HG ' HD11 ' A' ' 139' ' ' ILE . 3.0 mm? -117.39 72.27 0.83 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.551 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 34.1 t70 62.8 4.21 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.381 0.61 . . . . 0.0 109.853 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 t70 66.73 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.261 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' SER . 14.2 p -80.57 69.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.42 1.105 . . . . 0.0 112.866 -167.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -162.69 4.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.941 167.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.4 t -140.63 141.82 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.549 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 10.9 t -76.14 72.76 2.96 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 66.1 -48.87 0.42 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.072 -173.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.572 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 8.1 ptp85 -154.46 135.0 13.45 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.592 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -72.13 -36.84 69.49 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -159.95 176.56 11.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.225 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 102' ' ' ARG . 6.0 pt-20 -134.04 135.19 43.18 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.864 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -61.17 95.89 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -92.49 98.17 11.29 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.678 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -77.98 107.83 10.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.267 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.57 139.85 45.68 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.036 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 58.61 32.52 22.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.914 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.871 ' HA ' HD21 ' A' ' 103' ' ' LEU . 89.0 m-20 67.5 9.11 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.895 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 17.5 mm-40 -105.49 151.67 23.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.398 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -99.34 124.32 44.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.531 ' OD1' ' HB ' ' A' ' 130' ' ' VAL . 11.6 m-80 -136.19 157.8 45.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -174.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 12.3 m -107.94 123.29 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.196 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' A' ' 128' ' ' SER . 78.0 t -100.52 110.47 27.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.732 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -67.35 122.33 17.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 97' ' ' ARG . 17.1 m -127.45 -11.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 141.72 77.39 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.272 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 28.6 t -86.34 137.23 32.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.698 HD12 ' HB ' ' A' ' 24' ' ' VAL . 1.7 tm? -53.47 -54.01 43.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.042 -174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.662 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -73.81 -35.75 64.9 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.831 0.741 . . . . 0.0 109.936 172.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.12 171.9 12.84 Favored Glycine 0 C--O 1.253 1.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.076 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.4 m -111.37 130.26 55.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.651 -0.775 . . . . 0.0 110.904 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 68.0 m-85 -138.41 104.2 5.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.896 0.379 . . . . 0.0 110.859 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 137' ' ' VAL . 58.1 t -100.73 125.92 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 m120 64.53 22.89 12.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 61.79 38.2 15.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.764 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -142.35 144.63 31.81 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.76 122.54 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.423 2.082 . . . . 0.0 111.197 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 121' ' ' VAL . 19.3 m -114.74 171.51 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.6 t70 -111.93 -41.97 3.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.669 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.7 p -164.86 91.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.7 0.762 . . . . 0.0 110.21 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.95 128.13 53.09 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.307 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 9.1 p -73.01 154.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.429 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 108' ' ' PHE . 10.4 mp -62.25 165.7 5.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.52 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . . . -152.0 -176.78 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.3 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.31 90.94 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.825 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.55 4.89 37.09 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 119.922 -1.132 . . . . 0.0 114.538 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.645 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 2.4 t70 -93.99 166.59 12.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.954 0.877 . . . . 0.0 110.117 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 3.5 pt-20 -127.76 150.27 49.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.768 HG13 HG22 ' A' ' 121' ' ' VAL . 38.5 t -125.97 141.92 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.62 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -99.69 125.58 45.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.045 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.15 131.53 45.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 169.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.07 -76.33 1.07 Allowed Glycine 0 C--O 1.222 -0.649 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.949 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.912 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 7.4 pttt -171.93 28.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 111.08 171.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.811 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.24 143.51 44.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.583 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.427 ' HD3' ' OE1' ' A' ' 136' ' ' GLU . 7.0 ttm180 -90.67 100.81 13.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.0 mp -93.93 158.47 15.63 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.7 143.14 27.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.971 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -107.08 147.16 30.34 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.28 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 146' ' ' PHE . 3.1 mm? . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.543 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 93' ' ' THR . 74.6 m . . . . . 0 CA--C 1.518 -0.272 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.5 p -140.81 150.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.924 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.449 ' H ' ' HD2' ' A' ' 141' ' ' LYS . 8.5 t80 -176.73 -139.65 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.548 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.773 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.219 0 C-N-CA 124.001 0.921 . . . . 0.0 110.614 -177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.577 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -126.42 172.29 10.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.708 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.2 pt? -161.24 139.44 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 118.296 -1.362 . . . . 0.0 114.454 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 72' ' ' LEU . 2.7 mp -85.86 112.35 21.05 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.991 167.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 69' ' ' ARG . 62.1 t -101.46 125.31 55.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.032 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -70.46 109.89 3.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.89 -44.36 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.184 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -155.18 143.77 20.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 172.49 -155.45 23.32 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.081 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 24.7 Cg_exo -63.87 -59.96 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.061 1.841 . . . . 0.0 111.958 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.742 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 48.2 t30 -75.67 -49.94 16.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.655 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.96 164.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.403 -174.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 2.71 90.61 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.723 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.939 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.6 m -101.45 -169.05 1.64 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 117.6 0.7 . . . . 0.0 110.616 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.79 160.08 5.48 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -171.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.6 m-30 -96.48 127.88 42.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 167.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.3 tm? -80.77 97.34 7.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.708 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.5 mt -94.13 46.29 1.16 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.553 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 13.0 t70 -100.48 -19.15 16.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.756 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.58 -166.66 1.26 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.615 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.1 36.53 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.552 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -157.79 120.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.034 -175.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 8.7 p -113.41 119.86 39.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 87' ' ' ILE . 15.2 m -66.04 128.56 36.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -125.98 107.56 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -166.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.31 -132.97 2.85 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.854 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.855 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.49 110.56 6.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.828 0.823 . . . . 0.0 108.946 173.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.43 -1.471 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -162.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 121.443 0.64 . . . . 0.0 111.169 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -124.12 117.38 50.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.622 -174.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -115.57 127.48 55.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.036 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.854 HD21 HG11 ' A' ' 60' ' ' VAL . 11.5 mt -115.91 80.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.1 t70 70.02 -8.49 0.82 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p-10 43.6 32.41 0.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.396 1.479 . . . . 0.0 113.105 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 23' ' ' SER . 26.0 t -138.8 -9.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.428 -176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -110.56 -13.55 14.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.819 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -118.58 146.74 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.679 -171.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.535 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 27.1 m -71.59 75.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.999 0.428 . . . . 0.0 109.924 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.84 -61.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.319 -172.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -153.7 139.53 18.08 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.687 0.756 . . . . 0.0 110.967 177.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.663 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -69.51 -40.3 77.04 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.227 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -158.26 179.27 9.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.474 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.44 131.27 22.86 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -59.64 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.291 -175.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG3' ' HG2' ' A' ' 104' ' ' GLU . 3.0 tpp180 -89.98 100.4 13.23 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.239 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.825 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.6 tt -77.63 110.87 12.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 77.5 mm-40 -131.98 138.81 48.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.459 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 59.32 31.35 21.07 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.583 0.552 . . . . 0.0 110.11 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HD21 ' A' ' 103' ' ' LEU . 47.1 m-80 70.19 3.21 4.3 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.877 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.63 149.19 22.06 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.501 ' HD1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -93.8 124.08 37.57 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' HG22 ' A' ' 130' ' ' VAL . 12.9 m-80 -133.55 154.6 50.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.412 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 128' ' ' SER . 14.0 m -107.87 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.203 0.525 . . . . 0.0 110.867 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 128' ' ' SER . 84.1 t -101.22 111.47 31.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.833 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 119.52 12.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 111' ' ' VAL . 15.7 m -120.48 -11.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.432 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 146.36 71.47 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.354 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 98' ' ' HIS . 4.5 m -84.97 132.13 34.39 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.662 HD23 ' HB ' ' A' ' 24' ' ' VAL . 41.2 tp -60.94 -56.65 18.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.166 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -72.92 -35.78 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.38 0.61 . . . . 0.0 109.745 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.0 169.15 11.98 Favored Glycine 0 C--O 1.256 1.525 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.26 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -113.82 125.85 54.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.382 -0.909 . . . . 0.0 110.969 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -132.75 105.7 7.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.03 0.443 . . . . 0.0 110.906 173.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 137' ' ' VAL . 45.7 t -101.44 110.3 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.8 HD22 HG12 ' A' ' 121' ' ' VAL . 29.2 m-80 56.73 38.38 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.132 0.492 . . . . 0.0 110.484 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 9.6 mmm180 77.43 1.87 3.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.389 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.7 pt-20 -126.83 130.89 23.72 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.474 0.654 . . . . 0.0 111.442 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 23.2 Cg_exo -65.6 125.85 15.1 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 129' ' ' ALA . 27.8 m -115.54 165.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 111.701 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 m-20 -82.81 -51.83 7.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 171.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.3 p -160.31 91.03 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.554 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 126' ' ' VAL . . . -86.07 141.86 29.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.301 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 109' ' ' ASN . 39.7 t -78.32 124.17 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.956 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -59.28 156.18 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.342 0.401 . . . . 0.0 111.659 176.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.472 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -157.02 154.71 30.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -69.12 98.82 1.04 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.878 0.37 . . . . 0.0 110.011 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.23 0.84 29.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.06 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 17.2 t70 -69.17 148.87 49.28 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 9.0 tt0 -135.9 127.15 28.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.607 0.718 . . . . 0.0 111.824 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -123.64 133.19 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.568 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 20.1 tm0? -94.27 128.55 40.82 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.716 HG23 HD13 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -134.65 140.87 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 173.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 73.5 -68.12 1.52 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.231 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.081 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.7 ptmt -176.2 22.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.416 0.686 . . . . 0.0 109.345 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.742 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -123.15 161.83 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -171.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.41 ' HD2' ' OE1' ' A' ' 136' ' ' GLU . 26.9 ttp85 -112.18 119.59 38.91 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.434 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.828 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -109.5 154.11 23.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.411 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -141.26 139.87 32.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.155 171.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.654 ' O ' HD13 ' A' ' 147' ' ' LEU . 47.0 t80 -98.21 138.55 35.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.812 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.318 172.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 93' ' ' THR . 16.3 m . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 120.874 0.369 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HB ' HD21 ' A' ' 116' ' ' LEU . 14.7 p -138.7 135.89 43.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.646 -168.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 2.2 t80 173.34 -170.64 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.352 0.261 . . . . 0.0 110.759 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 C-N-CA 123.466 0.706 . . . . 0.0 111.284 172.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -123.77 172.8 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -155.06 144.27 21.05 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 117.566 -1.654 . . . . 0.0 114.743 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -93.56 112.57 24.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.807 166.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 5.9 p -111.97 131.67 62.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.695 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -76.51 110.48 11.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -72.33 -58.59 3.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.343 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -145.07 131.8 20.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.717 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.01 -174.34 38.77 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.921 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 44.7 Cg_exo -56.59 -47.55 23.21 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.964 1.776 . . . . 0.0 113.015 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 64.1 t30 -82.91 -51.76 7.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.815 0.816 . . . . 0.0 108.817 172.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.636 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 54.91 170.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.079 -171.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.79 2.5 90.56 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.778 -0.725 . . . . 0.0 114.057 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.976 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.2 m -99.91 179.32 4.55 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 117.901 0.85 . . . . 0.0 110.653 -170.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.689 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.81 154.7 4.41 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.008 0.367 . . . . 0.0 111.821 -175.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -93.54 116.26 28.78 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 171.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.8 tt -74.27 97.19 2.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 124.403 1.064 . . . . 0.0 108.809 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 58' ' ' LEU . 12.5 mt -91.19 32.27 1.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.786 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -88.69 -15.71 34.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.72 -167.08 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.375 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.68 -30.87 16.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.0 109.802 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -160.98 133.1 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 176.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 23.1 p -121.51 147.89 45.19 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.899 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.632 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -93.63 126.54 38.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.83 128.87 56.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -173.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.33 -117.0 1.1 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.109 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -101.55 101.69 12.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.719 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 76.1 m-70 . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 10.9 m-20 . . . . . 0 CA--C 1.521 -0.136 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -132.54 97.65 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.078 0.942 . . . . 0.0 110.203 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.441 ' C ' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -110.74 130.26 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.33 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 60' ' ' VAL . 4.5 mm? -116.2 76.09 1.0 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.94 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 67.98 -0.64 1.99 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.644 0.735 . . . . 0.0 110.019 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.3 p-10 35.67 44.0 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.306 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . 9.9 p -151.85 2.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.396 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 23' ' ' SER . 18.9 p -111.85 -7.95 14.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.849 -0.532 . . . . 0.0 112.045 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.9 t -126.81 147.3 31.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 O-C-N 122.043 -0.41 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 m -71.01 73.76 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.719 ' HG3' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 58.4 -61.59 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.292 -165.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 40.9 ttm180 -145.39 132.3 20.19 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.276 -0.89 . . . . 0.0 111.603 -163.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.867 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -87.92 -46.78 9.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.514 170.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.73 158.38 43.86 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.201 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 97' ' ' ARG . 7.8 pt-20 -124.27 130.96 53.42 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 166.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.07 95.97 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.272 -174.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -92.87 106.48 18.44 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.235 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 106' ' ' ASN . 9.3 tt -76.24 109.11 9.65 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.23 136.17 50.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.923 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 60.03 31.83 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.888 ' HA ' HD21 ' A' ' 103' ' ' LEU . 67.3 m-20 63.5 15.36 8.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.415 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -114.15 156.36 24.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.882 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -94.68 133.52 38.27 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.447 ' OD1' HG22 ' A' ' 130' ' ' VAL . 14.5 m-80 -139.91 159.49 42.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -107.79 126.3 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.267 171.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 34.2 m -101.92 123.64 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.684 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.93 126.35 30.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.819 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.77 -3.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 110.619 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 121.45 91.6 1.16 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.402 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 18.1 t -98.83 134.97 40.95 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.556 HD21 ' HB ' ' A' ' 24' ' ' VAL . 20.4 tp -52.47 -58.15 7.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 11.5 m-80 -70.6 -37.61 73.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.69 8.28 Favored Glycine 0 C--O 1.242 0.646 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.54 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.519 HG23 ' CE1' ' A' ' 98' ' ' HIS . 15.6 m -112.13 132.92 54.58 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.795 0.438 . . . . 0.0 111.148 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -141.29 140.14 33.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.655 0.264 . . . . 0.0 110.557 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 137' ' ' VAL . 73.1 t -127.89 107.63 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 135' ' ' ASP . 1.9 m120 64.0 35.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 109.386 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 59.42 30.18 19.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.926 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.8 pt-20 -139.62 128.06 13.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.43 122.66 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.142 1.895 . . . . 0.0 110.955 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.36 162.1 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 14.0 m-20 -72.16 -59.02 2.95 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 46.7 t -159.64 109.63 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.02 141.93 47.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 ' OD1' ' A' ' 109' ' ' ASN . 4.1 t -74.28 142.34 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.596 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.1 mp -51.0 150.93 2.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 111.489 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -134.33 -176.47 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.55 98.75 8.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.655 0.264 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.5 4.42 40.29 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.1 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.934 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 19.7 m-20 -101.81 157.84 16.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.134 0.467 . . . . 0.0 110.331 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -105.22 162.04 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 121' ' ' VAL . 47.7 t -136.22 126.57 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.595 172.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -98.87 111.35 23.77 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.933 178.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.867 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -111.95 134.97 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 61.64 -101.4 0.34 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.921 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 15.2 ptmt -141.64 19.36 2.18 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.76 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.678 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 m-85 -112.3 144.31 41.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.509 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -92.4 87.1 5.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -83.14 160.82 21.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.026 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.88 139.2 31.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.004 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -97.53 141.87 30.05 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.213 178.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.48 ' CD2' HG22 ' A' ' 145' ' ' VAL . 2.7 mm? . . . . . 0 N--CA 1.447 -0.593 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.422 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.758 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 43.1 m . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.863 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 8.1 t -110.92 131.86 60.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.11 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 20.6 t80 175.73 -177.38 0.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 173.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.633 ' CB ' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.127 0 C-N-CA 124.233 1.013 . . . . 0.0 111.21 172.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 p . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.21 172.78 9.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.732 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 1.8 pt? -160.76 142.05 11.96 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.81 -1.556 . . . . 0.0 114.964 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.2 mp -85.69 117.35 24.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.95 167.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.08 129.0 63.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.934 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -71.5 109.86 4.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.1 -67.37 0.44 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.048 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -145.26 125.23 13.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.726 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.758 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -163.27 -140.33 2.85 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.995 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 21.5 Cg_exo -66.87 -69.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.67 2.246 . . . . 0.0 112.446 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.752 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.5 t30 -69.09 -48.22 63.19 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.758 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.01 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.671 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.3 2.11 90.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.221 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.0 m -86.76 -179.86 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.316 0.558 . . . . 0.0 110.287 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.66 150.15 3.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.596 0.635 . . . . 0.0 112.412 -172.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -94.47 120.39 34.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.625 ' O ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -80.92 91.37 6.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.732 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.8 mt -83.38 52.12 2.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.063 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.614 ' HB2' HD21 ' A' ' 71' ' ' LEU . 17.7 t70 -96.36 -37.85 10.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.574 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -96.51 -166.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.774 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.22 39.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -154.0 123.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.634 0.73 . . . . 0.0 112.546 -177.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 65.2 p -103.99 138.74 40.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.519 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 48.8 m -82.05 124.88 30.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.688 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.77 114.77 21.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -171.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.716 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 152.25 -140.31 7.63 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -70.68 104.04 2.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.499 ' HE1' ' HD3' ' A' ' 96' ' ' ARG . 57.4 m-70 . . . . . 0 C--N 1.316 -0.87 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.821 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 7.1 m-20 . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.688 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -126.48 105.33 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.647 0.737 . . . . 0.0 111.124 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -103.89 134.44 47.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.647 177.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.049 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -118.6 77.14 1.14 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.738 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.6 t70 67.81 -18.5 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.473 0.654 . . . . 0.0 111.267 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 33.1 t70 67.05 24.13 9.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.429 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.758 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.8 p -156.47 53.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 122.296 1.046 . . . . 0.0 110.769 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -152.81 0.06 0.27 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.123 172.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.714 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.8 t -137.23 140.49 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.218 -173.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.9 m -73.68 74.03 1.52 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.238 177.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.499 ' HD3' ' HE1' ' A' ' 82' ' ' HIS . 0.2 OUTLIER 66.96 -66.64 0.18 Allowed 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.248 -173.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.423 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -139.57 144.1 37.64 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.702 -0.624 . . . . 0.0 110.523 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.96 -41.39 12.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.854 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.17 165.54 28.02 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.396 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.9 pt-20 -132.69 127.04 33.94 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.715 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -58.28 100.73 0.07 Allowed 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.692 -174.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -94.62 100.35 12.32 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.735 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -79.48 104.6 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.128 175.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -134.75 140.67 46.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.717 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 62.34 32.13 17.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.397 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.657 ' HA ' HD21 ' A' ' 103' ' ' LEU . 43.2 m-80 64.58 15.01 9.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.882 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -121.86 146.43 47.1 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.873 0.368 . . . . 0.0 110.809 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -85.8 122.14 29.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.534 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -123.87 166.16 16.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.8 m -115.65 128.53 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.245 172.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.8 t -101.51 111.87 32.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.298 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.77 119.88 21.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.564 HG13 HG12 ' A' ' 111' ' ' VAL . 35.6 m -116.59 -27.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 111.085 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.23 105.97 0.43 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.797 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.9 t -101.48 146.88 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.264 0.226 . . . . 0.0 110.6 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -60.52 -55.76 29.52 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.628 0.252 . . . . 0.0 110.904 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.863 ' OD1' ' HA ' ' A' ' 24' ' ' VAL . 61.5 m-20 -74.05 -36.42 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.22 160.82 8.6 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.559 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.2 m -112.81 132.5 55.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.616 0.367 . . . . 0.0 111.727 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.823 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 57.0 m-85 -141.37 105.38 4.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.995 0.426 . . . . 0.0 110.683 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 137' ' ' VAL . 88.0 t -92.04 114.24 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.17 36.98 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.823 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 35.0 mtp-105 53.85 31.99 14.21 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.974 -172.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.7 pt-20 -141.8 137.86 16.56 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 109.979 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.95 122.93 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.09 1.86 . . . . 0.0 111.8 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.0 m -116.93 176.89 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.561 0.219 . . . . 0.0 110.806 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 27.2 t70 -94.75 -66.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 43.4 t -153.15 92.45 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.82 142.41 29.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.023 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -79.45 129.83 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.09 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.725 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 1.0 OUTLIER -59.78 163.75 4.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -167.96 168.99 11.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -61.44 115.52 3.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.849 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.51 5.24 72.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.319 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.5 108.96 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 110.453 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 8.2 tt0 -94.79 131.8 40.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -124.14 130.84 73.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -101.24 121.68 42.3 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.904 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.049 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.52 140.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 58.12 -98.87 0.1 OUTLIER Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.3 -0.952 . . . . 0.0 110.869 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.995 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.2 ptmt -140.85 18.22 2.32 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.235 0.54 . . . . 0.0 111.096 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.752 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -110.42 150.29 29.04 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -107.37 105.46 15.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' A' ' 60' ' ' VAL . 5.3 mp -98.71 157.51 16.22 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.505 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.78 141.32 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.106 169.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.725 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 37.3 t80 -100.07 137.65 38.23 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.207 170.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.238 0.462 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 54.4 t -68.47 143.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.822 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 16.7 t80 174.29 -177.9 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.418 0.449 . . . . 0.0 110.794 168.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.792 HH22 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 123.933 0.893 . . . . 0.0 111.819 174.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.88 171.79 10.43 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.7 pp -155.0 137.91 15.43 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 117.541 -1.664 . . . . 0.0 114.93 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 131' ' ' LEU . 1.3 mp -85.29 110.88 19.39 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.457 162.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 57' ' ' LEU . 5.8 p -105.41 127.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.086 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.924 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -71.44 108.97 3.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 175.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.94 -57.5 6.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.604 -1.634 . . . . 0.0 109.881 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -150.7 131.06 13.71 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.304 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -169.93 -161.18 19.94 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.103 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 31.2 Cg_exo -60.55 -51.92 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.974 1.782 . . . . 0.0 113.055 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 63.9 t30 -78.2 -49.29 14.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.6 158.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.956 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.66 89.82 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.924 ' H ' HG22 ' A' ' 60' ' ' VAL . 12.3 t -98.49 -178.01 3.87 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.343 1.071 . . . . 0.0 110.811 -173.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.24 156.68 5.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.283 0.492 . . . . 0.0 112.112 -173.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.569 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.77 113.47 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 170.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 1.3 pt? -79.65 92.61 5.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.067 1.413 . . . . 0.0 108.609 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.592 HD13 ' CB ' ' A' ' 108' ' ' PHE . 12.1 mt -74.18 46.51 0.25 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.009 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 35.2 t70 -94.73 -25.49 16.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.743 0.782 . . . . 0.0 109.173 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -84.61 -167.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.745 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.67 -30.08 22.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.54 137.66 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.478 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 59.7 p -128.51 132.79 48.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.753 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.817 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 35.8 m -82.55 125.53 31.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 110.419 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' A' ' 87' ' ' ILE . . . -122.54 117.41 25.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.523 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 154.83 -82.72 0.16 Allowed Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.182 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -124.6 103.1 7.95 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.817 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.268 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.471 -171.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.608 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 121.386 0.612 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.42 109.83 28.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.667 0.746 . . . . 0.0 110.481 -177.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -116.17 135.07 54.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.979 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -122.37 74.04 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.652 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 39.0 t70 75.28 -22.49 0.26 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.488 0.661 . . . . 0.0 111.01 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 30.0 t70 59.68 36.19 22.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.036 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HB ' ' OD2' ' A' ' 90' ' ' ASP . 41.6 t -137.87 -10.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.626 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.433 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 31.3 p -106.98 -24.48 11.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.7 t -118.59 147.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -169.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 20.3 m -76.12 81.31 2.94 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.053 -0.404 . . . . 0.0 110.228 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HG3' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 67.28 -69.4 0.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.567 -173.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -156.04 142.28 18.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.566 0.698 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.806 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -79.46 -42.26 25.72 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.396 172.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.829 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.62 153.6 44.86 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.067 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' A' ' 76' ' ' ILE . 5.4 pt-20 -115.51 126.92 54.88 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 166.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.84 98.99 0.11 Allowed 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.552 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.477 HH21 ' CD ' ' A' ' 100' ' ' GLU . 19.9 tpp85 -90.07 101.13 13.85 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.019 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -83.2 110.76 18.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.434 ' HG2' HD22 ' A' ' 105' ' ' ASN . 32.6 tt0 -132.21 128.35 37.75 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.115 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.434 HD22 ' HG2' ' A' ' 104' ' ' GLU . 52.8 m-80 60.64 36.97 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.053 0.454 . . . . 0.0 110.484 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.842 ' HA ' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER 69.3 8.44 6.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.773 178.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 26.0 mm-40 -109.21 140.83 42.32 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.906 -0.496 . . . . 0.0 110.935 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.592 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -90.07 127.8 36.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.808 -177.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.579 HD22 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -127.03 159.99 32.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.34 -178.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -106.27 124.79 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 169.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.3 t -102.75 113.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.889 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' THR . 18.2 t0 -70.93 118.26 13.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.514 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.815 HG13 HG12 ' A' ' 111' ' ' VAL . 11.1 m -122.93 -37.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.77 79.68 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.099 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 25.7 t -93.34 122.98 36.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -45.45 90.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.592 -176.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 23.8 m-80 -82.52 -36.72 26.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 110.128 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 146.2 152.2 5.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 112' ' ' ASP . 17.1 m -111.87 128.44 56.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 23.3 m-85 -139.01 146.58 41.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 173.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 137' ' ' VAL . 97.0 t -134.3 106.6 8.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.5 OUTLIER 64.18 41.0 6.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 63.97 17.23 10.45 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.009 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.5 pt-20 -134.61 126.15 17.93 Favored Pre-proline 0 C--N 1.331 -0.218 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.89 122.34 9.46 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.294 1.996 . . . . 0.0 111.712 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.5 m -111.97 178.74 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 110.707 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.2 p-10 -101.86 -46.77 4.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.729 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 17.4 p -159.17 94.32 1.19 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.019 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.18 144.34 30.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 HD21 ' A' ' 109' ' ' ASN . 26.0 t -76.96 131.29 35.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.127 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -61.03 155.18 20.83 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.846 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -156.31 156.81 34.63 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.182 0.515 . . . . 0.0 111.738 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.27 111.02 2.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.702 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.88 1.58 59.85 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.839 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 15.6 t70 -72.29 128.45 35.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.618 0.247 . . . . 0.0 110.761 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.461 ' OE1' ' HD3' ' A' ' 143' ' ' ARG . 7.1 tt0 -112.81 129.56 56.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.401 0.62 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 121' ' ' VAL . 44.7 t -124.83 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.378 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -102.44 118.53 37.06 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.956 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -117.53 125.4 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 63.88 -103.03 0.63 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.101 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.103 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 10.1 pttt -143.02 24.75 1.81 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.283 0.563 . . . . 0.0 111.424 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.37 136.7 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -175.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.792 ' HB2' HH22 ' A' ' 26' ' ' ARG . 7.2 ttm180 -89.47 109.31 20.25 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.94 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 60' ' ' VAL . 6.7 mp -98.9 159.22 15.11 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.146 0.498 . . . . 0.0 111.825 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -141.76 140.99 30.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.004 166.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.622 ' O ' HD22 ' A' ' 147' ' ' LEU . 47.7 t80 -97.03 132.38 42.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 169.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 116' ' ' LEU . 1.4 p -143.42 157.31 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 O-C-N 121.259 -0.901 . . . . 0.0 112.42 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -172.76 -143.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.548 HH21 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 CA-C-N 118.365 0.529 . . . . 0.0 109.948 178.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.603 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -125.84 169.12 12.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.462 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -153.68 129.78 10.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.064 -1.054 . . . . 0.0 113.698 -173.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.028 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.8 mp -86.61 137.74 32.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.904 162.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 4.2 p -131.82 128.96 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.431 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -72.98 109.78 5.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -64.27 -70.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 113.079 -1.873 . . . . 0.0 110.413 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 62' ' ' ARG . 14.0 mtp85 -148.54 138.03 21.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.476 0.655 . . . . 0.0 109.781 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -162.28 -127.02 0.85 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.824 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 3.8 Cg_endo -89.18 -62.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.9 0 C-N-CA 122.163 1.909 . . . . 0.0 111.442 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.682 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -69.42 -53.35 19.75 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.18 174.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.113 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.73 89.52 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.871 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.5 m -96.87 179.61 4.9 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 117.308 0.554 . . . . 0.0 111.017 -169.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.75 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -168.5 147.2 4.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -169.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.845 ' HD2' ' HB2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -97.26 121.07 38.74 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.0 tt -83.68 101.38 11.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.662 0.744 . . . . 0.0 110.218 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -92.99 41.51 1.08 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.438 0.637 . . . . 0.0 110.254 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' A' ' 71' ' ' LEU . 25.2 t70 -92.0 -26.24 18.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.792 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.03 178.99 4.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.481 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.78 -44.46 81.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -162.56 128.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.933 -174.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 p -113.8 121.6 44.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.133 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.612 ' HB3' ' CE1' ' A' ' 82' ' ' HIS . 65.4 m -64.86 126.14 27.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.964 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.59 115.98 25.09 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.663 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 149.39 -142.96 10.28 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.12 104.38 3.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 109.966 173.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.764 ' CE1' ' HD3' ' A' ' 96' ' ' ARG . 69.7 m-70 . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 CA--C 1.515 -0.399 0 CA-C-O 121.41 0.624 . . . . 0.0 109.375 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -101.05 94.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.0 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -100.07 134.92 42.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.817 174.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.024 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -117.02 75.21 0.96 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.2 t70 58.92 15.75 4.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.74 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 2.3 p30 46.12 -73.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.285 1.434 . . . . 0.0 113.696 -170.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 92' ' ' VAL . 12.7 p -73.63 64.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -156.08 -1.24 0.13 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.263 164.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.581 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 9.2 t -131.7 137.83 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.125 -0.36 . . . . 0.0 110.732 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 114' ' ' GLY . 19.4 m -72.48 71.22 0.93 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.764 ' HD3' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 68.55 -59.63 0.45 Allowed 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.822 -174.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.518 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.0 ptp85 -149.31 138.67 21.53 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.661 -0.649 . . . . 0.0 110.625 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.705 ' CB ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -70.58 -43.16 69.98 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.46 175.12 13.68 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 112.704 -2.043 . . . . 0.0 108.949 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.691 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -128.37 115.05 17.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 1.041 ' HD1' HG13 ' A' ' 110' ' ' VAL . 2.4 t80 -78.07 91.46 4.28 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.877 0.846 . . . . 0.0 108.719 -171.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.69 ' HB3' HG13 ' A' ' 76' ' ' ILE . 12.8 ptp180 -101.54 140.3 36.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.343 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -83.25 112.29 19.74 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.501 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.35 139.75 39.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 36.2 m-80 62.51 32.52 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.704 ' HA ' HD21 ' A' ' 103' ' ' LEU . 6.8 t30 72.03 -0.1 3.35 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.568 0.747 . . . . 0.0 111.517 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 12.9 mm-40 -111.62 142.54 43.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.544 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.62 128.9 36.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 18.0 m-80 -138.05 161.86 35.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 1.041 HG13 ' HD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -104.54 117.34 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 117.962 0.346 . . . . 0.0 111.019 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.588 HG21 ' HD2' ' A' ' 102' ' ' ARG . 76.5 t -99.03 110.17 25.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -70.27 135.38 48.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.49 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 27.2 m -135.61 7.62 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.112 0.482 . . . . 0.0 109.78 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 102.96 107.19 3.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.292 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 25.6 t -102.35 157.26 17.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.661 HD12 ' HB ' ' A' ' 24' ' ' VAL . 1.6 tm? -58.13 -53.18 61.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.773 -174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.617 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -70.62 -36.03 73.25 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.725 0.774 . . . . 0.0 109.014 172.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 115' ' ' SER . . . 132.35 177.55 14.98 Favored Glycine 0 C--O 1.25 1.095 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.214 -173.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 98' ' ' HIS . 5.6 m -111.57 136.68 50.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.901 0.48 . . . . 0.0 111.474 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.9 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 22.8 m-85 -139.57 132.8 29.83 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.84 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 137' ' ' VAL . 84.6 t -129.3 121.69 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.75 32.6 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 56.89 26.36 11.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.595 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.0 pt-20 -137.86 143.21 39.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.426 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 20.2 Cg_exo -66.99 123.26 10.74 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.847 2.364 . . . . 0.0 112.348 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.43 175.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 p-10 -103.35 -49.94 3.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.12 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.87 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 33.3 t -157.72 91.44 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.41 137.81 36.57 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.025 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.411 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 7.4 p -80.57 143.16 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.784 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -49.44 133.19 20.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.227 174.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -128.38 -175.15 3.42 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -107.0 86.03 2.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.32 2.29 38.28 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.445 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.713 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 4.8 t70 -89.98 158.18 17.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.487 0.644 . . . . 0.0 109.744 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.5 pm0 -107.42 143.51 35.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.898 0.856 . . . . 0.0 113.209 -172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 121' ' ' VAL . 58.4 t -119.9 141.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.739 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.9 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 56.1 tp60 -108.05 122.97 47.95 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.082 0.467 . . . . 0.0 110.186 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.024 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.92 139.99 50.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 168.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 63.27 -90.27 0.07 OUTLIER Glycine 0 C--O 1.208 -1.481 0 C-N-CA 119.717 -1.23 . . . . 0.0 112.322 173.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.824 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 14.8 ptmt -156.95 31.9 0.3 Allowed 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.519 -0.989 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -123.87 138.44 54.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.548 ' HB2' HH21 ' A' ' 26' ' ' ARG . 0.7 OUTLIER -89.5 108.84 19.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.08 161.05 13.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.41 143.45 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.028 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -109.34 144.6 37.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.528 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? . . . . . 0 N--CA 1.453 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' THR . 57.2 m . . . . . 0 CA--C 1.519 -0.22 0 CA-C-O 121.388 0.614 . . . . 0.0 112.547 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 117' ' ' ASN . 14.1 p -127.87 141.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.482 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 t80 179.13 -168.1 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.903 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.8 tpt180 . . . . . 0 N--CA 1.475 0.821 0 O-C-N 123.876 0.735 . . . . 0.0 110.542 170.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -136.19 170.15 16.48 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -161.29 145.2 13.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.6 mp -87.1 116.5 25.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.759 164.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -113.11 130.02 67.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 118.158 0.435 . . . . 0.0 110.522 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.001 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.16 109.38 3.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -62.46 -54.46 39.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.216 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -165.42 106.94 0.77 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.989 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -127.68 -133.07 3.69 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.076 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 82.4 Cg_endo -76.0 -64.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.34 2.027 . . . . 0.0 112.191 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.916 ' HB3' ' HE2' ' A' ' 142' ' ' PHE . 66.5 t30 -70.13 -47.3 62.29 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 60.31 166.94 0.08 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.847 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.35 4.45 89.95 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.77 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.001 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -101.92 179.18 4.4 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 117.651 0.726 . . . . 0.0 110.655 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.49 154.98 3.29 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.802 0.728 . . . . 0.0 112.24 -172.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.15 127.94 41.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.5 tt -87.82 91.82 8.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.72 0.771 . . . . 0.0 109.534 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.812 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -85.39 55.78 3.66 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.512 ' HB3' HD21 ' A' ' 71' ' ' LEU . 16.7 t70 -108.75 -23.94 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.869 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -103.77 -166.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.52 -41.17 69.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.3 129.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.463 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 71.8 p -113.2 126.02 54.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 87' ' ' ILE . 39.1 m -68.29 126.58 30.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.54 108.65 13.38 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 165.45 -139.3 5.72 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.095 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.98 103.88 7.16 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 11.5 m-70 . . . . . 0 N--CA 1.436 -1.133 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.229 -172.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 6.3 m-20 . . . . . 0 N--CA 1.473 0.712 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -115.44 110.95 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.0 0.905 . . . . 0.0 111.672 -171.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.33 114.61 28.43 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.714 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.778 HD12 HG12 ' A' ' 139' ' ' ILE . 4.7 mt -102.4 80.05 1.9 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.942 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 14.6 t70 70.11 -7.48 0.95 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.148 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.6 p30 39.47 36.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 113.075 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.435 HG12 ' HB2' ' A' ' 23' ' ' SER . 41.1 t -148.42 -2.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 23' ' ' SER . 27.7 p -113.2 -34.92 5.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -116.72 154.6 18.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 122.116 -0.365 . . . . 0.0 110.602 -171.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 7.1 m -68.41 72.79 0.21 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.706 0.403 . . . . 0.0 112.049 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 59.36 -49.31 0.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.054 0.942 . . . . 0.0 112.709 -173.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.767 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 10.3 ptp85 -149.42 141.85 24.28 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.691 -0.631 . . . . 0.0 110.308 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.85 -41.3 12.55 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.911 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -140.26 170.55 15.61 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.808 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.6 pt-20 -137.45 123.27 20.03 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.812 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -55.52 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 124.413 1.071 . . . . 0.0 108.931 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.465 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -94.14 98.04 10.7 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.939 -174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -78.95 104.8 9.83 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.817 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.63 134.99 54.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.3 OUTLIER 40.75 47.24 2.43 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.313 1.008 . . . . 0.0 112.092 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.737 ' HA ' HD21 ' A' ' 103' ' ' LEU . 3.6 m-20 76.55 2.18 3.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.693 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 50.2 mt-10 -106.28 141.3 37.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.807 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.627 ' CB ' HD23 ' A' ' 72' ' ' LEU . 1.1 m-85 -89.05 126.99 35.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' ' 130' ' ' VAL . 24.4 m-80 -132.12 160.29 36.43 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.718 0.294 . . . . 0.0 110.576 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 128' ' ' SER . 5.6 m -111.76 126.96 69.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.016 0.436 . . . . 0.0 110.211 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.911 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 3.8 t -101.38 112.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.354 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 13.4 t0 -74.78 128.64 36.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.515 HG21 ' HG3' ' A' ' 97' ' ' ARG . 36.0 m -128.04 4.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 109.608 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.17 87.63 2.01 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.282 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.745 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.4 t -87.79 141.01 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 13.0 tp -53.15 -57.26 11.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.711 HD21 ' HA2' ' A' ' 140' ' ' GLY . 1.8 p30 -65.91 -37.79 87.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.642 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.11 164.06 9.84 Favored Glycine 0 C--O 1.262 1.847 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.724 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.533 HG23 ' CE1' ' A' ' 98' ' ' HIS . 17.7 m -113.82 129.27 56.61 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.239 -1.481 . . . . 0.0 110.297 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 14.0 m-85 -141.63 105.22 4.69 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 111.67 173.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 1.088 HG22 HG23 ' A' ' 137' ' ' VAL . 52.5 t -100.33 127.11 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 0.9 OUTLIER 63.22 25.61 14.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 63.05 13.8 7.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.834 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.85 156.88 58.7 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 120.762 0.315 . . . . 0.0 110.385 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.75 131.85 12.66 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.44 2.093 . . . . 0.0 112.645 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.26 176.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 10.0 m-20 -120.1 -31.34 4.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.56 174.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.858 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.0 p -161.63 91.48 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.509 0.671 . . . . 0.0 109.866 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -100.91 145.58 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.489 HG22 ' OD1' ' A' ' 109' ' ' ASN . 14.5 t -88.18 119.81 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.764 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -58.74 162.3 4.11 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -163.52 164.59 24.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.622 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -71.06 114.49 9.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.346 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.39 -7.96 51.77 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.856 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.409 ' CG ' HD21 ' A' ' 122' ' ' ASN . 8.7 t70 -66.49 110.64 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.621 0.369 . . . . 0.0 110.142 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -93.83 152.3 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.172 0.51 . . . . 0.0 112.251 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -133.4 141.24 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.653 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.1 tm0? -109.58 116.68 32.22 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 169.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.823 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -138.4 131.77 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.243 175.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.711 ' HA2' HD21 ' A' ' 117' ' ' ASN . . . 82.9 -56.88 5.07 Favored Glycine 0 C--N 1.317 -0.502 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.25 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.076 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 59.9 pttt 168.03 32.11 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.916 ' HE2' ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -114.5 161.52 17.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.232 -173.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.77 99.62 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 1.0 ' HB2' HG12 ' A' ' 137' ' ' VAL . 5.8 mp -88.83 163.54 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.365 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -141.53 140.29 31.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 166.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.764 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 45.9 t80 -100.04 143.08 30.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.402 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.76 170.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 93' ' ' THR . 70.4 m . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 12.3 p -127.64 147.18 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.986 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.3 t80 172.8 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.921 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.598 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 8.7 tpt180 . . . . . 0 N--CA 1.48 1.057 0 C-N-CA 122.873 0.469 . . . . 0.0 109.931 172.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.443 -0.788 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.87 170.63 14.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.5 pp -158.1 142.63 16.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.9 110.96 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.999 163.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 57' ' ' LEU . 4.9 p -107.94 124.81 64.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.351 0.596 . . . . 0.0 111.216 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.023 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -72.74 111.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.073 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.5 -70.12 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.708 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -142.99 128.11 18.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.607 0.717 . . . . 0.0 110.736 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -167.13 -153.69 8.07 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.01 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 52.9 Cg_exo -56.07 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 122.598 2.198 . . . . 0.0 113.052 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 8.1 t30 -70.39 -49.12 52.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.61 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.531 -173.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.08 0.07 84.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.316 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.897 ' H ' HG22 ' A' ' 60' ' ' VAL . 33.1 t -99.81 -171.59 2.08 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 118.412 1.106 . . . . 0.0 110.383 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.83 164.18 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -175.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HZ ' HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -95.95 129.13 43.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -85.94 96.54 9.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.761 0.791 . . . . 0.0 109.457 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.838 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -89.43 31.51 0.91 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.336 0.588 . . . . 0.0 109.703 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.0 -28.63 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.697 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.421 ' NE2' HG22 ' A' ' 77' ' ' THR . 13.2 pt20 -95.72 -166.35 1.43 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.747 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.86 -38.05 46.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -162.07 135.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 111.937 -177.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 54.1 p -123.77 133.28 53.86 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.58 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.735 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 44.3 m -76.84 126.08 30.38 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.45 112.4 19.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -167.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.624 ' HA3' HG11 ' A' ' 94' ' ' VAL . . . 156.56 -88.92 0.12 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.887 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -108.44 104.41 13.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.702 0.763 . . . . 0.0 109.002 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.735 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.081 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.289 -174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 115.273 1.583 . . . . 0.0 115.273 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.29 109.91 29.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.44 0.638 . . . . 0.0 111.574 -171.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.85 127.22 47.4 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.984 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.023 HD21 HG11 ' A' ' 60' ' ' VAL . 8.1 mt -121.1 82.78 1.97 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.077 170.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.26 -11.16 0.72 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.082 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.9 p30 40.23 32.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.489 1.515 . . . . 0.0 112.781 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.93 -9.28 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.84 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.675 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -112.64 -9.94 13.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -172.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.624 HG11 ' HA3' ' A' ' 80' ' ' GLY . 3.4 t -122.41 147.1 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.941 -0.474 . . . . 0.0 110.836 -171.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.9 t -77.39 73.49 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.5 OUTLIER 58.52 -58.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.788 -166.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 10.0 ptp85 -142.58 136.5 29.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.635 0.731 . . . . 0.0 111.35 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -78.06 -37.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.22 177.75 10.72 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.323 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 77' ' ' THR . 5.1 pt-20 -133.98 134.46 42.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.838 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -64.18 104.08 0.7 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.61 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 23.1 ttm180 -105.16 112.34 25.43 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.646 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.6 tt -84.28 103.77 13.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.577 0.704 . . . . 0.0 110.033 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.61 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 43.2 mt-10 -128.08 141.41 51.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 37.3 m-20 62.56 30.98 17.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.802 ' HA ' HD21 ' A' ' 103' ' ' LEU . 16.0 m120 62.15 11.97 4.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.253 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 9.3 pt-20 -117.56 147.11 43.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.645 ' CB ' HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -93.19 119.38 32.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.8 -174.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -123.61 163.02 21.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -107.75 118.49 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.982 170.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 83.5 t -99.41 110.72 27.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.27 136.75 55.41 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.581 0.551 . . . . 0.0 110.047 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 97' ' ' ARG . 24.2 m -133.69 3.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.093 0.473 . . . . 0.0 110.173 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.33 110.49 2.24 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.307 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.59 ' HB3' ' HA ' ' A' ' 98' ' ' HIS . 24.3 p -109.61 169.91 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.585 HD23 ' HB ' ' A' ' 24' ' ' VAL . 0.7 OUTLIER -64.26 -55.17 23.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.506 -175.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.53 HD21 ' H ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -66.62 -37.45 84.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.97 161.32 10.58 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 121.438 0.465 . . . . 0.0 113.321 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.3 m -112.13 131.21 55.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.954 0.901 . . . . 0.0 111.274 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -141.8 104.95 4.61 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.503 0.192 . . . . 0.0 111.483 175.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 137' ' ' VAL . 93.6 t -102.6 119.82 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.964 -0.46 . . . . 0.0 109.97 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.3 37.5 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.481 ' HA ' ' HD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 64.06 25.11 13.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -176.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.55 133.09 8.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.811 -0.556 . . . . 0.0 110.867 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.78 122.64 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.099 1.866 . . . . 0.0 111.547 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.605 HG13 ' HB ' ' A' ' 121' ' ' VAL . 26.1 m -106.29 179.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 111.309 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 24.2 t70 -108.95 -40.97 4.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.0 t -165.14 91.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.0 124.0 40.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.585 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.6 p -70.69 144.16 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.557 0.694 . . . . 0.0 111.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 1.1 tt -52.05 134.53 32.27 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.592 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.446 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -127.59 -176.25 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.66 88.47 2.93 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.015 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.86 -16.82 30.54 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.6 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.902 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 4.2 m-20 -68.85 155.08 40.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.133 0.492 . . . . 0.0 110.786 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -110.1 156.2 20.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 112.566 -170.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.98 HG13 HG22 ' A' ' 121' ' ' VAL . 47.0 t -135.39 132.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.04 118.07 33.8 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 172.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.641 ' CG1' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -128.96 131.35 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.368 173.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.62 ' CA ' HG22 ' A' ' 94' ' ' VAL . . . 82.03 -55.76 4.93 Favored Glycine 0 C--N 1.322 -0.231 0 C-N-CA 119.315 -1.421 . . . . 0.0 112.944 167.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.01 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 58.5 pttt 169.21 32.36 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 124.406 1.083 . . . . 0.0 109.082 163.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.808 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.08 150.96 44.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -169.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -93.2 92.15 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.0 mp -88.48 158.34 18.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.204 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.654 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.97 143.09 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.958 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -108.49 143.89 36.86 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.742 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? . . . . . 0 C--O 1.234 0.237 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 93' ' ' THR . 69.1 m . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.179 0.514 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 116' ' ' LEU . 8.0 p -135.36 147.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.315 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -177.35 -160.06 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.071 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.844 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.122 0 O-C-N 124.222 0.951 . . . . 0.0 110.676 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.537 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.439 -0.988 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.78 168.7 13.44 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -161.01 146.18 14.13 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.049 -1.06 . . . . 0.0 113.537 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.572 HD21 ' CG1' ' A' ' 110' ' ' VAL . 4.1 mp -87.91 141.16 28.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.634 164.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 147' ' ' LEU . 7.3 p -132.74 132.48 59.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.215 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.935 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -74.17 109.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 25.2 tptp -63.32 -54.74 32.23 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.885 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 71.9 mtt180 -158.38 138.18 12.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.054 174.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.727 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -175.65 -155.28 12.55 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 78.2 Cg_exo -55.68 -65.0 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.712 2.274 . . . . 0.0 112.949 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.775 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 52.3 t30 -71.03 -48.38 53.29 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.71 153.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.044 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.55 2.22 90.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.935 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.0 m -88.34 176.35 7.25 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.258 0.529 . . . . 0.0 110.26 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.665 HH21 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -170.23 148.27 3.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.812 0.733 . . . . 0.0 112.868 -169.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.89 129.67 43.08 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HH21 ' A' ' 69' ' ' ARG . 1.5 tm? -85.79 101.37 12.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.8 ' HG ' ' CG ' ' A' ' 101' ' ' PHE . 0.7 OUTLIER -95.86 31.58 2.07 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.297 -177.003 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 34.7 t70 -89.85 -11.52 41.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.84 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.568 ' O ' ' HE2' ' A' ' 101' ' ' PHE . 1.4 pp0? -121.42 153.84 37.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -42.63 -39.01 2.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.82 123.08 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.255 0.55 . . . . 0.0 112.149 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.63 ' CG2' ' HB3' ' A' ' 86' ' ' ASP . 1.6 p -113.79 121.84 45.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.802 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.615 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 30.5 m -76.61 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.579 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.611 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -122.21 116.47 24.21 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.871 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 170.66 -108.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.671 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -111.79 101.75 10.07 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.314 -0.972 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.955 -160.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.63 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 2.8 m-20 . . . . . 0 N--CA 1.464 0.273 0 CA-C-O 121.437 0.636 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.611 HG12 ' HB1' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -127.75 122.02 57.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.229 -176.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.71 133.16 56.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.238 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 139' ' ' ILE . 6.2 mt -108.15 80.33 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 29.7 t70 71.71 -6.84 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.57 0.7 . . . . 0.0 110.134 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.794 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.3 p30 40.5 38.77 0.62 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.121 1.368 . . . . 0.0 113.523 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 92' ' ' VAL . 70.8 t -145.67 6.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.737 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 23' ' ' SER . 10.3 p -124.47 -2.2 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -168.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.8 t -136.53 155.55 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.72 -172.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.0 m -75.52 79.28 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.032 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 1.054 ' HG2' ' HD2' ' A' ' 97' ' ' ARG . 11.4 ttm180 55.69 -58.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.753 -1.112 . . . . 0.0 112.869 -164.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 1.054 ' HD2' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -157.84 153.87 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.484 -0.76 . . . . 0.0 111.697 -177.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 1.01 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -95.41 -40.54 9.44 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.304 177.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.884 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -148.61 131.52 16.16 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.667 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -102.98 122.53 44.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -53.19 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 124.614 1.196 . . . . 0.0 108.406 -176.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.85 107.67 19.95 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 119.359 -0.937 . . . . 0.0 108.742 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.8 tt -77.02 107.87 9.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' C ' HD22 ' A' ' 105' ' ' ASN . 23.6 mt-10 -117.19 134.05 55.25 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.527 HD22 ' C ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER 39.07 43.34 0.8 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.1 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.892 ' HA ' HD21 ' A' ' 103' ' ' LEU . 53.2 m-80 72.08 15.63 5.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.561 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.706 ' HG3' HD21 ' A' ' 109' ' ' ASN . 15.5 pt-20 -122.26 151.68 40.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.939 173.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.95 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -93.42 129.13 39.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.942 -174.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.706 HD21 ' HG3' ' A' ' 107' ' ' GLU . 18.4 m-80 -135.19 161.82 34.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.4 m -107.03 126.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.37 174.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 4.0 t -100.3 111.59 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.297 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 11.2 t70 -73.26 115.05 12.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 111' ' ' VAL . 16.0 m -115.17 -12.36 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.122 0.487 . . . . 0.0 111.096 -174.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.8 87.57 0.34 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.586 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 1.01 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 30.7 t -92.32 145.15 24.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.445 ' CD2' ' HB ' ' A' ' 24' ' ' VAL . 23.9 tp -63.73 -55.41 23.47 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.334 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.78 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -67.77 -36.44 80.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.48 169.57 12.42 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.102 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.2 m -112.85 123.53 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.618 -0.791 . . . . 0.0 111.298 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 52.2 m-85 -140.96 103.67 4.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 172.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 1.007 HG12 HG13 ' A' ' 137' ' ' VAL . 1.3 m -99.45 130.27 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.6 OUTLIER 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.139 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 58.12 32.13 21.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 13.5 pt-20 -146.12 138.79 13.96 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 110.664 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 19.9 Cg_exo -65.46 123.26 11.19 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.599 2.199 . . . . 0.0 111.412 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 121' ' ' VAL . 27.3 m -123.65 169.41 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.41 -61.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.809 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.888 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.5 t -143.84 91.91 2.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.333 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.32 124.89 44.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 8.7 p -67.11 150.81 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.728 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.95 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.0 mp -58.67 145.93 38.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.497 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 146' ' ' PHE . . . -151.3 130.79 12.97 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -69.42 121.85 17.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.441 0.639 . . . . 0.0 111.234 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.79 60.98 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.17 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 36.0 m-20 -105.02 147.53 27.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.58 161.85 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -168.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.007 HG13 HG12 ' A' ' 121' ' ' VAL . 40.6 t -134.51 131.74 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.558 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.46 ' HG3' HD21 ' A' ' 117' ' ' ASN . 6.6 tp-100 -96.8 120.06 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 169.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.842 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -135.98 129.5 47.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.386 171.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.78 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 76.81 -62.25 3.25 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.597 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.006 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 54.1 pttt 176.41 28.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.122 0.569 . . . . 0.0 111.379 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.847 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -122.82 146.84 47.19 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 109.053 -168.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.622 ' NH1' ' HG2' ' A' ' 136' ' ' GLU . 11.6 ttm-85 -97.1 100.18 11.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.626 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.926 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.4 mp -91.75 166.08 12.95 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.922 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -143.36 144.25 23.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 171.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.818 ' HB3' ' HG ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -84.51 136.87 33.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.953 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 59' ' ' VAL . 2.0 mm? . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.063 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.905 HG12 ' H ' ' A' ' 25' ' ' PHE . 2.1 t 46.52 -152.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.11 0.564 . . . . 0.0 111.99 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.905 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER 100.1 -165.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.374 1.47 . . . . 0.0 114.376 160.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.967 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.889 0 C-N-CA 125.041 1.337 . . . . 0.0 110.578 -172.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.58 36.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.693 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 pt? -160.71 140.02 10.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.943 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.053 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.5 mp -89.67 112.33 23.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.679 168.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.53 125.82 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.993 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -73.0 113.43 10.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -77.51 -55.94 4.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.014 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -141.53 129.27 21.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -177.38 178.58 48.31 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 97.0 Cg_exo -48.46 -48.41 17.31 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.948 2.432 . . . . 0.0 113.465 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.531 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 58.0 t30 -83.16 -52.72 6.36 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.97 171.21 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.5 -1.682 . . . . 0.0 112.796 -170.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.6 2.54 89.84 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.917 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.993 ' H ' HG22 ' A' ' 60' ' ' VAL . 3.4 m -98.01 177.76 5.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.626 0.713 . . . . 0.0 110.465 -171.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.19 151.96 3.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.102 0.41 . . . . 0.0 111.636 -176.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.692 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -94.95 134.05 38.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 71' ' ' LEU . 6.4 tt -87.05 93.85 9.47 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.734 HD23 ' CD1' ' A' ' 101' ' ' PHE . 4.1 mp -93.39 45.43 1.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -99.0 -28.22 13.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.131 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.52 HE21 HG22 ' A' ' 77' ' ' THR . 7.2 pt20 -92.59 -162.3 0.92 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.006 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.2 -51.5 20.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -158.89 139.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 111.949 -178.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 38.3 p -121.16 152.03 39.23 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.343 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.636 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 75.8 m -95.57 124.8 39.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -126.54 116.23 20.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -166.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 148.99 -85.94 0.16 Allowed Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.176 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HG2' ' OD1' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.67 104.03 11.29 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.617 0.722 . . . . 0.0 109.174 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.636 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.437 -1.096 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.023 -169.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 87' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.56 0 CA-C-O 121.323 0.583 . . . . 0.0 111.285 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.85 113.94 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.215 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.44 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -116.77 134.32 54.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.132 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.5 mm? -122.22 74.43 1.16 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.934 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.6 t70 72.49 -17.37 0.39 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.454 0.645 . . . . 0.0 110.592 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.595 ' OD1' ' HG2' ' A' ' 81' ' ' ARG . 35.0 t70 61.82 29.52 17.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.386 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.1 p -153.75 32.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.952 0.882 . . . . 0.0 109.821 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.552 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 65.3 p -132.81 -9.57 3.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.965 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG21 ' CA ' ' A' ' 80' ' ' GLY . 2.0 t -136.38 159.57 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.4 t -87.57 77.3 8.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 58.48 -59.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.929 -165.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 5.7 ptt85 -143.65 137.63 28.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.621 0.724 . . . . 0.0 111.066 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -75.02 -39.27 61.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 170.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -156.94 149.45 23.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' CD ' HH21 ' A' ' 102' ' ' ARG . 7.8 pt-20 -108.0 133.1 52.8 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.734 ' CD1' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -56.98 106.12 0.28 Allowed 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.559 HH21 ' CD ' ' A' ' 100' ' ' GLU . 21.1 tpp85 -103.16 104.04 14.15 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.62 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.3 tt -86.44 110.72 19.92 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.351 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.28 135.36 48.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 57.51 37.74 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.606 0.566 . . . . 0.0 110.329 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.872 ' HA ' HD21 ' A' ' 103' ' ' LEU . 21.1 m120 64.64 12.52 7.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.03 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.1 mt-10 -106.33 144.73 32.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.893 0.377 . . . . 0.0 111.396 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.441 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -95.9 126.29 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.384 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 11.0 m-80 -135.86 163.36 30.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 128' ' ' SER . 7.2 m -111.26 122.59 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.942 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 36.7 t -101.18 110.4 27.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.865 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 18.6 t70 -68.5 128.29 36.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.689 HG21 HH11 ' A' ' 97' ' ' ARG . 18.9 m -126.0 9.51 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.22 0.533 . . . . 0.0 109.734 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.62 71.77 0.59 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.307 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 39.3 t -67.11 134.98 52.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.688 HD11 HG22 ' A' ' 24' ' ' VAL . 1.8 tm? -52.83 -55.82 20.3 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.682 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -76.17 -37.33 58.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 109.825 172.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.73 163.85 9.9 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.15 -173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -111.69 137.41 49.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.394 0.678 . . . . 0.0 111.282 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.11 103.78 4.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.292 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.977 HG22 HG13 ' A' ' 137' ' ' VAL . 61.7 t -112.8 121.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 122.079 -0.388 . . . . 0.0 110.236 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.7 m120 61.29 36.91 17.5 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 63.66 22.11 12.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.477 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.59 148.48 25.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 121.028 0.442 . . . . 0.0 110.949 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.03 123.6 11.5 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.271 1.981 . . . . 0.0 111.78 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.49 155.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.7 0.286 . . . . 0.0 110.281 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.3 m-20 -87.54 -47.08 9.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.641 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.895 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.6 p -154.86 91.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.342 0.592 . . . . 0.0 110.733 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.61 132.85 47.05 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.367 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.1 p -76.06 149.63 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.629 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.837 HD11 HD11 ' A' ' 58' ' ' LEU . 8.7 mp -65.49 133.44 51.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.653 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.08 -176.32 3.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.859 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -93.81 103.78 15.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.36 0.124 . . . . 0.0 111.306 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.09 69.64 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.114 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.718 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 3.8 t0 -81.59 162.25 23.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.7 pt-20 -126.89 148.26 50.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -166.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.977 HG13 HG22 ' A' ' 121' ' ' VAL . 61.4 t -123.09 141.44 43.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.024 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.42 ' NE2' ' HA ' ' A' ' 141' ' ' LYS . 20.9 tm0? -106.67 131.12 54.17 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.971 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.48 140.32 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.784 174.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.3 -73.73 0.72 Allowed Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.344 170.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.063 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 52.1 pttt -172.3 29.13 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.078 0.466 . . . . 0.0 110.445 170.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -127.02 149.32 49.95 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -171.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.569 ' HD3' ' OE1' ' A' ' 136' ' ' GLU . 3.8 ttm180 -98.6 120.26 38.72 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.64 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 4.3 mp -108.16 162.77 13.76 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.575 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.05 137.08 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.053 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.96 154.29 20.29 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.732 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 131' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.316 -0.852 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.06 171.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.597 ' HB2' HG22 ' A' ' 93' ' ' THR . 41.9 m . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 117' ' ' ASN . 7.1 p -112.46 125.69 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.273 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' HB3' ' HE3' ' A' ' 141' ' ' LYS . 2.5 t80 176.52 -165.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.822 0.076 . . . . 0.0 110.937 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.591 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 1.2 tmm_? . . . . . 0 N--CA 1.481 1.096 0 C-N-CA 124.348 1.059 . . . . 0.0 112.484 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -126.86 169.66 13.02 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.568 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.5 pt? -153.19 131.92 12.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.015 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.7 mp -87.48 146.64 25.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.6 163.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.8 p -136.1 128.94 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.806 0.336 . . . . 0.0 110.383 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -74.37 115.15 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 18.8 tptp -76.5 -66.35 0.82 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 -172.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -138.92 132.93 31.16 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.978 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -178.05 -171.37 41.35 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 51.0 Cg_exo -53.87 -52.23 8.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.25 1.967 . . . . 0.0 112.893 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.4 t30 -81.36 -54.14 5.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.647 0.737 . . . . 0.0 109.262 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.674 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.1 170.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.03 -170.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.35 2.28 90.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.994 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.5 m -97.96 179.55 4.75 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 118.423 1.111 . . . . 0.0 110.966 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -166.25 153.02 9.36 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.3 0.5 . . . . 0.0 111.743 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.674 ' HE1' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.95 125.35 42.83 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.12 94.41 9.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.63 0.729 . . . . 0.0 109.481 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -91.37 54.79 2.63 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.776 0.798 . . . . 0.0 109.642 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -98.71 -26.61 14.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.007 171.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.466 ' HG2' HD23 ' A' ' 71' ' ' LEU . 13.2 pt20 -97.31 161.11 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.45 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -16.14 55.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -171.15 133.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 111.761 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 35.3 p -120.82 144.34 48.39 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.351 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 87' ' ' ILE . 74.4 m -89.96 124.64 34.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.15 123.38 47.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 141.84 -142.07 11.55 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.319 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.898 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.14 104.7 3.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.575 0.702 . . . . 0.0 110.066 174.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.506 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 41.4 m-70 . . . . . 0 N--CA 1.436 -1.136 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.289 -173.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.214 0.531 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.33 96.68 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -101.15 130.64 47.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.398 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 60' ' ' VAL . 3.8 mm? -115.93 80.64 1.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 37.7 t70 70.46 -10.12 0.72 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.824 0.702 . . . . 0.0 110.481 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.6 p-10 41.89 33.25 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.581 1.553 . . . . 0.0 113.16 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 t -138.69 -10.7 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.183 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.597 HG22 ' HB2' ' A' ' 23' ' ' SER . 30.4 p -103.29 -33.64 9.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.85 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.4 t -98.36 149.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 122.238 -0.289 . . . . 0.0 111.358 -170.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.437 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 6.7 t -74.44 77.02 1.92 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER 59.17 -75.68 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.149 -168.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.755 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -136.45 134.87 38.14 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -174.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -71.26 -45.7 62.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.69 -179.5 7.92 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.402 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.9 pt-20 -137.84 124.74 21.27 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.833 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -81.12 90.67 6.05 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.064 0.935 . . . . 0.0 108.82 -177.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' HG21 ' A' ' 111' ' ' VAL . 10.6 ptp180 -94.17 151.97 19.07 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.762 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.0 tt -89.1 105.95 18.12 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.457 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 54.3 mm-40 -115.52 133.96 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 1.5 p30 48.74 33.44 4.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.692 0.797 . . . . 0.0 111.477 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.861 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.9 m-20 75.92 21.99 1.52 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.663 175.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.81 142.32 40.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.655 ' C ' HD22 ' A' ' 109' ' ' ASN . 7.0 m-85 -84.58 137.64 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -175.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.833 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -141.38 160.56 39.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -171.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -103.7 116.71 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.724 177.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 45.3 t -99.21 111.38 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.36 127.36 30.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.338 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 97' ' ' ARG . 10.4 m -127.36 -37.28 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 167.46 76.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.959 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 48.3 t -88.28 122.22 31.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.9 -55.58 19.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -170.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.643 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 7.4 t30 -74.86 -34.91 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.0 110.454 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.49 160.67 9.32 Favored Glycine 0 C--O 1.247 0.95 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.001 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' HE1' ' A' ' 98' ' ' HIS . 17.7 m -112.47 122.34 47.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.282 0.633 . . . . 0.0 111.073 171.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 126.13 28.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 1.013 HG22 HG13 ' A' ' 137' ' ' VAL . 75.5 t -124.91 119.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 61.31 37.17 17.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.7 19.27 10.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.104 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -143.26 145.08 30.9 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.736 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.8 122.87 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.358 2.039 . . . . 0.0 111.113 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 17.7 m -115.17 176.73 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 13.6 t70 -109.66 -41.94 4.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.525 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.877 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 10.1 p -165.16 91.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.886 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -92.17 145.3 24.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.001 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.59 135.64 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -46.51 129.09 10.76 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.022 174.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -135.45 -174.75 3.72 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -106.56 113.15 26.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.356 0.598 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.63 -5.62 84.69 Favored Glycine 0 C--N 1.32 -0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.908 170.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -88.02 154.66 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER -112.15 149.0 32.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 121' ' ' VAL . 60.7 t -124.9 141.4 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.721 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.0 tm0? -109.18 130.8 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.328 0.585 . . . . 0.0 110.42 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -125.09 130.55 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 67.18 -91.23 0.19 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.023 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.977 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 19.6 ptmt -147.23 14.19 1.12 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.8 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -111.03 157.81 19.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -105.48 112.96 26.26 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.871 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -107.78 156.69 18.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.542 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.23 143.56 29.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.015 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.37 150.04 27.17 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.685 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.6 mm? . . . . . 0 C--O 1.235 0.338 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.177 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 27.8 m . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.703 ' HB ' HD23 ' A' ' 116' ' ' LEU . 10.0 p -130.2 149.42 33.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.077 -171.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.7 t80 177.34 -146.36 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.017 -173.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.782 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.3 tpt180 . . . . . 0 N--CA 1.482 1.132 0 C-N-CA 123.406 0.683 . . . . 0.0 110.972 171.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.81 167.32 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.09 142.52 11.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 mp -86.51 114.02 22.91 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.092 166.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 68' ' ' SER . 4.2 p -109.62 128.39 65.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.621 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.56 109.89 4.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -65.53 -60.68 2.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.914 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 62' ' ' ARG . 27.5 mtm-85 -150.95 109.56 3.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.132 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -134.36 -147.55 5.62 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.033 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 72.8 Cg_endo -75.44 -48.99 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.232 1.955 . . . . 0.0 111.911 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.633 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 50.8 t30 -74.36 -49.69 21.74 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 59.31 154.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.56 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.62 1.38 90.14 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.7 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.903 ' H ' HG22 ' A' ' 60' ' ' VAL . 15.6 t -88.36 -178.3 5.85 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.863 0.832 . . . . 0.0 109.896 -174.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.648 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -173.26 150.32 1.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.44 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -95.16 127.19 41.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 172.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -83.28 91.5 7.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.966 0.791 . . . . 0.0 109.249 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.802 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 mp -86.12 53.93 2.96 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.0 109.688 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 22.9 t70 -113.47 -25.72 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.046 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 74' ' ' GLN . 22.3 mt-30 -86.44 -167.54 1.91 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.328 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.07 35.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.781 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.11 134.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.608 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 7.6 p -119.68 128.33 53.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.9 m -74.93 125.26 28.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -120.57 108.22 13.79 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -170.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.844 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.08 -146.96 12.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.335 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -69.24 107.63 3.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.604 0.716 . . . . 0.0 109.56 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.567 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 61.5 m-70 . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.968 -174.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.463 0.216 0 CA-C-O 121.513 0.673 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -120.68 113.01 38.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.167 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.448 ' HD2' ' O ' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -104.05 127.2 51.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.247 -174.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 3.2 mm? -114.77 76.22 0.98 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 9.5 t70 66.53 -0.77 1.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.543 0.687 . . . . 0.0 109.641 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.9 p-10 40.62 30.03 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.749 1.62 . . . . 0.0 113.389 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.1 p -166.19 59.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 110.973 172.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.67 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 3.0 p -143.93 -13.99 0.63 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.149 0.5 . . . . 0.0 110.803 170.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -140.84 141.83 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.9 m -64.78 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.118 0.567 . . . . 0.0 112.104 -173.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.795 ' HD3' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 68.53 -63.08 0.36 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 -177.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.844 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -154.83 132.99 11.71 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.656 -0.653 . . . . 0.0 111.839 175.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -63.24 -43.56 97.71 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.757 176.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -155.82 174.56 15.14 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.921 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.8 pt-20 -135.74 128.9 31.75 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.802 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -54.66 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 124.477 1.11 . . . . 0.0 108.117 -178.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 14.0 ttm180 -98.97 105.84 18.03 Favored 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.454 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.5 tt -80.24 105.11 11.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.604 0.716 . . . . 0.0 109.575 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 37.3 mt-10 -129.25 135.66 49.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.637 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 52.9 m-80 62.1 33.47 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.122 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.763 ' HA ' HD21 ' A' ' 103' ' ' LEU . 73.7 m-20 70.94 4.14 4.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.825 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.0 mm-40 -103.47 144.82 30.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -91.24 125.65 36.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 21.1 m-80 -131.18 163.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.619 0.247 . . . . 0.0 111.183 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -105.27 124.44 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 68.3 t -108.9 110.41 31.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.806 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.0 125.62 26.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.559 0.537 . . . . 0.0 109.722 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.53 -27.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.39 83.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.576 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.911 ' HA ' HG23 ' A' ' 94' ' ' VAL . 37.2 t -108.6 120.46 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.703 HD23 ' HB ' ' A' ' 24' ' ' VAL . 58.4 tp -53.16 -56.27 17.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.683 ' ND2' HE22 ' A' ' 138' ' ' GLN . 0.4 OUTLIER -63.44 -34.76 78.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.49 0.662 . . . . 0.0 109.641 177.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.75 169.49 12.37 Favored Glycine 0 C--O 1.253 1.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.145 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 m -112.02 117.33 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.761 0.424 . . . . 0.0 110.917 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -127.72 106.82 9.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.864 HG22 HG23 ' A' ' 137' ' ' VAL . 21.2 t -101.88 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.664 ' ND2' HG12 ' A' ' 121' ' ' VAL . 25.4 m-80 65.06 44.23 3.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 109.319 -174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 63.44 13.25 6.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.004 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 9.9 pt-20 -133.89 131.4 20.98 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-O 121.344 0.592 . . . . 0.0 110.804 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 16.4 Cg_exo -67.81 123.21 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.783 2.322 . . . . 0.0 112.257 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 129' ' ' ALA . 14.2 m -121.76 165.1 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 2.8 m-20 -108.38 -24.81 11.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.758 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 21.5 p -164.52 91.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.441 0.639 . . . . 0.0 109.59 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -110.22 148.41 31.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.355 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.62 127.63 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.086 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -63.32 162.9 11.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -166.33 160.83 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.297 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -60.14 100.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.132 0.492 . . . . 0.0 111.369 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.72 4.38 36.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.727 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.52 119.74 20.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 5.0 tt0 -106.73 134.25 50.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.666 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.962 HG12 ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -117.68 142.22 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.683 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -111.72 115.59 29.34 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.67 ' HB ' ' CB ' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -123.83 129.47 74.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.507 175.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.32 -68.21 1.78 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.066 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.033 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 17.7 ptmt -173.7 31.36 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 116.953 0.377 . . . . 0.0 110.712 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.71 149.95 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -172.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -103.12 100.87 10.82 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.7 mp -96.12 157.85 15.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.75 141.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.292 169.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 43.7 t80 -97.81 136.85 37.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.248 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.449 -0.5 0 CA-C-O 121.524 0.678 . . . . 0.0 110.958 170.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.616 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 48.6 m . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 6.8 t -101.91 146.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.656 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.8 t80 172.13 -159.11 0.01 OUTLIER 'General case' 0 C--N 1.35 0.592 0 O-C-N 123.603 0.564 . . . . 0.0 110.751 171.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 C-N-CA 124.512 1.125 . . . . 0.0 112.691 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 m . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.64 168.34 16.6 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.19 147.77 12.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.631 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 131' ' ' LEU . 2.5 mp -86.42 144.32 27.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -123.19 133.02 70.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.012 0.434 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.695 ' HB ' ' H ' ' A' ' 68' ' ' SER . 79.1 t -65.57 105.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 145' ' ' VAL . 59.0 tttm -70.4 -47.49 60.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.762 1.289 . . . . 0.0 110.151 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -165.78 144.55 6.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.576 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -173.67 -157.83 16.33 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 13.9 Cg_exo -67.22 -48.81 1.55 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 119.481 1.64 . . . . 0.0 111.723 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -77.63 -53.51 7.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.009 173.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.614 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.14 160.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.109 -172.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.4 2.02 90.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.564 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.695 ' H ' ' HB ' ' A' ' 60' ' ' VAL . 6.7 m -88.69 -172.42 3.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.226 0.513 . . . . 0.0 111.362 -173.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.05 152.51 2.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.962 0.346 . . . . 0.0 111.787 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.913 ' HD1' ' HB2' ' A' ' 58' ' ' LEU . 1.5 m-85 -98.2 116.95 31.5 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -78.04 90.13 4.2 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.705 0.764 . . . . 0.0 109.453 -174.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 58' ' ' LEU . 15.4 mt -82.75 59.46 4.78 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.573 0.701 . . . . 0.0 109.955 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -117.01 -26.87 6.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.645 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -98.67 177.64 5.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.84 97.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -157.56 135.8 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 43.2 p -109.91 140.37 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.665 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 37.0 m -88.31 124.23 33.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -123.21 119.9 31.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.515 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 150.2 -138.29 6.64 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.9 tmm_? -71.5 104.37 3.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 109.85 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.539 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 55.3 m-70 . . . . . 0 N--CA 1.438 -1.045 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.027 -174.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.428 ' HB2' HG22 ' A' ' 87' ' ' ILE . 3.2 m-20 . . . . . 0 N--CA 1.467 0.391 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -130.36 91.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 122.087 0.946 . . . . 0.0 110.987 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -95.41 134.19 38.51 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.269 174.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.019 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.5 mm? -122.03 77.54 1.39 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.768 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 24.6 t0 66.01 -3.76 0.73 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.6 p30 43.69 25.65 0.1 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.372 1.469 . . . . 0.0 113.817 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 23' ' ' SER . 10.8 p -147.43 45.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.32 1.057 . . . . 0.0 110.222 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.673 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.97 -0.6 0.31 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.045 172.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.667 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -135.64 143.15 37.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.9 t -78.29 73.0 4.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER 67.24 -58.47 0.41 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.672 0.749 . . . . 0.0 110.114 -171.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.61 ' HD2' HG11 ' A' ' 113' ' ' VAL . 22.5 ttm180 -146.18 125.28 12.88 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.879 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.776 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -67.18 -46.07 75.07 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -169.98 160.09 8.09 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.869 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.3 pt-20 -112.66 117.97 33.75 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.862 ' CZ ' ' HB ' ' A' ' 110' ' ' VAL . 4.4 m-85 -76.37 95.33 3.78 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.124 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -103.05 148.62 25.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.408 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.2 tt -91.73 117.54 29.85 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -142.88 135.68 27.9 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 48.8 m-80 62.45 32.35 16.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.683 0.615 . . . . 0.0 110.094 -172.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.71 ' HA ' HD21 ' A' ' 103' ' ' LEU . 5.1 t30 74.84 -1.29 3.12 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.085 0.865 . . . . 0.0 112.341 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 1.5 mm-40 -109.13 147.19 32.85 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.086 -0.383 . . . . 0.0 109.977 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 103' ' ' LEU . 12.9 m-85 -88.89 130.96 35.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 130' ' ' VAL . 13.1 m-80 -140.34 162.63 34.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.0 OUTLIER -107.09 122.02 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.37 172.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 128' ' ' SER . 26.8 t -101.93 110.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.999 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 24.9 t0 -59.28 144.03 47.52 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.867 0.729 . . . . 0.0 109.713 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.61 HG11 ' HD2' ' A' ' 97' ' ' ARG . 1.2 t -142.44 -32.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.824 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.93 103.35 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.723 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 44.2 t -110.23 145.7 36.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.902 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 24' ' ' VAL . 18.1 tp -58.81 -55.77 30.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.544 0.611 . . . . 0.0 111.675 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 59.2 m-80 -61.37 -38.06 85.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.238 0.542 . . . . 0.0 110.327 177.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.18 167.43 11.52 Favored Glycine 0 C--O 1.246 0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.97 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 ' HE1' ' A' ' 98' ' ' HIS . 16.0 m -111.66 133.63 53.78 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.004 0.522 . . . . 0.0 111.225 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 23.2 m-85 -140.73 131.19 25.31 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.848 173.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.853 HG22 HG13 ' A' ' 137' ' ' VAL . 77.4 t -127.91 113.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.0 42.01 16.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.813 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.64 -2.03 2.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.902 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.4 pt-20 -134.03 141.98 41.64 Favored Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 121.747 -0.596 . . . . 0.0 111.204 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 9.7 Cg_exo -70.83 121.99 8.41 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.11 1.874 . . . . 0.0 111.689 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.84 178.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.58 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 21.9 t70 -93.41 -64.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.864 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 5.8 p -146.77 92.9 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.231 0.538 . . . . 0.0 109.91 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.99 143.55 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.631 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.521 HG22 ' OD1' ' A' ' 109' ' ' ASN . 3.3 t -84.26 135.85 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.187 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -62.18 161.5 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -158.56 154.67 27.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.25 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.96 97.72 0.69 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.78 4.81 29.74 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.84 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 19.4 t70 -72.87 150.96 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.1 tt0 -141.32 133.39 27.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.467 0.651 . . . . 0.0 111.421 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG13 HG22 ' A' ' 121' ' ' VAL . 48.0 t -129.13 141.64 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.373 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -109.84 121.02 44.27 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.019 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.38 140.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 57.95 -109.79 2.05 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.04 -1.552 . . . . 0.0 109.274 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.812 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 1.8 pttm -136.3 34.03 2.79 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.907 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.732 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -114.96 150.81 35.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 143' ' ' ARG . 14.1 ttm180 -102.19 106.45 17.29 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 60' ' ' VAL . 2.0 mp -110.29 150.86 28.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.715 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.35 144.2 28.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.823 ' HB2' ' HG ' ' A' ' 58' ' ' LEU . 84.5 t80 -94.22 125.79 39.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.985 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? . . . . . 0 N--CA 1.444 -0.733 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.223 169.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 93' ' ' THR . 17.9 m . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.02 134.33 41.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.388 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 42.7 t80 176.51 176.08 0.31 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.051 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.5 tpt180 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 159.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.07 170.03 11.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 72' ' ' LEU . 2.1 pt? -155.5 133.03 11.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.066 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.3 mp -85.49 128.43 34.73 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.631 163.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -110.88 125.6 68.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.231 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.865 HG22 ' HG ' ' A' ' 144' ' ' LEU . 67.9 t -65.57 104.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 52.1 tttp -73.45 -57.25 4.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 124.23 0.956 . . . . 0.0 109.873 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -153.34 131.19 11.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.971 0.891 . . . . 0.0 110.944 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -168.78 -162.35 20.75 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.09 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 40.5 Cg_exo -59.37 -56.33 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 119.401 1.601 . . . . 0.0 112.669 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 59.8 t30 -70.01 -52.57 23.06 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.645 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.05 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.252 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.72 1.04 90.04 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.979 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.748 ' HB2' HG21 ' A' ' 60' ' ' VAL . 18.7 m -85.38 -167.93 2.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.584 0.692 . . . . 0.0 111.542 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.73 ' HD2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -170.23 154.74 5.02 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -175.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -95.39 125.1 39.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.668 ' O ' HG21 ' A' ' 77' ' ' THR . 1.1 tm? -84.48 98.27 10.01 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HG ' ' HD2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.12 51.61 1.03 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.454 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 11.3 t70 -95.68 -19.38 19.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.149 169.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.16 166.58 13.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.85 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.31 63.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.183 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 102' ' ' ARG . 3.2 tp -168.99 130.03 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.76 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.668 HG21 ' O ' ' A' ' 71' ' ' LEU . 22.9 p -123.68 146.91 47.89 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.081 -176.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 87' ' ' ILE . 23.4 m -82.13 125.2 30.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.533 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.04 128.39 54.31 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.18 -132.1 6.1 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.525 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.982 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -80.31 103.93 10.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.666 0.746 . . . . 0.0 109.905 174.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 67.1 m-70 . . . . . 0 C--N 1.31 -1.131 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.971 -176.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 28.3 m-20 . . . . . 0 N--CA 1.467 0.377 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.713 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -109.06 98.96 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 0.0 111.354 -171.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -103.65 128.13 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.29 178.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.781 HD12 ' CD2' ' A' ' 142' ' ' PHE . 3.3 mm? -120.03 86.91 2.65 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.208 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 17.1 t70 69.5 -7.74 0.82 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 0.0 109.611 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.762 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 p-10 37.9 34.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.034 1.734 . . . . 0.0 113.749 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.99 0.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.433 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' SER . 1.6 p -104.58 -25.53 12.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.823 -0.548 . . . . 0.0 111.658 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.9 t -105.12 150.18 8.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -172.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 114' ' ' GLY . 6.3 t -75.49 72.67 2.5 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.982 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 7.8 ttt180 56.53 -62.37 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.328 -165.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -141.25 127.6 19.86 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.802 -1.186 . . . . 0.0 112.178 -171.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.858 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.13 -45.04 24.35 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -144.23 174.52 10.82 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.104 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.716 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.7 pt-20 -138.09 120.13 15.54 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.078 -1.874 . . . . 0.0 106.072 166.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.751 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.4 93.16 5.93 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.654 0.74 . . . . 0.0 109.55 -171.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.759 ' HB3' HD13 ' A' ' 76' ' ' ILE . 9.3 ptp180 -92.61 134.51 34.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.525 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.707 HD12 ' CE2' ' A' ' 108' ' ' PHE . 6.3 tt -85.23 114.08 22.06 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -124.5 139.86 53.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.83 39.7 1.81 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.902 0.751 . . . . 0.0 112.229 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HA ' HD21 ' A' ' 103' ' ' LEU . 8.0 t30 75.23 13.9 3.1 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 112.429 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 2.3 mp0 -120.87 140.87 51.19 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.922 -0.486 . . . . 0.0 110.413 172.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.707 ' CE2' HD12 ' A' ' 103' ' ' LEU . 2.1 m-85 -89.25 139.92 30.0 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 32.8 m-80 -143.49 155.98 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.963 -170.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -103.49 120.74 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.634 0.731 . . . . 0.0 110.839 179.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 113' ' ' VAL . 2.3 t -99.8 118.05 45.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.957 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.14 119.07 19.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.764 HG13 HG12 ' A' ' 111' ' ' VAL . 5.8 m -121.54 -53.03 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . -171.19 79.02 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.118 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 32.4 t -91.75 122.64 34.48 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 16.0 tp -61.78 -54.13 46.51 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.961 -175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 24.2 m-80 -65.92 -38.77 89.56 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 141.37 157.36 7.14 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.43 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.454 HG23 ' CE1' ' A' ' 98' ' ' HIS . 16.6 m -111.6 125.63 54.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.602 0.361 . . . . 0.0 110.851 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 65.8 m-85 -139.74 105.53 5.16 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.88 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 137' ' ' VAL . 83.4 t -101.77 122.75 54.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 172.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 63.71 33.34 13.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 14.8 mtp-105 52.28 37.78 23.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.803 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.94 139.44 13.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.116 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 122.7 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.014 1.81 . . . . 0.0 111.278 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -114.49 178.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.914 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 18.5 t70 -96.71 -58.88 1.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.115 0.483 . . . . 0.0 109.844 174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.857 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 41.8 t -155.81 91.21 1.27 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.051 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.36 149.71 21.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.699 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.73 136.88 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.681 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 146' ' ' PHE . 2.6 tt -56.11 106.67 0.29 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.953 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.29 124.37 24.33 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.823 0.344 . . . . 0.0 111.358 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . 0.451 ' HA ' HD13 ' A' ' 147' ' ' LEU . 3.4 m-20 -54.23 123.93 14.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.84 24.88 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.619 168.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.8 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 1.7 t70 -97.26 165.89 11.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.619 0.71 . . . . 0.0 110.555 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.4 pp20? -116.12 156.99 25.46 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.813 0.816 . . . . 0.0 113.023 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 121' ' ' VAL . 68.5 t -131.8 130.08 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.253 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 113.76 25.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.072 0.463 . . . . 0.0 110.249 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.858 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -113.19 124.58 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.223 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 64.8 -108.13 2.18 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.476 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.09 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 7.8 pttt -134.93 21.08 3.5 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.597 0.713 . . . . 0.0 111.354 -174.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.781 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -113.04 143.99 43.37 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -95.65 102.87 14.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.865 ' HG ' HG22 ' A' ' 60' ' ' VAL . 5.1 mp -95.78 161.42 14.02 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.535 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.5 HG22 ' CD2' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -140.23 139.46 36.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 172.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.066 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.45 130.67 49.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD2' HG22 ' A' ' 145' ' ' VAL . 2.6 mm? . . . . . 0 C--O 1.232 0.177 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.76 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 18.8 m . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 116' ' ' LEU . 9.5 p -129.73 154.91 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.876 -0.515 . . . . 0.0 112.189 -173.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.6 t80 179.68 -156.51 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.699 0 C-N-CA 123.183 0.593 . . . . 0.0 110.274 175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -129.14 172.67 11.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.814 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.9 pp -161.07 140.08 10.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.7 mp -85.66 111.28 19.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.4 125.56 59.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.018 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -71.04 110.63 4.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' HG13 ' A' ' 145' ' ' VAL . 2.9 tpmt? -64.28 -65.58 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.063 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 62' ' ' ARG . 36.4 mtt-85 -146.54 134.75 21.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.831 0.824 . . . . 0.0 110.451 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.762 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.11 -159.7 17.83 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.126 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.4 Cg_exo -62.97 -57.94 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.96 1.773 . . . . 0.0 112.595 178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.634 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 53.9 t30 -73.04 -53.0 12.26 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.762 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.18 165.28 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.317 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.33 3.17 90.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.061 170.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -100.73 -170.32 1.84 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 117.729 0.765 . . . . 0.0 111.033 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -171.7 154.46 3.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.19 0.45 . . . . 0.0 112.042 -170.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -95.79 121.6 37.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 165.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -79.89 92.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.681 0.753 . . . . 0.0 109.469 -176.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.814 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 5.6 mt -85.23 51.4 2.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.367 0.603 . . . . 0.0 109.507 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.523 ' HB3' HD21 ' A' ' 71' ' ' LEU . 22.6 t70 -104.03 -22.18 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.487 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -104.29 -165.54 1.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.018 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.42 -39.85 45.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.793 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.64 133.1 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 111.534 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 70.7 p -111.29 143.94 41.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.762 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 87' ' ' ILE . 44.6 m -80.57 123.46 28.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 171.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.728 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.83 113.37 19.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 139' ' ' ILE . . . 149.89 -136.96 5.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.731 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.4 104.64 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 75.1 m-70 . . . . . 0 N--CA 1.439 -0.99 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.807 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 8.7 m-20 . . . . . 0 CA--C 1.521 -0.154 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.64 105.59 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.24 178.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -108.16 116.66 32.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.293 176.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.018 HD21 HG11 ' A' ' 60' ' ' VAL . 12.5 mt -102.67 87.57 3.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.635 177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 25.7 t70 66.88 -2.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.344 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.71 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p30 40.65 36.44 0.39 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.189 1.396 . . . . 0.0 113.418 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' SER . 11.9 p -168.64 44.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.421 173.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.703 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -138.11 -5.16 1.67 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.13 -0.981 . . . . 0.0 111.987 176.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -143.16 146.53 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.364 -173.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.2 m -66.5 77.35 0.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.811 0.445 . . . . 0.0 112.062 -174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HD3' ' HE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER 64.09 -70.02 0.08 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 123.425 0.69 . . . . 0.0 110.79 -174.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 ptp180 -140.41 130.68 25.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.801 -0.562 . . . . 0.0 110.737 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 1.092 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.83 -41.01 45.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.873 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.58 164.23 30.78 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.928 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.7 pt-20 -129.54 125.7 36.89 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.42 99.23 0.1 Allowed 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 100' ' ' GLU . 15.9 tpp85 -90.45 96.65 10.76 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.975 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -83.78 104.71 14.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.51 138.24 46.01 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 37.5 m-80 62.3 31.89 17.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 -173.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' HD21 ' A' ' 103' ' ' LEU . 7.4 t30 72.58 0.67 3.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.487 0.715 . . . . 0.0 111.831 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 28.2 mm-40 -104.69 139.67 39.18 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.934 -0.479 . . . . 0.0 111.021 -174.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.568 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.29 125.35 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.513 HD22 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -126.04 162.04 26.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.336 -178.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.4 m -106.71 124.82 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 9.2 t -101.77 112.52 35.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.32 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 14.1 t70 -74.31 116.4 14.92 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.57 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.812 HG13 HG12 ' A' ' 111' ' ' VAL . 27.0 m -124.67 -20.7 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.409 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.21 94.31 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.667 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 1.092 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.3 t -108.64 128.85 55.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 24' ' ' VAL . 44.3 tp -54.55 -54.37 42.19 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.408 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -65.67 -35.97 82.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.492 0.663 . . . . 0.0 109.3 175.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.29 170.19 12.59 Favored Glycine 0 C--O 1.257 1.537 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.52 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 98' ' ' HIS . 34.7 m -112.59 122.48 47.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.485 -0.857 . . . . 0.0 110.967 174.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 62.5 m-85 -136.59 103.05 5.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 173.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.736 ' HB ' HG13 ' A' ' 137' ' ' VAL . 2.6 p -102.95 110.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.631 HD22 HG22 ' A' ' 121' ' ' VAL . 30.6 m-80 68.7 37.64 2.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.499 -171.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 60.84 26.91 16.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.8 pt-20 -139.4 140.92 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.566 173.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 5.6 Cg_exo -79.86 123.42 5.21 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.223 2.616 . . . . 0.0 111.306 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 129' ' ' ALA . 34.3 m -118.6 -179.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 111.49 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 28.3 t70 -100.76 -50.33 3.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.77 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 42.1 t -158.03 91.55 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.233 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -94.15 138.97 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.22 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.71 129.56 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.823 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.618 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -62.57 161.42 12.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.294 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 135' ' ' ASP . . . -160.2 156.11 26.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.81 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -65.77 104.0 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.3 5.75 48.86 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 16.3 t70 -83.82 118.12 23.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.958 0.103 . . . . 0.0 110.795 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 53.7 mp0 -94.57 139.6 30.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.266 0.555 . . . . 0.0 112.343 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 121' ' ' VAL . 16.4 t -127.72 132.22 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.736 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.431 HE22 ' C ' ' A' ' 141' ' ' LYS . 54.8 tp60 -95.04 123.44 38.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.99 0.424 . . . . 0.0 110.353 174.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.742 HG12 HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.76 140.16 49.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 69.37 -72.62 0.45 Allowed Glycine 0 C--O 1.216 -0.987 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.865 167.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.126 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 15.9 ptmt -170.49 16.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.278 0.539 . . . . 0.0 110.276 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.703 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -118.82 147.18 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.182 -169.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -96.02 105.92 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.9 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.5 mp -98.42 153.7 18.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.978 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 1.9 m -141.42 145.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.661 ' CE1' ' HB1' ' A' ' 56' ' ' ALA . 63.4 t80 -97.24 134.52 40.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 146' ' ' PHE . 1.5 mm? . . . . . 0 C--N 1.332 -0.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.741 166.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 93' ' ' THR . 8.4 m . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.765 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.3 p -136.64 155.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -177.92 -147.61 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.995 0 C-N-CA 123.186 0.594 . . . . 0.0 109.926 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -125.95 172.69 9.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 3.3 pp -160.31 140.55 11.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.4 mp -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.152 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 68' ' ' SER . 3.3 p -103.13 125.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.212 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.967 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.07 114.69 9.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -68.87 -69.72 0.31 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.331 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -147.54 131.07 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.406 0.622 . . . . 0.0 110.268 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.707 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -176.13 -150.16 7.95 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.028 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.5 Cg_exo -62.07 -64.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.284 1.989 . . . . 0.0 112.867 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 54.9 t30 -76.31 -52.51 9.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 52.9 169.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.5 -172.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.24 90.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.011 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.967 ' H ' HG22 ' A' ' 60' ' ' VAL . 10.3 m -94.66 -178.03 4.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.34 0.57 . . . . 0.0 110.838 -170.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -169.14 149.25 4.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.259 0.481 . . . . 0.0 111.726 -173.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.497 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -94.35 121.9 36.36 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -79.86 94.58 5.86 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -175.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 101' ' ' PHE . 6.0 mt -90.04 46.59 1.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.867 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.466 ' HB3' HD11 ' A' ' 71' ' ' LEU . 7.8 t70 -99.34 -24.12 14.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.277 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.57 HE21 HG22 ' A' ' 77' ' ' THR . 21.4 pt20 -102.33 -166.65 1.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.531 178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.24 -37.63 60.95 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.419 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -159.99 131.47 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 11.3 p -119.12 127.21 53.14 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.375 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 87' ' ' ILE . 66.5 m -76.45 132.7 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -126.27 120.98 31.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.11 -127.89 2.61 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.1 tmm_? -73.82 105.77 5.25 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.903 0.859 . . . . 0.0 109.612 175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.159 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.465 -169.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.47 0.531 0 CA-C-O 121.378 0.609 . . . . 0.0 111.653 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.707 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.46 110.11 20.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.89 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -110.63 132.27 54.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.341 -178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.943 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.4 mm? -119.85 78.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.614 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 36.0 t0 68.75 -6.34 0.87 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.508 0.67 . . . . 0.0 109.93 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.4 p-10 41.89 32.86 0.3 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.422 1.489 . . . . 0.0 113.258 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.7 p -144.91 8.06 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.089 -179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.511 HG21 ' HD3' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -124.19 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.391 -177.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.653 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.3 t -109.16 152.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -173.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.3 m -77.2 66.25 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 0.0 110.454 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HE ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 67.43 -56.51 0.45 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.976 -173.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.567 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -146.54 147.04 30.74 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.78 0.8 . . . . 0.0 110.64 175.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB2' ' OG ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -90.53 -40.75 11.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.912 170.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.855 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -151.15 142.62 23.48 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.58 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.5 pt-20 -109.72 120.83 43.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.705 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.92 104.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.537 -174.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 10.4 tpp180 -96.01 107.12 19.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.662 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.85 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.7 tt -89.27 107.28 18.97 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.796 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 102' ' ' ARG . 34.8 mt-10 -128.53 137.76 51.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.074 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 57.19 34.11 24.32 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.49 . . . . 0.0 110.314 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.85 ' HA ' HD21 ' A' ' 103' ' ' LEU . 19.5 t-20 61.29 33.37 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.159 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.6 mt-10 -125.28 135.07 52.13 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.745 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -86.75 120.19 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -122.64 159.77 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.0 m -107.77 127.86 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.581 173.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.855 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.1 t -100.37 111.09 28.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.342 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 12.4 t70 -76.65 114.06 14.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.567 HG21 ' HG2' ' A' ' 97' ' ' ARG . 24.1 m -105.24 -20.21 6.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.34 0.59 . . . . 0.0 110.331 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.32 91.93 0.88 Allowed Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.442 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.684 ' OG ' ' HB2' ' A' ' 98' ' ' HIS . 0.7 OUTLIER -80.4 162.16 24.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.765 HD23 ' HB ' ' A' ' 24' ' ' VAL . 50.3 tp -61.68 -55.47 30.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.564 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.445 ' HB3' ' CG2' ' A' ' 24' ' ' VAL . 18.6 p-10 -69.02 -37.6 78.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.246 0.546 . . . . 0.0 110.301 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 127.24 169.98 12.79 Favored Glycine 0 C--O 1.254 1.374 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.845 -172.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.2 m -112.1 136.58 51.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.632 0.773 . . . . 0.0 111.118 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.4 m-85 -138.05 104.68 5.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 137' ' ' VAL . 47.2 t -94.52 105.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.69 HD22 HG12 ' A' ' 121' ' ' VAL . 20.4 m-80 56.61 43.03 26.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER 76.82 -6.9 1.94 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.969 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.6 pt-20 -119.2 123.92 28.52 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.339 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 17.1 Cg_exo -67.62 123.15 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.645 2.23 . . . . 0.0 111.695 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.68 175.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.802 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 31.5 t70 -96.1 -45.81 6.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.879 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.1 t -162.77 105.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.82 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.56 136.33 50.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.332 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.57 129.39 33.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.372 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.648 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -63.9 159.89 18.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.043 177.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -161.44 152.61 18.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.26 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -64.45 105.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.169 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.33 4.32 35.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.604 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.81 136.17 34.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.7 tt0 -122.52 134.01 54.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 111.432 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 121' ' ' VAL . 24.8 t -129.61 141.28 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.159 -174.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.514 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 53.3 tp60 -99.4 128.19 45.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.391 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 0.943 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -135.0 138.38 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.606 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 73.72 -69.08 1.52 Allowed Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.468 165.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.028 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.9 ptmt -176.38 16.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -117.4 149.95 39.68 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.817 -171.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -92.99 129.2 38.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.2 mp -124.04 152.57 42.49 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.804 0.335 . . . . 0.0 111.743 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.73 143.58 26.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.99 170.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.673 ' O ' HD13 ' A' ' 147' ' ' LEU . 45.8 t80 -100.87 136.58 40.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.892 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.58 170.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 93' ' ' THR . 15.2 m . . . . . 0 N--CA 1.469 0.501 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.686 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.7 p -144.28 168.68 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.047 -169.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 9.3 t80 171.91 -147.0 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.772 0 O-C-N 123.922 0.764 . . . . 0.0 110.554 174.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.4 m . . . . . 0 N--CA 1.448 -0.525 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 131' ' ' LEU . . . -124.59 170.64 10.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -159.87 137.1 9.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.75 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.078 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.08 111.41 20.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.275 161.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 p -108.73 128.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.444 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -72.19 109.01 4.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 35.0 ttpt -61.96 -60.55 3.46 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.511 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -149.93 115.47 5.53 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.506 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -144.9 -166.15 11.49 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 23.0 Cg_exo -64.3 -46.6 7.41 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.698 1.599 . . . . 0.0 111.572 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.819 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 41.7 t30 -74.69 -50.43 17.63 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.598 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 56.05 155.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.633 -1.622 . . . . 0.0 113.359 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.09 2.42 90.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.11 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -88.22 -179.83 6.23 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 117.397 0.598 . . . . 0.0 109.996 -171.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.86 151.78 3.48 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.861 0.755 . . . . 0.0 112.107 -173.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.759 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -93.94 125.49 38.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.58 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.1 tm? -80.9 94.89 6.58 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.805 HD22 ' CG ' ' A' ' 101' ' ' PHE . 5.2 mt -91.52 50.75 1.77 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.711 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' HD11 ' A' ' 71' ' ' LEU . 23.7 t70 -104.79 -21.88 13.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.923 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.434 HE21 HG22 ' A' ' 77' ' ' THR . 9.9 pt20 -103.29 -167.78 1.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.0 59.48 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.747 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.72 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.78 130.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.496 HG22 ' OD2' ' A' ' 86' ' ' ASP . 22.3 p -118.99 132.03 56.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.361 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.6 m -73.99 126.33 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -118.5 116.34 26.46 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 157.94 -139.58 6.45 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.21 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.51 104.1 8.89 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.568 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 68.1 m-70 . . . . . 0 C--N 1.315 -0.933 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.291 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 16.8 m-20 . . . . . 0 CA--C 1.518 -0.272 0 CA-C-O 121.029 0.442 . . . . 0.0 111.446 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -114.2 100.0 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.808 0.814 . . . . 0.0 111.755 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.93 134.41 50.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.366 173.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.015 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.9 mm? -115.21 73.15 0.82 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.5 t70 68.23 -5.01 0.95 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.544 0.688 . . . . 0.0 110.175 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.0 p-10 38.06 42.42 0.46 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.647 1.579 . . . . 0.0 113.133 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 23' ' ' SER . 18.5 t -142.81 -11.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -113.09 -12.16 13.22 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -170.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.9 OUTLIER -135.64 150.88 29.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.872 -0.518 . . . . 0.0 110.986 -170.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 m -69.15 71.97 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.231 0.613 . . . . 0.0 112.63 -171.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.74 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 62.34 -54.69 0.15 Allowed 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.426 0.69 . . . . 0.0 111.493 -174.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.74 ' HB3' ' NE ' ' A' ' 96' ' ' ARG . 3.5 ttm180 -155.63 124.67 6.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.687 -0.633 . . . . 0.0 110.84 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.978 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.62 -40.56 48.96 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.014 176.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.79 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -150.39 149.32 29.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.168 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 111' ' ' VAL . 5.3 pt-20 -113.11 130.58 56.13 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.805 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -63.42 101.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 111' ' ' VAL . 19.6 ttm180 -100.55 114.12 27.5 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.571 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 108' ' ' PHE . 14.7 tp -75.64 109.06 8.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.472 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -112.37 123.98 51.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.473 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 7.5 p30 42.47 44.26 3.44 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.049 0.843 . . . . 0.0 111.806 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 105' ' ' ASN . 8.0 t30 75.7 0.18 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.149 173.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.6 mm-40 -104.5 133.13 49.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.646 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -85.79 131.92 34.22 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -172.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 14.2 m-80 -134.1 171.21 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.3 m -110.1 156.58 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 168.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 27.0 m -126.28 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 170.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.77 116.77 14.76 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.426 HG21 ' HD2' ' A' ' 97' ' ' ARG . 31.5 m -123.42 -22.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.764 0.316 . . . . 0.0 111.366 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.82 102.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.9 t -115.81 133.53 55.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.686 HD12 ' HB ' ' A' ' 24' ' ' VAL . 2.7 tm? -56.44 -55.46 33.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.626 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -68.63 -36.02 78.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.06 170.64 12.08 Favored Glycine 0 C--O 1.251 1.205 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.866 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -112.04 133.22 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.036 0.535 . . . . 0.0 110.753 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.647 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.1 m-85 -138.19 103.35 4.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 120.938 0.399 . . . . 0.0 111.043 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.794 HG22 HG13 ' A' ' 137' ' ' VAL . 55.2 t -98.61 123.11 50.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 64.1 33.33 12.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 61.32 28.01 17.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.953 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.7 pt-20 -146.47 150.9 42.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 121.65 -0.656 . . . . 0.0 111.025 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 125.7 11.1 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.572 2.181 . . . . 0.0 111.88 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.24 179.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.741 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -106.55 -47.35 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.3 0.572 . . . . 0.0 109.808 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.8 t -158.16 91.75 1.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.946 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.56 136.65 38.36 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.616 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.94 150.51 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.919 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -63.72 119.41 9.87 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.307 175.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.61 121.89 25.11 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -61.2 118.88 7.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.743 0.782 . . . . 0.0 111.939 -171.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.31 -13.1 33.6 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.254 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.798 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 2.3 t0 -96.63 173.01 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 5.2 pt-20 -139.74 151.87 46.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.572 -168.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.794 HG13 HG22 ' A' ' 121' ' ' VAL . 39.8 t -127.56 141.57 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.3 tp-100 -98.28 129.64 44.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.944 0.402 . . . . 0.0 110.517 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ILE . . . . . 1.015 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -134.55 133.51 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 166.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.03 -77.14 0.56 Allowed Glycine 0 C--O 1.215 -1.04 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.956 172.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 1.031 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.9 ptmt -168.03 25.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.516 0.658 . . . . 0.0 110.755 173.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.819 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -115.81 141.43 48.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -173.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 143' ' ' ARG . 5.5 ttp85 -94.9 106.32 18.3 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.312 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.4 159.51 14.96 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.803 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.9 142.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 1.078 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -110.49 138.4 46.92 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.283 0.563 . . . . 0.0 112.326 -178.06 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 131' ' ' LEU . 2.8 mm? . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.156 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.235 0.308 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.6 m 63.23 48.74 3.54 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.888 0.851 . . . . 0.0 109.274 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -95.44 -153.41 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.136 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.8 mtt 65.65 50.19 1.65 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.444 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . 42.7 t30 70.45 96.91 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.223 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.588 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 5' ' ' ASN . 24.1 Cg_endo -62.48 -3.68 4.57 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.247 2.631 . . . . 0.0 113.147 -178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.402 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 19.5 t70 -66.97 -27.69 67.65 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mt -78.05 74.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.624 0.726 . . . . 0.0 109.233 175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -81.75 52.12 1.85 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.983 -176.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -135.93 137.22 41.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.034 0.445 . . . . 0.0 111.058 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -124.26 -176.48 3.51 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.29 -65.26 0.73 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 m -161.0 -45.77 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.597 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 24.0 p -167.06 -164.61 0.63 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.014 -0.993 . . . . 0.0 108.896 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 14' ' ' SER . 10.7 m-20 75.15 169.06 0.28 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.926 0.766 . . . . 0.0 112.834 170.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -145.52 -47.07 0.22 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.467 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.5 m -73.01 132.65 33.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-O 121.561 0.696 . . . . 0.0 111.295 -175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 m -141.44 -49.15 0.4 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.08 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.53 75.5 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.32 0.581 . . . . 0.0 110.249 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -90.41 -38.16 13.48 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 22' ' ' TPO . 94.4 m -103.24 142.05 34.84 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.321 -1.309 . . . . 0.0 109.41 174.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.704 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -66.61 134.5 52.44 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -162.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.594 HG22 ' CD1' ' A' ' 116' ' ' LEU . 92.2 t -102.24 137.38 30.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 113.744 -1.571 . . . . 0.0 110.272 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 12.6 t80 174.08 159.77 0.16 Allowed 'General case' 0 C--O 1.213 -0.859 0 CA-C-O 119.171 -0.442 . . . . 0.0 111.505 171.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.676 ' HG2' ' CD ' ' A' ' 64' ' ' PRO . 10.4 tpt85 64.31 -23.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 163.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.819 ' HB2' ' HB3' ' A' ' 117' ' ' ASN . . . -45.63 164.25 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -167.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.755 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 8.2 t70 -63.15 68.19 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.001 -172.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.456 ' CE2' ' HE2' ' A' ' 120' ' ' TYR . 51.3 m-85 -145.95 -48.81 0.21 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.943 -177.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 30' ' ' LEU . 2.7 pt? -117.28 -40.15 3.12 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.59 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 55.0 m -132.39 178.09 7.09 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.683 -0.636 . . . . 0.0 112.601 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.506 ' HG2' ' NH2' ' A' ' 26' ' ' ARG . 6.9 tp10 75.7 -57.18 0.58 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.509 1.124 . . . . 0.0 111.005 -176.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.675 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.5 -76.44 0.08 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.207 -177.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 68.74 -60.85 0.43 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 114.408 -1.269 . . . . 0.0 112.364 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -135.64 154.7 78.35 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.139 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 8.3 Cg_exo -72.66 57.59 3.06 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 112.355 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.77 103.46 16.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.109 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -96.52 122.28 39.25 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.21 -178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.08 102.91 15.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.25 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.74 77.95 2.01 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.687 177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 t -133.06 146.37 51.62 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.97 0.414 . . . . 0.0 110.675 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 42' ' ' GLU . 0.5 OUTLIER -101.27 170.48 8.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.958 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.4 m -84.47 65.45 8.96 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -171.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 61.93 -84.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.566 0.746 . . . . 0.0 112.42 175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.0 m -93.25 -7.19 10.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.936 0.398 . . . . 0.0 110.877 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.574 ' HA ' ' OE2' ' A' ' 49' ' ' GLU . 66.7 m 67.84 169.41 0.27 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.609 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.32 -1.56 28.08 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.5 p -137.13 21.26 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 122.258 1.027 . . . . 0.0 110.297 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.0 OUTLIER -128.47 -42.34 1.48 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.306 171.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.471 ' O ' ' HD3' ' A' ' 52' ' ' PRO . . . -96.44 60.04 1.3 Allowed Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 173.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HG ' ' O ' ' A' ' 51' ' ' LEU . 1.1 pt? -103.13 109.58 61.88 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -172.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.496 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 48.5 Cg_endo -108.11 28.92 0.05 OUTLIER 'Trans proline' 0 CA--C 1.552 1.412 0 C-N-CA 123.098 2.532 . . . . 0.0 115.795 170.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -83.38 39.7 0.84 Allowed 'Trans proline' 0 C--N 1.366 1.472 0 CA-C-N 121.646 1.624 . . . . 0.0 112.726 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.94 15.62 76.95 Favored Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -144.15 147.89 34.31 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.202 -0.499 . . . . 0.0 109.773 -178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.94 159.4 42.98 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 172.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.466 ' HA ' HD22 ' A' ' 72' ' ' LEU . 5.1 mp -148.38 139.24 23.02 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.06 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.6 mp -85.87 135.21 33.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 160.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 68' ' ' SER . 3.8 p -125.23 128.57 72.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.158 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.876 HG22 ' H ' ' A' ' 68' ' ' SER . 1.5 m -73.11 109.89 5.79 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HD2' ' HD2' ' A' ' 143' ' ' ARG . 2.2 ttmp? -57.76 -60.6 3.45 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 113.317 -1.765 . . . . 0.0 109.97 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -164.56 146.59 8.47 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.364 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 152.02 130.3 1.59 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -175.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.676 ' CD ' ' HG2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 1.67 -71.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.876 5.051 . . . . 0.0 118.054 -159.22 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.573 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.4 t30 -62.94 -51.67 66.0 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 119.116 0.871 . . . . 0.0 109.123 176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.66 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 53.5 165.29 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.221 -1.808 . . . . 0.0 114.172 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.08 4.45 90.24 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.841 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.876 ' H ' HG22 ' A' ' 60' ' ' VAL . 19.9 m -106.71 -167.79 1.33 Allowed 'General case' 0 C--O 1.22 -0.458 0 CA-C-N 118.053 0.926 . . . . 0.0 112.027 -166.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.555 ' N ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -170.86 151.74 3.46 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -168.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.699 ' HE1' ' CD2' ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.69 118.16 33.61 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 166.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -83.21 107.13 15.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 174.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.04 28.02 4.22 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.469 177.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.482 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 25.1 t70 -67.83 -28.24 67.39 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 173.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -96.89 164.19 12.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.683 171.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -63.85 -16.84 62.33 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -168.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.683 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -173.94 126.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.897 0.379 . . . . 0.0 111.425 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -119.41 131.98 55.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.899 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.586 ' HB3' ' CE1' ' A' ' 82' ' ' HIS . 70.0 m -71.76 129.53 38.88 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.358 172.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.733 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.32 121.31 41.6 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -175.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 147.0 -127.99 2.85 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.244 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.26 102.93 14.4 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.586 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 79.3 m-70 -137.73 123.77 13.0 Favored Pre-proline 0 C--N 1.318 -0.768 0 C-N-CA 119.555 -0.858 . . . . 0.0 112.729 -171.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 17.2 Cg_exo -71.56 -40.13 3.14 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.671 2.248 . . . . 0.0 111.001 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -146.44 104.52 3.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.154 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.412 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 42.9 m -160.76 -88.9 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' HB3' ' A' ' 71' ' ' LEU . 16.1 t70 -173.99 -59.91 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.501 174.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.733 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -90.23 91.65 3.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.911 0.862 . . . . 0.0 110.416 178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -104.58 123.89 48.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.353 172.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.982 HD11 HD21 ' A' ' 144' ' ' LEU . 15.4 mt -110.46 86.23 2.27 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.608 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.486 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 37.4 t70 74.09 -26.28 0.19 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 114.76 -1.109 . . . . 0.0 111.471 176.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 16.9 t70 63.52 28.15 15.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 122.658 1.218 . . . . 0.0 110.524 174.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.568 ' O ' HG23 ' A' ' 22' ' ' TPO . 46.2 t -135.73 -12.75 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 114.867 -1.061 . . . . 0.0 110.987 -177.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.619 HG21 ' HE3' ' A' ' 141' ' ' LYS . 1.5 p -108.38 -29.85 8.62 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -170.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.536 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.8 t -103.39 151.65 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 O-C-N 122.107 -0.371 . . . . 0.0 110.899 -169.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.704 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 15.9 m -74.56 69.3 1.7 Allowed 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 122.591 0.356 . . . . 0.0 110.074 177.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.678 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 56.33 -62.94 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.805 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.01 -166.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.639 ' HG3' HG21 ' A' ' 113' ' ' VAL . 7.6 ptp180 -133.85 139.38 46.2 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 120.849 -1.157 . . . . 0.0 111.047 176.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.815 ' HB2' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -83.88 -43.79 14.95 Favored 'General case' 0 CA--C 1.489 -1.373 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.733 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -147.3 163.35 36.68 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-N 113.202 -1.817 . . . . 0.0 110.308 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.683 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.5 pt-20 -122.47 122.14 38.25 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 165.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.793 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.3 OUTLIER -79.58 92.03 5.27 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -173.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.444 ' HD2' HG21 ' A' ' 111' ' ' VAL . 11.6 ptp180 -92.8 131.85 37.49 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.713 -173.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.706 HD21 ' HA ' ' A' ' 106' ' ' ASN . 6.2 tt -90.23 105.71 17.99 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.455 176.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 62.6 mm-40 -128.87 140.15 51.82 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 173.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-20 63.02 31.58 15.96 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.211 0.319 . . . . 0.0 110.456 -176.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.706 ' HA ' HD21 ' A' ' 103' ' ' LEU . 56.3 m-20 68.81 7.46 6.17 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.802 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.666 ' HG3' HD21 ' A' ' 109' ' ' ASN . 11.2 pt-20 -117.35 133.51 55.89 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 121.004 0.431 . . . . 0.0 110.391 -178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.663 ' CE2' HD12 ' A' ' 103' ' ' LEU . 0.3 OUTLIER -85.64 140.2 30.76 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 33.0 m-80 -144.73 157.15 44.3 Favored 'General case' 0 CA--C 1.512 -0.482 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.386 -173.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.869 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -102.13 118.98 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 CA-C-O 121.591 0.71 . . . . 0.0 110.329 177.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.733 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 2.1 t -99.81 113.36 34.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 114.209 -1.36 . . . . 0.0 109.792 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 119' ' ' THR . 14.4 t70 -74.67 129.86 38.47 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.929 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.639 HG21 ' HG3' ' A' ' 97' ' ' ARG . 20.3 m -132.16 19.3 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 83.7 103.99 0.55 Allowed Glycine 0 N--CA 1.434 -1.475 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.654 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.815 ' HB3' ' HB2' ' A' ' 98' ' ' HIS . 31.9 p -104.17 152.83 21.67 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.609 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 3.2 tm? -59.42 -55.84 29.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -170.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.819 ' HB3' ' HB2' ' A' ' 27' ' ' ALA . 31.2 m-80 -67.81 -36.39 80.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.876 0.369 . . . . 0.0 110.611 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 139.89 150.76 5.54 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.213 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' CE1' ' A' ' 98' ' ' HIS . 19.6 m -109.47 126.6 53.68 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.136 0.493 . . . . 0.0 111.52 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 38.1 m-85 -139.73 157.15 46.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.109 171.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.763 HG23 HG22 ' A' ' 137' ' ' VAL . 2.4 p -146.19 109.47 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 168.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.448 HD22 HG22 ' A' ' 121' ' ' VAL . 57.1 m-80 61.55 45.28 8.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.069 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 3.0 mmp_? 69.1 9.69 7.51 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -135.56 136.74 24.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.727 -0.389 . . . . 0.0 111.355 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.06 138.35 33.55 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.917 2.411 . . . . 0.0 111.771 173.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.587 HG21 ' HB2' ' A' ' 129' ' ' ALA . 19.7 m -135.47 179.08 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.674 0.273 . . . . 0.0 111.215 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.8 m-20 -95.84 -53.23 3.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.214 174.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.1 p -154.0 91.67 1.47 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.439 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.587 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -89.99 143.78 26.48 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.612 -176.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.9 t -77.15 135.87 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.893 -174.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.736 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 2.3 tt -53.08 117.76 3.24 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.501 -0.772 . . . . 0.0 108.979 168.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -124.7 -175.73 3.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.175 -172.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -103.14 94.55 5.59 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.45 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.52 -22.89 23.55 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.46 171.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.855 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 7.1 m-20 -73.0 158.86 34.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.444 0.164 . . . . 0.0 110.652 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 145' ' ' VAL . 9.2 pt-20 -133.89 150.56 51.35 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 122.079 0.942 . . . . 0.0 113.087 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.763 HG22 HG23 ' A' ' 121' ' ' VAL . 46.5 t -115.68 144.01 24.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 113.892 -1.504 . . . . 0.0 109.552 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.755 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.6 tp-100 -97.17 119.67 36.11 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.865 0.364 . . . . 0.0 110.085 172.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.788 HG23 HD13 ' A' ' 144' ' ' LEU . 0.1 OUTLIER -116.08 120.6 65.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.526 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 63.39 -102.14 0.51 Allowed Glycine 0 N--CA 1.435 -1.415 0 C-N-CA 118.871 -1.633 . . . . 0.0 110.889 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.619 ' HE3' HG21 ' A' ' 93' ' ' THR . 8.9 pttt -142.14 42.32 1.66 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 121.259 0.552 . . . . 0.0 111.651 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.758 ' HA ' ' HA3' ' A' ' 63' ' ' GLY . 0.1 OUTLIER -134.97 148.92 50.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.463 ' HD3' ' CD ' ' A' ' 136' ' ' GLU . 4.7 ttm180 -98.71 108.74 21.5 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.982 HD21 HD11 ' A' ' 89' ' ' LEU . 2.9 mp -116.6 110.65 18.8 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -170.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.793 ' HB ' ' HB3' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -103.4 140.85 20.49 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-O 120.9 0.381 . . . . 0.0 110.395 -177.033 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.06 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.88 147.22 31.26 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.215 0.531 . . . . 0.0 112.397 -177.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.625 ' HB3' ' O ' ' A' ' 49' ' ' GLU . 2.3 mm? -137.91 161.93 35.37 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.819 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.534 ' OG1' ' HD2' ' A' ' 150' ' ' PRO . 15.3 t -172.83 161.3 4.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.002 178.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 151' ' ' LYS . . . -60.47 -56.88 21.95 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 119.596 -0.558 . . . . 0.0 113.254 174.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.534 ' HD2' ' OG1' ' A' ' 148' ' ' THR . 82.6 Cg_exo -47.1 134.92 18.83 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.97 2.447 . . . . 0.0 112.367 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.641 ' HG3' ' H ' ' A' ' 152' ' ' GLN . 19.6 pttm -165.69 -63.79 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.042 -173.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.641 ' H ' ' HG3' ' A' ' 151' ' ' LYS . 31.8 mt-30 -137.12 19.0 2.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -176.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 90.14 157.45 33.38 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 -170.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -124.27 106.42 10.26 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.3 -21.43 36.13 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.22 -174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 27.5 t70 74.87 140.3 0.06 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.036 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -165.4 117.14 0.73 Allowed Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.205 -0.997 . . . . 0.0 113.074 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.0 m -108.14 -12.19 15.14 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.025 0.44 . . . . 0.0 109.888 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 31.7 m -88.38 107.61 18.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.285 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -162.13 48.7 0.34 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.76 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -110.55 103.91 1.71 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.021 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo . . . . . 0 C--O 1.247 0.945 0 C-N-CA 123.219 2.613 . . . . 0.0 112.056 178.961 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.464 0.271 0 CA-C-O 121.813 0.816 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 3' ' ' ASP . 1.7 m -98.48 132.78 43.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.044 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.403 ' HB3' ' O ' ' A' ' 2' ' ' THR . 32.6 t70 71.27 136.09 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 O-C-N 124.08 0.863 . . . . 0.0 111.043 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.434 ' C ' ' HD3' ' A' ' 6' ' ' PRO . 38.5 tpp -95.11 15.32 19.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 -174.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.438 HD22 HD12 ' A' ' 8' ' ' ILE . 18.9 m120 -126.49 67.4 65.62 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 120.772 0.32 . . . . 0.0 110.475 177.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -83.75 96.47 0.76 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.869 2.379 . . . . 0.0 112.136 -176.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.618 ' HB3' ' HD3' ' A' ' 10' ' ' LYS . 5.9 m-20 59.03 59.51 2.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.683 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.438 HD12 HD22 ' A' ' 5' ' ' ASN . 66.5 mt -102.02 125.88 56.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.81 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 58.28 53.78 6.21 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.465 0.65 . . . . 0.0 110.677 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.618 ' HD3' ' HB3' ' A' ' 7' ' ' ASP . 20.3 pttp -88.93 21.63 3.03 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.236 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.49 139.32 58.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.113 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 6.5 tp60 -123.54 140.84 52.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.806 178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 m 70.1 83.38 0.15 Allowed 'General case' 0 C--N 1.331 -0.233 0 O-C-N 123.709 0.631 . . . . 0.0 110.901 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.3 m 72.66 160.4 0.23 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.05 177.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.831 ' HB2' ' HB ' ' A' ' 18' ' ' THR . 19.4 m-20 -118.03 171.67 7.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.852 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -67.48 -65.06 0.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 t -120.15 79.2 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 174.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.831 ' HB ' ' HB2' ' A' ' 15' ' ' ASP . 11.6 t -80.84 -9.41 59.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.404 -173.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.08 126.9 57.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.969 0.414 . . . . 0.0 110.943 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -63.37 100.7 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.386 0.612 . . . . 0.0 110.236 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.654 HG22 HD21 ' A' ' 116' ' ' LEU . 12.3 m -97.51 138.01 35.58 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.431 -176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.714 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -15.92 94.93 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.96 1.704 . . . . 0.0 114.961 -170.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 117' ' ' ASN . 9.4 p -131.35 153.92 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.827 -173.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 141' ' ' LYS . 36.8 t80 178.98 -163.6 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.957 0 CA-C-O 118.265 -0.874 . . . . 0.0 109.238 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.732 ' HG3' ' N ' ' A' ' 27' ' ' ALA . 7.5 tpt180 50.5 -90.15 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.008 0.822 . . . . 0.0 111.171 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.732 ' N ' ' HG3' ' A' ' 26' ' ' ARG . . . 60.41 149.31 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 122.203 1.001 . . . . 0.0 112.392 -177.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.594 ' HB2' ' HG3' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -104.92 67.36 0.79 Allowed 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.954 175.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.427 ' O ' HD12 ' A' ' 33' ' ' LEU . 71.4 m-85 -121.71 -52.97 2.0 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.278 173.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.501 ' HG ' ' O ' ' A' ' 30' ' ' LEU . 15.4 tp -141.37 43.84 1.76 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.96 0.886 . . . . 0.0 110.508 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.0 t -138.84 -73.39 0.39 Allowed 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.265 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.581 ' HG3' HH21 ' A' ' 143' ' ' ARG . 15.8 tp10 -74.66 -26.91 60.17 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.074 0.464 . . . . 0.0 109.927 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 28' ' ' ASP . 0.6 OUTLIER -86.33 -77.8 0.3 Allowed 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 171.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 t70 67.62 -84.27 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 113.805 -1.543 . . . . 0.0 111.665 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -158.68 160.37 29.35 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.74 -65.51 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.538 2.159 . . . . 0.0 113.052 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 54.47 50.95 15.0 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.061 0.457 . . . . 0.0 111.078 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.554 ' OE1' ' HA ' ' A' ' 38' ' ' GLN . 5.4 tp60 57.52 43.24 23.1 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.943 0.877 . . . . 0.0 110.476 -174.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -157.35 162.7 39.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.486 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.92 151.51 18.68 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.681 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.8 m -64.55 108.6 1.72 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 66.13 101.22 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.15 0 O-C-N 123.878 0.736 . . . . 0.0 110.748 -174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.4 m -61.31 -33.92 74.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.348 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -141.7 -89.65 0.15 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.15 174.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.1 m -145.6 172.57 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.879 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.5 p -139.59 31.79 2.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -174.12 -73.36 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.782 174.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.8 m 36.23 55.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 123.979 0.912 . . . . 0.0 112.392 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' HB3' HD22 ' A' ' 51' ' ' LEU . 6.4 tp10 -80.11 -29.31 38.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.566 -175.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 60.04 53.54 44.9 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.835 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.677 HD11 ' HG ' ' A' ' 57' ' ' LEU . 1.1 pt? -106.01 112.22 64.28 Favored Pre-proline 0 N--CA 1.446 -0.625 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 -174.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.683 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 53.4 Cg_endo -112.93 32.11 0.03 OUTLIER 'Trans proline' 0 CA--C 1.551 1.326 0 C-N-CA 123.403 2.735 . . . . 0.0 114.379 161.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.683 ' HD3' ' N ' ' A' ' 52' ' ' PRO . 5.1 Cg_exo -77.91 57.05 5.93 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 121.826 1.684 . . . . 0.0 112.522 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 71.06 13.55 72.89 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.914 -178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 28.9 t -164.81 150.09 9.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.081 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.67 168.98 16.8 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 170.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.677 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.2 pp -152.53 134.06 14.53 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.03 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.8 mp -88.08 126.36 35.06 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.59 -1.186 . . . . 0.0 108.679 162.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.684 HG22 ' HB3' ' A' ' 69' ' ' ARG . 92.6 t -120.83 133.55 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 117.996 0.362 . . . . 0.0 110.616 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.938 HG11 HD11 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -78.14 119.7 27.54 Favored 'Isoleucine or valine' 0 C--O 1.246 0.883 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 176.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HG3' ' CG1' ' A' ' 145' ' ' VAL . 26.0 mtpp -53.78 -80.96 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 124.625 1.203 . . . . 0.0 111.663 -174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 43.3 ttt180 -161.74 81.32 0.58 Allowed 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.568 -174.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' N ' ' HB2' ' A' ' 66' ' ' ALA . . . -112.5 -143.84 9.05 Favored Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.058 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 42.5 Cg_exo -58.17 -66.17 0.08 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.21 1.94 . . . . 0.0 113.039 177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.483 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 61.6 t30 -69.35 -52.8 23.68 Favored 'General case' 0 CA--C 1.5 -0.972 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 174.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.619 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 55.09 166.13 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.106 -1.861 . . . . 0.0 113.227 -174.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.55 3.21 90.11 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.277 172.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.902 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -96.39 177.45 5.69 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.598 -167.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.684 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -166.29 153.43 9.62 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -173.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.688 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.46 122.88 38.65 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 167.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -83.17 93.84 7.73 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.43 0.633 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.716 ' HB3' ' CD2' ' A' ' 108' ' ' PHE . 0.8 OUTLIER -88.46 45.78 1.32 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.916 0.865 . . . . 0.0 109.219 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.449 ' HB3' HD21 ' A' ' 71' ' ' LEU . 13.5 t70 -90.95 -13.47 33.38 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.951 172.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -117.48 174.75 5.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.783 172.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.589 ' O ' ' HB2' ' A' ' 103' ' ' LEU . . . -66.0 -60.89 2.4 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -176.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.738 HD11 ' HB2' ' A' ' 100' ' ' GLU . 1.3 tp -125.68 122.3 61.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.313 0.578 . . . . 0.0 111.802 -173.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.9 p -104.83 171.71 7.17 Favored 'General case' 0 C--O 1.221 -0.419 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.062 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.698 ' O ' HG23 ' A' ' 87' ' ' ILE . 59.8 m -117.27 124.09 48.19 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 172.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.737 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.75 121.34 42.18 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -171.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 139.07 -129.95 4.64 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.204 177.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.789 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -84.88 103.27 13.79 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.643 ' CE1' ' HB3' ' A' ' 97' ' ' ARG . 89.0 m-70 -137.94 132.52 17.19 Favored Pre-proline 0 C--N 1.315 -0.917 0 C-N-CA 119.91 -0.716 . . . . 0.0 112.082 -173.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 37.9 Cg_exo -64.78 -65.52 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.943 2.429 . . . . 0.0 112.839 173.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -126.28 29.78 5.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.632 0.253 . . . . 0.0 111.41 -174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 10.0 m -93.4 -170.88 2.49 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.841 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -66.69 0.78 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.331 0.586 . . . . 0.0 111.085 -174.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.737 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -100.64 95.87 4.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.632 0.73 . . . . 0.0 110.867 -175.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -109.14 128.97 55.46 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.552 177.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.938 HD11 HG11 ' A' ' 60' ' ' VAL . 4.0 mm? -113.28 84.63 2.04 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.695 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.411 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 6.4 t70 66.18 -1.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.22 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.789 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 2.9 p30 41.01 37.43 0.54 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.171 1.388 . . . . 0.0 113.921 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 92' ' ' VAL . 9.9 p -161.11 21.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.541 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.625 174.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.585 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -123.17 -7.15 8.28 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.495 -0.753 . . . . 0.0 111.675 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.642 HG22 ' HA3' ' A' ' 140' ' ' GLY . 1.9 t -125.47 152.16 32.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -173.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.626 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 15.8 m -73.05 70.38 1.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.05 0.452 . . . . 0.0 110.279 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.7 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 58.56 -67.93 0.03 OUTLIER 'General case' 0 C--O 1.215 -0.722 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.936 -168.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.713 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 7.2 ptp180 -136.31 128.74 30.29 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 120.544 -1.347 . . . . 0.0 111.493 177.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.825 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -65.31 -46.05 81.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 171.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.548 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -148.95 179.13 8.1 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 113.013 -1.903 . . . . 0.0 109.008 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.738 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.29 123.55 14.71 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.12 93.05 3.28 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-O 122.098 0.951 . . . . 0.0 109.82 -168.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.402 ' HA ' HD13 ' A' ' 76' ' ' ILE . 6.1 tpp180 -81.3 123.6 28.65 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.382 -1.736 . . . . 0.0 110.762 -172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.904 HD11 ' HA ' ' A' ' 106' ' ' ASN . 0.5 OUTLIER -85.04 126.58 33.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 22.3 tt0 -150.55 126.52 10.46 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 172.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 64.82 41.69 4.87 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.651 0.594 . . . . 0.0 109.721 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.904 ' HA ' HD11 ' A' ' 103' ' ' LEU . 3.1 p-10 51.4 22.19 1.39 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.581 1.152 . . . . 0.0 113.313 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.793 ' HG3' HD21 ' A' ' 109' ' ' ASN . 12.5 pt-20 -118.19 134.27 55.16 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.716 ' CD2' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -87.91 143.25 27.22 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.793 HD21 ' HG3' ' A' ' 107' ' ' GLU . 25.0 m-80 -147.36 156.25 42.73 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 118.574 0.625 . . . . 0.0 111.447 -172.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.891 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -102.54 116.26 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.116 176.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.591 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 76.2 t -101.03 111.52 30.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.345 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -67.59 126.03 28.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.021 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 18.9 m -134.9 14.59 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 120.934 0.397 . . . . 0.0 110.23 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 113.47 105.08 2.67 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.058 -1.068 . . . . 0.0 113.791 176.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.718 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.2 t -118.57 128.04 54.18 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.714 HD22 ' HB ' ' A' ' 22' ' ' TPO . 29.3 tp -55.17 -56.24 22.1 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.877 -174.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 24' ' ' VAL . 16.9 t30 -62.85 -38.41 90.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.984 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.87 161.26 8.94 Favored Glycine 0 C--O 1.256 1.483 0 CA-C-N 115.063 -0.971 . . . . 0.0 112.646 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.599 HG23 ' HE1' ' A' ' 98' ' ' HIS . 8.1 m -111.39 134.11 53.21 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.218 -0.991 . . . . 0.0 111.103 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.548 ' CE2' ' HA ' ' A' ' 123' ' ' ARG . 0.1 OUTLIER -141.48 131.27 24.28 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.751 HG22 HG13 ' A' ' 137' ' ' VAL . 80.8 t -142.01 114.19 3.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 173.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.6 m120 60.01 43.54 14.44 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HA ' ' CE2' ' A' ' 120' ' ' TYR . 79.8 mtp180 66.86 14.13 9.7 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -142.3 141.59 21.59 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 121.914 -0.492 . . . . 0.0 110.622 173.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 122.96 11.09 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.968 1.779 . . . . 0.0 110.748 170.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.543 HG13 ' HB ' ' A' ' 121' ' ' VAL . 20.4 m -111.61 174.0 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.923 0.392 . . . . 0.0 111.389 -175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 6.1 m-20 -98.11 -47.67 5.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.045 176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.891 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.4 p -160.67 102.45 1.34 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.571 179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -99.9 142.45 31.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.037 -177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 18.8 t -80.83 131.06 34.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 O-C-N 123.421 0.45 . . . . 0.0 110.739 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.637 HD22 ' HB ' ' A' ' 148' ' ' THR . 2.1 tt -51.43 115.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 174.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.438 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -120.05 -175.21 2.94 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -174.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -112.51 96.78 6.19 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.624 0.249 . . . . 0.0 110.772 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.14 4.98 29.01 Favored Glycine 0 CA--C 1.518 0.26 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.144 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.915 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 11.6 m-20 -107.46 160.83 15.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.32 0.56 . . . . 0.0 110.247 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER -118.08 155.87 29.61 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -166.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.751 HG13 HG22 ' A' ' 121' ' ' VAL . 59.8 t -133.69 141.82 43.17 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 113.971 -1.468 . . . . 0.0 107.765 174.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.594 ' HG3' ' HB2' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -116.77 124.52 49.82 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.825 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -131.22 132.69 63.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.986 175.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.642 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 84.11 -56.44 5.04 Favored Glycine 0 C--O 1.217 -0.929 0 C-N-CA 119.258 -1.448 . . . . 0.0 113.763 166.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.058 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 43.3 pttt 171.17 27.18 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 123.144 0.578 . . . . 0.0 110.688 168.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.737 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.56 146.8 51.35 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -169.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.581 HH21 ' HG3' ' A' ' 32' ' ' GLU . 10.0 ttm180 -92.68 119.21 31.86 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 119.694 -0.803 . . . . 0.0 110.237 177.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.907 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -110.08 156.93 19.9 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.12 143.11 28.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 172.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.03 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -102.15 141.64 34.67 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.935 179.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.614 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -129.48 142.78 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.768 -1.105 . . . . 0.0 109.218 177.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.637 ' HB ' HD22 ' A' ' 131' ' ' LEU . 14.5 t -159.15 155.48 27.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.959 0.409 . . . . 0.0 110.185 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 52' ' ' PRO . . . -98.99 110.24 3.96 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.609 173.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.46 -45.06 32.65 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.522 2.148 . . . . 0.0 112.045 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.401 ' HE2' ' HB2' ' A' ' 151' ' ' LYS . 23.0 ttmm -154.25 0.36 0.21 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.561 ' HG3' ' CG ' ' A' ' 52' ' ' PRO . 17.4 mt-30 63.52 6.13 2.42 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.486 -173.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 155' ' ' ASP . . . -66.53 148.39 50.62 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.088 -178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -75.33 29.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.062 0.458 . . . . 0.0 111.19 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 153' ' ' GLY . 19.4 t70 -74.69 101.65 4.35 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.803 -177.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -83.25 -52.89 6.18 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 176.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 124.73 137.52 4.84 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.823 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.9 t -112.69 84.48 1.99 Allowed 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.46 -18.75 29.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.965 -169.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 135.76 -64.53 0.58 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -175.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -78.24 -67.08 1.66 Allowed Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 167.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo . . . . . 0 N--CA 1.447 -1.226 0 C-N-CA 122.788 2.325 . . . . 0.0 110.629 169.041 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.403 HG12 ' HB2' ' A' ' 4' ' ' MET . 13.7 m . . . . . 0 N--CA 1.45 -0.436 0 CA-C-O 121.439 0.637 . . . . 0.0 111.087 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.3 p -113.79 -16.76 12.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.174 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -143.6 34.2 1.29 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.406 -177.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.403 ' HB2' HG12 ' A' ' 1' ' ' VAL . 62.4 mtt -136.61 -76.65 0.42 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.541 -172.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -103.78 159.91 27.81 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 -174.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -42.76 111.61 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.423 2.749 . . . . 0.0 113.261 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.22 12.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.431 -175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 13.2 tt -90.05 -7.75 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 121.308 0.575 . . . . 0.0 110.944 -175.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 0.6 OUTLIER -85.38 107.85 17.56 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.334 -0.394 . . . . 0.0 109.957 -178.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' GLU . 51.1 mttp 72.76 1.77 4.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.383 0.673 . . . . 0.0 112.572 178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -149.33 159.08 44.59 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 52.18 43.71 30.34 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.686 0.755 . . . . 0.0 110.266 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 m -94.0 -54.43 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.886 -175.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.5 m -131.87 41.17 3.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -133.49 57.59 1.8 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.495 0.664 . . . . 0.0 110.697 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -71.76 116.96 12.75 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.2 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.0 t -95.81 -51.77 10.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.453 0.644 . . . . 0.0 109.462 174.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 t -148.34 125.89 11.72 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.48 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.3 t -116.89 107.14 21.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 51.56 55.56 9.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.073 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.7 m -108.93 133.06 53.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.369 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.79 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 17.2 m 9.84 115.08 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 126.509 1.924 . . . . 0.0 115.666 177.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.698 ' HB ' HD12 ' A' ' 116' ' ' LEU . 4.4 p -134.77 157.57 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.633 -176.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -177.07 -171.78 0.37 Allowed 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -171.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.912 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 51.66 -111.46 0.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.222 0.465 . . . . 0.0 110.078 171.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.457 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 64.11 169.24 0.17 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 167.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.577 ' HA ' HD21 ' A' ' 33' ' ' LEU . 12.4 t70 -84.19 77.85 9.89 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.739 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -143.22 -51.12 0.35 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.36 177.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.7 tp -93.59 -68.64 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.775 -176.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.8 p -169.73 -158.24 0.18 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.964 -0.294 . . . . 0.0 111.721 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 63.22 25.64 14.87 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.831 0.824 . . . . 0.0 110.497 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.577 HD21 ' HA ' ' A' ' 28' ' ' ASP . 1.9 pp -165.04 -34.44 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.09 -1.414 . . . . 0.0 108.151 177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.524 ' N ' HD12 ' A' ' 33' ' ' LEU . 38.7 t70 -80.08 59.04 3.15 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.354 -1.294 . . . . 0.0 109.21 172.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -168.13 67.78 0.78 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.5 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.0 67.54 8.04 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.153 2.568 . . . . 0.0 111.758 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.93 81.19 1.38 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -142.97 111.38 6.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.647 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.22 120.98 24.49 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -139.17 -79.93 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.788 -174.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.7 m -139.58 58.05 1.62 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.464 0.649 . . . . 0.0 110.295 -177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.5 pm0 -83.97 78.99 9.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.497 0.665 . . . . 0.0 110.643 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.5 t -125.67 145.48 50.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.39 178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.54 92.15 2.36 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.981 0.419 . . . . 0.0 111.45 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 150' ' ' PRO . 26.7 m -111.12 144.74 18.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.743 175.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.5 m -142.94 114.71 8.13 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.815 0.341 . . . . 0.0 110.535 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 164.08 -42.96 0.31 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.859 -0.686 . . . . 0.0 113.541 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 20.8 m -129.91 26.48 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.228 0.514 . . . . 0.0 112.097 -172.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -85.38 -59.96 2.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.077 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.644 ' CA ' ' HA ' ' A' ' 148' ' ' THR . . . 173.46 20.67 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.474 -0.869 . . . . 0.0 113.212 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 1.0 OUTLIER -44.21 134.95 4.23 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 122.073 0.939 . . . . 0.0 112.875 174.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HA ' ' HZ ' ' A' ' 108' ' ' PHE . 72.8 Cg_exo -50.25 -34.71 41.0 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 124.128 3.219 . . . . 0.0 115.11 178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.658 ' HD2' ' HB2' ' A' ' 51' ' ' LEU . 6.3 Cg_exo -80.63 36.34 0.62 Allowed 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 121.99 1.793 . . . . 0.0 112.191 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.85 -90.77 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.474 ' O ' ' HA2' ' A' ' 50' ' ' GLY . 1.6 m -156.34 153.68 29.38 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -124.45 167.72 14.03 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.425 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.74 145.76 12.65 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.971 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -95.37 115.92 28.08 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.173 -1.83 . . . . 0.0 108.889 163.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.3 p -110.6 125.41 67.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.893 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.911 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -70.37 116.49 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 173.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 45.1 tptt -68.72 -82.81 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.744 -171.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -144.22 123.38 12.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.474 0.654 . . . . 0.0 111.009 177.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.722 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -164.12 -105.37 0.19 Allowed Glycine 0 N--CA 1.439 -1.152 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.205 173.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.659 ' CG ' ' HG3' ' A' ' 141' ' ' LYS . 4.8 Cg_exo -77.76 -88.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 122.954 2.436 . . . . 0.0 112.333 177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.796 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.5 t30 -64.73 -48.29 75.14 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.722 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.34 158.36 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.221 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.0 0.92 89.56 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.543 -0.836 . . . . 0.0 113.09 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.911 ' H ' HG22 ' A' ' 60' ' ' VAL . 2.7 m -86.29 171.55 11.14 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 117.212 0.506 . . . . 0.0 109.673 -175.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.669 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -167.68 153.62 7.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.377 0.535 . . . . 0.0 111.581 -175.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.566 ' O ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -94.64 126.82 40.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 175.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.1 tm? -84.7 96.08 9.12 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 124.33 1.019 . . . . 0.0 108.571 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.864 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -93.38 50.3 1.48 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.844 -177.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.438 ' HB3' HD11 ' A' ' 71' ' ' LEU . 21.3 t70 -104.97 -19.41 13.85 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.832 177.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -101.82 -166.9 1.34 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.426 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.56 -40.63 56.46 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.423 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.32 135.6 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.003 0.43 . . . . 0.0 111.721 178.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.623 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 22.3 p -116.42 141.75 47.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.084 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 43.2 m -85.61 124.79 32.56 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 174.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.574 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.07 106.34 11.47 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.867 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 161.61 -129.47 2.11 Favored Glycine 0 N--CA 1.442 -0.902 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.701 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -68.77 108.34 3.38 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.72 0.771 . . . . 0.0 110.456 173.343 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.762 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -138.91 129.89 15.07 Favored Pre-proline 0 N--CA 1.429 -1.511 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.91 -174.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 19.2 Cg_exo -68.97 -62.89 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.871 2.381 . . . . 0.0 112.358 173.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -161.49 101.62 1.2 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.112 -179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.406 ' OG ' ' CD2' ' A' ' 82' ' ' HIS . 3.1 p -164.59 -85.73 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.188 171.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -112.08 -75.81 0.6 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.416 0.627 . . . . 0.0 111.115 -172.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.669 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -127.75 110.52 22.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.187 -174.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -109.27 134.37 51.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.2 177.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.045 ' HG ' HD11 ' A' ' 139' ' ' ILE . 3.0 mm? -117.39 72.27 0.83 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.551 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.796 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 34.1 t70 62.8 4.21 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.381 0.61 . . . . 0.0 109.853 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.701 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 16.9 t70 66.73 -79.61 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 114.673 -1.149 . . . . 0.0 111.261 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 23' ' ' SER . 14.2 p -80.57 69.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 122.42 1.105 . . . . 0.0 112.866 -167.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -162.69 4.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.941 167.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.443 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.4 t -140.63 141.82 31.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.621 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 10.9 t -76.14 72.76 2.96 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 66.1 -48.87 0.42 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.318 -0.856 . . . . 0.0 112.072 -173.218 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.572 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 8.1 ptp85 -154.46 135.0 13.45 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.325 0.583 . . . . 0.0 110.592 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -72.13 -36.84 69.49 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 170.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -159.95 176.56 11.73 Favored 'General case' 0 N--CA 1.422 -1.863 0 CA-C-N 112.832 -1.985 . . . . 0.0 108.225 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 102' ' ' ARG . 6.0 pt-20 -134.04 135.19 43.18 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 172.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.864 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -61.17 95.89 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -92.49 98.17 11.29 Favored 'General case' 0 N--CA 1.418 -2.074 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.678 -177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -77.98 107.83 10.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 119.936 -0.706 . . . . 0.0 109.267 176.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -134.57 139.85 45.68 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.036 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 58.61 32.52 22.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.914 -172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.871 ' HA ' HD21 ' A' ' 103' ' ' LEU . 89.0 m-20 67.5 9.11 6.8 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.895 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 17.5 mm-40 -105.49 151.67 23.99 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.398 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.955 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -99.34 124.32 44.35 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.531 ' OD1' ' HB ' ' A' ' 130' ' ' VAL . 11.6 m-80 -136.19 157.8 45.95 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -174.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' A' ' 128' ' ' SER . 12.3 m -107.94 123.29 63.31 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.196 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.708 HG22 ' HB3' ' A' ' 128' ' ' SER . 78.0 t -100.52 110.47 27.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.732 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -67.35 122.33 17.67 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 97' ' ' ARG . 17.1 m -127.45 -11.52 3.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 141.72 77.39 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 119.892 -1.147 . . . . 0.0 113.272 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.869 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 28.6 t -86.34 137.23 32.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.79 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.7 tm? -53.47 -54.01 43.18 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 120.346 -0.542 . . . . 0.0 112.042 -174.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.662 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -73.81 -35.75 64.9 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 118.831 0.741 . . . . 0.0 109.936 172.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 133.12 171.9 12.84 Favored Glycine 0 C--O 1.253 1.335 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.076 -174.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 49.4 m -111.37 130.26 55.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.651 -0.775 . . . . 0.0 110.904 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.604 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 68.0 m-85 -138.41 104.2 5.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.896 0.379 . . . . 0.0 110.859 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.768 HG22 HG13 ' A' ' 137' ' ' VAL . 58.1 t -100.73 125.92 54.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.3 m120 64.53 22.89 12.78 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 61.79 38.2 15.03 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.764 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -142.35 144.63 31.81 Favored Pre-proline 0 N--CA 1.452 -0.368 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 169.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.76 122.54 10.17 Favored 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.423 2.082 . . . . 0.0 111.197 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.673 HG11 ' HB ' ' A' ' 121' ' ' VAL . 19.3 m -114.74 171.51 4.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.068 0.461 . . . . 0.0 111.319 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 17.6 t70 -111.93 -41.97 3.88 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.669 175.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.867 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 1.7 p -164.86 91.53 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.7 0.762 . . . . 0.0 110.21 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -104.95 128.13 53.09 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.307 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.531 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 9.1 p -73.01 154.69 7.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.429 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.955 HD13 ' HB2' ' A' ' 108' ' ' PHE . 10.4 mp -62.25 165.7 5.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.52 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.436 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . . . -152.0 -176.78 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.3 176.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.31 90.94 4.5 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.825 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.55 4.89 37.09 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 119.922 -1.132 . . . . 0.0 114.538 169.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.645 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 2.4 t70 -93.99 166.59 12.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.954 0.877 . . . . 0.0 110.117 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 3.5 pt-20 -127.76 150.27 49.88 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -165.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.768 HG13 HG22 ' A' ' 121' ' ' VAL . 38.5 t -125.97 141.92 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.62 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -99.69 125.58 45.58 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.887 0.375 . . . . 0.0 110.078 169.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.045 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.15 131.53 45.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 169.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.07 -76.33 1.07 Allowed Glycine 0 C--O 1.222 -0.649 0 C-N-CA 119.341 -1.409 . . . . 0.0 111.949 177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.912 ' HB2' ' HB3' ' A' ' 26' ' ' ARG . 7.4 pttt -171.93 28.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.385 0.612 . . . . 0.0 111.08 171.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.811 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -114.24 143.51 44.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.583 -172.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.528 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 7.0 ttm180 -90.67 100.81 13.59 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.902 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.0 mp -93.93 158.47 15.63 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.7 143.14 27.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 169.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.971 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -107.08 147.16 30.34 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.264 -0.575 . . . . 0.0 111.28 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 146' ' ' PHE . 3.1 mm? -131.25 150.4 52.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.543 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.644 ' HA ' ' CA ' ' A' ' 50' ' ' GLY . 12.2 t -145.05 175.06 10.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 170.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 51' ' ' LEU . . . -64.34 123.41 27.51 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.851 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA2' ' A' ' 149' ' ' GLY . 29.1 Cg_exo -62.02 112.57 1.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.807 2.338 . . . . 0.0 111.906 -178.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -84.63 50.29 1.87 Allowed 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.426 0.631 . . . . 0.0 110.487 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -150.25 128.92 12.34 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.149 -178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -97.1 2.58 61.55 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.787 -0.72 . . . . 0.0 113.013 -174.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -131.57 155.74 46.96 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -135.35 130.29 34.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.427 0.632 . . . . 0.0 111.063 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -122.68 -2.69 8.82 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.444 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.34 8.96 78.7 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.764 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.5 p -79.67 62.29 3.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.54 0.686 . . . . 0.0 110.761 178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 27.5 m -89.69 123.39 33.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.468 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -71.93 113.83 4.74 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.388 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -75.42 128.44 9.79 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.49 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo . . . . . 0 C--O 1.249 1.032 0 C-N-CA 123.211 2.607 . . . . 0.0 111.732 176.752 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.7 m -80.14 -15.99 55.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.819 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -102.5 166.55 10.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.985 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.8 ptt? -130.6 152.73 49.65 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.596 -0.275 . . . . 0.0 110.848 -177.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.46 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 5.5 m-20 -91.69 132.62 32.72 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.712 -177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 7.6 Cg_exo -73.69 101.6 1.4 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 123.377 2.718 . . . . 0.0 112.672 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -86.21 88.05 7.54 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 173.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.8 pt -131.1 162.79 38.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.094 0.473 . . . . 0.0 112.198 -167.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -110.52 115.94 30.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 175.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -169.24 38.6 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.2 100.69 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.883 -175.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 53.46 29.69 9.33 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.966 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.2 m -96.41 52.16 1.23 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.462 0.648 . . . . 0.0 110.014 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.7 p -105.94 -76.61 0.6 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.208 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -128.4 -55.01 1.26 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.386 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -115.84 137.65 51.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.811 0.339 . . . . 0.0 110.661 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.4 t -106.91 78.98 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 121.363 0.601 . . . . 0.0 109.403 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 t -88.87 63.85 6.98 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.786 0.803 . . . . 0.0 110.819 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.0 m -82.7 57.57 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.695 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 55.28 67.87 0.95 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.635 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 89.2 m -147.92 143.05 27.09 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.693 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.738 ' O ' ' HA ' ' A' ' 93' ' ' THR . 74.6 m -61.24 122.78 15.94 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -168.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.662 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.5 p -140.81 150.22 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.924 -173.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.449 ' H ' ' HD2' ' A' ' 141' ' ' LYS . 8.5 t80 -176.73 -139.65 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.548 -176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.773 HH11 ' HG2' ' A' ' 26' ' ' ARG . 0.0 OUTLIER 36.53 -100.19 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.001 0.921 . . . . 0.0 110.614 -177.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.517 ' H ' ' HB3' ' A' ' 26' ' ' ARG . . . 63.85 120.25 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.215 0 CA-C-O 122.587 1.184 . . . . 0.0 112.723 171.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.724 ' HB3' ' CD2' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -88.76 84.77 6.69 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.144 -1.389 . . . . 0.0 112.453 -167.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.433 ' HE1' ' CD1' ' A' ' 120' ' ' TYR . 25.2 m-85 -116.3 -59.23 2.0 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.607 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.662 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.6 pt? -120.63 17.32 12.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.762 -177.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.6 p -148.72 164.82 33.24 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.163 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.712 ' HG3' ' HE ' ' A' ' 143' ' ' ARG . 21.7 tp10 67.52 -69.23 0.14 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 124.241 0.963 . . . . 0.0 110.756 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.724 ' CD2' ' HB3' ' A' ' 28' ' ' ASP . 0.4 OUTLIER -65.46 -33.2 75.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 171.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.476 ' N ' HD12 ' A' ' 33' ' ' LEU . 38.7 t70 42.12 75.07 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 124.273 0.983 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -117.89 117.83 35.21 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.994 -175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 1.6 Cg_endo -83.6 21.98 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.263 2.642 . . . . 0.0 111.896 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.68 157.8 30.23 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.106 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -110.32 128.62 55.64 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -82.12 72.55 9.18 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.612 -174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -75.67 79.45 1.11 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.694 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.1 m -147.28 101.68 3.41 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.782 0.325 . . . . 0.0 110.477 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -85.01 -78.94 0.24 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.767 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t 50.39 43.8 26.81 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.614 0.721 . . . . 0.0 109.295 -171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.94 107.72 9.49 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.872 -173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -95.59 115.78 35.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.183 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.9 m -102.39 120.41 40.46 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.266 178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.8 36.04 0.33 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 121.106 -0.568 . . . . 0.0 112.121 -178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HA ' ' OE2' ' A' ' 107' ' ' GLU . 49.6 t 66.78 95.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 123.203 0.601 . . . . 0.0 111.382 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -65.68 -71.5 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -153.37 5.37 0.37 Allowed Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.336 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.538 ' H ' HD12 ' A' ' 51' ' ' LEU . 4.0 mp -74.57 117.8 65.03 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 43.1 Cg_endo -109.02 31.65 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.428 0 C-N-CA 123.108 2.538 . . . . 0.0 115.13 170.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 52' ' ' PRO . 43.8 Cg_endo -92.75 153.64 2.81 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 121.516 1.477 . . . . 0.0 113.26 -176.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -88.41 -19.32 52.88 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 172.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.609 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -142.58 129.13 20.23 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 175.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.577 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -126.42 172.29 10.3 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 173.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.708 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.2 pt? -161.24 139.44 9.54 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 118.296 -1.362 . . . . 0.0 114.454 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.707 HD12 HD11 ' A' ' 72' ' ' LEU . 2.7 mp -85.86 112.35 21.05 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.991 167.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 69' ' ' ARG . 62.1 t -101.46 125.31 55.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.032 -177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -70.46 109.89 3.21 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 175.396 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -73.89 -44.36 55.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.184 -169.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.7 mtp85 -155.18 143.77 20.51 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.632 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.581 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . 172.49 -155.45 23.32 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 109.061 -1.615 . . . . 0.0 109.061 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.081 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 24.7 Cg_exo -63.87 -59.96 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.061 1.841 . . . . 0.0 111.958 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.742 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 48.2 t30 -75.67 -49.94 16.87 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.655 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.96 164.17 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 113.876 -1.511 . . . . 0.0 113.403 -174.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.49 2.71 90.61 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.745 -0.74 . . . . 0.0 113.723 172.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.939 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.6 m -101.45 -169.05 1.64 Allowed 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 117.6 0.7 . . . . 0.0 110.616 -171.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.65 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.79 160.08 5.48 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -171.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.468 ' HB2' HD13 ' A' ' 58' ' ' LEU . 1.6 m-30 -96.48 127.88 42.89 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 167.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.3 tm? -80.77 97.34 7.28 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.708 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.5 mt -94.13 46.29 1.16 Allowed 'General case' 0 C--N 1.309 -1.192 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.553 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.609 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 13.0 t70 -100.48 -19.15 16.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.756 178.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.58 -166.66 1.26 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.615 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -79.69 -37.1 36.53 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.552 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.759 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -157.79 120.24 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.049 0.452 . . . . 0.0 112.034 -175.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 8.7 p -113.41 119.86 39.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.943 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.558 ' O ' HG23 ' A' ' 87' ' ' ILE . 15.2 m -66.04 128.56 36.54 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 172.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.627 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -125.98 107.56 10.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -166.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.31 -132.97 2.85 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.854 177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.855 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.49 110.56 6.16 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.828 0.823 . . . . 0.0 108.946 173.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.526 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER -137.97 136.39 19.68 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -162.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -66.06 179.95 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.376 2.05 . . . . 0.0 108.872 155.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -76.6 73.89 3.3 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 111.738 -173.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.4 p -117.34 -69.93 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 175.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.629 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.1 OUTLIER -125.94 -80.04 0.61 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.443 0.64 . . . . 0.0 111.169 -174.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.627 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -124.12 117.38 50.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.622 -174.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.491 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -115.57 127.48 55.27 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.036 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.854 HD21 HG11 ' A' ' 60' ' ' VAL . 11.5 mt -115.91 80.5 1.46 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.795 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 36.1 t70 70.02 -8.49 0.82 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.182 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.855 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p-10 43.6 32.41 0.54 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.396 1.479 . . . . 0.0 113.105 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 23' ' ' SER . 26.0 t -138.8 -9.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.428 -176.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.738 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.1 OUTLIER -110.56 -13.55 14.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -171.465 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.819 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -118.58 146.74 22.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 121.88 -0.512 . . . . 0.0 110.679 -171.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.693 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 27.1 m -71.59 75.96 0.81 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.999 0.428 . . . . 0.0 109.924 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 62.84 -61.44 0.13 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.013 -0.994 . . . . 0.0 112.319 -172.024 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -153.7 139.53 18.08 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-O 121.687 0.756 . . . . 0.0 110.967 177.008 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.663 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -69.51 -40.3 77.04 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.028 -1.442 . . . . 0.0 108.227 176.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -158.26 179.27 9.31 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.474 -177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.711 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -142.44 131.27 22.86 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 173.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.5 OUTLIER -59.64 90.7 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.291 -175.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.551 ' HG3' ' HG2' ' A' ' 104' ' ' GLU . 3.0 tpp180 -89.98 100.4 13.23 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.239 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.825 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.6 tt -77.63 110.87 12.82 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.024 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.551 ' HG2' ' HG3' ' A' ' 102' ' ' ARG . 77.5 mm-40 -131.98 138.81 48.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.459 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 59.32 31.35 21.07 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 123.583 0.552 . . . . 0.0 110.11 -174.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.825 ' HA ' HD21 ' A' ' 103' ' ' LEU . 47.1 m-80 70.19 3.21 4.3 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.877 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 0.9 OUTLIER -96.63 149.19 22.06 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.097 0.475 . . . . 0.0 110.347 -179.48 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.501 ' HD1' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -93.8 124.08 37.57 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 177.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.439 ' OD1' HG22 ' A' ' 130' ' ' VAL . 12.9 m-80 -133.55 154.6 50.72 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.112 -0.235 . . . . 0.0 110.412 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.853 ' O ' ' HA ' ' A' ' 128' ' ' SER . 14.0 m -107.87 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.203 0.525 . . . . 0.0 110.867 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.796 HG22 ' HB3' ' A' ' 128' ' ' SER . 84.1 t -101.22 111.47 31.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.833 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -67.94 119.52 12.73 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 111' ' ' VAL . 15.7 m -120.48 -11.67 9.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.432 -170.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 146.36 71.47 0.02 OUTLIER Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.354 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.404 ' OG ' ' HA ' ' A' ' 98' ' ' HIS . 4.5 m -84.97 132.13 34.39 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.675 HD22 ' HB ' ' A' ' 22' ' ' TPO . 41.2 tp -60.94 -56.65 18.61 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 120.055 -0.658 . . . . 0.0 112.166 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.558 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -72.92 -35.78 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.38 0.61 . . . . 0.0 109.745 177.408 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.0 169.15 11.98 Favored Glycine 0 C--O 1.256 1.525 0 CA-C-N 115.355 -0.839 . . . . 0.0 113.26 -175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.1 m -113.82 125.85 54.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 114.382 -0.909 . . . . 0.0 110.969 170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' CD1' ' HE1' ' A' ' 29' ' ' PHE . 10.1 m-85 -132.75 105.7 7.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.03 0.443 . . . . 0.0 110.906 173.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 137' ' ' VAL . 45.7 t -101.44 110.3 27.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.8 HD22 HG12 ' A' ' 121' ' ' VAL . 29.2 m-80 56.73 38.38 29.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.132 0.492 . . . . 0.0 110.484 -176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 9.6 mmm180 77.43 1.87 3.05 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.389 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.7 pt-20 -126.83 130.89 23.72 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.474 0.654 . . . . 0.0 111.442 174.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 23.2 Cg_exo -65.6 125.85 15.1 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.104 2.536 . . . . 0.0 111.278 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 129' ' ' ALA . 27.8 m -115.54 165.54 10.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 111.701 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.6 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 m-20 -82.81 -51.83 7.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 171.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.3 p -160.31 91.03 0.91 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.554 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 126' ' ' VAL . . . -86.07 141.86 29.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.301 -174.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 109' ' ' ASN . 39.7 t -78.32 124.17 36.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.956 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.692 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -59.28 156.18 13.04 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 123.342 0.401 . . . . 0.0 111.659 176.242 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.472 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -157.02 154.71 30.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -69.12 98.82 1.04 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.878 0.37 . . . . 0.0 110.011 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.23 0.84 29.79 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.06 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 17.2 t70 -69.17 148.87 49.28 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 9.0 tt0 -135.9 127.15 28.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.607 0.718 . . . . 0.0 111.824 -175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -123.64 133.19 69.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.568 -177.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.528 ' CG ' ' HB2' ' A' ' 28' ' ' ASP . 20.1 tm0? -94.27 128.55 40.82 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 172.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.716 HG23 HD13 ' A' ' 144' ' ' LEU . 0.3 OUTLIER -134.65 140.87 44.77 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.891 173.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.558 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 73.5 -68.12 1.52 Allowed Glycine 0 C--O 1.223 -0.573 0 C-N-CA 120.391 -0.909 . . . . 0.0 113.231 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.081 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.7 ptmt -176.2 22.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 123.416 0.686 . . . . 0.0 109.345 170.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.742 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -123.15 161.83 23.68 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 -171.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.712 ' HE ' ' HG3' ' A' ' 32' ' ' GLU . 26.9 ttp85 -112.18 119.59 38.91 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.804 -0.358 . . . . 0.0 110.434 176.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.828 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -109.5 154.11 23.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.411 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.2 OUTLIER -141.26 139.87 32.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.155 171.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.654 ' O ' HD13 ' A' ' 147' ' ' LEU . 47.0 t80 -98.21 138.55 35.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.812 -177.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.654 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? -130.43 155.46 46.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.318 172.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.558 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 14.1 t -155.79 -175.39 5.41 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -124.48 79.66 0.36 Allowed Glycine 0 C--O 1.226 -0.344 0 C-N-CA 120.273 -0.965 . . . . 0.0 111.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.95 -59.29 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.111 2.541 . . . . 0.0 113.317 -173.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -80.5 79.2 7.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.147 0.499 . . . . 0.0 111.198 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -92.94 98.47 11.39 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -69.2 118.85 8.98 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.844 -0.694 . . . . 0.0 111.732 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -73.09 128.51 35.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.12 0.486 . . . . 0.0 110.213 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -68.79 -24.5 64.41 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.06 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -107.1 107.16 18.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.973 176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 135.24 4.26 2.6 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.136 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 25.8 m -95.43 68.17 2.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.872 0.368 . . . . 0.0 110.617 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 8.8 t -93.83 119.77 33.22 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.282 0.563 . . . . 0.0 110.587 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -138.37 -33.87 0.18 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.246 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -87.45 160.98 32.15 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.003 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 123.208 2.605 . . . . 0.0 112.123 179.116 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--O 1.233 0.186 0 CA-C-O 121.179 0.514 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.0 t -165.85 154.58 11.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.625 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -102.7 133.8 47.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.354 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.9 mtt -78.58 72.78 5.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.13 0.49 . . . . 0.0 111.069 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.849 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 38.7 m-80 -106.68 -45.69 0.12 Allowed Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.807 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.849 ' HD2' ' H ' ' A' ' 5' ' ' ASN . 15.1 Cg_endo -57.78 167.43 4.12 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.095 1.863 . . . . 0.0 112.684 176.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 6' ' ' PRO . 13.8 m-20 74.2 -62.28 0.47 Allowed 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.144 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.4 tp -72.71 -55.54 12.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -109.45 107.85 18.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.247 0.546 . . . . 0.0 109.815 -178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -94.9 72.35 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.685 -174.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 47.7 66.88 0.92 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.591 0.71 . . . . 0.0 110.866 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -100.98 82.31 2.36 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.279 -173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.4 m -66.0 102.01 0.75 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.144 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.3 m -86.62 43.29 1.07 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.002 0.429 . . . . 0.0 111.569 -173.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.94 25.2 11.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.301 178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 57.34 42.99 24.11 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.742 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 20' ' ' GLU . 16.9 m -92.1 47.36 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.94 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 p -67.98 -26.07 65.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.328 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -115.86 15.34 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.338 0.59 . . . . 0.0 110.483 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 17' ' ' VAL . 19.0 tp10 -81.88 -43.32 18.34 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 22' ' ' TPO . 94.2 m -152.86 133.01 13.47 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.441 174.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.708 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 93' ' ' THR . 16.3 m -54.68 125.65 20.73 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.874 0.369 . . . . 0.0 111.613 -175.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HB ' HD21 ' A' ' 116' ' ' LEU . 14.7 p -138.7 135.89 43.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.646 -168.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 2.2 t80 173.34 -170.64 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 122.352 0.261 . . . . 0.0 110.759 -175.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.662 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.9 OUTLIER 54.75 -153.03 0.32 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.466 0.706 . . . . 0.0 111.284 172.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 67.32 -177.91 0.21 Allowed 'General case' 0 C--O 1.236 0.363 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 171.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 33' ' ' LEU . 29.7 t70 -72.84 51.34 0.28 Allowed 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 122.459 1.123 . . . . 0.0 110.964 -177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.48 ' CD2' ' HB3' ' A' ' 27' ' ' ALA . 14.1 m-85 -142.04 -36.66 0.41 Allowed 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 51.8 tp -100.96 -68.82 0.8 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.958 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.5 m 176.29 -171.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.095 0.558 . . . . 0.0 110.779 -170.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER 78.33 43.72 0.08 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 166.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.775 ' HA ' ' NE ' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -153.05 -99.05 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.556 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.737 172.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 54.07 42.21 31.69 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 123.989 0.806 . . . . 0.0 111.566 175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.497 ' HA ' ' HG3' ' A' ' 136' ' ' GLU . . . 70.48 133.22 0.04 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 O-C-N 123.918 0.761 . . . . 0.0 111.23 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.696 ' HD3' ' HG3' ' A' ' 136' ' ' GLU . 70.3 Cg_endo -76.5 -25.34 9.69 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.476 2.117 . . . . 0.0 112.001 -177.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.17 161.37 16.92 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -91.3 94.91 9.74 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 68.69 -79.16 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 O-C-N 123.877 0.736 . . . . 0.0 111.318 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 169.97 108.89 0.21 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.115 -1.04 . . . . 0.0 113.31 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.2 t -99.1 -25.26 14.6 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -152.96 93.75 1.78 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.172 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.8 m -138.72 34.31 2.21 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.21 175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.87 -47.09 12.23 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.669 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.7 m -63.65 -29.33 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.05 178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.745 ' HB2' ' HG ' ' A' ' 147' ' ' LEU . 4.7 p -93.97 -12.57 28.45 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.102 0.477 . . . . 0.0 110.841 178.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.22 -32.91 12.7 Favored Glycine 0 CA--C 1.493 -1.325 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -177.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.8 m -86.21 10.48 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 114.769 -0.716 . . . . 0.0 110.519 175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -97.97 -29.36 13.34 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.298 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 147' ' ' LEU . . . -100.23 -68.05 0.85 Allowed Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.062 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.687 ' C ' ' HD2' ' A' ' 53' ' ' PRO . 11.5 mt 44.42 -175.46 0.0 OUTLIER Pre-proline 0 CA--C 1.551 0.998 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 -171.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' N ' ' HD2' ' A' ' 53' ' ' PRO . 14.1 Cg_endo -94.73 14.83 1.24 Allowed 'Trans proline' 0 CA--C 1.557 1.662 0 C-N-CA 122.243 1.962 . . . . 0.0 116.865 174.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.687 ' HD2' ' C ' ' A' ' 51' ' ' LEU . 18.5 Cg_endo -61.38 -158.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.691 0 C-N-CA 121.998 1.798 . . . . 0.0 113.462 167.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -54.59 -28.24 44.79 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 137.41 26.71 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -123.77 172.8 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 169.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -155.06 144.27 21.05 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 117.566 -1.654 . . . . 0.0 114.743 -179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.004 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.2 mp -93.56 112.57 24.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.776 -1.556 . . . . 0.0 108.807 166.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 5.9 p -111.97 131.67 62.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 120.859 -0.336 . . . . 0.0 110.695 -176.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.004 HG11 HD11 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -76.51 110.48 11.98 Favored 'Isoleucine or valine' 0 C--O 1.244 0.815 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -72.33 -58.59 3.28 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.343 -173.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -145.07 131.8 20.01 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.717 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.636 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.01 -174.34 38.77 Favored Glycine 0 N--CA 1.422 -2.256 0 N-CA-C 108.081 -2.008 . . . . 0.0 108.081 -177.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.921 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 44.7 Cg_exo -56.59 -47.55 23.21 Favored 'Trans proline' 0 C--N 1.321 -0.873 0 C-N-CA 121.964 1.776 . . . . 0.0 113.015 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.489 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 64.1 t30 -82.91 -51.76 7.31 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 121.815 0.816 . . . . 0.0 108.817 172.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.636 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 54.91 170.76 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.079 -171.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.79 2.5 90.56 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.778 -0.725 . . . . 0.0 114.057 171.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.976 ' H ' HG22 ' A' ' 60' ' ' VAL . 7.2 m -99.91 179.32 4.55 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 117.901 0.85 . . . . 0.0 110.653 -170.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.689 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.81 154.7 4.41 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.008 0.367 . . . . 0.0 111.821 -175.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.587 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -93.54 116.26 28.78 Favored 'General case' 0 C--O 1.244 0.794 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 171.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.8 tt -74.27 97.19 2.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 O-C-N 124.403 1.064 . . . . 0.0 108.809 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.756 HD11 HD12 ' A' ' 58' ' ' LEU . 12.5 mt -91.19 32.27 1.05 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.786 -175.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -88.69 -15.71 34.18 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -87.72 -167.08 1.77 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.375 176.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -91.68 -30.87 16.07 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.056 0.455 . . . . 0.0 109.802 173.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -160.98 133.1 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.04 176.48 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.593 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 23.1 p -121.51 147.89 45.19 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.899 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.643 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 59.8 m -93.63 126.54 38.85 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 110.515 -0.18 . . . . 0.0 110.515 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.617 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -115.83 128.87 56.15 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.974 0.731 . . . . 0.0 112.974 -173.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.33 -117.0 1.1 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.109 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -101.55 101.69 12.3 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.422 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.719 ' CE1' ' HG3' ' A' ' 96' ' ' ARG . 76.1 m-70 -139.65 122.1 10.17 Favored Pre-proline 0 N--CA 1.441 -0.917 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -169.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 8.3 Cg_exo -80.51 -13.84 11.91 Favored 'Trans proline' 0 C--N 1.327 -0.59 0 C-N-CA 123.683 2.922 . . . . 0.0 112.332 168.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -124.11 -34.89 2.89 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -170.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 1.4 m -78.52 -173.56 3.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 -164.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.484 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 10.9 m-20 -91.26 -16.91 26.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.543 -1.208 . . . . 0.0 112.791 -171.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.689 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -132.54 97.65 2.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 122.078 0.942 . . . . 0.0 110.203 178.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.441 ' C ' HD22 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -110.74 130.26 55.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.33 -178.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.004 HD11 HG11 ' A' ' 60' ' ' VAL . 4.5 mm? -116.2 76.09 1.0 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.94 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.2 t0 67.98 -0.64 1.99 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.644 0.735 . . . . 0.0 110.019 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.3 p-10 35.67 44.0 0.19 Allowed 'General case' 0 C--N 1.341 0.205 0 CA-C-N 113.748 -1.569 . . . . 0.0 113.306 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . 9.9 p -151.85 2.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.396 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.587 ' HA ' ' O ' ' A' ' 23' ' ' SER . 18.9 p -111.85 -7.95 14.15 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.849 -0.532 . . . . 0.0 112.045 -174.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.449 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.9 t -126.81 147.3 31.71 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 O-C-N 122.043 -0.41 . . . . 0.0 110.292 -173.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.594 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 4.2 m -71.01 73.76 0.62 Allowed 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 176.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.719 ' HG3' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 58.4 -61.59 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.292 -165.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.681 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 40.9 ttm180 -145.39 132.3 20.19 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 121.276 -0.89 . . . . 0.0 111.603 -163.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.867 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -87.92 -46.78 9.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.514 170.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.734 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.73 158.38 43.86 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 114.165 -1.38 . . . . 0.0 110.201 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.681 ' HB3' ' HD3' ' A' ' 97' ' ' ARG . 7.8 pt-20 -124.27 130.96 53.42 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 166.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.07 95.97 0.05 OUTLIER 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.272 -174.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 3.9 tpp180 -92.87 106.48 18.44 Favored 'General case' 0 N--CA 1.416 -2.165 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.235 -178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 106' ' ' ASN . 9.3 tt -76.24 109.11 9.65 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -128.23 136.17 50.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.923 -177.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 60.03 31.83 20.8 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.888 ' HA ' HD21 ' A' ' 103' ' ' LEU . 67.3 m-20 63.5 15.36 8.75 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.415 -177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -114.15 156.36 24.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.882 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.9 OUTLIER -94.68 133.52 38.27 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -176.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.447 ' OD1' HG22 ' A' ' 130' ' ' VAL . 14.5 m-80 -139.91 159.49 42.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -107.79 126.3 64.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.267 171.061 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 34.2 m -101.92 123.64 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.684 176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.93 126.35 30.8 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.819 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 m -128.77 -3.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.746 0.308 . . . . 0.0 110.619 -177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 121.45 91.6 1.16 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.402 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.761 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 18.1 t -98.83 134.97 40.95 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.708 HD22 ' HB ' ' A' ' 22' ' ' TPO . 20.4 tp -52.47 -58.15 7.63 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -172.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.71 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 11.5 m-80 -70.6 -37.61 73.89 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 145.72 159.69 8.28 Favored Glycine 0 C--O 1.242 0.646 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.54 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.519 HG23 ' CE1' ' A' ' 98' ' ' HIS . 15.6 m -112.13 132.92 54.58 Favored 'General case' 0 N--CA 1.462 0.132 0 C-N-CA 122.795 0.438 . . . . 0.0 111.148 173.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -141.29 140.14 33.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.655 0.264 . . . . 0.0 110.557 171.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.741 HG22 HG13 ' A' ' 137' ' ' VAL . 73.1 t -127.89 107.63 16.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 169.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 135' ' ' ASP . 1.9 m120 64.0 35.96 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.409 0.623 . . . . 0.0 109.386 -176.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 35.7 mtt180 59.42 30.18 19.83 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.926 -174.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.8 pt-20 -139.62 128.06 13.4 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 168.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.43 122.66 8.49 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.142 1.895 . . . . 0.0 110.955 176.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.36 162.1 16.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.713 0.292 . . . . 0.0 111.755 -174.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.602 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 14.0 m-20 -72.16 -59.02 2.95 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 173.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.752 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 46.7 t -159.64 109.63 1.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.299 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.02 141.93 47.47 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.173 0.434 . . . . 0.0 112.173 -173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 ' OD1' ' A' ' 109' ' ' ASN . 4.1 t -74.28 142.34 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.596 -178.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.882 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.1 mp -51.0 150.93 2.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 111.489 173.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -134.33 -176.47 4.21 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -109.55 98.75 8.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.655 0.264 . . . . 0.0 110.928 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 105.5 4.42 40.29 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.355 -0.926 . . . . 0.0 114.1 172.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.934 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 19.7 m-20 -101.81 157.84 16.55 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.134 0.467 . . . . 0.0 110.331 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.696 ' HG3' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -105.22 162.04 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -173.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.741 HG13 HG22 ' A' ' 121' ' ' VAL . 47.7 t -136.22 126.57 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.589 0 CA-C-N 114.058 -1.428 . . . . 0.0 107.595 172.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.531 ' OE1' ' HB1' ' A' ' 27' ' ' ALA . 0.9 OUTLIER -98.87 111.35 23.77 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.933 178.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.867 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -111.95 134.97 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.191 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 170.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.71 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 61.64 -101.4 0.34 Allowed Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.99 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 15.2 ptmt -141.64 19.36 2.18 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.76 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.678 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 1.5 m-85 -112.3 144.31 41.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.509 -173.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.775 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 10.1 ttm180 -92.4 87.1 5.89 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.887 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.1 mp -83.14 160.82 21.78 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.026 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.88 139.2 31.08 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 170.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.004 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -97.53 141.87 30.05 Favored 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.213 178.438 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.745 ' HG ' ' HB2' ' A' ' 46' ' ' SER . 2.7 mm? -126.6 114.9 18.69 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.422 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 10.9 t -126.23 -167.57 1.73 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 165.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.661 ' HA3' HD23 ' A' ' 51' ' ' LEU . . . -135.65 108.38 0.68 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 119.571 -1.299 . . . . 0.0 113.478 -175.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 154' ' ' GLU . 21.7 Cg_exo -66.63 103.23 0.67 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.925 2.417 . . . . 0.0 110.097 171.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 1.021 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 0.3 OUTLIER -92.55 -14.64 28.03 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -168.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -89.61 -37.91 14.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 146.24 -46.27 0.76 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 150' ' ' PRO . 2.2 mp0 55.76 33.1 20.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.566 0.698 . . . . 0.0 110.997 174.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.63 -6.64 54.34 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.863 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -72.18 103.02 3.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.413 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 161.33 137.56 2.23 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.5 t -162.07 145.14 11.78 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -177.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 3.7 m 57.46 58.84 3.58 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.72 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -123.61 140.54 12.96 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.742 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 143.6 -70.33 0.4 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.883 -177.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 C--O 1.249 1.035 0 C-N-CA 122.95 2.433 . . . . 0.0 111.887 178.143 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 121.963 0.887 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 94.9 m 66.91 79.11 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.577 -1.192 . . . . 0.0 111.287 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -84.54 111.68 19.73 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.185 173.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -141.75 14.1 2.11 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.094 0.473 . . . . 0.0 110.599 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -120.21 108.58 38.01 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.668 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -73.97 -27.16 12.39 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.36 2.04 . . . . 0.0 110.964 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -131.97 162.86 29.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.883 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -111.58 16.86 7.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.07 0.462 . . . . 0.0 110.564 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -85.88 -42.02 14.46 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.122 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -82.83 7.61 14.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.845 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -69.04 -43.74 74.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.023 0.44 . . . . 0.0 109.885 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.52 133.83 52.93 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 173.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 p -112.18 -11.58 13.74 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.5 t 57.56 78.24 0.24 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.431 0.634 . . . . 0.0 109.881 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -96.3 -34.98 11.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.568 -172.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -77.73 -10.04 59.32 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -169.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 p -67.55 -30.04 47.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.042 0.448 . . . . 0.0 111.198 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.2 p -98.26 87.12 3.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.99 0.424 . . . . 0.0 111.522 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.462 HG23 ' H ' ' A' ' 20' ' ' GLU . 2.6 m -96.2 -106.7 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.798 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' H ' HG23 ' A' ' 19' ' ' VAL . 47.8 mt-10 -87.4 80.35 8.17 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.081 0.467 . . . . 0.0 110.307 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.3 m -155.89 133.59 11.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.1 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.762 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.758 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 43.1 m 33.34 124.96 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 116.813 2.153 . . . . 0.0 116.813 -176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.863 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 8.1 t -110.92 131.86 60.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 113.813 -1.539 . . . . 0.0 112.11 -176.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.617 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 20.6 t80 175.73 -177.38 0.12 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 173.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.957 ' HD2' ' H ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER 54.86 -158.41 0.2 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.233 1.013 . . . . 0.0 111.21 172.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.957 ' H ' ' HD2' ' A' ' 26' ' ' ARG . . . 62.17 -174.87 0.14 Allowed 'General case' 0 C--O 1.237 0.425 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 170.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.725 ' HA ' HD11 ' A' ' 33' ' ' LEU . 25.6 t70 -72.71 57.45 0.42 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 122.18 0.991 . . . . 0.0 111.123 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.423 ' HD1' ' HB3' ' A' ' 27' ' ' ALA . 20.6 m-85 -145.21 -45.27 0.22 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.4 tp -90.01 -16.32 30.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.728 -1.124 . . . . 0.0 109.337 168.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.3 p 77.91 30.35 0.46 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.75 1.22 . . . . 0.0 111.717 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.708 ' HB2' ' HD3' ' A' ' 26' ' ' ARG . 46.0 mt-10 -79.18 66.73 4.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.804 0.812 . . . . 0.0 110.26 176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.725 HD11 ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -143.56 -50.21 0.32 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.473 -1.239 . . . . 0.0 107.821 -176.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.4 t70 52.21 83.96 0.05 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.155 -1.839 . . . . 0.0 111.869 175.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 48.17 65.86 6.48 Favored Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.553 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.52 ' HG3' ' HB3' ' A' ' 33' ' ' LEU . 86.1 Cg_endo -86.98 178.45 3.61 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.764 2.309 . . . . 0.0 112.534 -176.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 57.82 38.95 27.36 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.389 0.614 . . . . 0.0 110.445 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -76.4 -15.9 59.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.71 -176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.48 16.71 8.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.406 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.61 93.54 1.48 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.931 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.2 t -122.84 141.24 52.07 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.888 0.375 . . . . 0.0 110.653 -178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -79.2 70.83 5.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.967 176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -137.11 133.64 35.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.394 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.34 91.29 8.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.517 174.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 54.4 t -104.53 121.01 55.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.164 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.4 m -76.0 77.61 2.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.39 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.56 64.91 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.728 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 m -103.92 -114.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 121.012 0.434 . . . . 0.0 110.653 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -100.78 -25.57 14.08 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.588 0.709 . . . . 0.0 110.187 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.447 ' C ' ' HD3' ' A' ' 52' ' ' PRO . . . 76.06 45.07 16.77 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.395 177.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.696 ' HB2' ' HA ' ' A' ' 148' ' ' THR . 70.6 mt -116.26 76.64 6.92 Favored Pre-proline 0 C--N 1.326 -0.445 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.477 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 89.3 Cg_endo -104.59 39.37 0.04 OUTLIER 'Trans proline' 0 CA--C 1.551 1.364 0 C-N-CA 122.677 2.251 . . . . 0.0 115.271 170.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 51' ' ' LEU . 53.1 Cg_endo -92.51 -151.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.183 0 C-N-CA 121.832 1.688 . . . . 0.0 111.181 175.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -79.2 7.72 50.65 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.691 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 48.0 p -146.1 141.18 27.3 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -176.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.21 172.78 9.25 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 168.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.732 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 1.8 pt? -160.76 142.05 11.96 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 117.81 -1.556 . . . . 0.0 114.964 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.623 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.2 mp -85.69 117.35 24.53 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 113.687 -1.597 . . . . 0.0 107.95 167.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.8 t -108.08 129.0 63.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.934 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -71.5 109.86 4.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 172.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -65.1 -67.37 0.44 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 113.778 -1.555 . . . . 0.0 110.048 -170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 -145.26 125.23 13.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.726 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.758 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -163.27 -140.33 2.85 Favored Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 175.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.995 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 21.5 Cg_exo -66.87 -69.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.67 2.246 . . . . 0.0 112.446 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.752 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 55.5 t30 -69.09 -48.22 63.19 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 174.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.758 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.01 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 113.811 -1.54 . . . . 0.0 112.671 -175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.3 2.11 90.34 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.344 -0.931 . . . . 0.0 113.221 175.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.0 m -86.76 -179.86 6.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 117.316 0.558 . . . . 0.0 110.287 -173.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.66 150.15 3.29 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 118.596 0.635 . . . . 0.0 112.412 -172.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HB2' HD13 ' A' ' 58' ' ' LEU . 0.8 OUTLIER -94.47 120.39 34.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.625 ' O ' HG21 ' A' ' 77' ' ' THR . 0.7 OUTLIER -80.92 91.37 6.0 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 -175.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.732 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 6.8 mt -83.38 52.12 2.15 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.051 -0.66 . . . . 0.0 110.063 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.614 ' HB2' HD21 ' A' ' 71' ' ' LEU . 17.7 t70 -96.36 -37.85 10.31 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.574 178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -96.51 -166.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.774 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.84 -52.22 39.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.715 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -154.0 123.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.634 0.73 . . . . 0.0 112.546 -177.165 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.821 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 65.2 p -103.99 138.74 40.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.519 -177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.799 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 48.8 m -82.05 124.88 30.21 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.137 -0.319 . . . . 0.0 110.137 177.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.688 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -121.77 114.77 21.56 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -171.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.716 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 152.25 -140.31 7.63 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.72 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -70.68 104.04 2.72 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 172.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.499 ' HE1' ' HD3' ' A' ' 96' ' ' ARG . 57.4 m-70 -139.63 115.09 8.11 Favored Pre-proline 0 C--N 1.316 -0.87 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -68.47 -50.92 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.694 2.262 . . . . 0.0 111.389 168.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.21 77.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.015 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.799 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 8.2 m -146.74 -161.2 1.28 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.448 177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.821 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 7.1 m-20 -91.63 -42.57 10.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.099 0.476 . . . . 0.0 111.326 -175.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.688 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -126.48 105.33 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 121.647 0.737 . . . . 0.0 111.124 -177.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -103.89 134.44 47.19 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.647 177.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.049 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -118.6 77.14 1.14 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.738 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.4 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.6 t70 67.81 -18.5 0.15 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.473 0.654 . . . . 0.0 111.267 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 33.1 t70 67.05 24.13 9.53 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.854 -1.067 . . . . 0.0 111.429 172.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.758 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.8 p -156.47 53.2 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.375 0 CA-C-O 122.296 1.046 . . . . 0.0 110.769 172.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' HG2' ' A' ' 141' ' ' LYS . 0.2 OUTLIER -152.81 0.06 0.27 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.123 172.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.714 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 1.8 t -137.23 140.49 42.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.218 -173.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.455 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 15.9 m -73.68 74.03 1.52 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.784 0.326 . . . . 0.0 110.238 177.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.499 ' HD3' ' HE1' ' A' ' 82' ' ' HIS . 0.2 OUTLIER 66.96 -66.64 0.18 Allowed 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.248 -173.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.423 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -139.57 144.1 37.64 Favored 'General case' 0 C--N 1.312 -1.03 0 O-C-N 121.702 -0.624 . . . . 0.0 110.523 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.96 -41.39 12.41 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 170.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.854 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -145.17 165.54 28.02 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 113.553 -1.658 . . . . 0.0 109.396 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.9 pt-20 -132.69 127.04 33.94 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 167.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.715 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -58.28 100.73 0.07 Allowed 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.692 -174.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 18.8 tpp85 -94.62 100.35 12.32 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-N 114.781 -1.1 . . . . 0.0 109.735 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.657 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -79.48 104.6 10.2 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.128 175.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -134.75 140.67 46.1 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.865 -1.062 . . . . 0.0 108.717 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 62.34 32.13 17.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.397 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.657 ' HA ' HD21 ' A' ' 103' ' ' LEU . 43.2 m-80 64.58 15.01 9.38 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.882 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 49.0 mt-10 -121.86 146.43 47.1 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 120.873 0.368 . . . . 0.0 110.809 -177.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -85.8 122.14 29.45 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.534 -176.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -123.87 166.16 16.11 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -177.704 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.875 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.8 m -115.65 128.53 72.86 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.245 172.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.854 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.8 t -101.51 111.87 32.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.298 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.77 119.88 21.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.564 HG13 HG12 ' A' ' 111' ' ' VAL . 35.6 m -116.59 -27.52 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.77 0.319 . . . . 0.0 111.085 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 147.23 105.97 0.43 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.797 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 33.9 t -101.48 146.88 27.04 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 122.264 0.226 . . . . 0.0 110.6 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 3.2 tm? -60.52 -55.76 29.52 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.628 0.252 . . . . 0.0 110.904 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.863 ' OD1' ' HA ' ' A' ' 24' ' ' VAL . 61.5 m-20 -74.05 -36.42 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.22 160.82 8.6 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.559 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 20.2 m -112.81 132.5 55.24 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.616 0.367 . . . . 0.0 111.727 175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.823 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 57.0 m-85 -141.37 105.38 4.77 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.995 0.426 . . . . 0.0 110.683 171.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.961 HG22 HG13 ' A' ' 137' ' ' VAL . 88.0 t -92.04 114.24 28.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 62.17 36.98 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -172.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.823 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 35.0 mtp-105 53.85 31.99 14.21 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.974 -172.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.7 pt-20 -141.8 137.86 16.56 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.916 0.389 . . . . 0.0 109.979 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.95 122.93 10.33 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.09 1.86 . . . . 0.0 111.8 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.0 m -116.93 176.89 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.561 0.219 . . . . 0.0 110.806 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.448 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 27.2 t70 -94.75 -66.13 0.93 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 173.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.875 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 43.4 t -153.15 92.45 1.62 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.176 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.82 142.41 29.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.023 -175.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 26.0 t -79.45 129.83 36.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.09 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.725 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 1.0 OUTLIER -59.78 163.75 4.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -167.96 168.99 11.68 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.83 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.8 t30 -61.44 115.52 3.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.849 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.51 5.24 72.32 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.319 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -75.5 108.96 8.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.078 0.466 . . . . 0.0 110.453 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.441 ' OE2' ' HB2' ' A' ' 36' ' ' PRO . 8.2 tt0 -94.79 131.8 40.25 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.194 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.961 HG13 HG22 ' A' ' 121' ' ' VAL . 42.0 t -124.14 130.84 73.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.348 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 12.8 tm0? -101.24 121.68 42.3 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.904 172.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.049 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.52 140.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 170.219 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.59 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 58.12 -98.87 0.1 OUTLIER Glycine 0 N--CA 1.436 -1.335 0 C-N-CA 120.3 -0.952 . . . . 0.0 110.869 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.995 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.2 ptmt -140.85 18.22 2.32 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.235 0.54 . . . . 0.0 111.096 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.752 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -110.42 150.29 29.04 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -176.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 14.3 ttp85 -107.37 105.46 15.41 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.8 ' HG ' HG12 ' A' ' 60' ' ' VAL . 5.3 mp -98.71 157.51 16.22 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.505 -173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.78 141.32 32.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.106 169.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.725 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 37.3 t80 -100.07 137.65 38.23 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.133 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.602 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -135.74 169.93 16.78 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.207 170.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.696 ' HA ' ' HB2' ' A' ' 51' ' ' LEU . 13.9 t -175.54 168.62 3.19 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -173.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' N ' ' H ' ' A' ' 51' ' ' LEU . . . -110.06 138.59 14.96 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.561 171.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.71 113.63 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.293 0 C-N-CA 122.852 2.368 . . . . 0.0 112.225 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -102.38 2.89 37.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.468 0.651 . . . . 0.0 110.015 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -121.87 53.41 1.2 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.675 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -159.36 -116.96 0.46 Allowed Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.127 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -165.82 -71.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 54.47 45.72 26.45 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.85 171.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -83.99 140.92 31.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 116.65 45.23 0.56 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -174.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.4 m -87.97 135.57 33.35 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.704 0.288 . . . . 0.0 111.169 -175.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.2 t -172.0 74.49 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.007 0.908 . . . . 0.0 109.788 175.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -73.12 -15.66 78.62 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.675 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 149.02 156.76 7.3 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 121.036 -0.602 . . . . 0.0 111.791 179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 C--O 1.249 1.041 0 C-N-CA 122.832 2.355 . . . . 0.0 111.687 179.173 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 66.4 t . . . . . 0 N--CA 1.454 -0.238 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 t -58.57 105.96 0.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.739 0.78 . . . . 0.0 111.844 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -116.59 87.75 2.75 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.3 176.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.7 ptm -75.46 173.56 10.79 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.934 -177.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 48.9 t30 -59.1 120.36 46.54 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.608 175.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 5' ' ' ASN . 11.3 Cg_exo -72.09 53.79 2.08 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.296 2.664 . . . . 0.0 112.998 -177.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -100.2 138.22 37.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.847 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -82.01 89.86 2.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.564 0.697 . . . . 0.0 112.1 -173.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -81.78 58.18 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 170.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 1.2 tmmt? -156.33 98.17 1.82 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.3 -176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -127.6 146.8 50.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -141.67 25.06 2.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.919 0.39 . . . . 0.0 110.92 -177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 t -144.3 -27.17 0.52 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.961 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -121.35 59.37 0.96 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.688 0.756 . . . . 0.0 109.079 177.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -89.92 -155.87 0.39 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.801 -176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 62.36 33.43 16.4 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-O 121.311 0.576 . . . . 0.0 110.147 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 19' ' ' VAL . 5.1 p -73.51 100.75 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.863 0.84 . . . . 0.0 110.061 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.0 t -87.97 55.97 3.68 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 122.216 1.007 . . . . 0.0 111.59 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG22 HG22 ' A' ' 17' ' ' VAL . 15.5 m -92.64 57.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.116 176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -79.24 61.12 3.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.469 -174.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.617 HG23 HD21 ' A' ' 116' ' ' LEU . 95.8 m -103.47 132.14 49.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 169.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.67 HG21 ' O ' ' A' ' 94' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m -74.17 112.23 10.12 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -170.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 117' ' ' ASN . 54.4 t -68.47 143.05 15.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 114.085 -1.416 . . . . 0.0 111.822 174.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.568 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 16.7 t80 174.29 -177.9 0.09 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 123.418 0.449 . . . . 0.0 110.794 168.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.792 HH22 ' HB2' ' A' ' 143' ' ' ARG . 0.0 OUTLIER 42.88 -110.1 0.14 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.933 0.893 . . . . 0.0 111.819 174.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' A' ' 141' ' ' LYS . . . 65.38 158.49 0.1 Allowed 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 172.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.614 ' HA ' HD21 ' A' ' 33' ' ' LEU . 9.7 t70 -82.09 69.54 8.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.589 -174.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE2' ' HE1' ' A' ' 120' ' ' TYR . 85.7 m-85 -139.22 -72.15 0.39 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.657 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 30' ' ' LEU . 16.2 tp -141.4 45.36 1.74 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.703 0.763 . . . . 0.0 111.48 -177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.9 p -128.19 -146.42 0.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.233 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.677 ' HB2' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 -71.75 67.7 0.59 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.964 0.506 . . . . 0.0 111.886 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.631 ' HA ' ' NH2' ' A' ' 143' ' ' ARG . 1.6 pp -174.12 -28.51 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.363 0.601 . . . . 0.0 110.351 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -89.22 98.09 11.57 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.117 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.51 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -148.32 134.2 9.67 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.348 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 5.1 Cg_exo -75.12 65.47 6.17 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 123.401 2.734 . . . . 0.0 112.486 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.73 88.65 2.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.959 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 56.87 71.94 0.54 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.597 0.713 . . . . 0.0 110.566 -177.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.21 34.66 0.74 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.396 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.08 83.43 1.63 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 176.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.8 m -85.69 74.41 10.25 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.468 0.651 . . . . 0.0 110.326 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -114.93 90.11 3.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.25 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.5 m -83.93 153.77 23.75 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.546 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.56 73.2 10.58 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.326 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.507 ' HA ' ' CB ' ' A' ' 132' ' ' ALA . 5.8 p -59.84 -47.89 89.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.129 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 m -95.33 44.75 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.36 0.6 . . . . 0.0 109.873 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.24 27.31 4.81 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.716 -178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.623 HG21 ' HA ' ' A' ' 132' ' ' ALA . 3.1 t -111.94 -109.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 52.15 91.45 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 114.482 -1.235 . . . . 0.0 112.383 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.74 31.83 0.58 Allowed Glycine 0 C--N 1.317 -0.527 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.619 -178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.406 HD21 ' HE2' ' A' ' 108' ' ' PHE . 3.1 pp -80.23 126.85 78.27 Favored Pre-proline 0 N--CA 1.449 -0.521 0 CA-C-O 121.239 0.542 . . . . 0.0 110.551 175.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' CD ' ' HD3' ' A' ' 53' ' ' PRO . 40.0 Cg_endo -68.73 -29.03 29.91 Favored 'Trans proline' 0 CA--C 1.551 1.349 0 C-N-CA 123.335 2.69 . . . . 0.0 116.557 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.802 ' HG3' ' HD3' ' A' ' 150' ' ' PRO . 72.6 Cg_endo -91.94 158.62 3.34 Favored 'Trans proline' 0 C--N 1.36 1.178 0 CA-C-N 121.645 1.623 . . . . 0.0 112.825 -171.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -86.0 -19.32 57.84 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.8 OUTLIER -107.51 125.18 50.95 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.069 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 72' ' ' LEU . . . -125.88 171.79 10.43 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.506 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.7 pp -155.0 137.91 15.43 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 117.541 -1.664 . . . . 0.0 114.93 -178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 131' ' ' LEU . 1.3 mp -85.29 110.88 19.39 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 113.396 -1.729 . . . . 0.0 106.457 162.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.506 ' HB ' HD13 ' A' ' 57' ' ' LEU . 5.8 p -105.41 127.64 60.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.086 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.924 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -71.44 108.97 3.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 175.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.94 -57.5 6.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.604 -1.634 . . . . 0.0 109.881 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -150.7 131.06 13.71 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.304 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -169.93 -161.18 19.94 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 108.741 -1.744 . . . . 0.0 108.741 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.103 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 31.2 Cg_exo -60.55 -51.92 4.52 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 121.974 1.782 . . . . 0.0 113.055 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 63.9 t30 -78.2 -49.29 14.06 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 172.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.64 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.6 158.96 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.656 -1.611 . . . . 0.0 112.956 -172.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.05 0.66 89.82 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.924 ' H ' HG22 ' A' ' 60' ' ' VAL . 12.3 t -98.49 -178.01 3.87 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 118.343 1.071 . . . . 0.0 110.811 -173.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.24 156.68 5.9 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.283 0.492 . . . . 0.0 112.112 -173.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.569 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -95.77 113.47 25.1 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 170.316 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 71' ' ' LEU . 1.3 pt? -79.65 92.61 5.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 123.067 1.413 . . . . 0.0 108.609 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.592 HD13 ' CB ' ' A' ' 108' ' ' PHE . 12.1 mt -74.18 46.51 0.25 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.018 -1.447 . . . . 0.0 111.009 -175.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.643 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 35.2 t70 -94.73 -25.49 16.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.743 0.782 . . . . 0.0 109.173 177.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -84.61 -167.79 1.93 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.444 -1.253 . . . . 0.0 110.745 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.67 -30.08 22.0 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.755 0.312 . . . . 0.0 110.236 173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.739 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.54 137.66 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.478 179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.62 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 59.7 p -128.51 132.79 48.34 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.753 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.817 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 35.8 m -82.55 125.53 31.25 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.836 0.35 . . . . 0.0 110.419 177.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB2' HG21 ' A' ' 87' ' ' ILE . . . -122.54 117.41 25.83 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -168.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.523 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 154.83 -82.72 0.16 Allowed Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.241 -0.98 . . . . 0.0 111.182 174.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.599 ' HG2' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -124.6 103.1 7.95 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.817 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -138.75 126.52 13.52 Favored Pre-proline 0 C--N 1.307 -1.268 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.471 -171.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -65.58 -53.91 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.365 2.043 . . . . 0.0 112.228 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -162.74 92.17 0.77 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.596 0.236 . . . . 0.0 111.051 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.53 -82.0 0.1 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.524 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.608 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 0.1 OUTLIER -128.55 -74.6 0.57 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.386 0.612 . . . . 0.0 111.096 -172.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.762 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -118.42 109.83 28.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.667 0.746 . . . . 0.0 110.481 -177.489 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -116.17 135.07 54.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.979 -178.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.956 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -122.37 74.04 1.15 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.652 177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 92' ' ' VAL . 39.0 t70 75.28 -22.49 0.26 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.488 0.661 . . . . 0.0 111.01 176.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 30.0 t70 59.68 36.19 22.43 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.036 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 22' ' ' TPO . 41.6 t -137.87 -10.4 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.626 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.433 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 31.3 p -106.98 -24.48 11.99 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -169.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.67 ' O ' HG21 ' A' ' 22' ' ' TPO . 2.7 t -118.59 147.4 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.881 0.372 . . . . 0.0 111.375 -169.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.526 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 20.3 m -76.12 81.31 2.94 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 122.053 -0.404 . . . . 0.0 110.228 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.821 ' HG3' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 67.28 -69.4 0.13 Allowed 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.567 -173.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HG2' ' HG3' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -156.04 142.28 18.34 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.566 0.698 . . . . 0.0 111.461 -178.25 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.806 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -79.46 -42.26 25.72 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.396 172.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.829 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.62 153.6 44.86 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 114.739 -1.119 . . . . 0.0 111.067 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' A' ' 76' ' ' ILE . 5.4 pt-20 -115.51 126.92 54.88 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 166.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.739 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.84 98.99 0.11 Allowed 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.552 -176.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.477 HH21 ' CD ' ' A' ' 100' ' ' GLU . 19.9 tpp85 -90.07 101.13 13.85 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.019 -176.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.842 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.1 tt -83.2 110.76 18.34 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.434 ' HG2' HD22 ' A' ' 105' ' ' ASN . 32.6 tt0 -132.21 128.35 37.75 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.115 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.434 HD22 ' HG2' ' A' ' 104' ' ' GLU . 52.8 m-80 60.64 36.97 19.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.053 0.454 . . . . 0.0 110.484 -174.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.842 ' HA ' HD21 ' A' ' 103' ' ' LEU . 0.2 OUTLIER 69.3 8.44 6.8 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 114.814 -1.084 . . . . 0.0 111.773 178.083 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 26.0 mm-40 -109.21 140.83 42.32 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 121.906 -0.496 . . . . 0.0 110.935 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.592 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -90.07 127.8 36.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.808 -177.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.579 HD22 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -127.03 159.99 32.47 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.34 -178.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.729 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.4 OUTLIER -106.27 124.79 61.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.147 0.499 . . . . 0.0 109.916 169.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.829 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.3 t -102.75 113.97 40.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.889 178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.49 ' HB2' HG21 ' A' ' 119' ' ' THR . 18.2 t0 -70.93 118.26 13.48 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.301 -0.559 . . . . 0.0 109.514 177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.815 HG13 HG12 ' A' ' 111' ' ' VAL . 11.1 m -122.93 -37.12 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -175.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 178.77 79.68 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.022 -1.085 . . . . 0.0 113.099 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.639 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 25.7 t -93.34 122.98 36.31 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.617 HD21 HG23 ' A' ' 21' ' ' THR . 3.0 tm? -63.41 -45.45 90.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.592 -176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.656 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 23.8 m-80 -82.52 -36.72 26.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.843 0.354 . . . . 0.0 110.128 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 146.2 152.2 5.59 Favored Glycine 0 CA--C 1.524 0.609 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.606 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 112' ' ' ASP . 17.1 m -111.87 128.44 56.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.909 0.385 . . . . 0.0 111.539 175.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 23.3 m-85 -139.01 146.58 41.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 173.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 137' ' ' VAL . 97.0 t -134.3 106.6 8.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 173.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.655 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.5 OUTLIER 64.18 41.0 6.45 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -174.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 34.3 ttm105 63.97 17.23 10.45 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.009 -178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.5 pt-20 -134.61 126.15 17.93 Favored Pre-proline 0 C--N 1.331 -0.218 0 O-C-N 121.648 -0.657 . . . . 0.0 110.142 172.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.89 122.34 9.46 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.294 1.996 . . . . 0.0 111.712 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 30.5 m -111.97 178.74 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.678 0.275 . . . . 0.0 110.707 178.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.545 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.2 p-10 -101.86 -46.77 4.8 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 175.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.729 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 17.4 p -159.17 94.32 1.19 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.019 177.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.18 144.34 30.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.074 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.447 HG22 HD21 ' A' ' 109' ' ' ASN . 26.0 t -76.96 131.29 35.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.127 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -61.03 155.18 20.83 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.846 179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.623 ' HA ' HG21 ' A' ' 48' ' ' VAL . . . -156.31 156.81 34.63 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.182 0.515 . . . . 0.0 111.738 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -64.27 111.02 2.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.702 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.88 1.58 59.85 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.851 -0.69 . . . . 0.0 111.839 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 15.6 t70 -72.29 128.45 35.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.618 0.247 . . . . 0.0 110.761 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.461 ' OE1' ' HD3' ' A' ' 143' ' ' ARG . 7.1 tt0 -112.81 129.56 56.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.401 0.62 . . . . 0.0 111.197 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 121' ' ' VAL . 44.7 t -124.83 141.42 44.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.378 -176.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 6.6 tp-100 -102.44 118.53 37.06 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 173.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.956 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -117.53 125.4 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 167.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.656 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 63.88 -103.03 0.63 Allowed Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 118.925 -1.607 . . . . 0.0 110.101 -176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.103 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 10.1 pttt -143.02 24.75 1.81 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 121.283 0.563 . . . . 0.0 111.424 -173.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.631 ' CE2' ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.37 136.7 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -175.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.792 ' HB2' HH22 ' A' ' 26' ' ' ARG . 7.2 ttm180 -89.47 109.31 20.25 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.94 -178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 60' ' ' VAL . 6.7 mp -98.9 159.22 15.11 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-O 121.146 0.498 . . . . 0.0 111.825 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 135' ' ' ASP . 0.4 OUTLIER -141.76 140.99 30.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.004 166.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.622 ' O ' HD22 ' A' ' 147' ' ' LEU . 47.7 t80 -97.03 132.38 42.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 120.804 0.335 . . . . 0.0 111.116 177.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.622 HD22 ' O ' ' A' ' 146' ' ' PHE . 0.8 OUTLIER -135.62 171.58 14.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.646 169.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 9.4 t -165.83 166.06 17.92 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.111 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 83.66 88.21 0.79 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.422 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.802 ' HD3' ' HG3' ' A' ' 53' ' ' PRO . 87.5 Cg_endo -83.47 154.78 14.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.629 2.219 . . . . 0.0 111.898 178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -75.16 102.36 4.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.923 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.1 140.71 54.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.654 -177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -132.32 90.42 0.27 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -62.38 -34.25 76.34 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -175.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -75.5 103.43 5.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.762 0.792 . . . . 0.0 110.297 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.72 -13.05 27.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.111 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -108.37 124.11 7.32 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.767 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 17.1 m -88.28 105.73 17.75 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 11.8 m -76.47 75.78 3.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.597 0.713 . . . . 0.0 110.701 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -155.2 121.48 1.11 Allowed Glycine 0 N--CA 1.446 -0.672 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 177.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -98.57 109.63 3.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.806 -175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo . . . . . 0 C--O 1.246 0.924 0 C-N-CA 122.855 2.37 . . . . 0.0 111.754 177.443 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 24.6 m . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 121.708 0.766 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.4 t -130.27 -1.35 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.533 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -82.55 147.83 28.41 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 mmt -116.56 117.13 29.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -172.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -117.95 78.15 12.64 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 167.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.69 49.26 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.926 2.418 . . . . 0.0 112.772 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD2' ' HG2' ' A' ' 9' ' ' GLU . 30.9 t70 -129.95 126.65 38.34 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.944 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.78 75.07 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.432 ' HG2' ' OD2' ' A' ' 7' ' ' ASP . 25.4 mt-10 -63.33 -45.32 91.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.586 -177.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt 56.51 59.91 3.37 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -170.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.55 -41.25 80.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.47 -177.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -120.84 136.82 54.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.46 ' HB ' ' HA ' ' A' ' 16' ' ' GLU . 32.7 p -77.77 91.03 4.06 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.457 -178.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.5 p -59.54 -33.3 71.22 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 169.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -132.92 118.23 18.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.39 -1.277 . . . . 0.0 107.594 169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' HA ' ' HB ' ' A' ' 13' ' ' THR . 10.1 pt-20 -71.86 149.5 45.14 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.392 0.615 . . . . 0.0 111.809 -172.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -101.67 96.92 5.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.311 -172.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 m -90.94 126.51 36.09 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 173.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.4 t -73.29 74.59 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.232 0.539 . . . . 0.0 110.848 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 177.06 -45.17 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.543 ' CG2' HD11 ' A' ' 116' ' ' LEU . 25.3 m -104.62 133.6 49.2 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.916 178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.771 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 44.5 m -2.65 105.85 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.363 1.865 . . . . 0.0 115.139 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 ' HB ' HD12 ' A' ' 116' ' ' LEU . 1.4 p -143.42 157.31 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 O-C-N 121.259 -0.901 . . . . 0.0 112.42 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -172.76 -143.7 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.993 HH22 HD23 ' A' ' 33' ' ' LEU . 0.0 OUTLIER 45.19 -116.38 0.55 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.365 0.529 . . . . 0.0 109.948 178.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.67 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 65.56 165.79 0.18 Allowed 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 163.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.962 ' HA ' HD21 ' A' ' 33' ' ' LEU . 23.8 t70 -79.74 74.69 6.43 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.535 -1.211 . . . . 0.0 111.917 -172.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -149.6 -46.83 0.14 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.709 0.766 . . . . 0.0 109.52 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.83 -70.33 0.65 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.196 -174.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 79.1 p -171.61 -152.04 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.242 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 26' ' ' ARG . 3.9 mm-40 62.89 27.79 16.12 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.675 0.79 . . . . 0.0 110.912 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.993 HD23 HH22 ' A' ' 26' ' ' ARG . 1.2 pp -158.06 -33.92 0.07 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.798 0.809 . . . . 0.0 109.138 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.493 ' N ' HD12 ' A' ' 33' ' ' LEU . 20.9 p-10 -67.0 -48.48 68.31 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.994 171.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -96.76 123.13 54.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.464 176.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 2.8 Cg_exo -77.79 113.54 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.101 2.534 . . . . 0.0 111.951 177.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.1 -51.01 68.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.347 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.52 149.82 34.36 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.206 175.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.51 -28.97 64.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.162 0.506 . . . . 0.0 110.497 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 89.26 -76.75 1.77 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.933 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m 62.76 25.41 15.08 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.986 0.898 . . . . 0.0 110.302 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.5 145.66 25.02 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.262 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.4 m 62.55 30.12 17.06 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.441 0.638 . . . . 0.0 110.084 -173.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.64 176.11 7.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.386 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 60.0 t 65.27 -77.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.369 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -167.47 79.84 0.19 Allowed 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.118 0.485 . . . . 0.0 110.631 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.04 -7.89 73.14 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.406 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.8 t 57.58 49.1 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 CA-C-O 122.206 1.003 . . . . 0.0 109.189 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -120.57 -28.45 4.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.449 -1.251 . . . . 0.0 109.57 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -129.22 94.81 0.36 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.772 176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.793 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 50.1 mt -149.54 134.88 9.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 C-N-CA 123.267 0.627 . . . . 0.0 109.734 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.561 ' HG2' ' HD3' ' A' ' 53' ' ' PRO . 10.5 Cg_endo -55.68 -36.96 95.83 Favored 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.022 2.482 . . . . 0.0 114.829 173.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.793 ' HD2' ' HB3' ' A' ' 51' ' ' LEU . 92.2 Cg_endo -93.51 45.03 0.29 Allowed 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 121.731 1.621 . . . . 0.0 113.304 -175.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 175.63 -80.05 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.869 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -146.94 139.01 24.56 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -177.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.78 ' HA ' ' HA2' ' A' ' 50' ' ' GLY . . . -125.84 169.12 12.95 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 173.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.462 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 0.6 OUTLIER -153.68 129.78 10.35 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 119.064 -1.054 . . . . 0.0 113.698 -173.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.028 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.8 mp -86.61 137.74 32.24 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.228 -0.896 . . . . 0.0 108.904 162.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 4.2 p -131.82 128.96 60.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.431 176.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -72.98 109.78 5.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 175.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -64.27 -70.4 0.23 Allowed 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 113.079 -1.873 . . . . 0.0 110.413 -172.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 62' ' ' ARG . 14.0 mtp85 -148.54 138.03 21.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-O 121.476 0.655 . . . . 0.0 109.781 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.65 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -162.28 -127.02 0.85 Allowed Glycine 0 N--CA 1.428 -1.897 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.824 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 3.8 Cg_endo -89.18 -62.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.9 0 C-N-CA 122.163 1.909 . . . . 0.0 111.442 171.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.682 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -69.42 -53.35 19.75 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 173.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 52.18 174.32 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 113.917 -1.492 . . . . 0.0 113.113 -174.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.74 1.73 89.52 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.871 173.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 6.5 m -96.87 179.61 4.9 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 117.308 0.554 . . . . 0.0 111.017 -169.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.75 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -168.5 147.2 4.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -169.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.845 ' HD2' ' HB2' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -97.26 121.07 38.74 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 169.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.564 HD23 ' O ' ' A' ' 71' ' ' LEU . 2.0 tt -83.68 101.38 11.49 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.662 0.744 . . . . 0.0 110.218 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.866 HD11 ' HB3' ' A' ' 101' ' ' PHE . 0.8 OUTLIER -92.99 41.51 1.08 Allowed 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.438 0.637 . . . . 0.0 110.254 177.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.481 ' HB3' HD21 ' A' ' 71' ' ' LEU . 25.2 t70 -92.0 -26.24 18.46 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.792 173.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -105.03 178.99 4.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.481 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.78 -44.46 81.89 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.691 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -162.56 128.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.087 0.47 . . . . 0.0 111.933 -174.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.8 p -113.8 121.6 44.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.133 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.672 ' HB2' ' HB3' ' A' ' 85' ' ' SER . 65.4 m -64.86 126.14 27.04 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.316 -0.402 . . . . 0.0 109.964 172.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.59 115.98 25.09 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.663 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 149.39 -142.96 10.28 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.507 -0.637 . . . . 0.0 111.507 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -71.12 104.38 3.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.665 0.745 . . . . 0.0 109.966 173.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.764 ' CE1' ' HD3' ' A' ' 96' ' ' ARG . 69.7 m-70 -137.09 118.43 11.02 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.687 -173.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.02 -44.66 12.13 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.186 1.924 . . . . 0.0 110.848 166.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -147.33 110.59 4.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.641 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.672 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 33.7 m -158.3 -86.48 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.253 -0.885 . . . . 0.0 108.954 173.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -171.71 -58.16 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.375 178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER -101.05 94.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.0 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.498 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -100.07 134.92 42.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.587 -1.188 . . . . 0.0 109.817 174.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.024 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.8 mm? -117.02 75.21 0.96 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.363 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.682 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 27.2 t70 58.92 15.75 4.12 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.74 ' O ' ' HB2' ' A' ' 81' ' ' ARG . 2.3 p30 46.12 -73.72 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.285 1.434 . . . . 0.0 113.696 -170.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 92' ' ' VAL . 12.7 p -73.63 64.93 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -167.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.481 ' HB ' ' HD3' ' A' ' 141' ' ' LYS . 0.3 OUTLIER -156.08 -1.24 0.13 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.263 164.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.581 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 9.2 t -131.7 137.83 54.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 122.125 -0.36 . . . . 0.0 110.732 -173.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.477 ' HA ' ' O3P' ' A' ' 22' ' ' TPO . 19.4 m -72.48 71.22 0.93 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 110.303 -0.258 . . . . 0.0 110.303 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.764 ' HD3' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 68.55 -59.63 0.45 Allowed 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.822 -174.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.518 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 8.0 ptp85 -149.31 138.67 21.53 Favored 'General case' 0 C--N 1.309 -1.181 0 O-C-N 121.661 -0.649 . . . . 0.0 110.625 178.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.705 ' CB ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -70.58 -43.16 69.98 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 169.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.46 175.12 13.68 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 112.704 -2.043 . . . . 0.0 108.949 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.691 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.6 pt-20 -128.37 115.05 17.65 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 1.041 ' HD1' HG13 ' A' ' 110' ' ' VAL . 2.4 t80 -78.07 91.46 4.28 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.877 0.846 . . . . 0.0 108.719 -171.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.69 ' HB3' HG13 ' A' ' 76' ' ' ILE . 12.8 ptp180 -101.54 140.3 36.02 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 114.13 -1.395 . . . . 0.0 111.343 -169.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -83.25 112.29 19.74 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.501 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -138.35 139.75 39.15 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 173.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 36.2 m-80 62.51 32.52 16.55 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -171.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.704 ' HA ' HD21 ' A' ' 103' ' ' LEU . 6.8 t30 72.03 -0.1 3.35 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.568 0.747 . . . . 0.0 111.517 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 12.9 mm-40 -111.62 142.54 43.8 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.544 -172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.733 ' HB2' ' HE2' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.62 128.9 36.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.024 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 18.0 m-80 -138.05 161.86 35.66 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 1.041 HG13 ' HD1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -104.54 117.34 49.98 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-N 117.962 0.346 . . . . 0.0 111.019 177.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.588 HG21 ' HD2' ' A' ' 102' ' ' ARG . 76.5 t -99.03 110.17 25.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -70.27 135.38 48.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.49 -177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 97' ' ' ARG . 27.2 m -135.61 7.62 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.112 0.482 . . . . 0.0 109.78 179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 95' ' ' SER . . . 102.96 107.19 3.12 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.289 -0.958 . . . . 0.0 113.292 179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.494 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 25.6 t -102.35 157.26 17.03 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 174.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.771 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.6 tm? -58.13 -53.18 61.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.773 -174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.617 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -70.62 -36.03 73.25 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.725 0.774 . . . . 0.0 109.014 172.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 115' ' ' SER . . . 132.35 177.55 14.98 Favored Glycine 0 C--O 1.25 1.095 0 CA-C-N 114.917 -1.038 . . . . 0.0 112.214 -173.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.432 HG23 ' CE1' ' A' ' 98' ' ' HIS . 5.6 m -111.57 136.68 50.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 122.901 0.48 . . . . 0.0 111.474 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.9 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 22.8 m-85 -139.57 132.8 29.83 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.84 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 137' ' ' VAL . 84.6 t -129.3 121.69 54.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 171.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 62.75 32.6 15.97 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 56.89 26.36 11.58 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.595 -173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 13.0 pt-20 -137.86 143.21 39.1 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-O 120.734 0.302 . . . . 0.0 110.426 175.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 20.2 Cg_exo -66.99 123.26 10.74 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.847 2.364 . . . . 0.0 112.348 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.43 175.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.107 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.584 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 12.2 p-10 -103.35 -49.94 3.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.12 174.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.87 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 33.3 t -157.72 91.44 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.41 137.81 36.57 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.025 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.411 ' HB ' ' OD1' ' A' ' 109' ' ' ASN . 7.4 p -80.57 143.16 12.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.784 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.724 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.5 OUTLIER -49.44 133.19 20.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.227 174.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -128.38 -175.15 3.42 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -107.0 86.03 2.24 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.32 2.29 38.28 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.427 -0.892 . . . . 0.0 114.445 169.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.713 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 4.8 t70 -89.98 158.18 17.49 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.487 0.644 . . . . 0.0 109.744 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.5 pm0 -107.42 143.51 35.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.898 0.856 . . . . 0.0 113.209 -172.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 121' ' ' VAL . 58.4 t -119.9 141.63 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 114.534 -1.212 . . . . 0.0 108.739 176.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.9 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 56.1 tp60 -108.05 122.97 47.95 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.082 0.467 . . . . 0.0 110.186 174.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.024 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.92 139.99 50.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 168.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.617 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 63.27 -90.27 0.07 OUTLIER Glycine 0 C--O 1.208 -1.481 0 C-N-CA 119.717 -1.23 . . . . 0.0 112.322 173.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.824 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 14.8 ptmt -156.95 31.9 0.3 Allowed 'General case' 0 C--N 1.313 -1.012 0 O-C-N 121.519 -0.989 . . . . 0.0 110.488 177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' CZ ' ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -123.87 138.44 54.49 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -174.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.665 ' CZ ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -89.5 108.84 19.89 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 174.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.772 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.08 161.05 13.84 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.113 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.41 143.45 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 168.046 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.028 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -109.34 144.6 37.29 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.528 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? -127.66 128.11 44.91 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.749 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.629 ' HB ' ' HB1' ' A' ' 56' ' ' ALA . 14.2 t -160.93 137.61 8.69 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 167.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.471 ' HA2' ' HD3' ' A' ' 150' ' ' PRO . . . -132.27 124.62 3.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.278 -0.963 . . . . 0.0 112.603 -175.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.471 ' HD3' ' HA2' ' A' ' 149' ' ' GLY . 6.0 Cg_exo -78.85 1.04 9.47 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.898 2.399 . . . . 0.0 112.148 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt 57.48 45.9 18.89 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.931 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -76.28 109.64 10.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.61 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 178.26 113.64 0.37 Allowed Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -65.05 -35.11 80.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.934 0.397 . . . . 0.0 111.024 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -157.48 -58.0 0.08 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 174.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -80.16 150.19 30.26 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 170.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -106.38 160.4 14.56 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.323 -0.942 . . . . 0.0 112.171 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.2 m -80.32 94.06 6.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.083 0.468 . . . . 0.0 110.33 177.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 14.3 m -86.55 137.15 32.74 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.365 177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -81.45 -32.43 30.97 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.131 -174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 152.49 -71.6 0.28 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.06 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 C--O 1.248 0.991 0 C-N-CA 122.642 2.228 . . . . 0.0 111.916 176.154 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 19.9 p -103.16 1.52 33.29 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.031 0.919 . . . . 0.0 108.629 170.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.85 53.27 2.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.536 -176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.439 ' C ' ' HD3' ' A' ' 6' ' ' PRO . 22.5 ptp -67.62 148.52 51.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.408 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.434 HD22 HD11 ' A' ' 8' ' ' ILE . 8.9 m120 -124.87 67.9 53.33 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.67 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 4' ' ' MET . 7.0 Cg_exo -73.25 -68.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.415 2.077 . . . . 0.0 111.421 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -149.07 76.69 1.34 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.698 176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.434 HD11 HD22 ' A' ' 5' ' ' ASN . 27.4 pt -114.8 10.75 7.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.967 0.889 . . . . 0.0 109.168 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -88.17 156.07 19.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.115 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -129.59 53.93 1.87 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.518 0.675 . . . . 0.0 109.449 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -90.09 -7.74 53.08 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.014 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -65.48 -41.47 93.25 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 86.22 3.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.358 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.1 m -153.84 -38.31 0.1 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.324 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 41.8 -97.3 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 O-C-N 124.538 1.149 . . . . 0.0 113.468 168.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -124.57 73.82 1.29 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.879 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 t 59.1 38.68 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.992 0.901 . . . . 0.0 109.683 -176.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.8 m -100.03 89.14 3.94 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.932 179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.9 m -136.28 17.52 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.749 -175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -70.19 99.27 1.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.778 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.734 HG22 ' O ' ' A' ' 22' ' ' TPO . 54.1 m -78.65 137.09 37.66 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 120.934 0.397 . . . . 0.0 110.134 176.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.734 ' O ' HG22 ' A' ' 21' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' A' ' 93' ' ' THR . 57.2 m -80.08 140.42 36.48 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 120.801 -1.187 . . . . 0.0 112.547 -173.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG23 ' HB3' ' A' ' 117' ' ' ASN . 14.1 p -127.87 141.09 47.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.482 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.2 t80 179.13 -168.1 0.09 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.336 -0.364 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.903 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.8 tpt180 46.33 -123.29 1.26 Allowed 'General case' 0 N--CA 1.475 0.821 0 O-C-N 123.876 0.735 . . . . 0.0 110.542 170.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' H ' ' HG3' ' A' ' 26' ' ' ARG . . . 60.07 179.62 0.09 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 170.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.653 ' HA ' HD11 ' A' ' 33' ' ' LEU . 7.3 t70 -78.08 56.81 1.69 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 114.66 -1.155 . . . . 0.0 110.989 -175.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -147.4 -52.56 0.2 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.724 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -105.22 -44.42 4.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.63 -171.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.596 ' HB2' ' HD2' ' A' ' 26' ' ' ARG . 19.4 m -141.64 169.83 16.85 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.816 -167.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.65 ' C ' ' HG ' ' A' ' 33' ' ' LEU . 2.1 mm-40 67.67 -150.09 0.16 Allowed 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.839 0.712 . . . . 0.0 111.604 176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.653 HD11 ' HA ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER 49.99 -101.19 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.227 1.011 . . . . 0.0 112.014 -179.521 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.505 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 2.1 p30 -178.37 -169.64 0.19 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.078 -175.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.863 ' H ' ' HD2' ' A' ' 36' ' ' PRO . . . -122.6 -47.62 0.04 OUTLIER Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.913 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.863 ' HD2' ' H ' ' A' ' 35' ' ' ALA . 63.0 Cg_endo -72.08 -146.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.372 2.048 . . . . 0.0 111.817 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.94 101.67 1.96 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.809 0.338 . . . . 0.0 110.595 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 21.2 tm0? -140.69 129.44 23.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.184 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.05 144.05 50.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.591 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -132.39 86.17 0.28 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.266 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 t -119.02 147.42 44.12 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.845 0.355 . . . . 0.0 110.977 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -113.01 104.59 12.54 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.107 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.7 m -76.94 74.36 3.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.238 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.74 154.73 18.13 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.173 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 1.069 ' HA ' ' HA2' ' A' ' 50' ' ' GLY . 12.7 m -124.22 120.91 60.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.287 0.565 . . . . 0.0 111.662 -177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 52' ' ' PRO . 20.1 p -81.96 -70.06 0.57 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.571 176.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.57 -94.15 2.29 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.74 13.23 2.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.297 0.57 . . . . 0.0 110.742 173.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -111.98 -16.96 12.99 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.438 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 1.069 ' HA2' ' HA ' ' A' ' 45' ' ' VAL . . . 82.32 -54.13 4.85 Favored Glycine 0 N--CA 1.45 -0.371 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD13 ' CE2' ' A' ' 108' ' ' PHE . 16.9 mt -56.36 119.94 31.83 Favored Pre-proline 0 N--CA 1.446 -0.628 0 C-N-CA 123.752 0.821 . . . . 0.0 110.902 174.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.612 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 95.4 Cg_endo -98.18 11.59 0.89 Allowed 'Trans proline' 0 CA--C 1.557 1.642 0 C-N-CA 122.341 2.027 . . . . 0.0 117.022 177.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.735 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . 39.1 Cg_endo -103.95 161.83 0.22 Allowed 'Trans proline' 0 C--N 1.364 1.367 0 CA-C-N 122.401 1.893 . . . . 0.0 113.581 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.43 -20.75 36.95 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.56 132.65 31.43 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -136.19 170.15 16.48 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.1 pp -161.29 145.2 13.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.534 1.309 . . . . 0.0 114.534 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 146' ' ' PHE . 2.6 mp -87.1 116.5 25.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 113.929 -1.487 . . . . 0.0 107.759 164.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.8 p -113.11 130.02 67.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 118.158 0.435 . . . . 0.0 110.522 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.001 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.16 109.38 3.36 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 175.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -62.46 -54.46 39.78 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 113.939 -1.482 . . . . 0.0 110.216 -173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 14.6 ttm-85 -165.42 106.94 0.77 Allowed 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.989 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.517 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -127.68 -133.07 3.69 Favored Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 176.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.076 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 82.4 Cg_endo -76.0 -64.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.34 2.027 . . . . 0.0 112.191 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.916 ' HB3' ' HE2' ' A' ' 142' ' ' PHE . 66.5 t30 -70.13 -47.3 62.29 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 170.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.569 ' HA ' ' CG2' ' A' ' 60' ' ' VAL . . . 60.31 166.94 0.08 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.075 -1.875 . . . . 0.0 112.847 -176.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.35 4.45 89.95 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.77 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.001 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -101.92 179.18 4.4 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 117.651 0.726 . . . . 0.0 110.655 -166.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.49 154.98 3.29 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.802 0.728 . . . . 0.0 112.24 -172.623 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.15 127.94 41.59 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 169.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.623 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.5 tt -87.82 91.82 8.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.72 0.771 . . . . 0.0 109.534 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.812 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -85.39 55.78 3.66 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.512 ' HB3' HD21 ' A' ' 71' ' ' LEU . 16.7 t70 -108.75 -23.94 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.869 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -103.77 -166.66 1.28 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.109 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.52 -41.17 69.52 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.712 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -161.3 129.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.463 -178.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.632 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 71.8 p -113.2 126.02 54.97 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.429 179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.641 ' O ' HG23 ' A' ' 87' ' ' ILE . 39.1 m -68.29 126.58 30.02 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 172.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.806 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.54 108.65 13.38 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -171.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.767 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 165.45 -139.3 5.72 Favored Glycine 0 N--CA 1.44 -1.069 0 C-N-CA 120.059 -1.067 . . . . 0.0 112.095 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.827 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -76.98 103.88 7.16 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 11.5 m-70 -129.75 120.73 19.69 Favored Pre-proline 0 N--CA 1.436 -1.133 0 C-N-CA 119.967 -0.693 . . . . 0.0 112.229 -172.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.72 -16.23 18.78 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.292 1.994 . . . . 0.0 109.559 164.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -160.42 125.12 3.76 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.014 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.1 p 120.82 106.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 O-C-N 125.562 1.789 . . . . 0.0 113.362 164.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.518 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 6.3 m-20 56.91 -80.97 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 161.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -115.44 110.95 33.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 122.0 0.905 . . . . 0.0 111.672 -171.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.33 114.61 28.43 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.714 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.778 HD12 HG12 ' A' ' 139' ' ' ILE . 4.7 mt -102.4 80.05 1.9 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.942 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.58 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 14.6 t70 70.11 -7.48 0.95 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.148 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.827 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.6 p30 39.47 36.61 0.23 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.487 1.515 . . . . 0.0 113.075 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.588 ' O ' HG23 ' A' ' 22' ' ' TPO . 41.1 t -148.42 -2.48 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.836 -177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 23' ' ' SER . 27.7 p -113.2 -34.92 5.51 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -168.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.697 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.2 OUTLIER -116.72 154.6 18.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 O-C-N 122.116 -0.365 . . . . 0.0 110.602 -171.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.695 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 7.1 m -68.41 72.79 0.21 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 122.706 0.403 . . . . 0.0 112.049 -174.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.703 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.0 OUTLIER 59.36 -49.31 0.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.054 0.942 . . . . 0.0 112.709 -173.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.767 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 10.3 ptp85 -149.42 141.85 24.28 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 121.691 -0.631 . . . . 0.0 110.308 172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.823 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -88.85 -41.3 12.55 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 171.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.911 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -140.26 170.55 15.61 Favored 'General case' 0 N--CA 1.414 -2.255 0 CA-C-N 113.694 -1.594 . . . . 0.0 109.808 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.641 ' HB2' HD11 ' A' ' 76' ' ' ILE . 6.6 pt-20 -137.45 123.27 20.03 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 168.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.812 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -55.52 95.73 0.02 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 O-C-N 124.413 1.071 . . . . 0.0 108.931 -176.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.465 HH21 ' CD ' ' A' ' 100' ' ' GLU . 18.5 tpp85 -94.14 98.04 10.7 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.939 -174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.737 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.1 tt -78.95 104.8 9.83 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.817 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 -115.63 134.99 54.51 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 177.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 0.3 OUTLIER 40.75 47.24 2.43 Favored 'General case' 0 N--CA 1.47 0.552 0 O-C-N 124.313 1.008 . . . . 0.0 112.092 -178.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.737 ' HA ' HD21 ' A' ' 103' ' ' LEU . 3.6 m-20 76.55 2.18 3.4 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.693 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 50.2 mt-10 -106.28 141.3 37.85 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.807 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.627 ' CB ' HD23 ' A' ' 72' ' ' LEU . 1.1 m-85 -89.05 126.99 35.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.489 ' OD1' HG22 ' A' ' 130' ' ' VAL . 24.4 m-80 -132.12 160.29 36.43 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-O 120.718 0.294 . . . . 0.0 110.576 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.858 ' O ' ' HA ' ' A' ' 128' ' ' SER . 5.6 m -111.76 126.96 69.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.016 0.436 . . . . 0.0 110.211 174.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.911 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 3.8 t -101.38 112.32 34.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.354 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 13.4 t0 -74.78 128.64 36.04 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.515 HG21 ' HG3' ' A' ' 97' ' ' ARG . 36.0 m -128.04 4.81 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-O 121.222 0.534 . . . . 0.0 109.608 -176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.17 87.63 2.01 Favored Glycine 0 N--CA 1.441 -0.985 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.282 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.745 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 31.4 t -87.79 141.01 28.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.586 HD22 ' HB ' ' A' ' 22' ' ' TPO . 13.0 tp -53.15 -57.26 11.08 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.205 0.526 . . . . 0.0 112.409 -174.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.711 HD21 ' HA2' ' A' ' 140' ' ' GLY . 1.8 p30 -65.91 -37.79 87.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.642 176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 138.11 164.06 9.84 Favored Glycine 0 C--O 1.262 1.847 0 CA-C-N 115.266 -0.879 . . . . 0.0 113.724 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.533 HG23 ' CE1' ' A' ' 98' ' ' HIS . 17.7 m -113.82 129.27 56.61 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 113.239 -1.481 . . . . 0.0 110.297 170.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.653 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 14.0 m-85 -141.63 105.22 4.69 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 111.67 173.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.088 HG22 HG23 ' A' ' 137' ' ' VAL . 52.5 t -100.33 127.11 53.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 121' ' ' VAL . 0.9 OUTLIER 63.22 25.61 14.86 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -174.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 63.05 13.8 7.06 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.834 -173.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -121.85 156.88 58.7 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 120.762 0.315 . . . . 0.0 110.385 173.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.75 131.85 12.66 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 122.44 2.093 . . . . 0.0 112.645 176.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.26 176.6 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 10.0 m-20 -120.1 -31.34 4.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.56 174.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.858 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 18.0 p -161.63 91.48 0.83 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.509 0.671 . . . . 0.0 109.866 177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -100.91 145.58 28.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.2 -174.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.489 HG22 ' OD1' ' A' ' 109' ' ' ASN . 14.5 t -88.18 119.81 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.876 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.764 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -58.74 162.3 4.11 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -178.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.438 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -163.52 164.59 24.27 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.622 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -71.06 114.49 9.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.041 -0.664 . . . . 0.0 110.346 -176.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 103.39 -7.96 51.77 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.856 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.409 ' CG ' HD21 ' A' ' 122' ' ' ASN . 8.7 t70 -66.49 110.64 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.621 0.369 . . . . 0.0 110.142 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 144' ' ' LEU . 1.0 OUTLIER -93.83 152.3 19.0 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.172 0.51 . . . . 0.0 112.251 -177.334 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 121' ' ' VAL . 0.5 OUTLIER -133.4 141.24 44.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.653 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.1 tm0? -109.58 116.68 32.22 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 169.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.823 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -138.4 131.77 40.65 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.243 175.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.711 ' HA2' HD21 ' A' ' 117' ' ' ASN . . . 82.9 -56.88 5.07 Favored Glycine 0 C--N 1.317 -0.502 0 C-N-CA 119.118 -1.515 . . . . 0.0 111.25 171.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.076 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 59.9 pttt 168.03 32.11 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 160.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.916 ' HE2' ' HB3' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -114.5 161.52 17.89 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.232 -173.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.488 ' HG3' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -116.77 99.62 7.24 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 175.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 1.0 ' HB2' HG12 ' A' ' 137' ' ' VAL . 5.8 mp -88.83 163.54 15.62 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.365 -178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -141.53 140.29 31.33 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 166.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.764 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 45.9 t80 -100.04 143.08 30.67 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.402 -179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.609 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -130.34 134.6 47.3 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.76 170.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.607 ' HB ' ' CE2' ' A' ' 146' ' ' PHE . 2.5 t -116.02 149.67 38.48 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.964 177.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.644 ' H ' ' HG3' ' A' ' 53' ' ' PRO . . . 63.14 91.08 0.03 OUTLIER Glycine 0 CA--C 1.52 0.36 0 O-C-N 123.584 0.553 . . . . 0.0 112.318 -172.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.735 ' HD3' ' HB3' ' A' ' 53' ' ' PRO . 9.7 Cg_exo -72.0 57.12 2.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.026 2.484 . . . . 0.0 112.058 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.743 ' HG3' ' HG3' ' A' ' 152' ' ' GLN . 59.2 pttt -66.43 -32.29 73.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.41 -177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.743 ' HG3' ' HG3' ' A' ' 151' ' ' LYS . 49.7 mt-30 -105.9 -3.68 21.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.837 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 69.82 -96.02 0.5 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.417 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 67.97 -69.22 0.15 Allowed 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.553 0.741 . . . . 0.0 111.759 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -104.33 -67.72 0.89 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -84.53 137.82 33.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 88.3 18.95 54.45 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.283 -176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.8 t -82.31 -9.0 59.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.741 0.305 . . . . 0.0 110.345 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 25.1 p 54.29 -94.16 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.801 0.84 . . . . 0.0 112.356 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 97.39 -43.3 2.01 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.05 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 137.16 -159.03 24.58 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.171 177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo . . . . . 0 C--O 1.246 0.908 0 C-N-CA 123.27 2.647 . . . . 0.0 111.705 179.137 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 44.3 t . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.909 0.385 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 28.4 p -109.32 153.43 23.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -90.24 116.02 27.9 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 25.4 ptt? -135.47 149.19 49.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.951 0.405 . . . . 0.0 110.535 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -132.6 126.26 19.95 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.639 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.85 106.89 1.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.583 2.188 . . . . 0.0 112.194 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -85.71 -7.5 58.75 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.603 0.716 . . . . 0.0 109.424 175.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tt -92.93 143.22 11.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 114.866 -1.061 . . . . 0.0 109.591 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -76.95 134.39 38.91 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.894 0.378 . . . . 0.0 110.093 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' HG3' ' O ' ' A' ' 12' ' ' GLN . 3.6 tppp? -81.62 73.29 8.67 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -54.52 -43.24 71.72 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.164 -175.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.541 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 1.2 mp0 -77.16 119.24 20.57 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 171.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.8 m -33.04 -56.45 0.39 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 124.481 1.113 . . . . 0.0 113.619 -169.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -131.21 -9.54 3.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.162 0.506 . . . . 0.0 110.127 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.5 t70 65.4 40.62 4.64 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.792 176.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -72.93 117.81 15.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.022 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 p -119.75 -16.78 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.589 0.709 . . . . 0.0 109.326 171.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -86.45 78.16 9.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.632 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -136.1 129.16 46.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.782 176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -80.39 70.56 7.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.645 0.736 . . . . 0.0 111.142 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 73.1 m -155.77 132.84 10.7 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.456 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.797 ' O ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.671 ' O ' ' HA ' ' A' ' 93' ' ' THR . 70.4 m -34.55 146.84 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.658 2.095 . . . . 0.0 116.658 -162.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 12.3 p -127.64 147.18 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.986 -177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 7.3 t80 172.8 -166.87 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.921 175.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.943 ' HG3' ' H ' ' A' ' 27' ' ' ALA . 8.7 tpt180 47.64 -130.47 1.56 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.873 0.469 . . . . 0.0 109.931 172.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.943 ' H ' ' HG3' ' A' ' 26' ' ' ARG . . . 64.83 173.36 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 168.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.788 ' H ' ' HG3' ' A' ' 138' ' ' GLN . 8.5 t70 -76.18 55.24 0.93 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.389 -1.278 . . . . 0.0 110.68 -177.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.462 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 22.4 m-85 -147.46 -42.08 0.17 Allowed 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.219 -0.9 . . . . 0.0 108.966 -177.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.3 tp -97.58 -67.87 0.83 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.982 -179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.6 m -158.18 179.13 9.45 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -173.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.46 57.47 1.15 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.223 -0.899 . . . . 0.0 112.913 177.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.563 HD21 ' HA ' ' A' ' 28' ' ' ASP . 1.2 mt -141.36 -60.62 0.48 Allowed 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 122.475 1.131 . . . . 0.0 108.892 175.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -54.58 139.11 39.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.38 -2.191 . . . . 0.0 112.06 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 69.25 98.24 0.04 OUTLIER Pre-proline 0 C--O 1.235 0.338 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.158 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.68 76.06 3.37 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.929 2.419 . . . . 0.0 111.961 177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.93 -44.84 87.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.552 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -85.7 67.97 10.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.156 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -76.37 118.58 19.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -53.72 109.81 1.22 Allowed Glycine 0 C--N 1.33 0.196 0 O-C-N 123.594 0.559 . . . . 0.0 113.179 -175.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -82.62 -29.27 30.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.89 0.376 . . . . 0.0 111.246 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 1.3 pm0 -90.15 6.0 44.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.102 0.477 . . . . 0.0 110.47 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 39.0 t -88.75 55.45 3.37 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.687 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.91 52.8 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 110.636 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.691 ' HB ' ' HB3' ' A' ' 150' ' ' PRO . 17.9 m -102.43 131.3 50.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.567 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 152' ' ' GLN . 24.1 m -145.69 124.39 12.57 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.262 178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.19 -56.3 0.29 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.735 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t 62.49 81.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -167.24 98.15 0.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.756 -172.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 47.56 85.81 0.01 OUTLIER Glycine 0 C--N 1.327 0.032 0 CA-C-N 114.935 -1.03 . . . . 0.0 113.714 174.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 3.0 pp -48.96 121.73 10.68 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 121.65 0.738 . . . . 0.0 111.709 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 32.0 Cg_exo -61.17 -39.48 58.45 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.894 3.063 . . . . 0.0 115.999 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 1.6 Cg_endo -83.24 128.02 4.75 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.9 1.733 . . . . 0.0 112.689 -170.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.0 -31.48 61.84 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 177.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.22 123.73 41.09 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 173.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -131.87 170.63 14.6 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.475 HD13 ' HB ' ' A' ' 59' ' ' VAL . 2.5 pp -158.1 142.63 16.17 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.958 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.9 110.96 20.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 113.9 -1.5 . . . . 0.0 107.999 163.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HB ' HD13 ' A' ' 57' ' ' LEU . 4.9 p -107.94 124.81 64.38 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 CA-C-O 121.351 0.596 . . . . 0.0 111.216 -174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.023 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -72.74 111.46 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 176.073 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -69.5 -70.12 0.3 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.462 -1.244 . . . . 0.0 109.708 -173.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -142.99 128.11 18.6 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.607 0.717 . . . . 0.0 110.736 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.828 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -167.13 -153.69 8.07 Favored Glycine 0 N--CA 1.432 -1.567 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.01 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 52.9 Cg_exo -56.07 -67.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.593 0 C-N-CA 122.598 2.198 . . . . 0.0 113.052 177.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.63 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 8.1 t30 -70.39 -49.12 52.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 173.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.828 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.61 161.48 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.531 -173.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.08 0.07 84.8 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.548 -0.834 . . . . 0.0 114.316 169.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.897 ' H ' HG22 ' A' ' 60' ' ' VAL . 33.1 t -99.81 -171.59 2.08 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-N 118.412 1.106 . . . . 0.0 110.383 -174.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -170.83 164.18 7.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 -175.301 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.59 ' HZ ' HG21 ' A' ' 139' ' ' ILE . 0.2 OUTLIER -95.95 129.13 43.3 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 169.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -85.94 96.54 9.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.761 0.791 . . . . 0.0 109.457 -179.527 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.838 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.1 mp -89.43 31.51 0.91 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.336 0.588 . . . . 0.0 109.703 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -81.0 -28.63 35.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.697 178.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.421 ' NE2' HG22 ' A' ' 77' ' ' THR . 13.2 pt20 -95.72 -166.35 1.43 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.747 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.86 -38.05 46.93 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.702 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -162.07 135.55 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 120.853 0.359 . . . . 0.0 111.937 -177.089 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.566 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 54.1 p -123.77 133.28 53.86 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.58 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.735 ' HB2' ' CE1' ' A' ' 82' ' ' HIS . 44.3 m -76.84 126.08 30.38 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 172.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.665 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.45 112.4 19.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -167.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.624 ' HA3' HG11 ' A' ' 94' ' ' VAL . . . 156.56 -88.92 0.12 Allowed Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.887 173.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -108.44 104.41 13.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 121.702 0.763 . . . . 0.0 109.002 177.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.735 ' CE1' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -130.73 103.77 15.9 Favored Pre-proline 0 C--N 1.311 -1.081 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.289 -174.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -64.41 -37.17 40.6 Favored 'Trans proline' 0 C--N 1.328 -0.505 0 C-N-CA 122.677 2.251 . . . . 0.0 113.602 177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -147.0 30.85 0.95 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -170.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 2.4 p -151.2 -164.78 2.09 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -175.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.445 ' H ' ' HB2' ' A' ' 85' ' ' SER . 0.1 OUTLIER -32.44 -89.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 125.793 1.637 . . . . 0.0 115.273 -167.412 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.665 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.29 109.91 29.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-O 121.44 0.638 . . . . 0.0 111.574 -171.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -100.85 127.22 47.4 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.984 174.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.023 HD21 HG11 ' A' ' 60' ' ' VAL . 8.1 mt -121.1 82.78 1.97 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.077 170.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 71.26 -11.16 0.72 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.082 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.596 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.9 p30 40.23 32.74 0.14 Allowed 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.489 1.515 . . . . 0.0 112.781 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 t -136.93 -9.28 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.84 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.675 HG21 ' HE2' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -112.64 -9.94 13.7 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -172.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.624 HG11 ' HA3' ' A' ' 80' ' ' GLY . 3.4 t -122.41 147.1 26.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 O-C-N 121.941 -0.474 . . . . 0.0 110.836 -171.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.763 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 3.9 t -77.39 73.49 3.97 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.5 OUTLIER 58.52 -58.52 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.788 -166.267 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.596 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 10.0 ptp85 -142.58 136.5 29.29 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.635 0.731 . . . . 0.0 111.35 -174.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.59 ' HA ' ' HB3' ' A' ' 115' ' ' SER . 0.0 OUTLIER -78.06 -37.6 46.3 Favored 'General case' 0 CA--C 1.506 -0.739 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 168.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -159.22 177.75 10.72 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 113.089 -1.869 . . . . 0.0 108.323 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 77' ' ' THR . 5.1 pt-20 -133.98 134.46 42.54 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.838 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -64.18 104.08 0.7 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 176.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.61 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 23.1 ttm180 -105.16 112.34 25.43 Favored 'General case' 0 N--CA 1.415 -2.2 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.646 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.6 tt -84.28 103.77 13.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.577 0.704 . . . . 0.0 110.033 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.61 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 43.2 mt-10 -128.08 141.41 51.51 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.494 ' HB2' ' HG2' ' A' ' 107' ' ' GLU . 37.3 m-20 62.56 30.98 17.12 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -175.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.802 ' HA ' HD21 ' A' ' 103' ' ' LEU . 16.0 m120 62.15 11.97 4.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.253 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.494 ' HG2' ' HB2' ' A' ' 105' ' ' ASN . 9.3 pt-20 -117.56 147.11 43.11 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.279 0.561 . . . . 0.0 110.507 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.645 ' CB ' HD23 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -93.19 119.38 32.31 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.8 -174.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 0.8 OUTLIER -123.61 163.02 21.84 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -177.452 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.787 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -107.75 118.49 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.558 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.982 170.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 83.5 t -99.41 110.72 27.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -67.27 136.75 55.41 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 123.581 0.551 . . . . 0.0 110.047 -176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG21 ' HG3' ' A' ' 97' ' ' ARG . 24.2 m -133.69 3.37 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.093 0.473 . . . . 0.0 110.173 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.33 110.49 2.24 Favored Glycine 0 N--CA 1.437 -1.288 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.307 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.59 ' HB3' ' HA ' ' A' ' 98' ' ' HIS . 24.3 p -109.61 169.91 8.4 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 173.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.797 HD22 ' O ' ' A' ' 22' ' ' TPO . 0.7 OUTLIER -64.26 -55.17 23.32 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.506 -175.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.53 HD21 ' H ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -66.62 -37.45 84.9 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 128.97 161.32 10.58 Favored Glycine 0 C--O 1.258 1.618 0 CA-C-O 121.438 0.465 . . . . 0.0 113.321 -171.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.3 m -112.13 131.21 55.59 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.954 0.901 . . . . 0.0 111.274 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -141.8 104.95 4.61 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.503 0.192 . . . . 0.0 111.483 175.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.98 HG22 HG13 ' A' ' 137' ' ' VAL . 93.6 t -102.6 119.82 51.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.964 -0.46 . . . . 0.0 109.97 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.3 37.5 23.52 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.481 ' HA ' ' HD2' ' A' ' 120' ' ' TYR . 0.4 OUTLIER 64.06 25.11 13.72 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -176.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.55 133.09 8.91 Favored Pre-proline 0 CA--C 1.533 0.326 0 O-C-N 121.811 -0.556 . . . . 0.0 110.867 172.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -60.78 122.64 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.099 1.866 . . . . 0.0 111.547 175.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.605 HG13 ' HB ' ' A' ' 121' ' ' VAL . 26.1 m -106.29 179.05 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.816 0.341 . . . . 0.0 111.309 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 24.2 t70 -108.95 -40.97 4.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.787 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.0 t -165.14 91.56 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -97.0 124.0 40.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.585 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.6 p -70.69 144.16 13.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.557 0.694 . . . . 0.0 111.078 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.643 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 1.1 tt -52.05 134.53 32.27 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.592 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.537 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . . . -127.59 -176.25 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -104.66 88.47 2.93 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.015 -176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.86 -16.82 30.54 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.6 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.902 ' HB2' ' HE1' ' A' ' 146' ' ' PHE . 4.2 m-20 -68.85 155.08 40.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.133 0.492 . . . . 0.0 110.786 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.654 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.1 OUTLIER -110.1 156.2 20.88 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.49 0.662 . . . . 0.0 112.566 -170.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.98 HG13 HG22 ' A' ' 121' ' ' VAL . 47.0 t -135.39 132.07 51.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.788 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -98.04 118.07 33.8 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 172.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.641 ' CG1' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -128.96 131.35 68.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.368 173.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.62 ' CA ' HG22 ' A' ' 94' ' ' VAL . . . 82.03 -55.76 4.93 Favored Glycine 0 C--N 1.322 -0.231 0 C-N-CA 119.315 -1.421 . . . . 0.0 112.944 167.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.01 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 58.5 pttt 169.21 32.36 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.704 0 C-N-CA 124.406 1.083 . . . . 0.0 109.082 163.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.808 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.08 150.96 44.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -169.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 5.7 ttm180 -93.2 92.15 7.61 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.896 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.0 mp -88.48 158.34 18.37 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.204 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.654 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.5 OUTLIER -140.97 143.09 28.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 168.225 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.958 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -108.49 143.89 36.86 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.869 -0.732 . . . . 0.0 111.742 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.1 mm? -132.85 167.41 20.25 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.912 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -174.85 -150.4 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.389 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.509 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . -64.69 167.59 29.16 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.575 -0.821 . . . . 0.0 111.417 173.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.691 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 31.8 Cg_exo -59.28 85.14 0.06 OUTLIER 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.012 2.475 . . . . 0.0 113.751 -175.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 132' ' ' ALA . 86.3 tttt -101.23 46.06 0.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 171.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 46' ' ' SER . 36.3 tt0 -145.51 151.11 37.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.742 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -158.97 -165.92 16.96 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 30.3 mp0 -78.0 63.55 3.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.595 0.698 . . . . 0.0 110.639 177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' A' ' 156' ' ' ASP . 23.8 t70 -97.62 92.76 6.06 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 171.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.481 ' HB3' ' O ' ' A' ' 155' ' ' ASP . 21.4 t70 78.37 139.18 0.07 Allowed 'General case' 0 C--O 1.235 0.311 0 O-C-N 124.447 1.092 . . . . 0.0 110.002 -169.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.0 68.8 1.94 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.047 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.3 m -87.35 68.45 9.77 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.845 0.355 . . . . 0.0 110.55 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.3 m -75.83 -32.65 59.89 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.029 0.443 . . . . 0.0 110.38 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 102.13 -128.44 9.55 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.788 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -101.22 -67.65 0.82 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.966 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo . . . . . 0 C--O 1.247 0.972 0 C-N-CA 122.951 2.434 . . . . 0.0 112.609 -177.927 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 121.48 0.657 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.0 p -133.0 -60.85 0.85 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.67 178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.5 t70 69.94 120.05 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.861 0.726 . . . . 0.0 111.851 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ptp -140.31 8.08 2.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.471 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -92.59 112.09 53.92 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.879 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -80.81 114.41 2.92 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.782 2.321 . . . . 0.0 113.669 -173.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 63.79 73.45 0.44 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.95 172.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 41.1 pt -88.75 22.22 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.129 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -79.8 -0.97 36.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.064 0.459 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -90.68 4.03 52.59 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 169.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 65.24 -85.03 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.354 177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -84.79 106.74 16.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 t -118.74 142.16 47.95 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.453 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.1 m -148.04 -71.41 0.21 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.519 ' O ' HG12 ' A' ' 19' ' ' VAL . 16.9 m-20 -123.71 -15.8 6.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.94 0.4 . . . . 0.0 111.196 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -75.1 46.57 0.32 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.448 0.642 . . . . 0.0 111.613 -177.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.0 t -116.9 -60.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.044 178.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.7 p -97.01 -40.76 8.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 15' ' ' ASP . 6.9 p -86.23 6.48 2.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.335 0.588 . . . . 0.0 110.834 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.15 69.11 8.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.37 0.605 . . . . 0.0 109.733 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.725 HG22 ' O ' ' A' ' 22' ' ' TPO . 87.7 m -154.28 137.86 16.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.553 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.786 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.764 ' O ' ' HA ' ' A' ' 93' ' ' THR . 69.1 m -72.56 140.54 48.16 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 121.515 -0.741 . . . . 0.0 111.741 -175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.445 ' HB ' ' CD2' ' A' ' 116' ' ' LEU . 8.0 p -135.36 147.47 28.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.315 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -177.35 -160.06 0.05 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-O 118.679 -0.677 . . . . 0.0 110.071 -178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.844 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 42.52 -97.98 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 O-C-N 124.222 0.951 . . . . 0.0 110.676 176.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.514 ' H ' ' HB3' ' A' ' 26' ' ' ARG . . . 66.08 172.12 0.23 Allowed 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 165.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.859 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 7.4 t70 -89.7 53.87 2.7 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.744 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -148.09 -49.16 0.16 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.818 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 47.6 tp -74.64 -67.17 0.66 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.675 -175.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.7 t -162.9 -178.85 6.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.191 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.456 ' HG2' ' NH1' ' A' ' 26' ' ' ARG . 0.9 OUTLIER 68.69 36.18 2.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.944 0.898 . . . . 0.0 110.943 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.827 HD22 HH21 ' A' ' 143' ' ' ARG . 1.4 mt -133.71 -75.94 0.48 Allowed 'General case' 0 CA--C 1.501 -0.914 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 173.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 6.7 m-20 52.12 -89.52 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 112.988 -1.914 . . . . 0.0 112.212 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -164.87 -50.48 0.0 OUTLIER Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.207 -177.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 11.0 Cg_exo -71.54 118.15 5.51 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 122.301 2.001 . . . . 0.0 113.091 -177.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.84 75.18 7.32 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -64.21 117.2 6.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 -172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.84 75.23 1.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.235 178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.43 60.48 0.91 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.779 -178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 m 60.07 85.53 0.11 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.121 0.486 . . . . 0.0 111.731 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.17 -71.73 0.57 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.4 m -115.2 -49.98 2.76 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . 51.05 48.51 22.95 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.515 0.509 . . . . 0.0 111.376 176.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.84 116.35 31.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 m 70.43 -55.57 0.62 Allowed 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 123.382 0.673 . . . . 0.0 111.449 -178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.22 -53.43 0.49 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 12.0 t 50.97 59.02 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.301 0.572 . . . . 0.0 109.817 -176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.705 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 10.7 pt-20 -150.67 -65.0 0.2 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.75 -177.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.705 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -77.74 75.5 1.84 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.025 -0.607 . . . . 0.0 111.894 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 18.0 mt -108.95 89.89 7.09 Favored Pre-proline 0 N--CA 1.45 -0.432 0 N-CA-C 111.565 0.209 . . . . 0.0 111.565 -177.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 50' ' ' GLY . 90.4 Cg_endo -111.93 33.4 0.03 OUTLIER 'Trans proline' 0 CA--C 1.55 1.275 0 C-N-CA 123.343 2.696 . . . . 0.0 114.756 168.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 55' ' ' SER . 88.0 Cg_endo -88.27 39.78 0.53 Allowed 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 121.726 1.617 . . . . 0.0 112.419 -174.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 92.7 -12.17 70.45 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.619 ' O ' ' HD2' ' A' ' 53' ' ' PRO . 0.7 OUTLIER -134.3 141.73 47.04 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 114.783 -0.708 . . . . 0.0 109.738 -178.485 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.78 168.7 13.44 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' O ' HD12 ' A' ' 57' ' ' LEU . 4.0 pp -161.01 146.18 14.13 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 119.049 -1.06 . . . . 0.0 113.537 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.572 HD21 ' CG1' ' A' ' 110' ' ' VAL . 4.1 mp -87.91 141.16 28.8 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.634 164.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.606 HG12 HD23 ' A' ' 147' ' ' LEU . 7.3 p -132.74 132.48 59.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.215 176.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.935 HG22 ' H ' ' A' ' 68' ' ' SER . 0.8 OUTLIER -74.17 109.7 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 174.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 25.2 tptp -63.32 -54.74 32.23 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.885 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 71.9 mtt180 -158.38 138.18 12.08 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.054 174.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.727 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -175.65 -155.28 12.55 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.006 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 78.2 Cg_exo -55.68 -65.0 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 C-N-CA 122.712 2.274 . . . . 0.0 112.949 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.775 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 52.3 t30 -71.03 -48.38 53.29 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 56.71 153.62 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.673 -1.603 . . . . 0.0 113.044 -174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.55 2.22 90.43 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.332 174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.935 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.0 m -88.34 176.35 7.25 Favored 'General case' 0 C--O 1.214 -0.802 0 CA-C-N 117.258 0.529 . . . . 0.0 110.26 -170.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.665 HH21 ' HB2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -170.23 148.27 3.26 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.812 0.733 . . . . 0.0 112.868 -169.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.498 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -95.89 129.67 43.08 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 174.023 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.665 ' HB2' HH21 ' A' ' 69' ' ' ARG . 1.5 tm? -85.79 101.37 12.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.8 ' HG ' ' CG ' ' A' ' 101' ' ' PHE . 0.7 OUTLIER -95.86 31.58 2.07 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.297 -177.003 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 34.7 t70 -89.85 -11.52 41.73 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.84 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.568 ' O ' ' HE2' ' A' ' 101' ' ' PHE . 1.4 pp0? -121.42 153.84 37.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -42.63 -39.01 2.2 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -168.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.658 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.82 123.08 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.255 0.55 . . . . 0.0 112.149 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.63 ' CG2' ' HB3' ' A' ' 86' ' ' ASP . 1.6 p -113.79 121.84 45.26 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.802 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.615 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 30.5 m -76.61 126.68 31.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.745 0.307 . . . . 0.0 110.579 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.611 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -122.21 116.47 24.21 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -169.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.871 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 170.66 -108.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.671 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.794 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -111.79 101.75 10.07 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.7 ' CD2' ' HB2' ' A' ' 85' ' ' SER . 0.2 OUTLIER -139.37 146.86 50.36 Favored Pre-proline 0 C--N 1.314 -0.972 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.955 -160.5 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.91 -157.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.412 2.074 . . . . 0.0 110.039 165.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -78.25 52.42 1.12 Allowed 'General case' 0 C--N 1.321 -0.673 0 O-C-N 122.204 -0.31 . . . . 0.0 111.138 -177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.7 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . 5.7 m -91.02 -70.4 0.68 Allowed 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.73 0.3 . . . . 0.0 110.663 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.63 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 2.8 m-20 -143.14 -77.18 0.24 Allowed 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.437 0.636 . . . . 0.0 110.818 -171.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.611 HG12 ' HB1' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -127.75 122.02 57.95 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.229 -176.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.71 133.16 56.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.238 176.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.656 HD12 HG12 ' A' ' 139' ' ' ILE . 6.2 mt -108.15 80.33 1.36 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 172.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 29.7 t70 71.71 -6.84 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.57 0.7 . . . . 0.0 110.134 -178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.794 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.3 p30 40.5 38.77 0.62 Allowed 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 125.121 1.368 . . . . 0.0 113.523 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.495 ' O ' HG12 ' A' ' 92' ' ' VAL . 70.8 t -145.67 6.84 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.737 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.764 ' HA ' ' O ' ' A' ' 23' ' ' SER . 10.3 p -124.47 -2.2 7.99 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -168.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.525 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 2.8 t -136.53 155.55 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.42 -0.8 . . . . 0.0 111.72 -172.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.786 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 51.0 m -75.52 79.28 2.54 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.092 0.472 . . . . 0.0 110.032 174.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 1.054 ' HG2' ' HD2' ' A' ' 97' ' ' ARG . 11.4 ttm180 55.69 -58.07 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.753 -1.112 . . . . 0.0 112.869 -164.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 1.054 ' HD2' ' HG2' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -157.84 153.87 27.08 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 121.484 -0.76 . . . . 0.0 111.697 -177.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 1.01 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -95.41 -40.54 9.44 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.304 177.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.884 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -148.61 131.52 16.16 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.581 -1.19 . . . . 0.0 109.667 -178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -102.98 122.53 44.79 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 1.0 OUTLIER -53.19 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.498 -1.057 0 O-C-N 124.614 1.196 . . . . 0.0 108.406 -176.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.85 107.67 19.95 Favored 'General case' 0 N--CA 1.415 -2.208 0 C-N-CA 119.359 -0.937 . . . . 0.0 108.742 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.892 HD21 ' HA ' ' A' ' 106' ' ' ASN . 8.8 tt -77.02 107.87 9.68 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' C ' HD22 ' A' ' 105' ' ' ASN . 23.6 mt-10 -117.19 134.05 55.25 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.527 HD22 ' C ' ' A' ' 104' ' ' GLU . 0.0 OUTLIER 39.07 43.34 0.8 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.183 0.993 . . . . 0.0 112.1 -175.169 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.892 ' HA ' HD21 ' A' ' 103' ' ' LEU . 53.2 m-80 72.08 15.63 5.48 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 114.756 -1.111 . . . . 0.0 113.561 174.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.706 ' HG3' HD21 ' A' ' 109' ' ' ASN . 15.5 pt-20 -122.26 151.68 40.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.939 173.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.95 ' HB2' HD13 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -93.42 129.13 39.68 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.942 -174.166 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.706 HD21 ' HG3' ' A' ' 107' ' ' GLU . 18.4 m-80 -135.19 161.82 34.28 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -175.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.4 m -107.03 126.81 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.37 174.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.884 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 4.0 t -100.3 111.59 30.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.297 179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 11.2 t70 -73.26 115.05 12.15 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 111' ' ' VAL . 16.0 m -115.17 -12.36 11.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.122 0.487 . . . . 0.0 111.096 -174.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 132.8 87.57 0.34 Allowed Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.586 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 1.01 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 30.7 t -92.32 145.15 24.71 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.445 ' CD2' ' HB ' ' A' ' 24' ' ' VAL . 23.9 tp -63.73 -55.41 23.47 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.334 -174.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.78 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -67.77 -36.44 80.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.48 169.57 12.42 Favored Glycine 0 C--O 1.26 1.768 0 CA-C-N 114.643 -1.162 . . . . 0.0 112.102 -172.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 35.2 m -112.85 123.53 50.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.618 -0.791 . . . . 0.0 111.298 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 52.2 m-85 -140.96 103.67 4.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 172.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.007 HG12 HG13 ' A' ' 137' ' ' VAL . 1.3 m -99.45 130.27 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 174.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.626 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.6 OUTLIER 63.13 31.59 15.68 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.139 179.785 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 58.12 32.13 21.6 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -174.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 13.5 pt-20 -146.12 138.79 13.96 Favored Pre-proline 0 C--O 1.234 0.289 0 CA-C-O 121.102 0.477 . . . . 0.0 110.664 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 19.9 Cg_exo -65.46 123.26 11.19 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.599 2.199 . . . . 0.0 111.412 175.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' A' ' 121' ' ' VAL . 27.3 m -123.65 169.41 15.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -99.41 -61.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.809 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.888 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 35.5 t -143.84 91.91 2.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.333 177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -99.32 124.89 44.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.575 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 8.7 p -67.11 150.81 10.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.728 178.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.95 HD13 ' HB2' ' A' ' 108' ' ' PHE . 11.0 mp -58.67 145.93 38.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.497 178.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 146' ' ' PHE . . . -151.3 130.79 12.97 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 174.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -69.42 121.85 17.8 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.441 0.639 . . . . 0.0 111.234 -171.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.79 60.98 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.17 176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 145' ' ' VAL . 36.0 m-20 -105.02 147.53 27.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.622 ' HG2' ' NH1' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -106.58 161.85 14.26 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 -168.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.007 HG13 HG12 ' A' ' 121' ' ' VAL . 40.6 t -134.51 131.74 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 114.561 -1.2 . . . . 0.0 109.558 176.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.859 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 6.6 tp-100 -96.8 120.06 36.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.247 0.546 . . . . 0.0 110.05 169.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.842 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -135.98 129.5 47.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.386 171.105 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.78 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 76.81 -62.25 3.25 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 119.795 -1.193 . . . . 0.0 112.597 173.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.006 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 54.1 pttt 176.41 28.1 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.122 0.569 . . . . 0.0 111.379 169.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.847 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -122.82 146.84 47.19 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.595 0.758 . . . . 0.0 109.053 -168.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.827 HH21 HD22 ' A' ' 33' ' ' LEU . 11.6 ttm-85 -97.1 100.18 11.67 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.338 -0.545 . . . . 0.0 109.626 176.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.926 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 6.4 mp -91.75 166.08 12.95 Favored 'General case' 0 C--O 1.205 -1.246 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.922 -178.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.588 HG22 HD22 ' A' ' 147' ' ' LEU . 0.2 OUTLIER -143.36 144.25 23.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 171.13 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.818 ' HB3' ' HG ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -84.51 136.87 33.64 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.953 177.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.606 HD23 HG12 ' A' ' 59' ' ' VAL . 2.0 mm? -129.06 131.73 47.36 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 111.063 173.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.6 t -166.98 145.47 5.07 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.02 175.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.603 ' HA2' ' HA2' ' A' ' 50' ' ' GLY . . . -63.55 116.98 9.95 Favored Glycine 0 N--CA 1.452 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 113.841 -176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -85.49 130.06 3.78 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.353 2.702 . . . . 0.0 110.835 173.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -59.03 116.15 3.62 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 111.334 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.9 mm-40 -87.47 63.41 7.64 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.457 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -76.75 58.72 3.44 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 121.155 -0.545 . . . . 0.0 111.892 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -127.01 121.95 33.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.335 -177.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -93.93 -152.02 0.33 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 172.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.48 ' CG ' ' H ' ' A' ' 157' ' ' GLY . 19.0 t70 73.2 -166.79 0.11 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.48 ' H ' ' CG ' ' A' ' 156' ' ' ASP . . . 90.16 -59.77 3.45 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 -169.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.4 m -99.88 76.75 1.98 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 168.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.428 HG22 ' HD2' ' A' ' 162' ' ' PRO . 8.9 m -73.37 76.62 1.38 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.331 0.586 . . . . 0.0 111.298 -173.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -84.51 69.75 3.27 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.889 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -155.93 -91.25 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.821 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.428 ' HD2' HG22 ' A' ' 159' ' ' THR . 18.8 Cg_exo . . . . . 0 C--O 1.248 1.008 0 C-N-CA 123.031 2.487 . . . . 0.0 112.046 178.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 4.2 m . . . . . 0 N--CA 1.454 -0.226 0 CA-C-O 120.985 0.422 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 62.3 m 69.95 97.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.501 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -92.41 -12.12 33.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.82 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.4 mtp 69.32 -75.53 0.07 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.862 0.726 . . . . 0.0 111.342 -179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -154.65 159.4 31.91 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -59.51 -77.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.077 1.851 . . . . 0.0 111.724 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -133.39 -56.7 0.9 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.803 0.335 . . . . 0.0 110.645 176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.0 mp -110.29 -54.12 5.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.476 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -179.58 -72.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.352 0.596 . . . . 0.0 110.645 -174.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.436 ' NZ ' ' HB2' ' A' ' 10' ' ' LYS . 3.0 ttmp? -104.39 49.09 0.82 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.659 -173.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -73.53 108.01 6.14 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.871 -179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.535 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 10.7 mm-40 -85.41 72.82 10.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.28 0.562 . . . . 0.0 112.125 -173.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 m -122.35 32.02 5.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.811 0.815 . . . . 0.0 108.913 171.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.9 p -87.96 -32.87 18.65 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.464 -175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.611 ' HB2' HG13 ' A' ' 17' ' ' VAL . 3.8 p30 -69.61 -46.23 66.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.069 -173.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 54.71 47.57 22.2 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.801 0.334 . . . . 0.0 110.493 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.611 HG13 ' HB2' ' A' ' 15' ' ' ASP . 36.0 m -87.44 26.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.936 -177.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -67.41 125.96 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.882 0.372 . . . . 0.0 110.128 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 23.5 m -56.88 137.71 18.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.696 177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.96 96.94 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.058 -171.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.2 m -157.23 155.37 30.72 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.764 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.7 m -70.94 5.14 2.14 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 116.539 2.051 . . . . 0.0 116.539 -159.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.905 HG12 ' H ' ' A' ' 25' ' ' PHE . 2.1 t 46.52 -152.33 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 C-N-CA 123.11 0.564 . . . . 0.0 111.99 177.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.905 ' H ' HG12 ' A' ' 24' ' ' VAL . 0.2 OUTLIER 100.1 -165.62 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.374 1.47 . . . . 0.0 114.376 160.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.967 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 32.64 -95.42 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.041 1.337 . . . . 0.0 110.578 -172.177 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.809 ' H ' ' HB2' ' A' ' 141' ' ' LYS . . . 66.01 121.72 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 122.589 1.185 . . . . 0.0 113.087 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.932 ' HB3' HD21 ' A' ' 33' ' ' LEU . 2.2 m-20 -87.83 59.95 5.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.081 -1.418 . . . . 0.0 110.59 -173.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' HE1' HD21 ' A' ' 117' ' ' ASN . 30.5 m-85 -116.6 -42.27 3.01 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.771 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.0 tp -98.81 -27.49 13.91 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.292 -175.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' C ' ' H ' ' A' ' 33' ' ' LEU . 49.3 m -160.9 -173.72 4.05 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 -169.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.671 ' HG3' ' HD3' ' A' ' 26' ' ' ARG . 12.4 mm-40 72.03 -13.47 0.6 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.904 0.752 . . . . 0.0 111.298 177.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.932 HD21 ' HB3' ' A' ' 28' ' ' ASP . 2.9 mt -82.78 -44.31 15.7 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 64.23 -85.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 112.44 -2.164 . . . . 0.0 112.541 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -152.33 141.18 14.0 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.736 0.303 . . . . 0.0 110.933 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -87.91 -1.29 7.22 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.981 2.454 . . . . 0.0 112.604 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.51 53.77 1.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.321 0.582 . . . . 0.0 111.036 -177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -120.79 -38.77 2.81 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.437 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -93.77 133.7 36.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.561 179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.89 78.72 0.41 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.801 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 m -73.04 81.22 1.23 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.087 0.47 . . . . 0.0 110.556 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -62.48 -62.08 2.0 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.931 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 t -145.38 -138.3 0.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.55 68.03 0.79 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.328 0.585 . . . . 0.0 110.919 177.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.66 132.06 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.185 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 78.0 p 57.07 170.25 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.104 0.962 . . . . 0.0 112.164 -176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.33 -65.01 0.48 Allowed Glycine 0 N--CA 1.433 -1.549 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.6 m -86.08 26.75 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -175.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.1 -8.95 3.84 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.603 171.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -80.92 -45.91 7.41 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.412 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.644 ' HB3' ' HD3' ' A' ' 53' ' ' PRO . 5.2 mp -62.1 130.16 92.6 Favored Pre-proline 0 CA--C 1.516 -0.359 0 CA-C-O 120.527 0.203 . . . . 0.0 111.006 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -106.39 63.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 123.798 2.998 . . . . 0.0 112.203 166.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 51' ' ' LEU . 14.8 Cg_exo -29.13 109.05 0.03 OUTLIER 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 124.277 3.318 . . . . 0.0 114.421 178.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.84 -48.11 0.76 Allowed Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 -178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 p -143.11 147.33 34.81 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.58 36.43 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.693 ' HA ' HD13 ' A' ' 72' ' ' LEU . 2.3 pt? -160.71 140.02 10.62 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.747 -0.781 . . . . 0.0 112.943 -173.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.053 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 5.5 mp -89.67 112.33 23.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.501 -1.227 . . . . 0.0 109.679 168.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.7 t -104.53 125.82 59.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.993 HG22 ' H ' ' A' ' 68' ' ' SER . 0.7 OUTLIER -73.0 113.43 10.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.749 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 174.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -77.51 -55.94 4.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.014 -172.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.1 mtp85 -141.53 129.27 21.65 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.544 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -177.38 178.58 48.31 Favored Glycine 0 N--CA 1.425 -2.072 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.063 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 97.0 Cg_exo -48.46 -48.41 17.31 Favored 'Trans proline' 0 C--N 1.32 -0.931 0 C-N-CA 122.948 2.432 . . . . 0.0 113.465 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.531 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 58.0 t30 -83.16 -52.72 6.36 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 173.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.662 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.97 171.21 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 113.5 -1.682 . . . . 0.0 112.796 -170.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.6 2.54 89.84 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.917 171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.993 ' H ' HG22 ' A' ' 60' ' ' VAL . 3.4 m -98.01 177.76 5.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 117.626 0.713 . . . . 0.0 110.465 -171.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -171.19 151.96 3.3 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 118.102 0.41 . . . . 0.0 111.636 -176.356 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.692 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -94.95 134.05 38.04 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 174.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 71' ' ' LEU . 6.4 tt -87.05 93.85 9.47 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.734 HD23 ' CD1' ' A' ' 101' ' ' PHE . 4.1 mp -93.39 45.43 1.16 Allowed 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.563 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -99.0 -28.22 13.51 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.131 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.52 HE21 HG22 ' A' ' 77' ' ' THR . 7.2 pt20 -92.59 -162.3 0.92 Allowed 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.006 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.2 -51.5 20.85 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 177.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.524 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -158.89 139.69 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.092 0.473 . . . . 0.0 111.949 -178.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 38.3 p -121.16 152.03 39.23 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.343 -176.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.636 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 75.8 m -95.57 124.8 39.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 172.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -126.54 116.23 20.76 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -166.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 89' ' ' LEU . . . 148.99 -85.94 0.16 Allowed Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.176 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.595 ' HG2' ' OD1' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -115.67 104.03 11.29 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.617 0.722 . . . . 0.0 109.174 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.636 ' NE2' ' HB2' ' A' ' 78' ' ' SER . 0.1 OUTLIER -139.47 126.61 12.8 Favored Pre-proline 0 N--CA 1.437 -1.096 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.023 -169.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 16.7 Cg_exo -69.05 -50.18 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.654 2.236 . . . . 0.0 112.291 172.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -172.37 93.4 0.13 Allowed 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.514 ' HB2' ' NE2' ' A' ' 82' ' ' HIS . 2.1 m -151.14 -62.42 0.18 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.155 169.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 87' ' ' ILE . 0.4 OUTLIER -140.14 -72.74 0.37 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.323 0.583 . . . . 0.0 111.285 -170.525 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.644 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.85 113.94 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.215 -172.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.44 ' O ' ' HD1' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -116.77 134.32 54.93 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.707 -0.678 . . . . 0.0 112.132 179.934 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.971 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.5 mm? -122.22 74.43 1.16 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.934 178.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 29.6 t70 72.49 -17.37 0.39 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.454 0.645 . . . . 0.0 110.592 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.595 ' OD1' ' HG2' ' A' ' 81' ' ' ARG . 35.0 t70 61.82 29.52 17.98 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.386 171.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.511 ' C ' HG22 ' A' ' 22' ' ' TPO . 9.1 p -153.75 32.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.952 0.882 . . . . 0.0 109.821 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.552 HG21 ' HZ ' ' A' ' 142' ' ' PHE . 65.3 p -132.81 -9.57 3.1 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.965 -178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.51 ' N ' HG21 ' A' ' 22' ' ' TPO . 2.0 t -136.38 159.57 38.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -173.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.724 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 11.4 t -87.57 77.3 8.78 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 58.48 -59.15 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.929 -165.33 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.837 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 5.7 ptt85 -143.65 137.63 28.41 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.621 0.724 . . . . 0.0 111.066 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.699 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -75.02 -39.27 61.19 Favored 'General case' 0 CA--C 1.505 -0.779 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 170.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -156.94 149.45 23.33 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 113.072 -1.877 . . . . 0.0 108.633 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' CD ' HH21 ' A' ' 102' ' ' ARG . 7.8 pt-20 -108.0 133.1 52.8 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 173.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.734 ' CD1' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -56.98 106.12 0.28 Allowed 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.559 HH21 ' CD ' ' A' ' 100' ' ' GLU . 21.1 tpp85 -103.16 104.04 14.15 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.62 -175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.872 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.3 tt -86.44 110.72 19.92 Favored 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 120.164 -0.615 . . . . 0.0 110.351 179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -129.28 135.36 48.68 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.227 175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 57.51 37.74 27.8 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.606 0.566 . . . . 0.0 110.329 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.872 ' HA ' HD21 ' A' ' 103' ' ' LEU . 21.1 m120 64.64 12.52 7.61 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.03 -178.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.64 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.1 mt-10 -106.33 144.73 32.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 120.893 0.377 . . . . 0.0 111.396 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.441 ' HB3' ' HB3' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -95.9 126.29 41.05 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.384 179.623 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 130' ' ' VAL . 11.0 m-80 -135.86 163.36 30.41 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.895 ' O ' ' HA ' ' A' ' 128' ' ' SER . 7.2 m -111.26 122.59 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.942 174.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.633 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 36.7 t -101.18 110.4 27.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.865 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 18.6 t70 -68.5 128.29 36.07 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.689 HG21 HH11 ' A' ' 97' ' ' ARG . 18.9 m -126.0 9.51 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.22 0.533 . . . . 0.0 109.734 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.62 71.77 0.59 Allowed Glycine 0 N--CA 1.434 -1.458 0 C-N-CA 120.069 -1.062 . . . . 0.0 112.307 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.699 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 39.3 t -67.11 134.98 52.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 175.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.764 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 1.8 tm? -52.83 -55.82 20.3 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.682 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.0 OUTLIER -76.17 -37.33 58.04 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.139 0.495 . . . . 0.0 109.825 172.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 142.73 163.85 9.9 Favored Glycine 0 C--O 1.248 1.015 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.15 -173.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.1 m -111.69 137.41 49.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.394 0.678 . . . . 0.0 111.282 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.11 103.78 4.86 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.292 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.977 HG22 HG13 ' A' ' 137' ' ' VAL . 61.7 t -112.8 121.44 65.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 122.079 -0.388 . . . . 0.0 110.236 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.7 m120 61.29 36.91 17.5 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 63.66 22.11 12.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.477 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -149.59 148.48 25.98 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-O 121.028 0.442 . . . . 0.0 110.949 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.03 123.6 11.5 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.271 1.981 . . . . 0.0 111.78 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 6.1 m -122.49 155.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.7 0.286 . . . . 0.0 110.281 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 4.3 m-20 -87.54 -47.08 9.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.641 176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.895 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 7.6 p -154.86 91.87 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.342 0.592 . . . . 0.0 110.733 -179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -101.61 132.85 47.05 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.367 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 7.1 p -76.06 149.63 6.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.629 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.837 HD11 HD11 ' A' ' 58' ' ' LEU . 8.7 mp -65.49 133.44 51.28 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.653 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.08 -176.32 3.68 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.859 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -93.81 103.78 15.89 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.36 0.124 . . . . 0.0 111.306 -177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.18 -8.09 69.64 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.401 -0.904 . . . . 0.0 114.114 168.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.718 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 3.8 t0 -81.59 162.25 23.19 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.683 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.7 pt-20 -126.89 148.26 50.03 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -166.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.977 HG13 HG22 ' A' ' 121' ' ' VAL . 61.4 t -123.09 141.44 43.42 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.616 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.024 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.888 ' HG3' ' HB2' ' A' ' 28' ' ' ASP . 20.9 tm0? -106.67 131.12 54.17 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 173.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.971 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -137.48 140.32 41.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.784 174.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.682 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.3 -73.73 0.72 Allowed Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.344 170.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.063 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 52.1 pttt -172.3 29.13 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.078 0.466 . . . . 0.0 110.445 170.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.694 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -127.02 149.32 49.95 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.123 -1.065 . . . . 0.0 108.123 -171.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.616 ' NH2' ' HA ' ' A' ' 33' ' ' LEU . 3.8 ttm180 -98.6 120.26 38.72 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.018 -0.673 . . . . 0.0 109.64 175.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 4.3 mp -108.16 162.77 13.76 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.575 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.683 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.05 137.08 38.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 169.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.053 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -104.96 154.29 20.29 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.732 -178.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -127.75 171.63 11.54 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.06 171.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 9.5 t -138.11 159.79 41.11 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.428 -174.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . -160.64 70.89 0.23 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.44 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.422 ' HD2' HD23 ' A' ' 51' ' ' LEU . 32.0 Cg_exo -63.18 137.34 60.81 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.612 2.208 . . . . 0.0 111.215 175.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.15 51.23 2.18 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.788 0.327 . . . . 0.0 111.495 -174.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -78.56 89.72 4.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.253 0.549 . . . . 0.0 109.659 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -68.8 150.47 50.57 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.683 -176.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.31 41.23 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.323 0.582 . . . . 0.0 109.794 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.03 69.28 6.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.281 -173.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -151.79 80.07 1.27 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.962 175.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 149.68 106.85 0.39 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.171 -178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.9 t -110.49 -18.52 13.19 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 12.0 m -125.8 115.63 20.31 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.165 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 172.39 -20.04 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.811 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 88.99 149.5 20.39 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.164 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 122.606 2.204 . . . . 0.0 111.854 177.938 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 21.2 m . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 121.455 0.645 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.9 t -107.97 13.34 26.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.75 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -108.18 111.19 23.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.699 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 93.8 mmm -109.75 113.57 26.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.34 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.751 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 10.4 t30 -68.17 -51.8 24.87 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.179 174.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.751 ' HD3' ' HB3' ' A' ' 5' ' ' ASN . 44.3 Cg_endo -95.5 62.49 0.2 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.621 2.214 . . . . 0.0 111.12 169.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.32 -79.64 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.178 -175.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.9 tp -143.6 -9.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 122.003 0.906 . . . . 0.0 108.678 172.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -166.36 160.19 15.48 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 114.256 -1.338 . . . . 0.0 108.173 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -141.31 101.76 4.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.27 0.557 . . . . 0.0 110.709 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -74.6 125.54 28.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.395 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -169.8 -51.73 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.092 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -135.52 161.23 36.08 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.903 175.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.0 t -144.06 142.52 30.69 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' GLU . 23.7 t70 -71.88 145.77 48.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.893 177.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.529 ' HG2' HG23 ' A' ' 17' ' ' VAL . 44.0 tt0 75.36 127.2 0.04 OUTLIER 'General case' 0 C--O 1.235 0.341 0 O-C-N 124.041 0.838 . . . . 0.0 109.944 -175.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG23 ' HG2' ' A' ' 16' ' ' GLU . 12.5 t 66.15 28.07 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-O 122.364 1.078 . . . . 0.0 109.099 -172.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 m -85.03 83.87 7.9 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.627 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.69 170.54 14.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.5 -175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 66.58 169.16 0.23 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.975 0.797 . . . . 0.0 111.145 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.4 m 68.35 159.42 0.16 Allowed 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -171.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.818 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.597 ' HB2' HG22 ' A' ' 93' ' ' THR . 41.9 m -60.21 108.55 0.81 Allowed 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -170.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.504 HG23 ' HB2' ' A' ' 117' ' ' ASN . 7.1 p -112.46 125.69 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.273 -176.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' HB3' ' HE3' ' A' ' 141' ' ' LYS . 2.5 t80 176.52 -165.43 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.822 0.076 . . . . 0.0 110.937 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.591 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 1.2 tmm_? 43.48 -123.06 0.79 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.348 1.059 . . . . 0.0 112.484 171.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.883 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 65.05 174.74 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.907 ' H ' ' HG3' ' A' ' 138' ' ' GLN . 13.5 t70 -76.87 56.61 1.21 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.488 -177.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -146.95 -48.97 0.19 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.645 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.0 tp -81.29 -69.1 0.63 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.252 -175.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.3 m -170.17 -167.19 0.6 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 -175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 70.31 35.55 2.02 Favored 'General case' 0 C--O 1.234 0.259 0 O-C-N 123.686 0.616 . . . . 0.0 110.622 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.669 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.9 OUTLIER -176.36 -28.15 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.378 -179.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -71.32 54.28 0.2 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.243 174.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -154.25 77.08 5.57 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.751 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.447 ' HB2' HE21 ' A' ' 38' ' ' GLN . 15.4 Cg_exo -67.65 101.19 0.63 Allowed 'Trans proline' 0 N--CA 1.464 -0.24 0 C-N-CA 122.915 2.41 . . . . 0.0 111.864 -177.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.07 -29.28 63.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.173 0.511 . . . . 0.0 110.175 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 36' ' ' PRO . 74.4 mt-30 62.58 20.6 12.1 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.189 172.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.82 -33.67 14.87 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.922 0.392 . . . . 0.0 110.692 -178.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.38 -166.29 24.19 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.112 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 93.0 m -150.39 -65.38 0.2 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 56.41 53.14 9.03 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.261 0.553 . . . . 0.0 110.68 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 p -75.79 76.82 2.74 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.226 178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.72 98.52 9.12 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.898 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -95.1 -29.79 4.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.664 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.9 t -169.07 141.88 2.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.67 178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.497 ' CA ' ' HD2' ' A' ' 150' ' ' PRO . . . -114.93 -33.33 1.7 Allowed Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.4 43.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.347 0.594 . . . . 0.0 111.074 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -168.37 -46.04 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.358 -176.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -69.18 -23.49 76.21 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.83 -0.623 . . . . 0.0 114.202 -173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.665 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 96.1 mt -53.73 150.76 12.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.119 0.485 . . . . 0.0 111.861 177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.684 ' HA ' ' HE2' ' A' ' 108' ' ' PHE . 86.3 Cg_exo -47.92 -36.77 27.89 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 124.083 3.189 . . . . 0.0 115.188 176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.665 ' HD2' ' HB3' ' A' ' 51' ' ' LEU . 57.5 Cg_endo -72.09 55.13 2.32 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 121.518 1.479 . . . . 0.0 112.434 175.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 171.59 -79.99 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.6 t -164.7 132.81 3.33 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -126.86 169.66 13.02 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.568 ' HA ' ' CD2' ' A' ' 72' ' ' LEU . 2.5 pt? -153.19 131.92 12.34 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -176.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.015 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 4.7 mp -87.48 146.64 25.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.48 -1.237 . . . . 0.0 108.6 163.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.8 p -136.1 128.94 46.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.806 0.336 . . . . 0.0 110.383 177.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 68' ' ' SER . 0.9 OUTLIER -74.37 115.15 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 18.8 tptp -76.5 -66.35 0.82 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.639 -1.164 . . . . 0.0 110.11 -172.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 67.6 mtp180 -138.92 132.93 31.16 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.978 -177.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.574 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -178.05 -171.37 41.35 Favored Glycine 0 N--CA 1.424 -2.11 0 N-CA-C 108.625 -1.79 . . . . 0.0 108.625 -177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.977 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 51.0 Cg_exo -53.87 -52.23 8.92 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.25 1.967 . . . . 0.0 112.893 178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 65.4 t30 -81.36 -54.14 5.72 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-O 121.647 0.737 . . . . 0.0 109.262 173.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.674 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 53.1 170.38 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 113.618 -1.628 . . . . 0.0 113.03 -170.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.35 2.28 90.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.994 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.5 m -97.96 179.55 4.75 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 118.423 1.111 . . . . 0.0 110.966 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.621 ' HD3' ' N ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -166.25 153.02 9.36 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 118.3 0.5 . . . . 0.0 111.743 -175.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.674 ' HE1' HD23 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -97.95 125.35 42.83 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 173.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 71' ' ' LEU . 0.5 OUTLIER -87.12 94.41 9.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.63 0.729 . . . . 0.0 109.481 177.59 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.648 ' CD1' ' HB3' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -91.37 54.79 2.63 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.776 0.798 . . . . 0.0 109.642 -178.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -98.71 -26.61 14.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.545 -1.207 . . . . 0.0 108.007 171.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.466 ' HG2' HD23 ' A' ' 71' ' ' LEU . 13.2 pt20 -97.31 161.11 13.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.45 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.62 -16.14 55.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 -172.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -171.15 133.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.959 0.409 . . . . 0.0 111.761 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 35.3 p -120.82 144.34 48.39 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.351 -177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 87' ' ' ILE . 74.4 m -89.96 124.64 34.91 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 173.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.698 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -116.15 123.38 47.69 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 88' ' ' PHE . . . 141.84 -142.07 11.55 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.319 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.898 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -71.14 104.7 3.14 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.575 0.702 . . . . 0.0 110.066 174.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 85' ' ' SER . 41.4 m-70 -136.86 111.4 9.49 Favored Pre-proline 0 N--CA 1.436 -1.136 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.289 -173.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -83.36 -10.22 10.03 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.603 2.202 . . . . 0.0 111.428 177.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -164.82 69.72 0.16 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.097 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.541 ' HB2' ' HB3' ' A' ' 82' ' ' HIS . 34.6 m -147.95 -153.48 0.49 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.839 0.352 . . . . 0.0 110.72 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.48 -61.92 1.42 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.214 0.531 . . . . 0.0 110.582 -174.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.698 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -107.33 96.68 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.592 -177.246 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -101.15 130.64 47.26 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.398 178.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 60' ' ' VAL . 3.8 mm? -115.93 80.64 1.48 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 37.7 t70 70.46 -10.12 0.72 Allowed 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.824 0.702 . . . . 0.0 110.481 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.886 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 5.6 p-10 41.89 33.25 0.33 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.581 1.553 . . . . 0.0 113.16 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.1 t -138.69 -10.7 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.183 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.597 HG22 ' HB2' ' A' ' 23' ' ' SER . 30.4 p -103.29 -33.64 9.07 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -173.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.85 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 3.4 t -98.36 149.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 122.238 -0.289 . . . . 0.0 111.358 -170.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.686 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 6.7 t -74.44 77.02 1.92 Allowed 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.898 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 0.2 OUTLIER 59.17 -75.68 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.149 -168.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.755 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -136.45 134.87 38.14 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 121.338 -0.851 . . . . 0.0 111.239 -174.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.587 ' HB3' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -71.26 -45.7 62.61 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 173.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.506 ' HB3' HG12 ' A' ' 110' ' ' VAL . . . -159.69 -179.5 7.92 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.278 -1.783 . . . . 0.0 108.402 -178.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.9 pt-20 -137.84 124.74 21.27 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.833 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -81.12 90.67 6.05 Favored 'General case' 0 CA--C 1.487 -1.465 0 CA-C-O 122.064 0.935 . . . . 0.0 108.82 -177.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.461 ' HD2' HG21 ' A' ' 111' ' ' VAL . 10.6 ptp180 -94.17 151.97 19.07 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 113.548 -1.66 . . . . 0.0 109.762 -177.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.0 tt -89.1 105.95 18.12 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.457 ' OE2' ' HD3' ' A' ' 102' ' ' ARG . 54.3 mm-40 -115.52 133.96 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 106' ' ' ASN . 1.5 p30 48.74 33.44 4.32 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.692 0.797 . . . . 0.0 111.477 -178.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.861 ' HA ' HD21 ' A' ' 103' ' ' LEU . 4.9 m-20 75.92 21.99 1.52 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.663 175.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.81 142.32 40.82 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.975 -0.379 . . . . 0.0 109.975 173.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.684 ' HE2' ' HA ' ' A' ' 52' ' ' PRO . 7.0 m-85 -84.58 137.64 33.19 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -175.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.833 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -141.38 160.56 39.87 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -171.199 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.877 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.1 OUTLIER -103.7 116.71 47.96 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.704 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.724 177.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.742 ' HA ' ' O ' ' A' ' 127' ' ' ASP . 45.3 t -99.21 111.38 28.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 177.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -62.36 127.36 30.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.338 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.755 HG21 ' HG3' ' A' ' 97' ' ' ARG . 10.4 m -127.36 -37.28 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -176.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . 167.46 76.43 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.959 178.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.498 ' HB2' ' HA ' ' A' ' 98' ' ' HIS . 48.3 t -88.28 122.22 31.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.818 HD22 ' HB ' ' A' ' 22' ' ' TPO . 41.7 tp -51.9 -55.58 19.32 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 -170.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.643 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 7.4 t30 -74.86 -34.91 62.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.185 0.517 . . . . 0.0 110.454 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 149.49 160.67 9.32 Favored Glycine 0 C--O 1.247 0.95 0 C-N-CA 120.338 -0.934 . . . . 0.0 113.001 178.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' HE1' ' A' ' 98' ' ' HIS . 17.7 m -112.47 122.34 47.41 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 123.282 0.633 . . . . 0.0 111.073 171.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.66 126.13 28.49 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 172.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 1.013 HG22 HG13 ' A' ' 137' ' ' VAL . 75.5 t -124.91 119.4 55.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 61.31 37.17 17.28 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 66.7 19.27 10.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.104 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -143.26 145.08 30.9 Favored Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 120.718 0.294 . . . . 0.0 110.736 177.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.8 122.87 10.06 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 122.358 2.039 . . . . 0.0 111.113 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.402 ' CG1' ' HB ' ' A' ' 121' ' ' VAL . 17.7 m -115.17 176.73 2.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.027 0.441 . . . . 0.0 111.125 -177.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.742 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 13.6 t70 -109.66 -41.94 4.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.525 173.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.877 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 10.1 p -165.16 91.35 0.53 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.886 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 109' ' ' ASN . . . -92.17 145.3 24.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.001 -176.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.59 135.64 25.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.037 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.676 ' CD2' ' HB2' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -46.51 129.09 10.76 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.022 174.784 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.491 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . . . -135.45 -174.75 3.72 Favored 'General case' 0 C--O 1.225 -0.186 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -177.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -106.56 113.15 26.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.356 0.598 . . . . 0.0 112.185 -178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.63 -5.62 84.69 Favored Glycine 0 C--N 1.32 -0.317 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.908 170.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.508 ' HB3' ' CE1' ' A' ' 146' ' ' PHE . 0.2 OUTLIER -88.02 154.66 20.31 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER -112.15 149.0 32.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 -168.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.013 HG13 HG22 ' A' ' 121' ' ' VAL . 60.7 t -124.9 141.4 45.09 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.385 0 CA-C-N 114.131 -1.395 . . . . 0.0 107.721 174.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.907 ' HG3' ' H ' ' A' ' 28' ' ' ASP . 12.0 tm0? -109.18 130.8 55.48 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.328 0.585 . . . . 0.0 110.42 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 98' ' ' HIS . 0.5 OUTLIER -125.09 130.55 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 173.29 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.643 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 67.18 -91.23 0.19 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.023 174.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.977 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 19.6 ptmt -147.23 14.19 1.12 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 120.735 -0.386 . . . . 0.0 111.8 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.621 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -111.03 157.81 19.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -175.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -105.48 112.96 26.26 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.871 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 2.2 mp -107.78 156.69 18.84 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.542 -175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -140.23 143.56 29.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 175.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.015 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -107.37 150.04 27.17 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 120.039 -0.664 . . . . 0.0 112.685 -178.745 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.6 mm? -136.09 146.42 47.01 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.717 -1.128 . . . . 0.0 110.177 177.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.1 t -134.12 -164.51 1.51 Allowed 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 150' ' ' PRO . . . -69.04 133.62 26.72 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.065 -1.064 . . . . 0.0 111.261 176.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.497 ' HD2' ' CA ' ' A' ' 47' ' ' GLY . 17.0 Cg_exo -69.04 50.1 0.6 Allowed 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 123.394 2.729 . . . . 0.0 112.674 177.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.428 ' HB2' HD21 ' A' ' 51' ' ' LEU . 35.0 mmtp -130.74 -75.35 0.53 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.142 176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.469 ' H ' HD21 ' A' ' 51' ' ' LEU . 38.1 tp60 46.54 68.86 0.55 Allowed 'General case' 0 N--CA 1.466 0.335 0 O-C-N 124.14 0.9 . . . . 0.0 110.908 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . 130.48 56.17 0.1 OUTLIER Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -140.02 -67.35 0.43 Allowed 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 49.09 55.65 8.99 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 123.847 0.717 . . . . 0.0 111.295 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 14.2 t70 64.33 91.19 0.08 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.939 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -146.64 -161.16 9.15 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.715 -179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.8 m -83.34 116.01 22.27 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.775 0.322 . . . . 0.0 110.417 178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 19.0 m -117.64 92.62 3.89 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.842 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.407 ' O ' ' HD3' ' A' ' 162' ' ' PRO . . . -112.17 -153.97 12.22 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.518 -176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -114.68 89.46 0.5 Allowed Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.924 176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 160' ' ' GLY . 9.5 Cg_endo . . . . . 0 N--CA 1.45 -1.065 0 C-N-CA 123.279 2.653 . . . . 0.0 111.6 177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 58.6 t . . . . . 0 C--O 1.232 0.164 0 CA-C-O 121.209 0.528 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 t -103.31 62.53 0.79 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.715 0.769 . . . . 0.0 110.837 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -66.22 145.03 56.24 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.501 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.5 mtt -133.92 132.16 39.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.397 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.437 ' O ' HG22 ' A' ' 8' ' ' ILE . 26.9 p-10 -104.85 108.05 60.09 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-O 121.395 0.617 . . . . 0.0 109.948 174.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -69.45 -10.13 28.0 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.086 2.524 . . . . 0.0 112.463 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -64.58 -28.95 69.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.427 -177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.617 HG23 ' HG3' ' A' ' 9' ' ' GLU . 10.4 tp -69.54 -20.23 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.129 0.49 . . . . 0.0 110.599 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 8' ' ' ILE . 41.9 mt-10 -115.2 37.29 3.57 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.075 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -73.37 -39.31 65.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.047 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 12' ' ' GLN . 8.4 p-10 -137.69 -86.02 0.29 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.978 174.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.567 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 76.0 mt-30 -148.83 155.36 40.81 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.5 m -151.82 56.44 0.85 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.637 0.732 . . . . 0.0 109.906 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.5 m -83.3 42.86 0.84 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.424 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -95.59 67.42 2.84 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.454 -172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 48.43 36.0 6.62 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.349 175.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.7 p -137.12 -24.85 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.287 0.565 . . . . 0.0 110.58 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.6 p -96.03 1.19 52.45 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.92 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.8 t -76.87 86.08 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.429 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 60.37 -152.2 0.39 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.225 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.1 m -135.1 133.46 39.28 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 173.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.852 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 27.8 m -67.39 99.9 0.78 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.949 0.5 . . . . 0.0 112.173 -172.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.703 ' HB ' HD23 ' A' ' 116' ' ' LEU . 10.0 p -130.2 149.42 33.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.583 -0.447 . . . . 0.0 112.077 -171.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.7 t80 177.34 -146.36 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.967 -0.54 . . . . 0.0 110.017 -173.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.782 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.3 tpt180 46.28 -107.84 0.16 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.406 0.683 . . . . 0.0 110.972 171.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.576 ' H ' ' HG3' ' A' ' 26' ' ' ARG . . . 60.36 176.42 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 168.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.919 ' HA ' HD21 ' A' ' 33' ' ' LEU . 24.6 t70 -80.92 48.5 1.1 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.407 -173.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.52 ' CE2' ' HB1' ' A' ' 27' ' ' ALA . 21.5 m-85 -145.38 -44.84 0.22 Allowed 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.484 -172.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 40.7 tp -106.42 -50.1 3.21 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -174.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.1 m -132.2 147.95 52.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -167.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 66.91 42.08 2.59 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 166.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -168.53 -28.56 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 171.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -86.26 53.51 2.82 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.142 0.496 . . . . 0.0 110.984 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -114.13 129.53 24.73 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.242 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 29.1 Cg_exo -61.89 151.67 79.7 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.806 2.338 . . . . 0.0 111.994 179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 59.19 59.6 2.67 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.605 0.566 . . . . 0.0 110.361 -176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 22.8 mp0 -57.77 108.92 0.63 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.175 -178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -144.11 154.43 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.62 177.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.7 -96.47 0.11 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.547 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -123.81 -35.14 2.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.608 0.242 . . . . 0.0 111.4 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 56.12 -99.72 0.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.571 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.8 m 48.99 44.29 22.45 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.665 ' HB1' ' HB2' ' A' ' 133' ' ' ASN . . . -79.88 70.72 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.362 0.601 . . . . 0.0 109.821 176.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.75 87.5 2.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.031 -175.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.484 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 16.9 m -80.69 49.66 1.22 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.433 175.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -153.67 61.79 0.38 Allowed Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.603 HG13 ' HD2' ' A' ' 151' ' ' LYS . 22.1 t 63.82 77.55 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 122.938 0.495 . . . . 0.0 111.685 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 48' ' ' VAL . 35.4 tt0 171.71 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.948 175.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.3 -54.43 19.9 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.968 -0.634 . . . . 0.0 111.658 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.588 ' O ' HD12 ' A' ' 51' ' ' LEU . 4.3 pp -92.9 120.14 67.33 Favored Pre-proline 0 N--CA 1.443 -0.824 0 CA-C-O 121.676 0.751 . . . . 0.0 110.623 169.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.852 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 22.0 Cg_exo -69.35 -41.93 4.31 Favored 'Trans proline' 0 CA--C 1.551 1.336 0 C-N-CA 123.374 2.716 . . . . 0.0 114.737 170.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.852 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 58.8 Cg_endo -104.53 -154.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.365 1.405 0 C-N-CA 123.514 2.809 . . . . 0.0 112.431 -168.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.45 39.99 2.75 Favored Glycine 0 N--CA 1.453 -0.195 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.6 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -152.37 170.65 19.58 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.912 -0.644 . . . . 0.0 109.317 -169.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -125.81 167.32 15.36 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.464 ' O ' HD12 ' A' ' 57' ' ' LEU . 3.3 pp -161.09 142.52 11.79 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.3 mp -86.51 114.02 22.91 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 114.262 -1.335 . . . . 0.0 108.092 166.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 68' ' ' SER . 4.2 p -109.62 128.39 65.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.621 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.903 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.56 109.89 4.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 175.025 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -65.53 -60.68 2.68 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 113.92 -1.491 . . . . 0.0 109.914 -170.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 62' ' ' ARG . 27.5 mtm-85 -150.95 109.56 3.82 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.132 172.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -134.36 -147.55 5.62 Favored Glycine 0 N--CA 1.437 -1.278 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 175.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.033 ' HG3' ' HG3' ' A' ' 141' ' ' LYS . 72.8 Cg_endo -75.44 -48.99 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.232 1.955 . . . . 0.0 111.911 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.633 ' CB ' ' HE2' ' A' ' 142' ' ' PHE . 50.8 t30 -74.36 -49.69 21.74 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 166.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.581 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 59.31 154.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 113.825 -1.534 . . . . 0.0 112.56 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.62 1.38 90.14 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.7 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.903 ' H ' HG22 ' A' ' 60' ' ' VAL . 15.6 t -88.36 -178.3 5.85 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 117.863 0.832 . . . . 0.0 109.896 -174.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.648 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -173.26 150.32 1.88 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -171.389 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.44 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.9 OUTLIER -95.16 127.19 41.02 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 172.694 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 73' ' ' ASP . 1.0 OUTLIER -83.28 91.5 7.31 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 123.966 0.791 . . . . 0.0 109.249 -178.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.802 ' HG ' ' CD1' ' A' ' 101' ' ' PHE . 1.4 mp -86.12 53.93 2.96 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.448 0.642 . . . . 0.0 109.688 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 22.9 t70 -113.47 -25.72 8.65 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.046 177.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HB2' HE21 ' A' ' 74' ' ' GLN . 22.3 mt-30 -86.44 -167.54 1.91 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.328 178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.07 35.84 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.781 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -166.11 134.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.608 179.005 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.624 ' OG1' ' HB3' ' A' ' 101' ' ' PHE . 7.6 p -119.68 128.33 53.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.408 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.9 m -74.93 125.26 28.49 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.738 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -120.57 108.22 13.79 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -170.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.844 ' HA3' ' HA ' ' A' ' 97' ' ' ARG . . . 164.08 -146.96 12.04 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.335 -178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.5 OUTLIER -69.24 107.63 3.32 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.604 0.716 . . . . 0.0 109.56 172.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.567 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 61.5 m-70 -135.33 116.62 12.1 Favored Pre-proline 0 N--CA 1.437 -1.116 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.968 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.54 -42.96 8.53 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.523 2.149 . . . . 0.0 110.734 170.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -155.27 96.68 1.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.651 0.738 . . . . 0.0 110.338 175.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 48.7 m -146.32 -96.88 0.09 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.01 177.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -145.35 -59.45 0.34 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.513 0.673 . . . . 0.0 110.43 -172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.738 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -120.68 113.01 38.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.167 -177.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.448 ' HD2' ' O ' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -104.05 127.2 51.61 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.247 -174.513 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.736 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 3.2 mm? -114.77 76.22 0.98 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.469 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 9.5 t70 66.53 -0.77 1.44 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.543 0.687 . . . . 0.0 109.641 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.741 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.9 p-10 40.62 30.03 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 125.749 1.62 . . . . 0.0 113.389 -175.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.618 ' O ' ' HB2' ' A' ' 23' ' ' SER . 13.1 p -166.19 59.05 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 121.441 0.639 . . . . 0.0 110.973 172.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.67 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 3.0 p -143.93 -13.99 0.63 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.149 0.5 . . . . 0.0 110.803 170.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.911 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.2 OUTLIER -140.84 141.83 31.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.856 -169.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.446 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 4.9 m -64.78 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.118 0.567 . . . . 0.0 112.104 -173.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.795 ' HD3' ' HD2' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 68.53 -63.08 0.36 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.335 -177.516 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.844 ' HA ' ' HA3' ' A' ' 80' ' ' GLY . 0.2 OUTLIER -154.83 132.99 11.71 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 121.656 -0.653 . . . . 0.0 111.839 175.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -63.24 -43.56 97.71 Favored 'General case' 0 CA--C 1.498 -1.033 0 CA-C-N 114.353 -1.294 . . . . 0.0 108.757 176.824 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -155.82 174.56 15.14 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.215 -1.811 . . . . 0.0 107.921 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.64 ' HB2' HD11 ' A' ' 76' ' ' ILE . 4.8 pt-20 -135.74 128.9 31.75 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.802 ' CD1' ' HG ' ' A' ' 72' ' ' LEU . 0.2 OUTLIER -54.66 95.8 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.056 0 O-C-N 124.477 1.11 . . . . 0.0 108.117 -178.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.458 ' HG2' ' HG3' ' A' ' 104' ' ' GLU . 14.0 ttm180 -98.97 105.84 18.03 Favored 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 118.636 -1.226 . . . . 0.0 109.454 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.5 tt -80.24 105.11 11.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 121.604 0.716 . . . . 0.0 109.575 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.458 ' HG3' ' HG2' ' A' ' 102' ' ' ARG . 37.3 mt-10 -129.25 135.66 49.08 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.637 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 107' ' ' GLU . 52.9 m-80 62.1 33.47 16.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.122 -175.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.763 ' HA ' HD21 ' A' ' 103' ' ' LEU . 73.7 m-20 70.94 4.14 4.94 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.825 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.0 mm-40 -103.47 144.82 30.89 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -175.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -91.24 125.65 36.08 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 175.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 21.1 m-80 -131.18 163.08 28.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.619 0.247 . . . . 0.0 111.183 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.819 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.8 OUTLIER -105.27 124.44 60.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 169.159 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 68.3 t -108.9 110.41 31.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.806 174.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.0 125.62 26.9 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 123.559 0.537 . . . . 0.0 109.722 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.6 m -133.53 -27.93 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -175.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.39 83.14 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 119.752 -1.213 . . . . 0.0 113.576 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.911 ' HA ' HG23 ' A' ' 94' ' ' VAL . 37.2 t -108.6 120.46 42.52 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 175.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.852 HD22 ' HB ' ' A' ' 22' ' ' TPO . 58.4 tp -53.16 -56.27 17.62 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -170.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.683 ' ND2' HE22 ' A' ' 138' ' ' GLN . 0.4 OUTLIER -63.44 -34.76 78.46 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.49 0.662 . . . . 0.0 109.641 177.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.75 169.49 12.37 Favored Glycine 0 C--O 1.253 1.333 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.145 -171.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.9 m -112.02 117.33 32.39 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 122.761 0.424 . . . . 0.0 110.917 174.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -127.72 106.82 9.4 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.864 HG22 HG23 ' A' ' 137' ' ' VAL . 21.2 t -101.88 107.54 21.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.664 ' ND2' HG12 ' A' ' 121' ' ' VAL . 25.4 m-80 65.06 44.23 3.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.545 0.688 . . . . 0.0 109.319 -174.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 63.44 13.25 6.99 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.663 -1.153 . . . . 0.0 113.004 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 9.9 pt-20 -133.89 131.4 20.98 Favored Pre-proline 0 C--N 1.333 -0.138 0 CA-C-O 121.344 0.592 . . . . 0.0 110.804 174.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 16.4 Cg_exo -67.81 123.21 10.45 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.783 2.322 . . . . 0.0 112.257 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' A' ' 129' ' ' ALA . 14.2 m -121.76 165.1 17.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 2.8 m-20 -108.38 -24.81 11.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.758 -177.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.819 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 21.5 p -164.52 91.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.441 0.639 . . . . 0.0 109.59 176.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.617 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -110.22 148.41 31.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.355 -175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.62 127.63 40.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.086 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.603 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.9 OUTLIER -63.32 162.9 11.41 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.493 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -166.33 160.83 16.15 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.297 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.665 ' HB2' ' HB1' ' A' ' 44' ' ' ALA . 1.7 p-10 -60.14 100.76 0.1 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.132 0.492 . . . . 0.0 111.369 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 106.72 4.38 36.76 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.727 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -75.52 119.74 20.0 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 5.0 tt0 -106.73 134.25 50.15 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.666 -172.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.962 HG12 ' HB2' ' A' ' 144' ' ' LEU . 0.3 OUTLIER -117.68 142.22 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.683 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -111.72 115.59 29.34 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 167.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.67 ' HB ' ' CB ' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -123.83 129.47 74.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.507 175.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.598 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 74.32 -68.21 1.78 Allowed Glycine 0 C--O 1.221 -0.683 0 C-N-CA 119.776 -1.202 . . . . 0.0 112.066 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.033 ' HG3' ' HG3' ' A' ' 64' ' ' PRO . 17.7 ptmt -173.7 31.36 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 116.953 0.377 . . . . 0.0 110.712 172.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.76 ' HD1' ' H ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -124.71 149.95 46.69 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -172.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.458 ' HD3' HD23 ' A' ' 33' ' ' LEU . 40.0 ttp85 -103.12 100.87 10.82 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.962 ' HB2' HG12 ' A' ' 137' ' ' VAL . 4.7 mp -96.12 157.85 15.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.877 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.3 OUTLIER -141.75 141.39 29.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.292 169.264 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.603 ' CD2' ' HB3' ' A' ' 131' ' ' LEU . 43.7 t80 -97.81 136.85 37.54 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.248 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -128.55 152.19 48.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.524 0.678 . . . . 0.0 110.958 170.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.502 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 14.8 t -156.98 141.98 17.08 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.014 176.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 46' ' ' SER . . . -135.7 85.51 0.25 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.558 -178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.407 ' HD2' ' HA2' ' A' ' 149' ' ' GLY . 2.8 Cg_endo -39.49 114.6 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 124.321 3.347 . . . . 0.0 113.474 -175.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.603 ' HD2' HG13 ' A' ' 48' ' ' VAL . 64.1 tttp -126.75 103.75 7.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.651 177.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 62.63 76.99 0.35 Allowed 'General case' 0 C--O 1.235 0.339 0 O-C-N 123.944 0.777 . . . . 0.0 110.048 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -160.41 -165.43 17.24 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.312 -0.947 . . . . 0.0 113.073 -176.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 60.14 39.7 19.18 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.387 0.613 . . . . 0.0 110.336 -178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -140.42 101.33 4.09 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.861 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -121.44 -60.33 1.63 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.094 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 132.77 -96.74 0.31 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.98 -177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.2 p -136.99 16.62 3.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.637 0.256 . . . . 0.0 111.344 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 30.2 m 65.17 96.47 0.05 OUTLIER 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.648 -0.706 . . . . 0.0 112.023 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.34 107.81 2.22 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.9 -0.666 . . . . 0.0 111.643 175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -94.92 -114.7 2.74 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.973 -175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--O 1.246 0.921 0 C-N-CA 122.838 2.359 . . . . 0.0 112.414 -177.674 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 121.613 0.72 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.6 p -111.41 -61.88 1.63 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.287 174.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -111.05 110.83 21.54 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.191 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.7 ttt -140.2 -48.93 0.45 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.757 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -107.21 115.86 59.16 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.035 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -76.93 97.75 1.17 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.718 2.279 . . . . 0.0 110.406 173.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -56.74 104.99 0.17 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.638 -176.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.9 mm -82.56 -35.01 12.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.537 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -78.17 3.38 15.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.637 177.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 65.65 -148.98 0.23 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.253 175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.8 t70 73.84 -80.44 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.528 0.731 . . . . 0.0 110.61 -178.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 42.78 46.73 4.56 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 122.092 0.949 . . . . 0.0 111.24 -177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.5 m -115.61 54.26 0.82 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.852 176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.7 t -107.73 104.31 13.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.055 -175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 t70 58.09 78.58 0.24 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.323 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -94.48 101.21 13.11 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -107.23 111.88 37.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.139 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.5 m -78.97 113.21 16.9 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 174.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 20' ' ' GLU . 12.5 p -68.06 -23.42 28.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.608 0.242 . . . . 0.0 110.668 -176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 5.2 mm-40 75.52 166.78 0.28 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.778 0.799 . . . . 0.0 112.274 174.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.5 m -131.4 137.79 48.83 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.781 -1.099 . . . . 0.0 108.466 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.675 ' O1P' ' HA ' ' A' ' 95' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.616 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 48.6 m 18.36 120.92 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 117.921 2.563 . . . . 0.0 117.921 177.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 25' ' ' PHE . 6.8 t -101.91 146.36 10.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.656 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.8 t80 172.13 -159.11 0.01 OUTLIER 'General case' 0 C--N 1.35 0.592 0 O-C-N 123.603 0.564 . . . . 0.0 110.751 171.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.497 ' HB3' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 35.64 -119.03 0.12 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.512 1.125 . . . . 0.0 112.691 175.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . 61.82 -175.59 0.13 Allowed 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 172.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.436 ' HA ' HD11 ' A' ' 33' ' ' LEU . 1.4 t70 -80.93 40.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.148 -177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.451 ' HE1' ' CE2' ' A' ' 120' ' ' TYR . 2.1 m-30 -120.73 -55.22 2.02 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -174.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 68.8 tp -63.38 -17.61 62.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.52 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.2 m 73.65 25.99 1.96 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.485 174.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -79.43 56.46 2.15 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.71 0.767 . . . . 0.0 109.919 172.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.624 HD23 ' HG3' ' A' ' 143' ' ' ARG . 0.0 OUTLIER -143.63 -73.48 0.27 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 179.672 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -177.08 122.99 0.13 Allowed 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.34 -1.755 . . . . 0.0 109.397 175.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.629 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -72.9 -51.41 6.44 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.547 -174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 24.1 Cg_exo -65.21 117.05 4.22 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.99 1.794 . . . . 0.0 111.865 177.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.22 171.7 7.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.003 -177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.38 156.73 37.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -117.39 39.12 3.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.127 0.489 . . . . 0.0 111.413 -173.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.6 49.95 0.72 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.331 -178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.9 p -69.49 137.29 52.44 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.747 0.308 . . . . 0.0 110.637 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.83 74.35 3.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.175 0.512 . . . . 0.0 110.241 -178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.3 t -138.78 45.11 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.677 0.751 . . . . 0.0 109.576 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -85.37 53.96 2.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.471 0.653 . . . . 0.0 109.461 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.433 ' O ' HG21 ' A' ' 130' ' ' VAL . 59.7 t -110.7 133.59 55.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.888 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 49.9 m -156.44 76.17 0.89 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.284 176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.76 15.95 6.1 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.798 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.409 HG23 HG13 ' A' ' 45' ' ' VAL . 0.9 OUTLIER -157.92 65.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 123.123 0.569 . . . . 0.0 109.559 -177.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.874 ' HG2' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -53.11 -40.56 64.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.324 -169.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.55 -1.43 77.33 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.874 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 40.5 mt -67.41 121.13 77.48 Favored Pre-proline 0 N--CA 1.447 -0.622 0 C-N-CA 123.621 0.768 . . . . 0.0 111.226 177.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.615 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 37.1 Cg_exo -61.85 -35.95 75.66 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.147 2.565 . . . . 0.0 115.105 175.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.615 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 74.4 Cg_endo -98.09 177.8 0.42 Allowed 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 121.968 1.779 . . . . 0.0 112.941 -172.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.78 -34.42 13.43 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.281 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.5 m -116.78 134.46 54.76 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 72' ' ' LEU . . . -129.64 168.34 16.6 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.7 pp -162.19 147.77 12.94 Favored 'General case' 0 CA--C 1.508 -0.663 0 C-N-CA 119.038 -1.065 . . . . 0.0 112.631 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.958 HD21 HD11 ' A' ' 131' ' ' LEU . 2.5 mp -86.42 144.32 27.36 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.7 p -123.19 133.02 70.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-O 121.012 0.434 . . . . 0.0 110.568 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.695 ' HB ' ' H ' ' A' ' 68' ' ' SER . 79.1 t -65.57 105.75 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HD2' HG11 ' A' ' 145' ' ' VAL . 59.0 tttm -70.4 -47.49 60.57 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 124.762 1.289 . . . . 0.0 110.151 -173.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.9 ttm180 -165.78 144.55 6.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.576 173.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.614 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -173.67 -157.83 16.33 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 107.604 -2.198 . . . . 0.0 107.604 -176.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 13.9 Cg_exo -67.22 -48.81 1.55 Allowed 'Trans proline' 0 N--CA 1.444 -1.392 0 CA-C-N 119.481 1.64 . . . . 0.0 111.723 176.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 63.1 t30 -77.63 -53.51 7.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.009 173.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.614 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.14 160.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.63 -1.623 . . . . 0.0 113.109 -172.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.4 2.02 90.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.424 -0.893 . . . . 0.0 113.564 173.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.695 ' H ' ' HB ' ' A' ' 60' ' ' VAL . 6.7 m -88.69 -172.42 3.72 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 117.226 0.513 . . . . 0.0 111.362 -173.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.529 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -172.05 152.51 2.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 117.962 0.346 . . . . 0.0 111.787 -175.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.913 ' HD1' ' HB2' ' A' ' 58' ' ' LEU . 1.5 m-85 -98.2 116.95 31.5 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 169.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.7 OUTLIER -78.04 90.13 4.2 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.705 0.764 . . . . 0.0 109.453 -174.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.626 HD11 HD12 ' A' ' 58' ' ' LEU . 15.4 mt -82.75 59.46 4.78 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.573 0.701 . . . . 0.0 109.955 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 7.9 t70 -117.01 -26.87 6.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.645 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -98.67 177.64 5.24 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 174.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.84 97.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -174.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -157.56 135.8 2.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.997 0.427 . . . . 0.0 111.352 -178.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 43.2 p -109.91 140.37 43.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.665 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.608 ' O ' HG23 ' A' ' 87' ' ' ILE . 37.0 m -88.31 124.23 33.69 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 172.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -123.21 119.9 31.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.515 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 150.2 -138.29 6.64 Favored Glycine 0 N--CA 1.436 -1.34 0 N-CA-C 111.203 -0.759 . . . . 0.0 111.203 176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.9 tmm_? -71.5 104.37 3.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.395 0.617 . . . . 0.0 109.85 174.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.539 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 55.3 m-70 -137.36 119.12 11.01 Favored Pre-proline 0 N--CA 1.438 -1.045 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.027 -174.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -62.16 -48.37 8.3 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.411 2.074 . . . . 0.0 111.528 167.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -148.48 95.14 2.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.827 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.428 ' HB2' ' H ' ' A' ' 86' ' ' ASP . 5.3 p -169.51 -165.48 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.607 168.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 85' ' ' SER . 3.2 m-20 -61.74 -51.89 66.51 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -167.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.712 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -130.36 91.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 122.087 0.946 . . . . 0.0 110.987 -172.047 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.456 ' HB3' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -95.41 134.19 38.51 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.269 174.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.019 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.5 mm? -122.03 77.54 1.39 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.768 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 24.6 t0 66.01 -3.76 0.73 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 175.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.6 p30 43.69 25.65 0.1 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.372 1.469 . . . . 0.0 113.817 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 23' ' ' SER . 10.8 p -147.43 45.42 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 122.32 1.057 . . . . 0.0 110.222 174.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.673 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -151.97 -0.6 0.31 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.045 172.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.667 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.6 t -135.64 143.15 37.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -174.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.675 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 11.9 t -78.29 73.0 4.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 1.0 OUTLIER 67.24 -58.47 0.41 Allowed 'General case' 0 C--O 1.22 -0.474 0 CA-C-O 121.672 0.749 . . . . 0.0 110.114 -171.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.61 ' HD2' HG11 ' A' ' 113' ' ' VAL . 22.5 ttm180 -146.18 125.28 12.88 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.879 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.776 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -67.18 -46.07 75.07 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 172.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.695 ' O ' ' HB3' ' A' ' 79' ' ' ALA . . . -169.98 160.09 8.09 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.869 -177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HB2' HD11 ' A' ' 76' ' ' ILE . 7.3 pt-20 -112.66 117.97 33.75 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.862 ' CZ ' ' HB ' ' A' ' 110' ' ' VAL . 4.4 m-85 -76.37 95.33 3.78 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.124 -175.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -103.05 148.62 25.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.408 -170.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.2 tt -91.73 117.54 29.85 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -142.88 135.68 27.9 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 48.8 m-80 62.45 32.35 16.75 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.683 0.615 . . . . 0.0 110.094 -172.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.71 ' HA ' HD21 ' A' ' 103' ' ' LEU . 5.1 t30 74.84 -1.29 3.12 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 124.085 0.865 . . . . 0.0 112.341 178.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 1.5 mm-40 -109.13 147.19 32.85 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 122.086 -0.383 . . . . 0.0 109.977 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.635 ' CE1' HD12 ' A' ' 103' ' ' LEU . 12.9 m-85 -88.89 130.96 35.32 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 173.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.521 ' OD1' HG22 ' A' ' 130' ' ' VAL . 13.1 m-80 -140.34 162.63 34.84 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.864 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.0 OUTLIER -107.09 122.02 60.68 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.015 0 C-N-CA 120.17 -0.612 . . . . 0.0 111.37 172.412 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 128' ' ' SER . 26.8 t -101.93 110.74 29.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.11 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.999 176.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 24.9 t0 -59.28 144.03 47.52 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 123.867 0.729 . . . . 0.0 109.713 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.61 HG11 ' HD2' ' A' ' 97' ' ' ARG . 1.2 t -142.44 -32.71 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.824 -171.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 135.93 103.35 0.71 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.175 -1.012 . . . . 0.0 113.723 175.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.637 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 44.2 t -110.23 145.7 36.87 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 119.159 -0.448 . . . . 0.0 109.902 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.496 ' CD2' HG23 ' A' ' 24' ' ' VAL . 18.1 tp -58.81 -55.77 30.76 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.544 0.611 . . . . 0.0 111.675 -175.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 59.2 m-80 -61.37 -38.06 85.63 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.238 0.542 . . . . 0.0 110.327 177.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 134.18 167.43 11.52 Favored Glycine 0 C--O 1.246 0.846 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.97 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.537 HG23 ' HE1' ' A' ' 98' ' ' HIS . 16.0 m -111.66 133.63 53.78 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.004 0.522 . . . . 0.0 111.225 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' CE2' ' HE1' ' A' ' 29' ' ' PHE . 23.2 m-85 -140.73 131.19 25.31 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.817 0.341 . . . . 0.0 110.848 173.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.853 HG22 HG13 ' A' ' 137' ' ' VAL . 77.4 t -127.91 113.62 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 174.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.2 m120 60.0 42.01 16.6 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.813 -177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 76.64 -2.03 2.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.902 178.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 10.4 pt-20 -134.03 141.98 41.64 Favored Pre-proline 0 N--CA 1.468 0.427 0 O-C-N 121.747 -0.596 . . . . 0.0 111.204 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 9.7 Cg_exo -70.83 121.99 8.41 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.11 1.874 . . . . 0.0 111.689 175.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.2 m -113.84 178.02 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.718 0.294 . . . . 0.0 111.58 -177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 21.9 t70 -93.41 -64.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.939 175.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.864 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 5.8 p -146.77 92.9 2.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.231 0.538 . . . . 0.0 109.91 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.99 143.55 29.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.631 -175.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.521 HG22 ' OD1' ' A' ' 109' ' ' ASN . 3.3 t -84.26 135.85 23.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.187 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.958 HD11 HD21 ' A' ' 58' ' ' LEU . 0.5 OUTLIER -62.18 161.5 11.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 178.386 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -158.56 154.67 27.01 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.25 -179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -67.96 97.72 0.69 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.015 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.78 4.81 29.74 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.22 -0.991 . . . . 0.0 111.84 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.414 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 19.4 t70 -72.87 150.96 42.21 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.1 tt0 -141.32 133.39 27.75 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-O 121.467 0.651 . . . . 0.0 111.421 -177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG13 HG22 ' A' ' 121' ' ' VAL . 48.0 t -129.13 141.64 46.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.001 -0.999 . . . . 0.0 108.373 -176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.438 ' HB3' ' HB2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -109.84 121.02 44.27 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 173.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.019 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -118.38 140.21 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.973 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 171.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 57.95 -109.79 2.05 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.04 -1.552 . . . . 0.0 109.274 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.812 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 1.8 pttm -136.3 34.03 2.79 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 119.062 -1.055 . . . . 0.0 111.907 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.732 ' CD2' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -114.96 150.81 35.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.624 ' HG3' HD23 ' A' ' 33' ' ' LEU . 14.1 ttm180 -102.19 106.45 17.29 Favored 'General case' 0 C--N 1.321 -0.63 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.655 ' HG ' HG22 ' A' ' 60' ' ' VAL . 2.0 mp -110.29 150.86 28.12 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.715 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.35 144.2 28.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 177.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.823 ' HB2' ' HG ' ' A' ' 58' ' ' LEU . 84.5 t80 -94.22 125.79 39.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.06 0.457 . . . . 0.0 111.985 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.633 HD22 ' O ' ' A' ' 146' ' ' PHE . 2.8 mm? -128.14 169.32 14.25 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.223 169.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.789 HG21 HD22 ' A' ' 51' ' ' LEU . 8.7 t -155.12 -172.19 4.09 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.924 -177.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.54 ' HA3' ' HG3' ' A' ' 53' ' ' PRO . . . -59.74 166.19 10.09 Favored Glycine 0 C--O 1.236 0.241 0 O-C-N 123.632 0.582 . . . . 0.0 114.466 -170.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.608 ' HB2' ' O ' ' A' ' 153' ' ' GLY . 73.0 Cg_endo -76.29 118.3 4.89 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 123.19 2.593 . . . . 0.0 112.98 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 151' ' ' LYS . 31.2 ttmt -83.16 -3.86 57.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.255 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -112.63 14.59 20.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.723 175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.608 ' O ' ' HB2' ' A' ' 150' ' ' PRO . . . 74.02 -168.22 54.29 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 -169.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -78.05 69.45 4.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 117.795 0.798 . . . . 0.0 109.997 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 34.6 t70 70.35 101.95 0.06 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 114.651 -1.159 . . . . 0.0 111.648 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 28.6 t70 72.45 116.72 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.085 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -138.55 -114.82 1.27 Allowed Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.077 178.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.1 t -128.27 -166.32 1.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 18.2 m 64.53 75.22 0.38 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.532 0.682 . . . . 0.0 110.383 -176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -175.23 -47.27 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -151.69 64.42 0.37 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 111.311 -0.715 . . . . 0.0 111.311 173.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--O 1.249 1.037 0 C-N-CA 123.025 2.483 . . . . 0.0 112.007 -175.748 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.0 p . . . . . 0 CA--C 1.533 0.314 0 CA-C-O 120.977 0.417 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 p -83.03 118.2 23.36 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.862 0.363 . . . . 0.0 111.561 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -142.13 170.57 15.45 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.057 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.0 ttm -145.24 74.19 1.39 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.659 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 3.7 t-20 -99.21 -51.58 0.2 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.727 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' H ' ' A' ' 5' ' ' ASN . 19.4 Cg_endo -60.78 116.58 3.44 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 122.141 1.894 . . . . 0.0 112.797 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -79.67 106.84 11.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.627 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 9.5 tp -96.08 -17.99 6.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -71.13 104.04 2.94 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.451 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 86.9 tttt 66.56 117.48 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.954 0.783 . . . . 0.0 112.015 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -82.28 99.33 9.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.048 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -88.11 6.44 36.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.901 0.381 . . . . 0.0 110.316 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 m -67.1 -32.68 73.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.078 0.466 . . . . 0.0 110.013 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -69.49 -13.69 62.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.89 178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -98.01 106.99 19.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.936 -177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -109.39 120.56 42.87 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.88 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 45.2 t -95.45 109.02 21.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.919 -175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -92.26 139.48 30.57 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.15 -3.6 10.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -140.86 130.88 24.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.064 0.459 . . . . 0.0 112.062 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.591 HG22 ' O ' ' A' ' 22' ' ' TPO . 50.6 m -101.08 135.52 42.41 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.372 170.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.753 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 93' ' ' THR . 17.9 m -59.96 130.52 47.16 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.96 -0.463 . . . . 0.0 112.037 -173.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -139.02 134.33 41.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.388 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.455 ' O ' ' HB3' ' A' ' 141' ' ' LYS . 42.7 t80 176.51 176.08 0.31 Allowed 'General case' 0 C--O 1.215 -0.713 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.051 -169.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.617 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 7.5 tpt180 72.54 -42.41 0.53 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 159.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.752 ' HB2' ' HA ' ' A' ' 141' ' ' LYS . . . -60.11 -169.29 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 -169.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' HA ' HD11 ' A' ' 33' ' ' LEU . 25.1 t0 -61.04 58.09 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 122.424 1.107 . . . . 0.0 112.386 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 27' ' ' ALA . 11.6 m-85 -154.4 -34.69 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 26' ' ' ARG . 38.3 tp -98.88 -67.96 0.82 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 113.292 -1.776 . . . . 0.0 111.848 174.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 51.2 p 177.05 -177.44 0.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 60.5 59.88 2.12 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.629 -1.168 . . . . 0.0 113.839 170.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.558 HD11 ' HA ' ' A' ' 28' ' ' ASP . 1.2 pp 178.46 -24.62 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.694 175.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -53.15 147.41 9.88 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 113.754 -1.566 . . . . 0.0 110.822 172.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.95 84.9 62.24 Favored Pre-proline 0 C--N 1.32 -0.699 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.055 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.93 -43.48 30.38 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.593 2.195 . . . . 0.0 111.111 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -93.8 69.11 3.97 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -79.28 52.61 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.1 -174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.63 99.75 2.63 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.09 121.01 11.08 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.879 -0.6 . . . . 0.0 113.233 -173.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.4 m -128.52 71.9 1.42 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.603 0.716 . . . . 0.0 109.149 171.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' CD ' ' H ' ' A' ' 42' ' ' GLU . 0.3 OUTLIER -101.38 26.96 6.63 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.034 -179.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -79.42 49.15 0.96 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.459 -176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.69 49.73 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.532 0.682 . . . . 0.0 109.615 176.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.1 p -71.84 144.44 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.619 -176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HA ' ' CB ' ' A' ' 49' ' ' GLU . 14.8 m 66.88 31.7 7.04 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.266 0.555 . . . . 0.0 110.883 179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -107.66 -39.58 1.87 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.2 p -96.32 11.93 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 CA-C-O 122.469 1.128 . . . . 0.0 109.067 173.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 46' ' ' SER . 15.1 tp10 -87.1 -58.82 2.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.219 -1.355 . . . . 0.0 109.921 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -121.56 53.68 0.7 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.687 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 51' ' ' LEU . 3.5 pp -60.87 128.15 88.53 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 121.002 0.43 . . . . 0.0 111.118 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.617 ' HD2' ' HD3' ' A' ' 53' ' ' PRO . 72.1 Cg_endo -91.06 0.82 4.84 Favored 'Trans proline' 0 CA--C 1.558 1.707 0 C-N-CA 122.902 2.402 . . . . 0.0 117.989 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.617 ' HD3' ' HD2' ' A' ' 52' ' ' PRO . 44.4 Cg_endo -95.63 161.31 1.49 Allowed 'Trans proline' 0 C--N 1.361 1.226 0 CA-C-N 122.801 2.036 . . . . 0.0 112.787 -179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.92 -9.11 57.58 Favored Glycine 0 N--CA 1.451 -0.338 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 174.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.596 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 0.7 OUTLIER -137.24 136.7 38.34 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.07 170.03 11.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.611 ' HA ' HD22 ' A' ' 72' ' ' LEU . 2.1 pt? -155.5 133.03 11.09 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -177.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.066 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 3.3 mp -85.49 128.43 34.73 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.631 163.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.8 t -110.88 125.6 68.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.231 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.865 HG22 ' HG ' ' A' ' 144' ' ' LEU . 67.9 t -65.57 104.93 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 172.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.441 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 52.1 tttp -73.45 -57.25 4.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 O-C-N 124.23 0.956 . . . . 0.0 109.873 -172.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.0 ttm180 -153.34 131.19 11.66 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.971 0.891 . . . . 0.0 110.944 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.645 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -168.78 -162.35 20.75 Favored Glycine 0 N--CA 1.429 -1.806 0 N-CA-C 107.613 -2.195 . . . . 0.0 107.613 177.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.09 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 40.5 Cg_exo -59.37 -56.33 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 CA-C-N 119.401 1.601 . . . . 0.0 112.669 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.54 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 59.8 t30 -70.01 -52.57 23.06 Favored 'General case' 0 CA--C 1.508 -0.667 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 173.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.645 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 57.05 152.98 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.342 -1.299 . . . . 0.0 113.252 -176.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.72 1.04 90.04 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.979 171.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.748 ' HB2' HG21 ' A' ' 60' ' ' VAL . 18.7 m -85.38 -167.93 2.03 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.584 0.692 . . . . 0.0 111.542 -176.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.73 ' HD2' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -170.23 154.74 5.02 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -175.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.628 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.8 OUTLIER -95.39 125.1 39.78 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.668 ' O ' HG21 ' A' ' 77' ' ' THR . 1.1 tm? -84.48 98.27 10.01 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.641 ' HG ' ' HD2' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -98.12 51.61 1.03 Allowed 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.454 -179.851 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 11.3 t70 -95.68 -19.38 19.75 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.34 -1.3 . . . . 0.0 108.149 169.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -89.16 166.58 13.73 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.813 -1.085 . . . . 0.0 108.85 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.2 -21.31 63.05 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.183 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.759 HD13 ' HB3' ' A' ' 102' ' ' ARG . 3.2 tp -168.99 130.03 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.76 -178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.668 HG21 ' O ' ' A' ' 71' ' ' LEU . 22.9 p -123.68 146.91 47.89 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.081 -176.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.709 ' O ' HG23 ' A' ' 87' ' ' ILE . 23.4 m -82.13 125.2 30.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 119.662 -0.209 . . . . 0.0 110.533 173.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.713 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -119.04 128.39 54.31 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 135.18 -132.1 6.1 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.525 178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.982 ' HD2' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -80.31 103.93 10.51 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.666 0.746 . . . . 0.0 109.905 174.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.6 ' CE1' ' HB3' ' A' ' 78' ' ' SER . 67.1 m-70 -138.02 128.84 15.66 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.971 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.26 -63.97 0.13 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.267 1.978 . . . . 0.0 111.813 172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -145.19 47.19 1.31 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.897 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.402 ' OG ' ' HB3' ' A' ' 82' ' ' HIS . 2.3 p -128.53 97.37 4.69 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.984 0.421 . . . . 0.0 112.125 -179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' CB ' ' HB ' ' A' ' 77' ' ' THR . 28.3 m-20 57.44 -91.2 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.659 1.184 . . . . 0.0 113.575 171.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.713 HG23 ' HA ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -109.06 98.96 7.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 0.0 111.354 -171.224 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.0 OUTLIER -103.65 128.13 51.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.29 178.714 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.781 HD12 ' CD2' ' A' ' 142' ' ' PHE . 3.3 mm? -120.03 86.91 2.65 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.208 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.54 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 17.1 t70 69.5 -7.74 0.82 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 0.0 109.611 178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.762 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 p-10 37.9 34.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.034 1.734 . . . . 0.0 113.749 177.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.99 0.3 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.433 177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 23' ' ' SER . 1.6 p -104.58 -25.53 12.71 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.823 -0.548 . . . . 0.0 111.658 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.68 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.9 t -105.12 150.18 8.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -172.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.645 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 6.3 t -75.49 72.67 2.5 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 175.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.982 ' HA ' ' HD2' ' A' ' 81' ' ' ARG . 7.8 ttt180 56.53 -62.37 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.053 -1.43 . . . . 0.0 113.328 -165.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.821 ' HD2' ' HD3' ' A' ' 96' ' ' ARG . 0.1 OUTLIER -141.25 127.6 19.86 Favored 'General case' 0 C--N 1.308 -1.207 0 O-C-N 120.802 -1.186 . . . . 0.0 112.178 -171.161 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.858 ' CG ' ' HB ' ' A' ' 139' ' ' ILE . 0.0 OUTLIER -78.13 -45.04 24.35 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 171.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.716 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -144.23 174.52 10.82 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.104 179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.716 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.7 pt-20 -138.09 120.13 15.54 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.078 -1.874 . . . . 0.0 106.072 166.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.751 ' HA ' ' O ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.4 93.16 5.93 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.654 0.74 . . . . 0.0 109.55 -171.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.759 ' HB3' HD13 ' A' ' 76' ' ' ILE . 9.3 ptp180 -92.61 134.51 34.93 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.16 -1.382 . . . . 0.0 110.525 -174.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.707 HD12 ' CE2' ' A' ' 108' ' ' PHE . 6.3 tt -85.23 114.08 22.06 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 174.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -124.5 139.86 53.48 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 174.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.83 39.7 1.81 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.902 0.751 . . . . 0.0 112.229 -177.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.694 ' HA ' HD21 ' A' ' 103' ' ' LEU . 8.0 t30 75.23 13.9 3.1 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.825 0.85 . . . . 0.0 112.429 173.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 2.3 mp0 -120.87 140.87 51.19 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 121.922 -0.486 . . . . 0.0 110.413 172.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.707 ' CE2' HD12 ' A' ' 103' ' ' LEU . 2.1 m-85 -89.25 139.92 30.0 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 175.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 32.8 m-80 -143.49 155.98 44.5 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.201 -0.199 . . . . 0.0 110.963 -170.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -103.49 120.74 53.94 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 CA-C-O 121.634 0.731 . . . . 0.0 110.839 179.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.764 HG12 HG13 ' A' ' 113' ' ' VAL . 2.3 t -99.8 118.05 45.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 114.09 -1.414 . . . . 0.0 109.957 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -76.14 119.07 19.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.764 HG13 HG12 ' A' ' 111' ' ' VAL . 5.8 m -121.54 -53.03 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -175.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 95' ' ' SER . . . -171.19 79.02 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.152 -1.023 . . . . 0.0 113.118 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.613 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 32.4 t -91.75 122.64 34.48 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 176.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.753 HD22 ' HB ' ' A' ' 22' ' ' TPO . 16.0 tp -61.78 -54.13 46.51 Favored 'General case' 0 CA--C 1.521 -0.142 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.961 -175.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.573 ' HB2' ' O ' ' A' ' 140' ' ' GLY . 24.2 m-80 -65.92 -38.77 89.56 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 177.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 141.37 157.36 7.14 Favored Glycine 0 C--O 1.241 0.557 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.43 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.454 HG23 ' CE1' ' A' ' 98' ' ' HIS . 16.6 m -111.6 125.63 54.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 122.602 0.361 . . . . 0.0 110.851 174.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 123' ' ' ARG . 65.8 m-85 -139.74 105.53 5.16 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.88 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.935 HG22 HG13 ' A' ' 137' ' ' VAL . 83.4 t -101.77 122.75 54.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 172.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.1 m120 63.71 33.34 13.07 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 120' ' ' TYR . 14.8 mtp-105 52.28 37.78 23.07 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.803 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -148.94 139.44 13.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 120.868 0.366 . . . . 0.0 110.116 171.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.68 122.7 11.13 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.014 1.81 . . . . 0.0 111.278 174.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 25.3 m -114.49 178.03 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.914 -177.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 18.5 t70 -96.71 -58.88 1.93 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.115 0.483 . . . . 0.0 109.844 174.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.857 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 41.8 t -155.81 91.21 1.27 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.051 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.36 149.71 21.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.699 -173.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.73 136.88 21.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.681 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.643 HD23 ' HB2' ' A' ' 146' ' ' PHE . 2.6 tt -56.11 106.67 0.29 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.998 -1.001 . . . . 0.0 109.953 172.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.29 124.37 24.33 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.823 0.344 . . . . 0.0 111.358 -173.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.562 ' OD1' HG22 ' A' ' 148' ' ' THR . 3.4 m-20 -54.23 123.93 14.29 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -172.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 110.44 -20.84 24.88 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.619 168.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.8 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 1.7 t70 -97.26 165.89 11.82 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 117.619 0.71 . . . . 0.0 110.555 -174.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 1.4 pp20? -116.12 156.99 25.46 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.813 0.816 . . . . 0.0 113.023 -175.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.935 HG13 HG22 ' A' ' 121' ' ' VAL . 68.5 t -131.8 130.08 61.49 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-N 114.412 -1.267 . . . . 0.0 109.253 178.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -93.6 113.76 25.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.072 0.463 . . . . 0.0 110.249 174.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.858 ' HB ' ' CG ' ' A' ' 98' ' ' HIS . 0.1 OUTLIER -113.19 124.58 69.97 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.15 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 164.223 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.573 ' O ' ' HB2' ' A' ' 117' ' ' ASN . . . 64.8 -108.13 2.18 Favored Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 119.147 -1.501 . . . . 0.0 109.476 -177.139 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.09 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 7.8 pttt -134.93 21.08 3.5 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.597 0.713 . . . . 0.0 111.354 -174.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.781 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -113.04 143.99 43.37 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -176.968 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.439 ' NE ' ' HA ' ' A' ' 33' ' ' LEU . 5.7 ttm180 -95.65 102.87 14.71 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.865 ' HG ' HG22 ' A' ' 60' ' ' VAL . 5.1 mp -95.78 161.42 14.02 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.535 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.5 HG22 ' CD2' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -140.23 139.46 36.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 172.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.066 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.45 130.67 49.32 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -175.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' CD2' HG22 ' A' ' 145' ' ' VAL . 2.6 mm? -129.82 125.38 35.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 114.979 -1.01 . . . . 0.0 109.76 178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.562 HG22 ' OD1' ' A' ' 133' ' ' ASN . 15.2 t -94.77 -158.31 0.63 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 173.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.498 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . -54.04 121.77 20.46 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.542 179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.69 163.49 38.76 Favored 'Trans proline' 0 C--O 1.236 0.395 0 C-N-CA 122.914 2.409 . . . . 0.0 111.667 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -76.95 51.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.986 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -89.05 81.17 6.86 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -61.4 -32.12 79.85 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.654 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 -92.61 62.99 3.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.437 0.636 . . . . 0.0 111.085 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -113.18 132.34 55.52 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.551 172.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -119.63 21.47 12.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.024 0.916 . . . . 0.0 108.594 174.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.47 -3.04 67.23 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.814 -1.084 . . . . 0.0 112.202 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 27.3 t -52.81 -36.2 58.12 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.249 0.547 . . . . 0.0 109.751 174.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 7.0 m -131.06 50.0 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 171.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -130.6 96.19 0.35 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.474 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -178.95 -148.21 7.54 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.247 0.927 0 C-N-CA 123.109 2.539 . . . . 0.0 112.034 177.409 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.235 0.302 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.9 m -79.51 69.11 5.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.27 -177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -70.33 -40.11 74.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.006 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.418 ' O ' ' HD3' ' A' ' 6' ' ' PRO . 25.1 ttt -124.54 135.85 53.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.512 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -106.8 96.46 14.6 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.888 175.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 4' ' ' MET . 21.3 Cg_exo -66.2 -48.6 2.47 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.309 2.673 . . . . 0.0 113.254 -174.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -109.05 155.28 21.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 110.51 -177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 tt -168.11 124.76 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.083 178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.88 ' HG3' ' HD3' ' A' ' 10' ' ' LYS . 8.3 tp10 73.92 147.48 0.09 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.259 0.624 . . . . 0.0 110.738 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.88 ' HD3' ' HG3' ' A' ' 9' ' ' GLU . 4.1 mppt? 58.02 59.27 3.18 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.074 -172.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -67.19 121.56 15.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.081 -175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 64.64 -84.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 O-C-N 124.227 0.955 . . . . 0.0 112.307 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 p -127.35 108.24 10.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.982 0.42 . . . . 0.0 112.047 -175.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.1 t -151.47 134.31 15.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.18 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.4 t0 68.84 -83.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.912 0.758 . . . . 0.0 111.883 176.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -82.75 67.64 8.9 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.224 0.535 . . . . 0.0 111.288 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.9 t -87.12 -70.38 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.893 -0.781 . . . . 0.0 108.893 172.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.8 m 67.79 -70.75 0.12 Allowed 'General case' 0 CA--C 1.535 0.396 0 O-C-N 123.867 0.73 . . . . 0.0 112.576 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 21' ' ' THR . 7.1 p -91.52 133.06 34.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.28 0.562 . . . . 0.0 110.865 -175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' O ' ' HB ' ' A' ' 21' ' ' THR . 45.0 tt0 -67.21 -34.55 77.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.771 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.48 ' CG2' HD21 ' A' ' 116' ' ' LEU . 33.4 m 76.37 130.2 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.544 0.528 . . . . 0.0 111.16 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.609 ' O1P' HG21 ' A' ' 22' ' ' TPO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 92' ' ' VAL . 18.8 m -0.95 91.69 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.118 1.767 . . . . 0.0 115.049 -177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.654 ' HB ' HD23 ' A' ' 116' ' ' LEU . 9.5 p -129.73 154.91 40.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 O-C-N 121.876 -0.515 . . . . 0.0 112.189 -173.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.6 t80 179.68 -156.51 0.03 OUTLIER 'General case' 0 C--O 1.222 -0.381 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.55 ' HB3' ' H ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 49.65 -105.02 0.16 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.183 0.593 . . . . 0.0 110.274 175.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.692 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 61.0 -174.32 0.13 Allowed 'General case' 0 C--O 1.236 0.387 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 166.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.804 ' HB2' ' HG2' ' A' ' 138' ' ' GLN . 13.6 t70 -77.9 41.51 0.35 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.796 -176.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -136.18 -43.79 0.63 Allowed 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.804 -174.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 63.1 tp -66.09 -10.2 38.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.998 175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 t 78.5 8.72 2.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.163 174.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -77.99 60.56 2.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 110.275 175.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.784 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.2 OUTLIER -137.88 -54.45 0.66 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -178.5 145.11 0.31 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 112.354 -2.203 . . . . 0.0 108.264 178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.21 117.24 41.2 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -45.32 89.17 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.121 3.214 . . . . 0.0 113.702 -174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 173.62 -115.95 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.723 -1.126 . . . . 0.0 108.575 -177.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.826 ' HG2' ' H ' ' A' ' 39' ' ' ALA . 3.0 tt0 63.55 -177.48 0.15 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.413 0.625 . . . . 0.0 111.136 174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.826 ' H ' ' HG2' ' A' ' 38' ' ' GLN . . . -155.18 -37.74 0.09 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.098 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.31 -174.57 29.67 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.559 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -94.89 -2.55 50.45 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.375 0.607 . . . . 0.0 109.643 176.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 70.38 103.2 0.06 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 114.231 -1.35 . . . . 0.0 111.028 178.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -83.59 73.85 10.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.403 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.14 -30.42 67.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.308 177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.79 124.3 56.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.249 177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.3 m -93.82 155.75 17.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.088 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.97 59.75 0.5 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.5 p -130.04 69.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 CA-C-O 122.078 0.942 . . . . 0.0 110.622 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' H ' ' CD2' ' A' ' 51' ' ' LEU . 35.3 tt0 -117.97 -89.3 0.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.685 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' C ' ' HD2' ' A' ' 53' ' ' PRO . . . -97.31 26.08 24.4 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.633 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.792 ' HB2' ' HD3' ' A' ' 52' ' ' PRO . 1.1 mm? -89.17 -54.0 0.33 Allowed Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.792 ' HD3' ' HB2' ' A' ' 51' ' ' LEU . 77.7 Cg_exo -51.08 -34.9 49.22 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.155 1.903 . . . . 0.0 114.001 172.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.61 ' HD2' ' C ' ' A' ' 50' ' ' GLY . 11.9 Cg_exo -72.55 69.61 3.46 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.123 1.882 . . . . 0.0 112.582 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 177.87 -87.77 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 174.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -151.39 138.61 19.29 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -129.14 172.67 11.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.814 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.9 pp -161.07 140.08 10.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 172.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.686 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.7 mp -85.66 111.28 19.95 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 165.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.4 125.56 59.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.018 HG11 HD21 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -71.04 110.63 4.12 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.417 ' HB2' HG13 ' A' ' 145' ' ' VAL . 2.9 tpmt? -64.28 -65.58 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 113.75 -1.568 . . . . 0.0 110.063 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 62' ' ' ARG . 36.4 mtt-85 -146.54 134.75 21.69 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.831 0.824 . . . . 0.0 110.451 177.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.762 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -171.11 -159.7 17.83 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.126 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.4 Cg_exo -62.97 -57.94 0.36 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.96 1.773 . . . . 0.0 112.595 178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.634 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 53.9 t30 -73.04 -53.0 12.26 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.762 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 55.18 165.28 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.317 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.33 3.17 90.7 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.574 -0.822 . . . . 0.0 114.061 170.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.934 ' H ' HG22 ' A' ' 60' ' ' VAL . 5.6 m -100.73 -170.32 1.84 Allowed 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 117.729 0.765 . . . . 0.0 111.033 -169.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.768 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -171.7 154.46 3.68 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 118.19 0.45 . . . . 0.0 112.042 -170.653 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.538 ' HB2' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -95.79 121.6 37.68 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 106.109 -1.811 . . . . 0.0 106.109 165.628 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD23 ' O ' ' A' ' 71' ' ' LEU . 1.1 tt -79.89 92.69 5.54 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.681 0.753 . . . . 0.0 109.469 -176.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.814 ' HG ' ' HA ' ' A' ' 57' ' ' LEU . 5.6 mt -85.23 51.4 2.17 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.367 0.603 . . . . 0.0 109.507 -175.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.523 ' HB3' HD21 ' A' ' 71' ' ' LEU . 22.6 t70 -104.03 -22.18 13.49 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.487 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -104.29 -165.54 1.16 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.018 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -77.42 -39.85 45.56 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.793 -178.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.694 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -159.64 133.1 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.845 0.355 . . . . 0.0 111.534 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 86' ' ' ASP . 70.7 p -111.29 143.94 41.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.762 -178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.659 ' O ' HG23 ' A' ' 87' ' ' ILE . 44.6 m -80.57 123.46 28.14 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 171.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.728 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -122.83 113.37 19.06 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' HD11 ' A' ' 139' ' ' ILE . . . 149.89 -136.96 5.94 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.731 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.71 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -75.4 104.64 6.04 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 174.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.581 ' HD2' ' O ' ' A' ' 87' ' ' ILE . 75.1 m-70 -138.11 119.35 10.43 Favored Pre-proline 0 N--CA 1.439 -0.99 0 C-N-CA 120.142 -0.623 . . . . 0.0 111.807 -175.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.45 -42.7 38.85 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.457 2.104 . . . . 0.0 111.339 171.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -161.95 95.62 0.98 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.366 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 5.9 m -137.76 -100.33 0.19 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.188 174.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 77' ' ' THR . 8.7 m-20 -138.39 -48.15 0.53 Allowed 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -175.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.768 ' HB ' ' O ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -126.64 105.59 14.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.24 178.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -108.16 116.66 32.37 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.293 176.349 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.018 HD21 HG11 ' A' ' 60' ' ' VAL . 12.5 mt -102.67 87.57 3.01 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.635 177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.475 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 25.7 t70 66.88 -2.62 1.08 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.344 -179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.71 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 3.7 p30 40.65 36.44 0.39 Allowed 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 125.189 1.396 . . . . 0.0 113.418 179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 23' ' ' SER . 11.9 p -168.64 44.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 CA-C-O 121.104 0.478 . . . . 0.0 111.421 173.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.703 ' HG1' ' HE1' ' A' ' 142' ' ' PHE . 0.2 OUTLIER -138.11 -5.16 1.67 Allowed 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.13 -0.981 . . . . 0.0 111.987 176.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.686 HG23 ' HA ' ' A' ' 115' ' ' SER . 0.1 OUTLIER -143.16 146.53 21.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.364 -173.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.56 ' HA ' ' O1P' ' A' ' 22' ' ' TPO . 12.2 m -66.5 77.35 0.11 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.811 0.445 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HD3' ' HE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER 64.09 -70.02 0.08 Allowed 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 123.425 0.69 . . . . 0.0 110.79 -174.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 79' ' ' ALA . 2.7 ptp180 -140.41 130.68 25.11 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.801 -0.562 . . . . 0.0 110.737 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 1.092 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.83 -41.01 45.93 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 172.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.873 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -141.58 164.23 30.78 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-N 113.876 -1.511 . . . . 0.0 109.928 179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 76' ' ' ILE . 8.7 pt-20 -129.54 125.7 36.89 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 167.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 0.1 OUTLIER -61.42 99.23 0.1 Allowed 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -174.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.401 HH21 ' CD ' ' A' ' 100' ' ' GLU . 15.9 tpp85 -90.45 96.65 10.76 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.975 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.773 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.4 tt -83.78 104.71 14.1 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -133.51 138.24 46.01 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 37.5 m-80 62.3 31.89 17.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.023 -173.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.773 ' HA ' HD21 ' A' ' 103' ' ' LEU . 7.4 t30 72.58 0.67 3.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.487 0.715 . . . . 0.0 111.831 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 28.2 mm-40 -104.69 139.67 39.18 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.934 -0.479 . . . . 0.0 111.021 -174.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.568 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -89.29 125.35 35.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.367 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.513 HD22 ' C ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -126.04 162.04 26.21 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.336 -178.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.814 ' O ' ' HA ' ' A' ' 128' ' ' SER . 1.4 m -106.71 124.82 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 170.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.873 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 9.2 t -101.77 112.52 35.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.32 178.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 14.1 t70 -74.31 116.4 14.92 Favored 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.57 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.812 HG13 HG12 ' A' ' 111' ' ' VAL . 27.0 m -124.67 -20.7 2.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.409 -177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 156.21 94.31 0.1 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.076 -1.059 . . . . 0.0 113.667 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 1.092 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.3 t -108.64 128.85 55.2 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.654 HD23 ' HB ' ' A' ' 24' ' ' VAL . 44.3 tp -54.55 -54.37 42.19 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.408 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.661 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -65.67 -35.97 82.3 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.492 0.663 . . . . 0.0 109.3 175.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 131.29 170.19 12.59 Favored Glycine 0 C--O 1.257 1.537 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.52 -173.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.429 HG23 ' CE1' ' A' ' 98' ' ' HIS . 34.7 m -112.59 122.48 47.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.485 -0.857 . . . . 0.0 110.967 174.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.406 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 62.5 m-85 -136.59 103.05 5.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 173.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.736 ' HB ' HG13 ' A' ' 137' ' ' VAL . 2.6 p -102.95 110.0 28.34 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.631 HD22 HG22 ' A' ' 121' ' ' VAL . 30.6 m-80 68.7 37.64 2.41 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.499 -171.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 60.84 26.91 16.74 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.8 pt-20 -139.4 140.92 27.14 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 0.0 110.566 173.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 5.6 Cg_exo -79.86 123.42 5.21 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.223 2.616 . . . . 0.0 111.306 174.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 129' ' ' ALA . 34.3 m -118.6 -179.5 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 111.49 -177.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.444 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 28.3 t70 -100.76 -50.33 3.89 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.77 174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.814 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 42.1 t -158.03 91.55 1.12 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.233 -177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 126' ' ' VAL . . . -94.15 138.97 31.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.22 -175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.71 129.56 37.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.823 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.618 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -62.57 161.42 12.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.294 -179.371 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.503 ' HB3' ' HB2' ' A' ' 135' ' ' ASP . . . -160.2 156.11 26.05 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.81 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t-20 -65.77 104.0 0.99 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.086 -179.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.3 5.75 48.86 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.503 ' HB2' ' HB3' ' A' ' 132' ' ' ALA . 16.3 t70 -83.82 118.12 23.73 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.958 0.103 . . . . 0.0 110.795 -177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 53.7 mp0 -94.57 139.6 30.97 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.266 0.555 . . . . 0.0 112.343 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.736 HG13 ' HB ' ' A' ' 121' ' ' VAL . 16.4 t -127.72 132.22 69.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.736 177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.804 ' HG2' ' HB2' ' A' ' 28' ' ' ASP . 54.8 tp60 -95.04 123.44 38.53 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.99 0.424 . . . . 0.0 110.353 174.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.742 HG12 HD12 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -129.76 140.16 49.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 169.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.661 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 69.37 -72.62 0.45 Allowed Glycine 0 C--O 1.216 -0.987 0 C-N-CA 120.256 -0.973 . . . . 0.0 113.865 167.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.126 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 15.9 ptmt -170.49 16.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 117.278 0.539 . . . . 0.0 110.276 174.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.703 ' HE1' ' HG1' ' A' ' 93' ' ' THR . 0.3 OUTLIER -118.82 147.18 44.2 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.182 -169.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -96.02 105.92 18.02 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.9 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.5 mp -98.42 153.7 18.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.82 -0.173 . . . . 0.0 110.978 -178.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 1.9 m -141.42 145.59 24.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 171.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 148' ' ' THR . 63.4 t80 -97.24 134.52 40.43 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.592 HD13 ' O ' ' A' ' 146' ' ' PHE . 1.5 mm? -135.4 141.05 45.4 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.741 166.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.673 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -106.56 -108.01 0.31 Allowed 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 121.099 -0.241 . . . . 0.0 110.887 -177.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 51' ' ' LEU . . . -69.8 135.53 26.63 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.829 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 149' ' ' GLY . 7.2 Cg_exo -73.33 67.25 4.38 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.312 2.674 . . . . 0.0 112.48 -177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.3 tptt -67.42 117.15 9.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.929 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -95.14 109.56 21.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -98.39 90.4 1.03 Allowed Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 176.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -95.46 -177.87 4.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.879 0.371 . . . . 0.0 111.082 -174.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.56 85.62 6.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.478 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -93.01 143.07 26.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.897 178.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -134.98 81.12 0.3 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.614 -178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.4 m -72.46 110.34 6.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.819 0.342 . . . . 0.0 110.116 176.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 2.2 t -103.04 91.21 4.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.586 0.708 . . . . 0.0 110.251 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -170.18 52.07 0.2 Allowed Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.067 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 162' ' ' PRO . . . -78.88 -86.23 0.52 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.267 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 161' ' ' GLY . 2.7 Cg_exo . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.101 2.534 . . . . 0.0 111.086 175.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.0 m . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 121.595 0.712 . . . . 0.0 109.955 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 16.5 p -84.28 30.16 0.55 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.34 -173.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 59.03 28.84 18.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.459 0.647 . . . . 0.0 110.454 -176.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 26.2 mmt -113.8 127.51 56.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.438 178.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -87.12 123.35 70.25 Favored Pre-proline 0 C--N 1.32 -0.689 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -57.67 114.17 1.83 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 123.353 2.702 . . . . 0.0 113.097 -175.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -84.27 85.94 7.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.769 176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.0 tt -115.13 119.18 61.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-O 121.25 0.548 . . . . 0.0 111.306 -176.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -96.57 153.23 17.97 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 170.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 10' ' ' LYS . 22.5 tptp -79.17 110.1 14.12 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.501 -174.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 12' ' ' GLN . 5.1 t70 67.51 -169.75 0.19 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.76 175.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' H ' ' CG ' ' A' ' 11' ' ' ASP . 25.4 tt0 -161.29 102.11 1.23 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -177.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.85 124.01 20.41 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.214 176.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 m -46.22 -64.27 0.79 Allowed 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.843 0.715 . . . . 0.0 112.566 -171.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -162.38 149.42 13.57 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.671 0.272 . . . . 0.0 110.939 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -135.46 116.43 14.22 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.5 176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.0 m -87.97 140.35 15.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.296 0.569 . . . . 0.0 111.618 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 m -92.12 -17.66 24.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.767 0.794 . . . . 0.0 109.05 171.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.724 HG22 ' H ' ' A' ' 20' ' ' GLU . 8.2 p -83.36 -179.79 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.514 175.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.724 ' H ' HG22 ' A' ' 19' ' ' VAL . 34.0 mm-40 67.18 25.29 9.03 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.515 0.674 . . . . 0.0 110.55 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.0 m -82.73 137.27 34.46 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.044 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.849 ' HB ' HD22 ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 93' ' ' THR . 8.4 m -79.44 106.95 11.84 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 122.533 0.333 . . . . 0.0 111.729 -172.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.765 ' HB ' HD23 ' A' ' 116' ' ' LEU . 5.3 p -136.64 155.18 33.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -177.92 -147.61 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.646 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 46.33 -113.69 0.45 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.186 0.594 . . . . 0.0 109.926 177.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.758 ' HA ' ' NE2' ' A' ' 138' ' ' GLN . . . 63.62 173.27 0.17 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 114.455 1.279 . . . . 0.0 114.455 167.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.958 ' HA ' HD22 ' A' ' 33' ' ' LEU . 8.5 t70 -76.72 60.38 1.69 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.424 -178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -150.46 -44.03 0.12 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.207 -178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.2 tp -73.94 -66.77 0.67 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.583 -1.189 . . . . 0.0 112.765 -174.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.1 t -167.21 -72.77 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.431 -0.508 . . . . 0.0 112.035 -168.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 26' ' ' ARG . 8.8 mm-40 -78.79 108.83 12.51 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.779 0.323 . . . . 0.0 111.221 -177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.958 HD22 ' HA ' ' A' ' 28' ' ' ASP . 0.3 OUTLIER -166.27 -40.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.748 -174.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.02 122.92 45.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.316 0.579 . . . . 0.0 111.463 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.663 ' HB3' ' HD3' ' A' ' 36' ' ' PRO . . . -106.28 -55.3 0.07 OUTLIER Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.329 179.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.663 ' HD3' ' HB3' ' A' ' 35' ' ' ALA . 12.8 Cg_exo -69.95 109.05 2.25 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.06 1.84 . . . . 0.0 112.587 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.48 133.5 48.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 64.41 87.56 0.11 Allowed 'General case' 0 C--O 1.235 0.31 0 O-C-N 123.639 0.587 . . . . 0.0 109.881 -172.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.86 117.7 5.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 79.34 65.87 1.75 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -176.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.5 t -79.25 -9.73 59.64 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.242 0.544 . . . . 0.0 110.666 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -156.15 161.73 40.3 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.951 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.8 m -69.51 84.05 0.42 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.34 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.75 57.27 3.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.284 0.564 . . . . 0.0 110.487 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.6 m -88.33 12.82 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.766 -178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 m -143.13 100.7 3.69 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.459 -0.792 . . . . 0.0 109.485 177.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.79 -35.13 0.57 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.12 -176.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.618 HG23 HD11 ' A' ' 51' ' ' LEU . 6.8 p -119.6 67.98 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 122.545 1.164 . . . . 0.0 109.956 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -142.68 -63.82 0.42 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.937 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -84.79 48.39 4.04 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.127 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.618 HD11 HG23 ' A' ' 48' ' ' VAL . 4.1 mt -86.14 115.91 63.75 Favored Pre-proline 0 N--CA 1.445 -0.681 0 C-N-CA 122.265 0.226 . . . . 0.0 111.12 179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.627 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 18.7 Cg_endo -63.45 -32.94 70.66 Favored 'Trans proline' 0 CA--C 1.553 1.442 0 C-N-CA 122.3 2.0 . . . . 0.0 114.93 169.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' CD ' ' A' ' 52' ' ' PRO . 31.4 Cg_endo -98.59 170.52 0.59 Allowed 'Trans proline' 0 C--N 1.365 1.44 0 C-N-CA 122.3 2.0 . . . . 0.0 112.769 -175.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -100.6 14.16 59.28 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.625 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.446 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 4.0 p -149.85 144.56 26.04 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 146' ' ' PHE . . . -125.95 172.69 9.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.628 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 3.3 pp -160.31 140.55 11.54 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.698 ' O ' ' HA ' ' A' ' 69' ' ' ARG . 2.4 mp -86.06 112.93 21.72 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.704 -1.589 . . . . 0.0 108.152 166.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 68' ' ' SER . 3.3 p -103.13 125.75 57.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.212 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.967 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -71.07 114.69 9.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 176.151 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -68.87 -69.72 0.31 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.331 -170.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.0 mtm180 -147.54 131.07 16.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.406 0.622 . . . . 0.0 110.268 -179.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.707 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -176.13 -150.16 7.95 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.028 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 37.5 Cg_exo -62.07 -64.44 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.284 1.989 . . . . 0.0 112.867 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 90' ' ' ASP . 54.9 t30 -76.31 -52.51 9.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.707 ' HB2' ' H ' ' A' ' 63' ' ' GLY . . . 52.9 169.25 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 113.49 -1.686 . . . . 0.0 113.5 -172.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.94 2.24 90.5 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.037 -0.602 . . . . 0.0 114.011 172.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.967 ' H ' HG22 ' A' ' 60' ' ' VAL . 10.3 m -94.66 -178.03 4.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.34 0.57 . . . . 0.0 110.838 -170.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -169.14 149.25 4.17 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.259 0.481 . . . . 0.0 111.726 -173.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.497 ' N ' ' HD1' ' A' ' 70' ' ' PHE . 0.4 OUTLIER -94.35 121.9 36.36 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 174.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -79.86 94.58 5.86 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -175.382 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.705 HD22 ' CG ' ' A' ' 101' ' ' PHE . 6.0 mt -90.04 46.59 1.37 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.712 -0.795 . . . . 0.0 109.867 -175.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.466 ' HB3' HD11 ' A' ' 71' ' ' LEU . 7.8 t70 -99.34 -24.12 14.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.277 178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.57 HE21 HG22 ' A' ' 77' ' ' THR . 21.4 pt20 -102.33 -166.65 1.31 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.531 178.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.24 -37.63 60.95 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.419 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -159.99 131.47 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.576 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 11.3 p -119.12 127.21 53.14 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.375 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 87' ' ' ILE . 66.5 m -76.45 132.7 39.79 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.626 ' HB1' HG12 ' A' ' 87' ' ' ILE . . . -126.27 120.98 31.34 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -170.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.11 -127.89 2.61 Favored Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.829 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.1 tmm_? -73.82 105.77 5.25 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.903 0.859 . . . . 0.0 109.612 175.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.542 ' HB2' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -137.01 134.72 19.16 Favored Pre-proline 0 N--CA 1.436 -1.159 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.465 -169.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 82' ' ' HIS . 30.3 Cg_exo -65.59 -67.72 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.581 2.187 . . . . 0.0 113.132 173.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -156.01 9.35 0.25 Allowed 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -174.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 2.9 p -77.53 -88.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -174.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.539 ' HB3' ' CG2' ' A' ' 77' ' ' THR . 0.2 OUTLIER -105.33 -76.73 0.6 Allowed 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.378 0.609 . . . . 0.0 111.653 -170.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.707 HD11 HD21 ' A' ' 89' ' ' LEU . 0.1 OUTLIER -128.46 110.11 20.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.89 -173.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.542 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -110.63 132.27 54.33 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.341 -178.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.943 ' HG ' HD11 ' A' ' 139' ' ' ILE . 4.4 mm? -119.85 78.69 1.36 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.614 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 65' ' ' ASN . 36.0 t0 68.75 -6.34 0.87 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.508 0.67 . . . . 0.0 109.93 178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.829 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 4.4 p-10 41.89 32.86 0.3 Allowed 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.422 1.489 . . . . 0.0 113.258 178.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 22' ' ' TPO . 5.7 p -144.91 8.06 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 C-N-CA 120.003 -0.679 . . . . 0.0 112.089 -179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.511 HG21 ' HD3' ' A' ' 141' ' ' LYS . 0.1 OUTLIER -124.19 -19.84 5.45 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.391 -177.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.653 ' HB ' ' H ' ' A' ' 81' ' ' ARG . 2.3 t -109.16 152.49 11.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -173.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.446 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 49.3 m -77.2 66.25 2.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.772 0.32 . . . . 0.0 110.454 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HE ' ' CE1' ' A' ' 82' ' ' HIS . 0.0 OUTLIER 67.43 -56.51 0.45 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.976 -173.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.567 ' HG2' HG21 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -146.54 147.04 30.74 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.78 0.8 . . . . 0.0 110.64 175.427 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.684 ' HB2' ' OG ' ' A' ' 115' ' ' SER . 0.0 OUTLIER -90.53 -40.75 11.79 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.244 -1.344 . . . . 0.0 107.912 170.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.855 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -151.15 142.62 23.48 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.58 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.654 ' HB2' HD11 ' A' ' 76' ' ' ILE . 3.5 pt-20 -109.72 120.83 43.71 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 169.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.705 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -54.92 104.1 0.11 Allowed 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 113.762 -1.563 . . . . 0.0 108.537 -174.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.478 ' HG3' ' HG3' ' A' ' 104' ' ' GLU . 10.4 tpp180 -96.01 107.12 19.37 Favored 'General case' 0 N--CA 1.42 -1.95 0 C-N-CA 119.687 -0.805 . . . . 0.0 109.662 -176.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.85 HD21 ' HA ' ' A' ' 106' ' ' ASN . 7.7 tt -89.27 107.28 18.97 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.796 177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.478 ' HG3' ' HG3' ' A' ' 102' ' ' ARG . 34.8 mt-10 -128.53 137.76 51.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.074 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 57.19 34.11 24.32 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.483 0.49 . . . . 0.0 110.314 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.85 ' HA ' HD21 ' A' ' 103' ' ' LEU . 19.5 t-20 61.29 33.37 19.03 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.089 -0.959 . . . . 0.0 111.159 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 48.6 mt-10 -125.28 135.07 52.13 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.745 175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.528 ' CB ' HD13 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -86.75 120.19 27.78 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 178.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -122.64 159.77 27.17 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.879 ' O ' ' HA ' ' A' ' 128' ' ' SER . 3.0 m -107.77 127.86 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 C-N-CA 119.981 -0.687 . . . . 0.0 110.581 173.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.855 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 5.1 t -100.37 111.09 28.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.342 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 98' ' ' HIS . 12.4 t70 -76.65 114.06 14.97 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.567 HG21 ' HG2' ' A' ' 97' ' ' ARG . 24.1 m -105.24 -20.21 6.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 121.34 0.59 . . . . 0.0 110.331 -177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 125.32 91.93 0.88 Allowed Glycine 0 N--CA 1.433 -1.553 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.442 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.684 ' OG ' ' HB2' ' A' ' 98' ' ' HIS . 0.7 OUTLIER -80.4 162.16 24.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 174.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 22' ' ' TPO . 50.3 tp -61.68 -55.47 30.13 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 118.566 -1.253 . . . . 0.0 111.564 176.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.684 HD22 ' HB1' ' A' ' 27' ' ' ALA . 18.6 p-10 -69.02 -37.6 78.74 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.246 0.546 . . . . 0.0 110.301 177.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.48 ' H ' ' HB2' ' A' ' 115' ' ' SER . . . 127.24 169.98 12.79 Favored Glycine 0 C--O 1.254 1.374 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.845 -172.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.2 m -112.1 136.58 51.3 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 123.632 0.773 . . . . 0.0 111.118 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.514 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.4 m-85 -138.05 104.68 5.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 172.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.753 HG22 HG13 ' A' ' 137' ' ' VAL . 47.2 t -94.52 105.99 17.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.69 HD22 HG12 ' A' ' 121' ' ' VAL . 20.4 m-80 56.61 43.03 26.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.412 -174.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' ASN . 0.0 OUTLIER 76.82 -6.9 1.94 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.23 -0.895 . . . . 0.0 112.969 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.433 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 12.6 pt-20 -119.2 123.92 28.52 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.379 0.609 . . . . 0.0 111.339 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 17.1 Cg_exo -67.62 123.15 10.43 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.645 2.23 . . . . 0.0 111.695 176.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 m -111.68 175.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.633 -0.258 . . . . 0.0 110.802 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 31.5 t70 -96.1 -45.81 6.73 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.879 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.1 t -162.77 105.7 1.07 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.82 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.56 136.33 50.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.332 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 25.1 t -69.57 129.39 33.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.372 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.648 ' HB3' ' CD2' ' A' ' 146' ' ' PHE . 0.7 OUTLIER -63.9 159.89 18.8 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.043 177.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.419 ' O ' ' HD2' ' A' ' 146' ' ' PHE . . . -161.44 152.61 18.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.26 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -64.45 105.32 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.169 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 107.33 4.32 35.21 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.604 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.81 136.17 34.74 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' VAL . 14.7 tt0 -122.52 134.01 54.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.369 0.604 . . . . 0.0 111.432 -174.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.753 HG13 HG22 ' A' ' 121' ' ' VAL . 24.8 t -129.61 141.28 46.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.159 -174.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.758 ' NE2' ' HA ' ' A' ' 27' ' ' ALA . 53.3 tp60 -99.4 128.19 45.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.391 172.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.943 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -135.0 138.38 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 171.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.606 ' HA3' HG22 ' A' ' 94' ' ' VAL . . . 73.72 -69.08 1.52 Allowed Glycine 0 C--O 1.223 -0.548 0 C-N-CA 120.135 -1.031 . . . . 0.0 113.468 165.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.028 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 17.9 ptmt -176.38 16.91 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 171.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.664 ' CD2' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -117.4 149.95 39.68 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.817 -171.577 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.479 HH11 ' HB2' ' A' ' 35' ' ' ALA . 7.8 ttm180 -92.99 129.2 38.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 176.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.775 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.2 mp -124.04 152.57 42.49 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 120.804 0.335 . . . . 0.0 111.743 -177.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -141.73 143.58 26.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.99 170.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.689 ' CZ ' ' HB ' ' A' ' 148' ' ' THR . 45.8 t80 -100.87 136.58 40.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.892 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 146' ' ' PHE . 2.4 mm? -130.68 149.04 52.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.58 170.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.689 ' HB ' ' CZ ' ' A' ' 146' ' ' PHE . 13.8 t -143.49 143.86 31.74 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.627 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . 55.99 56.02 26.19 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.857 -0.687 . . . . 0.0 111.915 -172.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 149' ' ' GLY . 9.5 Cg_endo -89.05 98.47 0.35 Allowed 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.035 2.49 . . . . 0.0 112.479 -174.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 149' ' ' GLY . 0.0 OUTLIER -132.27 127.46 35.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.108 0.48 . . . . 0.0 110.295 174.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -117.35 57.04 0.81 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -77.42 146.87 32.11 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.752 -178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.09 106.86 3.41 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.3 0.572 . . . . 0.0 109.628 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -77.49 73.0 4.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.551 -172.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 t70 50.4 77.63 0.12 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.503 175.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -163.12 134.26 3.35 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.241 -0.98 . . . . 0.0 113.131 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.0 t -134.67 18.95 3.56 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 174.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 10.3 t -86.45 68.34 10.17 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 122.308 1.051 . . . . 0.0 110.645 -175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -112.73 51.42 0.7 Allowed Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.669 177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.82 134.27 3.63 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.088 -178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 C--O 1.249 1.044 0 C-N-CA 123.147 2.565 . . . . 0.0 111.619 178.269 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 C--O 1.232 0.174 0 CA-C-O 121.013 0.435 . . . . 0.0 111.513 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 24.6 p -87.11 49.63 1.86 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.65 133.12 55.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.241 0.543 . . . . 0.0 111.398 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.6 mtt -90.88 64.76 5.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.349 -177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -121.02 91.86 48.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.74 179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.08 89.14 1.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 123.01 2.473 . . . . 0.0 112.633 -177.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -88.81 -17.38 29.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.49 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.59 HD13 ' HA ' ' A' ' 15' ' ' ASP . 5.7 tp -82.39 82.37 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 122.021 0.915 . . . . 0.0 110.411 179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -90.37 -45.95 8.69 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.159 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -82.72 93.62 7.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.354 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -106.86 75.6 1.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.562 0.696 . . . . 0.0 110.774 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 12' ' ' GLN . 6.7 tp60 -139.03 -46.03 0.47 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -88.55 141.86 28.18 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.482 166.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.5 p -56.93 98.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.776 -175.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.59 ' HA ' HD13 ' A' ' 8' ' ' ILE . 2.2 m-20 58.76 22.4 10.01 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.485 -177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 50.87 42.55 28.07 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.166 -177.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 64.2 t -80.63 73.77 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.825 0.821 . . . . 0.0 110.059 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 m -110.09 93.94 4.76 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.266 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -41.97 -71.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 O-C-N 124.128 0.892 . . . . 0.0 112.162 -170.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -146.76 -100.06 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -163.37 128.98 3.12 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TPO . . . . . 0.692 ' HB ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.682 ' O ' ' HA ' ' A' ' 93' ' ' THR . 15.2 m -54.35 120.12 6.13 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -165.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.686 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.7 p -144.28 168.68 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.047 -169.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 9.3 t80 171.91 -147.0 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -177.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.712 ' HB3' ' HB2' ' A' ' 141' ' ' LYS . 0.0 OUTLIER 43.26 -107.37 0.1 Allowed 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.922 0.764 . . . . 0.0 110.554 174.581 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.574 ' N ' ' HD2' ' A' ' 26' ' ' ARG . . . 63.5 176.59 0.16 Allowed 'General case' 0 C--O 1.236 0.39 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 169.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.906 ' HA ' HD21 ' A' ' 33' ' ' LEU . 9.9 t70 -94.82 79.46 3.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.517 -170.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -137.58 -90.46 0.24 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.434 176.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 30' ' ' LEU . 2.2 pt? -126.75 -0.24 6.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 111.038 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.3 m -62.98 -86.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.186 -171.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -121.85 50.72 1.4 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.933 0.873 . . . . 0.0 110.546 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.906 HD21 ' HA ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -161.91 -143.86 0.09 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.79 173.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.7 t70 62.13 86.03 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.355 0.598 . . . . 0.0 109.649 -175.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . . . -138.13 147.34 55.63 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.6 -174.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 35' ' ' ALA . 32.6 Cg_exo -59.63 103.65 0.2 Allowed 'Trans proline' 0 C--O 1.236 0.408 0 C-N-CA 122.85 2.366 . . . . 0.0 111.653 176.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 112.0 4.6 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.16 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -85.91 -60.3 2.05 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.25 178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.47 ' HA ' ' OE2' ' A' ' 42' ' ' GLU . . . 56.35 77.64 0.24 Allowed 'General case' 0 C--O 1.232 0.152 0 O-C-N 123.632 0.582 . . . . 0.0 110.526 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.06 -125.24 0.67 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 -177.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 m -87.6 40.68 0.94 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.905 0.86 . . . . 0.0 110.156 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' A' ' 39' ' ' ALA . 35.5 mt-10 -82.3 57.26 3.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.179 177.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 m -93.84 100.51 12.68 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.915 -175.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.6 131.96 43.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.047 177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.35 -15.13 17.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.98 0.419 . . . . 0.0 111.016 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 70.7 m -154.67 112.74 3.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.87 175.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.64 ' HA2' ' ND2' ' A' ' 133' ' ' ASN . . . -95.81 -57.81 1.15 Allowed Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 178.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.424 ' HA ' HD21 ' A' ' 51' ' ' LEU . 2.3 m -137.58 51.11 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.911 -0.645 . . . . 0.0 110.244 172.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -120.02 -86.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.427 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -86.63 51.86 4.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.371 -178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.781 HD22 HG23 ' A' ' 148' ' ' THR . 34.6 mt -64.65 121.02 70.78 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 122.678 0.391 . . . . 0.0 111.375 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.67 ' HD2' ' HA3' ' A' ' 149' ' ' GLY . 71.3 Cg_endo -109.78 46.01 0.02 OUTLIER 'Trans proline' 0 CA--C 1.548 1.187 0 C-N-CA 123.633 2.889 . . . . 0.0 114.527 172.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.614 ' HB3' ' H ' ' A' ' 149' ' ' GLY . 66.0 Cg_endo -96.07 145.07 1.13 Allowed 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 121.855 1.703 . . . . 0.0 113.284 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -87.32 -28.75 24.13 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 170.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.451 ' HB3' ' HB2' ' A' ' 73' ' ' ASP . 1.4 m -146.53 152.28 38.71 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 131' ' ' LEU . . . -124.59 170.64 10.73 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 176.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.64 ' HA ' ' HG ' ' A' ' 72' ' ' LEU . 2.7 pt? -159.87 137.1 9.54 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.75 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.078 ' HG ' ' HB3' ' A' ' 146' ' ' PHE . 6.0 mp -87.08 111.41 20.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 113.665 -1.607 . . . . 0.0 108.275 161.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 69' ' ' ARG . 3.9 p -108.73 128.83 64.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.444 -175.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.005 HG22 ' H ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -72.19 109.01 4.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.843 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HB2' ' CG1' ' A' ' 145' ' ' VAL . 35.0 ttpt -61.96 -60.55 3.46 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 112.903 -1.953 . . . . 0.0 110.511 -175.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.4 ttp180 -149.93 115.47 5.53 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.506 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.583 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -144.9 -166.15 11.49 Favored Glycine 0 N--CA 1.432 -1.576 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 1.031 ' HG2' ' HG3' ' A' ' 141' ' ' LYS . 23.0 Cg_exo -64.3 -46.6 7.41 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.698 1.599 . . . . 0.0 111.572 179.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.819 ' HB2' ' HE2' ' A' ' 142' ' ' PHE . 41.7 t30 -74.69 -50.43 17.63 Favored 'General case' 0 CA--C 1.511 -0.545 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.598 ' HA ' HG23 ' A' ' 60' ' ' VAL . . . 56.05 155.44 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 113.633 -1.622 . . . . 0.0 113.359 -175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.09 2.42 90.45 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.11 174.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 1.005 ' H ' HG22 ' A' ' 60' ' ' VAL . 4.2 m -88.22 -179.83 6.23 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 117.397 0.598 . . . . 0.0 109.996 -171.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -170.86 151.78 3.48 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.861 0.755 . . . . 0.0 112.107 -173.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.759 ' HA ' ' HB ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -93.94 125.49 38.6 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 172.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.58 ' O ' HD13 ' A' ' 71' ' ' LEU . 1.1 tm? -80.9 94.89 6.58 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.805 HD22 ' CG ' ' A' ' 101' ' ' PHE . 5.2 mt -91.52 50.75 1.77 Allowed 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.711 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.504 ' HB3' HD11 ' A' ' 71' ' ' LEU . 23.7 t70 -104.79 -21.88 13.28 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.923 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.434 HE21 HG22 ' A' ' 77' ' ' THR . 9.9 pt20 -103.29 -167.78 1.43 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.42 -39.0 59.48 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.747 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.72 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -156.78 130.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -177.618 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.496 HG22 ' OD2' ' A' ' 86' ' ' ASP . 22.3 p -118.99 132.03 56.04 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.361 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 87' ' ' ILE . 69.6 m -73.99 126.33 30.23 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' HG23 ' A' ' 87' ' ' ILE . . . -118.5 116.34 26.46 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -176.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 89' ' ' LEU . . . 157.94 -139.58 6.45 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.21 178.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -78.51 104.1 8.89 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.568 ' HE1' ' HD2' ' A' ' 96' ' ' ARG . 68.1 m-70 -136.85 118.08 11.13 Favored Pre-proline 0 C--N 1.315 -0.933 0 C-N-CA 120.032 -0.667 . . . . 0.0 112.291 -171.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.04 -42.77 10.33 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.12 1.88 . . . . 0.0 110.618 162.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -129.9 118.49 21.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.347 175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.459 ' OG ' ' HB2' ' A' ' 78' ' ' SER . 4.2 m 174.4 -175.55 0.08 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.8 1.24 . . . . 0.0 108.092 174.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 71' ' ' LEU . 16.8 m-20 -89.89 -36.93 14.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.029 0.442 . . . . 0.0 111.446 177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.759 ' HB ' ' HA ' ' A' ' 70' ' ' PHE . 0.3 OUTLIER -114.2 100.0 9.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.808 0.814 . . . . 0.0 111.755 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.93 134.41 50.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.366 173.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.015 ' HG ' HD11 ' A' ' 139' ' ' ILE . 2.9 mm? -115.21 73.15 0.82 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.833 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 33.5 t70 68.23 -5.01 0.95 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.544 0.688 . . . . 0.0 110.175 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 81' ' ' ARG . 6.0 p-10 38.06 42.42 0.46 Allowed 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.647 1.579 . . . . 0.0 113.133 -177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.652 ' O ' HG23 ' A' ' 22' ' ' TPO . 18.5 t -142.81 -11.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 23' ' ' SER . 0.8 OUTLIER -113.09 -12.16 13.22 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 -170.072 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 81' ' ' ARG . 0.9 OUTLIER -135.64 150.88 29.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 121.872 -0.518 . . . . 0.0 110.986 -170.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.637 ' HA ' ' P ' ' A' ' 22' ' ' TPO . 2.5 m -69.15 71.97 0.27 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.231 0.613 . . . . 0.0 112.63 -171.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.74 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 0.0 OUTLIER 62.34 -54.69 0.15 Allowed 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.426 0.69 . . . . 0.0 111.493 -174.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.74 ' HB3' ' NE ' ' A' ' 96' ' ' ARG . 3.5 ttm180 -155.63 124.67 6.15 Favored 'General case' 0 C--N 1.307 -1.247 0 O-C-N 121.687 -0.633 . . . . 0.0 110.84 -178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.978 ' HB2' ' HB2' ' A' ' 115' ' ' SER . 0.0 OUTLIER -76.62 -40.56 48.96 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.014 176.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.79 ' HA ' ' O ' ' A' ' 111' ' ' VAL . . . -150.39 149.32 29.89 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-N 114.308 -1.315 . . . . 0.0 109.168 -178.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.472 ' O ' HG22 ' A' ' 111' ' ' VAL . 5.3 pt-20 -113.11 130.58 56.13 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.805 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -63.42 101.06 0.29 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.43 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.508 ' NH2' HG21 ' A' ' 111' ' ' VAL . 19.6 ttm180 -100.55 114.12 27.5 Favored 'General case' 0 N--CA 1.418 -2.063 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.571 -178.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 108' ' ' PHE . 14.7 tp -75.64 109.06 8.9 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.472 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -112.37 123.98 51.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.473 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 106' ' ' ASN . 7.5 p30 42.47 44.26 3.44 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 124.049 0.843 . . . . 0.0 111.806 -176.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.419 ' HB3' ' O ' ' A' ' 105' ' ' ASN . 8.0 t30 75.7 0.18 3.33 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.149 173.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.6 mm-40 -104.5 133.13 49.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.646 ' HB3' ' CE1' ' A' ' 101' ' ' PHE . 0.9 OUTLIER -85.79 131.92 34.22 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 -172.593 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.556 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 14.2 m-80 -134.1 171.21 14.53 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.83 ' O ' ' HA ' ' A' ' 128' ' ' SER . 2.3 m -110.1 156.58 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.561 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 168.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.79 ' O ' ' HA ' ' A' ' 99' ' ' ALA . 27.0 m -126.28 117.64 49.13 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 170.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -73.77 116.77 14.76 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.642 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.426 HG21 ' HD2' ' A' ' 97' ' ' ARG . 31.5 m -123.42 -22.06 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.764 0.316 . . . . 0.0 111.366 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 158.82 102.41 0.18 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.049 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.978 ' HB2' ' HB2' ' A' ' 98' ' ' HIS . 29.9 t -115.81 133.53 55.93 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.692 ' HG ' ' HB ' ' A' ' 22' ' ' TPO . 2.7 tm? -56.44 -55.46 33.32 Favored 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.626 ' HB3' ' O ' ' A' ' 140' ' ' GLY . 0.2 OUTLIER -68.63 -36.02 78.07 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 173.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 136.06 170.64 12.08 Favored Glycine 0 C--O 1.251 1.205 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.866 -172.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.2 m -112.04 133.22 54.34 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.036 0.535 . . . . 0.0 110.753 175.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.647 ' HB2' ' HB3' ' A' ' 138' ' ' GLN . 45.1 m-85 -138.19 103.35 4.91 Favored 'General case' 0 C--O 1.22 -0.473 0 CA-C-O 120.938 0.399 . . . . 0.0 111.043 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.794 HG22 HG13 ' A' ' 137' ' ' VAL . 55.2 t -98.61 123.11 50.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 107.953 -1.129 . . . . 0.0 107.953 173.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.2 m120 64.1 33.33 12.09 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 33.8 ttp180 61.32 28.01 17.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.953 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 121' ' ' VAL . 12.7 pt-20 -146.47 150.9 42.05 Favored Pre-proline 0 C--N 1.33 -0.27 0 O-C-N 121.65 -0.656 . . . . 0.0 111.025 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -72.15 125.7 11.1 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.572 2.181 . . . . 0.0 111.88 176.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.3 m -120.24 179.01 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.741 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -106.55 -47.35 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.3 0.572 . . . . 0.0 109.808 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.83 ' HA ' ' O ' ' A' ' 110' ' ' VAL . 22.8 t -158.16 91.75 1.12 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.946 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -98.56 136.65 38.36 Favored 'General case' 0 CA--C 1.512 -0.513 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.616 -176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.94 150.51 5.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.919 -177.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.725 HD12 HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -63.72 119.41 9.87 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.307 175.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.61 121.89 25.11 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . 0.64 ' ND2' ' HA2' ' A' ' 47' ' ' GLY . 9.4 p30 -61.2 118.88 7.41 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.743 0.782 . . . . 0.0 111.939 -171.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 109.31 -13.1 33.6 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.216 -0.902 . . . . 0.0 113.254 174.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.798 ' HB3' ' HE1' ' A' ' 146' ' ' PHE . 2.3 t0 -96.63 173.01 7.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . 0.703 ' HB2' ' O ' ' A' ' 144' ' ' LEU . 5.2 pt-20 -139.74 151.87 46.18 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 120.172 -0.611 . . . . 0.0 112.572 -168.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.794 HG13 HG22 ' A' ' 121' ' ' VAL . 39.8 t -127.56 141.57 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.481 -177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.783 ' HB2' ' HB2' ' A' ' 28' ' ' ASP . 6.3 tp-100 -98.28 129.64 44.99 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.944 0.402 . . . . 0.0 110.517 169.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 1.015 HD11 ' HG ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -134.55 133.51 54.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 166.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 117' ' ' ASN . . . 71.03 -77.14 0.56 Allowed Glycine 0 C--O 1.215 -1.04 0 C-N-CA 119.726 -1.226 . . . . 0.0 112.956 172.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 1.031 ' HG3' ' HG2' ' A' ' 64' ' ' PRO . 12.9 ptmt -168.03 25.02 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 117.516 0.658 . . . . 0.0 110.755 173.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.819 ' HE2' ' HB2' ' A' ' 65' ' ' ASN . 0.1 OUTLIER -115.81 141.43 48.1 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -173.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . 0.451 ' HD3' HD22 ' A' ' 33' ' ' LEU . 5.5 ttp85 -94.9 106.32 18.3 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.096 -0.642 . . . . 0.0 109.312 174.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.884 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 5.3 mp -99.4 159.51 14.96 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.803 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 136' ' ' GLU . 0.2 OUTLIER -140.9 142.02 30.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 1.078 ' HB3' ' HG ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -110.49 138.4 46.92 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.283 0.563 . . . . 0.0 112.326 -178.06 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.418 ' N ' HD21 ' A' ' 131' ' ' LEU . 2.8 mm? -127.96 145.53 50.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.156 178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.781 HG23 HD22 ' A' ' 51' ' ' LEU . 10.9 t -135.46 151.06 50.03 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.67 ' HA3' ' HD2' ' A' ' 52' ' ' PRO . . . 60.65 61.94 6.5 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.409 -175.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.67 118.62 5.79 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.519 2.146 . . . . 0.0 111.737 -178.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -75.65 60.68 1.28 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.646 0.736 . . . . 0.0 110.974 179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -148.53 177.59 9.35 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.737 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . . . . . . . . . . . -150.6 81.8 0.18 Allowed Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -101.93 111.42 23.67 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -136.59 160.89 37.43 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -110.23 6.03 22.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.823 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -138.8 -71.07 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.64 -1.267 . . . . 0.0 113.953 -171.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 74.5 m 56.37 46.96 19.96 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.597 . . . . 0.0 109.829 -171.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 4.9 p -80.83 102.3 9.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.198 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -106.99 -88.35 2.02 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.12 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 146.36 -160.12 28.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.116 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo . . . . . 0 C--O 1.25 1.106 0 C-N-CA 123.02 2.48 . . . . 0.0 111.672 178.586 . . . . . . . . 0 0 . 1 stop_ save_